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the Physiological Adaptation to Spaceflight
Joel I. Leonard
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Houston, Texas 77030 
Preface 
This book is a summary of interdisciplinary 
research (physiology, space medicine, 
engineering, computer science, mathematics) that 
spans two decades (1972-1992).  The research was 
an attempt to use systems analysis, mathematical 
modeling, computer simulations, and database 
systems to integrate the biomedical spaceflight 
data that was being collected during this period.  
The goal of the effort was to achieve a better 
understanding of the human physiological 
response to short-term and long-term space travel.   
The activity was primarily devoted to analyzing 
the biomedical results of  Skylab (1973-74), a 
series of three space missions which is still ranked 
as the most comprehensive of all long-term 
biomedical space studies to date. 
This work was begun as a coordinated effort 
between the National Aeronautics and Space 
Administration (Johnson Space Center) and the 
General Electric Company’s Space Division 
(Houston, TX).  It was the intent that this multi-
disciplined, integrative approach could reveal 
aspects of the then-new science of microgravity 
adaptation that were not obvious by adhering to 
the traditional methodology of examining each 
organ system in isolation.  Some joint work with 
the Russians, including the Apollo-Soyez test 
project and a joint bedrest study was also 
supported during this period.  In the 1980’s the 
systems analysis group’s effort was redirected to 
support the science management of human and 
animal experiments on the Space Shuttle. A few 
examples from this era are also included in the 
book.  
Parts of this work have been published elsewhere, 
presented at technical meetings, and documented 
in reports with limited distribution. These 
publications will be referenced throughout the text 
and the interested reader is advised to use these as 
resource material where additional details are 
desired. The intent of this book is not to reproduce 
these documents but rather to present a coherent 
view of the integrative analysis under one cover. 
This volume contains the first detailed publication 
(other than in internal reports) of an extensive 
metabolic balance analysis of Skylab data, the 
development and validation of the “Whole-Body 
Algorithm,” and simulation studies of diverse 
hypogravic environments.  An analysis of 
cardiovascular deconditioning and a description of 
the calcium regulatory model are also new.    
A long period has passed between the completion 
of the main body of work represented in this book 
and its publication in this form.  It was inevitable 
that new research efforts would lead to 
developments related to the spaceflight problems 
addressed and thereby make some of our 
biomedical conclusions obsolete.   Although in 
some cases reference to more recent work have 
been included, for the most part this book should 
be considered an historical summary 
demonstrating the approach and utility of systems 
analysis and computer modeling in the NASA Life 
Sciences program at the time the studies were 
conducted.   
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The author is deeply indebted to Drs. John A. Rummel and 
Ronald J. White who were responsible for managing the 
research that is summarized in this book.  Dr. Rummel was 
originally a NASA research physiologist at Johnson Space 
Center and ultimately Deputy Director of Bioastronautics at 
the Center.  He conceived a plan of utilizing mathematical 
models and systems analysis as research tools for 
understanding the complexities of the human response to 
spaceflight that his research team witnessed during the early 
manned spaceflights and he created and managed a joint 
team of space biomedical researchers and computer modelers 
to implement his vision.    Dr. White, originally a 
mathematician and researcher at the University of 
Mississippi and ultimately Director of the National Space 
Biomedical Research Institute, Houston, Texas, managed the 
team responsible for developing and utilizing mathematical 
and computer tools for analyzing spaceflight data and 
coordinating the entire interdisciplinary team.  The author’s 
career path was greatly influenced by these two gentleman 
and their wisdom and management skills were critical to the 
success of this project. 
The NASA principal investigators who were directly 
responsible for the development and sponsorship of the 
analyses activities described in this book, and who provided 
the primary guidance for its direction include Drs. John A. 
Rummel (cardiovascular, metabolic activity), Carolyn S. 
Leach (endocrine and fluid balance), Stephen L. Kimzey 
(hematology), Paul C. Rambaut (metabolic and energy 
balance) and G. Wycliff Hoffler(cardiovascular/lower body 
negative pressure).   The General Electric Company systems 
analysis team was managed consecutively by Dr. Clay 
Fulcher, Dr. Ron C. Croston, Mr. Darryl G. Fitzjerrell, Dr. 
Ronald J. White, and the author.  Other members of the 
group who participated in various activities that contributed 
directly to this research include: Susan Brand, Dennis 
Grounds, David Lipson, Victor Marks, Alan Nordheim, Jafar 
Nochedechi, and Srini Srinivasan.  Dr. Srini Srinivasan 
helped to prepare the chapter on cardiovascular regulation 
(Chapter 7).  Ms. Susan Brand’s study reports formed the 
basis for the chapter on the musculoskeletal system and the 
calcium regulatory model (Chapter 8).  Editorial, layout and 
stenographic support was provided by Trudy Thompson- 
Rice, Wilson Lauderdale and Dolly Bingham for the early 
draft and Leigh Anne Lotridge for the layout of the current 
version.   
The major portion of this effort was conducted under the 
following NASA contracts:  NAS9-11657 (Modeling and 
Integration of Physiological Control Systems), NAS9-
12932 (Automated System for Integration and Display of 
Physiological Data), NAS9-13192 (Skylab Endocrine-
Metabolic Experiment Data Analysis), NAS9-14523 
(Skylab Medical Data Evaluation Program).  Additionally, 
the first draft of this book and some ancillary analyses were 
performed under the following NASA contracts:  NAS9-
15487, NAS9-16328, NAS9-15850, and NAS9-17151.  
This book was drafted under the auspices of the National 
Space Biomedical Research Institute, a research partner of 
the Johnson Space Center, Houston, TX.    
The author would like to especially acknowledge Dr. 
Arthur C. Guyton (deceased), one of the most important 
physiologists of modern times and a major contributor to 
mathematical modeling in biology and medicine.  His 
model of circulatory, fluid and electrolyte control, first 
published in 1972,1 remains not only a classic example of 
the use of models to understand the behavior of complex 
physiological systems, but as shown in this volume, is even 
today a highly relevant tool that can be applied to man’s 
newest frontier – the space environment. There have been 
few, if any, other outstanding attempts to subject whole-
body biochemical and circulatory functions to the rigors of 
systems analysis, modeling and simulation, especially as it 
relates to long-term adaptation.   The Guyton model is a 
keystone model in the current study as well as a major 
building block of the “Whole-Body Algorithm” that was 
developed.  The model of calcium regulation, featured in 
this book, was also developed under Dr. Guyton’s 
stewardship.  Although Dr. Guyton never became 
involved with spaceflight research (thus further attesting to 
the power of his model’s capabilities), the author and 
project managers were fortunate for the opportunity to 
benefit personally from discussions with him.  
Finally, the author wishes to acknowledge the research 
subjects and astronauts whose ground-based and 
spaceflight data were subjected to our sometimes unique 
form of analyses.  In particular, the nine Skylab 
astronauts who served as science investigators and 
subjects during their space flights agreed to release their 
individual data to the general scientific community.  
1 A. C. Guyton, T. G. Coleman and H. J. Granger, 
Circulation Overall Regulation, Ann. Rev. 
Physiol., 34, pp. 13-46 (1972). 
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Chapter 1
Executive Summary
1.1 Introduction
One of the most complete set of observations on man’s
adaptation to weightlessness collected by the United States
to date was obtained during the Skylab Program.* The pri-
mary goal of the Skylab medical experiments was to de-
fine the changes which took place in the human body and,
thus, to achieve an understanding of the physiological re-
sponses which occur during extended exposure to the space-
flight environment. Achieving a unified theory of
adaptation to weightlessness, during the Skylab era had
been difficult because of the requirement to integrate a
voluminous quantity of data obtained by many scientists
from various disciplines. This task was further confounded
by the need to consider supplementary results from a di-
verse spectrum of ground-based studies that mimic the
hypogravic environment of spaceflight. Interpretation of
all these data requires the unraveling of a complex net-
work of feedback regulators involving many individual
physiological subsystems. Therefore, a project was devel-
oped in the early 1970’s, based on an interdisciplinary sys-
tems analysis approach, to address this task. The systems
analysis approach is particularly applicable in this situa-
tion because of the requirements to analyze and assimilate
vast quantities of information, to understand the behavior of
complex homeostatic systems, and to test scientific hypoth-
eses explicitly and in as unambiguous a manner as possible.
Of the various analytical techniques developed to sat-
isfy these requirements, the primary tool used was a set of
mathematical models capable of simulating a number of
physiological systems. Physiological function of the hu-
man body is often viewed as consisting of an aggregate of
subsystems, each one of which is complicated, and these
subsystems are integrated so that the organism as a whole
maintains homeostasis. Each subsystem may be viewed as
a type of control system operating with negative feedback
to restore stability following a stress disturbance. These
control features are often amenable to mathematical de-
scription, and the use of a computer permits such models
to be used in a dynamic simulation mode. The benefits of
using mathematical models are well known among physi-
ologists who employ them in their research studies. Among
other benefits, such models provide a systematic approach
for: (a) assembling and organizing existing knowledge
about a system; (b) identifying important parameters and
determining the overall system sensitivity to the varia-
tion in these parameters; (c) predicting the values of quan-
tities that may be difficult or impossible to measure di-
rectly; (d) developing and testing hypotheses rapidly,
quantitatively, and relatively inexpensively; and (e) iden-
tifying specific elements that must be further quantified,
thereby suggesting the type of experiments that are needed
to obtain missing information.
Although mathematical modeling is now well estab-
lished in the life sciences, this study represents the first ap-
plication of a large array of models in a uniform manner to
solve problems in spaceflight physiology. Since the time
between major space missions is so great and the number
of astronaut subjects is relatively small, the decision was
made to use mathematical simulation as an alternative
means of examining physiological systems and maximiz-
ing the yield from previous spaceflight experiments. This
use of mathematical models was expected to be comple-
mentary to the ongoing NASA program of employing
ground-based experimental analogs of zero-g to provide
additional insight into man’s response to weightlessness.
1.2 Systems Analysis Techniques and
Approach
An important objective of the systems analysis program,
at the outset, was to develop the mathematical and statis-
tical techniques required to support an extensive integra-
tive effort related to man’s response to weightlessness. It
was apparent that data from most all of the major flight
experiments of Skylab would need to be available in a
single database, coupled with the appropriate analysis
software. Toward this end, a medical data analysis system
was created. The system consisted of an automated data-
base, a computerized biostatistical and data analysis sys-
tem, and a set of simulation models of physiological
systems (see Fig. 1-1).
Data from a wide variety of investigative areas were
collected and placed in this database, including cardiop-
ulmonary function, body fluids, biochemistry, nutrition
and energy metabolism, musculoskeletal function, body
composition, and hematology (see Table 1-1).† An indica-
tion of the data utilized during the course of these studies
is given by the selected parameters shown in Fig. 1-2. The
total quantity of data contained in the database is quite
large, in spite of the small number of astronaut subjects;
information for approximately 900 man-days of spaceflight
study is provided by 80,000 measurement values repre-
senting over 900 independent parameters. Algorithms were
* This chapter and accompanying book should be read in the historic
context in which it was first drafted – during the period between NASA’s
first (Skylab, 1973-74) and second generation (Spacelab Life Sciences
dedicated missions, 1991-1997) major biomedical flight experiments.
† The most significant omission from this list are the experiments related
to the neurophysiological aspects of spaceflight. Time and resources did
not permit an extensive systems analysis in this area, and therefore, this
Skylab data was not included.
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Figure 1-1. Skylab integrated medical data analysis system (SIMDAS)
provided to perform routine statistical tests, multivariate
analysis, nonlinear regression analysis, and autocorrelation
analysis. Special purpose programs were prepared for rank
correlations, factor analysis, and the integration of the
metabolic balance data using conservation models for
mass, water, and energy.
1.2.1 Simulation Models
Five basic models were employed in this project: a
pulsatile cardiovascular model (Fig. 1-3); a respiratory
model (Fig. 1-4); a thermoregulatory model (Fig. 1-5); a
circulatory, fluid, and electrolyte balance model (Fig. 1-
6); and an erythropoiesis regulatory model (Fig. 1-7). A
major objective that was achieved early in the program
was the integration of these subsystem models into a com-
mon framework termed the “whole-body algorithm” (Fig.
1-8). In addition, the development of a model of calcium
regulation was begun but was not completed (Fig. 1-9).
The basic similarity of the subsystem models seems evi-
dent from the diagrams in Figs. 1-3 to 1-9, since they are
all represented by an active controlling system which regu-
lates a relatively passive controlled system, and taken to-
gether, these units function as a negative feedback control
system. The feedback variables for these models include
representations of many of the sensors present in the body
including temperature sensors, chemoreceptors, barorecep-
NASA/CR—2020-220487 2
Table 1-1. Biomedical Experiments of Skylab in SIMDAS Database
Cardiovascular System Musculoskeletal Function
• Lower body negative pressure (LBNP) • Bone densitometry
• Submaximal exercise response • Calcium (Ca+) balance
• Resting flows, pressures, heart rate • Strength measurements
• Anthropometric measurements
• Lean body mass measurements
Pulmonary Function Body Fluids and Composition
• Respiratory function during rest and exercise • Body fluid volumes
• Mechanical and metabolic efficiences during exercise • Composition of plasma, urine, and feces
• Hormones related to fluid electrolyte balance and
stress
Nutrition and Biochemical Metabolism Hematology
• Metabolic balances of water, nutrients and electrolytes • Red cell mass (RCM)
• Energy balance • Blood volume
• Body mass measurements • Hemoglobin (Hb)
• Indices of erythropoiesis
tors, oxygen sensors, and osmoreceptors. A majority of
these models resulted from research directly associated
with this project.
These models can be characterized as being determin-
istic, non-linear, and use finite difference formulations.
All models operate on a large scale computer in an inter-
active timesharing mode with the automated capability to
display responses graphically on remote terminals, and
with the capability to compare experimental data and
model responses simultaneously. Most models were modi-
fied to include gravity-dependent effects and to enable
simulation of a human response to the stresses related to
the spaceflight. Some of the experimental and clinical con-
ditions for which the models were validated include
•
    BLOOD
• [Na+]
• [K+]
• [Hb]
• Osmolarity
TOTAL BODY
CHANGES
 •∆  Water
 •∆  ECF
 •∆  PV
 •∆  RCM
 •∆  TBK+
 •∆  Mass
 •∆  Density
LEGS
•Volume
•Blood Flow
LBNP & EXERCISE
STRESS TESTS
Cardiopulmonary
Function
   URINE
•Water
•Na+
•K+
•Nitrogen
•Osmolarity
•Specific Gr
•Aldosterone
•Angiotensin
•ADH
FECAL
 •Water
 •Na+
 •K+
 •Nitrogen
 •Calories
 •Solids
DIET
 •Water
 •Na+
 •K+
 •Nitrogen
 •Fats
 •Carbohydrates
 •Calories
 •Solids
•
•
•
•
Figure 1-2. Selected data utilized in systems analysis study.
•
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Figure 1-3. Model of Cardiovascular Regulation. A model of the human cardiovascular system and its controls was developed to
simulate short-term bicycle ergometry exercise, lower body negative pressure, tilt, and tilt bicycle ergometry. This model includes gravity
effects, muscle pumping, venous tone, venous valves, respiratory frequency, and intrathoracic pressure effects. Complex cardiovascular
control hypotheses are modeled for the control of the heart period, peripheral flow resistances, venous tone, and other controlled
variables. Metabolic control mechanisms are modeled by mathematical representations of oxygen uptake, oxygen deficit, and accumulat-
ing metabolites to simulate a transient metabolic state. The cardiovascular circulatory system is divided into 28 compartments to describe
pulsatile blood flows, pressures, and volumes. Command inputs to the model are assumed to be from chemoreceptors, neurogenic inputs
from muscular activity, and neurogenic anticipation. Other inputs needed are the exercise workload, work rate, blood volume, and angle
and magnitude of the gravity vector. Typical outputs that can be selected are oxygen uptake, oxygen deficit, total metabolites, heart rate,
various blood flows, systolic pressure, mean pressure, diastolic pressure, stroke volume, venous pressures, and arterial pressures. This
model occupies a central position in the short-term segment of the Whole-Body Algorithm and was used to simulate the provocative
cardiovascular stress tests used in the spaceflight program.
Table 1-2. Stresses Related to Spaceflight That Were Studied Using Simulation Models
• Hypogravic Stress • Environmental Disturbances
- Supine Bedrest - Hypoxia
- Head-down Bedrest - Hypercapnia
- Water Immersion - Temperature
- Spaceflight - Ambient Pressure
• Orthostatic Stress • Fluid Shifts (non-gravity dependant)
- LBNP - Hemorrhage
- Tilt Table - Infusion
- Postural Change - Water and Salt Loading
- Dehydration
• Metabolic Stress
- Exercise
- Diet Restriction
hypogravic stresses, orthostatic stresses, metabolic stresses,
environmental disturbances, and fluid shifts (see Table 1-
2). Multiple stresses and sequential degrees of stress can
be simulated just as in a real experimental protocol. Many
hypotheses can be tested merely by adjusting the value of
one or more of the fixed system parameters.
1.2.2 Hypothesis Testing Approach
The combination of the data base analysis system with
the group of simulation models formed the basis of the
hypothesis testing approach that was used for integrating
the Skylab findings (see Fig. 1-10). The basic analysis
system enabled the rapid scanning of large arrays of space-
flight data, the graphical visualization of correlations be-
tween variables, and the statistical testing of hypotheses.
This preliminary evaluation of spaceflight data led natu-
rally to qualitative examination of the mechanism involved
in producing the observed responses. This procedure drew
heavily upon the theory of physiological feedback regu-
lating systems and often suggested hypotheses capable of
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Figure 1-4. Model of Respiratory Regulation. The respiratory system model of Grodins was selected for use in the development of the
whole-body algorithm. The controlled system is divided into three compartments (lung, brain, and tissue). The blood passes through the
lungs and after a transport delay that is dependent on vascular volume and blood flow rate, the arterial blood arrives at the brain or the
tissue compartment. In this model, carbon dioxide (CO2) and oxygen (O2) exchange rates are governed by metabolism. Venous blood
exiting the brain combines with venous blood from the tissue after a time delay, to form mixed venous blood. After another delay this
mixed venous blood enters the lungs to complete the cycle of gas transport and exchange. The real system is composed of receptor
elements that monitor chemical concentrations, afferent nerves that transmit this information to the central nervous system, neural
centers, and motor nerves to the respiratory muscles that drive the thorax lung pump. In the model of this system, this process is
represented by using chemical concentrations at receptor sites as inputs to the system and ventilation as the output. Typical short-term
stresses for which this model is suited include hypoxia, hypercapnia and acid-base disturbances. Modification of the original respiratory
model for use in the Whole-Body Algorithm provided the capability to simulate exercise.
Figure 1-5. Model of Thermal Regulation. A dynamic model of physiological regulation of body temperature in man has been developed
by Stolwijk and modified by NASA for various applications to the spaceflight program. The controlled system is the mathematical
representation of the thermal characteristics of the various geometric compartments of the body. These compartments (or nodes)
represent the head, trunk, arms, hands, legs, and feet and are further divided into concentric layers designated as blood core, muscle, fat
and skin. Each of the forty nodes has appropriate metabolic heat production and convective heat exchange with adjacent compartments.
The skin exchanges heat with the environment via radiation, convection, and evaporation. The thermoregulatory model receives tempera-
ture signals from all tissue compartments and, after integration and processing, the control system sends commands to all appropriate
compartments changing metabolic heat production, blood flow, distribution, or the rate of sweat secretion. The thermoregulatory model
is well suited to examine short-term stresses such as the effects of external temperature variation (environmental change) and the effects
of changing metabolic heat production (exercise level change). This model formed an important link in the Whole-Body Algorithm,
especially for the simulation of exercise. It was also employed to predict evaporative water losses in the hypobaric, reduced convective
flow environment of Skylab.
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Figure 1-6. Model of Circulatory, Fluid and Electrolyte Regulation. The long-term model of circulatory, fluid, and electrolyte control,
which was originally developed by Guyton is the largest and most complex of all the stand-alone models used in this project. It has been
modified to include several new representations of certain regulatory functions. This model consists of 354 blocks, each representing
one or more mathematical functions that describe an important physiological facet of circulatory regulation including autonomic,
metabolic, renal, hormonal and fluid transport function. The circuit of blood flow in the Guyton model is divided into five volume
segments: system arteries, system veins, right atrium, pulmonary arteries, and pulmonary veins-left atrium. Exchange of fluids (water
and proteins) and electrolytes (sodium and potassium) is permitted to occur between the plasma, interstitial and intracellular fluid
compartments by way of diffusion, active transport, transcapillary exchange, and lymph flow. Heart function is represented in a high
degree of detail and includes representations for ventricular muscle strength, hypertrophy of the heart, deterioration of the heart, and
sympathetic stimulation. Most of the above characteristics of the model can be viewed as the controlled system, while the controlling
system consists of three major components: local control, hormonal control, and autonomic control. The inclusion of such elements as
hormonal control, autoregulation, baroreceptor adaptation, erythropoiesis control, protein formation and destruction, venous stress
relaxation and cardiac conditioning factors clearly indicate that the Guyton model was developed to be useful as a long-term model. Many
varied experiments have been simulated with this model including infusions of water, electrolytes, and plasma; congestive heart failure;
loss of kidney function; nephrotic proteinuria; and angiotensin infusions. The addition of gravity-dependent stress and the inclusion of
leg compartments (developed under the current project) extended the capability of this system to include simulation of orthostasis,
bedrest and weightlessness.
Figure 1-7. Model of Erythropoiesis Regulation. A model representing the control of erythropoiesis was originally developed to replace
the red cell control algorithm in the Guyton model, but it has become an important investigative tool in a stand-alone mode as well.
Elements in the feedback regulation loop include oxygenation of hemoglobin, oxygen supply by blood transport to a renal site, change in tissue
pO2 based on the balance between oxygen supply and oxygen demand, and secretion of erythropoietin from tissues sensitive to pO2 levels.
Production of red cells is based on the levels of circulating erythropoietin. Hemoglobin concentration in blood is computed from the addition
of new cells to existing cells and plasma while accounting for cell destruction. The model is designed to investigate the relative influence
of the controlling factors of erythropoiesis on total red cell mass. A wide variety of simulations have been performed with this model
including altitude hypoxia, red cell infusions, dehydration, bedrest and spaceflight, as well as certain clinical abnormalities.
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Figure 1-8. Whole-Body Algorithm. The design of the whole-body algorithm provides for the simulation of both long- and short-term
stresses. The long-term simulation is accomplished by the circulatory, fluid, and electrolyte subsystem model (Fig. 1-6), which then
initializes a set of three short-term models representing the cardiovascular, respiratory, and thermoregulatory systems. These three
short-term models, which are designed to simulate the responses to acute environmental changes and short-term experimental stresses,
operate in parallel fashion interchanging information as often as every half second of simulation time. Modifications were required to
interface these subsystem models and to enable simulation of the stresses and experimental conditions of interest. One advantage of
combining subsystem models is that each model considers various time lags, fast and slow controllers, and integration step sizes
appropriate for their respective simulations. The primary function of this complex model is to enable evaluation of physiological
interactions between subsystems. It also provides a capability for realistically simulating spaceflight missions in which long-term
adaptation occurs concomitantly with shorter term environmental or experimental stresses. For example, a typical Skylab protocol can be
simulated by performing stress tests such as lower body negative pressure or exercise at regular intervals over a prolonged inflight
period during which time adaptation to the zero-g environment is achieved. In addition, the whole-body algorithm provides a central
repository of hypotheses for explaining changes due to weightlessness in a variety of physiological systems.
being tested by using the predictive capabilities of the
simulation models. The elements of the medical data analy-
sis system (Fig. 1-1) were designed to interact in either
sequential or parallel fashion, so that, for example, results
from a data analysis could be employed as input forcing
functions to a simulation model and the model’s predicted
responses could than be compared to additional data from
the data base. Although good agreement between model
and data was desirable at times, it was not always essen-
tial. The heuristic value of modeling is such that even
more important objectives are often realized when this
agreement is poor, including suggestions for data analy-
sis, refinements of the mathematical models, changes in
the hypothesis being considered, and suggestions for the
design of new to be performed either in space or on Earth.
This is an iterative process, as suggested by Fig. 1-10, and
is the heart of the systems analysis approach.
Statistical and modeling techniques naturally comple-
mented each other for integrating and correlating results
from many different investigative areas. Predicting the con-
sequences of hypotheses on unmeasured variables from
many subsystems is within the capability of models, such
as the whole-body algorithm, but is impossible if the hy-
potheses are tested using traditional statistical methods.
As the simulation study progressed, it was possible to in-
corporate increasingly diverse kinds of experimental re-
sults and hypotheses into a single model. Although each
hypothesis alone would not support a generalized theory,
all of them taken together should converge toward a co-
herent picture of zero-g adaptation.
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Figure 1-9. Model of Calcium Regulation. Development of this model of calcium metabolism is not complete. The design specifications
define the calcium fluxes between the intestinal tract, kidney, bone, and plasma as the controlled system. These elements are controlled
by the plasma concentrations of parathyroid hormone (PTH), calcitonin (CT), and the active metabolites of vitamin D, as well as by
changes in mechanical stresses due to alterations in the gravitational load. Other controlling elements include the urinary excretion rates
of sodium and water. The feedback loops influencing the controlling system are directed via the plasma concentrations of calcium and
phosphate (PO4). Thus, the model is designed to investigate the relative influence of the factors controlling calcium and bone metabolism.
Figure 1-10. Systems analysis approach for evaluation of spaceflight data.
1.3 Subsystem Hypotheses for the
Response to Weightlessness
In this study most of the physiological systems that were
of major interest to spaceflight researchers prior to and
during the Skylab Program, were addressed. These investi-
gative areas will be grouped, for purposes of summation,
into five categories: (a) fluid, electrolyte, and renal func-
tion; (b) cardiovascular function; (c) hematology; and, (d)
musculoskeletal function and (e) body composition. The
major systems analysis accomplishments for each area are
summarized in Table 1-3. The results from these studies
have led to an interpretation of the spaceflight findings
that are reviewed briefly in the sections below. Under-
taken only recently was an analysis of the musculoskel-
etal system, with particular emphasis on calcium regulation.
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Table 1-3. Accomplishments of Systems Analysis Study
A. Accomplishments: Fluid-Electrolyte Regulation
• Modification of the Guyton model (circulatory, fluid and electrolyte regulation) to include gravity-dependent elements, leg compart-
ments, and improvements in the erythropoietic, renal, autonomic and renin-angiotensin subsystems
• Validation of the modified Guyton model for fluid-loading, hemorrhage, and postural-change studies
• Simulation analysis of the fluid-electrolyte response to hypogravic studies including water immersion, head-down tilt, bedrest, and
spaceflight
• Analysis of evaporative water loss in the hypobaric, reduced-convective-flow environment of Skylab using metabolic balance
analysis and the modified Stolwijk thermoregulatory model
• Metabolic balance analysis of water, sodium, potassium, calcium, nitrogen, and magnesium including Skylab nine-man composite
summaries of dietary intake, renal excretion, and sweat losses
• Composite time profiles of the nine-man Skylab mean responses for plasma and urinary electrolytes, hormones, and total body
changes in water, sodium, and potassium
• Analysis of fluid-electrolyte regulatory feedback mechanisms involved in acute and long-term responses to weightlessness
• Interpretation of all Skylab data related to disturbances in body fluid volumes and their composition including an integrated
hypothesis to explain the behavior of renal regulating hormones
• Major support of bedrest and Spacelab flight experiment proposals
B. Accomplishments: Cardiovascular/Cardiopulmonary Regulation
• Development of a new pulsatile cardiovascular system model
• Validation of cardiovascular model for exercise, tilt, lower body negative pressure (LBNP) in one-g
• Modification of the pulsatile model to include elements responsive to hypoxia and hypercapnia
• Modification of the respiratory model of Grodins to include the capability to respond to exercise
• Simulations of the exercise response using the combined thermoregulatory, respiratory, and cardiovascular subsystem models of the
whole-body algorithm
• Simulation analysis of spaceflight LBNP and postflight exercise (supine and sitting) using pulsatile model
• Simulation of disturbances in the circulatory system during short-term water immersion and head-down tilt and long-term bedrest
and spaceflight using the modified Guyton model and the whole-body algorithm
• Composite time profiles of the nine-man Skylab mean responses to LBNP
• Sensitivity analyses for effects of blood loss and venous compliance changes on tilt and LBNP responses
• Analysis to examine possible changes in inflight baroreceptor sensitivity
• Analysis of mechanical and metabolic efficiencies and other performance indices during bicycle ergometry flight experiments
• Modification of the pulsatile cardiovascular model to include physical training (conditioning) effects and evaluation of these
hypotheses against Skylab exercise data
• Formulation and evaluation of hypotheses to account for decreased orthostatic tolerance and decreased aerobic capacity during
inflight and postflight phases
• Analysis of cardiovascular response during the high-g of Shuttle reentry with reduced blood volume including identifying thresh-
olds for visual grayout
• Utilization of models to develop countermeasures for orthostatic intolerance during and after Shuttle reentry including fluid loading
and pressure garments
• Support of flight experiment proposal for advanced cardiopulmonary studies
C. Accomplishments: Hematology
• Development of new models for control of erythropoiesis in the human and the mouse
• Simulation analysis of hematological responses to altitude hypoxia and descent, red cell infusions, bedrest, water-restricted dehy-
dration, and spaceflight
• Interactive support of a research program that examined suppressed erythropoiesis in dehydrated mice
• Analysis of spaceflight and ground-based studies related to loss of red cell mass during hypogravity
• Formulation and tentative evaluation of candidate hypotheses to explain the “anemia” of spaceflight with particular emphasis on
explaining the differences in red cell loss among crewmen
• Simulations of clinical syndromes (anemias, polycythemias, and Hb abnormalities) and partial development of a teaching model of
erythropoiesis regulation
• Support of spaceflight experiment by predicting expected results, critical measurements, frequency of measurements, and effect of
blood sampling on the hematological response to microgravity.
D. Accomplishments: Musculoskeletal System and Body Composition
• Metabolic mass, water and energy balance analyses including a new method for estimating cumulative total body changes (water,
fat, protein, electrolytes) as a function of flight duration
• Analysis of body composition changes (lean body mass and fat) based on body water, body potassium, nitrogen-potassium balance,
and body density data
• Analysis of inflight requirements for exercise and diet
• Interpretation of components of body weight loss based on fluid and energy regulation and gravity unloading
• Design and development of a new model for calcium regulation, including validation studies of bedrest and spaceflight
• Support of a flight experiment proposal for advanced calcium regulation studies
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Therefore, the progress summarized in this area is more
limited. In addition, whereas the indirect effects of space
motion sickness on diet were considered in some detail,
the vestibular system (which is believed to be the origin
of this disturbance) and other neurologic aspects were not
addressed directly.
The interpretation of the spaceflight data was guided
by the need to answer certain questions that can be con-
sidered fundamental to a new area of environmental physi-
ology such as weightlessness. These can be briefly stated
as follows: (a) can the spaceflight findings be explained
in terms of well-known homeostatic systems or are patho-
logical components and non-regulatory characteristics in-
volved?, (b) are there only a few common elements in the
spaceflight response (i.e., gravity unloading, fluid shifts,
lack of orientation, deconditioning), the identification of
which would explain most of the observed findings?, (c)
is there a typical “zero-g response” and if so, what are its
most characteristic features? Also, is it permissible to treat
the nine Skylab crewmen as a composite group in order to
delineate this response, or were there significant differ-
ences between the three missions (other than duration)
that are important to consider?, and (d) in what ways are
certain ground-based experimental maneuvers (i.e., water
immersion, bedrest, head-down tilt, suitable analogs of
weightlessness), and in what significant ways do they dif-
fer from the spaceflight environment?
As a starting point in the analysis of each discipline
area, an in-depth review was performed to identify find-
ings that appeared paradoxical or otherwise unexplained
following Skylab and that would be ripe for systems analy-
sis investigation. A selected group of the most important
of these ‘critical’ areas is listed in Table 1-4. Each was
systematically addressed using the hypothesis testing pro-
cedures previously outlined and most of these observa-
tions and their resolution are mentioned in the following
discussion. Taken as a whole, many of the tentative con-
clusions discussed below might have been considered
novel when the original research was completed 20 years
ago, although today they could be taken for granted. The
book (but not this summary) includes updates that indi-
cate whether the conclusions were subsequently verified
or were found to be erroneous or incomplete.
1.3.1 Fluid-Electrolyte Response
There is unequivocal evidence that hypogravic
stresses such as bedrest, water immersion, and spaceflight
result in significant fluid redistribution within the body.
The removal or reduction of the hydrostatic pressure in
the blood column, coupled with the normal tissue elastic
forces and muscle tone of the lower body, results in shifts
of blood and tissue fluid from the lower body to the in-
trathoracic circulation. The consequences of this event
are widespread and long lasting, as suggested by Fig. 1-
11. As a result of central volume expansion, a complex set
of reactions occurs: (a) stimulation of all cardiopulmo-
nary pressoreceptors and decreased sympathetic activity;
(b) increased blood pressures and secondary decreases in
peripheral resistance, promoting enhanced renal blood flow;
(c) altered secretion of the fluid-electrolyte regulating hor-
mones including ADH, the renin-angiotensin aldosterone
triad, catecholamines, a natriuretic agent, and renal pros-
taglandins; (d) enhanced renal excretion of fluid and elec-
trolytes as a result of the alterations in sympathetic activity,
hormone secretion, and blood pressures and flows; (e) in-
creased transcapillary filtration of plasma into the intersti-
tium; and, (f) a decrease in thirst following reduction in
angiotensin levels and augmented by space motion sickness
anorexia. The net result of these processes is the loss of extra-
cellular fluid and electrolytes, which has been observed fre-
quently during and following weightless spaceflight.
This description evolved from examining such
ground-based studies as water immersion and blood vol-
ume infusion. A simulation of immersion demonstrating
many of these events is shown in Fig. 1-12. Most, if not
all, of the rapidly acting mechanism described previously
(which serve to correct the original blood volume distur-
bance) would most likely be observed only during the
first hours of a hypogravic stress. However, based on
24-hour metabolic balances, urine flow in the Skylab crew
was not increased and the entire loss of body fluids could
be accounted for by deficit fluid intake (possibly as a re-
sult of space motion sickness). Computer simulation analy-
sis of the acute stress period indicated that a decrease in
fluid intake reduced, but did not abolish, the diuresis re-
sponse and that the period immediately following this di-
uresis was accompanied by a reduction of renal excretion
below control. Thus, it is postulated that a diuresis was
not observed because void-by-void urine samples could
not be obtained and because an early diuresis would be
masked in a 24-hour pooled sample in the presence of
diminished intake. The short-term renal response to space-
flight in well-hydrated subjects is not yet known.
Whatever the mechanism, most of these early fluid
losses were believed to be ultimately derived from ob-
served decrements in leg volume involving a contraction
of the plasm, interstitial, and possibly intracellular fluid
spaces of the lower limbs. By the end of the first 2 days in
space the reduction in body water and body sodium was
largely complete (see Fig. 1-13). Also during the early
stages of flight, significant quantities of potassium escape
from intracellular compartments. This shift may be de-
duced from elevated renal excretion of potassium; in-
creases in plasma potassium; increased levels of cortisol
and aldosterone that are involved in releasing and con-
trolling potassium; and potassium balance studies on
which the data of Fig. 1-13 are based.
The more prolonged adaptive phase (commencing af-
ter the first several days of flight) was characterized by a
new steady state with respect to water and sodium and a
slightly negative balance of potassium (Figs. 1-13 and 1-
14). The modest increase of water and sodium excretion
throughout this adaptive phase (not shown) did not neces-
sarily reflect continued body loss inasmuch as excretion
could have been offset by a decreased sweat component.
Both a steady state metabolic balance analysis and a model
simulation analysis support this concept. The continued
loss of body potassium is expected from the atrophy of
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Table 1-4. Selected Observations from Skylab Experiments Addressed by Systems Analysis
Fluid-Electrolyte System
• Rapid loss of water early in flight
• Much larger increase in leg fluid volume during inflight LBNP compared to preflight and bedrest
• Absence of measurable diuresis following headward fluid shifts contrary to expectations
• Unusual combination of hormonal changes compared to bedrest and water immersion
• Presence of hyponatremic plasma maintained throughout flight
• Increased water and sodium excretion throughout mission without continuous body losses.
• Differences in ADH response between missions.
• Decreased evaporative water loss in presence of hypobaric atmosphere.
• Disproportionate losses of potassium and cell water
Cardiovascular System
• Absence of acute cardiovascular disturbances expected from headward fluid shifts
• Decreased orthostatic tolerance as measured by LBNP tests
• Maintained aerobic capacity during flight despite decreased blood volume and decreased orthostatic tolerance
• Decreased aerobic capacity immediately following flight.
• Differences in aerobic capacity among the three crews.
Erythropoietic System
• Inflight loss of red cell mass despite normoxic environment
• Delay in postflight recovery of red cell mass on shortest mission.
• Significant differences in rates of red cell loss among the three crews.
Musculoskeletal System
• Progressive loss of calcium from body.
• Urinary calcium stabilizes at elevated level while fecal calcium increases progressively with flight duration
• Changes in PTH during spaceflight dissimilar to changes in bedrest
• Apparent decreases in rates of nitrogen losses as a function of flight duration and increasing levels of exercise
Body Composition
• Apparent disproportion in rates of water, muscle, and fat losses in relation to their normal ratio in body tissues
• Decreases in body mass losses with flight duration
• Water losses in astronauts apparently independent of flight duration
• Large differences in body composition changes between the three Skylab missions
• Apparent similar energy requirements in zero-g and one-g contrary to prior belief
lean body tissue, a consequence of gravity unloading and
muscle disuse.
The importance of autonomic, hemodynamic, and hor-
monal regulators of circulatory and renal function during
the chronic phase was ascertained by model simulation.
These pathways were influenced by fluid shifts between
body compartments, altered metabolic balance, potassium
loss from the cells, and plasma electrolyte concentrations.
Based on model analysis it appears that plasma volume is
depressed about 0.5 liter throughout the flight. This pre-
diction is supported by postflight measurements. The fail-
ure of the plasma volume to return to normal in zero g is
presumptive evidence of the presence of blood volume
controllers responding to the tendency of fluids to pool
headward. During the adaptive phase of flight, angiotensin
and aldosterone presumably reversed direction from the
suppression hypothesized in the acute stress stage. In-
creased release of these substances can account for the
elevated renal potassium rates of excretion. It was neces-
sary to introduce a natriuretic factor in the model (respond-
ing to central blood volume expansion) in order to obtain
realistic simulations of enhanced sodium excretion in the
face of elevated aldosterone, and also to generate the
hyponatremic plasma that was observed. The average be-
havior of ADH for all Skylab subjects (increased during
the first 10 days and suppressed thereafter) exhibits the
expected inverse correlation with urine output. Not so easy
to understand is the elevation of plasma angiotensin I.
Since renin-angiotensin is usually released in response to
hypovolemia, the reason for elevation of angiotensin in
zero-g (and also in some bedrest studies) at a time when
there is a tendency for central blood volume expansion
(i.e., upper body hypervolemia), is not clear. A mild reduc-
tion in plasma osmolarity and sodium concentration oc-
curs early in flight and continues through the longest
mission. The mechanisms that maintain this condition are
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Figure 1-11. Hypothesis of fluid-electrolyte regulation following acute stress of weightlessness leading to a reduction in plasma volume.
WEIGHTLESSNESS ON ONE-G ANALOG
not clear. However, the combination of mild hypoosmo-
larity and hyperkalemia, helps account, at least in part, for
the increases in angiotensin and aldosterone and decreased
ADH.
1.3.2 Hematological Response
The most important hematological finding is a reduc-
tion in the circulating red cell mass during the flight inter-
val. Before Skylab, the working hypothesis was that the pure
oxygen gaseous atmospheres in the space capsule represented
a toxic stimulus and resulted in early destruction of signifi-
cant numbers (as great as 20% loss) of red cells. For the Skylab
crewmen who existed in a supposedly normoxic environ-
ment, this hypothesis was no longer tenable to explain their
average loss of 10% of total red cell mass. In the absence of a
consistent finding of increased red cell destruction, it was
assumed that this loss was likely a result of suppressed eryth-
ropoietic activity. However, no conclusive proof of this
theory is available and no one mechanism has been iden-
tified which is consistent with all the data.
The regulation of erythropoiesis during weightless
spaceflight was studied using a theoretical model (Fig. 1-
7). Several approaches were used, including: (a) param-
eter sensitivity analyses, which helped identify the factors
most likely to have a sensitive influence on erythropoie-
sis; (b) dynamic simulation of experimental studies such
as altitude hypoxia and recovery from altitude hypoxia,
red cell infusions, dehydration, and bedrest, all of which
helped reveal behavior of the real system; and, (c) col-
laboration with investigators, performing human and ani-
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Figure 1-12. Simulation of acute effects of water immersion in
normally hydrated subjects using the Guyton model.
Figure 1-13. Changes in body fluids and electrolytes of Skylab
crew during first month of flight (N = 9).
mal studies, to test in the biological system those hypoth-
eses suggested by the computer model.
The most important finding from these theoretical and
experimental studies was that moderate increases in he-
matocrit, as great as the 12% measured on Skylab, if unop-
posed by other factors involving oxygen delivery to
tissues, can proportionately increase oxygen tension at a
renal sensing site and exert a sensitive suppressant effect
on erythropoietin and red cell production (Fig. 1-15). The
erythropoietic regulatory system may be viewed, when
operating in this fashion, as a hemoglobinometer; (i.e.,
red cell production) decreases so as to eventually relieve
the hyperoxic condition. The final predicted result is a
nearly complete restoration of hematocrit accompanied
by a diminished red cell mass. Although not yet confirmed
experimentally, model simulations suggest that during
hypogravic maneuvers red cell mass will eventually stabi-
lize as hematocrit normalizes. Therefore, the Skylab find-
ing of red cell loss in spaceflight can be explained in terms
of normal feedback regulation of the erythropoietic sys-
tem in the face of sustained decreases in plasma volume.
The dissimilarity between red cell mass loss on the
different Skylab missions could not be explained by hemo-
concentration effects alone. Two theories were examined
to explain the findings that the Skylab crews who returned
to Earth after longer periods of weightlessness exhibited
smaller losses of red cell mass. The time course of red cell
loss in spaceflight is not yet known because of difficulties
of performing this measurement inflight. But based on a
composite of postflight measurement of all crewmembers,
it was postulated by the Skylab research team that red
cells disappear by some yet unknown mechanism during
the first month and then begin to replenish during the
second and third months. This notion would predict that
after a duration in space longer than 3 months, the red cell
mass might return to normal. Acceptance of this hypoth-
esis as a generalized theory of erythropoietic regulation
in weightlessness is confounded by the fact that decreas-
ing losses of red cell mass in Skylab were associated not
only with longer flight duration but also with increasing
levels of diet and exercise. Based on animal studies, it was
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Figure 1-14. Fluid-electrolyte response to hypogravity. Acute response is shown in the top portion and in Fig. 1-11, while longer-term
adaptive effects are indicated in the bottom portion.
hypothesized that dietary restriction can reduce, and increas-
ing exercise can enhance, erythropoiesis. Diet and exercise
also appeared to have demonstrable effects on maintenance
of body tissue and cardiovascular condition of the Skylab
crewmen, and their further involvement in the oxygen
transport-erythropoietic system was postulated in this study.
An alternate and more plausible theory was, therefore,
proposed during the current project. This theory suggests
there are two components to the suppression of red cell
production: one related to energy balance and one related
to water balance. Differences among the crewmen’s red
cell losses were thereby considered a result of different
levels of dietary intake and exercise, superimposed on a
common loss due to hemoconcentration (see Fig. 1-15).
According to this concept, the kinetics of red cell disap-
pearance in space would not include regenerative behav-
ior but would be more similar to the continuous, linear
losses observed in bedrest. Statistical correlations between
diet levels and red cell losses, as well as model analysis,
also tend to support this theory. Thus, it is not necessary
to invoke the occurrence of red cell regeneration to ex-
plain the Skylab data.
Other factors (also shown in Fig. 1-15) which may have
enhanced oxygen delivery and produced the same effects as
hemoconcentration cannot be ruled out at this time (i.e.,
shifts in renal blood flow, oxygen-hemoglobin affinity and
arterial pO2) but direct data are only available to support
the hemoconcentration effect. Also, the simulation analy-
sis indicated that a major role of inflight cell destruction
was considered unlikely, although it was impossible to
rule out some degree of acute red cell destruction early in
flight that may have contributed to the reduced red cell
loss. Indeed, Skylab measurements indicated that some
hemolysis may have occurred on the shortest flight.
Recommendations were proposed for future flights
based on this analysis. For example, it is crucial to obtain
direct inflight measurements of red cell mass, erythropoi-
etin and bone marrow activity. If reduced erythropoietin
levels cannot be demonstrated during spaceflight, then
the hemoconcentration theory may have to be abandoned.
Also, the importance of diet and exercise on erythropoie-
sis needs to be studied more carefully in humans with and
without accompanying hypogravity. Finally, the differ-
ences between postflight and post-bedrest kinetics of red
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Figure 1-15. Hypothesis of erythropoiesis regulation during prolonged spaceflight. Erythropoietin is secreted from kidneys in response
to tissue pO2. Erythrocytes are produced in the bone marrow.
cell recovery were not entirely resolved in this study, and
it would be desirable to examine bone marrow activity
upon recovery from hypogravic maneuvers.
1.3.3 Cardiovascular Response
The most striking changes in the resting cardiovascu-
lar system probably occurred early in flight, well before
the first measurements could be performed. As simulated
by the modified Guyton model and demonstrated by one-g
experimental analogs of weightlessness, the primary event
of the headward fluid shifts leads to central blood volume
expansion, increased venous and arterial pressures, in-
creased stroke volume, and elevated cardiac output. Sec-
ondary reactions following stimulation of central
mechanoreceptors are immediately activated and include
a decrease in heart rate and decreased peripheral resis-
tance. These reflexes,  together with enhanced
transcapillary filtration and excess renal excretion, tend
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Figure 1-16. Hypotheses to account for inflight cardiopulmonary responses to orthostatic and exercise stress tests. 
Postflight findings(not shown) reveal degradation in exercise performance as well as continued orthostatic 
intolerance, both tests being adversely affectedby an anemic blood volume. 
to correct both the central blood volume and 
associated pressures. Although the Guyton model 
predicts a complete normalization of central blood 
volume, whether or not this occurs is still a matter of 
controversy. Engorgement of neck veins and facial 
tissues and feelings of headfullness, which continue 
throughout the flight, are symptomatic of the 
continued tendency of fluids to pool in the upper body 
in zero g. Also, a residual excess volume in the 
vicinity of the low-pressure cardiopulmonary receptors 
may account for the longer-term increase in resting 
heart rates, e.g., Bainbridge reflex, noted in most of 
the Skylab crewmen (and in bedrest subjects). 
Therefore, one of the long-term effects of spaceflight 
may be that as arterial pressure normalizes, the low-
pressure volume receptors increase their influence 
while the high-pressure receptors decrease their 
influence with respect to their cardiac influence. Also 
identified during simulations of weightlessness were 
other long-term effects that assist the circulation to 
adapt to a reduced blood volume, an emptying of leg 
veins, and fluid pooling in the upper body. These 
poorly defined mechanisms include volume-receptor 
adaptation, devascularization, stress relaxation, 
baroreceptor resetting, and autoregulation of blood 
flow. 
    Cardiovascular function was evaluated during the 
Skylab missions by an LBNP orthostatic stress test and 
by an bicycle ergometry exercise stress test. The most 
prominent findings from these tests were a decrease in 
orthostatic tolerance during and following flight and a 
postflight decrease in aerobic capacity. Hypotheses to 
explain these findings were formulated and tested in 
the pulsatile cardiovascular model. (See Figs. 1-3 and 
1-16). It was convenient and useful that the same 
model for the cardiovascular system be used to 
analyze both LBNP and exercise, each of which 
represents different challenges to the cardiovascular 
system with significantly different responses. 
 
 
1.3.3.1 Analysis of Orthostatic Testing. The observed 
decrease in orthostatic tolerance is not unexpected in 
the light of significant loss of blood volume  (Skylab avg. 
= -590 ml). Upon application of LBNP or standing in one-g, 
the increase in leg pooling coupled with a reduced blood 
volume significantly lowers central blood volume and 
venous return to the heart. The model simulations 
quite accurately predicted the increased heart rates and 
decreased pulse pressures characteristic of the Skylab 
crewmens’ intolerance to orthostasis (see Chapter 7.4). 
The inflight heart rate response to maximal LBNP (-50 
mmHg) was shown to be nearly equivalent to a 15% 
hemorrhage.    However, blood volume loss alone was 
not sufficient to explain all of the observed find-     
ings. For example, an increase in leg volume pooling 
* 
* 
* 
* 
* 
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during LBNP (compared to the degree of preflight pooling) 
was noted during spaceflight. The most promising 
explanation of this phenomenon, as suggested by simula-
tion analysis, was the partial collapse of leg veins in asso-
ciation with a reduced leg blood volume during the pre-
LBNP control period. Small increments of LBNP would be 
expected to draw significant quantities of blood into the 
empty leg veins, more so in zero-g than in one-g. 
       The response to orthostasis was observed to stabilize 
and even improve in some subjects during the latter part of a 
mission (i.e., inflight heart rate response) becoming closer to 
that of the one-g control. One of the more promising 
hypotheses to explain these findings was a long-term 
downward adjustment of vascular capacity in the legs (in 
response to the reduced leg fluid volume) which could be 
manifested physiologically by retoning, devascularization,or 
reverse stress relaxation. Changes in plasma electrolyte 
concentrations (increased potassium and calcium, de-
creased sodium), may also be involved in altering vascular 
tone. Little is known concerning autonomic influences on 
venous tone during long-term adaptation to hypogravity. 
 
1.3.3.2 Analysis of Exercise Response.   Tolerance to 
exercise was essentially maintained during the flight pe-
riod. It was only after return to Earth that aerobic capacity 
was found to be diminished. This result is similar to results 
reported for bedrest. Analyses performed with the whole-
body algorithm permitted the circulatory adaptations of long
-term bedrest to initialize the short-term LBNP and exercise 
model so that pre- and post-bedrest stress tests could be 
simulated with new initial conditions. Results from these 
studies suggested that decrements in blood volume in 
association with some reduction in unstressed volume in the 
legs could quantitatively account for most of the observed 
changes in post-bedrest exercise (and LBNP) and postflight 
exercise in the crews of the two shortest Skylab missions.  
(see Chapter 9.2). However, there was a notable qualitative 
difference between the degraded postflight exercise 
responses of the crews of the two shortest flights and the 
crew of the longest flight that was tentatively ascribed to an 
inflight exercise training effect. (The level of personal daily 
exercise increased on each longer flight). A systems analysis 
task was therefore devoted to developing the most feasible 
explanation of the interaction of zero-g adaptive changes 
(deconditioning) and exercise training (conditioning). In this 
regard, the cardiovascular exercise model was modified and 
validated to represent the simulation of a highly trained 
subject’s response to bicycle exercise in one -g. This model 
was used in the“trained” and “untrained” mode to simulate 
the postflight bicycle ergometry experiments in both sitting 
and supine positions. The results led to the conclusion that a 
training effect was quantitatively consistent with the 
exercise response for the crew that trained the hardest (see 
Chapter 7.3.2).  
       The absence of a notable decrease in inflight exercise 
capacity in any of the Skylab crewmembers indicates that 
the contracted blood volume is an appropriate adaptation to 
hypogravity. Nevertheless, the nature of this adaptation is 
not clear. Results of the current analysis suggested that 
normal oxygen delivery was maintained in the face of 
diminished blood volume by the hemoconcentration of 
weightlessness and by the tendency of fluid to pool in the 
upper circulation and thereby to augment venous return to 
the heart. Conversely, the hemodilution observed on 
recovery (in addition to reduced blood volume) would be 
expected to contribute to the postflight degradation in 
exercise performance. 
 
1.3.4 Musculoskeletal Responses to Weightlessness 
The Skylab findings support the concept of a generalized 
atrophic response of the total musculoskeletal system during 
extended exposure to hypogravity. Losses in bone and 
muscle mass were among the more significant physiological 
changes observed in the astronaut subjects (see Fig. 1-17). 
 
1.3.4.1 Muscle Atrophy. The losses in muscular tissue 
were particularly well documented in the Skylab crew (see 
Chapter 4). One of the systems analysis projects demon-
strated that lean body mass was reduced by 
approximately1.5 kg (N = 9) over the inflight period. This 
was revealed by several independent methods that showed 
losses in body water, potassium, nitrogen, and body volume. 
More direct evidence of muscle and collogen breakdown 
was provided by the measured increase in renal excretion of 
ur inary3 -methylhis t idine,  hydroxylycine,  and 
hydroxyproline. Also, excesses of intracellular electrolytes 
and amino acids appeared in the plasma and urine. Further 
analysis of spaceflight data indicated a significant degree of 
local muscle loss in the legs and perhaps in the skeletal 
muscle groups that normally control anti-gravity or posture. 
The data supporting these contentions come from 
spaceflight studies showing a gradual loss of leg volume, 
decreased leg strength, a reduction in duration of the 
Achilles reflex, and, in animals, diminished mass and 
response of red fiber groups. It is well known that atrophy 
of skeletal muscle occurs in response to disuse, inadequate 
functional load, and insufficient food intake. Spaceflight 
may be associated with more than one of these conditions. 
The absence of gravity results in diminished use of the 
lower limbs for postural support and locomotion, reduced 
body weightloading on weight-bearing tissues, and perhaps 
interference with proprioceptor reflexes which can 
influence muscle metabolism and function. A reduced 
caloric intake appears to be capable of increasing the loss of 
body protein, but increased caloric intake may not prevent 
this loss. The muscle disuse atrophy hypothesis receives sup- 
port from the finding that the more intensive exercise 
performed by the crew of the longest flight (mainly exercise 
of the leg muscles) was associated with the smallest 
decreases in leg volume and strength. Little is known, 
however, about the changes occurring in other muscle 
groups, particularly those used for postural support in the 
upper body. If postural muscles are the primary targets of 
loss induced by zero-g, appropriate locally applied exercise 
might reverse this trend. Because each Skylab crewmember 
exercised, it is not possible to quantitatively predict the 
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Figure 1-17. Hypotheses of musculoskeletal changes during prolonged spaceflight.
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zero-g effect of complete lack of exercise. There is no rea-
son to question, however, that exercise does maintain
strength, muscle tone, and probably mass in the legs and
improves circulatory condition similar to one-g training.
1.3.4.2 Bone Demineralization. Evidence for inflight
loss of bone mass comes primarily from observations of
calcium metabolic balance and bone density. Inflight cal-
cium balances were consistently negative on all flights, a
result of excess urine excretion throughout the missions
and a progressive increase in fecal calcium loss as a func-
tion of mission duration. Bone densitometric data indi-
cated losses in the calcaneus (of the heel), but not in the
radius and ulna (of the arm), suggesting that losses are
concentrated in load-bearing bones. A significant correla-
tion between changes in calcaneus bone density and cal-
cium balance for the nine crewmen was demonstrated.
Additional evidence of demineralization is suggested by in-
creases in urinary hydroxyproline and hydroxylycine which
indicates breakdowns of the collagen matrix in the bone.
As expected, plasma and urine biochemistry showed sig-
nificant increases in calcium and phosphate, but the cal-
cium regulatory hormones did not reveal a consistent trend.
Analysis of all these data suggest that bone losses became
progressively more severe on each longer mission, in con-
trast to the trend toward stabilized losses noted for muscle.
The initiation of bone loss is assumed to come from a
reduction of mechanical forces induced by gravitational un-
loading, and/or reduced musculoskeletal interactions. These
forces (piezoelectrical, compressional, tensile, and shearing
forces) are known to be important in the normal mainte-
nance and repair of bone. It appears logical that external
forces, appropriately applied, might reverse the decalcifi-
cation process. However, the search for suitable counter-
measures has not met with notable success. The effect of
exercise on bone demineralization remains unresolved.
Current understanding of the physiology of calcium
metabolism, including the systems analysis, provides a
partial explanation of the biomedical findings. Upon re-
lease from the bone into the extracellular pool, calcium
and its concentration in plasma is under the control of a
feedback system which is mediated by a hormonal system
which influences renal excretion and gastrointestinal ab-
sorption as well as new bone formation. The observed el-
evation of urinary calcium may have been a result of
increased plasma calcium concentration, decreased par-
athyroid hormone, and increased renal tubular sodium (see
Figs. 10-8 and 8-9). Progressive losses of fecal calcium
have been tentatively attributed to a net decrease in di-
etary absorption of calcium from the gastrointestinal tract.
The active metabolite of vitamin D (1, 25 dihydroxychole-
calciferol) is an important regulator of GI tract absorption,
and a decrease in circulating levels of this substance could
explain the fecal data. As suggested in Fig. 10-8, a depres-
sion of parathyroid hormone and Vitamin D could have a
negative feedback effect on demineralization and limit
the losses of calcium from the bone. These preliminary
hypotheses have been incorporated into proposals for fu-
ture flight experiments that will examine several features
of calcium regulation, including fluxes into and out of the
bone and GI tract, hormonal regulation, and the effect of
exercise as a countermeasure.
The systems analysis approach for understanding bone
demineralization in space centered on understanding the
complex feedback systems of calcium regulation includ-
ing the development of a mathematical model. Various
interpretations of spaceflight and bedrest findings were
addressed which helped formulate the hypothesis of cal-
cium metabolism adaptation to long-term spaceflight that
is summarized above. Although the model is not yet com-
plete, formulation of the model was instrumental in unify-
ing spaceflight and bedrest data and in identifying critical
areas in the regulatory system that might become altered
in zero-g. When fully developed the model should be able
to provide guidance in understanding these mechanisms.
Can the acute renal calcium excretion be explained as an
initiating event or as a feedback response? Can some pri-
mary disturbance in the calcitropic hormones cause renal
excretion and bone loss or is there a primary event at the
bone level due to alterations in mechanical forces? What
biological activity is occurring in the bone tissue during
these events?
1.3.5 Body Composition Changes
One of the more consistent findings in astronauts re-
turning from spaceflight of any duration has been a loss in
body weight. The dynamic behavior of this weight loss
during flight was observed for the first time in the Skylab
Program, but ancillary measurements of body composi-
tion were performed before and after the flights and, there-
fore, provided only estimates of gross overall change.
Therefore, an analytical method was developed during the
current systems analysis program to numerically deter-
mine the major components of body weight loss in terms
of continuous time profiles for body water, body protein,
body fat, body potassium, and body sodium (Fig. 1-18).
The basis of the approach was a group of metabolic mod-
els for water, mass, and energy balance, which, when com-
bined with whole-body measurements, enabled sequential
accumulation of daily balance without incurring unrea-
sonable error. Selected results of this study are illustrated
in Fig. 1-19. The general conclusion of this study was that
little more than half of the weight loss observed during
the Skylab missions can be attributed to loss in lean body
mass; the remainder is derived from fat stores. As a work-
ing hypothesis, the following conclusions have been as-
sumed: (a) acute water and sodium losses are obligatory as
a result of normal physiological responses to headward
shifts of fluid in zero-g; (b) protein and intracellular min-
eral losses are primarily a result of disuse atrophy of pos-
tural muscles and may be obligatory in weightlessness
(without appropriate exercise), although the losses appear
to stabilize after about a month; (c) fat losses are more
variable and are probably dependent on the usual one-g
influences of diet and exercise; and (d) if present, the an-
orexia associated with space motion sickness will aug-
ment fat and protein losses by virtue of a caloric deficiency
and will enhance water loss as a result of reduced fluid
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Figure 1-18. Integrated metabolic balance analysis
intake. These conclusions must be considered tentative
because of the indirect method of estimation and because
adequate experimental controls for assessing the effect of
diet and exercise in weightlessness were not available.
1.4 Integration of Subsystem Hypotheses
Figure 1-20 is offered as an integrated hypothesis of the
adaptive response to weightlessness. It is obviously lim-
ited to the subsystems and specific hypotheses considered
in the present analysis. Although a great amount of detail
has been omitted for the sake of clarity, of interest here are
the interactions between subsystems and the generaliza-
tions that can be made about the behavior of the com-
bined systems. The following broad picture has emerged.
Disturbances in the cardiovascular, fluid-electrolyte,
erythropoietic, musculoskeletal, and metabolic systems,
which are found during and after flights of varying dura-
tion, appear to be attributed to two major effects of weight-
lessness: first, the absence of hydrostatic forces resulting
in severe fluid shifts within the body and, second, the
absence of deformation forces resulting in degradation of
normally load-bearing tissues. The first of these effects
leads to a reduction in body fluids, most importantly, blood
volume. The consequence of the second effect is a reduc-
tion in bone and muscle mass. In addition, a third factor, a
long-term alteration of the metabolic state, a reflection of
changes in dietary intake and activity levels, was found to
have an important effect in the responses of the Skylab
crewmen. This latter factor may be within the realm of
human intervention and correction on future missions. All
of these events have both acute and long-term effects which
lead to the notable and consistent findings of a loss in
weight, a change in body composition, a decreased toler-
ance for orthostasis, and additionally, upon return to a
one-g environment, a decreased aerobic capacity. Adapta-
tion is said to occur when the body adjusts to these changes
and reaches a new steady-state level. Figure 1-21 is an
attempt to show the relative time course of adaptation for
each major physiological system. The return to new
baseline values reflects the establishment of a new ho-
meostatic level appropriate to weightlessness.
These studies have supported the concept that within
the time span for which man has so far been studied in
space, these responses to weightlessness can be explained
in terms of normal feedback regulatory processes. One clas-
sical example of these processes concerns the blood vol-
ume controllers that reduce plasma volume when
challenged by the cephalad shifts of peripheral fluid. Also,
the reduction in red cell mass has been postulated to be
partly a result of the homeostatic response to hemocon-
centration and tissue hyperoxia. Another, of many ex-
amples, concerns the biochemical mechanisms which
sensitively respond to small changes in electrolyte shifts
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Figure 1-19. Body composition changes of the Skylab crew.
resulting from cell demineralization, and, within limits,
maintain the plasma composition at the expense of excess
renal excretion.
Exposure to weightlessness invariably leads to loss of
major body constituents at rates that, according to the
present analysis, are disproportionate to their concentra-
tions in the body. The most rapid losses are observed for
extracellular fluids and salts, and are reflected by equally
rapid decrements in leg volume. At the other extreme is a
class of substances that disappear much more slowly. Cal-
cium and, perhaps, red cells are representative of this cat-
egory. Depending on the degree to which caloric intake
matches energy requirements, fat stores can be included
in this group as well. Muscle tissue appears to degrade at
intermediate rates as exemplified by nitrogen and potas-
sium losses. All these rates of disappearance from the body
most likely depend on the nature of the disturbance and
on the effective time constant of the correcting homeo-
static system.
These studies have confirmed the hypothesis previ-
ously suggested that the loss of blood volume is of central
importance to the understanding of the zero-g responses
of several major systems. Although this loss is essentially
an acute circulatory adaptation to volume overload, it was
found to have a significant long-term effect on the ortho-
static intolerance and reduced exercise performance ob-
served after flight. Also, the reduced plasma volume was
found to have a potentially strong influence on the eryth-
ropoietic response. Finally, the long-term adaptation of
the circulation may depend on the vascular elements re-
sponding to accommodate the hypovolemic condition. It
should be noted, however, that in none of these cases was
the loss of blood volume alone sufficient to explain the
entire response . Another event that had a widespread ef-
fect was the negative energy balance noted for the crews
of the two shortest missions and for all crews during the
early flight period. In addition to the obvious effect on fat
stores, an inadequate intake of fluid and food was found
to be implicated in the lack of expected acute renal re-
sponse, the loss of muscle tissue, the loss of water, and the
differential loss of red cells among the crews.
Although this study has not provided a definitive
theory to explain the available data, it has resulted in the
examination of available evidence to support or deny vari-
ous scientific hypotheses, the identification of qualita-
tive and quantitative interactions between various
experimentally measured responses to spaceflight, and the
formulation of a tentative integrated physiological hy-
pothesis for the adaptive processes. The elements of this
hypothesis can be included in the subsystem models or
the Whole-Body Algorithm. At that point, the models will
serve their main function as a central repository of a de-
tailed integrated hypothesis of zero-g adaptation and can
be used for more advanced applications such as develop-
ment of countermeasures or a quantitative approach for a
crew health monitoring and maintenance system.
1.5 Conclusions
The contribution of the simulation models was significant in
constructing the hypotheses discussed above, although the
limitations of space in this summary may not make this fact
apparent. It is appropriate, therefore, to consider several il-
lustrations of these benefits of the modeling process.
The normal functions of simulation models include
the capability to evaluate hypotheses retrospectively, and
thereby to enable greater use of the acquired information,
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and perhaps lead to the most likely interpretation of the
previously collected data. Using the computer simulation,
the models predicted the dynamic changes of variables
which may have been difficult or impossible to measure
during spaceflight. Table 1-5 illustrates two categories of
biomedical measures that were found to be very useful or
necessary for a characterization of spaceflight adapatation.
Quantities in the left column were measured inflight dur-
ing the Skylab experiments; quantities in the right col-
umn were not measured at all during flight. But all
quantities shown were capable of being predicted by the
computer models.
The utility of models, however, extended beyond these
predictive capabilities. A benefit that was attributed to
the modeling process related to the ways in which models
shaped the data analysis effort. Quantitative modeling of-
ten required a new look at data that had already been ana-
lyzed by more traditional methods. The simulation
approach requires certain patterns of data in very specific
forms. Satisfying these model requirements led, in one in-
stance, to the integrated metabolic balance analysis for
describing body composition changes during spaceflight.
In another situation, the study that led to an analysis of
evaporative water loss in the Skylab crew was suggested
originally by the need to validate the sweating mecha-
nism in the thermoregulatory model for weightlessness.
Another prime benefit of modeling, at this stage of its
application to space physiology, was in forcing the ana-
lyst to think systematically, comprehensively, and quan-
titatively about the system of interest. The formation of
the model, based on experimental evidence and known
concepts, provided insights into the organization of the
system elements and the multiple pathways connecting
Table 1-5. Selected Quantities Predicted by Simulation Models
Parameters for Which Parameters for Which
Inflight Data Exists Inflight Data Does Not Exist
Total body water Extracellular water
Leg volume Intracellular water
Body potassium Interstitial water
Extracellular sodium Plasma volume
Plasma sodium Red cell mass
Plasma potassium Red cell production rate
Plasma proteins Plasma erythropoietin
Plasma hemoglobin Tissue oxygenation
Plasma angiotensin Autonomic activity
Plasma aldosterone Volume receptor stimulation
Plasma ADH Natriuretic factor
Capillary filtration
Urine volume Cardiac output
Urine sodium Peripheral resistance
Urine potassium Venous pressure
Evaporative water loss Local blood flows
Blood pressure Body temperature
Leg blood flow Circulatory, renal, fluid, and
  hormonal changes on first
  inflight day
LBNP heart rate LBNP cardiac output
LBNP blood pressure LBNP venous pressures
LBNP leg volume LBNP blood volume and flow
   distribution
Exercise heart rate Exercise cardiac output
Exercise oxygen uptake Exercise stroke volume
Exercise minute ventilation Exercise blood gases
Figure 1-21. A highly idealized view showing the approach toward homeostasis of physiological systems during spaceflight. Each
physiological subsystem has a different time course of adaptation and appears to be driving towards a new homeostatic level. Note that
the time scale is exponential.
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Table 1-6. Significant Data Analysis Accomplishments
? A more definitive data analysis of Skylab based on a com-
posite picture of the nine crewmen from all flights
? Estimates of quantities which could not be measured directly
but could be derived from metabolic balance models or simu-
lation models
? Integration of data across disciplinary lines
? Quantitative evaluation of hypotheses by computer simula-
tion and interpretation of data in terms of feedback control
theory
? Reevaluation and reinterpretation of previously published
Skylab data in the light of more recent findings from
ground-based studies
Figure 1-22. Relative duration of various hypogravic stresses showing typical data collection periods. Skylab experiments stretched the time
horizon of study to several months but with few measurements during the first day. The ground based experiments helped to fill in this data gap.
qualities of the models. These one-g study employing
hypogravic maneuvers often provided more abundant data
than spaceflight investigations, especially for the acute
stress stage. Postural changes, water immersion, and
head-down tilt studies have helped to characterize the
short-term phase, whereas bedrest and spaceflight were
useful in describing long-term processes (see Fig. 1-22).
All of these stresses have the common characteristic of a
reduction in hydrostatic gradients and a rapid headward
shift of fluid. The modified Guyton model and the
whole-body algorithm, both capable of simulating short-
and long-term events, provided a framework upon which
these diverse experimental results could be systematically
examined. Within limits, the approach resulted in a better
understanding of the complete temporal spectrum of
hypogravic responses and in explaining results which oth-
erwise appeared to conflict.
During the present project, a qualitatively more ad-
vanced data evaluation was achieved than was previously
available. Some of the key features of these accomplish-
ments are summarized in Table 1-6. The fundamental con-
tribution of the systems analysis effort has been to organize
many of the major biomedical findings from spaceflight
and correlate these findings with the scientific concepts
that describe the requisite organ system. Out of this effort
has come an array of methods, tools, and techniques that
have proven essential for the handling, processing, and
interpretation of experimental data in general and space-
flight data in particular. Another result is an improved
understanding of the physiological events that occur dur-
ing human adaptation to weightlessness. When this un-
derstanding is enhanced, it may be possible to predict
these elements. The complexity of models, reflecting the
redundancy of the mechanisms in the body helped resolve
some paradoxical findings by suggesting the involvement
of one or more competing pathways. Also, it was not al-
ways possible to explain the long-term adaptation phase
of spaceflight in terms of regulatory feedback mechanism
more suited to corrective action of acute disturbances. This
difficulty suggested a logical division of the spaceflight
period into acute and chronic segments for purposes of
systems analysis.
A comprehensive approach for relating the experimen-
tal findings from various ground-base studies to the space-
flight observations was also facilitated by the integrative
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individual responses to weightlessness and appropriately
define indices of health during prolonged spaceflight and
subsequent recovery. Finally, this study led to identifica-
tion of critical areas ripe for future study. Recommenda-
tions for new experimental approaches generated by the
current program have already contributed to the design of
ground-based and future Spacelab investigations. Full po-
tential of the systems analysis method will be realized
only by maintaining an iterative cycle between model de-
velopment and experiments.
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Chapter 2
Introduction
2.1 Introduction
2.1.1 Purpose of the Book
The first set of comprehensive observations on hu-
mans in space was collected during the early 1970’s aboard
the United States’ first space station, Skylab. The primary
goal of the Skylab medical experiments was directed to-
ward defining the changes in the human body and achiev-
ing a better understanding of the physiological responses
that occur during extended exposure to the spaceflight
environment. The objective of achieving a unified theory
of adaptation to weightlessness was confounded by the
task of integrating a voluminous quantity of data obtained
by many scientists from various disciplines. The experi-
mental findings were interpreted and reported as individual
disciplinary studies by the principal investigators [1]. But
there was no significant attempt at that time to integrate
this collection of disciplinary studies or to develop a theo-
retical framework to describe these interrelationships.
Therefore, separate from the original experimental find-
ings of Skylab, a theoretical analysis was initiated that
was concerned with the very difficult problem of integrat-
ing these different studies. This book will summarize the
results of this ensuing project whose purpose was to ana-
lyze the human physiological response to spaceflight from
the unique perspective of systems analysis.
At the heart of this interdisciplinary analysis was the
recognition that a coherent theory of adaptation to weight-
lessness should entail integration of data from a large body
of research, primarily those from Skylab and other space
missions, but also including analogous ground-based stud-
ies on both humans and animals. The human body, while
conveniently divided into organ systems for research pur-
poses, is of course designed to function as a whole. It is
only by crossing the discipline boundaries that we can
discover how quite different regulatory elements through-
out the body interact, compete with and complement each
other as they react to the space environment with an inte-
grated response. At the same time it is important to un-
ravel the observed total human physiological response to
obtain an understanding of the role that each of the major
components of the body plays following the transition to
and from space. It was believed such an integrative analy-
sis would yield new insights into the overall process of
man’s adaptation to weightlessness.
2.1.2 Requirements, Objectives and Approach
A systems analysis approach was particularly suited
to address three primary requirements of the project: a) to
analyze and assimilate large quantities of information col-
lected by many investigators from different investigative
areas; b) to understand the behavior of complex physi-
ological regulatory processes that may be operating dur-
ing spaceflight; and c) to pose and analytically test alter-
native hypotheses in terms of these regulatory systems in
order to account for the experimental data.
The following objectives were established to meet
these project requirements:
1. To identify and develop new and improved mathemati-
cal approaches for the solution of problems in the
space life sciences,
2. To provide methods of organizing, integrating, and
analyzing spaceflight and supportive ground based
research data across interdisciplinary lines,
3. To develop and test, using quantitative approaches,
individual physiological subsystem hypotheses that
attempt to explain the experimental findings,
4. To integrate these hypotheses into a unified and in-
ternally consistent understanding of physiological ad-
aptation to weightlessness.
5. To apply the systems analysis techniques to the sup-
port of NASA’s ongoing research program by contrib-
uting to improved experimental design and data
analysis.
A longer-range purpose was to develop a quantita-
tive approach for a crew health monitoring and mainte-
nance system. This would include the means to establish
criteria for zero-g health, detection of clinical deviation
from these norms, and development of countermeasures
for restoring normal function.
New technology and quantitative methodology would
be required to satisfy these ambitious objectives. These
new approaches, described fully in Chapter 3, would in-
clude several critical software systems:
1. An automated database for storage, retrieval and dis-
play of experimental results from spaceflight and
ground based studies,
2. A biostatistical and data analysis system to support
interdisciplinary analysis across the major biomedi-
cal flight experiments with the purpose of developing
candidate hypotheses for explaining critical space-
flight findings,
3. A group of mathematical models (including an inte-
grated multi-system model of human physiology) ca-
pable of simulating a variety of physiological stresses,
4. A wide range of modeling techniques to simulate the
experiments performed on Skylab and in ground-based
analogs of zero-g, and
5. A software system for quantitatively evaluating can-
didate hypotheses in the models by comparing simu-
lation responses and spaceflight data.
While today there are special computers and software
that make the formulation and solution of mathematical
models a relatively simple affair, this was not so true in the
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1960’s and 1970’s when the models used in this project
were created. Computer speed and memory storage was an
important issue as was the algorithms used to solve the
mathematical expressions, usually by iterative procedures.
In addition, the user interface was relatively primitive in
those early years. In the current project a custom designed
interface, using recently developed remote graphical termi-
nals attached to a mainframe computer, was created that per-
mitted the modeler to easily change the independent variables
(parameters) of the model and to allow the simulation re-
sults to be displayed graphically in a manner that permit-
ted comparisons with experimental data. Likewise, the
databases for storing, retrieving and displaying the vast
number of Skylab measurements were all custom designed
because commercial off-the-shelf software did not exist.
Two facets of the analysis activities will be presented
in this volume. One concerns the advantages and limita-
tions of the modeling process itself and how this approach
served in integrating and interpreting the spaceflight find-
ings. The other concerns the results of this approach, that
is, a description of the spaceflight adaptation process as
seen thru the prism of systems analysis. However, it is not
the authors intention to provide either a detailed presen-
tation of modeling theory or a comprehensive treatise on
spaceflight physiology.
2.2 Background
2.2.1 Systems Analysis in Space Life Sciences
The significant benefit of using systems analysis and
mathematical modeling to study the physiological effects
of long duration space missions was recognized early in the
history of the space program by the National Academy of
Sciences [2]. They believed that such an approach would
“advance and accelerate knowledge of the functions, control
and regulations of the (human) system under space condi-
tions.” and would be “particularly useful in those areas where
experimentation and actual flights are especially costly in
time and resources.” Following the Skylab missions the chief
biomedical officers of NASA discussed the need for an inter-
disciplinary analysis approach to assimilate the volumi-
nous quantities of data collected in space [3] and for
in-depth studies to resolve some of the paradoxical find-
ings [4]. It was realized that until additional experiments
can be performed on future space missions, some years
hence at that point, methods such as systems analysis could
be very useful for integrating data and testing hypotheses.
The projects discussed in this book were meant to address
these concerns and recommendations.
The only other broad-based study that was similar to
the one reported on in this volume was conducted by the
Russian space agency. Throughout the 1970’s and 1980’s,
prior to the normalization of diplomatic and political re-
lationships between the U.S. and the Soviet Union, a group
of scientists from NASA and the Institute of Biomedical
Problems (Moscow), met on a regular basis to discuss the
most pressing biomedical issues confronting human space
travel. A regular portion of their deliberations (led by one
of the current authors, JAR) was devoted to the systems
analysis and mathematical modeling activities of both
countries. Some of the material contained in this volume
was presented at those meetings. This information on a
systems analysis of space biology and medicine was com-
piled by the Russians, along with their own work [5]. In
addition, several overviews of the current project were
previously published [6,7,8]. One of these [8] also reviews
smaller modeling projects that NASA has sponsored that
were not part of the current project.
2.2.2 Project History
This project, representing the work of many NASA
investigators and contractor personnel, was initiated in
the early 1970’s at the Johnson Space Center during the
period prior to the Skylab missions. The overriding goal
was to use mathematical simulation as an alternative means
of examining physiological systems and maximizing the
yield from the multi-discipline, large scale Skylab biomedi-
cal program. The first effort began in 1970 with Contract
NAS9-11657, Modeling and Integration of Physiological
Control Systems. The objective of this initial effort was to
provide information needed to make both technical and
managerial decisions regarding the development or use of
algorithms of the primary homeostatic regulatory mecha-
nisms of man, and the integration of these algorithms into
a total interactive simulation system. Progress was encour-
aging enough that Contract NAS9-12932, Automated Sys-
tem for Integration and Display of Physiological Data,
was initiated to develop working models and to simulate
the response to various biomedical experiments and envi-
ronmental stressors. A major objective of this three year
study was the development of a Whole-Body Algorithm
that was designed for evaluating hypotheses related to the
physiological adaptation to spaceflight. The development
of customized prototype software systems for organizing
spaceflight data conducting hypothesis testing with the
models from remote terminals was a secondary benefit. A
biostatistical analysis and display system was accom-
plished as part of a corollary Contract NAS9-14192, Skylab
Endocrine-Metabolic Experiment Data Analysis. Contract
NAS9-14523, Skylab Medical Data Evaluation Program
(SMEDEP), utilized the basic elements previously devel-
oped to complete a computerized integrated data base,
analysis and simulation system. A major objective was to
use this system to process and analyze the major Skylab
biomedical experiments, to develop and test individual
physiological subsystem hypotheses, and to integrate
these hypotheses into a general understanding of physi-
ological adaptation to weightlessness.
2.2.3 Spaceflight and Weightlessness*
Spaceflight presents a unique stress to man; its physi-
ological effects have only been studied since the early
1960’s. The spaceflight environment can be considered as
* In this text the terms weightlessness, zero-g and microgravity are
used interchangeably. Strictly speaking, objects in low earth orbitg
are not weightless but are subjected to very small forces, hence the
term microgravity.
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a multiplicity of factors that affect human physiological
systems. These factors include weightlessness, ionizing
space radiation, noise and vibrations, accelerations, at-
mospheric composition, temperature and humidity, hy-
giene and diet, isolation and emotional stress, and
circadian rhythm alteration. Although each of these fac-
tors doubtless contributes to the overall response, the fac-
tor that appears to have the most important effect on man’s
physiological systems is weightlessness, or zero-g. Zero-g
is known to affect a number of physiological systems in-
cluding cardiovascular, vestibular, fluid and electrolyte
balance, and other hormonal and musculoskeletal systems.
Many of the changes that occur cannot be fully appreci-
ated until return to the one-g environment.
Gravitational forces have been present in the evolution-
ary development of every species of land animal and plant.
But because of the ubiquity of Earth’s gravity it is difficult
to study its physiological influence and therefore one can-
not adequately predict the effects of the removal of grav-
ity. For this reason, spaceflight offers the opportunity to
not only understand the phenomena of gravity unloading
but, by analogy, can teach us much about the mechanisms
we possess for living in a gravitational environment. In
essence, the “stress” of zero-g is the removal of forces to
which our bodies are adapted and genetically designed to
counteract. Adaptation to the zero-g environment involves
disuse or modified use of these structures and mechanisms.
The degree of adaptation that occurs during zero-g affects
the severity of problems encountered upon return and ad-
aptation to the one-g environment.
2.2.4 Skylab
Skylab was a large, comfortable habitat containing
facilities for conducting biomedical studies. These mis-
sions provided the longest stays in space for the U.S. space
program until the collaboration with the Russians (and
the use of their space station, Mir) in the 1990’s. The three
manned Skylab flights provided the vast majority of space-
flight data upon which this analysis project was based.
Although earlier missions (i.e., Mercury, Gemini, Apollo)
included medical evaluations and some physiological test-
ing, the data were severely limited due to operational con-
straints on the scientific investigations and do not approach
the significance of the Skylab data. Prior to Skylab the
biomedical evaluations of astronauts were restricted
mainly to pre- and postflight measurements. Nothing was
known about the time course of physiological events in
space beyond three weeks. Skylab was the first (and one of
the few ever) NASA program whose primary aim was the
gathering of a broad spectrum of inflight biomedical data
on space travelers. At the time of this writing much of the
data collected on Skylab remains unique in both its scope
and duration of inflight exposure to microgravity.
The three Skylab missions were flown consecutively
starting in May 1973 and completed the following year.
The three missions had durations of 28 days, 59 days and
84 days respectively. On each mission there were three
astronauts who served both as investigator and subject for
the various biomedical experiments. During the preflight
and postflight phases the actual principal investigators
were in charge of the research procedures. The capabili-
ties of the Skylab spacecraft to conduct biomedical ex-
perimentation is fully described elsewhere [1].
2.3 Scope
2.3.1 Skylab Data
There were many scientific questions still unresolved
following the Skylab missions [4,9]. The most pressing of
these were addressed in the current study. The data from
five major physiological areas were placed in the custom-
ized automated data base and were examined using a com-
bination of data analysis and computer simulation. These
five areas, shown in Table 2-1 include: a) nutrition, metabo-
lism and body composition; b) fluid-electrolyte regulation;
c) hematology and erythropoiesis regulation; d) cardiopul-
monary function; and e) musculoskeletal function. Table
2-1 identifies the Skylab researchers that served as the
subject matter experts in each area, the types of measure-
ments collected, and the issues and questions that were
examined by systems analysis. There was a diverse spec-
trum of issues from a number of disciplines. Thus, an analy-
sis was undertaken of the primary components of weight
loss and changes in body composition, the volume and
biochemical changes of the fluid compartments, the loss
of red cell mass, the cardiovascular responses to exercise
and LBNP, and the atrophy of musculoskeletal tissue. Not
all of the “issues” listed in Table 2-1 were objectives of
the Skylab experiments, but rather became issues once the
data was analyzed. For example, regarding the hematol-
ogy experiments, it was not expected that red cell loss
would even occur in Skylab, much less be quite different
on different missions. Yet these questions became critical
to the present study following analysis of the Skylab re-
sults. The analyses for each of the discipline areas will be
presented in separate chapters in the order shown in Table
2-1 (left column) starting with Chapter 4.
The experiments shown in Table 2-1 represent a signifi-
cant portion, but not all, of the investigations that were con-
ducted during Skylab. There were, in addition, experiments
in the areas of vestibular function and motion sickness,
biostereometrics, sleep monitoring, muscle function, limb
occlusion plethysmography, and other minor investiga-
tions and clinical data. While these studies were not the
primary focus of our analysis, the data that was generated
was often very useful to supplement other findings. For
example, motion sickness incidences with its associated
restriction of fluid and nutrient intake were used to inter-
pret metabolic balances; body volume segments from
biostereometrics was important to confirm body weight loss
studies; and muscle strength tests verified the time course of
body protein loss. Undertaken rather late in this project was
an analysis of the musculoskeletal system, with particular
emphasis on calcium regulation (Chapter 8). Therefore, the
progress summarized for this area is more limited. In addition
to data from the Skylab missions, this analysis project used
some data from the Apollo-Soyez Test Project flight in 1975
and from several Shuttle flights from the 1980’s.
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The findings from this project will be discussed in terms
of their physiological, rather than their medical significance.
Also, the development and evaluation of countermeasures
against the deleterious effects of space travel will not be a
major focus except for one study designed to relieve ortho-
static impairment during reentry (Chapter 7 and 9).
2.3.2 Zero-g Analogs
In addition to data from spaceflight missions, this
analysis takes advantage of data from other related ground-
based experiments such as bedrest, water immersion or
head-down tilt. These so called “zero-g analog” studies
are useful because they approximate the reduced gravity
(hypogravic) aspect of spaceflight without introducing the
other confounding spaceflight factors discussed in Chap-
ter 2.2.3. Also, ground laboratories can provide more di-
rect measurements than data collected during spaceflight.
In the era following Skylab, animal studies became an
important adjunct to human studies in both ground labo-
ratories and space. The information from these studies in
the mouse, rat and primate, showed sufficient promise that
a version of one of the “human” models was adapted espe-
cially for animal use (Appendix B). The mathematical
models are capable of simulating both the ground-based
analogs and spaceflight, in animals and humans, and can,
therefore, form a bridge between these experimental
environmnets since the same physiological systems are
involved in all cases and are also represented in the model.
2.4 Systems Analysis
2.4.1 General Concepts
Novel analytical techniques were required in order to
develop mechanistic hypotheses to explain the spaceflight
experiments and to integrate these hypotheses into an over-
all theory of spaceflight adaptation. These techniques were
needed to assimilate large quantities of data, account for
complex physiological processes, and have the capability
to quantitatively test hypotheses both singly and in com-
bination. The analytical techniques chosen for these chal-
lenging tasks were those using systems analysis concepts.
Systems analysis is a methodology for logically de-
ducing the behavior of complex processes with the goal of
satisfying a set of specific objectives irrespective of the
scientific field. A system can be defined as one or more
elements that bear certain functional relationships to each
other and can be identified from their surroundings by a
real or conceptual boundary. For example, a cardiac cell,
the heart, or the entire circulatory network of vessels and
heart pump can each be considered systems worthy of study.
The systems analysis approach can be described as fol-
lows: 1) careful formulation of the problem to be solved
and objectives to be accomplished, 2) development of a
logical solution to the overall problem by dividing it into
smaller, easily handled problems (i.e., subsystems) accord-
ing to a prescribed plan, often involving quantitative mod-
els, 3) using this “road map” for logically relating the
subsystem solutions to the solution of the larger problem,
and 4) interpretation and evaluation of the analysis re-
sults so that they directly address the stated objective. A
key ingredient of a systems approach is the precise identi-
fication and rigorous definition of what, all too often, are
vague concepts. The intellectual discipline of even for-
mulating a problem using this methodology often requires
systematic and logical thinking and generally provides
considerable insight into the complex processes involved.
This approach can lead to solutions for many seemingly
unsolvable problems.
This is normally the approach used for many years to
develop man-made or technological systems. Examples of
such applications include the design of chemical process-
ing units, electrical circuits, and software systems. In other
cases, of which biological processes are a good example, the
system already exists, and the goal is to break the system
into smaller units and examine them in a manner that en-
ables one to understand the behavior of the larger system.
Physiologists studying the human body must deduce from
observation and experimentation, the features and func-
tions of the various anatomical subsystems, including the
relationships between these subsystem elements. Systems
concepts have only recently (since the 1960’s) been ap-
plied to studying biological function [10,11,12].
One immediate problem that faces the systems ana-
lyst is the level of detail required. For the human body,
various levels of organization exist which can form the
basis for the modeling of human physiology as shown in
Fig. 2-1. Thus, functional areas of physiology are catego-
rized by the “organ systems” such as nervous system, car-
diovascular system, etc. Each organ system can, in turn,
be built up by a “structural hierarchy” which ranges from
subcellular entities to whole organ modules (i.e., vertical
integration). Also, an organ system may be considered by
itself or in combination with one or more other organ sys-
tems (i.e., horizontal integration). The level of detail is
dictated entirely by the models objectives. It is the job of
the systems analyst to determine the level of detail neces-
sary to represent the phenomenon of interest in his prob-
lem. For example, one circulatory model that was used in
this project was designed to simulate blood pressure
changes over hours or days, while another was designed
for beat-to-beat heart changes and to exhibit pulsatile flow.
A guideline of systems analysis is to focus on the grossest
level of detail necessary to satisfy the area of interest.
Another way of saying this is that models should be de-
signed as simply as possible at each stage of their devel-
opment. In summary, the physiological systems analyst
has to identify the elements of interest and the level of
detail necessary to address the particular problem. Con-
versely, in any systems analysis, it would not be expected
that every level of detail would be represented or consid-
ered. In the current project, the main emphasis of the sys-
tems analysis was on the higher (less detailed) levels
describing overall organ systems, with particular interest
on addressing the integration of multiple organ systems.
2.4.2 Simulation Models
An essential step in the systems approach is the cre-
ation of a facsimile or model to represent both known and
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Figure 2-1.  Various approaches to modeling human physiology.  Left side indicates horizontal integration of organ systems.  Right side
indicates vertical integration within an organ system.
postulated features of the system. The model is usually in
a form that is different and usually less complex than the
real-world object being studied. This may include three
dimensional physical models or abstract models. The hu-
man body is so complex that all who study it must utilize
models of some type to relate and interpret the vast amount
of experimental data. Modeling of human body functions
is a relatively new area of scientific endeavor. Until the
middle of the 20th century, models of physiological func-
tion have been mostly qualitative with many being en-
tirely verbal and schematic.  The quantitative or
mathematical model for simulating the behavior of com-
plex physiological systems did not gain importance as an
investigative tool until the development of large scale
computer systems and the advances in control engineer-
ing and integrative physiology [13].
Mathematical modeling is one manifestation of the
systems approach to problem solving and has become a
very powerful tool for understanding and analyzing com-
plex system operations and interactions. The human body
systems are certainly complex, and modeling in the life
sciences becomes a way of communicating, a way of test-
ing hypotheses, and a way of designing experiments.
The major body systems that are of concern in this
project, including the cardiovascular system, respiratory
system, thermoregulatory system, renal regulatory system
and the fluid-balance system, all have a similar basic fea-
ture of control. They are characterized by an active con-
trolling system that regulates a relatively passive con-
trolled system, and taken together, these two major
components function as a negative feedback control sys-
tem. In physiological systems, control is an inherent fea-
ture and is most often exerted to maintain homeostasis of
the internal environment of the body. This concept of the
stability of the milieu intérieur is perhaps the best known
biological generalization attributed to the great physi-
ologist Claude Bernard [14]. Examples of quantities that
are thought to be under homeostatic control include, the
arterial blood pressure, the partial pressure of oxygen in
the blood, the heart rate, core temperature, and elec-trolyte
concentrations in the blood. The body detects these quan-
tities using sensors such as baroreceptors, che-moreceptors,
oxygen sensors, temperature sensors and osmoreceptors.
Using the control features, the system continuously at-
tempts to restore stress conditions to normal.
Modelers tend to be enthusiastic about their models
and researchers who do not use mathematical models tend
to be skeptical or outright critics. As in any branch of
science objectivity is important. The researchers in this
project understood the advantages and disadvantages of
modeling, but may have been biased to the extent that
they thought the former outweighed the latter. It was grati-
fying that during the research phase of this project, a pres-
tigious physiology publication was born that attempted
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Table 2-1. Biomedical Areas of Investigation on Skylab Studied with Systems Analysis
Physiological Area/(Book Chapter) Investigators, Measurements and Issues
• Nutrition, Metabolism and Investigators: Drs. P.C. Rambaut, C.S. Leach, M. Whittle, and J. Waligora
Body Composition (Chapter 4) Measurements: The most extensive metabolic and energy balance studies ever
made in space of water, nutrients and minerals in diet, urine and feces. Supple-
mentary measurements were made to quantify bone, protein and body mass and
volume losses.
Issues:
• Why do astronauts lose body mass in space?
• Can differences in body mass loss be attributed to diet and exercise?
• What are the components of weight loss and what is their time course?
• What are the energetic costs of living in space?
• Fluid-Electrolyte Regulation Investigators: Drs. C.S. Leach, P.C. Johnson, P.C. Rambaut
(Chapter 5) Measurements: Extensive measurements of fluid volumes in plasma, extracellu-
lar and body water compartments. Blood and urine biochemistries, including
electrolytes and hormones (related to fluid regulation and stress).
Issues:
• What changes in fluid-electrolyte status occur during long-term spaceflight?
• What is the role of fluid regulatory mechanisms (renal, endocrine, circulatory, neural)
   in adaptation to spaceflight?
• What changes in the internal distribution of body fluids occur in space?
• Is there an early spaceflight dieresis as predicted by many researchers?
• Hematology and Investigators: Drs. S. F. Kimzey, C.D.R. Dunn, and P.C. Johnson
Erytheopoiesis Regulation Measurements: Measurements of various indices related to the regulation of the
(Chapter 6) circulating red cell mass, blood volume and hemoglobin.
Issues:
• Why do astronauts lose red cells during spaceflight?
• Why is there a two-fold difference in the degree of red cell loss on two separate
   Skylab missions?
• Cardiopulmonary Function Investigators: Drs. J.A. Rummel, C. Sawin, and M. Buderer
(Chapter 7) Measurements: Measurement of indices of cardiopulmonary status (blood
pressure, heart rate, oxygen uptake) at rest and during exercise. Orthostatic
intolerance studied inflight and at recovery using lower body negative pressure.
Issues:
• What is the etiology of the loss of blood volume in space and how does the circulatory
  system adapt?
• What other mechanisms regulate circulatory changes in spaceflight?
• What changes in exercise performance occur during and following long-term
   spaceflight? Do increasing periods of personal exercise in space improve the
   metabolic response to stress tests?
• What causes cardiovascular deconditioning and the decrease in orthostatic
   intolerance seen in astronauts? What is its time course?
• Musculoskeletal Function Investigators: Drs. P.C. Rambaut, C.S. Leach, J.A. Rummel
(Chapters 4 and 8) Measurements: Measurements of blood and urine biochemical markers of
muscle and bone loss. Metabolic balance studies of calcium, magnesium,
potassium and nitrogen. Supplementary measurements of bone density, muscle
strength and total body potassium.
Issues:
• What is the extent and time course of muscle and bone loss during 3 months in
  space? Do the losses eventually abate?
• What regulatory mechanisms are involved?
• How are the losses influenced by diet and exercise?
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to exemplify the best in life science modeling and set stan-
dards in the field [15]. The following sections attempt to
introduce the reader to a discussion of advantages and
disadvantages of modeling.
2.4.3 Advantages of a Modeling System
In science, mathematical models are built and studied
for several reasons. A model is a framework on which all
known observations or hypothesized workings of a physi-
ological system along with appropriate real-world data
can be integrated. The construction of a model which is
composed of separate elements generally provides new
insight into the organization of the system elements, the
processes within the elements, and the multiple pathways
connecting these elements. Any useful model should be
able to account for known behavior of the most important
variables under consideration. A model built up of com-
ponent parts allows one to readily isolate each component
and its parameters to determine it relative influence on
overall system behavior. Simulation enables an investiga-
tor to understand how a biological system works through
variation of the system’s parameters. During simulation,
dynamic interaction between various subsystems of the
model becomes more apparent. Otherwise regularities and
patterns of behavior can be hidden from view simply be-
cause one does not know what to look for. By clarifying
what to look for, a model may predict both correlations
and cause-and-effect relations that are subject to actual
verification in the real system.
In contrast to a statistical model or a “black box”
model, a deterministic model is based on known physi-
ological processes and feedback pathways. As such, this
type of model can predict (not merely extrapolate) be-
yond the data from which it was generated under a wide
range of environmental and metabolic conditions. A bio-
logical model will offer some heuristic value and extend
the knowledge of the system under study by predicting
responses of difficult to measure quantities, by resolving
paradoxical behavior, by demonstrating the alterations in
the system necessary to produce an observed response,
and by design of crucial experiments.
Model building leads almost immediately to the iden-
tification of gaps in the experimental knowledge of the
system of interest and often suggests the type of experi-
ment needed to obtain missing information. When experi-
mental evidence is conflicting, difficult to interpret or
difficult to obtain, it is possible to test the plausibility of
a hypothesis by using an appropriate model. By reducing
the hypothesis to unambiguous mathematical expression
and incorporating it into a model, the consequent changes
in the system’s behavior often suggests the more signifi-
cant of alternate hypotheses. By using the model to deter-
mine those conditions under which competing hypotheses
predict the most divergent results, it is possible to design
decisive experiments. These uses of mathematical models
provides a new way to look at physiological systems and
adds another dimension to experimental physiology.
While it may seem desirable to obtain a successful
prediction from a model (i.e., in comparison with real-
world data), paradoxically, the most useful results are ob-
tained when the simulation does not match observed find-
ings. Analysis of the differences involved can then lead to
a modification of the hypotheses that define a portion of
the model, or to the need for new and clarifying experi-
ments. Such a practice is generally iterative, being ap-
plied over and over again with new stresses designed to
force the model to display more and more of its weak-
nesses. Reconstruction of the model by modification of
its hypotheses leads to a stronger model. As the model
behavior moves closer to the behavior of the real system
through iterative modification of the hypotheses, the probe
of science sinks ever deeper into the subject. In fact, this
iterative use of models is only a restricted form of the
general scientific method. Perhaps the real power of mod-
els is not in simply making predictions but in forcing us to
think clearly about a problem and its ability to raise the
critical questions. Modelers are forced to ask questions in
order to understand why a model behaves as it does or why
it doesn’t behave as we think it should. These critical ques-
tions then point the way for further experimentation. Thus,
models can lead us not necessarily to the right answers,
but to the right questions. There are many examples in
this book of this approach in the study of the physiologi-
cal problems of weightlessness.
Another paradoxical advantage of modeling is that
even a relatively simple model or one that is not extremely
accurate can provide useful insights. Without a quantita-
tive method of keeping track of different biophysical pro-
cesses, such as a simulation model, it is impossible to
intuitively visualize the dynamic behavior of a system
that has short and long time constants, multiple stimuli,
interconnecting and redundant pathways, or special ef-
fects like time delays, hysteresis and receptor adaptation.
Models offer a way of sorting through this complexity.
Special modeling techniques are available that allows the
researcher to learn much about the behavior of a system
that incorporates these features without the need for com-
paring the theoretical results to real-life data.
In summary, modeling and simulation are useful as a
means for providing:
1. A systematic and effective way of assembling exist-
ing knowledge about a system,
2. A means for identifying important parameters and to
determine the overall system sensitivity to variation
in each parameter,
3. Methods for calculating quantitative values of vari-
ables that are difficult or impossible to measure,
4. A method to test hypotheses, either individually or in
combination, rapidly, efficiently, and inexpensively,
5. Identification of specific elements or information gaps
that must be further quantified, thus leading to the
suggestions for new experiments.
6. An effective method for predicting the behavior of a
real system,
7. A quantitative technique to assist in designing and
interpreting biological experiments, and
8. A valuable means of communicating both concepts
and detailed function of a system.
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2.4.4 Limitations and Considerations in the
Design and Use of Models
There are certain limitations of modeling and simula-
tion that should be understood. No model is ever a perfect
fit to reality, and the difference between the model and the
real system should always be kept in mind. In spite of the
fact that models are quantitative and model results may
show decimal significance, the response of a model should
not be considered more than a prediction subject to verifi-
cation. Care must be taken in the use of models in order to
preclude extrapolating an element of a model beyond the
region for which the model element was designed. There-
fore, the application of a model should be preceded by an
understanding of the simplifying assumptions on which it
is based.
The importance of designing a model to meet specific
objectives was discussed above but cannot be overem-
phasized. The fact that most successful models have a
fairly narrow set of objectives is sometimes, and errone-
ously, thought to be a serious deficiency of modeling.
However, a biological model is a simplification of the un-
derlying processes; it is not designed to reproduce all or
even most aspects of the human body, but rather only a
specific aspect of the real system. The discussion of Fig.
2-1 illustrated the various levels of model objectives. The
best approach is to design a model to meet the desired
objective and accept the limitations that naturally follow.
The requirement for good experimental data in the
modeling process creates its own problems and limitations.
The success of a model will be a function of the degree to
which data from the real system can be gathered. Data is
used in the construction of the model and the setting of
parameter values. Data different from this “construction”
data is used to compare with the simulation responses. In
many cases it will be found that a model will exhibit a
good fit with the results of one experiment only to find
that the model’s validity is challenged by the results of
another. A model must be permitted to evolve as condi-
tions change or as additional data becomes available. Data
that is in conflict with the model should never be rejected
if it is known to be reliable, rather it should be used to
refute, modify, or improve the model. While it is always
desirable for the response of a model to correspond closely
with a particular set of experimental data, it is even more
important to use the model to understand the basic behav-
ior of a system. Using this guideline will assure that the
model remains an integral part of the scientific process
and does not become a process serving only itself.
There were often major problems in the course of the
present study in locating the proper type of data needed
for model comparison. Most of the models that were used
were capable of simulating dynamic (i.e., non-steady state)
responses. However, it was very common in the 1970’s,
when these studies were conducted, for researchers to col-
lect data only at the beginning and endpoint of their study,
rather than make continuous measurements. Models are
capable of deriving much more information from a series
of measurements when the system is responding or recov-
ering from a highly dynamic stress compared to measure-
ments made at steady-state [10]. In a similar vein, because
data from spaceflight and bedrest were often collected not
more than once a day, and not at the very start of the study,
it was not possible to validate the model’s capabilities to
predict acute changes that occurred during the first few
hours after initiation of these hypogravic stresses. In some
cases, this led to the use of published ground-based stud-
ies to uncover appropriate data; in a few cases it was pos-
sible to recommend new data collection protocols to
researchers or to develop novel data analysis techniques
for deriving the type of data needed from data already
collected. But in most cases the model responses were sim-
ply offered as predictions awaiting future experimental
verification.
Another class of model limitations and design con-
siderations concerns certain mathematical and computer
issues. The human system is notoriously nonlinear and
the biological modeler is bound to encounter
nonlinearities and higher order control systems. The math-
ematics and numerical solutions of these systems are very
difficult, even with the aid of the large high-speed com-
puters available at the time. For this reason, it was neces-
sary when developing models, to simplify as much as
possible, to linearize wherever possible, and to limit the
scope of the model as much as is acceptable. Special simu-
lation algorithms for computations involving integration
step sizes and the use of fast and slow controllers for the
same function were developed for this purpose. Simplic-
ity, linearity, and efficiency of operation are worth striv-
ing for in model design when they can be accomplished
without compromising the basic purpose of the model.
In formulating the individual equations that compose
a model, one often creates the simplifying assumptions
that make the problem solvable. These typically include
lumping compartments and parameters, linearizing other-
wise non-linear processes, assuming perfectly mixed com-
partments, and transforming a system variable into a fixed
parameter. Assumptions such as these should be supported
by some type of experimental evidence. It may seem that
models constructed with these assumptions may bear little
relevance to the real system being modeled, but it has
been shown that such models can provide useful informa-
tion that cannot be easily obtained by other methods.
Finally, it should be mentioned that the application
of mathematical simulation models to physiology and
medicine was not generally accepted as a research tool in
the 1970’s, even within the ranks of NASA scientists. Not
all physiologists have the mathematician’s training to criti-
cally evaluate the mathematical description given in a
model, and they are understandably often skeptical. The
simplifying assumptions, described above, do not always
receive general acceptance, nor does the building of “black
box” transfer functions that often are found in math mod-
els. The team approach of systems analysts and modelers
on one hand, and the principal investigators and research-
ers on the other hand was crucial to the success of this
project. Modelers contributed their special systems analy-
sis approach including models and data analysis tech-
niques while researchers provided the data,  their
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understanding of the biology, and hypotheses that could
be tested in the models.
2.4.5 Models Considered for Spaceflight Simulation
As the data related to each disciplinary area was ex-
amined, the mathematical models were valuable for search-
ing for underlying mechanisms. It was therefore important
to utilize models of different organ systems to generally
correspond to the different investigative areas of flight
research. The following physiological subsystems were
identified as being critical for meeting the simulation re-
quirements of the biomedical spaceflight research program
and for subsequent inclusion in an integrated whole-body
model: cardiovascular, respiratory, thermoregulatory, re-
nal, endocrine, body fluids, autonomic controls and eryth-
ropoietic. Candidate biological models were identified and
evaluated for their ability to simulate various aspects of
the spaceflight physiological testing protocols. This in-
cluded identifying, developing, or modifying input/out-
put transfer functions, assumptions, verification and
validation concepts, limitations, success criteria, and miss-
ing model elements. Modifications were necessary in most
of the models that currently existed in order to satisfy the
research requirements. In several cases, existing models
were not available and they were developed under this
project. Their utility was greatly increased in all cases by
programming them for interactive use on remote terminals
with graphical display capabilities – a feature quite un-
common at the time. This initial study provided a basic
framework for evaluating models, defining objectives and
developing software requirements for models and data-
base management systems.
During the development of a program to study man’s
physiological adaptation to weightlessness, it became
obvious that a large-scale human simulation system would
be a valuable asset to such an undertaking. Therefore, a
major objective of the study was to develop a Whole-Body
Algorithm that would be useful for evaluating hypotheses
related to the physiological adaptation to spaceflight.
Although the physiologic interaction of major body sub-
systems had been a subject of interest to researchers for
some time, the use of interacting models in concert to study
this phenomenon had received little attention. These stud-
ies were also limited by the availability of computational
equipment and software capable of handling models of
the required magnitude and scope (a constraint that no
longer exists). By “whole-body”, it is meant that the model
will include significant aspects of several of the major
body regulatory systems including the cardiovascular, res-
piratory, renal, erythropoietic, endocrine, and thermoregu-
latory systems. Independently operating subsystem
simulations have important applications, but, as such,
important interactions between subsystems are lost. The
full power of the scientific approach is only utilized when
respiratory, cardiovascular, thermoregulatory, renal regu-
latory system and fluid balance influences are fully ac-
commodated in a dynamic sense. Thus, a disturbance in
one subsystem could reveal its influence on other subsystems.
Also, the effects of spaceflight are presumably not confined
to any one of these individual subsystems and so the Whole-
Body Algorithm would permit evaluation of an integrated
total body response.
In addition, the Whole-Body Algorithm would be ca-
pable of responding to both long and short-term stresses
of various kinds. Perturbations of interest are exercise,
chemical imbalances, gravitational changes (i.e., postural
change, bedrest, weightlessness), internal fluid distur-
bances (i.e., LBNP, water immersion), other abnormal en-
vironmental conditions (i.e., hypoxia, hypercapnia,
ambient temperature excursions), and simple dietary
changes of fluids and electrolytes. It was envisioned that
such a model would be capable of simulating the inte-
grated physiological response to a “typical” Skylab mis-
sion, as shown in Fig. 2-2. This scenario included the entire
sequence of major physiological events for long-duration
spaceflight consisting of gravitational and environmental
disturbances and physiological tests such as exercise and
LBNP. With all these models, multiple stresses and se-
quential stresses of varying degrees can be applied, just as
in an actual experimental protocol. For example, a simu-
lation might attempt to show that LBNP tests at regular
intervals might exhibit different results as the body adapts
to the zero-g environment in a long-term mission, as was
observed in Skylab.
Other uses of this technology in medicine and physi-
ology can be realized when subsystem models are joined
together to simulate the interaction between major body
systems. For example, simulation could be used for real-
time monitoring of patients, providing extrapolation of
clinical trends in important parameters, identifying the
critical parameters in a system and the level of accuracy
needed in their measurement, aiding in diagnosis, and in-
dicating patient response to simulated therapy.
In summary, the following mathematical models have
been developed and modified for six physiological sub-
systems and further integrated into a combined model:
1. A pulsatile model of the cardiovascular system
2. A model of the thermoregulatory system
3. A model of respiratory control
4. A model of the circulatory regulation and fluid-elec-
trolyte balance
5. A model of erythropoiesis control
6. A model of calcium and bone regulation.
7. A Whole-Body Algorithm capable of simulating dy-
namic subsystem interactions for short term experi-
mental stresses and long term adaptation.
The first three models were designed to simulate short-
term stress responses (shown in Fig. 2-3) while the next
three models were capable of long-term stress responses
(shown in Fig. 2-4). The general scheme for incorporating
these models (except for the calcium regulatory model) in
a Whole-Body Algorithm is illustrated in Fig. 2-5. All these
models can be characterized as being deterministic, non-
linear, and continuous, using finite difference formula-
tions. The models themselves are described in detail in
Chapter 3 and Appendices. An example of an entire model
development, including the physiological overview, the de-
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Figure 2-2. A hypothetical spaceflight sequence of events that the Whole-Body Algorithm was designed to simulate. Typical events
include changes in gravity including acute and long term adaptation, environmental disturbances such as temperature or carbon dioxide
excursions, and periodic physiological tests such as exercise and lower body negative pressure (LBNP).
Figure 2-3. Three models use for simulating short-term physiological responses. The numbers of input parameters and output variables
indicate the relative complexity of the models. (Key: pO2 and pCO2, partial pressures of oxygen and carbon dioxide, respectively).
O2
CO2
pO2
pCO2
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Figure 2-4. Three models used for simulating long-term physiological responses. See caption for Fig. 2-3.
Figure 2-5. Schema of the Whole-Body Algorithm showing the mode of connection between short-term and long-term subsystem
models.
pO2
pO2
O2
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tailed equations and the validation simulations are provided
for the model of erythropoiesis regulation, a small but very
useful model (see Appendix B). Applications for using these
models to solve problems in spaceflight physiology are
presented in Chapters 5 to 9.
2.5 Approach to Hypothesis Testing
The systems analysis approach used in formulating a deeper
understanding of the physiology of weightlessness is illus-
trated in Fig. 2-6. One of the first steps in the process is to
describe the acute and long-term changes that occur during
weightless spaceflight. The database and analysis system is
an essential tool in this process. This system permits large
arrays of data to be scanned rapidly, while variables are cor-
related visually or automatically, and hypotheses are tested
for statistical significance. It is necessary to examine both
spaceflight and ground-based data to arrive at a complete a
picture as possible of hypogravic responses.
Such an evaluation of experimental data can lead, under
appropriate conditions, to a qualitative formulation of alter-
native mechanisms involved in producing the observed re-
sponses. The procedure draws heavily upon the theory of
physiological feedback regulating systems and often sug-
gests hypotheses capable of being tested in a model. A quali-
tative description of these pathways, while useful as a starting
point, does little to suggest the relative influence of each
mechanism. Only by a quantitative evaluation of that system
is it possible to discern if the sum total of positive and nega-
tive effects, interacting in a manner previously postulated,
will indeed lead to the observed response.
Actual testing of the hypotheses using the mathemati-
cal models constitutes the next step in this process. Ac-
ceptable candidate hypotheses can be reduced to
mathematical expressions and inserted into the models,
and by performing the appropriate simulations, they can
be used to predict the effect of the hypotheses on other
subsystems. It is then possible to study the physiological
mechanisms in detail that brought about the appropriate
response. As the simulation study proceeds, it is possible
to incorporate increasingly more diverse kinds of experi-
mental results and hypotheses into a single model. While
each hypothesis alone would not support a generalized
theory, all of them taken together may converge toward a
coherent picture of zero-g adaptation. Examples that il-
lustrate this important process of hypothesis testing will
be found in abundance throughout the book.
The simulation models can be considered a collec-
tion of integrated theories and empirical relationships
against which a large portion of the spaceflight data can
be compared, evaluated, and tested for consistencies or
discrepancies. Good agreement between model output and
experimental data furnishes a certain level of confirma-
tion for the hypothesis under consideration, but does not
“prove” that the hypothesis is true. Poor agreement or con-
tradictions between model output and actual data cause
one to question the hypothesis under investigation, the
structure of the model itself, or the validity of the experi-
mental data. As emphasized previously, such a state of
poor agreement, at least initially, is the more interesting
scenario, and becomes the basis for additional data analy-
sis, the design of new experiments, new model refinements,
or new hypotheses. Using this approach, the findings of
each of the Skylab experiments could be integrated with
each other with a goal of formulating an overall hypoth-
esis of spaceflight adaptation.
The modeling system and hypothesis testing approach
developed for the spaceflight biomedical program, was
built as a research tool that could evolve along with a
long term and broad based physiological research pro-
gram. This is meant to be an iterative process with the
researcher as a crucial element in the loop. It offers the
capability for developing, modifying, and refining hy-
potheses as well as aiding the investigator to visualize the
dynamic physiological consequences in the response of
the total system due to the hypotheses. By suggesting new
experiments and aiding in their design, this process be-
comes an even more powerful research tool. This combi-
nation of theoretical simulation analysis (to test
hypotheses and identify gaps in knowledge) and acquisi-
tion of experimental data (to reveal actual system behav-
ior) has long been recognized as providing the most
effective use of mathematical models [10].
Hypothesis testing is a time-honored approach to solv-
ing scientific questions. In hypothesis-driven research, the
experimental procedures for collecting data and the sub-
sequent statistical analysis are based, largely, on formu-
lating the hypothesis prior to the experimental design. In
contrast, it is perfectly acceptable to use model simula-
tions to help interpret data by formulating and testing
hypotheses after the experiment is completed. This is an-
other reason for viewing modeling as a complement to
more traditional research activities.
2.6 Critical Questions
As should be evident from the above discussion, the ac-
tivities discussed in this volume were not meant to be
simply an exercise in technological approaches or math-
ematical modeling, but rather a meaningful (although non-
traditional) contribution to space biology. As is true for
most research endeavors, this one was driven by hypoth-
eses, themes, and critical questions. The central overrid-
ing hypothesis and theme is dependent upon the systems
analysis approach, specifically,
Central hypothesis: A systems analysis approach,
including the use of mathematical models of physiological
systems, can assist in resolving current issues in space
biology and provide a better understanding of the
physiological adaptation to spaceflight.
The physiological issues themselves are directly ad-
dressed by posing several broad non-trivial critical ques-
tions. The answers to these questions, while not dependent
on systems analysis, might benefit from the insights of
such a quantitative approach. One should read these ques-
tions in the context of the time period in which they were
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Figure 2-6. Schematic illustrating the systems analysis approach to hypothesis testing in the space life sciences.
posed – approximately 10 years after the first manned flight
and with much uncertainty regarding fundamental effects
of gravity on the human body.
a) Can the physiological changes observed in humans
during space travel be attributed to normal and pre-
dictable consequences of known physiological mecha-
nisms and adaptation processes or are they
pathological in nature?
b) Are there underlying phenomena common to all the
physiological events observed in space, the identifi-
cation of which would help explain most of the ob-
served findings?
c) What is the common thread between the physiologi-
cal response to spaceflight and that found during one-
g analogs such as water immersion, bedrest and
head-down tilt? In what significant ways do they differ?
d) Can the differences between the Skylab missions (i.e.,
exercise levels) caloric intake, motion sickness inci-
dence, ambient oxygen content, help explain the differ-
ences in the responses among the nine crewmembers?
e) Is there a generalized response to spaceflight and other
hypogravic maneuvers? Can a unified theory of physi-
ological adaptation to weightlessness be formulated
that explains the most significant findings, and if so,
what are its most characteristic features?
2.7 Structure of Book
The themes and critical questions discussed above will be
addressed in the remainder of the book which may be con-
veniently divided into four categories:
Systems Analysis Approach
Chapter 3 is a presentation of the systems analysis
tools that were developed and used in this project, in-
cluding the data analysis systems and mathematical
models. Appendix A is a summary of the fundamentals
of modeling and simulation methodology for the unfa-
miliar reader.
Appendices B, C and D contains supplementary de-
tails of the model of erythropoiesis regulation, the Guyton
model of circulatory control, and the Whole-Body Algo-
rithm, respectively.
Appendix E is an illustration of sensitivity analysis
using the thermoregulatory model.
Subsystem Hypothesis Development
This grouping of chapters focuses on the application
of mathematical modeling for the development and test-
ing of hypotheses in four discipline (or subsystem) areas:
Chapter 5, Fluid-Electrolyte Regulation features studies
with the Circulatory, Fluid and Electrolyte model of Guyton.
Processed Data Qualitative
Quantitative Evaluation of
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Chapter 6, Erythropoiesis Regulation features stud-
ies with the Erythropoiesis Regulatory model.
Chapter 7, Cardiovascular Regulatory features stud-
ies with the pulsatile Cardiovascular Regulation model.
Chapter 8, Calcium Regulation features studies with
a Calcium Regulatory model.
Integrated Analysis
The two chapters in this “section” emphasize integra-
tion of topics in two different types of areas:
Chapter 4, Integrated Metabolic Analysis describes a
data analysis, rather than a simulation modeling, activity. It
extends the analysis of the valuable metabolic data collected
on Skylab (water, electrolytes, protein, and fat) beyond that
intended by the Skylab researchers. Several simple but novel
approaches for metabolic balances were developed. An inte-
grated approach for computing balances of water, sodium,
potassium, evaporative water loss, nitrogen, and calories is
contained in this single chapter. The results of this chapter
were useful in many of the modeling studies and therefore,
they are placed in a chapter which precedes the chapters on
Subystem Hypothesis Development. Appendix F contains
supplementary information for these analyses.
Chapter 9, Integrated Systems Analysis attempts to
integrate the concepts and hypotheses developed in pre-
ceding chapters by applying them to major simulation
studies of various hypogravic situations. Here you will
find simulations of postural changes including orthostasis
and head-down tilt, supine bedrest, head-down bedrest and
water immersion. The validation study of the Whole-Body
Algorithm is also included. Most of the other simulations
utilize a modified Guyton model.
Conclusions
Chapter 10, Discussion and Conclusions summarizes
the most significant aspects of the project focusing on the
two major aspects of this work: a) the advantages and limi-
tations of the systems analysis approach and b) the con-
clusions reached regarding physiological adaptation to
microgravity.
Chapter 11, Future Activities describes possibilities for
applications of systems analysis and modeling that are be-
yond the scope of the current volume, but which were ad-
dressed in some fashion during the project. Ideas for new
models including an advanced whole-body model are in-
cluded, as well as applications in countermeasure develop-
ment, support for flight experiment design, crew health and
performance, science management, and teaching models.
Appendix G, Accomplishments and Recommendations
succinctly lists the accomplishments of the current project
in one place and specific recommendations for model im-
provements and the research that can provide answers to
issues raised in the analysis.
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Chapter 3
A Systems Approach for Understanding Spaceflight
Physiology
The Skylab missions provided an opportunity to study
the effects of spaceflight on man by enabling the collec-
tion of experimental data from several individuals over
extended periods. Because such data describing human
performance and adaptation was vast in quantity and wide
in scope, a systems analysis approach was taken to ana-
lyze the data and to develop hypotheses relating to the
nature of the physiological events underlying the data.
This approach is illustrated in Fig. 3-1. A unique as-
pect of this approach is the blending of two separate teams
of researchers: an interdisciplinary team of NASA biomedi-
cal investigators and a systems analysis team. The NASA
team consisted of principal investigators for some of the
most important Skylab biomedical experiments in the ar-
eas of cardiovascular, musculoskeletal, fluid-endocrine
regulation, and hematology. The systems analysis team
(from General Electric Co., Space Systems Division) were
experts in bioengineering, computer systems, systems
analysis and mathematical modeling; they provided ana-
lytical tools for interpreting and integrating the space-
flight related data such as simulation models of
physiological systems and automated data analysis pack-
ages. An hypothesis development and testing approach
was used for data interpretation which is described below
and at the end of this chapter, the purpose of which was to
formulate an integrated hypothesis for human adaptation
to the microgravity of spaceflight. It was envisioned that
if such an overall hypothesis could be developed and in-
corporated in simulation models, it would be possible to
predict responses that were not previously measurable,
design experiments that would test these predictions, and
eventually develop a system for real-time physiological
monitoring of spaceflight crews.
Figure 3-2 illustrates the typical kinds of interactions
that occurred between the principal scientific investiga-
tors and the members of the systems analysis team. To
begin with, the data are subjected to preliminary analysis
and tentative hypotheses are advanced which might ex-
plain the observed data. Then, using detailed mathemati-
cal models of the systems involved, these hypotheses are
tested by comparing the model output for the stress being
considered with the experimentally observed responses
for the same stress. These comparisons lead to additional
and more sophisticated data analysis, to refinements of
the mathematical models, to changes in the hypotheses
being considered or even suggest the design of new ex-
periments to be performed either in space or on Earth. Given
the new data, the modified model, or the changed hypoth-
eses, the entire process is repeated until satisfaction is
obtained. This iterative process is the heart of the systems
analysis method, because it enables the scientific investiga-
tor to visualize the suite of dynamic changes and conse-
quences that accompany certain hypotheses (given the state
of the model) and to change either the model or the hypoth-
eses (or both) if the model output does not agree with the
experimental data or if an hypothesis proves to have im-
plausible consequences. In this manner, knowledge of the
systems in question can be built up in a logical manner.
The following sections contain discussions of the main
elements of this approach and the manner in which they
were applied to the overall project. These elements in-
clude a data base and analysis system, simulation models,
and hypothesis testing procedures.
3.1 The Data Base and Analysis System
The Skylab medical experiments yielded data describing
many aspects of man’s reaction to spaceflight. Inflight
experiments were conducted and measurements were made
to gather data regarding such investigative areas as circu-
latory function, biochemistry, body fluids, nutrition, he-
matology, and body composition. In addition to data
collected during flight, additional data were collected
through ground-based measurements; some of the non-
flight data were used as control data. The data also in-
cluded extensive clinical and environmental factors (i.e.,
environmental parameters, medical signs and symptoms,
drug usage, and personal exercise) useful for evaluating
unusual trends in the experimental observations. The con-
tents of the clinical and environmental data sets have been
documented [1], and includes the most significant daily
changes in physiological function.
To enable effective use of this information, it was or-
ganized into an integrated data system that could be used
by scientists and engineers. This database and analysis
system, called the Skylab Integrated Medical Data Analy-
sis System (SIMDAS)*, was connected to a high-speed, time-
sharing computing system at the Johnson Space Center.
Although the number of components integrated into
SIMDAS was large, they can be conveniently divided into
three main categories: (1) a data base containing all the
necessary spaceflight medical data, (2) an automated data
analysis system including statistical analysis programs and
various special-purpose analysis programs, and (3) com-
puter simulation models of the major physiological sys-
tems. The total interactive capability of this system is
suggested in Fig. 3-3. The quantity of data contained in
SIMDAS is quite large; information for approximately 900
man-days of spaceflight study is provided by 80,000 mea-
surement values representing 860 independent parameters.
                                                                                                *h
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Figure 3-1. Technical approach for Skylab data integration.
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Figure 3-2. Interdisciplinary team concept for testing hypotheses.
3.1.1 Data Analysis System
The data analysis capabilities of SIMDAS helped re-
veal subtle as well as striking changes in the physiologi-
cal status of the crewmen at any time during the preflight,
inflight, and postflight phases of the missions. The pro-
grams included in SIMDAS can retrieve each set of data
(all values of a given parameter measured during a speci-
fied period) and can generate routine statistical informa-
tion such as maximum and minimum values, arithmetic
means, standard deviation, and 95% confidence intervals
(see Fig. 3-4). To assist in hypothesis development and
testing, a set of regression functions was also included.
Because the data of all experiments were available in a
common system, the capability existed to correlate results
from different investigative areas and thereby to achieve
an interdisciplinary analysis.
To increase the capability of the analysis system,
SIMDAS was structured to allow the addition of analysis
programs from two large statistical packages, the Univac
STAT-PAK and the University of California (Los Angeles)
Biomedical Computer Program (BMD). The statistical ca-
pabilities offered by these packages include programs for
multivariate analysis (including discriminant and factor
analysis techniques), time series analysis, analysis of vari-
ance, non-linear regression analysis, significance tests, and
distribution functions. Cross-correlation and autocorre-
lation functions can be used to discern periodicities in the
data and similarities between different time series.
Several basic programs were written to enable rapid
analysis of data from any mission or group of missions.
These programs plot the average response of all nine crew-
men for specific parameters and provide analysis of vari-
ance data from the same crewmen, either separately or col-
lectively. This group of programs also compiles the
observations that are outside three standard deviations
from the preflight mean for a given parameter.
Another group of programs was designed as a means
of scanning the entire database for statistically signifi-
cant relationships between parameters in different investi-
gative areas. These programs were capable of performing
correlation analyses, including data from all nine Skylab
crewmen for any group of measurements selected, rank
correlation based on the number of significant deviations
from the preflight mean, and a factor analysis for any group
of measurements selected [2].
A group of more sophisticated programs was designed
for converting some of the raw data into meaningful pa-
rameters and indices. The programs in this group calcu-
lated, among other things, mechanical and metabolic
efficiencies during bicycle ergometry tests and also cal-
culated other performance indices during exercise. Con-
versions such as these contributed extensively to the
development of hypotheses concerning the effect of space-
flight on the cardiovascular system.
3.1.2 Integrated Metabolic Balance Analysis
An important set of programs was developed to inte-
grate all of the data relevant to measuring changes in body
composition and metabolism. The concept of the integrated
metabolic balance analysis is shown in Fig. 3-5. As shown
here, the data and the major computed quantities can be
categorized into water balance, energy balance and nutri-
Systems Analysis Team
▲
▲
▲
NASA Principal
Scientific Investigators
Model development
Provide descriptive analyses,
interactive data system, and
secondary analyses
Develop model formulation
of hypotheses
Test hypotheses
Combine hypotheses
Preliminary findings, hypotheses,
interpretations, suggested analyses
Refine and develop
additional hypotheses
Verify assumptions and
simplifications
Physiological interpretation,
hypotheses modification or
refinement, ground-based
experiments
▲
▲
▲
▲
▲
▲
▲
▲
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Figure 3-3. Skylab integrated medical data analysis system (SIMDAS).
NASA/CR—2020-220487 44
Figure 3-4. Typical Skylab data retrieval display. In this example, the preflight (PRE) urine volume (URVOL1) for the commander (C)
on the first mission (SL2) is displayed in chronological order in the leftmost column, with the Julian and calendar dates given in the other
columns. The notation H,M,S, refers to the time. In certain experiments, several measurements were obtained on the same day and, in that
case, the time (hours, minutes, seconds) is also given. Statistical data for the entire set of values are computed and recorded above the
tabular listing.
DATA FUNCTN ....START.... ....STOP....  NO.
 IDEN  NO.  BASE  EXPER  MAN PHASE  DAY  HR MN SE DAY HR MN SE DATA
> URVOL1 1  SL2  M073  C  PRE  114  144  18
 1923.0 = HIGH VALUE  710.0 = LOW VALUE
964.25 = MEAN  247.81 = STD. DEV  1.99 = T AT .95
 1239.0  115D  H  M S APR 25  1973
 911.0  116D  H  M S APR 26  1973
 1336.0  117D  H  M S APR 27  1973
 901.0  118D  H  M S APR 28  1973
 710.0  119D  H  M S APR 29  1973
 1503.0  123D  H  M S MAY 3 1973
 938.0  124D  H  M S MAY 4 1973
 83?.0  125D  H  M S MAY 6 1973
 1441.0  126D  H  M S MAY 6 1973
 1150.0  127D  H  M S MAY 7 1973
 1775.0  128D  H  M S MAY 8 1973
 1014.0  129D  H  M S MAY 9 1973
 1495.0  130D  H  M S MAY 10  1973
 1284.0  131D  H  M S MAY 11  1973
 1923.0  132D  H  M S MAY 12  1973
 851.0  133D  H  M S MAY 13  1973
 1883.0  134D  H  M S MAY 14  1973
 1816.0  137D  H  M S MAY 17  1973
Figure 3-5. Integrated metabolic balance analysis. Complete metabolic data on water, minerals, nutrients, and calories were collected daily for
each crewman. The analysis of these data (shown in ovals) enabled calculation of the components shown by the arrows.
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ent balance groups. The extensive Skylab data base in-
clude such relevant measurements as complete inflight
daily metabolic balances for energy, water, nitrogen and
electrolytes; body mass; as well as pre- and postflight de-
terminations of changes in body water, body density, and
whole-body electrolytes. The analysis yielded the time
course for rates of water, electrolyte, protein and fat losses
from the body during long-duration spaceflight. The ap-
proach for the analysis is based on fundamental equations
of conservation for mass, water, and energy. Some quanti-
ties shown in Fig. 3-5 were not measured directly, or were
measured very infrequently. A new technique for analyz-
ing this metabolic balance data was developed which per-
mits cumulative balances to be computed without incurring
the large errors that are normally obtained when this is
done. The use of mathematical models resulted in plau-
sible estimates of some changes that were not amenable to
direct measurement. The models also provided a means to
understand the physiological processes that regulate fluid
and electrolyte fluxes and volumes. The results of this
extended analysis are presented in Chapter 4.
3.1.3 Graphical Interface
Interpretations of data analyses and of simulation out-
puts were simplified by using graphical rather than tabu-
lar computer monitor display. Discrete jumps, linear trends,
periodicity and some other complex functions are more
quickly recognized by the user when computer-plotting ca-
pabilities are used and the results are displayed in a graphi-
cal manner on a monitor screen. Data concerned with a
dependent variable can be plotted either against time or
against values of another dependent variable to construct
time-trend plots or scatter diagrams (Figs. 3-6 to 3-8).
Computer graphics were also used directly with the
simulation models, both to display the model output in a
convenient form (Fig. 3-9) and to facilitate comparison of
the simulation results with Skylab experimental data (Fig.
3-10). All software for SIMDAS was designed for the Univac
1108/1110 computer under the EXEC 8 remote operating
system and programmed using Fortran V language. The
approximate core memory required by these programs is
20,000 words.
3.2 The Physiological Models
A distinctive feature of the integrative data analysis was
the use of a group of mathematical models describing each
physiological system of interest. The object of develop-
Figure 3-6. Example of cathode-ray-tube (CRT) display of Skylab
data (urine calcium for the pilot crewmember on Skylab 4 (SL-4
PLT) with separate regression analysis lines for preflight, inflight,
and postflight phases.
Figure 3-7. Example of a SIMDAS-generated scatter diagram
showing relationship between urine volume (abscissa) and urine
osmolarity (ordinate) as well as regression line.
Figure 3-8. Four examples of the variety of formats in which the
SIMDAS-generated data can be graphed.
 URINE VOL VS. OSMOLALITY SL2 CDR
UDS2C   1122
UDS2C    328
                       530                1070 1610 2150
UU2C
TIME (DAYS)
URVOLI 2500.0
URVOLI 500.0
URVOLI 2500.0
URVOLI 500.0
URVOLI 2500.0
URVOLI 500.0
URVOLI 2500.0
URVOLI 500.0
 —— —
 — - - —
 — — —
 — - — -
 – – – –
P4307 00
I4307 00
B4307 00
P4P07 00
I4P07 00
B4P07 00
                      293                     320                       350                        380                       410
TIME (DAYS)
B4P07  20  00
I4P07  20 00
P4P07 20 00
B4307  20 00
I4307   20 00
P4307  20 00
 URINE CA (MEQ/TV) SL4 PLT
 – – – –
 — - — -
 — — —
 — - - —
 —— —
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Figure 3-9. Example of SIMDAS-generated CRT display of simu-
lation output from cardiovascular model showing transient re-
sponses to exercise (5 minutes at 200 watts). Symbols: HR =
heart rate, SYST = systolic blood pressure, DIAS = diastolic
blood pressure, CO = cardiac output, SV = stroke volume, and
TPR = total peripheral resistance.
 ———
 - - - - -
 - -- - --
HR    200 00
SYST  200 00
DIAS  200 00
 ———
 - - - - -
 - -- - --
DIAS 00
SYST 00
HR 00
 ———
 - - - - -
 - -- - --
CO    40 00
SV               00
TPR   20 00
 ———
 - - - - -
 - -- - --
TPR 00
SV 00
CO 00
  0 2.0               4.0                  6.0                 8.0                10.0
TIME (MINUTES)
ing models suitable for computer simulation was to pre-
dict physiological behavior in weightlessness and to com-
pare the predictions with the experimental data generated
in the Skylab Program. This procedure would be expected
to provide insight into the process of zero-g adaptation
(see Chapter 2). The basic elements of mathematical mod-
eling and simulation are summarized in Appendix A for
the reader unfamiliar with these concepts.
Five separate models were employed in this project: a
pulsatile cardiovascular model, a respiratory model, a ther-
moregulatory model, a combined circulatory, fluid and
electrolyte balance model, and a red blood cell model. A
sixth model, termed a Whole-Body Algorithm, integrates
the five basic models into a common framework. In addi-
tion, a model of calcium regulation was developed more
recently, and its description is also included in this sec-
tion. The respiratory model and the circulatory, fluid, and
electrolyte model were selected from existing models de-
scribed in the scientific literature and modified to render
them appropriate to this project. The remaining models
resulted from research directly associated with this project
or other NASA programs. These models and their applica-
tions have been recently reviewed [3].
Taken as a group, these models are capable of simulat-
ing responses to many of the stresses that occurred on the
Skylab missions (fluid shifts, lower body negative pressure
(LBNP), tilt, exercise tests, and environmental disturbances).
The cardiovascular, respiratory, and thermoregulatory mod-
els may be considered to be exclusively short-term models,
inasmuch as they are useful for simulating events lasting
for several hours or less. The circulatory, fluid, and elec-
trolyte model as well as the erythropoiesis (red blood cell)
model are noted for their ability to simulate long-term
hormonal, reflex, and adaptive influences that last for sev-
eral weeks or months. The combination of both types of
models (short-term and long-term) into the Whole-Body
Algorithm resulted in a model for studying the interac-
tions between major sub-systems of the body and a means
of simulating with one model the short-term and long-
term stresses of spaceflight (see Figs. 2-3 to 2-5).
The models of physiological subsystems used in this
project provide a flexible method by which hypotheses of
spaceflight adaptation can be tested. Multiple stresses and
sequential degrees of stress can be simulated just as in a
real experimental protocol; by adjusting the value of one
or more of the fixed system parameters, many hypotheses
can be tested. Other hypotheses requiring a reformulation
of program structure may often be evaluated without dis-
turbing the remainder of the model (see Fig. 3-1).
Each physiological model examined in this volume
contains the basic elements of a feedback control system,
and each model can be represented by an active control-
ling system that regulates a relatively passive controlled
system. The feedback variables for these models include
representation of many of the actual sensors present in the
body (temperature sensors, chemoreceptors, baroreceptors,
oxygen sensors, and osmoreceptors). Each model is con-
structed of elements that represent real physiological func-
tion using algebraic or ordinary differential equations.
Such a model is termed deterministic. Less realistic mod-
els, often based on a “black box” design, do not have the
predictive range of deterministic models.
Many of the model features, including the major input
or system parameters and the variables generated or predicted
by the models, are summarized in Table 3-1. The total num-
ber of parameters and the variables indicated in this table
reflect the size and/or complexity of each model. It is ap-
parent that the current models are capable of integrating a
Figure 3-10. Example of simultaneous CRT display of Skylab
data and simulation results showing preflight LBNP test. Sym-
bols: HR = heart rate, SYS = systolic blood pressure, DIAS =
diastolic blood pressure, M = model results, and D = data.
 ———
 - - - - -
HR D 100 00
HR M 100 00
MODEL VS. SKYLAB PREFLIGHT DATA CREW SL3-SPT
 - - - - -
 ———
HR M 50 00
HR D 50 00
 ———
 - - - - -
SYS D 140 00
SYS M 140 00
 ———
 - - - - -
DIAS D 100 00
DIAS M 100 00
 - - - - -
 ———
DIAS M 60 00
DIAS D 60 00
 - - - - -
 ———
SYS M 100 00
SYS D 100 00
0                    1.0                 2.0                 3.0                 4.0 5.0
TIME (MIN)
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Circulatory, fluid-
electrolyte regulatory
model (7 circulatory
compartments; 5 body
fluid compartments)
Table 3-1. Capability of Current Models to Utilize and Predict Important Physiological Parameters
 Subsystem model Validated simulations  System parameters Output variables
 (known or assumed)  (predicted)
Exercise: salt loading; renal
failure; proteinura; intravenous
infusions; bedrest; congestive
heart failure; hemorrhage;
postural change; water
immersion; supine bedrest;
head-down bedrest
Fluid intake; sodium ion (Na+) and
potassium ion (K+) intake;
evaporative water loss; exercise
work rate; arterial oxygen (O2)
saturation; vascular compliances;
ventricular strength factor; plasma
protein production and destruction
rates; red blood cell (RBC)
production and destruction rate;
external body pressure; angle of tilt
(130 parameters)
Cardiac output; heart rate; stroke volume;
arterial pressure; venous pressure;
peripheral resistance; urine flow rate; Na+
and K+ excretion rates; renal and muscle
blood flows; blood volume; extracellular
fluid; intracellular fluid; total body water;
RBC mass; hematocrit; blood viscosity;
antidiuretic hormone concentration;
aldosterone concentration; renin and
angiotensin concentrations; Na+ and K+
plasma concentrations; O2 uptake
(370 variables)
Pulsatile
cardiovascular model
(28 compartments)
Exercise; tilt table; LBNP;
hemorrhage; training vs.
deconditioning
External workload; exercise
efficiency; LBNP intensity; tilt
angle; total blood volume;
compliances of veins, venules,
arteries, and arterioles; fixed flow
resistances; stress relaxation
sensitivity; length of vascular
segments (100 parameters)
Cardiac output; heart rate; stroke volume;
total peripheral resistance; systolic blood
pressure; diastolic blood pressure; heart
period; diastolic filling time; whole-body
blood volume distribution; blood pressure
(static and dynamic) profiles; whole-body
blood flow distribution; resistances to flow;
O2 uptake (350 variables)
Respiratory model
(4 compartments)
Hypoxia; hypercapnia; exercise Inspired O2; inspired carbon
dioxide (CO2); inspired nitrogen;
barometric pressure; metabolic rate;
total blood hemoglobin (Hb); blood
and tissue gas solubilities; blood-
brain gas diffusivities; tissue
masses; blood transport delays (30
parameters)
Minute volume; respiratory rate; dead-space
ventilation; cardiac output heart rate; arterial
partial oxygen pressure (pO2) and partial
carbon dioxide pressure (pCO2); venous
pO2 and pCO2; blood and brain pH; brain
blood flow; alveolar respiratory quotient;
O2-Hb concentration
(80 variables)
Thermoregulatory model
(41 compartments)
Environmental heat stress;
environmental cold stress;
exercise; effects of humidity,
clothing, air velocity, and
pressure
Total metabolic rate; tissue basal
metabolic rates; useful work
efficiency; body surface area; body
posture; ambient temperature; wall
temperature; ambient humidity;
ambient free-air velocity; ambient
pressure; gravity factor; clothing
factor; emissivity of outerwear;
specific heat of atmosphere; tissue
thermal conductivities; tissue heat
capacities; convection and radiation
coefficients; basal blood flows;
sweat distribution factors;
shivering distribution factors
(330 parameters)
Body temperature distribution; sweating
rate; insensible water losses; sensible heat
losses; heat storage; shivering rate; skin
blood flow; muscle blood flows
(300 variables)
Erythropoietic control
 model
   Human model
   Mouse model
Hypoxia; anemia; hyper-
volemia; polycythemia; red cell
infusion; dehydration;
abnormal Hb; bedrest
Arterial pO2; blood flow; plasma
volume; tissue metabolism; O2-Hb
capacity; RBC lifespan, bone
marrow gain
(20 parameters)
Red cell mass; hematocrit; red cell
production rate; red cell destruction rate;
tissue pO2; venous pO2; erythropoietin (40
variables)
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large quantity of information and are capable of predict-
ing behavior of a large number of physiological variables,
most of which have been previously identified as impor-
tant elements in spaceflight biomedical investigations.
Simulations performed during this study and by others are
also listed in Table 3-1. This table demonstrates the diver-
sity of conditions for which the models can be used in a
predictive mode. Details of many of the simulations are
provided in this section and throughout this publication.
The mathematical models used in this project were
designed or modified through a basic problem-solving ap-
proach. First, the system under study was thoroughly ana-
lyzed, and its most important elements and parameters were
identified. Then, a conceptual model was constructed by
specifying the simplifying assumptions to be used and
formulating the interactions, which would exist between
the elements of the system. All information was translated
into mathematical notation and, finally, into computer lan-
guage (Appendix A).
After the model had been defined in this manner and
the computer program had been written, values were se-
lected for the constants (parameters) contained in the model,
and the computer program was checked for correctness.
The program was then subjected to a series of tests that
ensured appropriate model responses when major param-
eters were changed. This entire process is called model
verification.
Next, the model was validated to establish its rela-
tionship to the real system. Probably the most significant
and demanding activity of model development, valida-
tion usually consists of comparison of model output to
real system responses for several specific stresses identi-
fied as being related to the model’s objectives. It is an
important guideline in model develoment that data used
for model validation be independent from that used for
model verification. Also, validation should be a continual
process, using data collected under different conditions;
this is vital to ensuring a model’s continued credibility. It
is critical that the modeler stay abreast of current research
regarding the real system that is being modeled; as new
knowledge is gained regarding this system, the model, in
turn, must be altered to reflect this new knowledge. Each
time the model is refined or otherwise modified, it must be
validated to ensure that it still accurately represents the
real system.
The models were validated for stresses in a one-g en-
vironment, and the experimental studies used for valida-
tion were derived from the ground-based experiments
associated with NASA’s training and biomedical program
where possible. Such stresses included bicycle ergometry
exercise, tilting, LBNP, bedrest, and water immersion. In
other cases, such as those involving hypoxia and thermal
stress, data from the literature were used. Some simula-
tions could not be properly validated, because data were
insufficient. For example, little information regarding
sweat losses during exercise at high altitude was avail-
able, and this information was necessary to validate the
thermoregulatory model for the low ambient pressure of
the Skylab environment. Situations such as this identified
new areas for research. When data was inadequate for quan-
titative validation, model credibility was demonstrated
using simulation techniques, e.g., sensitivity analysis, ca-
pable of systematically analyzing the general behavior of
a model for subsequent evaluation by subject-matter ex-
perts (see Appendix E for example).
A good example of the range of stresses required for
demonstrating model capability and credibility is illus-
trated in Table 3-2. In the left column are the various types
of fluid-electrolyte shifts encountered during the acute
and chronic inflight and recovery phases of weightless-
ness. In the right column are well-known one-g stresses
that are similar, in many respects, to the zero-g stress. Thus,
the response to the fluid shift from the legs in a zero-g
environment has many aspects similar to the one-g re-
sponse to water immersion, blood infusions, or saline in-
fusions. In the same manner, similarities can be seen
between one-g stresses such as dehydration, sodium and
potassium depletion, and hemorrhage in relation to the
spaceflight events of prolonged weightlessness and sub-
sequent recovery. Considerable effort was concentrated
on collecting suitable data for validating the circulatory,
fluid, and electrolyte model for the one-g counterparts of
zero-g stresses (postural changes, water immersion, and
bedrest). These studies are described in the remaining sec-
tions of this document (especially in Chapter 9). This dis-
cussion is not meant to suggest that an appropriate
simulation of spaceflight can be performed by combining
any or all of the one-g stresses, but this systematic valida-
tion approach has suggested improvements in the models
and adds credibility to their overall capabilities.
The final step in modeling a system included testing
the model over a wider data base than was used for valida-
tion, estimating parameters that were not yet measured,
predicting responses that are impractical to measure in the
real system, evaluating hypotheses, and making inferences
Table 3-2. Comparison Between Fluid-Electrolyte Shifts in
One-g and Spaceflight
Spaceflight stress Analogous one-g stress
Acute fluid stress at launch Water immersion
Blood shift from legs toward Blood infusion
head
Filtrate shift from leg Isotonic saline infusion
tissues toward head
Long-term fluid stress Bedrest
Loss of 1 to 1.5 liters fluid Dehydration
Loss of sodium Sodium depletion
Recovery fluid stress Bedrest recovery
Loss of central fluid volume Hemorrhage
due to loss of total blood volume
Loss of central fluid volume Hemorrhage
due to orthostasis and standing
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from the model to guide laboratory experimental design.
These advanced studies use a number of simulation tech-
niques including dynamic simulation, sensitivity analy-
sis, variation of parameters, error analysis, stability
analysis, and parameter estimation procedures (Appendix
A). The ultimate objective was to produce valid model
simulations for the stresses of interest when accompanied
by the long-term absence of gravity.
The models used in this project are described in the
following pages and their controlled and controller sys-
tems are illustrated in schematic diagrams. These models
have been described either in the open literature or in
NASA reports referenced under each model description.
User guides which include the computer programs (in For-
tran) are also available in the Scientific and Technical
Aerospace Report (STAR) library retrieval system.  When
description of some major  aspect of the model  (such as 
design concept, mathematical formulation, or modifications 
for  spaceflight simulation)   is not readily available in 
published  form, an  appendix is  provided to describe it. 
These models  were developed in  the 1965–1975  time-
frame. A brief review of more recent organ system models 
can be found in Ref. [3].
3.2.1 Pulsatile Cardiovascular Model
A pulsatile model of the cardiovascular system was
included in the collection of models to simulate the short-
term cardiovascular experiments performed on the Skylab
missions and other selected physiological stresses of
manned spaceflight. The simulation required a model con-
taining a physiological representation of the circulatory
system, including the arterial tree, the veins, the capillary
beds, and the heart; pulsatile blood flow; a closed-circuit
circulatory system; and the control functions regulating
the circulatory system. Such a model should be capable of
simulating steady-state and transient responses for short-
term events and responding to the selected stresses of ex-
ercise, LBNP, and an altered gravity vector to simulate
tilt. The cardiovascular model, as defined by these objec-
tives, required a representation of both the heart and the
circulatory system and a description of their interactions.
Much of the work on modeling and computer simula-
tion of the cardiovascular system and its controls has been
accomplished since the early 1950’s, although simple
mathematical formulations date back 200 years to Euler. One
of the most important models of this early period is that of E. H.
Starling [4]. Starling’s “law” or model has provided the basis for
an initial understanding of some of the dynamic characteris-
tics of the cardiovascular system and has been used di-
rectly in other mathematical models. Reviews of this and
other cardiovascular models are available [5,6,7,8].
The most recent models of the cardiovascular system
can be classified into two basic categories:pulsatile and
nonpulsatile. Pulsatile models are designed to account for
the inertial components of flow and periodic heartbeats
and thereby to enable simulations of the full range of pres-
sure pulses (i.e., systolic and diastolic pressures). In con-
trast, non-pulsatile models are less complex, have more
linear than nonlinear elements, and provide only continu-
ous blood flow and mean pressures. In these studies, a
pulsatile model [9] was used to simulate the short-term
cardiovascular events, whereas a non-pulsatile model [10]
was used for the longer-term adaptive processes.
Early mathematical analyses of pulsatile blood flow
contain assumptions of linearity and steady state. The re-
sults from these models agree very well with measured
values, unless nonlinear characteristics or transient re-
sponses are studied. These limitations in modeling pulsa-
tile blood flow were partly overcome in the present model
by a method developed by Rideout and Dick [11]. The
method yields difference-differential equations for fluid
flow in distensible tubes and forms the basis for solving
the fluid flow equations in many pulsatile models. The
most significant advantages of this approach are that non-
linear terms, important to a particular model, can be in-
cluded easily and that a complex solution of the model
may be avoided. Models using this approach have been
found to exhibit a higher fidelity of response and a greater
level of system detail.
Non-pulsatile, lumped cardiovascular models devel-
oped in recent years are especially effective in simulating
the long-term aspects of the circulatory system. In 1972,
Guyton and his associates [10] published a non-pulsatile
model that is very detailed and includes many mecha-
nisms outside the circulatory system that impact the fluid
balance and blood volume within the circulatory system.
Elements are also included to account for both short-term
and long-term stresses. This design resulted in a powerful
model that has been used successfully as a research tool
by the present authors. Nevertheless, the portion of the
Guyton model representing the circulation consists of a
limited number of compartments and does not contain the
level of detail required for certain aspects of this project.
The cardiovascular model as used here required pul-
satile, nonlinear, and non-steady-state features. In addi-
tion, the model needed the capability to respond to exercise
and to an altered gravity vector. Because models with the
required fidelity and complexity were not available, a
puslatile cardiovascular model was developed. The model
presented in this section was developed by Croston [9]
and was later modified to extend its application to space-
flight experiments [12,13].
3.2.1.1 Description of the Croston Model. The basic
mathematical model of the cardiovascular system is repre-
sented by two major blocks:the circulatory system, which
is the system being controlled, and the regulating or con-
trolling system, which provides feedback control to change
various circulatory parameters in response to imposed stress
changes (see Fig. 3-11). The circulatory system describes
pulsatile blood flows, pressures, and blood volumes for
the 28 compartments. Circulatory effects such as venous
tone, venous valves, leg muscle pumping, respiratory pres-
sure effects, gravity, and heart pumping are represented.
The regulatory system contains neurogenic and metabolic
factors that control heart rate, arteriolar resistance, and
venous tone. The load disturbances that may be specified
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by the simulator include exercise workload, work rate,
gravity, LBNP level, and blood volume. Any one of nearly
150 cardiovascular parameters can also be altered to test
hypotheses regarding changes in such factors as compli-
ance, controller gain, and heart strength. The more useful
output quantities that are generated by the model are oxy-
gen uptake, oxygen deficit, cardiac output, heart rate, vari-
ous blood flows, systolic pressure, diastolic pressure, mean
pressure, stroke volume, and venous and arterial pressures.
3.2.1.1.1 The Controlled System. The controlled sys-
tem consists of the heart and vascular systems. Figure 3-12
illustrates the 28 compartments of the circulatory model, in-
cluding arterial segments, venous segments, arteriovenous
branches, and the heart. Published anatomical and physi-
ological data in addition to selected data from previous
models are used to characterize the parameters of the gov-
erning differential equations. Nonlinear characteristics are
assigned to particular arteriovenous segments, as required,
to simulate elastic properties of the vessels over the wide
range of pressures observed during exercise. Figures 3-13
and 3-14, derived from Altman and Dittmer [14], illustrate
typical nonlinear characteristics of arteries and veins.
The pumping action of the heart is simulated with
time-varying inverse compliances. Other pumping actions
include the intrathoracic pressure effects, based on a simu-
lated respiratory frequency, and leg muscle pumping. The
beat-by-beat mode of operation exhibits a realistic pulsa-
tile response, including the dynamic effects of breathing
superimposed on the blood pressure responses for the rest-
ing or exercising human subject.
Solution of this mathematical model, which describes
unsteady, laminar fluid flow in a distensible tube, requires
solution of the Navier–Stokes equations. The previously
mentioned method of Rideout and Dick [11] was selected
since this technique yields a set of first-order, ordinary differ-
ential equations that can be solved routinely on a digital
computer. Also, the lumped-parameter coefficients of the
equations have anatomical and physiological significance,
and gravity forces and nonlinear terms are included easily.
Controlled variables shown in Fig. 3-11 include venous
tone, strength of heart contractions, and flow resistances.
These variables are controlled in proportion to simulated
metabolic and neurogenic factors discussed next.
3.2.1.1.2 The Controller System. Figure 3-15 is an over-
view block diagram of the model’s controlling sub-sys-
tem. Neural commands are assumed to be from
baroreceptors, chemoreceptors, muscular activity, and so-
matic anticipation and arousal inputs. The controller func-
tion is assumed to be proportional with a variable set-point
based on the sum of the command inputs.
Pressure sensors for the neural control loop consist of
stretch receptors located in the aortic arch and the carotid
sinuses. The model assumes activity from both the carotid
sinuses and the aortic arch, since pressures differ in the
vertical position in these two locations because of differ-
ent hydrostatic pressure. An important effector mechanism
of the blood pressure control loop is the sinoatrial (SA)
node of the heart, which is the site of neurogenic stimula-
tion. Heart rate is controlled by varying the diastolic de-
polarization period.
The effects of the sympathetic and vagus nerve
efferents are combined into a single signal. This combina-
tion is justified by noting that the sum of the two effects is
approximately linear over the range of mean arterial pres-
sures encountered during submaximal exercise [15]. Other
assumptions are that the controller gain is fixed in this
model throughout the range of submaximal exercise and
that the set-point for the arterial baroreceptor reflex is el-
evated during exercise. These assumptions are based on
studies by Bevegärd and Shepard [16].
The model uses the accepted hypothesis that meta-
bolic substances that are transported by the blood and are
significant factors in the control of heart rate are produced
during exercise. The variable “total metabolites” indi-
cated in Fig. 3-15 is meant to include products of metabo-
lism (i.e., lactate) concentrations of several known (i.e.,
catecholamines, and unknown chemical components), and
thermal energy. A key point of this hypothesis is that al-
Figure 3-11. Schematic of the pulsatile cardiovascular model showing major input parameters and output responses in addition to
elements of the controlled system and mechanisms of the controlling system.
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Figure 3-12. Block diagram of the cardiovascular model’s controlled system.
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Figure 3-14. Pressure-volume (compliance) relationship for venous segments.
Figure 3-13. Pressure-volume (compliance) relationship for arterial segments.
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Figure 3-15. Block diagram of the cardiovascular model’s controlling system.
though the total effect of metabolites is not proportional
to the exercise workload or to the rate of metabolism, it is
proportional to the time-dependent state of a cardiorespi-
ratory metabolic balance. The state is expressed in this
model as the sum of metabolic components due to an ini-
tial exercise transient (based on oxygen deficit), plus a
component due to accumulating metabolites (based on
oxygen uptake).
During exercise, these controlling elements elevate car-
diac output and leg blood flow by altering flow resistances
in the arterioles and the precapillary sphincters. Other flow
branches are controlled similarly to produce a realistic car-
diac-output distribution. At the same time, venous return
is enhanced by vasoconstrictor activity in venules and
small veins. This enhancement effectively decreases com-
pliance and decreases the unstressed volume [17].
3.2.1.2 Modifications to the Original Model. Croston’s
original computer simulation model for exercise was de-
signed to simulate the dynamic response of the cardiovas-
cular system to various levels of exercise. The experiment
simulated is bicycle ergometry in which the subject is sit-
ting erect on the bicycle ergometer in a one-g environ-
ment. A modification to the cardiovascular model enabled
simulation of tilt ergometry, in which the body angle rela-
tive to horizontal can be changed while bicycle ergometry
is simulated. This modification is related to developing a
zero-g simulation of bicycle ergometry for Skylab inflight
experiments. A supine or slightly tilted position (such that
the heart and the bicycle pedal axis are in the horizontal
plane, whereby the gravity heads of the circulatory ves-
sels are nulled) was thought to be a good representation of
microgravity effects on the blood column. In addition, a
version of the model was developed for simulating LBNP
and static tilt experiments. Many of the controlling mecha-
nisms required for exercise simulation are not necessary
to simulate LBNP and tilt (such as oxygen debt and total
metabolites). The control system model for LBNP and static
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tilt simulations is, therefore, a subset of the one shown in
Fig. 3-15 [7,8,13].
3.2.1.3 Limitations. During the course of this study, it was
apparent that the original exercise model did not contain
sufficient detail to simulate all the events of interest to the
investigators. Some of these deficiencies were overcome by
modifications that provided the capability for simulating
static tilt, tilt ergometry, and LBNP as described previously.
Other limitations remained; they are described here.
1. The model lacked adequate representation of tissue
filtration, hormonal regulation, and baroreceptor ad-
aptation and could not be used to maintain a satisfac-
tory simulation of experimental responses beyond 30
minutes. Consequently, the model is considered a
short-term model.
2. The model lacked the capability to simulate maximal
oxygen-uptake stress tests. It is likely that cardiac re-
serve or cardiac filling was inadequately modeled. At
intense levels of exercise, the arterial pressure falls
and creates an unrealistic reflexive increase in heart
rate.  This deficiency limits the model to the
submaximal range of exercise.
3. The model was validated for subjects who, although
not sedentary, were not as physically fit as the astro-
naut population. In addition, some of the Skylab crew-
men were in much better physical condition than
others. These differences in physical condition lead
to different exercise responses which could not be eas-
ily accounted for by the model.
4. The model does not have an explicit representation of
chemoreceptors. Although the model has the capabil-
ity to detect oxygen deficiencies that result from meta-
bolic effects, it could not respond to changes in the
content of inspired gases. Modifications were later
added to the Whole-Body Algorithm that corrected
this limitation during rest but not during exercise (see
section entitled “Description of the Whole-Body
Algorithm”).
In terms of the purpose and objectives of the model,
the limitations described are minor. Although they sug-
gested areas for improvement, they did not hinder the ini-
tial purposes for which the model was intended.
3.2.1.4 Model Validation. Specific simulations of bi-
cycle ergometry, lower body negative pressure, and tilt
experiments were developed and validated for one-g re-
sponse [12,13]. The validated model was then used to test
hypotheses of cardiovascular system changes in weight-
lessness by comparison of model results with actual crew
responses to these experiments while inflight. The one-g
validation studies are summarized below, while the zero-g
hypothesis testing studies are described in Chapter 7.
a) Validation for Exercise. The exercise simulation
model was initialized with characteristic parameters
for a group of young, untrained men in the sitting
position. This selection was made because of the ap-
plicability and availability of experimental data and
the observation that the experimental data are less
consistent when age groups are mixed. The steady-
state model values are compared (Fig. 3-16) with a set
of experimental data published by Ekblom et al. [18].
This particular set of data is for a group of eight male
students, age 19 to 27 years, exercising on a bicycle
ergometer. The model’s oxygen uptake for the par-
ticular group simulated is 1.5 liters/min at a work rate
of 100 watts with an assumed exercise work efficiency
of 25%. Simulation results indicate agreement within
plus or minus one standard deviation of the experi-
mental workloads run. Figure 3-9 is an example of the
model’s graphic output which shows a typical simula-
tion of the transient response to exercise.
b) Validation for LBNP and Tilt. The computer simu-
lation model for LBNP and tilt experiments [13] is
designed to simulate the dynamic response of the car-
diovascular system to an induced external negative
pressure applied to the lower body or to tilting of the
subject (on a tilt table) from supine to a head-up posi-
tion. Both experiments cause pooling of blood in the
lower body and are used by biomedical researchers as
a test of orthostatic tolerance. The simulation of LBNP
(Fig. 3-17(a)) is accomplished by applying externally
to the leg vessels a negative pressure term which in-
creases the transmural pressure and results in an in-
crease in blood volume of the leg compartments. The
tilt experiment is simulated in the model (Fig. 3-17(b))
by applying gravity pressure gradient terms to the vas-
cular compartments. The overall effect is a decrease
in blood volume above the heart and an increase in all
segments below the heart.
The major difference between LBNP and tilt stress
is that LBNP causes distention of the leg vascular seg-
ments and thereby pulls more blood into the legs from
the upper body, whereas the tilt experiment causes a
gradient in the direction of the gravity vector in every
vascular segment in the body in varying amounts,
depending on the length of the segment and its dis-
tance from the heart. The response of the cardiovascu-
lar system is somewhat different also. The model’s
response, supported by the experimental data of most
investigators, shows a large increase in diastolic blood
pressure and little change in systolic blood pressure
for the tilt simulation, and a substantial drop in sys-
tolic with little change in diastolic blood pressure for
the LBNP simulation. For both tilt and LBNP, an in-
crease in leg volume and heart rate and a decrease in
stroke volume are obtained.
Table 3-3 contains the steady-state model results
obtained for selected variables at rest in the supine
position after exposure to three levels of negative pres-
sure on the lower body and after a 70 ° tilt. The vari-
ables presented are heart rate (HR) in beats per minute;
cardiac output (CO) in liters per minute; stroke vol-
ume (SV) in milliliters; mean pressure (PM), systolic
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Figure 3-16. Exercise validation study showing steady-state responses of the cardiovascular model compared with experimental data
taken from Ref. [18]; (a) Oxygen uptake as a function of work rate, (b) Heart rate as a function of oxygen uptake, (c) Stroke volume as
a function of oxygen uptake, and (d) Blood pressure as a function of oxygen uptake.
● Experimental [18]
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pressure (SYST), and diastolic pressure (DIAS) in mil-
limeters mercury; and blood volume contained in the
legs (LEG BV) in milliliters. The simulations also
agree reasonable well with experimental results, in-
cluding Apollo and Skylab crew preflight data as
shown in Table 3-4 for LBNP and Table 3-5 for tilt.
There has been some disagreement in the experimen-
tal findings with regard to the similarity of response
to –40 to –50 mmHg LBNP and 70° head-up tilt. Some
investigators consider these to be similar stresses and
to produce similar responses (see review by Wolthuis
et al. [25]) However, the simulations and the data (Fig.
3-17 and Tables 3-3 to 3-5) demonstrate that in some
important respects, they are quite different and pro-
duce different responses.
3.2.2 Thermoregulatory Model
The first physiological computer model to be used in
the manned spaceflight program was that of the thermoregu-
latory system. The model selected for the present study re-
sulted from many years of development, modification, and
revision by several institutions, including NASA, the John
B. Pierce Foundation, Lockheed Electronics Division, and
General Electric Company. The NASA sponsored much of
this work and participated directly in the model’s validation
and application to designing life support systems of space
cabins and space suits. Five major objectives were formu-
lated for the thermoregulatory model used in this project.
1. Compute modes of heat loss from the body and heat
production within the body.
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Table 3-3. Steady-State Model Results
Stress  Parametera
HR  CO SV PM SYST DIAS LEG BV
Supine (rest) 62.4 6.55 105 90.3 126.7 72.4    447
LBNP
–30 mmHg 69.7 6.46 93 88.7 121.9 72.0    720
–40 mmHg 72.2 6.43 89 88.2 119.2 71.8    812
–50 mmHg 77.2 6.37 82 87.3 115.8 72.6    903
Tilt (70°) 80.9 5.6 69 89.4 124.6 80.4    851
 a
 Parameters and units described in text
Figure 3-17. Computer simulation of tilt (left) and LBNP (right). Upper pressure trace demonstrates pulsatile capability of model.
2. Compute heat balances, body heat storage, and tem-
peratures for the major segments of the body.
3. Predict body water loss from the three avenues of evapo-
ration: diffusion from skin, sweating, and respiratory
losses.
4. Simulate thermoregulatory responses to heat loads
caused by variable environmental conditions and ex-
ercise rates.
5. Simulate both dynamic responses and steady-state re-
sponses of the body in the cases under study.
The thermoregulatory model used in this program was
originated by Stolwijk and Hardy [26] as a seven-compart-
ment system. It was later expanded by Stolwijk [27,28] to a
25-node system that was validated not only for environmen-
tal effects but also for exercise. To increase the model’s fidel-
ity and extend its capabilities, it was subsequently
modified for NASA to include options for various layers
of clothing and liquid-cooled garments, and the number
of passive compartments was expanded to forty-one [29].
Other modifications made under the present program in-
NASA/CR—2020-220487 57
Table 3-5. Comparison of Tilt Model Results with Test Data
Change from rest Data Source
Model Apollo crew preflight  Ref.  Ref.  Ref.  Ref.  Ref.
 Avg. 12 subjects [20] [21] [22] [23] [24]
Increase in heart rate, beats/min,   18.5  15.3 15.0  15.5 14.0 15.6 13.0
Decrease in cardiac output, liters/min     0.94  —  —   — —   —   —
Decrease in cardiac output, percent   15.0  —  —   —       15 to 35   — 19.0
Decrease in stroke volume, ml   36.0  —  —   —  45   —   —
Decrease in stroke volume, percent   34.0  —  —   —  40   — 31.0
Decrease in systolic blood pressure, mmHg     2.1  — 10.0   –1.0  —   1.7   3.0
Increase in diastolic blood pressure mmHg     7.8  — –2.0     9.0  — 13.0   7.0
Increase in leg blood volume, ml 403.0  —  —           620.0  —   —    —
3.2.2.1 Description of the Thermoregulatory Model.
The thermoregulatory system was modeled as a control-
ling system and a controlled system (Fig. 3-18). The con-
trolled system consists of the body divided into
geometrical segments, each segment having its own ther-
mal characteristics. Changes in environmental thermal
clude improved equations for convection, radiation, evapo-
rative and respiratory loss, and shivering [30,31,32]. Cur-
rently, both a steady-state and a transient version are available
for use in the shirt-sleeve model [33,34]. Other approaches
to modeling the human thermal system are available and
have been reviewed by Fan et al. [35].
Table 3-4. Comparison of LBNP Model Results with Available Data Sources
Change from rest Data Source
Model  Apollo crew preflight Ref. [19] Ref. [20]
 Avg. 12 subjects
Increase in heart rate, beats/min, for LBNP, mmHg, of
–30 mmHg   7.3   4.4 —  —
–40 mmHg   9.8   8.9 8.0 11.89
–50 mmHg 15.1 14.6 —  —
Decrease in stroke volume, ml, for LBNP, mmHg, of
–30 mmHg 12.0  — —  —
–40 mmHg 16.0  — — 18.62
–50 mmHg 23.0  — —  —
Decrease in systolic blood pressure, mmHg,
for LBNP, mmHg, of
–30 mmHg   4.8  — —  —
–40 mmHg   7.5  — 7.0 6.61
–50 mmHg 10.9  — —  —
Increase in diastolic blood pressure mmHg,
for LBNP, mmHg, of
–30 mmHg –0.4  — —  —
–40 mmHg –0.6  — –3.5 0.16
–50 mmHg   0.2  — —  —
Increase in leg blood volume, ml, for LBNP, mmHg, of
–30 mmHg 274  — —  —
–40 mmHg 365  — –614 a419
–50 mmHg 456  — —  —
a
 Blood volume shifts calculated from percent change in leg volume by conversion factor derived from Ref. [19], where both calf circumference and
water plethysmograph measurements are given.
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loads act on the controlled system and change the tem-
peratures of its compartments. Heat production from exer-
cise is also permitted to alter body temperatures by way of
increased muscle metabolism. These disturbances are
sensed by thermal receptors that transmit temperature sig-
nals to an integrating and processing center. The control-
ling system is designed to maintain a heat balance using
all avenues of heat transfer. Control equations consist of
functions of the central temperature signal and the inte-
grated skin temperature signal. Appropriate commands are
sent to thermoregulatory elements changing skin and
muscle blood flow, rates of sweat secretion, and shivering.
The blood flow responses act to remove the excess heat
load by bringing greater quantities of warm blood to the
body surface, where thermal energy can be transferred
through the skin to the environment. Evaporation of sweat
is also a particularly effective cooling mechanism. In cool
environments, metabolic heat production may be increased
internally by the shivering mechanism in muscle tissue.
A total of 41 nodes is used to represent the thermal
characteristics of the body with 4 nodes each for the head
and trunk and each arm, hand, leg, and foot. The forty-first
node represents the central blood compartment. The four
nodes representing each of the segments are composed of
concentric layers treated as core, muscle, fat, and skin.
Each node has the appropriate metabolic heat production,
convective heat exchange with the central blood compart-
ments, and conductive heat exchange with adjacent com-
partments. The nodes exchange heat with the environment
by way of conduction, radiation, convection, and evapo-
ration. The mathematical basis of the controlled system
rests entirely on heat balances taken around each anatomi-
cal element. Figure 3-19 is a schematic diagram for one
typical segment; in this case, the head. Each compartment
represents a lumped heat capacitance with its own meta-
bolic heat production, conductive heat exchange, evapo-
rative heat loss, and convective heat transfer.
A thermal balance for the body as a whole is illus-
trated in Fig. 3-20. The rate of heat stored in the body is
determined by the rate of metabolic production of energy
offset by rates of heat dissipation from convection, radia-
tion, respiratory processes, diffusion of water from skin,
and evaporation of sweat. For any particular combination
of activity and environment, the rate of heat storage must
eventually reach zero (i.e., thermal steady state). This state
is ensured by the control elements adjusting such factors
as evaporation (by sweat secretion), radiation and convec-
tion (by diverting skin blood flow and changing skin tem-
perature), and metabolism (by shivering mechanism). Rates
of evaporation, convection, and radiation are also deter-
mined by ambient conditions such as temperature, humid-
ity, wind velocity, and pressure.
Figure 3-21 indicates the main features of the model,
including the most important input parameters and output
variables available. This system is based on a man with a
body weight of 74 kilograms and a surface area of 1.9
square meters. Inputs to the system include work rate, basal
conditions, environmental conditions, and time or dura-
tion of exposure. The thermal properties and the geomet-
ric parameters of the body tissues are usually fixed in the
model but may be altered to test unusual conditions. For
any exposure time, the model generates values for such
quantities as temperatures for all 41 nodes, mean skin tem-
perature, mean core temperature, rates of heat storage, sen-
sible and insensible heat and water losses, and blood flow
distribution.
Figure 3-18. Block diagram of the thermoregulatory system showing the determinants of body temperature and the three major
regulatory mechanisms.
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3.2.2.2 Validation and Application Studies. Valida-
tion of the thermoregulatory model has been reported by
the original model developers for a variety of conditions
and situations, including experimental fever, disturbances
in ambient temperatures, ingestion of cold fluids, and in-
tense bicycle ergometer exercise [26,28]. The model’s per-
formance was in reasonable agreement with experimental
findings throughout the dynamic range, including the
steady-state region, for periods of as long as 5 hours. More
recently, the steady-state version of the thermoregulatory
model was validated for resting conditions [32], and a sen-
sitivity analysis was performed that demonstrated some
unique methods for examining model behavior and uses
of the model for guiding research and designing environ-
mental systems [36]; also see Appendix E.
The model has been used by NASA life support sys-
tem engineers to define the limits of thermal comfort for
manned spaceflight [29,37]. This complex model is flex-
ible enough to permit combining it with models of a space
life support system so that reasonable predictions can be
made about the interactions between the two systems [38].
Coupling the thermoregulatory model with a respira-
tory control model [39] was another task under NASA spon-
sorship. This effort demonstrated the feasibility of
combining separately developed models and was the fore-
runner of the Whole-Body Algorithm project. As part of
the Whole-Body Algorithm, the thermoregulatory sub-
system was validated for both steady-state and dynamic
behavior, and the results of these simulations are presented
later in this section.
The thermoregulatory model was a useful addition to
the Whole-Body Algorithm, primarily because it provided
more realistic descriptions of skin blood flow during exer-
cise based on thermal considerations. The capability of the
model to predict evaporative water losses was also useful in
assessing the importance of this component of water balance
in the hypobaric atmosphere of Skylab and during some un-
usual temperature excursions that were experienced.
Figure 3-20. The thermal balance for man on which the ther-
moregulatory model is based. Evaporative heat loss is divided
into skin (mass diffusion), respiratory (lung), and sweat compo-
nents. (Q = rate of heat transfer, T = temperature.)
Figure 3-19. Block diagram of the controlled system for one segment: the head. The four major concentric compartments of tissue plus
the central blood compartment are indicated as well as their thermal resistances. (M = basal metabolic heat production.) Lines connecting
each element represent heat flows.
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3.2.2.3 Limitations. Validation studies performed on the
thermoregulatory model demonstrated that, as good as the
model was, it was not always capable of achieving close
correspondence with experimental data when tested over
a wide range of stress intensities. In some cases, such as the
sweating response to exercise, better agreement was obtained
by readjusting several controller sensitivity parameters.
Whether such a mechanism is physiologically plausible is
not known, although resetting of controller gain is suspected
to occur in the thermoregulatory system under certain con-
ditions [40]. In other cases, however, the assumptions used
in building the model led to unrealistic responses in cer-
tain special situations. For example, blood flow in exer-
cising muscle is assumed to vary in a stepwise fashion
with flow proportional to steady-state work rate rather than
as a function of local oxygen demand. Another example is
the absence of countercurrent heat exchange between large
arteries and veins. (A modified countercurrent algorithm
was introduced to improve model performance in cool
environments (Appendix D)). In addition, the partial inhi-
bition of sweating due to the degree of skin wettedness is
not accounted for in the model. This inhibition was sus-
pected to have existed in the Skylab zero-g environment,
in which sweat could not drip off the body (see Chapter 4).
3.2.3 Respiratory Control Model
One of the earlier models selected for incorporation
into NASA’s set of computer models was a description of
respiratory control. It was desirable to employ such a model
for predicting the respiratory effects of alterations in the
artificial gaseous atmosphere of space cabins. The follow-
ing objectives were formulated for the respiratory model
selected for use by NASA. The model should respond to
changes in oxygen and carbon dioxide concentrations in
inspired gas and respond to exercise ventilatory demand.
The model should also be capable of predicting respira-
tory function in terms of respiratory frequency and minute
volume, contain elements to control acid-base status of
blood by respiratory compensation, and have the capabil-
ity to interact with and complement cardiovascular and
thermoregulatory models.
Several excellent models were selected for study
[41,42,43,44]. Consideration of the previously stated objec-
tives, together with availability, led to selection of the model
developed by Grodins and co-workers [45]. The models of
Milhorn and co-workers [46,47,48], which are very closely
related to Grodins’ respiratory model, were in some respects
superior to it but were unavailable for immediate use.
Under NASA’s sponsorship, the Grodins model was
evaluated and modified for spaceflight application [39,49].
The model was originally designed to respond to distur-
bances in gaseous atmospheres (such as hypoxia and hy-
percapnia) with the subject in the resting state. The most
important structural modifications involved adding an ex-
ercise response capability for ventilatory control. Empha-
sis was placed on the exercise stimulus, since several
manned-spaceflight experiments stress man’s physiologi-
cal performance under various exercise levels in an artifi-
cial gaseous atmosphere. It was envisioned that this model
would appropriately complement the capability of the car-
diovascular and thermoregulatory model to simulate ex-
ercise and that this synergism would become manifest in
the Whole-Body Algorithm. Preliminary studies of these
model interactions were performed for the thermoregula-
tory-respiratory models [39] and for the cardiovascular-
respiratory models [50,51].[UPDATE #1]
3.2.3.1 Description of the Respiratory Model.
Grodins’ model is a closed-loop control system having a
controlled system divided into three compartments corre-
sponding to the lungs, the brain, and the tissue, with a
fluid-interconnecting path representing the blood (see Fig.
3-22). A set of differential-difference equations describes
a gas transport and exchange system between these com-
partments. The lungs are treated as a box of constant vol-
ume, uniform content, and zero dead space that is ventilated
by a continuous unidirectional stream of gas.
The blood passes through the lungs, and after a trans-
port delay, the arterial blood arrives at the brain or tissue
compartment. In this model, carbon dioxide (CO2) and
oxygen (O2) exchange rates are governed by metabolism.
If the alveolar respiratory quotient (RQ) differs from unity,
Figure 3-21. Schematic of the thermoregulatory system model.
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the rates of inspired and expired gas will differ. The time
delays associated with transport are not fixed but are real-
istically based on vascular volume and blood flow rate.
The brain compartment communicates with the cerebrospi-
nal fluid (CSF) reservoir by way of a membrane permeable
only to respiratory gases. Diffusion rates across the mem-
brane are proportional to their tension gradients. Venous
blood exiting from the brain combines with venous blood
from the tissue after a time delay to form mixed venous
blood. After another delay, this mixed venous blood en-
ters the lungs to complete the cycle of gas transport and
exchange. Total cardiac output and local blood flow are
considered to vary as functions of arterial CO2 and O2 ten-
sions. This assumption is in contrast to that used in
Guyton’s circulatory model, in which the control of these
flows is based only on O2 tensions (see Chapter 3.2.5).
The actual physiological control system is composed
of receptor elements which monitor the chemical concen-
trations, the afferent nerves that transmit this information
to the central nervous system, the respiratory neural cen-
ters, the motor nerves of the respiratory muscles, and the
respiratory muscles which drive the thorax-lung pump. In
this model, the chemical concentrations at receptor sites
are used to adjust the respiratory rate. The equations gov-
erning the controller system permit inspired ventilation
to vary as a function of the hydrogen-ion concentration
(pH) in the cerebrospinal fluid and in the arterial blood as
well as the arterial blood oxygen partial pressure (pO2). A
mathematical description of acid-base buffering relates
blood CO2 levels and blood pH. The control of respiration
is still a subject of controversy, and this model can accept
various control functions other than the one originally pro-
posed by Gordins. Thus, the model easily enables evaluation
of different basic respiratory control concepts.
3.2.3.2 Modifications. The original respiratory model
developed by Grodins and his associates has been modi-
fied to include the effects of performance of physical work
on respiratory parameters. A simplified overview of the
changes made to Grodins’ original model is given in Fig.
3-23. Work performance in the respiratory model prima-
rily affects metabolic rates (oxygen uptake), cardiac out-
put, and alveolar ventilation. The steady-state and dynamic
responses for an adult human exercising on a bicycle er-
gometer at a fixed useful work rate have been determined
experimentally by Åstrand and Rodahl [52], Whipp [53],
and D’Angelo and Torelli [54]. Simple approximation to
their data leads to expressions used in this model. Figure
3-23 suggests that both neural and chemical control are
involved in the ventilatory and flow responses. However,
there are still some uncertainties as to the degree of neural
control in the “on and off” transient responses in
ventilation.[UPDATE#2] The functional expressions which
simulate this component do not actually describe the
physiology involved, and more realistic modeling requires
experiments that clarify ventilatory control. The complexi-
ties of the interactions between neural and chemical con-
trol are manifested during exercise. The individual must
increase ventilation to a level sufficient to provide the
additional oxygen intake and carbon dioxide venting de-
manded by the body’s high level of exercise metabolism.
A schematic of the modified respiratory model is given
in Fig. 3-24. The output responses of this model include
minute volume, frequency of respiration, brain blood flow,
and chemical factors (pH, CO2, and O2). The fidelity of
cardiac-output and heart-rate descriptions in the modified
respiratory model differs from that provided by the car-
diovascular model. These quantities are provided by the
cardiovascular model in the Whole-Body Algorithm.
The strength of the Grodins model lies in its detailed
consideration of respiratory chemistry, including the in-
teractions between the O2 and CO2 dissociation and bicar-
bonate buffering. These pathways, which have the ability
to “blow off” metabolically produced CO2, allow the res-
piratory system to effectively regulate CO2 and O2 levels.
That is, a change in CO2 level or a decrease in O2 level
brings about regulatory effects through ventilatory and
circulatory parameters.
The model is primarily suited for short-term stress re-
sponses lasting not much longer than a half hour. Fortunately,
human subjects can approach a new steady-state response
within that period for many gaseous and exercise stresses.
3.2.3.3 Simulations. The basic model as developed by
Grodins is capable of responding to disturbances away
Figure 3-22. Controlled system of the respiratory model. Blood
oxygen, carbon dioxide, and hydrogen-ion concentrations are af-
fected by lung ventilation and metabolism. These quantities are
continuously monitored by the chemosensor.
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Figure 3-23. Block diagram of respiration control model as modified for exercise. The blood gases and hydrogen-ion concentrations are
monitored by the chemosensor and their values compared to the normal set-point value (N).
Figure 3-24. Schematic of the respiratory system model.
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Figure 3-25. Transient responses of the respiratory model to step changes in varying levels of inspired carbon dioxide. (a) Inspired
ventilatory volume rate; (b) Alveolar oxygen tension; (c) Respiratory rate; (d) Alveolar carbon dioxide tension.
from the normal resting state, including changes in baro-
metric pressure; in gas composition (i.e., inspired gas frac-
tions, in blood hemoglobin content) and in brain, blood,
tissue, and CSF bicarbonate concentration. Simulations
of these conditions were reported by Grodins et al. [45]
and Gallagher [49]. An example of the model’s dynamic
responses to varying levels of inspired CO2 is given in
Fig. 3-25. These responses compare favorably with those
measured experimentally [47]. Steady-state responses of
the respiratory subsystem for hypoxia and hypercapnia
are illustrated in a later section as part of the Whole-Body
Algorithm validation (see Fig. 3-44).
The added modifications provide the capability to
respond to different levels of work, as illustrated in Fig. 3-
26. When a transition in exercise level occurs, inspired
ventilation is controlled in the simulation by a fast neural
component and a slow linear component, related to oxy-
gen consumption. At rest, a control function that consid-
ers changes in blood oxygen, carbon dioxide, and hydro-
gen-ion levels appears adequate to account for respiratory
regulation during such stresses as hypoxia, hypercapnia,
or acid-base disturbances. However, blood chemical sen-
sor control does not appear to fully explain the exercise
response as can be inferred by the chemical responses
shown in Fig. 3-26. Exercising subjects ventilate at rates
which exceed increases that could be caused by arterial
O2, pH, and CO2 alone. Therefore, there appears to be a
form of neurogenic control. This control is represented
empirically in the model,  but i t  is  not well
understood.
The first manned space cabins (i.e., Mercury, Gemini,
Apollo programs) were equipped to provide a hyperoxic
environment (100% O2 at 1/3 atmosphere) with the CO2
level maintained by canisters of lithium hydroxide. It was
important to ascertain the human responses to breathing
in this artificial atmosphere and also to establish toler-
(b)(a)
(c ) (d)
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ance levels in the event of failure of the life support sys-
tem. Computer models of respiration had the potential to
assist in predicting human responses and in designing at-
mospheric control devices as previously described for the
thermoregulatory system. However, the Skylab cabin was
maintained at nearly normal CO2 levels, and the CO2 lev-
els were maintained within design specifications by the
efficient regenerable molecular sieve system. In the analy-
sis of Skylab data, there was little need to expect an ab-
normal respiratory response either at rest or during exercise
on the basis of atmospheric factors. As a result, the respira-
tory computer model by itself received relatively little
attention during this modeling activity by comparison to
the other models. Nevertheless, the Whole-Body Algo-
rithm would have been incomplete without the inclusion
of the respiratory subsystem model, particularly for simu-
lating exercise responses. The respiratory model provided
a more detailed analysis of head blood flow than was avail-
able from other subsystems, and it added the capability to
study the concentration of respiratory factors to the total
exercise response in altered environments.
3.2.4 Erythropoiesis Regulation Model
A mathematical model was developed for use as a tool
to investigate the relative influence of the controlling fac-
tors of erythropoiesis on total red blood cell (RBC) mass.
Figure 3-26. Selected variables from the respiratory system simulation of an exercise (workload) excitation using exercise modifica-
tions. (a) Inspired ventilatory volume rate VI and workload; (b) CSF bicarbonate concentration CCSF(H+) and brain blood flow rate QB; (c)
Alveolar carbon dioxide tension Pa(CO2) and alveolar oxygen tension Pa(O2).
(c)
(b)
(a)
NASA/CR—2020-220487 65
Figure 3-27. Schematic of the erythropoiesis control system model.
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The loss of red cell mass has been a consistent finding during
spaceflight and certain ground-based analogs of weightless-
ness such as bedrest. Computer simulation of this phenom-
enon required a model that could account for oxygen
transport, red cell production, and red cell destruction.
The control of erythropoiesis is amenable to a model-
ing approach, as demonstrated by a variety of investiga-
tors. These models have ranged from conceptual, qualitative
feedback schemes [56,57] to more detailed mathematical
descriptions [58], some of which have led to computer
simulation models [10,59]. Quantitative models have been
developed for different aspects of erythropoiesis regula-
tion, including ferrokinetic models [60,61] and those de-
scribing the control of stem cell production [62,63,64].
A limited number of models are available that inte-
grate the entire feedback circuit in sufficient detail to en-
able quantitative simulation of diverse hematological
stresses directly affecting oxygen transport, tissue oxy-
genation, erythropoietin release, and red cell production.
Hodgson [58] has proposed such a model but apparently
has neither implemented it for computer use nor performed
the studies necessary for validation. An algorithm capable
of predicting red cell mass changes by feedback processes
was coupled to a much larger model of circulatory and
fluid control [10], but it provided only a gross representa-
tion of the renal/bone-marrow axis and failed to recognize
renal oxygenation as a major control element. The most
complete simulation model previously developed is that
of Mylrea and Abbrecht [59]; this model was validated for
a single stress (altitude hypoxia in mice).
A review of the factors that control erythropoiesis and of
existing models led Leonard to the formulation of a concep-
tual model and eventually the design and development of a
computer model [65]. The initial structure was derived from
the best features of the mathematical models of Guyton et al.
[10], Hodgson [58], and Mylrea and Abbrecht [59]. The model
has a wide range of applicability; the most important appli-
cation is its simulation of spaceflight events.
3.2.4.1 Description of the Erythropoiesis Model.
Those elements in the feedback regulation loop that have
been incorporated into the model are shown schematically
in Fig. 3-27. The formulation is based on the accepted
concept that erythrocyte production is governed by the
balance between oxygen supply and demand in the body
and, in particular, at a renal sensing site. The mechanisms
and pathways of the control circuit include oxygenation
of hemoglobin and oxygenation of tissues by blood trans-
port and diffusional processes. An erythrocyte-stimulat-
ing hormone, erythropoietin, is produced and released at
a renal site in amounts that vary inversely with the levels of
tissue oxygen tension (pO2). Plasma levels of erythropoietin
control the production of erythrocytes in the bone marrow.
The amount of circulating red cell mass is based on the addi-
tion of new cells to existing cells with allowance for the
destruction of older cells. Blood hematocrit, an index of red
cell concentration in whole blood, is determined by divid-
ing the circulating red cell mass by the plasma volume. Other
features of the model include an oxygen-hemoglobin affin-
ity, which can be varied, and time delays that represent time
for erythropoietin distribution in plasma and time for matu-
ration of erythrocytes in the bone marrow.
In terms of control system theory, the controlled sys-
tem includes the elements of redistribution of new cells,
lung oxygenation, blood transport, and tissue oxygen ex-
traction, whereas the controller system consists of erythro-
poietin release, marrow red cell production, and splenic
destruction. The hematocrit (or hemoglobin level) may be
considered to be the primary feedback quantity, and the level
of tissue oxygenation can be taken as the directly controlled
variable. Figure 3-27 indicates the input parameters that have
been found most useful in these studies, as well as the pre-
dicted output responses that the model is capable of generat-
ing. Appendix B and Chapter 6 contain a more complete
description of the model system and its applications.
3.2.4.2 Sensitivity Analysis. The effect of variation of
the model parameters on the overall behavior of the sys-
tem can be studied by sensitivity analysis techniques (see
Appendix E). Sensitivity analysis is a systematic method
of evaluating the relative importance of different param-
eters, one at a time, by small increments around the nor-
mal control state. Table 3-6 contains the percent change
in one dependent variable (red cell production rate) caused
by a 1% decrease in the model parameters (shown in the
left column) and determined after a new steady-state con-
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dition was reached. Positive values of these coefficients
indicate a response to hypoxic conditions, and negative
values indicate a response to tissue hyperoxia. In each
case, the response is in a direction that agrees with the
concepts of erythropoiesis regulation [66]. The unusually
high influence of oxygen uptake on red blood cell pro-
duction indicated may not be representative of the real
intact system. Compensatory action by cardiorespiratory
factors usually intervene to normalize oxygen transport
and thereby limit the correction required by the erythro-
poietic system (Appendix B). However, this analysis does
support the assertion that P50 shifts can dramatically aug-
ment tissue oxygenation [67,68].
The results from a dynamic sensitivity analysis are
illustrated in Fig. 3-28. In this case, the six most important
parameters were changed by 10% in a direction that would
initiate a hypoxic response. The dynamic behavior of four
important dependent system variables during this constant
load disturbance is shown over a period of 30 days. It is
apparent that the general ranking of parameter importance
found in the steady state is maintained for the dynamic
state as well. If, however, a new equilibrium state was simu-
lated for a specific hypoxia condition and sensitivity co-
efficients were obtained by small perturbations from that
state, both the magnitude and the ranking of the coeffi-
cients might be altered. Such behavior would not be unex-
pected for a nonlinear control system.
Figure 3-28 also illustrates the wide difference in dy-
namic properties of the various elements in the model.
This model may be viewed as consisting of four sequen-
tial processes, each with a characteristic time constant that
is correspondingly longer with respect to alterations in
tissue oxygenation (seconds to minutes), erythropoietin
release (hours), red cell production (days), and red cell
mass (days to months). An interesting prediction of these
simulations is that the dynamic characteristics of the hy-
poxia response are similar for a variety of constant load
disturbances, whether it is an increase in plasma volume
or a decrease in renal flow rate. Unfortunately, the experi-
ments required to confirm this conclusion are difficult to
perform. These simulation results should, therefore, be
considered as model-to-model comparisons that demon-
strate that the model responds appropriately in a gross
sense to both equilibrium and dynamic states.
3.2.4.3 Model Validation. Model-to-data comparison is
a more challenging validation process that must be used
to establish ultimate credibility of any model system. The
erythropoiesis control model has been validated for long-
term altitude hypoxia.
Buderer and Pace [69] studied the dynamic changes
in red cell mass, hematocrit, and plasma volume in sea-
level pigtailed monkeys during 6 months at 3800 meters
altitude followed by descent to sea level for 3 months.
Comparable data for human subjects were not available.
However, the human model would not be expected to be
fundamentally different from that for a monkey at sea level,
especially if responses are expressed as normalized val-
Figure 3-28. Hypoxic response of erythropoietic model to a 10%
constant load disturbance (i.e., step change) of various param-
eters. Algebraic sign in legend refers to direction of change in
each parameter. These simulations are useful for demonstrating
dynamic behavior of model and relative sensitivities of important
parameters. See Table 3-6 for the definition of each parameter.
Table 3-6. Steady-State Sensitivity Coefficients of the Erythro-
poiesis Regulatory Model*
Parameter      Change in red
      cell production
     (percent)
Oxygen uptake, Vm –4.55
O2-Hb affinity, P50   3.90
Capillary diffusivity, Kd   3.25
Blood flow, Q   1.45
Mean corpuscular hemoglobin concentration, MCHC   1.45
Hemoglobin O2 carrying capacity, CHbO   1.45
Arterial O2 tension, PaO   1.10
Plasma volume, PV –0.90
Red cell half-life, TRHL    0.85
Controller gain, G –0.03
* Values shown are percent change in red cell production at steady
 state due to a 1% decrease in parameter value.
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ues. The major driving function for the model was an arte-
rial blood oxygen tension of 50 and 95 mmHg for the
altitude and sea-level phases, respectively. The model’s
response was adjusted using the bone marrow controller
gain until a visual “best fit” was obtained. This is an ex-
ample of parameter estimation (see Appendix A). The com-
parison of model output and data are illustrated in Fig.
3-29. In combination with the arterial blood oxygen ten-
sion, the experimentally determined change in plasma vol-
ume (bottom curve) was used as a driver for the simulation,
but the effect on the overall response system for this sec-
ondary load input was relatively small.
In addition to predicting the measured dynamic
changes of red cell mass and hematocrit, the model is ca-
pable of predicting other system variables that were not
measured, such as plasma erythropoietin and red cell pro-
duction-destruction rates. The simulation shows the gen-
eral sequence of events, generally assumed to characterize
the hypoxic response, including tissue hypoxia (not
shown), elevated erythropoietin, and augmented red cell
production levels, which increase the mass of circulating
blood cells [70,72]. Figure 3-29 also shows the opposite
scenario for the descent phase. The difference between
production and destruction rates provides a visual indica-
tion of the dynamic behavior of deviation from steady
state. The slow approach to equilibrium at altitude is also
evident from the asymptotic nature of the measured quan-
tities. Upon return to sea level, the increased hematocrit
serves as a prolonged stimulus for tissue hyperoxia to the
extent that red cell production may be totally inhibited
for several weeks.
The erythropoietin response in humans and mice dur-
ing hypoxia is known to return toward control more rap-
idly than indicated in Fig. 3-29 [70,73]. Adaptive
mechanisms of the circulatory, ventilatory, and biochemi-
cal systems respond to hypoxia and thereby improve oxy-
gen transport faster than does the more sluggish
erythropoietic system [74]. Several simulations were per-
formed to test the hypothesis that some of these pathways
contribute to the observed erythropoietin response. Fig-
ure 3-30 illustrates the relative influence of three adap-
tive mechanisms (an increase in pO2 due to greater
ventilation efficiency, a decreased plasma volume, and a
diminished oxyhemoglobin affinity) as predicted by the
model. These simulations, although not strictly a valida-
tion study, not only illustrate a more realistic response for
erythopoietin but also indicate the manner in which simu-
lation techniques can be used to test hypotheses regard-
ing physiological mechanisms.
3.2.4.4 Mouse Model. Experiments with animals are rou-
tinely conducted in support of spaceflight biomedical in-
vestigations. In particular, mice have been examined for
their potential use as experimental models for the study of
the early erythropoietic disturbances found in astronauts
[75]. The desirability of using a species-specific model of
erythropoiesis for predicting experimental results with ani-
mal subjects prompted the formulation of a “mouse model.”
This model was based on the human model but incorporated
parameter values that describe the unique characteristics
of the oxygen transport and erythropoietic system for the
mouse. Thus, red cell lifespan, arterial oxygen tension,
oxygen-hemoglobin affinity, and many other parameters
were found to differ significantly from the human [76].
 The mouse model, described in Appendix B, was vali-
dated in a preliminary study by examining its responses
to hypoxia [75] and to erythropoietin infusions [77]. An
example of the dynamic behavior of the mouse model is
provided in Fig. 3-31. In this simulation, a pulse decrease
in arterial oxygen tension results in a corresponding dis-
turbance in tissue oxygen levels, followed by a short burst
of erythropoietin and a resulting wave of erythropoiesis,
the effects of which may last 2 weeks or longer. The tran-
sient nature of red cell production shown here has been
previously observed after injecting erythropoietin into
mice [78]. A similar simulation performed with the human
model results in more prolonged effects, as indicated in
Figure 3-29. Simulation of altitude hypoxia and descent to sea
level (solid lines) Experimental data from pigtailed monkeys (filled
circles plus or minus standard error) [69]. Hypoxia was simulated
by reducing arterial oxygen tension from 95mmHg (sea level value)
to 50 mmHg. At 180 days, arterial oxygen tension is returned to
95 mmHg. Experimental plasma volumes (bottom curve) were
also used to drive model.
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Fig. 3-31. These differences result primarily from the shorter
erythropoietin disappearance rates, red cell lifespan, and
erythropoietin half-life in the mouse when compared to
the human. Simulations such as this suggest that some
information regarding erythropoiesis may be obtained in
a shorter time interval using the mouse as an experimental
model of the human.
3.2.4.5 Other Simulations. Although the major purpose
of the erythropoiesis regulation model was to investigate
mechanisms related to the loss of red cells during space-
flight, other applications have been investigated to vali-
date the model, to test hypotheses, and to introduce
refinements. Table 3-7 is a summary of the major simula-
tions accomplished with the human and mouse models.
Human bedrest and mouse dehydration studies have been
found to be useful experimental analogs of spaceflight
effects. A more recent area of model development is in the
simulation of hematological disease states that have known
physiological etiologies (such as anemias, polycythemias,
and abnormalities in hemoglobin functions). Toward this
end, a steady-state model based on the dynamic model
described previously has been formulated. A program is
now in progress to developed a teaching model of patho-
physiology based on the human red cell model [65].
3.2.4.6 Limitations. The erythropoiesis control system
model is the least complex of all the models used in this
project. Various features have been added during its de-
velopment to increase its simulated realism. These have
included elements representing erythropoietin release, cell
maturation time delays, and a variable oxygen-hemoglo-
bin affinity. Other limitations have been identified which
either are acceptable within the scope of this program or
form the basis for suggested improvements. These limita-
tions are summarized here.
1. Red cell production is modulated by factors other than
those considered in the model. These include iron lev-
els, hormones other than erythropoietin, and neural stimu-
lation, as well as inhibitors and activators of
erythropoietin. Although it may be desirable to include
these effects in future model applications, quantita-
tive informmation regarding them is presently lack-
ing or the need for their inclusion is not yet warranted.
2. The model has a limited representation of bone mar-
row red cell production. For example, it does not in-
clude the full maturation cycle from multipotential
cells to denucleated red cells. Furthermore, it has no
means of predicting reticulocyte index.
3. The model does not include extrarenal erythropoietin
production or extramedullary erythropoiesis. These
factors are of much greater importance in the mouse
than in the human. However, sufficient quantitative
information is lacking for inclusion in a mathemati-
cal model.
Figure 3-30. Simulations of altitude hypoxia showing effect of three adaptive mechanisms (see text). Models can be useful in studying
several simultaneous stresses either in combination or acting alone. Simulated altitude = 4000 meters, pO2 ART = arterial oxygen
tension, PV = plasma volume, P50 = parameter describing oxygen-hemoglobin affinity. (a) No adaptive mechanisms; (b) Stepwise
addition of three adaptive mechanisms; (c) Combined effect of three mechanisms. The dynamic behavior of erythropoietin illustrated in
panel (c) is much closer to the experimentally measured response than is panel (a) [70].
 (a)  (b)  (c)
ART = +5 mmHg
∆P50 = +3 mmHg
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4. Blood viscosity and blood volume changes are known
to influence blood flow and, thereby, issue oxygen-
ation. These effects are not explicitly represented in
the model [87,88].
5. Overall oxygen transport is under the control of ho-
meostatic mechanisms in addition to the erythropoie-
sis system. Thus, some of the fixed parameters of the
model such as blood flow, capillary diffusivity, arte-
rial oxygen tension, plasma volume, and oxygen-he-
moglobin affinity can be considered variable elements
of circulatory, ventilatory, biochemical, and fluid regu-
latory feedback mechanisms that are beyond the scope
of the present model’s design objectives.
Although these mechanisms are not included explic-
itly in the present erythropoiesis model, their influence
can be tested, in most cases, by manual alteration of exist-
ing model parameters. Larger models (such as Guyton’s
model discussed next) that incorporate many of these fea-
tures are available, and these have been shown to be com-
patible with an erythropoiesis subsystem model. In fact,
the erythropoiesis model just presented was inserted into
the Guyton model to replace the existing inferior algo-
rithm for red cell production (Appendix C). As a result,
performance of the Guyton model was enhanced.
3.2.5 Model of Circulatory, Fluid, and Electrolyte
Control
Physiologists have long recognized the intimate rela-
tionship between circulatory function and fluid-balance
function. Early in the manned spaceflight program, the
biomedical investigators of NASA identified the need to
monitor these systems for their involvement in the fluid
redistribution in microgravity and the orthostatic intoler-
ance usually accompanying recovery. With the extension
of flight duration from weeks to months, the need to ex-
amine the long-term adaptive responses of both the circu-
latory and fluid-balance systems with systems analysis and
simulation models was proposed by a National Academy
of Sciences panel [89].
Figure 3-31. Simulation response to a pulse decrease in arterial oxygen tension for the mouse model (solid line) and the human model
(dashed line).
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The following objectives were established for a model
of body fluid regulation. The desired model should:
1. Be capable of predicting the volume and electrolyte com-
position of the major fluid compartments, including
plasma, interstitial, and intracellular fluid compartments;
2. Contain the appropriate capillary and membrane in-
terfaces between these compartments and the capabil-
ity to simulate exchange of fluids and electrolytes
under the influence of hydrostatic, oncotic, osmotic,
and active transport forces;
3. Contain representation of at least two of the major
body cations:sodium (extracellular ion) and potassium
(intracellular ion);
4. Contain a representation of the kidney with sufficient
detail to predict realistic urine excretion of salts and
water under such conditions as fluid/salt loading and
restricted fluid intake;
5. Contain neural, hormonal, and hemodynamic feed-
back control pathways regulating the volume and
composition of the extracellular fluid compartment;
6. Contain a circulatory system with sufficient detail to
realistically simulate blood pressures, flows, and vol-
umes in arteries and veins during acute and long-term
disturbances such as hemorrhage and infusions;
7. Contain an autonomic system with efferents sensitive
to blood pressure, plasma osmolarity, and tissue oxy-
genation and with afferents for controlling blood flow
and pressures, hormonal secretion (antidiuretic hor-
mone (ADH), angiotensin, and aldosterone), and body
water, the latter by thirst and renal mechanisms;
8. Contain a representation of adaptation effects (both
active and passive) in the heart, vessels, and pressure
receptors for controlling long-term blood pressure
disturbances.
As this list of objectives suggests, the complete speci-
fication of a fluid-electrolyte regulatory system requires
the inclusion of several fluid compartments that are con-
trolled by the kidneys acting in conjunction with the en-
docrine and circulatory systems. An important part of the
model selection phase of this project was directed toward
identifying models that contained these subsystems or,
alternatively, searching for fluid-electrolyte models that
could be used to complement existing circulatory models
[90,91]. With regard to the latter approach, most of the
mathematical models with the required fidelity to simu-
late responses to circulatory disturbances were relatively
short-term models and did not have the elements neces-
sary to account for changes in fluid balance. On the other
hand, the models of fluid-electrolyte regulation had rep-
resentations of cardiovascular function that were highly
simplistic or absent altogether.
The renal system is perhaps one of the most complex
body systems amenable to a mathematical modeling ap-
proach. When the model identification search was initi-
ated, few models were available that contained an
adequate representation of the fluid-electrolyte regulat-
ing capability of the renal system. Some of the most de-
tailed models of the kidney were presented as complex
mathematical formulations unaccompanied by numerical
solutions and they, therefore, remained conceptual in na-
ture [92,93,94]. The model of DeHaven and Shapiro [95,96]
contained excellent representations of the relationships
between more than 100 chemical species in several fluid
compartments but was devoid of dynamic regulation as
well as direct representations of the circulatory, neural,
and endocrine systems. Other models considered a num-
ber of important conceptual ideas but had characteristics
that limited their applicability [97,98]. Other models of
fluid and electrolyte balance include those of Cameron
[99], Toates and Oatley [100], and Badke [101]; these were
unavailable for consideration in this project and are men-
tioned here merely for completeness.
The most comprehensive model of fluid and electro-
lyte control available, and one which satisfied the require-
ments of the project, was that developed by Guyton and
co-workers [10,102,103,104]. This model has been par-
ticularly useful in the NASA physiological simulation
project, and it formed the cornerstone of the Whole-Body
Algorithm. At the time of its formulation, it was perhaps
the most complex physiological mathematical model in
existence. There have since been few such comprehensive
attempts to subject long-term, whole-body biochemical
and circulatory function to the rigors of systems analysis
and mathematical modeling, which are not directly, re-
lated to the fundamental work of Guyton.
3.2.5.1 Description of the Guyton Model. The sys-
tems analysis of overall circulatory regulation as devel-
oped by Guyton involves a large number of physiological
Table 3-7. Computer Simulation Studies Performed With
Erythropoiesis Model
 Study Duration, days  Source
 Human model
Altitude hypoxia and descent 270  Ref. [69]
Altitude hypoxia   6  Ref. [72]
Red cell infusion 120  Ref. [79]
Bedrest   35  Refs. [80,81]
      14, 28  Ref. [82]
Skylab       59, 84  Ref. [83]
Clinical conditions:   Long term  Ref. [84]
Anemia
  (primary, secondary, hemolytic)
Polycythemia
  (primary, secondary, hypoxic)
Abnormality (hemoglobin)
Mouse model
Multiple sequential
erythropoietin infusion 7 Ref. [78]
Altitude hypoxia 28 Ref. [73]
Dehydration and recovery 7 Ref. [75, 85]
Red cell infusion 3 Ref. [86]
NASA/CR—2020-220487 71
subsystems. The current model, illustrated in Fig. 3-32, is
based on cumulative knowledge of the circulation and on
experimental data. A model as complex and encompass-
ing as this one is difficult to summarize in one or two
diagrams; detailed flow charts and model explanations
are available elsewhere [10,90,104,105]. Schematic dia-
grams are included in the following pages, and a more de-
tailed analog circuit diagram is included in Appendix C.
The relevant physiological systems have been divided
into 18 major subsystems, each describing some important
physiological aspect of circulatory, fluid, and electrolyte con-
trol (Fig. 3-33). The circuit of blood flow in the original
model is divided into five volume compartments:arterial
volume, venous volume, right atrial volume, pulmonary
venous volume, and combined left atrial and pulmonary
venous volume (Fig. 3-34). Cardiac output is calculated
from function curves, whereas other flow rates are calcu-
lated from simple pressure-resistance relationships. Arte-
rial-venous flow is determined by summing flow through
three parallel circuits (muscle, renal, and other).
The circulation is not closed but “leaks” through the
capillaries, “excretes” through the kidneys, and “drinks”
directly into the blood. Fluid intake is controlled by plasma
osmolarity and tissue oxygen tension. Fluid excretion is
based on glomerular filtration and the action of ADH. The
blood, composed of plasma (with dissolved proteins and
electrolytes) and red blood cells, serves as a filterable fluid.
Other fluid-volume compartments include the interstitial
compartment (composed of a gel volume and free fluid
volume), the intracellular volume, and pulmonary fluid
volume. The relationships between these compartments
are illustrated in Fig. 3-35. The capillary filtration rate is
determined from a whole-body version of Starling’s rela-
tionship, which states that net filtration pressure is equal
to capillary pressure plus tissue colloid osmotic pressure,
minus interstitial fluid pressure, and minus plasma col-
loid osmotic pressure. Lymph flow rate is calculated from
free interstitial fluid pressure, total tissue pressure, and
lymphatic pumping. Flow into the pulmonary reservoir is
obtained by subtracting pulmonary lymph return from pul-
monary capillary filtration. Protein (colloid) is produced
and lost by the body and is distributed between the inter-
stitial space and the plasma. The representation of the in-
terstitial fluid compartment reflects the years of study by
Guyton and co-workers which revealed the importance of
the gel-free fluid matrix and sub-atmospheric pressures of
this compartment in controlling edema and transcapillary
filtration [106]. Fluid flows into the cells are assumed to
occur by osmotic imbalance between extracellular and in-
tracellular fluids.
Two electrolytes are considered in the model. Sodium
is distributed evenly in the extracellular fluid, and potas-
sium is stored primarily in the intracellular fluid with al-
lowance for active transport from the extracellular to the
intracellular compartments. Dietary intake of both these elec-
trolytes is considered as well as renal excretion, the latter
being controlled in large part by a renin-angiotensin-aldos-
terone mechanism. The pathways that regulate fluid and elec-
trolyte balance are described in more detail in Chapter 5.
The model uses basic cardiac function curves modi-
fied by the effects of autonomic stimulation, arterial pres-
sure after-load, and cardiac hypertrophy or degeneration
of the pumping ability of the heart. The unstressed vol-
umes of each capacitive region are controlled by the level
of autonomic stimulation, the level of angiotensin in
blood, and the pressure in the veins (through stress relax-
ation). The flow resistances are controlled by a combina-
tion of local effects and hormonal effects. The oxygen
transport features of the circulation are present, and hema-
tocrit and red cell control are considered. The autonomic
system included is basically regulated by mean blood pres-
sure and tissue oxygen tension and includes the effects of
Figure 3-32. Schematic diagram of the circulatory, fluid, and electrolyte regulatory model.
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Figure 3-33. Composition of Guyton model of the circulatory, fluid, and electrolyte system. Each block represents a subsystem which
consists of a family of function blocks indicated by the numerical figure in parentheses. Modified by Sagawa [4].
Figure 3-34. Blood volumes and flows in the original Guyton model.
the baroreceptors, chemoreceptors, and ischemia of the
central nervous system. Total autonomic output is ex-
pressed as a positive effect for sympathetic output and a
negative effect for parasympathetic output.
Comparison of the blood flow circuit in the Guyton
model (Fig. 3-34) to that of the Croston model shows a
great difference in the number of volume segments. These
differences reflect a higher fidelity response for short-term
stresses in the latter model. However, the Croston model,
as well as the other models described earlier, have used a
basic closed circulatory flow system with no leaks. This
kind of approach can be justified when the simulated chal-
lenge is acute. When longer duration simulations are re-
quired, a large number of other regulatory mechanisms
must be included to describe overall circulatory control,
even in a crude manner. The lack of detail in Guyton’s
circulatory subsystem can be contrasted with the complex-
ity of the connections between the cardiovascular system
and the interstitial-cell complex. The inclusion of such
elements as cardiac hypertrophy, cardiac deterioration,
baroreceptor adaptation, hormonal pathways, regeneration
of red blood cells and plasma proteins, delayed autoregu-
lation of resistance vessels, and stress relaxation of veins
clearly indicates that the Guyton model was developed to
be useful as a long-term model. This feature has made it
very attractive as a companion to a short-term pulsatile
model for the Whole-Body Algorithm application.
The evolution of the Guyton model from a basic cir-
culatory system to a much more complex grouping of sub-
systems revealed that a model of the cardiovascular system
VOLUME INPUT
VOLUME OUTPUT
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Figure 3-35. Fluid-containing reservoirs of original Guyton model. The volume of each compartment is controlled by active and passive
regulators.
must include elements from most of the entire body if it is
to be used in the study of intermediate to long-term
phenomena. The Guyton model clearly illustrates the im-
portance of considering the interaction between various
subsystems in predicting fluid volumes and electrolyte
levels. The real system and the model itself are extremely
stable, so much so, in fact, that the function of any single
control mechanism can be in error by as much as 50%
without significantly affecting the overall output of the
system. This characteristic is the result of a number of
overlapping regulatory circuits that create a large degree
of redundancy. One of the most important features of the
model is that it is large enough to obtain this stability
level, similar to that in the real system, despite the fact
that each subsystem is modeled in a gross sense with many
minute details omitted. Because of this stability, the model
is adequate for predicting the outcome of many long-term
experiments.
The system of equations representing this closed-loop
model contains more than 370 mathematical relationships
and is a large, stiff system with response times ranging
from 0.5 second to 40 days. Numerical integration over
extended periods would be extremely time consuming un-
less special techniques were employed. The basic method
of integration is a variant of the simple Euler method made
possible by the fact that, for many simulations, all short-
term subsystems can be separated from the rest of the model
and integrated many times using small time steps without
disturbing the remainder of the system. When these rapidly
acting subsystems have developed near steady-state values,
the remainder of the system is numerical integrated, using a
relatively large time step, and the whole process is repeated.
This procedure is only possible when slow, nonvascular
changes are taking place. With rapid overall transitions, as in
exercise, a small integration step must often be used for the
entire system, greatly slowing the model simulation.
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3.2.5.2 Limitations and Modifications. The original
Guyton model was built to simulate a large number of
diverse situations, but there were some specific stresses
for which the model response was inadequate. Since the
model did not include separate vascular compartments rep-
resenting the legs, the model was incapable of realisti-
cally responding to either gravitational or postural
changes. Analysis of Skylab data has shown that the rapid
shifts of fluid from the lower to the upper body as well as
a more gradual dehydration of leg tissues play a very im-
portant role in the physiological adaptation to zero-g
[107,108]. The data from bedrest studies, taken as a ground-
based experimental analog to microgravity, have also
shown similar important changes involving the legs [109].
There have been a few studies in which the gravita-
tional effects of posture on the body fluid compartments
have been modeled. However, no studies have been done
to account for long-term simulation of gravity disturbances
such as bedrest or weightlessness. Models of the circula-
tory system that contain short-term gravity effects have
met with various degrees of success. The models of short-
term circulatory gravity effects include those of Snyder
[17], Croston et al. [12], and Green and Miller [110]. Sev-
eral studies by Luetscher and co-workers [111,112,113]
resulted in models that included the effects of intravascu-
lar-interstitial fluid shifts on circulatory and renal re-
sponses to postural changes and, thereby, allowed for
slightly longer term simulations. These latter models, how-
ever, were not designed to account for even longer term
effects such as lymph return, extravascular protein circu-
lation, and hormonal effects. Nevertheless, the ideas em-
bedded in these models were useful in altering the Guyton
model.
The circulatory subsystem of the Guyton model con-
tained only two lumped systemic blood compartments rep-
resenting the arteries and veins. Modifications made to the
model included increasing the number of compartments of
the circulatory system so that lower body (i.e., legs) and
upper body blood and tissue fluid compartments could be
identified separately and adding gravity effects on blood
flow and baroreceptor elements to permit the new circula-
tory system to respond to a variable gravity vector. These
structural modifications are illustrated in Fig. 3-36.
Cardiac output was divided into three pathways, as
previously described. However, flow through the legs was
taken to be the same as the muscle flow of the original
model. In addition, a filterable capillary bed was added to
this pathway. Details of these modifications are discussed in
Appendix C. These changes added the basic capabilities to
simulate such stresses as postural change (tilt, including head-
up and head-down), LBNP, bedrest, and weightlessness.
Other modifications to the Guyton model, introduced
during the course of this project, included alterations in
the renin-angiotensin system, the baroreceptor system, the
stress relaxation of the vasculature, the autoregulation of
muscle blood flow, and the red blood cell control system.
Most of these changes were not made because of limita-
tions of the model for spaceflight applications; they were
made because other ground-based physiological studies
revealed that their inclusion would be more appropriate.
Details of these modifications, including the changes for
gravity dependency, are available in two study reports and
in Refs. [105] and [114] as well as in Appendix C.
One weakness in the Guyton model, for some special
circumstances, is the lack of a description of hydrogen-
ion regulation (i.e., acid-base balance). Hydrogen-ion lev-
els are controlled by the renal system, the buffering system
of the body, and the respiratory system, all acting together.
In fact, the hydrogen-ion control system is one of the main
links between the circulatory, renal, and respiratory sys-
tems. A preliminary analysis that lays the foundation for a
model of this valuable subsystem was performed during
this project [105], and other researchers have studied this
subsystem in some detail [115].
In the latter stages of this project, it became apparent
that new techniques were required to simulate the weight-
lessness of spaceflight and its ground-based experimental
analogs such as water immersion and head-down bedrest.
These stresses were never contemplated in the design of
the original Guyton model. Some of the required features
that have been identified include collapsible leg veins,
fluid reservoirs above the heart (i.e., jugular vein system)
and head tissues, and orthostatic mechanisms. The latter
elements would allow the model to assume an upright ref-
erence position in addition to its present supine reference.
These modifications are presented in Chapter 9.
3.2.5.3 Validation of the Basic Guyton Model. The
formulation of the Guyton model was based on a wide
variety of experimental data, and the model has been tested
extensively. Some of the experiments that have been simu-
lated with this model by Guyton and co-workers are the
development of hypertension in a salt-loaded, renal defi-
cient patient; simulation of congestive heart failure; neph-
rosis; circulatory changes during severe muscle exercise;
and unilaterial heart failure of the right or left side. Other
simulations performed were of the effects of the removal
of the sympathetic nervous system on circulatory func-
tion, infusions of various types, and the effects of extreme
reduction of renal function on circulatory function. The
model performed adequately in almost every case. These
initial validation studies are discussed in reports issued
by Guyton and co-workers [10,102,104,106].
The basic model itself was based on detailed organ
level studies and required almost 20 years to develop. But
Guyton and his co-workers were primarily interested in
developing a model for hypertension research. It remained
for the GE/NASA team to demonstrate the capability of
the model to predict the appropriate response to fluid-
volume shifts in the spaceflight environment. This was
accomplished more easily and convincingly by suitable
validation studies based on ground-based experiments as
suggested in Table 3-2. Since the weightless state is asso-
ciated with initial expansion of the central blood volume
and subsequent partial depletion of plasma and body flu-
ids, the model was validated for such common one-g stresses
as infusions, dehydration and hemorrhage for which much
data are available. (The reader is referred to the discussion
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associated with this table for the rationale for studying
these and other one-g stresses).
Several of these studies are illustrated in Figs. 3-37 to
3-39. The first two figures illustrate the responses to fluid-
electrolyte infusions and the third demonstrates the re-
sponse to dehydration and subsequent rehydration. In all
cases, a variety of infusions were performed, including
those of hypertonic, isotonic, and hypotonic fluid. The
model is obviously capable of distinguishing between
variations in the tonicity of the infusion.
In the first series of simulations (Fig. 3-37), 1 liter of
water, 150 meq sodium, and 1 liter of isotonic saline (1
liter water plus 150 meq sodium), respectively, were in-
fused. These infusions were made directly into the circu-
lation, so that the response was more rapid and more dra-
matic than if they had been administered orally. The three
infusions all produce appropriate osmotic shifts between
extracellular/intracellular spaces and renal excretions of
salt and water, as well as proper hormonal responses. Simi-
lar responses would be expected for the human subject
[118,119]. For water infusion, the diuresis is completed
within the first few hours. For isotonic saline, the diuresis
is maintained at a lower level but continues beyond sev-
eral hours. In the case of water or sodium infusion, large
variations in cell fluid volume are observed, whereas in
the case of isotonic saline, the cell fluid volume is essen-
tially unaffected. Antidiuretic hormone was also appro-
priately responding to osmotic concentrations of extracellular
Figure 3-36. Circulatory and fluid compartments in modified Guyton model. Leg blood and interstitial compartments have been added.
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fluid [120], decreasing rapidly in the case of the water infu-
sion, increasing threefold in the case of pure sodium, and
barely changing in the case of isotonic saline. Aldosterone
in the model is a regulated by angiotensin, extracellular
potassium, and extracellular sodium. It reacted appropri-
ately to the primary stress of these experiments by show-
ing a change in extracellular sodium concentration in the
first two cases and a fall in angiotensin (not shown) in the
last case, due to increased renal arterial pressure. Experi-
ments such as these illustrate the importance of electro-
lyte considerations in water-balance studies, a concept
quite familiar to most clinicians.
A more detailed study of an isotonic saline infusion,
particularly as it affects plasma-interstitial fluid exchange,
is shown in Fig. 3-38. The simulation consisted of a 2-liter
transfusion over a 30-minute period into a nephrectomized
subject. Capillary filtration increases markedly as the
transfusion begins and lymph return increases more slowly,
resulting in a net outward flow of fluid from the plasma.
Since net flow into the interstitial space is less than the
transfusion rate, fluid accumulates in the plasma, and
plasma volume increases considerable. When the transfu-
sion is stopped, capillary filtration falls to equal lymph
flow, and the interstitial fluid continues to expand at the
expense of plasma volume until transcapillary flow is re-
duced and equals lymph flow. At the end of the transfu-
sion, 37% of the added fluid remained in the plasma, but
within 30 minutes, only 24% of the transfusion volume
Figure 3-37. Simulated infusion responses using circulatory, fluid, and electrolyte model. These studies demonstrate capability of model to
distinguish between the tonicity of fluids in acute water and salt loading. Arrows demarcate infusion period. (a) Infusion: 1000 ml water
(hypotonic), (b) Infusion: 150 meq sodium (hypertonic), (c) Infusion: 1000 ml saline (isotonic).
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remained. If the transfusion had been large enough, the
interstitial fluid compartment would have entered the re-
gion of low compliance and almost all additional fluid
beyond a certain point would have entered the interstitial
space. The results of this simulation compare quite favor-
ably with recent experiments [121] and demonstrate the
suitability of this model for studying situations involving
fluid shifts and circulatory function.
Model validation was also extended to include such
similar stresses as hemorrhage, salt depletion, and salt load-
ing—for both short-term and long-term changes. Rehy-
dration through use of various fluids has different effects
on plasma-volume recovery. In these studies, shown in
Fig. 3-39, and others not shown, interstitial fluid does not
always act like the fluid reservoir that some investigators
have claimed [122]. Following simulated hemorrhage, for
example, the interstitial space provides only 20% of the
acute plasma refilling response. This has also been noted
experimentally by others [123]. After dehydration with-
out rehydration, there is very little tendency for acute re-
filling of blood either in the model or in the real system.
Also, after infusion, the interstitial compartment first ex-
pands but, within 24 hours, returns to normal. This has
relevancy to the Skylab experience, in which inflight
losses from all fluid compartments were observed to change
except for the interstitial space.
Simulations that are even more relevant to the zero-g
model validation are the water-immersion studies dis-
cussed in Chapter 9. Where appropriate, the model was
modified slightly in accordance with more recent experi-
mental evidence.
3.2.5.4 Validation of the Modified Guyton Model. Al-
though the validation studies cited are related to the fluid
shifts associated with weightlessness, they do not directly
evaluate the new capabilities of the model concerned with
the added leg compartments and gravity dependency (see
Chapter 3.2.5.2). Therefore, the modified Guyton model
was validated for the following four conditions. (Results
of these studies are presented in Chapter 9).
a) Supine Mode at Rest. The Guyton model is initial-
ized in a so-called “supine position.” That is, the val-
ues of such quantities as heart rate, blood pressure,
and cardiac output agree with measurements from hu-
man subjects in the resting horizontal (supine) posi-
tion. Steady-state values for the gravity-dependent
model in the supine, unstressed mode should have
agreed with those of the original unmodified model,
and they did. This test does not really represent a vali-
dation study; however, it was important to ensure that
the modifications (of adding leg compartments) did
not change the basic output variables of the model
such as cardiac output, mean arterial pressure, fluid
volumes, concentrations, and renal function. In addi-
tion, for the sake of consistency, values of flows, pres-
sures, and volumes of the new lower body compartment
should compare favorably with the pulsatile cardio-
vascular model (Croston model) and with available
Figure 3-38. Simulation of 2 liters isotonic saline infusion during
first 30 minutes showing capillary filtration responses in nephrecto-
mized subject (from [116]).
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Figure 3-39. Plasma volume response to thermal dehydration and
subsequent rehydration with fluids of different tonicity: Guyton
model response compared to data. (a) Experimental data [117].
(b) Computer simulation.
data on human subjects who are supine for relatively
short periods. Documentation of this study is provided
in Ref. [114].
b) Supine Mode Under Stress. The restructured model
responded to various supine stresses in a manner es-
sentially similar to that of the original model. The
stresses were those already discussed in the section
describing the validation of the basic Guyton model.
In addition, the capability to perform LBNP simula-
tions was demonstrated. Simulation results for this
stress were compared with results of the pulsatile car-
diovascular model that were previously validated for
LBNP. The Guyton model did not exhibit the same
degree of accuracy as the Croston model for some car-
diovascular indices during LBNP; however, the capa-
bility to account for capillary fluid shifts was more
realistic (see [114] and Chapter 5.4.2.2).
c) Standing Mode at Rest. Quiet standing results in
different values of circulatory parameters (i.e., cardiac
output, blood pressures, hematocrit) than those found
in the supine position. Changing posture from supine
to upright represents a stress to the individual and a
suitable challenge to the model. Values of basic cir-
culatory parameters in the standing mode should agree
with data from human subjects performing quiet stand-
ing or tilt for relatively short periods of time. The
model contains the capability to vary the angle of tilt
with respect to gravity but does not include protec-
tive orthostatic mechanisms. These simulations of
passive tilting and erect standing suggested adding
new elements to account for muscle pumps, venous
valves,  abdominal compression reflex, and
venoconstriction, all of which are important in the
real system to prevent orthostatic collapse (see [114]
and Appendix C). The additional lower body com-
partment helped to realistically simulate blood pool-
ing, extravascular fi l tration, and peripheral
vasoconstriction (see Chapter 9.6). Comparison of re-
sponses was made not only with human data but also
with simulation responses from the models of other
investigators. The “open” nature of Guyton’s circula-
tory system was expected to provide increased fidel-
ity for simulations of tilt and LBNP. Extremely
long-term effects of standing at rest without leg activ-
ity will result in continued pooling of blood in the
legs, but these effects were not considered. The capa-
bility to simulate long-term stress was demonstrated
only in the supine position.
d) Long-term Bedrest. Long-term bedrest can be con-
sidered a special case of the supine mode. However,
the Guyton model (already initialized in the supine
position) required additional modification and hy-
potheses to simulate the headward shifts of fluids and
the dehydration of leg tissues; both are characteris-
tics of bedrest. Incorporation of the lower body seg-
ments into the Guyton model and the successful
completion of the studies outlined previously has pro-
vided a solid foundation and the necessary level of
detail with which to test theories of long-term adapta-
tion, including weightlessness. The validation stud-
ies discussed here (LBNP, postural change, and
long-term bedrest) are fully described in Chapter 9.
The Guyton model represents an attempt to under-
stand the interactions between acute and long-term adap-
tive control of the body fluids and the circulation. Because
there is a notable scarcity of information regarding these
complex processes in healthy subjects, long-term bedrest
and spaceflight have been of particular importance in vali-
dating and modifying the original model of Guyton. This
model is clearly relevant to spaceflight because some of
the most notable physiological changes that occur can be
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traced to disturbances in fluid-electrolyte regulation. By
accounting for long-term adaptive effects in the circula-
tory and autonomic systems, the model has been useful in
predicting responses to stresses lasting up to several weeks
or months.
3.2.6 The Whole-Body Algorithm
Most previous physiological modeling has empha-
sized detailed function at the subsystem (organ) level or a
more limited whole-body function. In an effort to extend
modeling capabilities, an attempt was made to design a
combined model of all the sub-system models previously
described. The “Whole-Body Algorithm” (a grandiose term
used for convenience only) was envisioned to be a large-
scale dynamic mathematical model that contained descrip-
tions of the important physiological functions of the major
body subsystems and the primary interactions between
these subsystems. It was developed to simulate responses
to a wide variety of specific stresses related to the space-
flight environment.
To be useful in evaluating hypotheses related to physi-
ological adaptation to spaceflight, such a model must have
the capability (1) to contain representations of the cardio-
vascular, thermoregulatory, respiratory, and fluid-electro-
lyte systems, (2) to simulate both acute and long-term
changes in these systems, (3) to simulate the experiments
used to evaluate the spaceflight adaptation process, and
(4) to simulate the environmental stresses which may in-
fluence the results of these experiments. The experiments
of interest include bicycle ergometry (supine and erect),
orthostatic tests including LBNP and head-up tilt, and en-
vironmental stresses of changes in cabin temperature and
atmospheric composition (increased carbon dioxide con-
centration and hypoxia). The Whole-Body Algorithm was
designed such that the entire sequence of major physi-
ological events for long-duration spaceflight could be
simulated. This sequence includes preflight (baseline or
control) experiments, acute physiological response to zero-
g, long-term adaptation to zero-g, changes in cabin envi-
ronment, inflight responses to the experiments of interest,
acute reentry to one-g, long-duration readaptation to one-
g, and postflight experiment simulation (see Fig. 2-2).
These objectives and design requirements are discussed
fully in the Whole-Body Algorithm design specification
document [124].
3.2.6.1 Background. Before the development of the
Whole-Body Algorithm, there were only a few attempts at
modeling interacting physiological subsystems. These at-
tempts were limited in the number of stresses they were ca-
pable of simulating [see Refs. 125-132]. Two studies [133,134]
represent attempts to integrate the cardiovascular, respira-
tory, and thermal subsystems. Both models were structured
to evaluate exercise response while varying the thermal
environmental conditions and inspired gas concentrations.
Guyton et al. [10] successfully integrated the circula-
tory, fluid, and electrolyte subsystems. However, this
model was not capable of simulating thermoregulatory or
ventilatory behavior, could not simulate several short-term
experiments of interest, and the capability to simulate ex-
ercise was quite redimentary.
In preparation for the development of the Whole-Body
Algorithm, two limited studies were performed that involved
coupling a thermoregulatory and respiratory model [139]
and a circulatory and respiratory model [50].
3.2.6.2 Approach to a Whole-Body Algorithm. Two
main approaches were identified for modeling a large sys-
tem composed of major subsystems. In the first (bottom
up) approach, each subsystem could be modeled indepen-
dently by using hypotheses appropriate for that subsystem.
After each subsystem had been verified, the subsystem
models could be combined into a unit by restructuring or
modifying the subsystems to function together. In the sec-
ond (top down) approach, the system as a whole could be
assembled into a cohesive model using interrelated hy-
potheses, with all subsystems designed to function as a
unit from the outset (for example, Guyton’s model).
The concept of coupling existing subsystem models
offers the advantage that the validity of each model, oper-
ating independently, has been established for simulating
each stress of interest. Each model thus incorporates vari-
ous time lags, fast and slow controllers, and integration
step sizes as appropriate for its simulation requirements.
Use of the first approach also enables modification of sub-
system models without total disruption of the overall sys-
tem. Then, the Whole-Body Algorithm can evolve as
additional experimental data become available, as new
information is gained form the literature, as new hypoth-
eses are verified, or as simulation results indicate inappro-
priate formulations. An additional advantage of this approach
is that certain poorly represented elements of one subsystem
can often be replaced by a similar, but more accurate algo-
rithm from another subsystem, if one exists. For these rea-
sons, the basic approach of combining previously existing
individual subsystem models using physiologically mean-
ingful interactions was selected for developing a first-gen-
eration Whole-Body Algorithm. (Of course, this approach
also has its disadvantages; these will be discussed follow-
ing a description of the model validation).
Individual subsystem models were developed or modi-
fied from existing models that had been previously vali-
dated for the stresses of interest. They were programmed
on the same computer system and in the same computer
language. Long-term physiological simulation was accom-
plished by using the Guyton model that incorporated cir-
culatory, fluid and electrolyte subsystems. This long-term
model initialized (provided initial values of major system
variables) a set of three short-term models representing
the cardiovascular, respiratory, and thermoregulatory sys-
tems. The three short-term models, designed to simulate
physiological responses to acute environmental changes
and short-term experimental stresses, operate in parallel
fashion, interchanging information as often as every 0.5
second of simulation time. Using this approach, a Whole-
Body Algorithm was evolved that is capable of simulat-
ing with equal facility those adaptive changes requiring days,
weeks, or even months as well as those experimental stresses
NASA/CR—2020-220487 80
evoking significant changes within seconds. Additional in-
formation can be found elsewhere [124,125,136].
 Joining models designed specifically to simulate dif-
ferent aspects of physiological function into a composite
Whole-Body Algorithm required solving several problems
that arose because each model may have components that
overlap similar components of another model and each model
may respond slightly differently to the same stimuli. If the
models are compatible with regard to simulation duration, it
may be possible to form a composite or bilateral model that
offers advantages to each subsystem. Therefore, combin-
ing compatible models requires that all overlapping com-
ponents be eliminated, that the effect of stimuli acting on
one model be properly related to the effects of stimuli acting
on the other models, and that non-overlapping components
function to yield consistent results.
Also essential to the design of a Whole-Body Algo-
rithm was the development of several intramodel inter-
faces (Fig. 2-5). In addition to the short-term/long-term
interface, both circulatory-thermoregulatory and circula-
tory-respiratory bilateral interfaces were required. The ra-
tionale for selecting the appropriate subsystems and the
means for dealing with the problems associated with in-
terfacing these subsystems were considered during sev-
eral preliminary studies [50,51,91,105,124,137] and are
summarized in Appendix D.
Other problems arose from the fact that each model
was originally developed with no thought of combination
with other models, as well as with different goals in mind.
Further, each model assumes or calculates common pa-
rameters using different techniques, and each model was
developed to respond to different specific experimental
stresses. To further complicate the model interfacing,
baseline data and structure such as blood volumes, basal
or resting metabolic rate, control systems, units, variable
names, volume compartmentalization, integration
schemes, time increments, and programming approaches
all differed considerably in the various subsystem mod-
els. These and many other details were worked out di-
rectly at the program level.
3.2.6.3 Subsystem Models and Modifications. The
individual subsystem models used in the Whole-Body
Algorithm were selected and modified to simulate the re-
sponse of a human subject exposed to the same stresses
under investigation in the Skylab medical experiments.
These models and the various modifications made during
this program have been detailed in earlier sections and in
Appendix D. They include the following.
1. The Guyton model [10] with modifications by White
[90,105,138] and Leonard and Grounds [114]. This
model is capable of simulating intermediate and long-
term changes in circulatory, fluid, and electrolyte
control;
2. The respiratory model of Grodins [45] with modifica-
tions by Gallagher [49,50,51,139];
3. The thermoregulatory subsystem model of Stolwijk [27]
with modifications by General Electric Company
[31,32,34];
4. The cardiovascular model of Croston [9] for exercise
with modifications by Croston and Fitzjerrell [13].
This model simulates LBNP, tilt, and tilt ergometry
[9,140,141];
5. The erythropoiesis control model developed by
Leonard [65,77,142,143].
(The models of Croston and Leonard, mentioned above,
were developed especially for this GE/NASA systems
analysis effort).
These models were selected after careful study and
with cognizance of the differences in parameters, control
systems, and various approximations used as constant pa-
rameters or set points, as well as their compatibility with
each other and to the requirements of the Whole-Body
Algorithm. Each model’s structure was modified where nec-
essary to improve the realism of the subsystem perfor-
mance. These modifications included:
1. Adding a chemoreceptor function to the short-term
cardiovascular model to allow blood oxygen and car-
bon dioxide levels to influence resistance elements in
blood vessels, heart rate, and strength of heart con-
traction;
2. Adding a countercurrent heat exchanger to the blood
supply of the thermal model to improve performance
in cool environments;
3. Adding a modified oxygen-uptake function for exer-
cise in the respiratory model to improve ventilatory
control;
4. Adding a thermoregulatory influence on heart rate.
Appendix D contains further details on these modifications.
3.2.6.4 Description of the Whole-Body Algorithm.
The individual models described earlier are in the form in
which they were used in the Whole-Body Algorithm. A
diagram illustrating the interfaces developed to represent
the interaction between these subsystems is presented in
Fig. 3-40. The long-term/short-term interface represents
one of the most important relationships in the Whole-Body
Algorithm, in that it provides the capability to simulate
the spaceflight event sequence.
The basic plan was to use the long-term model to ini-
tialize simulations by the short-term models. The short-
term experiments or transient environmental conditions
would, after steady-state conditions were reached,
reinitialize the long-term model for simulation of the sub-
sequent long-term phase. Since the long-term/short-term
interchange is sequential rather than simultaneous, the
modeling problem was primarily one of providing for the
transfer of the interface variables through a common block.
A secondary problem involved modeling the mechanism
necessary to use these variables on either side of the inter-
face in a physiologically representative manner.
Extensive computer programming was required to ini-
tialize and execute the subroutines in a synchronous man-
ner, since integration step sizes of the models were not
indentical. An executive program was developed that al-
lowed operation of the models through an “overlay” struc-
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Figure 3-40. Subsystems and interfaces of the Whole-Body Algorithm. Shown are the quantities generated by each subsystem model
that are used to influence one or more of the other models.
ture because they were far too large to all fit into core
memory at the same time. Limitations of computer technol-
ogy in the early 1970’s required these innovations which
would be relatively straightforward today. A description of
the executive program is proved in Appendix D.
The variables transferred through the interface are di-
rect functions of the long-term stresses simulated and of
the resultant hypotheses that relate to the physiological
representation of these stresses. The short-term experiment
stresses (other than environmental) do not impose any in-
terface requirement on the long-term model. It is assumed
that the short-term experiment simulation will always in-
clude recovery to the pre-stress state (i.e., no long-term
physiological changes are permitted to result from the simu-
lation of short-term stresses).
The interactions between the short-term models are
quite different. These models operate simultaneously, and
a stress applied to any one of them evokes a response in all
three subsystems. The structure of the Whole-Body Algo-
rithm permits the short-term models to operate essentially
independently of the long-term model. The integration of
thermal, respiratory, and circulatory mechanisms into a
single model structure has been the goal of other investi-
gators; therefore, the short-term portion of the Whole-Body
Algorithm constitutes a separate contribution to physi-
ological modeling. The block diagram of Fig. 3-41 de-
scribes, in highly schematic form, the integration of major
elements of the three models representing the thermoregu-
latory, respiratory, and cardiovascular control systems.
Only those elements essential for proper integration of the
feedback signals are shown; other factors important to
proper function of only a single subsystem model (such as
radiation and convection factors in the thermoregulatory
model) are not shown. Many of the blocks represent a con-
siderable degree of complexity in the simulation model.
Nevertheless, the diagram is useful for visualizing the in-
tegrated system in terms of central controllers which pro-
cess the input from three kinds of receptors
(chemoreceptors, baroreceptors, and thermoreceptors) and
in terms of a controlled system which is affected not only
by the central controllers but by environmental stimuli as
well. (In the case of exercise, environmental stimuli di-
rectly affect not only the controlled system but the con-
troller as well, as represented by the block labeled “Somatic
and proprioceptor inputs.”) Integration of the major regu-
latory subsystems occurs in both the controller and the
controlled systems. Shown on the right of the diagram are
the environmental and experimental parameters used to
test the responses of the model and also the primary ele-
ments they affect.
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The individual models differed in structural detail.
For example, the number of compartments in the controlled
system were vastly different; the thermoregulatory model
has 40 compartments for heat transfer, the pulsatile circu-
latory model has 28 compartments for blood flow, the res-
piratory model has 3 compartments for gas exchange and
the Guyton model has 5 circulatory compartments. Of
these, the only overlapping function was blood volume
and flow. These differences were reconciled and accom-
modated by either lumping blood compartments when in-
formation flowed in one direction or distributing them
when information flowed in another.
The net result of this subsystem integration was a large
model that, we believe, was superior to the sum of its parts.
This result was achieved by combining the best features
of each model and replacing subsystem algorithms known
to exhibit poor responses. For example, the segments that
compute brain and skin blood flow in the respiratory and
thermoregulatory subsystems, respectively, have been used
to replace corresponding segments of the cardiovascular
model. Conversely, the cardiovascular model contains a
better representation of flows in other tissue compartments
than is found in either the stand-alone thermoregulatory
model or the stand-alone respiratory model.
In another example, the long-term circulatory model can
be shown to be a useful counterpart to a short-term, pulsatile
cardiovascular model as part of the Whole-Body Algorithm.
Disadvantages of the short-term model are the lack of fluid
and protein transfer into and out of the central blood com-
partment and the lack of a drinking mechanism or func-
tioning kidney. Thus, whenever fluid regulation is
important (as in dehydration, weightlessness, or water load-
ing), errors are likely. Therefore, the long-term model, which
has the capability to account for drinking, renal function,
and fluid volume shifts, has been used in the Whole-Body
Algorithm to automatically define the fluid status for initial-
izing the short-term model. The short-term model could then
be used in a simulation of local exercise, postural change
in a gravitational field, or lower body negative pressure.
Thus, each subsystem can provide its own unique fine
level of detail to the other subsystems where previously
only a gross representation existed or was absent entirely.
3.2.6.5 Limitations. As previously discussed, the versa-
tility and performance of each subsystem model was im-
proved to some extent during its incorporation into the
Whole-Body Algorithm. However, many of the limitations
of each subsystem model were carried over to, and thereby
limited the capability of, the Whole-Body Algorithm. In
addition to these limitations (which have been discussed
in the description of each subsystem model), there are also
restrictions that arise because of the combining of several
Figure 3-41. Integration of short-term subsystem models of the Whole-Body Algorithm. This diagram indicates the general manner in
which environmental and metabolic stimuli can affect the respiratory, cardiovascular, and thermoregulatory systems. Validation of this
portion of the WBA is shown in Figs. 3-42 to 3-49.
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Table 3-8. Capability of Short-Term Subsystem Models to Simulate Short-Term Stresses Before and After Incorporation
into Whole-Body Algorithm
Model Stress
LBNP Tilt Hypoxia Hypercapnia Thermal stress Exercise
Cardiovascular   X*   X  WBA†      WBA       WBA     X
 subsystem
Respiratory WBA WBA    X        X      WBA     X
 subsystem
Thermoregulatory WBA WBA  WBA      WBA         X     X
 subsystem
*X designates stresses for which subsystem has been previously validated on stand-alone basis.
†WBA designates additional capability due to integration of subsystem into Whole-Body Algorithm.
models. One such restriction was the increase in time re-
quired for performing simulations. Because of this limita-
tion, it was not always desirable to use the Whole-Body
Algorithm when the response to only one of its subsystems
was required; the stand-alone model operated much more
rapidly. A more fundamental limitation was that the inte-
gration of several self-contained models resulted in differ-
ent control centers and different descriptions of the
circulatory system. In addition, short- and long-term con-
trollers were artificially divided by the basic structure of
the Whole-Body Algorithm. The difficulties associated
with combining these subsystems were largely overcome
as previously described, and the final model does achieve
most of the simulation objectives established. At the same
time, in a number of ways the true capabilities of the Whole-
Body Algorithm have yet to be tested and realized. Never-
theless, the lack of a more unified controller and controlled
system structure (i.e., a bottoms up design) has resulted in
a somewhat unwieldy model that may limit the ease with
which major expansion can take place. The knowledge
gained from developing the present Whole-Body Algo-
rithm should certainly provide a basis for designing other
alternative approaches.
3.2.6.6 Simulation Studies. Validating the Whole-Body
Algorithm was more difficult than validation of other physi-
ological models because this large model is more complex
than most models. This complexity is reflected in the many
subsystems, parameters, and dependent variables that it con-
tains. Also, it is difficult to find data for validating a model as
encompassing as this one; very few research laboratories re-
port results from more than one major body systems. The
reader should also note that the validation studies reported
below were performed in 1975 , which, of course, limited the
available data to publications prior to that date.
The short-term stresses chosen for simulation were
similar to those used to validate at least one of the short-
term subsystem models when operated independently. A
summary of the short-term models and the corresponding
stresses for which they have been tested on a stand-alone
basis is shown in Table 3-8. Not all the models were previ-
ously capable of responding to all the stresses; the label
“WBA” in Table 3-8 appears whenever a new capability
was added to the individual models embedded in the
WBA. The formulation of the Whole-Body Algorithm has
increased the capability of each model and has provided a
basis, through the interfacing links and simultaneous op-
eration of all models, for simulating additional stresses in
an integrative manner. Validation of a model as versatile
and complex as the Whole-Body Algorithm could involve
testing an almost endless variety of conditions and stresses.
Table 3-9 is a summary of tests chosen to limit the process
to a reasonable number of stresses of interest.
The stresses chosen to validate the Whole-Body Al-
gorithm involve some highly complex physiological in-
teractions and some special formulations to provide an
accurate simulation. Appendix D contains a detailed ac-
count of these facets as well as the rationale for choosing
this subset of validations. The stresses and the results of
their simulations follow.
a) Lower Body Negative Pressure/Tilt. Primary re-
sponses to LBNP and tilt occur in the cardiovascular
system. Changes in several important variables of the
cardiovascular system are shown in Fig. 3-42 and 3-
43. Some striking changes occur during these stresses,
and different responses occurred in the tilt and LBNP
experiments. Most of these changes and differences
are reproduced by the simulation response. Both LBNP
and tilt cause increases in heart rate and decreases in
stroke volume. The change in heart rate for the higher
levels of LBNP are similar to those observed for a 70°
tilt, but the stroke volume decreases are more severe
during tilt. A significant difference between these two
stresses is seen in the blood pressure response. Tilt
results in a large increase in diastolic pressure with
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little change in systolic pressure, whereas LBNP
evokes a substantial drop in systolic pressure. The
simulation of these two stresses results in different
hydrostatic gradients in the blood columns and, hence,
in dissimilar effects on the baroreceptors. During the
onset of LBNP, blood pressure changes are induced
primarily through depletion of central blood volume,
whereas during tilt, pressure changes occur because
of fluid volume and gravity vector changes. The sym-
pathetic response of the model is different for these
two stresses, and the model compares favorably with
the data from most investigations shown in Figs. 3-42
and 3-43.
b) Hypoxia and Hypercapnia. Validation of the simu-
lation of both hypoxia and hypercapnia was limited
by the available data on human subjects. Comparison
was attempted for these two cases only with studies in
which a large number of physiological variables have
been measured. Hypoxia was simulated with 8% oxy-
gen in nitrogen and hypercapnia was simulated with
7% carbon dioxide in air, both at atmospheric pres-
sure. The simulation and experimental results were
compared after 7 minutes and are shown in Fig. 3-44.
Agreement between model results and experimental
data is good for all cardiorespiratory variables and for
both stresses. The major differences between hypoxia
and hypercapnia appear to be a much lower blood
pressure change for the former and a much higher ven-
tilatory response for the latter. Brain blood flow is
considerable increased during the hypercapnia stress.
The large increases in cardiac output are not entirely
due to direct effects on the heart. Analysis of the simu-
lation experiment shows that decreasing peripheral
resistance alone will account for a significant portion
of the changes in cardiac output.
It is unfortunate that, because of data limitations,
validation was possible for only a single inspired gas
composition and for a single point in time for each of
these stresses. This is a serious limitation to the mod-
eling process, and it does not represent a complete
challenge to a model capable of simulating dynamic
responses to a wide range of stress intensities. Never-
theless, the results achieved must be considered sig-
nificant, inasmuch as the same structural changes that
were made in the model to simulate the hypoxic stress
also permitted an accurate simulation of the hypercap-
nic stress. The modeling technique was useful for inte-
grating the dynamic responses to these stresses and the
numerous pathways involved (see Appendix D).
Table 3-9. Whole-Body Algorithm Validation Tests
Stress  Validation criterion
           Simulation forcing       Primary WBA               Simulation Dynamic mode
                 function Subsystems validated               duration, hr         tested
LBNP (-30 to –50 mmHg) Decreased extravascular pressure Short-term      0.08    S*
(cardiovascular)
Tilt (70°) Increased gravity vector Short-term      0.08    S
(cardiovascular)
Hypoxia (8% O2) Decreased pO2 of inspired air Short-term      0.12    S
(respiratory, cardiovascular)
Hypercapnia (7% CO2) Decreased pCO2 of inspired air Short-term      0.12    S
(respiratory, cardiovascular)
Thermal stress (20o to 43oC) Increased ambient temperature Short-term (thermoregulatory,      6.0    S
cardiovascular, respiratory)
Exercise (0 to 200 W) Increased external workload Short-term (thermoregulatory,      0.5   S,T†
cardiovascular, respiratory)
Bedrest (300 ml Increased vascular stressed volume Long-term  672.0   S,T
change in stressed volume)
Combination of bedrest Combined bedrest, tilt, and Long-term plus  672.0    S
with pre-exercise, exercise plus automatic all short-term subsystems
post-exercise, and tilt sequencing between
(300 ml change in long- and short-term subsystems
stressed volume,
50 W exercise, 70° tilt)
*S = steady state
†T = transient
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Figure 3-42. Effect of 70o tilt on simulated WBA cardiovascular
subsystem response (hatched bars) compared to experimental re-
sults (open bars).
Figure 3-43. Effect of LBNP on simulated WBA cardiovascular
subsystem response (solid circles) compared to experimental data
(open symbols).
A Ref. [21]
B Ref. [22]
C Ref. [23]
D Ref. [24]
E Ref. [144]
Ref. [19]
Ref. [20]
Ref. [145]
Ref. [146]
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Figure 3-44. Effect of hypoxia and hypercapnia on simulated WBA cardiorespiratory subsystem response (hatched bars) compared to
experimental data (open bars) for following parameters: (A) cardiac output, (B) heart rate, (C) stroke volume, (D) mean arterial pressure,
(E) peripheral resistance, (F) arterial pCO2, (G) arterial pO2, (H) brain blood flow, and (I) ventilation rate. Scale values for brain blood
flow should be multiplied by 2, and values for ventilation rate should be multiplied by 10. (a) Hypoxia; inspired air: 8% oxygen in
nitrogen (data from [147] and [148]). (b) Hypercapnia; inspired air: 7% carbon dioxide in air (data from [149] and [150]).
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c) Ambient Temperature. No previous studies were found
which contained reports of simultaneous responses of
cardiovascular, thermoregulatory, and respiratory vari-
ables in resting man exposed to graded levels of ambi-
ent temperature. The greatest experimental effort has
been placed on investigating the thermoregulatory sys-
tem directly, and there are relatively few studies con-
cerning circulatory and respiratory responses.
Temperatures from 20°C to 42°C were chosen as a rea-
sonable range over which to test the model. The re-
sponses of the model and of human test subjects to this
graded heat stress are shown in Figs. 3-45 and 3-46.
It is apparent that the Whole-Body Algorithm cor-
rectly predicts responses for a wide variety of vari-
ables in all  major subsystems throughout the
temperature range studied. Inflection points in the data
where changes become more marked with increasing
temperature (skin temperature, heart rate, cardiac out-
put) are faithfully reproduced by the model. Discrep-
ancies between the model and the data (especially
evaporative loss) can be partly explained by the fact
that the resting metabolic rate of the model was 10 to
20% higher than that observed experimentally. The
stand-alone thermoregulatory model also predicted
higher values for evaporative losses than were shown
experimentally. Previous work with the thermoregula-
tory model has shown that evaporative loss rates are par-
ticularly sensitive to the choice of metabolic rate [32].
The increasing stroke volume trend of the model
as a function of temperature, is at variance with the
decreasing experimental values observed, although
the divergence is small. This difference may reflect a
decreased myocardial contractility but more probably
represent a decreased central venous pressure in the
human subjects as a result of temperature effects on
venous tone. Neither of these effects has been intro-
duced into the model. The decreasing arterial-venous
oxygen (A-VO2) difference is a reflection of increased
cardiac output being shunted mainly through the skin
while oxygen uptake remained constant. Note that
between 26oC and 33oC, the cardiac output remained
constant during the experiment but increased slightly
in the model. The findings suggest that increased skin
blood flow at lower temperature is caused by divert-
ing blood flow from the internal organs, whereas at
higher temperatures, the further demands on skin blood
flow require an increase in cardiac output [152]. This
result suggests modifying the cardiovascular sub-
system model to include such an effect on the visceral
organs. However, any further modifications should be
postponed until experiments can be designed to si-
multaneously measure the cardiovascular, thermoregu-
latory, and respiratory effects of graded thermal stress.
d) Exercise. Understanding the physiology of exercise
is a difficult and significant challenge, not only to
experimental research but to modeling as well. Be-
cause exercise is essentially a short-term stress involv-
ing a complex interrelationship of metabolic,
circulatory, respiratory, thermal, and neural activities
[52], it represents a stress perfectly suited to rigor-
ously test the validity of the entire short-term section
of the Whole-Body Algorithm. Each quantity shown
in Fig. 3-41 would be expected to change significantly
if the exercise levels were rigorous enough or contin-
ued for sufficient time. Each of the three models that
comprise this section (respiratory, thermoregulatory,
and cardiovascular) had the capability of simulating
its respective subsystem response to exercise before
incorporation into the Whole-Body Algorithm. How-
ever, the representation of certain physiological func-
tions were contained in more than one model and the
process of integration provided an opportunity to sub-
stitute the algorithm with the best performance. For
example, the stand-alone respiratory and thermoregu-
latory models had a relatively crude representation of
the cardiovascular system. During integration, the su-
perior Croston model was used to replace these repre-
sentations. Also, the thermoregulatory model added
appropriate elements to the cardiovascular subsystem,
such as changes in skin blood flow that previously
did not exist. This substitution process was imple-
mented in most cases via the passing of information
through the interface links between subsystem mod-
els, as illustrated in Fig. 3-40. These interface modifi-
cations and other improvements to the individual
subsystems are described in detail in Appendix D.
The Whole-Body Algorithm was validated for ex-
ercise by simulating bicycle ergometry in the sitting
position for graded levels of exercise. The external
workload is entered at the start of simulation as the
only required forcing function. Both steady-state and
transient responses have been validated for a wide
range of activity levels.
The behavior of some of the more important de-
pendent variables of the Whole-Body Algorithm dur-
ing graded levels of exercise (50, 100, 150, and 200
watts) is illustrated in Fig. 3-47. Comparison with ex-
perimental data from a single published source [18] is
also shown. Both simulation and experimental values
were obtained after 5 minutes of exercise. The model
correctly predicted a wide variety of hemodynamic and
respiratory responses, including steep linear changes
(heart rate and oxygen uptake) and highly nonlinear
changes (stroke volume, blood pressures, and ventila-
tion rate) over a wide range of metabolic rates.
Compared to the cardiorespiratory system, the
thermoregulatory processes require a much longer
time to equilibrate, or reach a quasi-steady state. This
delay is partly attributable to the high degree of ther-
mal inertial of the body tissues as well as the rela-
tively slow response of the thermoregulatory feedback
processes. Significant changes in such variables as
body temperature, sweat rates, and skin blood flows
are usually not seen by the end of short-term (5 min-
utes) exercise [153]. If exercise had been continued
for a longer period (both in the human subject and in
the model), changes would be expected in the response
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Figure 3-45. Effect of environmental temperature on simulated
WBA thermoregulatory subsystem response (dashed lines) com-
pared to experimental data (solid lines) from [151].
Figure 3-46. Effect of environmental temperature on simulated
WBA cardiovascular subsystem response (dashed lines) com-
pared to experimental data (solid lines) from [152], shown as
percent change from values at 26°C).
that are dependent on heat production as well as in
the variables of the cardiorespiratory subsystems that
are dependent on skin blood flow (cardiac output, A-
VO2 difference, peripheral resistance, and blood pres-
sure). This effect is shown more clearly in the next
two examples, which also demonstrate the capability
of the Whole-Body Algorithm to simulate transient as
well as steady-state physiological responses.
In the first of these examples (Fig. 3-48), a typical
Skylab-type exercise protocol was simulated. The
simulation consisted of 5-minute sequences of three
graded levels of exercise (50, 100, and 150 watts) fol-
lowed by a recovery period. Selected responses from
all three short-term subsystem models are shown, and
all, except heat storage rate and body temperature,
tend toward steady-state values at the end of each 5-
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Figure 3-47. Effect of exercise on simulated WBA cardiorespira-
tory subsystem response (open squares) compared to experimen-
tal data (open circles and solid lines) from [18]. Error bars represent
plus or minus one standard deviation. (a) Oxygen uptake as a
function of work rate. (b) Heart rate as a function of oxygen
uptake. (c) Ventilation rate as a function of oxygen uptake. (d) A-
VO2 difference as a function of oxygen uptake. (e) Stroke volume
as a function of oxygen uptake. (f) Blood pressure as a function of
oxygen uptake. (g) Cardiac output as a function of oxygen uptake.
        0       50     100         150   200
 (a) Work rate, W
         0      1.0      2.0          3.0  4.0
(b)  Oxygen uptake, liters/min
         0       1.0      2.0          3.0  4.0
(c)  Oxygen uptake, liters/min
          0       1.0      2.0          3.0  4.0
(d)  Oxygen uptake, liters/min
        0      1.0      2.0           3.0     4.0
(e)  Oxygen uptake, liters/min
              0         1.0       2.0       3.0      4.0
 (f)  Oxygen uptake, liters/min
       0      1.0     2.0           3.0   4.0
(g)  Oxygen uptake, liters/min
O
xy
ge
n 
up
ta
ke
, l
ite
rs
/m
in
H
ea
rt 
ra
te
, b
ea
ts
/m
in
A-
VO
2 
di
ffe
re
nc
e,
 m
l/li
te
r
Ve
n
til
at
io
n 
ra
te
, s
ite
rs
/m
in
St
ro
ke
 v
ol
um
e,
 m
l
Bl
oo
d 
pr
es
su
re
, m
m
Hg
Ca
rd
ia
c 
ou
tp
ut
, l
ite
rs
/m
in
NASA/CR—2020-220487 90
Figure 3-48. Simultaneous subsystem responses of the Whole-Body Algorithm during simulation of a sequential exercise protocol: 5
minutes exercise at 50 watts (0 to 5 minutes on time scale), 5 minutes exercise at 100 watts (5 to 10 minutes on time scale), and 5 minutes
exercise at 150 watts (10 to 15 minutes on time scale) followed by a 5-minute recovery period (15 to 20 minutes on time scale). The
parameters shown represent only a few of the many variables that can be predicted. (a) Respiratory subsystem. (b) Cardiovascular
subsystem. (c) Thermoregulatory subsystem.
minute exercise segment. It also should be observed
that no significant changes are predicted to occur for
arterial pO2 and pCO2 during exercise except for the
onset transient. This result supports many physiologi-
cal observations and illustrates the current dilemma
of respiratory physiologists in explaining the strik-
ing hyperpnea of exercise despite these small changes
in gas tensions.
The capability of the Whole-Body Algorithm to
predict significant changes in thermoregulatory re-
sponses to longer and more severe exercise (200 watts
for 30 minutes) is shown in Fig. 3-49(a). These predic-
tions of transient behavior agree with the observa-
tions reported by Saltin et al. [153], which are shown
in Fig. 3-49(b). Similar changes in body temperatures
are shown by both simulation and experiment. The
esophageal temperature of the subject and the blood
temperature of the model, both representing deep body
temperature, rose half as much as skin temperature.
The simulated skin blood flow is characterized by a
steep rise similar to the experimentally determined
thermal conductance (a crude estimate of skin flow).
Maximum sweat rate of the human subject was ap-
proximately 15 g/min, a value also predicted by the
model.
Significant delays occurred in the responses of
deep body temperature, skin temperature, and sweat-
ing rates both in the human experiment and in the
simulation. Since conductance measures both skin and
muscle blood flow, it would be expected that the de-
lay in skin flow predicted by the model, might not be
revealed by this experimental indicator. However,
more recent studies have demonstrated a significant
delay in skin flow during the onset of exercise
[154,155]. The model responses reveals that the extra
demands of blood flow to the skin result in a greater
cardiac pumping requirement, a decrease in periph-
eral resistance, and an (A-V)O2 difference. All these
predictions are reasonable but not yet fully confirmed
in the laboratory.
Also shown in Fig. 3-49 are the predicted re-
sponses of the conductive and radiative losses (known
to remain relatively constant) and the rate of heat pro-
duction. In the model, almost 80% of the energy pro-
duced during exercise is converted to heat within the
body, and the rise in heat production parallels the
(a) Respiratory (b) Cardiovascular (c) Thermoregulatory
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Figure 3-49. Simulated responses of the Whole-Body Algorithm to 200-watt exercise (left side) compared to experimental data from
[153] (right side). (a) Simulation. Ventilatory oxygen rate = 2.75 liters/min; air temperature = 24oC. (b) Experimental data. Ventilatory
oxygen rate = 3.15 liters/min; air temperature = 20oC.
(a) Simulation (b) Experiment
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dynamic behavior of oxygen uptake as well as muscle
blood flow.
In comparing the stand-alone cardiovascular
model responses to exercise and the response of the
Whole-Body Algorithm, it has become apparent that
the Whole-Body Algorithm simulation is superior in
many respects. This superiority is evident in accuracy
of response, stability, and, in particular, the capabil-
ity to predict detailed simultaneous responses from
several important physiological systems involved in
the exercise stress. Although still untested, the capa-
bility now exists to combine multiple environmental
and metabolic stresses for studying some very impor-
tant physiological conditions. These include supine
or sitting exercise in environments of abnormal pres-
sures, temperatures, humidities, and gas concentra-
tions as well as studying the effects of such important
parameters as blood volume and hemoglobin concen-
trations. Because of the importance of exercise as a
stress in daily human function and the complexity of
the response to exercise, we believe that the ability to
simulate short-term exercise is the single most prom-
ising aspect of the WBA and one which time (and lack
of suitable data) did not permit full exploration.
The initial validation of the Whole-Body Algorithm
was limited to a one-g stress simulation as described for
short-term subsystems. The stress chosen to validate the
long-term (Guyton) subsystem of the Whole-Body Algo-
rithm was bedrest, because it has long been considered an
analog to zero-g. This simulation study is presented in
Chapter 9.2. The capability of the Whole-Body Algorithm
to simulate a typical spaceflight sequence of long-term
stress preceded and followed by acute metabolic orthos-
tatic tests will also be demonstrated. The model, validated
for sequencing of events in one-g, can then be used to
help formulate and test zero-g hypotheses by direct com-
parison of the model output with the mission data. This
aspect also is considered in Chapter 9.
 In summary, the development of a Whole-Body Algo-
rithm, has resulted in a model which:
1. Provides a flexible structure for making changes with-
out total disruption of the entire system;
2. Provides a central repository for collecting hypoth-
eses for physiological changes due to the spaceflight
environment;
3. Provides the capability to test multiple system inter-
actions and total system hypotheses related to any
stress it was designed to simulate;
4. Provides basic capability to simulate multiple and sequen-
tial stresses with little or no change in model structure;
5. Provides the basic structure for adding new subsystem
models, improved sections in the sub-system models,
and the mechanisms and/or interface changes neces-
sary to simulate additional stresses.
3.2.7 Calcium Regulatory Model
Although the Skylab Program provided the first op-
portunity to study the long-term effects of weightlessness,
the much shorter-term Gemini and the Apollo missions
suggested the occurrence of a negative calcium balance
and bone mineralization [156,157,158]. Data gathered
from the Skylab crewmen provided solid experimental evi-
dence supporting the existence of an altered state of cal-
cium metabolism on exposure to zero-g [159]. Because of
the complicated nature of calcium regulation, it was de-
cided to develop an appropriate model for use as an analy-
sis tool.
3.2.7.1 Model Rationale. The purpose of the calcium
model is to simulate altered states in calcium metabolism
and bone demineralization during bedrest and zero-g ex-
posure. To function satisfactorily, the model should have
the following characteristics:
1. Be capable of describing plasma concentrations and
effects of specific calcium regulatory agents. Initially,
the regulatory agents of interest will be vitamin D and
its metabolites, parathyroid hormone, and calcitonin;
2. Be capable of simulating both steady-state and transient
calcium changes and important interactive biochemical
and physiological responses to selected stresses;
3. Embody plausible mechanistic hypotheses for the ac-
tion of complex stresses such as spaceflight and bedrest
on those systems concerned with calcium homeosta-
sis and thereby indicate areas where further study is
needed;
4. Provide a validated baseline model of calcium me-
tabolism which can be improved or updated by addi-
tional mechanisms or improved formulations of
various aspects of the model;
5. Help interpret spaceflight data and related ground-
based analog studies with regard to bone demineral-
ization and plasma and urinary levels of associated
minerals and their regulatory agents.
Most existing mathematical models capable of simu-
lating calcium metabolism are compartmental models de-
signed to reproduce the distribution kinetics of a tracer.
The main objective of such compartmental models is to
describe the calcium pools and the fluxes between these
pools, primarily in the bone and secondarily throughout
the body. The parameters contained in these models are
determined from experimental metabolic balance data, and
the models can be used to describe the calcium kinetics in
either normal or stressed individuals, depending on the
experimental procedure used to gather the data. An ex-
amination of the results of previous compartmental model
analyses helped in the formulation of hypotheses concern-
ing calcium regulation. Some of the compartmental mod-
els considered were those of Aubert, Bronner, and Richelle
[160]; Cohn et al. [161]; and Neer et al. [162]. Further discus-
sion of existing calcium models is contained in Brand [163].
Unfortunately, most compartmental models have sev-
eral important disadvantages that greatly limit their applica-
tion to simulation of low gravity. All compartments and rate
constants derived from these models are mathematical con-
structs which represent a multitude of physiological com-
ponents and processes that are indistinguishable from each
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other; thus, the elements in the calcium regulatory system
that are responsible for a particular experimental result
cannot be resolved in these type of models. A secondary
disadvantage of these models is the assumption of steady-
state conditions used to assess the rate of bone activity in
calcium regulation. The rate of intestinal calcium absorp-
tion is generally assumed to be constant in the models.
Then, with steady-state conditions, a constant rate of cal-
cium absorption, and a known rate of calcium excretion
(an experimentally supplied value), the changes in cal-
cium balance, theoretically, would be due to changes in
bone calcium. Consequently, any changes in calcium bal-
ance were assumed to reflect only bone activity (i.e., bone
resorption or bone deposition of calcium). In the space-
flight environment, these assumptions concerning the cal-
cium balance and bone activity may be realistic, but the
steady-state assumption is not. Another disadvantage of com-
partmental models that represent non-physiological compart-
ments or pools is that such models are difficult to use in a
predictive mode, especially in situations that are different
from those used to determine the model parameters. Thus,
an alternative type of model, a deterministic, physiologi-
cally-based model, was sought for the present project.
3.2.7.2 Description of the Calcium Regulatory Model.
Extensive research has been done in deciphering the regu-
latory features of calcium homeostasis since the discov-
ery of parathyroid hormone, calcitonin, and the
metabolites of vitamin D [164-168]. The influence of diet
and hormonal activity in the gastrointestinal tract and the
kidney and the many feedback pathways between the hor-
mones and plasma calcium concentrations are becoming more
clearly defined. The skeleton is perhaps the least understood
site of calcium metabolism, but rapid progress is also being
made in this area. Consideration of all these facts in relation
to the purpose for which the model was being built led to
the development of the model shown schematically in Figs.
3-50 and 3-51. Design requirements for this model included
the following.
1. The model parameters should have physiological sig-
nificance in terms of calcium metabolism and should
include:
a. The rate of calcium absorbed from the gastrointes-
tinal tract;
b. The rate of calcium reabsorbed by the renal tubules
or the rate excreted in the urine;
c. The rate of calcium released or retained by osteocytic
regulation of rapidly exchangeable bone calcium;
d. The rate of calcium derived from bone resorption by
osteoclasts or deposited into bone by osteoblasts;
e. The concentration of plasma parathyroid hormone;
f. The concentration of plasma 1,25 dihydroxy-chole-
calciferol (the active form of vitamin D);
g. The concentration of plasma calcitonin.
2. The calcium model should be developed as an inte-
grated set of subsystem models, each of which de-
scribes one particular aspect of calcium metabolism.
With this model structure, modifications and improve-
ments can be easily made in the model without affect-
ing the other subsystems of the model. The subsystem
models should describe (1) the plasma concentrations
of parathyroid hormone, calcitonin, vitamin D, cal-
cium, and phosphate, (2) the rate of renal clearance of
calcium and phosphate, (3) the rate of intestinal ab-
sorption of calcium and phosphate, and (4) the skel-
etal content and the fluxes of calcium and phosphate.
3. The controlling system should include the regulatory
features of parathyroid hormone, calcitonin, and 1,25
dihydroxycholecalciferol. The controlled system
should include the intestinal tract, kidney, bone, and
plasma concentrations of calcium and phosphate. The
major regulators in the feedback loops should be the
plasma concentrations of calcium and phosphate (see
Chapter 8 for a more detailed schemata of the model).
4. Validation of the calcium model should involve two
steps. First, as each subsystem model is developed, it
should be validated individually. Secondly, the model
should be validated as a composite of its subsystems.
The calcium model should be validated by simulat-
ing the responses to the following stresses:
a. Calcium loading or deficiency;
b. Phosphate loading or deficiency;
c. Vitamin D loading or deficiency;
d. Parathyroid hormone loading or deficiency;
e. Calcitonin loading or deficiency;
f. Changes in dietary calcium or phosphate.
5. Initially, only one-g simulation of stresses should be
required. Only after the model is so validated will the
simulation of the zero-g stress (bone demineraliza-
tion) be attempted.
The model should also contain a structure appropri-
ate for the inclusion of additional levels of detail in some
subsystems, particularly in the area of bone metabolism.
Bone is a dynamic tissue the main function of which is to
provide support and structure to the skeletal muscles and
body and the secondary function of which is to act as a
calcium reservoir in the maintenance of plasma calcium.
Bone metabolism may be affected either by the physical
stresses induced by its primary function or by the bio-
chemical alterations induced by either function. The bio-
logical effects of the physical stresses, such as piezoelectric
effects and tensile or shearing forces, affect the bone di-
rectly rather than being mediated by any soft-tissue me-
tabolism. The kidneys, the intestinal tract, and the
biochemical regulators also influence bone maintenance.
Since the soft-tissue kinetics of calcium regulation are
better understood at present than the physical effects on
hard-tissue metabolism, the initial calcium model should
not be a bone model as such but a calcium model encom-
passing the important biochemical calcium regulatory
events in the body. As this model is validated, it should be
expanded into the area of physical bone regulation, with
the ultimate purpose being to understand the effects of
hypogravic environments on bone composition.
 In view of the fact that the calcium model is such a
recent development in this project, validation studies have
not yet been completed. Further details on the design
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Figure 3-50. Model of Calcium Regulation. Development of this model of calcium metabolism is not complete. The design specifications
define the calcium fluxes between the intestinal tract, kidney, bone, and plasma as the controlled system. These elements are controlled
by the plasma concentrations of parathyroid hormone (PTH), calcitonin (CT), and the active metabolites of vitamin D, as well as by
changes in mechanical stresses due to alterations in the gravitational load. Other controlling elements include the urinary excretion rates
of sodium and water. The feedback loops influencing the controlling system are directed via the plasma concentrations of calcium and
phosphate (PO4). Thus, the model is designed to investigate the relative influence of the factors controlling calcium and bone metabolism.
Figure 3-51. General description of calcium model showing the major elements that control plasma calcium and the hormones involved
in calcium metabolism. Only the primary pathways are indicated. A more detailed description of the feedback pathways is presented in
Chapter 8. PTH = Parathyroid hormone; CT = Calcitonin; Ca = Calcium; P = Phosphate.
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specifications for the calcium model can be obtained from
Brand [163] and simulation examples are presented in
Chapter 8.
3.3 Hypothesis Testing Approach
The overall objective of the study documented herein was
to formulate a unified and consistent hypothesis that ex-
plained the major physiological responses to weightless-
ness. To accomplish this objective, it was necessary to
process spaceflight crew data into a form appropriate for
use with simulation and modeling and then to use these
data in the development and testing of hypotheses. The
systems analysis approach results in an interactive cycle
whereby preliminary data processing suggests hypotheses
as well as the type of simulation models required for physi-
ological interpretation. In turn, during the course of the
simulation studies, hypotheses are tested and procedures
for analyzing and processing data are redefined. Some of
the important aspects of this process are discussed in this
section (see Fig. 2-6).
3.3.1 Environmental and Metabolic Disturbances
Although weightlessness was the major spaceflight
factor of interest in these studies, a number of other envi-
ronmental and metabolic disturbances are present in space-
flight in general and Skylab in particular. The following
factors became important in the data analysis:
- Absence of gravity
- Hypobaric ambient pressure (1/3 atmosphere)
- Artificial gaseous atmosphere (190 mmHg pO2,
5 mmHg pCO2)
- Elevated temperatures during early period of 28-day
mission
- High g-forces at launch and reentry
- Caloric content of diet that was different on each mission
- Exercise levels which were different on each mission
- Space motion sickness incidence
These factors have the potential to confound conclu-
sions about ascribing the cause of any particular physi-
ological observation to the influence of gravity (or lack of
gravity). The data analysis, therefore, included not only a
comparison of 1-g and 0-g but also attempted to account for
the effect of such factors as oxygen partial pressure, caloric
intake, exercise training, and incidence of motion sickness.
3.3.2 Preparation of Crew Data
At the beginning of this effort, it was decided that the
analysis of data should be restricted to the support of the
program’s main objective, which was the use of the theory
of feedback regulatory systems to elucidate some of the
major physiological mechanisms crucial to weightlessness
adaptation. Indeed, one important question that was be-
ing pursued was “do the normal feedback pathways that
appear to regulate body function in on Earth, operate in a
similar manner in weightlessness”? This approach meant
that data analysis as such would not be a goal of this
project but that such analysis would be used as a tool to
develop and test specific hypotheses. Experimental data
were to be used in conjunction with simulation models in
two ways:first, as a means of providing values for model
input or forcing functions and, second, for comparing ex-
perimental observations with responses predicted by the
model. Each principal investigator had already done ex-
tensive data processing, and readily available results, e.g.,
Johnston and Dietlein [159], defined the point of depar-
ture for the project described here. The systems analysis
approach was expected to contribute to the integration
of data from various disciplines; this had not yet been
accomplished.
3.3.3 Scope of Data Considered
Table 3-10 illustrates the kinds of information selected
for the integrated data analysis project and the Skylab
biomedical experiments from which they were derived.
This list is merely representative and is not complete, as
more data than indicated here were collected for each of
the experiments. Despite the fact that all the measured
data could not be used in the simulation models, a great
deal of interdisciplinary analysis was required, especially
since an integrated simulation response which was in ba-
sic quantitative agreement with most of the experimental
findings was sought. Represented in this list are approxi-
mately 80,000 individual measurements spanning the pre-
flight, inflight, and postflight periods of three missions
and for nine subjects. In many cases, the analyses were
extended by comparing spaceflight and bedrest responses
and the total amount of data processed in this integrative
effort was increased proportionally as ground-based stud-
ies were included.
3.3.4 Grouping of Subjects
One of the primary objectives that guided the data
analysis was the characterization of a generalized response
to weightlessness. Therefore, the limited number of Skylab
subjects suggested that all nine subjects be treated as a
single group. This approach was complicated by differ-
ences between missions, such as duration, subjects, aver-
age caloric intake, exercise levels, and degrees of motion
sickness (see Chapter 3.3.1) On the first manned mission,
a temporary malfunction of the spacecraft heat shield re-
sulted in higher ambient temperatures for several days;
this fact was used to explain apparent anomalies in the
water balance analysis. In the final analysis, the treatment
of data by subject (N = 1), by mission (N = 3), or by com-
bining flights (N = 9) was dictated by the particular sub-
system or response of interest. For example, the loss of red
cell mass was progressively smaller on each subsequent
mission for unknown reasons, and it became an important
objective to explain these differences between flights. In
this case, the data from each mission were treated sepa-
rately. Alternatively, combining data for three missions
was deemed permissible if there was reason to believe flight
duration had little effect on a particular response. An il-
lustration of the latter was the significant loss of body
fluids and electrolytes, which appeared to be a common
occurrence in all crewmembers on all three flights. Nine-
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man averages were used, in this situation, to validate the
fluid-electrolyte model. In most cases, the nine-man aver-
age was only appropriate for the period consisting of the
first 28 days of flight; this was the period common to all
flights. In other cases, a composite Skylab response was
developed for a 3-month mission by averaging nine sub-
jects for the first month, six subjects for the second month,
and three subjects for the third month.
Another consideration that guided the data analysis
was the number of variables considered as factors in a par-
ticular hypothesis. In general, as the number of observed
variables available for comparison with a model’s responses
increased, the precision that we demanded in matching these
responses decreased. This guideline usually meant that a
larger number of subjects could be included in the pooled
data, since it was not necessary to distinguish the more
subtle changes between subjects or flights. Also, the group
size was permitted to increase as the data became more
noisy (that is, trends with time were poorly delineated).
Regardless of the grouping method employed, it was re-
quired that a consistent treatment be applied to all data
used for testing a given hypothesis or set of hypotheses.
This flexible approach to data grouping was necessary to
enable the consideration of a maximum number of sub-
jects for a particular hypothesis without neglecting im-
portant differences between subjects and flights.
3.3.5 Hypothesis Testing and Development
3.3.5.1 The Process. The analysis process, described
earlier in Chapters 2.6 and 3.1, assisted the investigative team
in rapidly scanning large quantities of time-dependent data
for crew-men (individually or as a group), in detecting sig-
nificant changes or trends in the measured variables, and in
making statistical correlations between variables, flights,
flight phases, and subjects. This process often suggested
hypotheses regarding basic changes in physiological func-
Table 3-10. Skylab Experiment Data Used for Integrated Systems Analysis
  No.           Experiment Title Data Used
M071 Mineral balance Na+, K+, N, Ca++ in diet and excreta
M073 Bioassay of body fluids H2O intake and excreta
Fluid volumes of total body, extracellular and plasma compartments
Exchangeable body K+
Biochemical assay of urine and plasma: Na+, K+, osmolarity,
 catecholamines, cortisol, angiotensin, aldosterone, and ADH
Urine specific gravity
M074 Specimen mass measurement Fecal weights
Food residues
M092 Lower body negative pressure Resting and stressed heart rates, systolic and diastolic pressures,
 and change in leg girth
Leg blood flow
Venous compliance
Change in leg volume
M110 Hematology and immunology Red cell mass
Reticulocytes
Inflight hemoglobin
M171 Metabolic activity O2 uptake
Blood pressures
Cardiac output
Heart rate
Pulmonary efficiencies
Mechanical efficiencies
M172 Body mass measurement Daily body mass
Stereophotogrammetry
  Body volume
  Body density
  Change in leg volume
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tion that could be tested either statistically or by using
the predictive capabilities of the simulation models.
The models, validated for preflight experiments, were
used to simulate experiments during and following the
mission. These “experiments” included not only well-de-
fined stress tests such as LBNP and exercise but also the
observations from the biochemical and biophysical analy-
ses (that is, blood sample analyses, urine collections, and
whole-body measurements). Because the models were vali-
dated for preflight experiments, the models, without any
modifications for describing weightlessness, acted as a
one-g control to the Skylab data. Any discrepancy be-
tween inflight data and inflight simulation predictions
was assumed to be associated with adaptation to weight-
lessness or to other environmental, e.g., high ambient tem-
peratures, dietary, metabolic, e.g., extravehicular activities
or intense exercise periods, or medical, e.g., drug usage,
factors. Candidate hypotheses that might account for these
differences were then developed and incorporated into the
mathematical model for testing.
Any hypothesis, to be acceptable, should meet spe-
cific criteria. The hypothesis should be physiologically
plausible and should yield simulation results that exhibit
the same trends observed in the Skylab data over the course
of the mission. Furthermore, the hypothesis should also
be consistent with other working hypotheses and with the
results of other acceptable model simulations.
Often, more than one hypothesis or combination of
model parameter values can lead to a given simulation
response. The more plausible of these may be identified
for further experimental examination. It may be quite pos-
sible to choose between competing hypotheses when the
regulating system is easily defined and when the system
variables can be measured directly. However, given the
complexity of the physiological and modeling systems
and the limited number of measurements available on
Skylab, simulations were better suited for eliminating in-
appropriate hypotheses. The systems approach applied to
hypothesis testing, therefore, usually resulted in a rank-
ing of candidate hypotheses rather than in isolating one
definitive conclusion.
Testing hypotheses using computer simulations of a
mathematical model is not unlike performing experiments
in the laboratory on an unknown system. The starting point
is to ask simple and easily understood questions (based
on a simple model) and progressing to the more complex
world of reality. At each stage in this process, it was im-
portant to ensure that the model’s response was appropri-
ate. This objective was accomplished by validating the
model for similar stresses for which the response mecha-
nism was known (see Tables 3-2 and 3-7). In this way, it
was possible to evaluate complex hypotheses involving
multiple and competing stresses, each characterized by its
own dynamic behavior. Figure 2-6 illustrates the steps in
the use of models to test hypotheses.
As an example of how several models could be used
as part of this hypothesis testing approach, consider the
following hypotheses that involves three major body sys-
tems and three of the simulation models:
Hypothesis (A)
Total blood volume losses observed in spaceflight are
a result of two separate occurrences:plasma volume losses
and red cell mass losses.
Hypothesis (B)
Plasma volume is diminished in spaceflight as a result of
headward fluid shifts activating renal excreting mechanisms.
Hypothesis (C)
Red cell mass is diminished in spaceflight as a result
of hypovolemia-induced hemoconcentration which inhib-
its red cell production.
Hypothesis (D)
The higher heart rate observed in astronauts in space
during LBNP testing (compared to the same LBNP tests on
the ground) is a result of a decrease in total blood volume
which causes enhanced signals from the baroreceptors.
Figure 3-52 is a pictorial representation of these hy-
potheses indicating the boundaries of interest for the ap-
propriate simulation model. Hypothesis (B) can be tested
in Guyton’s circulatory-fluid-electrolyte model; hypoth-
esis (C) can be tested in Leonard’s erythropoiesis regulat-
ing model; and hypothesis (D) can be tested in Croston’s
cardiovascular system model. Alternatively, all the hy-
potheses can be tested in a single model – the combined
Whole-Body Algorithm.
These hypotheses are only presented in abbreviated
form; the complete spectrum of physiological pathways
considered for each of these events is more complex and
they are discussed in later chapters. Nevertheless, Fig. 3-
52 indicates the systems concept used in this study. An
integrated view of spaceflight physiology is achieved by
segmenting the larger hypothesis into subsystem hypoth-
eses, evaluating them separately on the individual sub-
system models, and using the Whole-Body Algorithm to
test the integrated total-body zero-g hypothesis.
3.3.5.2 Limitations. Although systems analysis tech-
niques are useful in formulating and testing hypotheses,
conclusions should be approached cautiously. One can
conclude that a good simulation match with experimental
data, even if only for one or two individuals, does support
the hypothesis being tested, particularly when the inclu-
sion of the hypothesis into the model changes the simula-
tion results from a poor to a good match. However,
successful simulation of the response to an experiment
does not constitute proof that the hypotheses are valid.
Alternatively, the failure to match the response of one or
two crewmen is not proof that the hypotheses are invalid.
Nevertheless, it must be considered encouraging when a
complex process provides accurate simulations (in terms
of magnitude and direction) of the dynamic response of a
complicated physiological system to a wide range of
stresses. Although the procedure is sound, the verification
of any hypothesis involves a considerable amount of work,
including verifying all data input to the models as well as
experimental data, rechecking all calculations, estimates,
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and assumptions and supporting them with independent
analyses or data from other sources, and comparing ex-
perimental data for different, but related, experiments for
all crewmen with results from the model containing the
hypotheses being tested.
Even with all of the precautions for assuring accuracy
of the simulation, the model is only a representation of the
real system and, as such, will probably never attain exact
reproduction of that system. It is recognized that computer
models cannot replace well-planned experimentation; it is
also recognized that additional spaceflight studies are both
infrequent and expensive. Ground-based studies, includ-
ing both experimental and computer simulations of
hypogravity, are viable alternatives in this situation. All
conclusions drawn from the simulation models should be
accepted cautiously and verified experimentally.
3.3.5.3 Relationship to Statistical Analysis. In con-
clusion, it would be appropriate to briefly discuss the re-
lationship between statistical analysis and simulation
analysis. Both approaches have been used in these studies
to test hypotheses. Statistical tests of differences (i.e., t-
tests), analysis of variances, can predict the likelihood
that one group of data is different from another, and statis-
tical correlation tests suggest causal relationships among
variables. The simulation modeling process is capable of
testing the significance of data and the relationships among
variables from a viewpoint other than that of a statistical
approach. Also, the simulation models, because of their
homology to the real system, can be useful in revealing
the behavior of the real system and in formulating hy-
potheses. Statistical models are limited in this regard.
Statistical models suggest, but cannot prove, a casual
relationship between measured quantities. This limitation
is also characteristics of simulation models, but the simu-
lated results have a more direct association with the mea-
sured quantities. Simulation algorithms already contain
the basic feedback-regulating mechanisms that are be-
lieved to have produced the observed response. If the simu-
lation model has gained a high degree of credibility and
there is agreement between the observed and simulated
responses for several variables, one can reasonable assume
(but not prove) that the models’ mathematical representa-
tion is basically correct and that the experimental find-
ings are also real and internally consistent, even if the
data do not achieve significance by conventional statisti-
cal tests. In many cases, changes in mean value or trends
in experimental data do not achieve statistical significance
merely because of an insufficient number of subjects of a
low-resolution measuring device. These data would be
ignored in more traditional methods of analysis.
Therefore, in using experimental data to evaluate and
test hypotheses with simulation models, there was often
little regard for the statistical significance of the observed
Figure 3-52. Example of subsystem and integrated hypothesis testing with simulation models. Shown here are three subsystem models
that are contained in the Whole-Body Algorithm. The diagram illustrates how the effects of plasma volume disturbances can be studied
in each model subsysem and integrated effects studied in the combined model.
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changes, especially in the earlier stages of the program.
This approach was thought appropriate since the model
simulation represents a high level of data and systems in-
tegration and it was likely that inconsistencies in the data,
if present, would be revealed in the final analysis by com-
parison with the simulation responses. In this way, it was
possible to use a greater diversity of data. Of course, at
later stages of simulation applications, it was important to
verify inconsistencies in the relationships by performing
suitable statistical tests.
Although the emphasis in the study described here is
on hypothesis testing using simulation rather than statis-
tical models, it is recognized that both approaches are
complementary and more powerful than either one alone.
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Update Endnotes
Update #1
Recent developments in????????????????????????????
Another model of respiratory control superior to that
of Grodins’, became available in the late 1970’s. Dickinson
[55] developed his model known as “MACPUF” to simu-
late experimental and clinical conditions including exer-
cise, hypocapnia and Cheyne-Stokes respiration. This
model was tested by NASA but was not available in time
to be incorporated into the Whole-Body Algorithm as a
replacement for the Grodins model. Because there were no
undesirable changes in pulmonary function noted during
the Skylab missions, neither model was used on a stand-
alone basis to help solve problems of spaceflight adapta-
tion. A respiratory model was nevertheless, considered
critical to the overall systems analysis planning effort be-
cause of the possibility of hypoxia or hypercapnia occuring
in space capsules and because respiratory control is inte-
gral to models attempting to simulate exercise.
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Chapter 4
Integrated Metabolic Balance and Body Composition
During Spaceflight
4.1 Introduction
One of the most consistent findings in astronauts return-
ing from spaceflight has been a loss in body weight. The
Skylab biomedical findings provided the first detailed set
of data designed to examine this loss of body weight, and
allowed more definitive conclusions to be made about the
metabolic and body composition changes that occur dur-
ing zero-g. This chapter presents a comprehensive series
of analytical studies designed to address the fundamental
questions, “how does spaceflight alter the components of
body fluid, mass and energy?” and “why do astronauts
lose weight in space”? Figures 10-2 and 10-9 indicate the
systematic approach used for characterizing the major
routes of fluids and energy into and out of the body as
well as the changing size of their storage compartments
within the body. The extensive Skylab database was used
to provide the information necessary to integrate the en-
ergy balance, mass balance, water balance, and body fluid
volumes of the astronauts (Fig. 3-5).
4.1.1 Objectives
Although data gathered on the manned spaceflight
missions through Apollo indicated that significant
changes in human body fluid and mineral content were
induced by hypogravity, it was not possible to follow these
changes closely until the Skylab Program. Even in the
workshop environment of Skylab, it was not feasible to
measure whole-body composition directly, and only indi-
rect analyses based on metabolic balances of minerals,
nitrogen, and water losses have been performed [Refs. 1–
9]. In the absence of direct data, these indirect methods
have played a large role in the formulation of hypotheses
related to the physiological effects of spaceflight.
In this section, the previous indirect analyses of the
Skylab data are extended to include the following:
1. Integrate the most important Skylab findings related to
the losses of body mass and biochemical constituents;
2. Process the metabolic balance data to obtain more mean-
ingful interpretations regarding the dynamic behavior
of metabolic changes and the relative influence and
importance of the different avenues of metabolic losses;
3. Express body composition changes in a graphical for-
mat suitable for validating computer simulations using
the fluid-electrolyte model;
4. Interpret body composition changes so that the influ-
ence of weightlessness can be distinguished from that
of diet, exercise, and flight duration.
4.1.2 Approach
With these objectives in mind, procedures were de-
veloped to compute metabolic balances of water, miner-
als, mass, and energy in the common framework of a
special-purpose algorithm called the Integrated Metabolic
Analysis Program. This algorithmic approach is described
in general terms in Chapter 3 and more fully in the next
paragraphs.
The software developed for this analysis effort consisted
of several specially designed subsystems (Fig. 4-1):
1. An extensive data base containing daily metabolic in-
puts and outputs for each of the nine subjects on each
day of the preflight, inflight, and postflight periods;
2. Metabolic balance algorithms for computing daily bal-
ances and summarizing balance components (i.e., di-
etary inputs and urinary and fecal outputs);
3. A numerical time-integrating procedure for cumulat-
ing the sequential changes in daily balance;
4. An algorithm for using direct whole-body measure-
ments to provide a check on the accuracy of the meta-
bolic balance results and to minimize the errors inher-
ent in conventional cumulative balance techniques;
5. A statistical algorithm for computing means and vari-
ances for each parameter by pooling results for each
subject across a mission phase, by pooling results for
each three-man crew, or by pooling all individual data
on a daily basis;
6. A correlation analysis algorithm for determining rela-
tionships between variables and sources of errors in the
balance method;
7. A plotting package that generates microfilm time-trend
plots of any input or derived variable for any subject or
for groups of subjects over any time interval. All re-
sults could be plotted as continuous daily values for
convenience in displaying, scanning, and interpreting
the data.
In general, metabolic balance techniques are based
on the law of conservation requirement that, for a given
substance, subtraction of the amount excreted (output)
from the amount ingested (input) provides a measure of
net retention or loss of that substance (so long as that
substance is not created or destroyed within the body).
Thus, cumulative sums of daily metabolic balances can be
used to estimate continuous whole-body changes of the
substance as a function of time. Direct total body mea-
surements, obtained at intervals throughout the mission,
provide a check on the results of the cumulative balances.
The present analysis not only provides overall balances
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for water, tissue mass, minerals, and energy but allows these
balances to be partitioned into components of input in-
gested from fluids or solids and of metabolic products and
output (urinary, fecal, and sweat). Thus, a partitional wa-
ter balance would describe the changes that result from
water intake (free drinking water plus food water plus meta-
bolic water) and water output (urine plus fecal water plus
evaporative water loss). The input and output components
of the various substances studied using the balance analy-
sis described in this chapter, together with the available
whole-body measurements, are shown in Table 4-1.
The data gathered during the Skylab Program that are
relevant to the present analysis can be conveniently di-
vided into the following categories.
1. Metabolic balances (intake, fecal, and urine analyses) for
calories (bomb calorimetry), water, nitrogen, fats, carbo-
hydrates, calcium, sodium, potassium, and other cellular
electrolytes, which were performed each day of the pre-
flight, inflight, and postflight periods [5,6,7,8, 9]. Dietary
intake was controlled by pre-packaging meals. More
than 900 man-days were included in these studies.
2. Total body weight/mass measurements, which were per-
formed daily (before, during, and flight) using conven-
tional scales in the terrestrial environment and using
Figure 4-1. Flow diagram of the integrated metabolic balance analysis. Dashed boxes refer to specially designed software modules.
the oscillation period of a spring-loaded balance in the
zero-g environment [10,11].
3. Total body measurements of water (by tritium dilution),
extracellular fluid (by 82Br dilution), potassium (by 40K
dilution), and body volume (by stereophotogrammetry),
which were performed only during the preflight and
postflight phases; [4,12,13].
All these data used in the integrated metabolic bal-
ance analysis as summarized in Fig. 4-2.
4.1.3 Analytical Methods with Examples
The collection of metabolic data did not include losses
associated with the skin (i.e., evaporative water loss, sweat
secretions, nail and hair clippings, and skin flaking). Al-
though neglect of these unmeasured losses usually does
not represent serious errors in a daily balance (except for
evaporative water loss in a water balance), errors do accu-
mulate over time and can become quite large when com-
puting cumulative balances. In our studies correction of
daily balances by a term representing the unmeasured skin
losses was accomplished by using the general procedure
shown in Fig. 4-3. The correction factor is obtained by
comparing the uncorrected cumulative daily balance dur-
Crew metabolic
balance and direct body
measurement data
Calculation of individual
crew daily and
cumulative balances
Analysis after grouping
of crewmen
Automated graphical and
tabular output
Error
analysis
algorithm
Microfilm
generation
software
Numerical
integration
algorithm
Software for
averaging and
variance analysis
Daily and cumulative
balances as function
of mission duration
Mission phase means:
     preflight
     inflight
     postflight
●
●
●
Individual balances (n = 1)
Mission averages (n = 3)
Skylab averages (n = 9)
▲
▲
▲
▲
▲
▲
▲
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▲
▲
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Table 4-1. Components of Metabolic Balances Considered in Analysis
Type of balance Input Output Direct total body measurement
Water Drinking water Urine water Total body water (tritium dilution)
Water bound in food Fecal water
Metabolic water* Evaporative water loss*
Dry mass (gravimetric) Dry food mass Urine solids Total body mass/weight
Metabolic oxygen mass* Dry fecal mass
Metabolic carbon dioxide mass*
Energy Diet calories Urine calories No direct measurements;
Energy from body protein Fecal calories  assume total energy use constant
 catabolism* Energy for body protein anabolism*  (work plus heat)*
Energy from body fat Energy for body fat anabolism*
 catabolism*
Sodium Diet sodium Urine sodium Extracellular fluid times plasma
Fecal sodium  sodium concentration
Sweat sodium  = exchangeable body sodium
Potassium Diet potassium Urine potassium Total exchangeable potassium
Fecal potassium  (40K dilution)
Sweat potassium
Nitrogen, calcium, Diet Urine None
 phosphorus, and Feces
 magnesium
*Quantities not measured directly
ing a given time interval with the true body change as
obtained by the direct whole-body measurement. The dif-
ference between these terms (shown graphically in the dia-
gram of Fig. 4-3 as the “cumulative error”) is expressed as
a constant daily loss rate (calculated by dividing the net
mission change by the number of days in the time inter-
val), which is applied directly to the uncorrected meta-
bolic balance. Use of this process ensures that the
cumulative corrected balance agrees precisely with direct
body measurements at the end-points of the time period
being studied.
In terms of numerical analysis, this is a well-known
parameter-estimation technique with known and restricted
boundary conditions. The parameter being estimated in
this case is the correction factor, and the boundary condi-
tions are the measured total body changes. In addition to
improving the accuracy of the cumulative balances, this
method also enables estimation of unmeasured evapora-
tive water loss, electrolyte sweat losses, and total dry skin
losses. These derived quantities may be examined for their
plausability bt comparing them with independently mea-
sured values from the literature.
The diagram in Fig. 4-3 represents only the inflight
period, but similar calculations were performed for the
preflight and postflight periods whenever wholebody mea-
surements were available. In either case, CF is calculated
as a cumulative error over the time interval of interest,
divided by the number of days in the interval; the result-
ing daily value of CF is assumed constant throughout the
time interval.
An example of a water balance study for a single crew-
man is presented in Fig. 4-4, in which the capability of
these procedures in deriving and plotting daily and cumu-
lative balances is shown. Subtle changes in the balance
data (top graph) can lead to substantial total body changes
as represented by the cumulative daily balance (bottom
graph). These changes might not be fully appreciated by
scanning daily balance data alone. The time-integrated
analysis method (cumulative daily balance) challenges
the accuracy of the experimental balance methods, since
experimental errors become more apparent when cumula-
tive balances are employed. An investigator may have more
reason to be confident in the balance data if the results of
the cumulative analysis appear reasonable, particularly
when long time periods are involved. An example of the
effect of the correction factor on the cumulative water bal-
ance is provided in Appendix F (Fig. F-1).
4.1.4 Reference Data for Crew and Skylab
Environment
The physical characteristics of the Skylab crewmen,
measured preflight, are presented in Table 4-2. The values
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Figure 4-2. Data used in the integrated metabolic balance analysis. All date were obtained daily—before, during, and after flight—except
as noted. (*) indicates pre- and post-flight measurements only; (**) indicates weekly inflight measurements.
Table 4-2. Physical Characteristics of Skylab Crew for Each Mission [N=3; Mean ± SD]
Mission Age,  Height,    Surface   Body wt.,  Body fat,** Oxygen uptake***
duration,   yr    cm   area,* m2       kg   percent     cm3/kg/min
days
28 42 ± 1 177 ± 7 1.85 ± 0.17 73.43 ± 9.81 11.2 ± 2.8     35.5 ± 1.0
59 40 ± 3 178 ± 5 1.81 ± 0.19 72.80 ± 13.60 15.0 ± 0.5     33.4 ± 4.7
84 40 ± 3 175 ± 0 1.77 ± 0.02 68.95 ± 2.22 12.1 ± 4.2     39.8 ± 6.6
Mean**** 41 ± 2 177 ± 4 1.81 ± 0.13 71.73 ± 8.71 12.8 ± 3.1     36.2 ± 4.9
* Determined by stereophotometric measurements
** Derived from  water immersion technique
*** Measured at 160-beat/min heart rate during bicycle ergometry exercise
**** n = 9
Fecal data
● Dry weight
● Fecal water
● Calories
● Nitrogen
● Sodium
● Potassium
● Calcium
● Phosporus
● Magnesium
Whole-body data
● Body weight/mass
● Body volume*
● Body water*
● Extracellular fluid*
● Plasma volume*
● Exchangeable potassium*
● Plasma sodium concentration**
● Energy expended in exercise
Urine data
● Volume
● Specific gravity
● Nitrogen
● Sodium
● Potassium
● Calcium
● Phosporus
● Magnesium
Diet data
● Free water
● Water bound in food
● Dry food weight
● Calories
● Carbohydrates
● Fat
● Nitorgen
● Sodium
● Potassium
● Calcium
● Phosporus
● Magnesium
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Figure 4-3. Method of reducing errors in cumulative metabolic balances. Bar over quantities indicates average value over the time period
of N days.
Uncorrected daily balance
Total body balance (uncorrected) = diet - urine - fecal
Corrected daily balance
Total body balance (corrected) = diet - urine - fecal -
       = total body balance (uncorrected) -
Correction factor
CF= ed)(uncorrectbalancebody-total  - ∆ total body χ/N days
Cumulative losses
Uncorrected losses over N days = ∑
N
i
total body balance (uncorrected)
Corrected losses over N days = ∑
N
i
total body balance (corrected)
CF
CF
are grouped according to missions. The astronauts formed a
fairly uniform population with regard to age, body size, body
composition, and physical condition. The environmental
parameters of the Skylab workshop (Table 4-3) were also
very similar from flight to flight. Although each flight con-
sisted of a small statistical sample, the uniformity of these
environmental and physical characteristics reduces the prob-
ability that the differences between crewmen would obscure
the effects of spaceflight on metabolic factors.
4.1.5 Summary of Analyses Performed
The integrated metabolic balance analysis resulted in
several distinct studies, which are summarized in this sec-
tion. The major type of results derived from these studies are
listed here.
1. Daily inflight metabolic balances for
a. Water
b. Nitrogen
c. Sodium
d. Potassium
e. Calcium
f. Phosphorus
g. Magnesium
2. Cumulative losses or gains of
a. Body water
b. Body tissue solids
c. Body fat
d. Body protein
e. Body sodium
f. Body potassium
3. Preflight body composition (lean body mass and per-
cent fat) and net inflight changes using five indepen-
dent methods based on
a. Total body water
b. Total body potassium
c. Body density
d. Nitrogen balance
e. Potassium balance
4. Estimates of unaccountable metabolic losses representing
a. Evaporative water loss (sensible plus insensible)
b. Dry skin losses
c. Sodium sweat losses
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Figure 4-4. Daily water balance and cumulative water balance computed from water balance equation for a single Skylab crewman
(subject 7). Cumulative water balance values represent changes from preflight baseline measured 1 day before liftoff.
Table 4-3. Skylab Environmental Parameters [Mean ± SE]
Mission            Temperature, °C      Pressure, mmHg
duration,
days Ambient pH2O* pO2** pCO2***
28 24.3 ± 2.2 252 ± 0.04 8.9 ± 1.4 194 ± 0.5 3.7 ± 0.1
59 23.1 ± 1.1 263 ± 0.12 9.7 ± 0.7 185 ± 1.0 4.9 ± 0.1
84 24.1 ± 1.6 259 ± 0.11 9.8 ± 1.5 189 ± 0.5 5.1 ± 0.0
* Partial pressure of water vapor
** Partial pressure of oxygen
*** Partial pressure of carbon dioxide
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d. Potassium sweat losses
5. Estimates of energy metabolism parameters
a. Net energy use
b. Metabolic efficiency
c. Caloric intake requirements
d. Exercise requirements
Complete reports of each analysis are available and
are cited in the sections that follow. The methods of com-
putation and associated assumptions that were used to
obtain these results are provided in Appendix F.
4.2 Skylab Water Balance Analysis
A water balance analysis of the Skylab crewmen during
the entire preflight, inflight, and postflight phases is sum-
marized here. A knowledge of inflight changes in the fluid
content of the body is essential for a complete understand-
ing of the dynamics of body fluid shifts, renal function,
electrolyte regulation, and hormonal regulation in re-
sponse to extended periods of weightlessness. This infor-
mation will also be useful in interpreting other inflight
experiments such as lower body negative pressure and ex-
ercise responses, in comparing weightlessness with bedrest,
and in providing validation data for the simulation of
weightlessness using mathematical models.
4.2.1 Approach
Daily changes in total body water (∆TBW) are taken
as the difference between changes in body weight/mass
(∆BWgt) and dry tissue (∆TIS) as shown in Fig. 4-5.
Changes in the dry tissue were determined by a daily bal-
ance of solids on each crewmember. The amounts of dry
food, urine, and feces were measured directly, whereas the
values of insensible metabolic loss (IML) involved in food
metabolism were obtained from dietary constituents, known
stoichiometric relationships, and the metabolic efficiency
η
 
. A correction factor (CF) was employed to represent the
unmeasured losses of sweat solids and skin flaking and
the insensible metabolic losses from catabolism of body
tissue. The correction factor was derived from the differ-
ence between the directly measured losses of body water
Figure 4-5. Method of computing daily changes in water balance using a solids balance. (Key: η  = metabolic efficiency, TBW = total
body water, BWgt = bodymass, Tis = dry tissue mass).
where
IML = Insensible metabolic losses = (H2O + CO2 - O2) met
= η (Cho + Fat + 0.563Pro)
CF = correction factor = ∆TBW (direct) - ∆TBW (balance)
Cho = carbohydrate
Pro = protein
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[∆TBW(direct)] and the losses over the same time interval
obtained from an uncorrected water balance [∆TBW
(balance)](see Fig. 4-5). As mentioned earlier (see Fig. 4-
3), the use of the correction factor in the balance equation
ensures that the results from the indirect balance analysis
agree with the total body water changes revealed by direct
isotope-dilution methods. The water balance was com-
puted as described in Fig. 4-5 and was expressed using the
following definitions for water intake and output.
Total water intake = water(drink) + water(food)
 + water(metabolic)  (1)
Total water output = urine volume + fecal(water)
 + evaporative water  (2)
Water balance = total water intake
 – total water output (3)
From the daily water balance equations, changes in
total body water and evaporative water loss (EWL) can be
calculated. Total body water changes between any two
points in time were obtained from the accumulation of the
daily water balances over that interval. The evaporative
water loss was determined by using the two metabolic bal-
ance equations—the water balance and the mass balance—
as shown in Fig. 4-6. In the mass balance equation, all the
mass inputs and outputs of the body (liquid and solid)
plus the changes in body mass are considered. In the water
balance equation, only the fluid inputs and outputs of the
body plus the changes in body water are considered. Meta-
bolic oxygen, carbon dioxide, and water were determined
from dietary components as shown in Fig. 4-6. Determina-
tion of evaporative water loss on a daily basis, using the
water balance equation, was not possible since values of
TBW were only known before and after flight – not on a
daily or even weekly basis inflight. Therefore, the mass bal-
ance equation was used because all terms in the equation,
including ∆BWgt, were measured daily. Details of these
methods are included in Appendices F(1) and F(2) or are
available in technical reports [14,15].
4.2.2 Results and Discussion
4.2.2.1 Total Body Water Changes. Average changes in
total body water during the 2 weeks before and after launch
and the 2 weeks after recovery are shown in Fig. 4-7 for all
Skylab crewmen. The most notable feature of the total body
water changes is the rapid change following launch and re-
covery. Immediately after launch, a significant loss of total
body water occurs. The loss approaches a mean of 1400 ml
and appears to be complete at the end of 2 days in flight.
During recovery, nearly a week is required for the daily
changes in total body water to equilibrate.
In the few days before launch, nearly a half liter of
water was depleted from the body. This loss probably re-
sulted from the busy workload during the period immedi-
ately before flight that may have precluded adequate
hydration for the first few days in flight. For a variety of
reasons, a diuresis was expected to occur the first day or
two of the inflight period, but preflight dehydration can
partly suppress this diuretic response [16]. Thus, the loss
of body water immediately before flight may partly help
to explain why the expected early flight diuresis was not
detected.
The mean inflight body water changes for the crews
on each of the three Skylab missions are shown in Fig. 4-8.
The largest losses occurred on the 59-day mission and the
smallest on the 28-day mission. However, there appears to
be a trend during the first 2 weeks in flight for the losses to
converge toward a common value. Although not shown,
the convergence continues for the following 2 weeks (see
Fig. 4-27). The crew of the 59-day mission showed initial
water losses that were more than twice as high as losses of
either of the other crews. Half of this initial water loss is
replenished by the end of the first month in flight. Data
will be presented later in this section to suggest that the
initial decrement in body water can be attributed to the
large and persistent decrease in water intake, possibly as a
result of motion sickness.
Throughout the manned spaceflight program prior to
Skylab, there had been an unproven assumption that the
large, rapid weight gain seen within the first few days after
flight resulted from the recovery of body water that was
lost in the first few days after launch. The rapid losses in
body mass during the early inflight period, measured for
the first time on Skylab, have been assumed to result from
these body water losses. The results of this study tend to
support that assumption. However, there is an increasing
difference between body water and body weight change
beginning almost immediately after launch and recovery
as can be seen from Fig. 4-7. The computed change in
total body water is always less than the change in body
mass that is measured directly. The difference between
body mass and body water is assumed to represent the
change in body fat and body protein. This assumption
implies a net loss of body tissue before and during flight
and a net gain of body tissue after flight. Upon reentry,
there appears to be a nearly linear rate of increase in body
tissue that continues for the two weeks of measurment..
It is possible, using the present analysis, to obtain an
estimate of the true total body water measurements be-
tween the morning of launch and the morning of recovery,
rather than just between the days on which total body
water was actually measured. These estimates are shown
in Table 4-4. Total body water changes determined from
direct measurements are lower than true inflight TBW
changes by about 30%, possibly because direct measure-
ments immediately before launch or reentry were not pos-
sible. The water balance approach may provide better
estimates of the true responses of microgravity.
4.2.2.2 Water Loss. The water balance charts of Figs. 4-
9 and 4-10 illustrate the particular routes by which total
body water is lost or gained following launch or recov-
ery.*  Figure 4-9 is a summary of the water balance data 14
*
 In Figs. 4-9 and 4-10, the scale of the water balance charts is negative
below the zero line; therefore, a rise (i.e., a deflection toward the top
of the page) in urine or total output signifies a decrease in that quan-
tity. This is a traditional method of graphing metabolic balance data.
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Figure 4-6. Methods of calculating evaporative water loss using a total mass balance (top) and a water balance (bottom). (Key: met =
metabolic, Pro = protein, Cho - carbohydrate, Wbody = body mass, WH2O = body water, ∆ = change over time-period of balance).
days before and after launch of the Skylab crews, whereas
Fig. 4-10 is a summary of the data 14 days before and after
recovery. The major disturbance in the balance appears to
occur during the first 2 days following launch and during
the first week after recovery. It is evident that the body did
not lose water after launch by either of the major output
pathways: urine or evaporative water.  Both urine and fe-
cal water output, as well as evaporative water loss, were
reduced during the first 2 mission days and therefore could
not account for the decrement in water balance. The dec-
rement appears to be due to changes in intake. An unex-
pected decrease in total water intake appears to account
for the negative water balance observed in flight.
The mean decrease in total water intake reached a value
as high as 40% of the preflight value by the second day.
This decrease in total intake is highlighted in Fig. 4-11,
which contains the average data from the crews of each
Skylab mission. Total water intake in these charts repre-
sents the sum of free liquid intake plus food water plus
metabolic water. In all three Skylab missions, total water
intake was reduced at least the first 2 days in flight. A
possible cause of the decreasing intake may be motion
Evap H2O = H2O in + met H2O - Urine - Fecal H2O - ∆WH20
where
Met H2O = 0.41 Pro + 0.60Cho + 1.07Fat
Evap H2O = Food + H2O in - Urine - Fecal + (O2 - CO2)met - ∆Wbody
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Figure 4-7. Daily changes in total body water and body mass at launch and recovery for all Skylab crewmen (n = 9). Values are shown
as changes from morning of launch or recovery. The data for body mass was measured directly while that for body water was computed
from the equation shown in Fig. 4-5.
Figure 4-8. Daily changes in total body water of each Skylab
crew (n = 3). Values are shown as changes from morning of
launch.
Figure 4-9. Average water balance for all Skylab crewmen (n = 9) 14
days before and after launch. The difference between the ‘urine plus
fecal’ and ‘total output’ curves represents the evaporative water loss.
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Table 4-4. Estimates of Changes in Body Weight and Body Water due to Weightless Flight: Comparison of Ground-Obtained
Data with Those Obtained from the Water Balance Analysis
   Flight duration,        Water balance,* Direct measurement,
days    kg kg
∆BWgt  ∆TBW ∆BWgt** ∆TBW***
28 –2.33  –0.89 –2.77 –1.22
59 –3.90  –1.53 –3.73 –0.60
84 –0.93  –1.00 –1.40 –0.63
Mean –2.39  –1.14 –2.63 –0.82
* Measurement interval: morning of launch to morning of recovery day
** Measurement interval: morning of launch to first shipboard weight
*** Measurement interval: varies from 32 days before launch to recovery day
Figure 4-10. Average water balance for all Skylab crewmen (n = 9)
14 days before and after recovery. The difference between the ‘urine
plus fecal’ and ‘total output’ curves represents the evaporative water
loss.
Figure 4-11. Total water intake (includes drinking water, fluid
content of foods, and metabolic water) after launch of each Skylab
mission (N = 3).
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Table 4-5. Average Daily Evaporative Water Loss for the Three Skylab Missions
Flight Subject                      Preflight EWL       Inflight EWL
duration,
days No. days No. days
Observed ml/day ml/day-m2 Observed* ml/day          ml/day-m2
28     1     30 1472    892    23 1206   731
    2 1814    926 1372   700
    3 1664    862 1725   894
Mean 1650    893 1434   775
SE ±99    ±18 ±153   ±60
59     4     20 1124    646    54 1351   776
    5 1794  1081 1410   849
    6 2036  1008 2170 1074
Mean 1651    912 1644   900
SE ±273  ±134 ±264   ±90
84     7     26 1378    787    79 1302   745
    8 2333  1311 1625   913
    9 2104  1189 1862 1052
Mean 1938  1096 1597   903
SE ±288  ±158 ±162   ±89
SL mean 1747    967 1558   859
SE ±127    ±68 ±105   ±46
* First 5 days excluded
sickness, since the first several days following launch were
accompanied by motion sickness in most crewmembers.
Motion sickness and/or anti-motion-sickness drugs prob-
ably was a factor in blunting appetite and thirst. However,
it is possible that the decreased intake is a normal result of
the weightlessness response (i.e., possibly by way of the
angiotensin-thirst mechanism [17]) and would have oc-
curred even in the absence of motion sickness.
Evaporative water loss was expected to increase dur-
ing the flight because of the low barometric pressure (1/3
atmosphere) in the Skylab orbital workshop. However,
evaporative water loss does not appear to be a major factor
in the inflight changes in overall water balance. It does
appear to be significant in the postflight changes in water
balance (Fig. 4-10). The first day of recovery was character-
ized by large increases in evaporative water loss (perhaps
because of the thermal stresses of entry) that were nearly
counterbalanced by increases in water intake. It was of inter-
est whether the evaporative water loss changed during flight
and whether this change was marked by other components
of the balance. This is the subject of the next section.
4.2.2.3 Evaporative Water Loss
4.2.2.3.1 Evaporative Water Loss: Results. Evapora-
tive water loss (EWL) was computed from the mass bal-
ance formulas shown in Fig. 4-6 and in Appendix F(2).
Mean daily EWL results for all Skylab crewmen are shown
in Table 4-5. Results are expressed in ml/day and ml/day
per body surface area. Contrary to expectation, there was
an average decrease in EWL of 10.8% (probability p <
0.01) for all subjects. There were significant changes from
preflight values on the shortest (–13%, p < 0.05) and long-
est (–18%, p < 0.01) missions; the crew of the 59-day flight
showed a negligible decrease. Two of the three crewmen
who increased their inflight EWL were on the 59-day flight.
In general, the effect of spaceflight on EWL was different
in magnitude for each mission and was not related to any
single variable such as mission length or exercise levels.
The first 5 days of the inflight period was excluded from
the statistical analysis performed for each crewman be-
cause, as will be shown below, this period was character-
ized by unusual variations in EWL and water balance.
When EWL is expressed in terms of body surface area,
it is apparent that the mean of each successive crew in-
creased during both the preflight and the inflight periods.
This increase was qualitatively (but not quantitatively)
related to the amount of exercise performed.
Although the results in Table 4-5 show a large varia-
tion in the different crewmen’s inflight EWL response rela-
tive to preflight (a range of 70 to 120% of preflight value),
these changes were significantly correlated with their pre-
flight EWL values (correlation coefficient r = –0.71, p <
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0.05). This first-order relationship, illustrated in Fig. 4-
12, shows that the largest decrements of EWL during each
mission occurred in those crewmen having the highest
preflight EWL.
A comparison of the results of the two methods used
to estimate EWL—mass balance and water balance (see
Fig. 4-6) —is shown in Table 4-6. Inasmuch as TBW was
measured strictly at the beginning and end of preflight
and inflight periods in only six crewmen, the results from
only these subjects could be computed. Values for the mass
balance were averaged over the time-span coinciding with
the indicated interval between TBW measurements. The
results show a small but significant systematic difference
(< 3%, p < 0.05) between the two methods.
The average EWL for the first 10 days of each mission
compared to preflight controls is presented in Fig. 4-13.
There is an obvious difference between the EWL response
for the 28-day crew and the other crews. In Figs. 4-13 and
4-14 the EWL changes could be qualitatively related to
activity and ambient temperature loads, a testament to the
accuracy of the methodology. The increase during the first
week of the 28-day flight is related to the unusually high
temperature (about 32°C) in the Skylab workshop during
Figure 4-12. Correlation of inflight evaporative water loss (shown
as percent of preflight mean) with preflight EWL values (r = –
0.71, p < 0.05).
Figure 4-13. Average crew evaporative water loss during the first 10 days of each Skylab mission. The crew of the 28-day mission
entered the Skylab workshop on the third day and encountered high ambient temperatures caused by a heat-shield malfunction. Crews
on the other two flights may have been relatively inactive for several days because of space motion sickness.
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this period, resulting from a temporary heat-shield mal-
function. The first crew was able to restore cabin tempera-
ture to near normal after 5 days. Figure 4-13 also indicates
a significant decrement in EWL during the first few inflight
days of the longer missions, when the crew was relatively
inactive because of motion sickness symptoms.
Daily EWL for a single crewman on the 84-day flight
is plotted as a function of mission time in Fig. 4-14. In this
subject, EWL was less on days when no planned exercise
occurred and during periods when the workshop was at its
lowest temperatures. Also, EWL increased during periods
of extravehicular activity (EVA) and when environmental
temperatures were increased. Otherwise, evaporative loss
was usually lower in flight than before flight and showed no
tendency to return to preflight levels. Although postflight
values are also shown in this figure, they have not been in-
cluded in the remainder of the analysis. No physical activ-
ity program was scheduled during the postflight period;
therefore, it was unlike the preflight and inflight phases.
4.2.2.3.2 Evaporative Water Loss: Discussion. Evapo-
rative water loss is affected by many factors, including
environment, metabolic rate, physical activity, clothing,
psychological stress, hydration, degree of heat acclimati-
zation, and interactions in the physiological systems that
Table 4-6. Comparison of Two Methods for Determining Evaporative Water Loss
Mission  Subject  ∆t,* ∆TBW,               Water Balance**      Mass Balance*** ∆,****
duration, days ml/day ml/day ml/day ml/day
Preflight
28 1 20 –500 1307 1316   –9
2 20   800 1726 1790 –64
3 20 –300 1656 1702 –46
84 7 20   100 1390 1398   –8
8 20   200 2253 2299 –46
9 20   700 2050 2132 –82
Mean   167 1730 1773 –43
SD ±520 ±368 ±390 ±30
Inflight
  28 1 29   –500 1344 1390   –46
2 30 –1200 1515 1620 –105
3 29 –2000 1770 1824   –54
  84 7 85   –900 1318 1326     –8
8 85   –600 1604 1637   –33
9 85   –900 1859 1858     –1
Mean –1017 1568 1609   –41
SE  ±221   ±90  ±89 ±16
* ∆t = time between TBW measurements
** Evaporative water loss from water balance
*** Evaporative water loss from mass balance
**** ∆ = Water Balance - Mass Balance
are directly or indirectly involved in thermoregulation
[18]. This study suggests, for the first time, that gravity or
its absence may also influence EWL.
The preflight and inflight environments (the Skylab
workshop and, on the ground, the buildings and trainers
used by the crewmen) differed in only two major aspects:
gravitational force and atmospheric pressure.‡  In seeking
the reason that EWL did not increase during flight as ex-
pected (because of diminished ambient pressure), four
possibilities were examined: the indirect method used to
measure EWL was neither sufficiently accurate nor suffi-
ciently sensitive to detect significant changes; the pre-
flight environment in which the crew exercised could not
be precisely controlled and acted to elevate preflight EWL,
which masked the anticipated effect of the hypobaric en-
vironment; the effects of weightlessness, directly or indi-
rectly, decreased one or more components of EWL; and
specific biochemical effects. These possibilities will be
discussed next and in doing a hypothesis to explain the
inflight decrease in EWL will be advanced.
‡ The difference in atmospheric composition between preflight and
inflight environments (i.e., 21% oxygen compared to 70% oxygen) is
believed to have little influence on thermoregulatory processes [19].
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Figure 4-14. Example of evaporative water loss for a Skylab crewmember (subject 9).
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a) Sensitivity of Indirect Method. For this study, it was
estimated that the indirect method could detect real
differences between preflight and inflight EWL that
were greater than 8 to 12%. The method’s sensitivity
was enhanced because of the large number of consecu-
tive daily observations, and instrument error was less
than ±4% of EWL. The reader is referred to Leonard
[20] and to Appendix F(1) and F(2) for a full discussion
of balance technique errors.
It has been shown that EWL measurements obtained
indirectly from mass and water balances do not always
agree with more direct measurements [21]. However, in
this study, the indirect method of calculation was suffi-
ciently sensitive to reveal changes in daily EWL that could
be correlated with ambient temperature variations and
changing levels of metabolic activity (see Figs. 4-13 and
4-14). The day-to-day variation in EWL shown in Fig. 4-
14 reflects similar fluctuations in water intake, urine loss,
and body mass that were directly measured.
Variation of EWL between subjects was significant,
but relatively small, and was similar to that noted in
two previous studies employing the direct method of
measurement [21,22]. Absolute levels of preflight EWL
in the Skylab crew were similar to estimates of EWL for
other astronauts at sea level who had comparable energy
requirements [23]. A further indication of the precision
of the analysis is the close agreement between the mass
and water balance estimates of EWL (Table 4-6).
b) Effects of Environment and Metabolic Activity.
Evaporative water loss consists of three components:
respiratory losses, skin diffusion losses, and sweating.
It is believed that reduced barometric pressure increases
water diffusion from the skin, primarily as a result of
enhanced vapor conductivity and, to a lesser extent, as
a result of diminished heat convective loss [24,25]. Pre-
vious studies of inactive subjects in hypobaric cham-
bers at (1/3 atmosphere) have demonstrated increases
in skin diffusion ranging from 36 to 59% above that
measured at sea level [26,27]. Others have found that
diffusion loss across the incompletely wet skin mem-
brane is inversely proportional to the square root of the
pressure [25]. Respiratory water loss, although not mea-
sured directly on Skylab, probably increased, since rest-
ing minute volume increased in flight by nearly 20%
[28]. Overall increases in insensible water loss (com-
bined diffusion plus respiratory losses) of 15 to 38%
have been reported for subjects in a one-g chamber at a
pressure of 1/3 atmosphere [26,27].
Regarding sweat responses in high activity subjects,
there have been no studies in hypobaric, normoxic en-
vironments that are comparable to the Skylab atmo-
sphere, although it might be expected that this EWL
component would also increase because of the reduced
pressure, at least in one-g [29]. Therefore, the failure of
inflight EWL to increase appears to involve a mecha-
nism capable of causing major reductions of either in-
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sensible or sensible water loss. The crew’s environment
and metabolic activity were examined to detect factors
that may have affected EWL.
The Skylab medical experiments were designed to
closely monitor and/or control the physical activity,
diet, physiological condition, and environment of the crew-
men before, during, and following the flights. During the
2- to 3-week isolation period preceding each flight, the
crew was confined to environmentally controlled areas
except for the time devoted to physical training outdoors.
The mean temperatures of the preflight physical train-
ing environments were 22°C for the 28-day crew, 25°C
for the 59-day crew, and 21°C for the 84-day crew. These
temperatures were not very different from those of the
Skylab workshop and appear uncorrelated with the pre-
flight EWL levels for any of the crews.
Each successive crew exercised more frequently and
vigorously during the preflight as well as the inflight
periods. Starting with 30 minutes per day in the first
mission, the crew of each succeeding mission was al-
lowed an additional 30 minutes per day exercise.
Whereas the preflight exercise regimen paralleled but
did not exactly duplicate the flight program, routine
daily activity was similar for all subjects throughout
each mission. There is no indication that these tasks are
different under zero-g conditions with regard to mean
energy consumption.
Differences in EWL among the missions could result
from variations in the sweat component caused by exer-
cise. The average preflight plus inflight EWL rates of 834,
906, and 999 ml/day-m2 for the 28-, 59-, and 84-day mis-
sions, respectively, are consistent with this assumption,
although differences between flights were not statisti-
cally significant. But this, of course, does not explain
the inflight decrease in EWL relative to preflight.
The crew and crewmen that performed the most
inflight exercise showed the largest decrease in EWL.
This fact suggests that, on the average, the inflight ex-
ercise protocol caused a much lower EWL than did the
preflight exercise protocol. The decrease in EWL could
be explained if the energy expenditure for exercise was
less during flight. This lower energy expenditure may
have occurred on the first mission, but there is indirect
evidence, based on aerobic fitness, to show that there
was a similar or higher energy expenditure on the two
longest missions [30,31]. Energy balance consider-
ations lead to the same conclusion [32]. It appears that
the decrease in EWL inflight cannot be completely ex-
plained by uncontrolled environmental and metabolic
activity factors.
c) Effects of Weightlessness on EWL. Several effects
of weightlessness may directly or indirectly alter the
absence of natural convective forces, a decrease in sweat
drippage, an increasing influence of surface tension
forces compared to gravity forces, and biochemical al-
terations. In weightlessness, both evaporation and heat
transfer are reduced because natural convective forces
are absent [26].
Since convective air flow assists in the evaporation
of water from the skin, one must take into account the
complete lack of natural convection in microgravity.
Forced air movement in Skylab was not greater than in
the preflight office and laboratory environment. Also
in a normal gravity office or laboratory, natural convec-
tion may accounted for a significant proportion of total
air movement [24]. The net effect of the Skylab envi-
ronment on EWL is the result of a balance between the
enhanced evaporative power of a hypobaric atmosphere
and the reduced convective forces of a microgravity
environment.
A clue to a possible mechanism for EWL reduction
was provided by observations made by the Skylab crew-
men. They observed that during zero-g, sweat gener-
ated during exercise does not readily drip from the body
but rather tends to spread and to become evenly dis-
tributed on the skin surface, much like a film. One fac-
tor known to modify sweat rates is the degree of skin
wettedness, which is determined by the balance between
sweat production and evaporative loss rates. It has been
demonstrated that as the wetted area increases, the
buildup of surface water acts to inhibit the rate of sweat-
ing by nonthermal mechanisms that are poorly under-
stood [34,35,36]. These studies have shown that this
phenomenon (skin wettedness and hidromeiosis) can
suppress sweat rates by as much as 80% and easily ac-
count for the discrepancy between expected and mea-
sured inflight EWL. It is tempting to speculate that dur-
ing periods of high exercise activity, sweat rates were
suppressed to an extent that masked the effect of an
increased insensible water loss, which may have oc-
curred during the remainder of the day with the net
effect being a decrease in total daily EWL. The
hidromeiosis hypothesis is consistent with the obser-
vation that crewmembers who performed the greatest
amount of exercise also showed the largest decline in
EWL from preflight levels. Also supporting this theory
is the observation that the one crewman whose EWL
was most markedly increased inflight consistently used
a fan during his personal exercise period. A fan was not
used by the other crewmen during exercise. It has been
demonstrated that this maneuver can dramatically re-
verse a hidromeiotic effect by reducing skin wettedness
[35], similar to the effects obtained by wiping the skin.
d) Biochemical Effects. There is a growing body of evi-
dence indicating the ability of certain physiological
parameters, other than those normally associated with
environmental effects and metabolic activity, to influ-
ence evaporative loss rates. Factors that have been im-
plicated in modifying thermal sweating during exer-
cise in normal environments include the state of hydra-
tion [37], plasma sodium and calcium concentrations
[38], body fluid osmolarity [36], and antidiuretic hor-
mone levels [39]. These factors were altered in the
Skylab crewmen [2]. However, when the direction and
magnitude of these changes were evaluated, it seemed
likely that the shifts would tend to increase rather than
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decrease evaporative water loss. It may be speculated
that these biochemical effects tended to increase early
sweating [38], a condition known to favor overall sweat
suppression [34].
4.2.2.3.3 Analysis of Insensible and Sensible EWL.
It is instructive to quantify the degree to which EWL would
have been expected, on the basis of prior studies, to in-
crease in the Skylab hypobaric environment, and to com-
pare the expected EWL with the EWL actually observed.
The estimates of sensible and insensible EWL for the pre-
flight and inflight environments are summarized in Table
4-7. The expected inflight values are based on studies from
one-g hypobaric environments. The assumptions and sup-
portive studies for each of the values are indicated in foot-
notes to the table. In addition, the following assumptions
were made: (1) inflight insensible water loss was assumed
to be affected only by the reduced atmospheric pressure
and unaffected by gravity, (2) other than differences in
pressure and gravitational field, the preflight and inflight
environments were considered identical, and (3) inflight
metabolic activity was considered similar to preflight ac-
tivity. Table 4-7 indicates that inflight values for total
losses were expected to be 7 to 34% higher than preflight
values. However, a decrease of 11% in EWL was actually
determined in these studies. Therefore, the total inflight
EWL ranged from 17 to 33% below expected values. Simi-
larly, it is estimated that actual inflight sweat losses ranged
from 35 to 67% below expected values. This range is within
acceptable limits of sweat suppression previously attrib-
uted to high degrees of skin wettedness [35].
Estimates of skin wettedness during sweating were
also made [15] and are included in Table 4-7. The degree
of skin wettedness is defined as sweating rate divided by
maximal evaporative rate. It was assumed that the sweat
losses were associated with an hour of daily exercise, and
formulations from the literature were used to compute the
evaporative loss rate for sea level and spaceflight environ-
ments [19,35,41]. Sweat begins dripping when skin
wettedness is greater than 0.33 in terrestrial environments
[42]. The results show that the potential for a buildup of
skin surface water exists for all the cases considered, de-
spite the hypobaric environment.
4.2.2.3.4 Predictions of EWL Using the Thermoregu-
latory Model. The mathematical model of the human ther-
Table 4-7. Estimates of Insensible and Sensible Evaporative Water Loss
EWL Mission phase
Preflighta  Inflightb
Expected Estimated Difference
Insensible, ml c850 d980 to 1170 d980 to 1170
Rate, ml/day
Expected vs. estimated,
percent change        0
Sensible
Rate, ml/day e900 f900 to 1170  e390 to 580
Skin wettednessg 1.10 0.69 to 0.90 0.30 to 0.45
Expected vs. estimated,
percent change –35 to –67
Totalh
Rate, ml/day i1750 e1800 to 2340          i1560
Expected vs. estimated,
percent change –17 to –35
Change from preflight,
Percent    0      7 to 34       –11
a
 1 atmosphere, one-g
b
 1/3 atmosphere, zero-g
c
 Nominally accepted value for comfortable sea-level environment [27,40]
d
 Based on hypobaric chamber studies showing a 15- to 38% increase over sea-level values [22,26,27]
e
 Determined by subtraction or addition
f
 Based on hypoxic, hypobaric exercise studies showing increases as great as 30% over sea-level values [29]
g
 Skin wettedness = sensible EWL divided by maximum EWL
h
 Total EWL = insensible EWL plus sensible EWL
i
 Data from present study
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moregulatory system, described in Chapter 3, can simu-
late responses to environmental and metabolic thermal dis-
turbances. This model was of particular interest because
of its capability to predict evaporative water loss from the
three major pathways: respiration, skin diffusion, and
sweating. As has been demonstrated, EWL was altered in
spaceflight and has been responsible for secondary distur-
bances in fluid-electrolyte metabolism.
The model has been validated for one-g simulations
at normal atmospheric pressure. Data are still lacking for
testing the model under simulated hypobaric conditions
at high metabolic rates. Since the environment of Skylab
included both a zero-g and a hypobaric atmosphere, the
Skylab simulations included in this section should be con-
sidered a preliminary study whose longer term objective
is a validated model for weightlessness.
For this preliminary prototype simulation, the model was
used to predict EWL for a single crewmember on the second
Skylab mission. These results are compared to observed flight
losses, as calculated from the metabolic technique discussed
previously. Table 4-8 contains the input parameters to the
model that were based on inflight records for the second
Skylab mission. For purposes of computing daily EWL, each
day was divided into 6 types of activities. Six separate simu-
lations were performed for the basic activities shown. Meta-
bolic rates for sleep and gymnastic activity were estimated
from average values found in the literature, whereas bicycle
ergometry and EVA rates were measured directly inflight.
The metabolic rate for “routine work” (which accounts for
the largest fraction of daily evaporative loss) was based on a
caloric balance of the nutrients consumed during the flight
(see Chapter 4.6). Table 4-8 also indicates the capability of
this model for considering a large number of input param-
eters and, thereby, for describing a given environmental and
metabolic situation in considerable detail.
The evaporative losses predicted by the model are shown
in Table 4-9 for two different ambient pressures — 760 and
264 torr — the latter case representing the Skylab environ-
ment. The model’s output is in the form of an evaporative
rate (grams per hour), which must be multiplied by the ap-
propriate time period for each particular activity; these
times are shown in the first two columns and are based on
inflight records for the selected crewman. The average daily
evaporative loss rate predicted by the model for the two
ambient pressures is compared with the preflight and
inflight values obtained from experimental data using the
metabolic balance technique (last 2 rows of Table 4-9).
Agreement between the simulation and the data is ex-
cellent and well within several percentage points for both
environmental conditions. (The crewmember chosen for
this example was only one of two crewmen showing an
increase in inflight EWL). However, the simulation was
Table 4-8. Values of Input Parameters for Human Thermoregulatory Model
(a) Activity parameters
Parameter Activity
Sleep Routine        Ergometry       Gymnastics EVA
work
Leg Arm
Metabolic rate,*
   kcal/hr 75 109 630 405 405 230
Work efficiency,
   percent 0 5 22 22 10 10
Clothing
   resistance,
    clo 1.0 0.35 0.2 0.2 0.2 6.6
Position** 1 0.5 0 0 1 1
* Estimated from inflight records for subject 4
** 0 = seated; 1 = standing
(b) Environmental Parameters
Ambient temperature (°F) 73
Wall temperature (°F) 73
Ambient dewpoint temp (°F) 52
Ambient pressure (psia)   5.1
Air velocity, m/sec (ft/min) 40.0
Atmospheric specific heat (kcal/kg-°C)   0.22
Body emissivity   0.95
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not designed to duplicate the preflight case. Unfortunately,
physical activity and environmental conditions were not
controlled variables during preflight activities, and data
are insufficient to quantify these conditions as was done
with the inflight period.
It must be remembered that these simulations only
reflect the differences due to an altered ambient pressure
and not the effects of weightlessness. Mechanisms for ther-
moregulation in zero-g are entered in the model to a lim-
ited extent (i.e., only a convective heat flow influence).
Some of the influences of weightlessness that would be
candidates for inclusion in a future model are: the lack of
sweat dripping in a gravity-free environment, a high de-
gree of skin wettedness, and a resultant suppression of
thermal sweating [43]. It is significant that the astronaut
logs indicated that the crewmember selected in this study
was the only subject that invariably used a fan during bi-
cycle ergometry workouts. An enhanced convective air-
flow during exercise has been shown to reduce sweat
suppression on wetted skin. Therefore, if this mechanism
is the major effect in weightlessness, and if it was only
minimally present in this crewmember, comparison of this
subject with the others could provide a means of distinguish-
ing between the effects of low ambient pressure and zero-g.
The simulation does reveal that the effect of the hypobaric
environment is to increase evaporative loss by 32% (com-
pared to 21% for the measured change in the astronaut) for
this particular metabolic protocol and environmental con-
dition. Unfortunately, time restrictions prevented both a
similar analysis for the other crewmembers and an evalua-
tion of the sweat suppression effect in the model.
The metabolic balance studies have provided an overall
estimate of daily evaporative losses. The model used is ca-
pable of revealing the components of this total loss. Table 4-
10 contains the contribution to the total evaporative loss
that may be assigned to each major activity and to each evapo-
rative loss pathway. The values shown have been obtained
from the simulation and predict that 32% of the total evapo-
rative loss can be attributed to less than 1 hour of exercise per
day. In addition, 57% of the total loss is derived from thermal
sweating; half this amount occurs during routine work at
reasonably low levels of metabolism.
In Fig. 4-15, these components of evaporative water
loss as predicted by the model are graphically shown and
the daily water loss rate is compared with that of a Skylab
crewmember (the same subject whose data was used in
Table 4-9) as well as with the mean value for all Skylab
crewmen. The predictions of the model are in general agree-
ment with one-g hypobaric chamber studies and with the
single crewmember studied, but not with average zero-g
data. This preliminary study, however, demonstrates the
capability of using the model for predicting evaporative
Table 4-9. Evaporative Water Losses Predicted by Human Thermoregulatory Simulation Model for Inflight Activities at
Two Ambient Pressures*
Activity  Time,  No. of Predicted EWL
Hr/day    days
 Rate,g/hr        Total, g/mission Change,
    760 torr 264 torr 760 torr 264 torr  %
Sleep  8.0  58       17.7   20.1   8213   9326  14
Routine work 15.3  59       32.1  48.8 28977 44052  52
Leg ergometry  0.54     46       662  738 16444 18332  12
Arm ergometry  0.92       6  375  431     207     238  15
Gymnastics  0.38     40       368  420   5594   6384  14
EVA  2.68       1  173  213     464     571  23
Total mission EWL (59 days) 59899 78903
Avg daily EWL, simulation model  1015  1337  32
Avg daily EWL, metabolic balance data* **1056            ***1275  21
* Estimated from inflight records for subject 4 (59-day mission)
** Preflight
*** Inflight
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Table 4-10. Relative Contribution of Major Activities and Evaporative Pathways to Total Simulated Evaporative Loss at 1/3 atm
[Percent]
Activity Respiration Diffusion Sweat Total
Sleep (8 hr) 4.4 7.4 0.0 11.8
Routine work 12.5 15.4 27.9 55.8
 (25.7 hr)
Exercise (0.7 hr) 2.8 0.4 29.2 32.4
Totals 19.7 23.2 57.1 100.0
Figure 4-15. Predicted effect of ambient pressure on evaporative water loss compared to the measured Skylab crew results. (Preflight 
average = 100%).
1 atm
1/3 atm
Preflight, 1 atm
Inflight, 1/3 atm
Preflight, 1 atm
Inflight, 1/3 atm
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water losses and for incorporating specific hypotheses into
the model to improve the fidelity of future simulations.
4.2.2.4 Water Balance Analysis—Summary and
Conclusions
4.2.2.4.1 Evaporative Water Loss. Daily evaporative
water losses during the three Skylab missions were com-
puted using the indirect mass and water balance tech-
niques. A mean inflight EWL (plus or minus standard error)
of 859 ± 46 ml/day-m2 was obtained for nine men who
averaged 1 hour of daily exercise compared to a preflight
value of 967 ± 68 ml/day-m2. Although it was expected
that EWL would increase in the reduced barometric pres-
sure environment of Skylab, an average decrease of 11%
from preflight sea level conditions was observed. Com-
parison of these results with previous studies in hypobaric
chambers revealed that the effective decrease was prob-
ably higher than this value. The decrease in EWL cannot
be explained by the various uncontrolled environmental
and metabolic factors; therefore, weightlessness itself ap-
pears to have been a factor in modifying EWL.
Various factors that could explain the effects of the
spaceflight environment on EWL are summarized in the
hypothesis chart of Fig. 4-16. It is suggested that the two
major environmental effects (reduced ambient pressure and
zero-g) act to increase respiratory and skin diffusion losses
but reduce sweat loss by hidromeiosis, leading to a net
reduction in EWL. The absence of gravity may have con-
tributed to the formation of a sheeting effect (a sweat film
on the skin surface), which reduced sweat loss sufficiently
to account for the discrepancy between the expected and
measured EWL. It is more difficult to speculate on the net
heat loss from the body because insensible evaporative
effects act to increase heat loss, although the convective
losses may be decreased. Although sweat rates may be
reduced, additional study is required to determine whether
evaporation of sweat from a fully wetted skin (and the
accompanying heat loss) is decreased.
This conclusion is stated guardedly, because the evi-
dence supporting it is indirect, and because there was a
lack of strict controls. A wide range of EWL changes was
seen, and the results may be peculiar to the nine astro-
nauts involved in this study. This study does not support
the argument that the reduction in body fluids found in
Skylab astronauts after their return to Earth is due to an
increase in EWL during flight. The importance of EWL in
overall water balance and its influence on thermoregula-
tory processes indicates a need to study insensible water
loss and sweating in upcoming space missions, using a
specifically designed and rigorously controlled protocol.
4.2.2.4.2 Water Balance. This study supports the gener-
al belief that a major source of weight loss found in humans
returning from spaceflight is a reduction in body water.
The water balance analysis has demonstrated that the first
2 days following launch were characterized by negative
water balance. This can be attributed primarily to a de-
creased water intake. This rapid fluid loss amounted to
Figure 4-16. Hypothetical effects of Skylab environment on evaporative water and heat loss. Pluses signify increasing loss; minuses
denote decreasing loss.
-
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about 1300 ml for the nine Skylab crewmembers, or about
2% of their body weight.
During periods of unusually high evaporative water
loss (such as that which occurred during the first week of
the 28-day mission), overall water balance was not sig-
nificantly affected because of compensation of water in-
take. Contrary to prior expectation, evaporative water loss
was generally lower inflight than before flight. Urine vol-
ume was reduced throughout the first week in zero-g, and
the expected diuresis was not observed during the period in
which body water decreased significantly. The urine response
is tentatively attributed to a mild dehydration before launch
and a severe reduction in fluid intake following launch.
The decrease in total body water measured directly by
isotope dilution on recovery day can be attributed to losses
that occurred immediately following launch. During the
inflight phase, there appears to be a tendency for partial
recovery of the initial water loss in the crewmen who lost the
greatest volume of body water. On recovery day, the inflight
water loss measured directly in the terrestrial environment
(820 ml) amounted to about 33% of the total weight loss.
However, the indirect water balance analysis indicated that
the true mean water loss at the end of the zero-g phase
might have been about 48% of the total weight loss (1100
ml). The difference may reflect partial fluid replenishment
between the time of entry and the time of the ground-
based measurement. During the postflight period, the gain
in water was only slightly less than the original zero-g
loss and required 5 or 6 days to reach completion.
To a large extent, the results reported in this study are
supported by several other Skylab studies: the stereomet-
ric body volume measurement experiment performed be-
fore and after flight [12]; the lower body negative pressure
study, in which calf girth was measured inflight and limb
volume before and after flight [44]; and an experiment
designed specifically to study inflight fluid shifts and an-
thropometric changes in the 84-day mission [45]. These
Skylab experiments confirm the magnitude and time course
of the water loss and subsequent recovery. Furthermore,
they suggest that the zero-g fluid losses were derived from
fluid losses in the legs. The shift of fluids from the legs
toward the head begins within a few hours after launch, or
even just before launch while the crew are strapped in
their seats with their legs elevated. However, it is not pos-
sible to determine whether total body water begins to de-
crease that early.
Finally, these results help clarify the frequently poor
correlation between weight loss and flight duration and
between weight loss and water loss in men returning from
space. Weight loss is the sum of fluid and tissue losses.
Fluid losses occur early in flight and the volume lost is
seemingly dependent on the leg fluid volume, which is
shifted headward on exposure to weightlessness. Gener-
ally, fluid loss is independent of flight duration. Tissue
loss, however, is dependent on caloric intake, exercise lev-
els, and mission duration. On short-duration missions, close
correlation of weight loss and fluid loss would be expected
but correlation of fluid loss and flight duration would not
be expected. Conversely, for longer duration missions in
which tissue loss may continue because of inadequate ex-
ercise or low caloric regimes, reasonable correlation be-
tween weight loss and flight duration, but not necessarily
between weight and fluid losses, might be expected.
4.3 Skylab Sodium and Potassium
Balance
The loss of significant quantities of body water during
spaceflight strongly suggests that an equivalent loss of
electrolytes may have occurred. Sodium and potassium
represent the body’s major cations in the extracellular flu-
ids and intracellular fluids, respectively. Knowledge of
total sodium and potassium losses and their rates of loss
can provide important clues regarding the effects of
weightlessness on tissue metabolism and on intracellular/
extracellular fluid distribution. Sodium loss would be ex-
pected to accompany the zero-g loss of plasma, which is
purported to result from headward fluid shifts. Potassium
losses could arise from extracellular osmolarity changes
and tissue atrophy, both expected phenomena in an envi-
ronment in which postural muscles are not required. The
whole-body fluid, mass and electrolyte ground-based mea-
surements performed on each crewman before launch and
on the day of recovery indicated an average inflight loss
in exchangeable body potassium and extracellular sodium
of 240 meq and 90 meq respectively as well as postflight
gains of 164 meq of potassium and 100 meq of sodium.
4.3.1 Approach
Daily electrolyte balances and cumulative balances
were calculated for both sodium and potassium using the
following equations.
 Daily Electrolyte Balance =
= Diet – Urine – Fecal – CF (4)
 Cumulative Electrolyte Balance =
      b
= Σ  Daily Electrolyte Balance (5)
    i=a
where CF is a correction factor which represents sweat
losses, unaccounted losses, and error terms; a is the first
day and b the last day of mission phase i. The correction
factor was defined as follows:



 ∆
−=
i
i
ii N
XTB
BalCF (6)
where iBal  is the uncorrected average balance (that is,
diet minus urine minus fecal values) for mission phase i (i
= preflight, inflight, or postflight), ∆TBXi represents the
directly measured total body loss of that electrolyte in
phase i, and Ni represents the number of days in phase i.
Changes in total body potassium values were obtained from
direct measurements of body 40K. However, the changes in
total body sodium were based on a calculation using directly
measured extracellular fluid and plasma sodium concen-
tration values. (For further details of the methods of com-
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putation and the associated assumptions used in this
section, see Appendix F(3)). Balances were computed for
varying time periods corresponding to the first 2 weeks,
the first month, the second month, and the third month in
flight. These periods represented the period of the most
significant changes with the first two periods containing
nine crewmen and the third and fourth periods containing
six crewmen and three crewmen, respectively. Since urine
data from the first day of the 28-day mission were missing,
urine sodium averages were computed using the data only
from the 59- and 84-day missions.
4.3.2 Results and Discussion
The uncorrected sodium and potassium balances for in-
dividual Skylab crewmen are given in Table 4-11. The re-
sults of these uncorrected balances show a decrease of 16.3
meq for sodium from the preflight phase to the inflight phase
and a decrease of 11.8 meq for potassium. Preflight and post-
flight balances were nearly identical for each electrolyte.
The average daily values for each term in the sodium
balance equation corrected for skin losses are shown in
Fig. 4-17 for the crewmen of the 59- and 84-day missions
(n = 6). Dietary sodium is shown to decrease for 7 days
following launch, but for the remainder of the first month
inflight, it is slightly increased over the preflight average
(234 meq before flight and 244 meq for mission days 8 to
28). The 59-day mission is largely responsible for the de-
creased intake for the first 7 days, since the crewmen on
the 84-day mission had regained preflight sodium intake
levels on the third inflight day. A probable explanation
for this decreased intake was the space sickness that oc-
curred during the first week of the missions, with the 59-
day crew suffering longer than the other crews.
Average urine sodium values also declined for the first
7 days in flight, with the exception of the value for the
first inflight day, which actually exceeded preflight val-
ues. This elevation occurred despite the decreased diet
and, therefore, can be considered a saluresis, probably ac-
companying the loss of extracellular fluid. After the ini-
tial decrease, average inflight urine values were elevated
(169 meq before flight vs. 192 meq for mission days 8 to
28). This long-term increase in urine Na+ can be partly ex-
plained by the increased dietary intake for the same period.
Fecal sodium appears slightly decreased during the
first 28 days in flight. However, the magnitude of these
changes (3.01 meq before flight and 1.44 meq for mission
days 1 to 28) has little effect on the overall balance. Since
fecal values did not change significantly, urinary and fe-
Table 4-11. Individual Electrolyte Balances for the Skylab Crewmen
 Mission          Subject   Electrolyte balance, meq/day
     Duration,
 Days           Preflight            Inflight          Postflight
Sodium (uncorrected)
28 1 46.7 35.5 54.8
2 65.3 36.9 60.2
3 44.1 28.9 42.2
59 4 48.1 38.1 56.6
5 62.0 39.1 65.1
6 70.0 60.6 77.2
84 7 57.3 51.4 69.4
8 88.1 68.0 75.0
9 82.3 59.4 54.0
  Mean 62.7 46.4 61.6
SE ±5.2 ±4.6 ±3.7
Potassium (uncorrected)
28 1 21.7   5.5 17.8
2 24.9   5.0 22.3
3 17.3   5.1 20.0
59 4 17.9   5.0 21.8
5 14.0   6.4 24.9
6 23.2 12.8 32.8
84 7 12.3   1.1   2.3
8 13.6   6.9 15.5
9 17.5   7.8   7.4
 Mean 18.0   6.2 18.3
SE ±1.5 ±1.0 ±3.0
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Figure 4-17. Corrected average sodium balance around launch and recovery for the 59-day and 84-day mission crews (n = 6). This is a
traditional metabolic balance graph in which inputs are shown as increasing in the upward direction, while outputs are shown as
increasing in a downward direction. The algebraic addition of the input and output is depicted as the “balance”.
cal outputs are shown combined. The combined fecal and
urine sodium values represent the directly measured out-
puts of sodium from the body.
Also shown in Fig. 4-17 is the corrected sodium bal-
ance for the six crewmen of the 59- and 84-day missions.
The most prominent event in the balance occurs immedi-
ately after launch and consists of a large negative balance
for the first 2 days in flight.
The corrected potassium balance and its components
for all nine Skylab crewmen are shown in Fig. 4-18. Potas-
sium intake was decreased for the early inflight phase,
because of the anorexia of space sickness. The intake was
at a minimum on the second inflight day and remained
reduced for 10 days in flight. As in the case of sodium, the
crew of the 59-day mission had the greatest influence on
the mean dietary potassium changes during this period.
During the remainder of the first month in flight, the po-
tassium intake remained relatively constant at slightly re-
duced levels compared to preflight values (102.9 meq be-
fore flight vs. 100.5 meq measured from mission day 11 to
28). Combined urine and fecal potassium excretion was
elevated inflight from a preflight mean of 79.8 meq to
92.34 meq for mission days 1 to 28. Average fecal potas-
sium was unchanged; therefore, any changes observed can
be attributed to urine changes. The average potassium bal-
ance is negative for the first 10 inflight days. The balance
is at a minimum the second inflight day and does not ap-
pear to reach an apparent inflight steady state until day
10, when the intake also appears to reach steady state.
Values of the terms in the sodium and potassium bal-
ances around recovery are also shown in Figs. 4-17 and 4-
18, respectively. The composite graph includes the
recovery of three men each from the 28-, 59-, and 84-day
missions. Any conclusions from these data should account
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Figure 4-18. Corrected average potassium balance around launch and recovery for all Skylab crews (n = 9). See caption for Fig. 4-17.
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for the fact that the average recovery values include data
from subjects that resided in space for different periods of
time. Recovery of both sodium and potassium during the
postflight phase will be discussed next.
The mean diet sodium for all nine Skylab crewmen
during recovery (Fig. 4-17) was 217.5 meq, which was less
than preflight or inflight levels. Urinary sodium decreased
markedly the first few days after flight. This decrease co-
incides with the retention of sodium as shown in the bal-
ance data for the same time frame. The sodium balance
appeared to return to inflight levels for the remainder of
the postflight period.
Postflight diet potassium (102.6 meq) appeared to
change little from either preflight or inflight levels (Fig.
4-18). The potassium balance indicates retention of this
electrolyte for the first postflight week, apparently as a
result of diminished urinary excretion. The increased ex-
cretion on recovery day can be seen in all three missions,
but the factors present during and immediately before re-
entry prevent a clear explanation of this phenomenon.
When the corrected sodium and potassium balances
are integrated (using Eq. (5)) from the reference day (day
of launch), they illustrate the time course of change in the
“total body” pools. The changes in total body sodium for
the 59- and 84-day mission crews around launch and re-
covery are shown in Fig. 4-19. A rapid decrease in total
body sodium of approximately 200 meq that occurred
within 4 days of launch and remained essentially constant
for the first month inflight, is shown. The greatest de-
creases occurred on the first and second inflight days.
The total body sodium changes around recovery ap-
pear to be opposite and of about the same magnitude as
the changes immediately following launch. However, two
other factors shown here should be considered. First, the day
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of recovery had a relatively large influence on the recovery
changes, since 75 meq appeared to have been lost on that
day. This influence could force the reference point on the
day of recovery to be artificially low. Second, there seemed
to be an overshoot in retaining total body sodium that was
corrected within 10 days of recovery. This observation
can be correlated to overshoots in extracellular fluid vol-
umes and plasma volumes observed following bedrest
[46,47]. These two factors, entry and overshoot, could make
the net change in total body sodium by the end of the
missions only about 100 meq. This change would be less
than the initial change following launch and would sug-
gest some inflight replacement of sodium or a reduction
in the capacity of the extracellular fluid compartment.
Changes in total body potassium for 28 days in flight
are shown in Fig. 4-20 for all nine Skylab crewmen. Acute
potassium losses of about 100 to 150 meq appear to occur
during the first 10 days of spaceflight. A further decline in
total body potassium to about a 200 meq deficit appeared
to occur after the second week inflight. Although not
shown, the potassium losses level off after the first inflight
month. Total losses measured were 240 meq for all nine
subjects.
The change in total body potassium at recovery showed
a much slower replacement (125 meq in 14 days) than that
of sodium. The changes after recovery appeared to be much
more linear with time, at least for the first 14 days, than the
changes which occurred following launch.
4.3.3 Summary and Conclusions
A balance analysis was performed on the sodium and
potassium data measured for the nine Skylab astronauts.
The known terms of the balance equations were dietary
intake and fecal and urinary losses. The remaining term, a
correction factor, includes changes due to sweat losses,
unaccounted losses and measurement error. The results of
an uncorrected balance analysis performed neglecting this
last term showed the Skylab crewmen to be in positive
sodium balance of slightly greater than 60 meq/day be-
fore and after flight and about 46 meq/day during inflight.
Potassium analyses reflected a positive balance of about
18 meq/day before and after flight and about 6 meq/day
inflight. Since a net loss was observed for both electro-
lytes by independent measurements, these balances dem-
onstrate that the combined sweat, unaccounted, and error
term, if neglected, would result in significant errors in com-
puting the cumulative balances. This result suggests that
notable changes had occurred in the correction factor term
between mission phases.
The correction factors used to account for these un-
measured losses were based on matching the measured
changes in the total body pools of sodium and potassium
with the integrated balances. For sodium, this correction
factor was based on plasma sodium concentrations and
extracellular fluid volumes. The resulting changes in
exchangable body sodium and total body potassium were
computed with respect to the day of launch. An average of
the 59- and 84-day mission crews showed a decrease in
sodium of approximately 200 meq that occurred approxi-
mately exponentially with a time constant of about 1-1/4
days. The exchangable body pool appeared to remain con-
stant for the remainder of the first month in flight. However,
the change in exchangable body sodium as estimated from
postflight measurements indicated a total inflight loss of
only 90 meq. This result suggests that there was a recov-
ery of approximately 100 meq of sodium during the re-
maining two inflight months.
Total body potassium decreased between 100 and 150
meq immediately following launch. The time course also
appears to be approximately exponential with a time con-
Figure 4-19. Average change in total body sodium from day of launch for the 59-day and 84-day mission crews (n = 6). This chart was
computed from the cumulative sum of corrected daily sodium balance.
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stant of about 2 days. The initial decrease appeared to be
complete by the tenth inflight day, but a further decline of
100 meq, which was more a linear function with respect to
time, was seen by the end of the first inflight month. The
average measured change in total exchangeable potassium
of only 240 meq indicated that this trend could not con-
tinue at the observed rate for the remainder of the mission.
One revealing aspect of the analyses was that the diet
had a strong influence on the time course of change in the
balances for sodium and potassium early in the flight pe-
riod. This result was surprising because the diet was de-
signed to be basically constant for the duration of the
missions. This change in intake levels of sodium and po-
tassium was most likely the result of the anorexia associ-
ated with acute space sickness, since food and water intake
was reduced by similar amounts.
The balances computed after recovery were a compos-
ite of recoveries of all three crews from missions of differ-
ing duration. During recovery, the balances indicated that
the diet was relatively constant and, therefore, changes in
urine and fecal amounts were more clearly responsible for
the observed changes in the balances. The sodium bal-
ance for all nine Skylab crewmen was more positive after
flight and appeared to level off after about 5 days of re-
covery with the most striking changes occurring within
the first 2 days after flight. Potassium balance, however,
did not appear to approach a new steady state even after 2
weeks following flight.
4.4 Integration of Fluid and Electrolyte
Balance
The metabolic balance studies of the previous sections,
indicated that the most dramatic disturbances to the body
stores of water, sodium and potassium occurred during the
first week of flight and the first few days of recovery. After
these periods, a relative state of equilibrium in the body
existed. During this inflight quasi-steady state period,
which occupied most of the mission, the measured urine
and fecal amounts were somewhat higher in general than
during the preflight period. The purpose of this section is
to develop a simplistic model that can help explain the
increased urine and fecal water, sodium and potassium
based on what is known or estimated about dietary intake
and evaporative or sweat losses. This model is a gross rep-
resentation of the metabolic inputs and outputs and as-
sumes that after the first few days of flight, there is a relative
state of metabolic equilibrium. The following analysis pre-
sents a different way of grouping the data discussed previ-
ously and examining them in terms of acute and chronic
stages of flight. The simplified grouping of data devel-
oped here was also used as input forcing functions to per-
form simulations of the Skylab mission using the Guyton
model (see Chapter 9.4).
4.4.1 Skin Losses
Summary estimates of total body and daily skin losses
for all crewmen combined can be found in Table 4-12 for
water, sodium, and potassium for each phase of the mis-
sion. These estimates as well as those presented in Table
4-13 discussed next, were based on the analysis presented
earlier in this Chapter and in Appendix F. Reasonable val-
ues for skin losses were obtained for preflight control. Al-
though sweating rates were not available for the Skylab
crewmen, it was reasonable to assume that of the nearly
1700 ml/day of total preflight evaporative water loss, ap-
proximately 850 ml represents obligatory insensible water
loss, and the remaining 850 ml was attributable to sweating.
These figures agree with values obtained for normally ac-
tive subjects [40]. At these sweat rates, the electrolyte skin
Figure 4-20. Average change in total body potassium from day of launch for all Skylab crews (n = 9). This chart was computed from the
cumulative sum of corrected daily potassium balance.
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Table 4-13. Water and Electrolyte Balances During Prolonged Composite Spaceflighta [n = 9]
Quantity Preflight (A)   Inflight            Differenceb
    First   Remaining Change Percent
5 days (B)     52 days (C) change
Water, ml/day
  Intakec 3320   2785        3200 –120 –4
  Loss:
Urine and fecal 1625   1290        1700 75 5
Evaporative 1675   1780        1495 –180 –11
Balance:
Daily d20 –285 5
Cumulative, ml d280 –1425          260
Sodium, meq/day
  Diet 223     177          228     5       2
  Loss:
Urine and fecal 160     149          181    21     13
Sweat 63       48            48 –15 –24
Balance:
Daily e0 –20 –1
Cumulative, meq e0 –100 –52
Potassium, meq/day
  Diet 103       83          101 –2 –2
  Loss:
Urine and fecal 85       93           93 8 9
Sweat 18       10           10 –8 –44
Balance:
Daily d0 –20 –2
Cumulative, meq d0 –100 –104
a Average flight duration = 57 days
b Column (C) minus column (A)
c Includes liquid, food water, and metabolic water
d Based on direct total body measurements
e Assumed zero
Table 4-12. Estimates of Total Body Balances and Skin Losses in Skylab Crews [n = 9]*
Quantity Preflight Inflight Postflight
Measured total body change*
Water, ml    170 –880 1120
Sodium, meq        0 –93   103
Potassium, meq        0 –236   128
Daily skin loss
Water, ml/day  1675 1550 1641
Sodium, meq/day      63     48     54
Potassium, meq/day      18   10       7
* Change over entire mission phase
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losses are well within previously recorded ranges [48],
although they are somewhat higher than mean values. It
should be noted, however, that dietary intake of these elec-
trolytes was higher than normal.
It can be observed from Table 4-12 that the estimates
for inflight skin losses are less, in each case, than the cor-
responding preflight value. The water balance analysis of
Chapter 4.2 supports the conclusion that, contrary to prior
expectation, evaporative water losses were not greater in
flight. In that analysis, it was postulated that overall evapo-
rative water loss (sensible plus insensible loss) may have
been reduced about 10% and the degree of sensible water
loss during exercise could have decreased even more sig-
nificantly (at least 30%). If it is assumed that electrolyte
losses from the skin occur only during periods of meta-
bolic sweating and if the concentrations of sodium and
potassium in sweat are relatively constant for given levels of
exercise in either one-g or zero-g, then it may be expected
that the loss of body electrolytes attributed to sweating would
decrease by amounts comparable to sensible water sup-
pression; that is, about 30%. The results in Table 4-13
support this contention and indicate a decrease in inflight
skin losses of 24 and 44% for sodium and potassium, re-
spectively. A modeling technique for estimating inflight
sweat losses was developed (see Appendix F.3.3) and was
particularly useful in estimating sodium sweat losses for a
spaceflight simulation (see Figs. 5.32 and 5.33).
4.4.2 Water and Electrolyte Balance
Most of the major losses in body fluids and electro-
lytes appeared to have occurred during the first several
days in flight. Analysis of this early phase showed that
these early decrements in fluids and electrolytes were not
associated with increased excretion but rather with deficit
intake. An additional analysis was performed for the much
longer period following this initial disturbance to deter-
mine whether the body was in relative balance at these
new homeostatic levels. The results of this analysis are
shown in Table 4-13.
For convenience, a composite Skylab mission with an
average duration of 57 days was assumed, and all nine
crewmen were grouped together. In addition, the data from
the first 5 days of flight (the acute stage) were considered
separately from the remaining days. The values for urine
and fecal excretion have been combined for convenient
use in the Guyton model. However, it is known that fecal
excretion represents only a small fraction of total excretion
(i.e., 4% for water, 3% for sodium, and 12% for potassium).
Intake and excreta data were obtained by direct daily
measurement of each crewmember for all flight phases.
Preflight evaporative and sweat losses were obtained by
subtracting the balance values from “Intake – Urine &
Fecal”. Body potassium was in balance during the pre-
flight phase and water balance was slightly positive. In
the case of sodium, there were insufficient preflight data
to determine a direct balance and, for convenience, a zero
balance was assumed.
Inflight electrolyte sweat losses were obtained as dis-
cussed in the previous Chapter 4.3 and Appendix F.3. It
was assumed, because of limited information, that daily
sweat losses of electrolytes were the same for the acute
and chronic phases of flight. However, there were suffi-
cient inflight data to calculate evaporative water loss for
the two time periods. It was found that mean EWL for the
first 5 days was about 6% higher than preflight EWL,
whereas the EWL for the remainder of the flight was de-
pressed by 11%. If electrolyte sweat losses followed a simi-
lar pattern, the values for sodium and potassium sweat
losses would be somewhat higher than shown for the first
5 inflight days, whereas values for the remainder of the
flight would be smaller than shown. This pattern would
result in slightly more positive sodium and potassium bal-
ances for the longer inflight period. Simulation results
lend support to this concept, especially for sodium.
Although the sodium balance of –1 meq/day (Table 4-
13, column C) was close to a zero balance, it still repre-
sented a significant amount of sodium lost over 52 days
(i.e., 52 meq). Only a negligible portion of sodium would
be expected to be associated with observed losses of intra-
cellular muscle and bone during the latter portion of the
flights. Using the metabolic balance equations given ear-
lier, small errors in estimated daily sodium sweat losses
could result in large errors in cumulative sodium loss.
These uncertainties are present because there was no di-
rect measure of body sodium loss. On the other hand, the
components of potassium metabolic balance shown in
Table 4-13 were in more consistent agreement with the
inflight losses of potassium as measured by tracer dilution
methods. Taken as a whole, the results of this analysis
suggested that for the portion of flight beyond the first
few days, the daily water, sodium, and potassium balance
was much closer to zero when compared to the acute phase.
4.4.3 Estimation of Excretion from Metabolic
Balance Data
The analyses shown in Tables 4-12 and 4-13 revealed
that the fluid and electrolyte losses from the body were
not as severe as one would expect from an analysis of the
excretion data alone. For example, renal excretion of wa-
ter and electrolytes during the longer phase of the flight
are slightly higher than preflight.  If other elements of the
balance equation were the same preflight and inflight, even
these small renal increments would cause a large cumula-
tive body loss over 57 days of flight.  Therefore, the  effect
of renal excretion on body loss must only be evaluated in
perspective with all other avenues of loss or gain from the
body. For example, at steady state with fixed intake, the
water excretion (renal and fecal excretion combined) can
be derived as
Water excretion
     = water intake – evaporative water loss   (7)
Therefore, if evaporative water loss decreases, the body
must excrete water to maintain a zero water balance. Un-
der steady-state conditions, a decrease in urine volume
would be predicted by the 120 ml/day decrease in water
intake. (Refer to Table 4-13, next to last column, and to
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Table 4-14. Combined Renal and Fecal Excretion of Water and Electrolytes During Skylab Missions
Quantity Preflight (A)  Inflight Differencea
    First Remaining Change      Percent
5 days (B) 52 days (C) (C) - (A)      change
Urine vol, ml/day 1625 1290 1700      75            5
Na+, meq/day 160   149   181      21          13
[Na+], meq/literb 98.5   115.5   106.5        8            8
K+, meq/day 85     93     93        8            9
[K+], meq/literb 52.3     72.1     54.7        2.4            5
a Column (C) minus column (A)
b Derived from other measured values shown
Eq. (7).) However, the estimated 180 ml/day decrease in
evaporative water loss more than offsets the measured 120
ml/day decrease in water intake and results in an increased
urine volume. The net result is a slightly positive balance
rather than a large negative balance.
A similar argument can be applied to the sodium and
potassium balances. The measured increase in urine and
fecal sodium (21 meq/day) can be attributed almost en-
tirely to a 25% decrease in sweat loss (1.6 meq/day) and a
2% increase in dietary sodium (5 meq/day). In the case of
potassium, it is possible to account for half of the 8 meq/
day increase in excretion because of changes in diet (–2
meq/day) and sweat losses (–6 meq/day). Despite a 44%
decrease in estimated potassium sweat loss, the potassium
balance still remains negative, representing continued loss
from the tissues.
The postulated effects of decreased sweat losses on
excretion are illustrated in Fig. 4-21. Double arrows indi-
cate that the decrements in daily electrolyte sweat losses
were greater than those of evaporative water losses. There-
fore, excretion of electrolytes would be expected to be
relatively greater than that of water. Consequently, the
concentrations of potassium and sodium in excreted fluid
would be predicted to increase in accordance with inde-
pendent Skylab measurements. These renal effects are sum-
marized in Table 4-14. It was possible to demonstrate these
effects of sweat losses on renal excretion in the Guyton
model (see Chapter 9.4).
The preceding analysis suggests the manner in which
gross metabolic factors can account quantitatively for the
increased excretion of fluids and electrolytes. The body ap-
pears to increase urinary and fecal excretion to compensate
for decrements in sweat loss in a manner that maintains an
overall body balance that is appropriate to prolonged
spaceflight conditions. It cannot be overemphasized, how-
ever, that this analysis was based on indirect estimates of
evaporative and sweat losses of fluids and electrolytes.
Although the results were internally consistent and ap-
peared to provide reasonable explanations for changes in
renal excretion and maintenance of body balance, they
have not been verified by direct measurement.
4.5 Quantitation of Tissue Loss Resulting
from Prolonged Spaceflight
Prior to Skylab, the losses in body weight found after as-
tronauts returned to Earth had been tentatively ascribed
to a) alterations in water balance resulting from headward
shifts of fluid; b) loss of musculoskeletal tissue as a result
of gravity unloading deconditioning (i.e., postural dis-
use); and c) alterations in fat due to the imbalance be-
tween caloric intake and energy expenditure [4,10,49,50].
The Skylab experiments allowed confirmation of these
early inferences, and much of the data describing mineral,
tissue, and fluid losses in the Skylab astronauts have been
reported in one form or another [2,3,4,9,32,51,52]. But
there has been no systematic attempt to integrate all of the
information directly related to the changes in body tissue
(i.e., lean body mass and fat) that occur during spaceflight.
The study summarized in this section (and in the original
reports [53,54]) addresses this void. Direct measurements
that were critical in this effort include preflight and post-
flight measurements of total body water, total body potas-
sium, and body volume. In addition, daily inflight
metabolic balance (potassium and nitrogen) and body mass
measurements provided, for the first time, a description of
the time course of change of the major components of
weight loss. A number of different methods are available
for equating changes in these quantities to changes in lean
body mass. The purpose of the present analysis was to
compare these various methods and to arrive at the best
estimate of body composition change for the Skylab as-
tronaut population.
4.5.1 Approach
A detailed discussion of the general approach used in
this analysis and of the various methods employed can be
found in Appendix F(4) as well as the original reports [53,54].
4.5.2 Results
A summary of the preflight and postflight values for
the body composition parameters used to determine lean
body mass (LBM) by the various methods is presented in
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Table 4-15. These data, shown as mean values for all nine
Skylab subjects, were used to compute body composition
changes resulting from spaceflight according to relation-
ships shown in Table F-18, Appendix F(4). (Individual
crew values corresponding to the data in Table 4-15 ap-
pear in Appendix F(4), Table F-19). A simple two-com-
partment model was assumed in which body mass was
divided into lean and fat tissue. Body protein was assumed
to be 19.4% of the lean body mass. Daily nitrogen and
potassium metabolic balances were used to estimate the
time course of the inflight changes. The values for nitro-
gen and potassium balances listed under the “postflight”
column of Table 4-15, in fact, represents the average daily
inflight balance.
Table 4-16 contains the preflight values and inflight
changes of LBM and fat obtained using the various meth-
ods. Also shown for each method is the percent of body
weight loss that is due to LBM or fat. The results are shown
for all crewmen pooled into a single group. Values have
been normalized to an inflight weight loss of 2.63 ± 1.33
kgs (mean ± SD) measured from the morning of launch to
the first shipboard weight measurement. Supportive calcula-
tions showing the results for each subject and for each method
are given in Table 4-17 for preflight values and Table F-20
(Appendix F.4) for inflight changes in LBM.
The method for estimating lean body mass changes,
based on TBK, gave results quite out of range from the
other methods studied. These are shown on the line TBK
(uncorrected) in Table 4-16 where inflight losses of lean
body mass are computed as 3.63 kg, more than twice as
large as with any of the other methods. This discrepancy
was considered to be due to one of three possibilities: a)
the formula used (LBM = TBK/65) does not apply to the
astronaut population, b) the measured values of TBK are
erroneous, or c) potassium loss from cell was not accom-
panied by other cellular components such as nitrogen and
Figure 4-21. The effect of decreasing sweat and evaporative losses on renal excretion during the steady-state portion of spaceflight. See
text for meaning of double arrow. [Na+] and [K+] refer to the concentration of sodium and potassium, respectively, in the urine.
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water. There are good arguments that favor the last of these
possibilities [53,54]. In fact, a corrected LBM loss was
calculated on the assumption that a significant amount of
potassium leaves the cellular compartment independently
of other cell constituents due to osmotic considerations.
This correction yielded more reasonable inflight results
for LBM and fat changes, but did not affect preflight values
(see Table 4-16, TBK (corrected)). The “TBW and TBK”
method shows a similar treatment in Table 4-16. A full dis-
cussion of these calculations and the assumptions on which
they are based are provided in Appendix F(4)) (see “Errors in
the TBK method”). In the remainder of this section only the
corrected values for the TBK method will be considered.
As shown in Table 4-16 the inflight LBM losses cal-
culated by the various methods ranged from 1.12 to 1.63
kg representing from 43 to 62% of the total body weight loss.
Protein (solids) and fat losses were estimated to range from
0.22 to 0.36 kg and from 1.00 to 1.51 kg, respectively.
The confidence in the capability of these various meth-
ods to estimate inflight changes in LBM is enhanced by
demonstrating their capability to predict absolute values
of preflight LBM. With the exception of the “uncorrected”
total body potassium method, there was close agreement
between the estimates of preflight LBM obtained by the
various methods employed (Table 4-16). The individual
subject values of preflight LBM for each method are shown
in Table 4-17(a) and as can be seen in Table 4-17(b) there
is a significant degree of correlation between the meth-
ods. The nitrogen balance method was not suitable for
determining absolute values of LBM.
Table 4-16. Preflight Body Composition and Inflight Changes for Skylab Crews Using Various Methodsa
[Mean ± SD; n = 9]
Method Preflight values Inflight changes
LBM,kg Fat, percent   ∆LBM   ∆Fat
body wt.           kg          %∆BWgt         kg           %∆BWgt
Total body water (TBW) 62.3 ± 6.8 12.8 ± 3.1 –1.18 ± 1.09b 45.0 –1.45 ± 1.83c 55.0
Total body potassium (TBK)
 a) Uncorrected 55.8 ± 7.4 22.3 ± 3.3 –3.63 ± 1.93 (d) +0.94 ± 2.56  (d)
 b) Corrected 55.8 ± 7.4 22.3 ± 3.3 –1.52 ± 1.92c 57.8 –1.11 ± 2.71 42.2
TBW and TBK
a) Uncorrected 60.7 ± 6.9 15.3 ± 2.8 –1.53 ± 0.96c 59.3 –1.10 ± 1.63 43.0
b) Corrected 60.7 ± 6.9 15.3 ± 2.8 –1.12 ± 0.83b 42.6 –1.51 ± 1.59c 57.4
Body density 60.3 ± 9.3 16.0 ± 8.6 –1.51 ± 3.50 57.4 –1.12 ± 3.26 42.6
“Combined” method 61.3 ± 7.0 14.9 ± 4.5 –1.59 ± 1.09b 60.5 –1.04 ± 1.21c 39.5
Nitrogen balance (d) (d) –1.63 ± 0.87b 62.0 –1.00 ± 1.82 38.0
a Inflight losses normalized to an inflight body weight loss of 2.63 ± 1.33 kg
b p < 0.01
c p < 0.05
d Cannot be determined
Table 4-15. Body Composition Parameters Measured Before and After Skylab Missions [Mean ± SD; n = 9]
Parameter    Preflight  Postflight       Change
Body weight, kg   71.7 ± 8.7   68.9 ± 8.1 –2.8 ± 1.4†
Body volume, liters   67.6 ± 8.4   64.6 ± 7.6 –3.0 ± 1.7†
Body water, liters   45.6 ± 5.0   44.8 ± 4.4 –0.8 ± 0.8†
Body potassium, meq  3625 ± 480  3390 ± 470 –235 ± 125
Nitrogen balance, g/day  3.10 ± 2.50 –1.05 ± 0.62* –4.15 ± 0.85†
Potassium balance, meq/day 18.05 ± 4 6.20 ± 3* –11.86 ± 4
† p < 0.005
* Measured from inflight balance
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The results for inflight LBM and fat losses derived
from each of the methods are grouped by mission and
shown in Table 4-18. A corresponding presentation of in-
dividual subject data for LBM results is given in Table F-
20 (Appendix F4)). A correlation analysis between the
different methods was performed for the inflight tissue
losses. Unlike the results shown in Table 4-17(b) for the
preflight correlations, the inflight correlations between
the methods were insignificant at the 95% level. The one
exception was the expected strong correlation between
the TBW method and the combined “TBW and TBK”
method. However, weaker relationships (p < 0.1) are con-
sistently found between the corrected TBK method and
all other methods. The biostereometry-body density
method, although on the average in agreement with the
other methods, exhibited the poorest subject-to-subject
correlation with other methods (both preflight and
inflight), the highest coefficient of variation, and, conse-
quently, the least statistically significant inflight losses.
No meaningful trends were observed between LBM loss
and flight duration (Table 4-18). This observation supports
the pooling of all subjects in estimating mean inflight losses.
However, there was agreement with five of the six methods
that the smallest fat loss occurred on the longest mission, the
same flight on which the smallest weight loss occurred.
Daily metabolic balances (accounting for diet, urine,
and feces but not sweat or skin losses) were determined for
nitrogen and potassium. A comparison between these two
balances is presented in Fig. 4-22 in terms of monthly
averages. The inflight loss of potassium and nitrogen has
been expressed as a shift from the preflight control value.
The mean daily losses of nitrogen and potassium have
been converted to the common units of grams of protein
by using the factors 6.25 grams protein per gram nitrogen
[55] and 2.23 grams muscle protein per meq potassium
[48]. In Fig. 4-22, the entire population of nine subjects is
represented in the first month’s data, whereas the second
and third month’s data include six and three subjects, re-
Table 4-17. Preflight Lean Body Mass Using Different Methods
(a) Mass determined from all methods*
Subject Method
TBW TBK            TBW and Body Combined
TBK density
1 56.8 50.3 55.2 52.2     55.3
2 66.7 60.3 65.1 54.8     63.7
3 71.3 59.5 68.2 66.7     69.1
4 58.1 51.4 56.4 62.7     58.0
5 53.4 47.1 51.8 59.8     53.8
6 73.2 71.5 72.9 81.7     75.4
7 57.2 49.7 55.3 57.3     56.3
8 62.0 56.5 60.7 52.7     59.7
9 62.4 55.6 60.7 55.3     60.3
       Mean 62.3 55.8 60.7 60.4     61.3
+SD   6.8   7.5   6.91   9.3       7.1
* In kg
(b) Correlation coefficients for method-to-method comparison
Method TBW TBK TBW plus  Body   Combined
TBK  density
TBW  —  —     —     —         —
TBK 0.94 a  —     —     —         —
TBW plus TBK 1.00 a 0.97 a     —     —         —
Body density 0.64 0.70 b   0.66b     —         —
Combined 0.97a 0.96 a   0.98 a   0.79 a         —
a p < 0.01
b p < 0.05
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Table 4-18. Lean Body Mass and Fat Losses for Each Skylab Mission (Kg) [n = 3]
       Method
Mission TBW TBK TBW plus Nitrogen Combined  Body
   TBK  balance density
Lean body mass loss
28-day –1.68 –2.27 –1.69 –1.47 –1.47 –2.16
59-day –0.82 0.31 –0.54 –1.63 –4.72 –2.45
84-day –0.86 –2.68 –1.18 –1.78 –0.96 –0.88
Fat loss
28-day –1.52 –1.16 –1.74 –0.86 –2.37 –1.69
59-day –2.58 –3.97 –3.12 –2.27 0.69 –1.58
84-day –0.003 1.69 0.19 0.85 –2.16 –0.32
spectively. The control group followed the same pattern.
This balance analysis demonstrated a similar time profile
for both constituents. Both showed the largest losses dur-
ing the first month with losses half as large thereafter. Simi-
lar losses during the last 2 months suggest an attainment
of a constant loss rate.
4.5.3 Discussion and Conclusions
The estimates for preflight lean body mass and fat
content (Table 4-16) all fall within the range previously
reported for either active or athletic males [48,56,57]. In
addition, the coefficient of variation for each of the differ-
ent methods was considerably less than the values reported
in a previous comparative study [57] attesting to the nar-
row variability in the combined population. There was
less precision in the estimation of the changes in LBM
during flight, although all methods indicated a loss of at
least 1 kg. Even though these losses are large when com-
pared to the overall losses observed in body weight, losses
of this magnitude are not outside the error limits for these
methods [13,58,59,60]. Since there was no suitable method
available for directly measuring the true LBM losses, it
was not possible to determine which of the methods stud-
ied was most accurate.
Certain methodological considerations with regard to
the procedures used could have contributed toward
method-to-method variations. The determination of body
composition from the methods used in this study requires
the assumption that the body tissues (fat and fat free) have
a fixed density as well as an unvarying proportion of water
or potassium. Furthermore, estimates of changes in body
composition demand that water, potassium, and nitrogen
be lost from the lean body in the same proportion as they
exist in the normal intact individual. Agreement among
the different methods may be limited by the degree to
which these assumptions are correct.
More evidence is available to verify the accuracy of
these methods in measuring absolute values in a control
population than there are to validate the capability of the
methods to estimate changes in body composition result-
ing from some disturbance. The strong correlations be-
tween total body water, total body potassium or nitrogen,
and lean body mass may be invalidated in certain condi-
tions [61]. For example, in starvation, infection, tissue is-
chemia, and anoxia, tissues are depleted of potassium and
water in amounts proportionally greater than the protein
loss [62,63]. Potassium loss from cells can occur not only
from actual breakdown of protein but also from loss of
intracellular fluid and the inefficiency of the energy me-
tabolism process on which the maintenance of the
transcellular membrane potassium gradients is dependent
[62]. These factors undoubtedly had an influence on the
TBK method and may have led to the large departure of
this methods’ results relative to the other methods. The
reader is referred to Appendix F(4) for a discussion of er-
rors in the TBK method.
A constancy of lean body density (the premise under-
lying these methods) demands proportional losses of tis-
sue solids (protein and electrolytes) and water. In
weightlessness the quantities of protein, electrolytes, and
water are known to change and they appear to be depleted
from the body at widely different rates. Water and sodium,
for example, exhibit large reduction within the first sev-
eral days of hypogravity because of internal fluid distur-
bances. Changes in the cell protein pool are influenced by
slower acting metabolic processes [4]. Anorexia associ-
ated with space motion sickness early in flight would be
expected to augment the loss of cell components, includ-
ing fat [63]. These findings are supported by ground-based
hypogravic stress studies such as water immersion [64]
and bedrest [65,66]. Thus, the premise that the propor-
tions between whole-body constituents observed during
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Figure 4-22. Mean (plus or minus standard deviation) monthly nitrogen (N) and potassium (K+) balances expressed as inflight protein
loss relative to preflight values.
preflight conditions are maintained during the nonsteady-
state conditions of the inflight period is questionable.
Whether or not the net results of these inflight changes are
to establish a new equilibrium level appropriate to the
zero-g state with the same proportions of body composi-
tion as in one-g is unknown. However, it should be pointed
out that the data analyzed in this study were obtained
after 1 to 3 months inflight, a period long enough to per-
haps have achieved a new steady state. More direct mea-
surements such as can be obtained from tissue biopsy
samples may provide further information regarding the
dynamic relationships among water, mineral, and protein
at the cellular level.
Evidence that the inflight loss of two important cell con-
stituents are depleted in proportion to their preflight compo-
sition ratios is provided by comparing the nitrogen and
potassium metabolic balances (Table 4-19). There is good
correlation between the nitrogen and potassium losses of the
nine crewmembers (r = 0.59, p < 0.01) (see also Fig. 4-22).
Just as important, the loss rates of nitrogen and potassium are
in a ratio consistent with normal skeletal muscle composi-
tion. The overall loss ratio, ∆K+:∆N = 11.9 meq/day: 4.2 g/
day = 2.86, compared with 2.80 given for the normal potas-
sium nitrogen content of skeletal muscle tissue [48].
In spite of these good correlations, the absolute value
of inflight ∆LBM calculated from the ∆K+ or ∆N values of
Table 4-19 are both higher than is reasonable (i.e., three
times the total body weight loss). Explanations for this
discrepancy may be traced to general sources of error in
the nitrogen balance method. For example, the nitrogen
balance shows a net protein retention during the preflight
period. This has often been observed and questioned by
others [67], but sources of methodological errors in care-
fully controlled studies are not apparent [68]. A full dis-
cussion of errors in the nitrogen balance method are
presented in Appendix F(4). Notwithstanding these errors,
the inflight nitrogen balance without correction for sweat
losses or preflight balances provides reasonable estimates
of inflight loss and is the basis of one of the methods used
for determining LBM loss in our analysis.
NASA/CR—2020-220487 141
The general conclusion of this study, obtained from
averaging results of the six methods, is that a weight loss
of 3.8% observed during the Skylab missions can be at-
tributed to a 2.5% loss in lean body mass and a 10.4% loss
in body fat corresponding to the following inflight losses:
body weight, 2.7 ± 0.3 kg; LBM, 1.5 ± 0.3 kg; and body
fat, 1.2 ± 0.3 kg. Using the relationships that protein is
19.4% of LBM and water is 73.2% of LBM, total body
decrements of water and protein are found to be 1.1 kg and
0.3 kg, respectively. Supportive qualitative evidence for
these whole-body losses comes from measurements of leg
volume [44] and other body segments [52]; intracellular
and extracellular fluid volumes [4,67];  urinary
methylhistidine, cortisol creatinine, 17-ketosteroids, and
hydroxyproline; plasma potassium concentrations [4];
metabolic balances for cellular electrolytes (i.e., magne-
sium, phosphorus, calcium) [32]; limb strength tests [69];
and skin-fold measurements [5]. No trend indicated that
losses continued with increasing periods of weightless-
ness. In fact, the longest mission (84 days) was character-
ized by the smallest losses in weight and body fat.
Interpretation of these losses and the degree to which diet,
exercise, and the zero-g environment influences them is
discussed in the next section.
4.6 Energy Balance and Composition of
Weight Loss During Prolonged Spaceflight
In previous sections of this chapter the loss of body weight
during spaceflight was analyzed  from the perspective of a
daily water balance, daily nitrogen balance, and certain
whole-body measurements including total body potassium,
total body water and body density made prior to and fol-
lowing the inflight phase. However, information was also
obtained from the Skylab astronauts concerning the
changes in energy balance, and analysis of this data can
lead to inferences made on the composition of the weight
lost, not just for the mission as a whole but for more dis-
crete time periods. Interpretation of spaceflight related
weight loss in terms of the major body elements and tis-
sues (i.e., water, muscle, fat) is essential for understanding
metabolic processes in weightlessness and predicting and
minimizing weight losses in future missions. Also, since
diet and activity affect lean and fat tissues differently,
knowledge of expected changes will assist in establishing
caloric and exercise requirements.
Before the Skylab missions, a definitive analysis of
spaceflight-related body composition changes had been
hampered by the difficulty in quantifying inflight physi-
cal activity and ensuring an adequate caloric intake. In
addition, many operational constraints prevented direct
measurements of tissue loss. On missions lasting less than
one week (Mercury and some Gemini flights), a weight
loss of several kg was ascribed almost completely to a
negative water balance [71]. An analysis of the longer
Apollo missions (about 12 days) indicated that of the to-
tal weight loss (average, 3.5 kg; range, 0.8 to 5.9 kg), only
half could be attributed to water loss. The remainder con-
sisted of tissue loss (both fat and fat-free solids). This re-
sult indicates the presence of a negative energy balance,
which was caused by an estimated caloric deficiency of
about 1000 kcal/day [50,63]. Among factors proposed to
explain the weight loss were an inadequate dietary intake,
reduced, or inappropriate, exercise level, adaptive meta-
bolic effects possibly involving tissue catabolism and
weightlessness itself. These earlier studies were inadequate
Table 4-19. Nitrogen and Potassium Balances of Skylab Crew*
            Nitrogen Balance (gm/d)   Potassium Balance (meq/d)
Man Preflight Inflight ∆ Preflight Inflight     ∆
1   2.95 –0.96 –3.91   21.71   5.53 –16.18
2   3.12 –2.22 –5.34   24.94   5.04 –19.90
3   3.00 –1.71 –4.71   17.33   5.11 –12.22
4   3.07 –0.99 –4.06   17.84   5.01 –12.88
5   3.42 –0.78 –4.20   14.03   6.43 –7.60
6   4.05 –0.81 –4.86   23.19 12.79 –10.40
7   3.31 –1.24 –4.55   12.30   1.13 –11.17
8   2.20 –0.68 –2.88   13.62   6.93 –6.69
9   2.78 –0.06 –2.84   17.48   7.79 –9.69
Mean   3.10 –1.05 –4.15   18.05   6.20 –11.86
SD ±0.50 ±0.62 ±0.85  ± 4.43 ±3.09 ± 4.13
Correlation coefficient: ∆N vs. ∆K = 0.59 (p < 0.01)
* No corrections for sweat losses
Avg. Protein Loss
From Nitrogen Balance: Avg ∆N Bal x Avg Mission Length x 6.25 = 1478 gm protein ÷ 19.4% = 7.6 Kg LBM
From Potassium Balance: Avg ∆K Bal x Avg Mission Length x 2.23 = 1508 gm protein ÷ 19.4% = 7.8 Kg LBM
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to either describe the effects of spaceflight on body com-
position changes nor to assign their causes.
During the Skylab missions, a major effort was di-
rected at measuring, and partly controlling, the essential
components of body weight including the daily collec-
tion of metabolic balance and body mass data. This was
supplemented by pre- and postflight measurements of body
composition. Weight loss, which results from tissue ca-
tabolism, must be consistent with metabolic balance find-
ings for water and nitrogen, with energy balance data, and
with evidence from directly measured body composition
changes. Several previous studies have described the net
changes in body composition of the Skylab astronauts,
whose weight loss averaged 2.8 kg(range, 0.1 to 4.2 kg)
[5,10,13,54]. The current study is a more comprehensive
analysis because of the use of daily caloric balance (rather
than water balance) to account for body fat changes, a
determination of caloric and exercise requirements for
spaceflight, and a superior computational approach. In this
section, the energy balance of the Skylab crewmen is re-
lated to the observed changes in body composition. In
particular, we describe, here and in Appendix F(5) sepa-
rately for each of the three manned Skylab missions, the
development of numerical procedures which allow: a) com-
plete partitional metabolic balances for water, nitrogen
and energy, b) time-continuous metabolic profiles on a
daily basis, c) quantitative descriptions of the changes in
the three major body components (fluid, protein, and fat)
and d) estimates of caloric and exercise requirements nec-
essary to maintain good health during spaceflight.
One important result of these analyses is a continu-
ous-time profile of daily total body changes of water, pro-
tein and fat throughout the mission. Visualization of these
changes facilitates an understanding of the gross meta-
bolic disturbances which can occur in prolonged space-
flight. The overall conclusions, confirming an earlier, less
detailed analyses [32,72], appear consistent with the con-
cept of an acute obligatory loss of body water and a more
gradual degradation of certain postural muscles. Changes
in fat appear to depend on the gradual cumulative effects
of a positive or negative energy balance. A more detailed
account of this analysis is available [73].
4.6.1 Approach
Two basic formulations were used to analyze continu-
ous body composition changes. First, an equation of body
composition was used in which it was assumed that the
changes in total body weight (∆WGT) resulted from
changes in total body water (∆TBW), total body protein
(∆PRO), and total body fat (∆FAT). Thus,
     ∆WGT = ∆TBW + ∆PRO + ∆FAT (8)
Second, an energy balance equation was used in which
net energy utilization (Eutil) was computed as the sum of
energy intake from diet (Ediet) minus energy excreted in
urine (Eurine) and feces (Efeces) plus energy available from
body fat (Efat) and body protein (Epro) catabolism.
Eutil* = Work (internal + external) + Heat lost  (9)
= Ediet – Eurine – Efeces + Efat + Epro
As suggested by Eq. (9) the net energy available from
food and tissue metabolism is utilized entirely to perform
work and produce heat. Eutil* could not be measured or es-
timated on a daily basis (i.e., by measuring work and heat
lost or oxygen consumption) as were the other terms in the
equation. It is designated with an asterick to indicate that
it is estimated as an average constant quantity throughout
each flight phase (preflight, inflight, postflight) and for
each crewmember.
Equations (8) and (9) were used to compute daily
changes in body composition, specifically, body water
(∆TBW) and body fat (∆FAT). Daily values of all other
terms in these two equations were measured directly in the
crewmembers except for Eutil*. Specifically, this includes
body mass measurements, protein changes from nitrogen
balance, dietary energy from caloric values of foodstuffs,
caloric value of urine from specific gravity, and bomb calo-
rimetry of feces. While it was not possible to discern val-
ues of Eutil* on a daily basis, it was assumed that this
quantity (daily energy use) for each crewmember was rea-
sonably constant during the inflight phase, since the as-
tronauts adhered to a strict, standardized work and exercise
schedule for each mission [5]. Accordingly, the values of
the crewmembers energy use was computed by summing
each term in Eq. (9) over the entire mission and then di-
viding the sum by the number of mission days. This calcu-
lation was possible because of the additional total body
measurements of TBW and lean body mass (directly re-
lated to PRO) made prior to and following flight (see Chap-
ters 4.2 and 4.5). See Appendix F(5) for a detailed
discussion of the determination of each term in these mass
and energy equations (Table F-22). Also in Appendix F(5)
the reader will find tables for computed values of Eutil*
(Table F-23)as well as all other terms of these equations
(Table F-26 to F-29).
As an example of these calculations refer to Fig. 4-23.
The solid line on this graph illustrates the caloric value
for net food intake (diet minus excreta) averaged for all
nine crewmembers for each day of the preflight period and
the first inflight month. The decline in food intake is asso-
ciated with the onset of motion sickness symptoms in
microgravity. The dashed line represents the average en-
ergy use, Eutil*, as computed by the method discussed pre-
viously. From Eq. (9) we note that if the body is in caloric
balance and does not gain or lose tissue, Eutil* is simply
equal to the energy supplied in food less that excreted.
Therefore, the difference between the dashed and solid
lines is taken to be the energy deficit as supplied by fat
and protein tissue catabolism. Or put another way, the defi-
cit is the caloric equivalent of the tissue mass that was
lost. If this difference is composed only of fat and protein,
and if daily protein changes can be derived from the nitro-
gen balance, it should be possible to derive daily fat losses
from Eq. (8). The difference between total weight loss and
the sum of fat and protein losses was taken to be the daily
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Table 4-20. Inflight Body Mass Changes in Each Skylab Mission [Mean ± SD]
Mission    Change in Body Element
duration, days       ∆Mass       ∆Water     ∆Tissue   ∆Protein        ∆Fat
(A) Total losses, g
28 (n=3) -2,330 ± 1100 -890 ± 1,040 -1,440 ± 960 -290 ± 110 -1,160 ± 860
(-1,020)a
59 (n=3) -3,900 ± 300 -1,530 ± 1740 -2,370 ± 1440 -320 ± 40 -2,060 ± 1440
(-1,260)
84 (n=3) -930 ± 810 -1,000 ± 530  62 ± 790 -350 ± 310 -410 ± 940
(-910)
Mean (n=9) -2,390 ± 1,460 -1,140 ± 1.090 -1,250 ± 1,430 -320 ± 170 -940 ± 1,440
(-1,160)
(B) Average daily losses,b g/day-kg body wt.
28 (n=3) -1.10 ± 0.42 -0.42 ± 0.45 -0.68 ± 0.41 -0.14 ± 0.14 -0.55 ± 0.37
59 (n=3) -0.93 ± 0.10 -0.32 ± 0.34 -0.60 ± 0.43 -0.08 ± 0.02 -0.53 ± 0.42
84 (n=3) -0.16 ± 0.14 -0.17 ± 0.09 0.01 ± 0.13 -0.06 ± 0.05 0.07 ± 0.16
Mean (n=9) -0.73 ± 0.47 -0.30 ± 0.31 -0.43 ± 0.45 -0.09 ± 0.05 -0.33 ± 0.42
a Values in parentheses are water losses calculated from protein and fat losses based on 74% water content of lean body mass and
15% water content of adipose tissue
b Values have been normalized with respect to mean body weight of the preflight period
Figure 4-23. Average net food intake for the Skylab crews (n = 9).
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change in body water as shown by Eq. (8). The cumulative
losses of water, fat, and protein can then be computed as a
function of flight duration by summing consecutive daily
balances.
From Fig. 4-23, it is apparent that the Skylab crew
was, on average, in negative energy balance during the
first month of flight (and during the preflight period as
well). The computed deficit averages 350 kcal/day during
the first month inflight. Figure F-6 (Appendix F) shows
this same graphical illustration for each of the three mis-
sions separately. While the first two missions show clearly
that there was a caloric deficit, the third and longest mis-
sion appears to indicate that the crew was in approximate
caloric balance.
Errors in the metabolic balances can produce seriously
misleading results, especially if the balances are cumula-
tive, as they are in this study. For this reason, considerable
attention has been paid to addressing and minimizing these
types of errors. An analytical approach, based on cumula-
tive daily metabolic balance data, was developed to derive
continuous changes in the major components of body weight
loss (i.e., water, protein, and fat) for each crewmember ex-
posed to weightlessness. The procedure avoided the large
errors normally inherent in cumulative metabolic balances
by restricting the endpoints of the balance period (i.e.,
inflight phase) to values (say, of body water) determined
directly by isotope dilution methods and by using daily
body mass measurements to determine losses in tissues
that were not measured directly. This technique of correct-
NASA/CR—2020-220487 144
Table 4-21. Energy Balance for Each Skylab Crew [Mean ± SD, N=3)]
Component   Energy rate, kcal/day
28-day mission 59-day mission 84-day mission
Preflight
Total dieta 3086 ± 147 3354 ± 749 3214 ± 61
Excreta
   Urineb   107 ± 3   122 ± 38   124 ± 10
  Feces   148 ± 9   135 ± 32   145 ± 15
  Total   255 ± 8   257 ± 70   269 ± 6
Body tissue lossc
  Protein -107 ± 3 -124 ± 18 -98 ± 20
  Fat 512 ± 297 490 ± 226 413 ± 416
  Total 405 ± 295 366 ± 238 315 ± 423
Net energy used 3226 ± 434 3463 ± 480 3260 ± 462
Inflight
Total dieta 2930 ± 88 3225 ± 608 3260 ± 106)
Excreta
    Urineb   139 ± 10   145 ± 38   153 ± 7
  Feces   106 ± 2   141 ± 36   136 ± 31
  Total   245 ± 11   286 ± 74   289 ± 36
Body tissue lossc
  Protein     58 ± 23     30 ± 4     23 ± 21
  Fat   391 ± 289)   330 ± 231 -46 ± 105
  Total   449 ± 309   360 ± 231 -23 ± 94
Net energy utilizationd 3134 ± 383 3299 ± 338 2948 ± 97
a Diet calculated from 4.182 (carbohydrates) + 9.461 (fat) + 5.6 (protein)
b Urine energy = 8.32 (urine nitrogen)
c Energy available from body tissue loss: 5.65 kcal/g protein; 9.461 kcal/g fat. Minus sign indicates gain in body tissue
d Eq. (9)
Table 4-22. Skylab Inflight Exercise (Bicycle Ergometer) [Mean ± SD, N=3]
Mission             Total mission  Avg daily          Total avg
Duration  useful exercise  useful exercise,         daily work*
Days kW-min  kW-min/day kcal/day-kg body wgt
28  55 ± 9 1.951 ± 0.315        1.77 ± 0.52
59 276 ± 95 4.686 ± 1.615        4.12 ± 0.63
84 411 ± 60 4.894 ± 0.716        4.62 ± 0.56
* Bicycle work (in kilowatt-minutes per day) converted to total work expended (in kilocalories per day per kilogram of body weight) on exercise
by dividing values in the center  column (avg daily exercise) by 0.22 (mechanical efficiency of bicycle riding) and by the preflight body weight and
then converting from watt-minutes to kilocalories by using the factor 1 kilocalories = 70 watt-minutes. Data from Michel (Ref. [28]).
ing cumulative errors in daily metabolic balances is de-
scribed at the beginning of Chapter 4 (see Fig. 4-3). In the
case of errors in the nitrogen balance, it has already been
discussed in Chapter 4.5 and Appendix F(4) that the cu-
mulative nitrogen balance method (without correction) is
in agreement with other independent methods.
4.6.2 Results
4.6.2.1 Overall Mission Weight and Tissue Losses.
The tissue components of body mass that were lost on
each mission as well as mean Skylab losses are summa-
rized in Table 4-20 and Fig. 4-24. Data for the individual
crewmembers are provided in Table F-24 (Appendix F).
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Table 4-23. Inflight Energy Consumed in Diet, Expended on Exercise, and Available from Tissue Loss for the Three Skylab
Missions [Mean ± SD, N=3]
Component Energy balance, kcal/day-kg body wt.
28-day mission 59-day mission 84-day mission
Dieta 40.4 ± 5.5 44.3 ± 2.1 47.3 ± 3.0
Exerciseb 1.77 ± 0.52 4.12 ± 0.63 4.62 ± 0.56
Diet minus exercise 38.6 ± 5.0 40.2 ± 2.1 42.7 ± 3.3
Body tissue lossc 5.94 ± 3.75 5.43 ± 4.01 -0.35 ± 1.36
a Calculated from caloric equivalent of carbohydrate, fat, and protein (Table 4-21)
b Based on bicycle exercise only assuming 22% efficiency in converting bicycle work to exercise energy expended (Table 4-21)
c Obtained from Table 4-21
Figure 4-24. Inflight changes in body mass resulting from spaceflight.
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urine and feces (Table F-27). This fraction was nearly con-
stant for all crewmen during preflight and inflight phases.
A negative energy balance exists when energy intake
is less than energy utilization; this condition is accompa-
nied by loss of energy-bearing tissue (i.e., fat and muscle).
The net caloric intake (dietary calories less urine and fe-
cal calories) was less than the net energy utilization (esti-
mated from Eq. (9)) for the 28-day mission (inflight phase),
and this difference diminished for each longer mission.
Figure 4-25. Energy balance (mean ± SD) during Skylab mis-
sions. (a) Energy from diet. (b) Energy expended on exercise, (c)
Energy available from tissue loss.
(a)
(b)
(c)
The time period for these changes is computed from the
morning of launch to the morning of the recovery day
inclusive. Of the quantities shown in Table 4-20, body
weight/mass was the only one measured directly. Total
body water changes for this period were calculated from
direct measurements obtained within one day after splash-
down and corrected (for water replenishment and water
lost) to reflect values on the morning of recovery day (see
Table F-25 (Appendix F). Body protein, fat, and total tis-
sue changes were estimated by using Eqs. (8) and (9).
The average loss of water, fat, and protein for the nine
crewmen was found to be 48%, 39%, and 13%, respec-
tively, of the total body mass loss of 2.4 kg. No statisti-
cally significant trends relating weight changes to mission
duration were apparent from these data. Compared to the
28-day mission, the losses of all quantities were most se-
vere during the 59-day mission but less severe (with the
exception of body protein) during the 84-day mission. On
the two shortest missions, body fat losses accounted for
about one-half of the total weight loss, the remainder be-
ing attributed to lean body mass loss (i.e., the loss of wa-
ter and protein). There was an apparent net increase in
body fat on the longest mission. Protein losses were rela-
tively similar on all missions and are, therefore, appar-
ently independent of mission length. The computed water
losses for all missions were found to be totally consistent
with the estimated water losses derived from protein and
fat losses (see footnote (a) in Table 4-20(A)).
When the data in Table 4-20(A) were converted to
daily loss per kg body weight by division by the mission
length and preflight body weight, the trend was towards
smaller rates of loss as mission length was increased (Table
4-20(B)). That this trend was somewhat artificial and arose
mainly because the major part of the changes occurred
early in flight, rather than to several other possible causes,
is explained below. In other words, dividing a relatively
constant absolute loss by an increasing number of days
gives the false impression of a decreasing rate of loss for
longer missions. Improvements in diet and exercise dur-
ing the longer missions could also be explanatory factors.
4.6.2.2 Energy Balance. The energy balance (Eq. (9))
for each mission is shown in Table 4-21; the two-week
preflight phase and the inflight phase are shown sepa-
rately. Corresponding data for each crewmember is pro-
vided in Tables F-26 to F-29 (Appendix F). Inflight dietary
intake averaged 3138 ± 350 kcal/day (mean ± SD) for all
nine subjects. This value was only slightly lower than the
preflight average of 3218 ± 400 kcal/day. Although this
difference was statistically insignificant, examination of
the data for the individual crewmen provided a clue to the
weight loss mechanism. Five of the nine crewmen de-
creased their mean caloric intake during flight; these sub-
jects lost 75% more weight than the other crewmen, who
increased or maintained their preflight intake. Small dif-
ferences in caloric intake maintained for long periods are
known to produce significant weight changes. Approxi-
mately 9% of the total calories consumed was excreted in
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These differences averaged over the inflight period, are –
448 kcal/d, –360 kcal/d, and the +23 kcal/d for the 28-day,
59-day and 84-day missions, respectively. These deficits are
reflected in the net loss of body tissue shown in Tables 4-20
and 4-21 and shown graphically in Fig. F-6 (Appendix F). On
average there appears to have been an apparent loss in tissue
on the two shortest flights but not on the longest flight.
Other investigators also concluded (without benefit
of a complete energy balance) after examining data from
earlier missions, e.g., Apollo, Gemini program, that the
energetic cost of life in space was much higher than indi-
cated by the actual total energy content of the food con-
sumed [50,74]. It appears that for one reason or another it
has been difficult for mission planners to predict the ca-
loric value of the food supplied to astronauts needed to
offset their energy expenditures in space and prevent body
weight from declining. Alternatively, there may be obliga-
tory tissue losses in a microgravity environment that are
independent of caloric requirements. This matter will be
discussed below.
4.6.2.3 Effects of Diet and Exercise. Both dietary ca-
loric intake and the amount of daily exercise were inten-
tionally increased on each subsequent mission in order to
improve the crew’s health parameters. The rigidly con-
trolled diet provided for the crew on the first mission was
based on an assumption (which has proved erroneous) that,
without gravity to work against, the caloric expenditure
for crews living in space is approximately 10% less than
similar work expenditure on earth. (Although, astronauts
can move around quite effortlessly in space it was not
appreciated that they often require more energy to stabi-
lize their body when performing a stationary task with
their hands). After the crew on the first mission was ob-
served to lose weight gradually and continuously over the
course of 28 days inflight, the caloric content was increased
for the next 3-man crew. Observation of that crew also
showed continual weight loss and the dietary intake was
again adjusted upward for the last crew. These adjustments
in dietary kcal/day-kg BWgt are shown for all crewmen and
missions in Appendix F, Table F-29, (i.e., Ediet); in general
there was a increase of 3 to 4 kcal/day per kilogram of body
weight on the inflight phase for each subsequent mission,
while the caloric content of the preflight phase remained
relatively constant. Specifically, the caloric content of food
consumed by the crewmembers was 40.4 kcal/day-kg BWgt,
44.3 kcal/day-kg BWgt, and 47.3 kcal/day-kg BWgt for the
28-day, 59-day, and 84-day missions, respectively.
The time devoted to exercise and the number of exer-
cise devices employed was also intentionally increased
on each subsequent mission in an attempt to provide the
crew with an optimal exercise program. The benefit of ad-
ditional exercise was demonstrated by a superior postflight
exercise and strength performance, as well as by an in-
creased feeling of well-being during the flight [70].
All crewmembers exercised on the bicycle ergometer.
In addition, a commercial mini-gym exerciser was used by
the crews of the two longest missions, and a treadmill-
type device was used on the longest mission. Quantitative
estimates of exercise workload are available only for the
bicycle ergometer [28]. However,these data, shown in Table
4-22, tend to reflect the time and intensity devoted to
total exercise by each crew.
The relationship between diet, exercise, and body tis-
sue loss for the three crews becomes more apparent when
these quantities are expressed in the common units of kilo-
calories per day per kilogram of preflight body weight, as
shown in Table 4-23 and Fig. 4-25. The increase in dietary
intake for each subsequent mission more than offsets the
increase in exercise expenditure, as indicated by the dif-
ference between diet and exercise (“Diet minus exercise”
in Table 4-23), which also increases with mission dura-
tion. The crew that exercised the most (the 84-day mis-
sion) lost the least body fat, which would be paradoxical
were it not for the fact that their caloric intake was also the
highest. The data in Table 4-23, while not including all
exercise, suggest that excess ingested calories may have
been available to the crew on the longest mission to offset
the increase in energy expended through exercise and to
increase fat stores relative to the other two crews.
4.6.2.4 Continuous Changes During First Month:
Skylab Mean. The dynamic profile for the changes in
weight/mass (∆BWgt), total body water (∆TBW), protein
(∆PRO), and fat (∆FAT) are shown in Fig. 4-26. These data
represent the average response of all nine crewmen and
include a preflight period, the first month in flight (the
longest inflight interval common to all three missions),
and a postflight period. Values for these quantites were
computed as previously discussed in Chapter 4.6.1 and
shown in Table F-22. The curve labeled “change in body
tissue” is the sum of protein and fat losses. Protein losses
were obtained directly from the nitrogen balance and rep-
resent loss of dry tissue. The sum of protein and water
losses will be termed “lean body mass” losses.
The following information can be derived from the
average responses shown in Fig. 4-26.
a) Body weight decreased significantly during the first
few days following launch largely as a result of a body
water loss of more than 1 liter. Body water remained
relatively constant at this reduced level (with some re-
plenishment), whereas body mass continued to decline
gradually as body tissue (both fat and protein) were
catabolized.
b) The time course of the body mass change can be ex-
plained by the losses of water, protein, and fat, each
proceeding at different rates; water is lost most rapidly,
followed by fat, and then by protein.
c) At the end of 28 days in flight, ∆BWgt ± SE was –2.2 ±
0.31 kg. The component losses were computed as: ∆TBW
= –1.02 ± 0.21 kg, ∆FAT = –0.85 ± 0.30 kg, and ∆PRO = –
0.34 ± 0.03 kg. Water accounts for 46% of the total mass
loss, and the remainder is attributed to tissue loss. In
analyzing for the muscle/fat ratio, we find that 62% of
the total mass loss was attributed to lean body mass and
38% was attributed to fat. Lean body mass normally con-
tains 75% water and 25% protein [75], which was the same
ratio found in this analysis after 1 month in flight.
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d) The loss of protein and fat was consistent with an aver-
age inflight caloric deficiency of approximately 350
kcal/day, which was estimated to occur during this 28-
day period, as illustrated in Fig. 4-23. The rate of tissue
loss was much greater during the first week (where there
was the highest caloric deficiency) than during the last
2 weeks of the first inflight month.
e) The preflight period was characterized by increases in pro-
tein mass and decreases in fat stores. This behavior could
be expected for subjects on a high-protein, controlled diet,
and who are engaged in physical conditioning [76].
f) During the postflight period, weight gain was nearly as
rapid as the original inflight loss, and resulted prima-
rily from changes in body water. Postflight recovery of
protein was at rates similar to the preflight retention
rates, whereas inflight fat losses did not show signs of
postflight recovery.
4.6.2.5 Continuous Changes During First Month: Mis-
sion Differences. First-month inflight changes in diet
and body composition for each of the three missions are
presented in Fig. 4-27. The most remarkable intermission
observation during the first month period is that the 59-
day crew had, by far, the largest relative decrease in ca-
loric (and water) intake (compared to their preflight level),
as well as the sharpest and most sustained decline in body
water and body fat. Most of these losses occurred during
the first week after launch and could be attributed to symp-
toms of space motion sickness which were more severe in
this crew than in the other two.§ Therefore, it was not un-
expected that the crew of the 59-day mission would ex-
hibit the largest decreases and rates of decrease in total
body weight, water, tissue, protein, and fat (Figs. 4-27(b)
to 4-27(f)), especially during the first week in weightless-
ness, when intake of water and food was at a minimum. In
contrast, the crew having the most adequate caloric intake
(the 84-day mission) showed the least loss of fat and total
tissue. By the end of the first month in flight, this crew
showed the smallest losses in total body mass as well as a
small gain in fat.
A caloric deficit by itself would be expected to result
in fat loss and perhaps some muscle loss [74]. A deficit in
water intake would deplete body water and further attenu-
ate the total body mass loss. These differences in caloric
and water intake between flight phases and between mis-
sions are offered as a possible explanation to account for
many of the intramission differences of weight, fluid, and
tissue loss.
4.6.2.6 Continuous Changes in Body Composition:
Long-term Responses. The continuous changes in body
composition for each mission are illustrated in Fig. 4-28(a)
to 4-28(c). Long-term responses for the period beyond the
first month are exemplified by the results of the 59-day
and 84-day missions.Figure 4-26. Mean (± standard error) changes in body composi-tion during all mission phases for all Skylab crewmen (n = 9).
Values are shown as changes from morning of launch.
§ Interestingly, the crew that was said to have essentially few symptoms of space
motion sickness (i.e., the 28-day mission) also had a large dietary decrease for a week
after launch. This crew may have eaten less because of a heavy activity schedule that
included repair of a heat shield. The possibility also exists that the mechanisms
which regulate caloric intake in proportion to energy expenditure are not always
operative during weightlessness for reasons other than motion sickness. The hy-
pothesis that a decrease in caloric intake is not always closely correlated with space
motion sickness is supported by the data (Fig. 4-27) from the 84-day crew that showed
the second highest incidence of motion sickness but had the least drop in caloric
intake during the first few days inflight. A similar form of anorexia was described in
the Apollo crew who generally ate less food than was provided and did not exhibit
signs of motion sickness [63].
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A small decline in body mass during the second month,
reflecting a continuing loss of fat, was observed in the 59-
day crew. Also, rehydration of body water continued to some
extent. The 84-day mission was characterized by the greatest
stability of body mass, water, and total body tissue. This was
the only flight without a net change in tissue mass; in fact, a
small degree of increased fat stores may have been observed.
This stability reflected the combined adequacy of diet, exer-
cise, and general physical condition. By most accounts, this
crew returned from space in better general health than any
other crew [31]. The crew of the 84-day mission both exer-
cised more and had a higher dietary intake than the crews of
other missions. Because of this, it is difficult to separate the
effects of flight duration, exercise, and diet.
The most important trend observed in this data that
was not discernable in the first month’s results, is the lev-
Figure 4-27. Changes in dietary intake and body composition before flight and during the first month of flight for each Skylab crew (n
= 3). Values shown are referenced from the morning of launch. (a) Diet energy. (b) Change in body mass. (c) Change in body water. (d)
Change in body tissue. (e) Change in body protein. (f) Change in body fat.
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eling off of protein losses during the second and third
months. This behavior could have been suspected from
other Skylab data, such as the mineral balance [50] and
leg volume measurements [10] that indicated a relative
stability of lean body tissue during the last 2 months in
flight. As in the analysis of the first month’s data, these
long-term trends in body protein appeared to be indepen-
dent of the amount of exercise performed. Also remark-
able is the overall uniformity of the body protein loss
response among the three crews, especially in light of the
potential error of the nitrogen balance method (see Ap-
pendix F). In all cases, the body protein increased during
the preflight phase, decreased at variable rates during the
inflight phase with an almost exponential decrease during
the first month, followed by periods of relatively stable
body protein mass, and then exhibited a complete recov-
ery during the two week postflight phase.
The most severe inflight decline in protein mass
among the three crews occurred on the 59-day mission
and may be related to the fact that that crew had experi-
enced the largest inflight caloric deficits relative to the
other crews. However, the fact that the crew with the most
adequate intake (84-day mission), as well as performing
the most exercise, did not show the smallest protein loss
suggests that total body protein loss cannot be prevented
by increasing caloric intake.
4.6.2.7 Electrolyte Losses. Metabolic balances were
performed on a variety of electrolytes that are associated
primarily with musculoskeletal tissue [6,7]. A summary of
these analyses is presented in Table 4-24. The data were
analyzed over four different time intervals: before flight,
first month inflight, second month inflight, and third month
inflight. These balances were uncorrected in the sense that
losses from the skin and sources other than urine and fecal
excreta were not measured. Normally, this procedure re-
sulted in a positive balance during the control period. In
all cases, the inflight balance was less than the preflight
balance, suggesting a net loss during spaceflight.
The total of these mineral losses (excluding nitrogen)
was estimated to be only 50 grams, which was insignifi-
cant relative to the total loss in body mass. Nevertheless,
these results do support other findings that indicate a gen-
eral loss of body tissue.
Table 4-24. Metabolic Balances of Intracellular Minerals
Preflight  First Inflight            Second Inflight         Third Inflight
     montha  monthb monthc
Nitrogen, g
Diet    18.8        17.2     19.3     19.4
Urine    14.1        17.7     17.6     17.7
Fecal      1.5          1.3       1.5       1.5
Balance      3.2          1.8       0.2       0.2
Potassium (meq)
Diet  103.3        96.3   101.7    98.1
Urine    74.4  81.6     79.9    78.6
Fecal    11.9        10.7     12.6    10.8
Balance    17.0          4.0       9.2       8.7
Calcium (mg)
Diet  872.0      872.0   940.0  974.0
Urine  166.0  288.0   291.0  242.0
Fecal  699.0      602.0   819.0  900.0
Balance       7.0 -18.0 -170.0 -168.0
Phosphorus (mg)
Diet 1749.0    1716.0 1861.0 1801.0
Urine 1055.0    1271.0 1202.0 1181.0
Fecal   514.0      469.0   596.0   601.0
Balance  180.0 -24.0     63.0     19.0
Magnesium (mg)
Diet  311.0      302.0   333.0   310.0
Urine  109.0      131.0   116.0   120.0
Fecal  176.0      155.0   192.0   175.0
Balance    26.0        16.0     25.0     15.0
a N = 9
b N = 6
c N = 3
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Figure 4-28. Body composition changes (mean + SE) for each Skylab crew (n = 3). (a) 28-day mission. (b) 59-day mission.
(a)
(b)
28-Day Mission 59-Day Mission
Preflight Inflight Postflight
Preflight Inflight Postflight
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Figure 4-29. Change in body weight as a function of dietary
intake for all Skylab crewmen.
Figure 4-28(c). Body composition changes (mean + SE) for each
Skylab crew (n = 3). (c) 84-day mission.
caloric food content and exercise required to prevent sig-
nificant loss of body mass. These estimates were derived
by performing linear regression analyses on the inflight di-
etary intake or exercise levels as functions of the rate of body
weight loss. The minimum required levels were estimated by
determining the x-intercepts of the derived equations, which
correspond to a zero change in body mass. Figure 4-29 is an
example of the linear regression analyses performed; the nor-
malized daily rate of body weight loss (determined by divid-
ing total mission loss by mission duration) is plotted as a
function of normalized daily dietary intake for each of the
nine Skylab crewmembers. The line determined by least
squares regression can be extrapolated to zero weight loss
to determine the caloric intake required to maintain body
weight; in this case, the necessary energy intake is 49.5
kcal/day-kg body weight. Additional analyses were per-
formed using body fat and body protein losses as depen-
dent variables and exercise as an independent variable.
This analysis was similar to that reported by Whittle [52],
who used biostereometrically determined regional body
losses rather than whole-body losses to estimate caloric
and exercise requirements for the Skylab crewmen.
The assumptions and regression equations used in the
analysis are provided in Appendix F.5.1.4, The data used
(c)
84-Day Mission
Preflight Inflight Postflight
4.6.2.8 Estimates of Caloric and Exercise Require-
ments. The three Skylab missions, by virtue of their wide
variation in dietary intake, exercise expenditure, and
weight loss, provided a basis for estimating the minimum
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to compute the overall mission regression coefficients are
provided in Appendix F, Table F-30. A correlation analy-
sis was also performed using similar data, but for only the
first inflight month. This latter data was derived from the
analysis that produced Figs. 4-26 and 4-27. Average daily
exercise values for the first month were obtained from crew
logs, and they are not significantly different from the daily
whole-mission means.
The results of this study are summarized in Table 4-
25. The first two columns of data are the regression coeffi-
cients and zero-weight-loss intercepts, respectively, for the
entire mission analysis. The last two columns are the corre-
sponding quantities for the first inflight month of the study.
The following interpretations were derived from this
analysis.
a) Regressions using the data from the entire mission
suggest that weight, fat and protein loss can be pre-
vented if caloric intake is approximately 46 to 50 kcal/
day-kg body weight and if exercise energy expendi-
ture is approximately 5 to 6 kcal/day-kg body weight.
By way of comparison, the highest level of caloric
intake of any crewmember was 49.7 kcal/d-kg and the
highest level of exercise was 5.1 kcal/d-kg. Regres-
sions from the first month of data produce similar ca-
loric requirements for the entire mission, but those for
exercise are not statistically significant. These caloric
and exercise requirements are similar to those obtained
by Whittle [52] and Thornton [10].
Another method of estimating caloric requirements
is from the net energy utilization data (Table 4-21 and
Table F-23, Appendix F(5)). This quantity accounts
for all calories needed for living in space whether de-
rived from ingested food or via tissue catabolism. The
average inflight value of this quantity for the nine
crewmen is 3127 ± 300 kcal/day. Accounting for the
9% loss of diet calories in urine and feces, a value of
3127 kcal/day ×  1.09 = 3410 kcal/day or 47.5 kcal/
day body weight is obtained for an estimate of dietary
intake with no tissue loss or gain. This value is well
within the range of the estimates from the linear re-
gression discussed previously.
b) The correlation coefficients using caloric intake as
the independent variable were much larger for both
time intervals examined when compared to those ob-
tained using exercise as the independent variable. This
result was interpreted to mean that on Skylab, tissue
loss may have been dependent on caloric intake and
independent of exercise.
c) The strong correlations for exercise obtained over the
entire mission interval were probably a result of using
data from different mission durations. Dividing tissue
losses (the greatest percent of which occur during the
first month) by an increasing number of days gives
the erroneous impression that the daily rate of loss
decreases as mission length increases.
d) The caloric intake requirement of 46 to 50 kcal/day-
kg body weight found in this study may be too low.
Five of the crewmen consumed diets that fell within
this range, but only two showed no fat loss. No astro-
naut, however, reached the level of 50 kcal/day-kg)
body weight. In establishing caloric requirements, the
level of exercise and other activity as well as indi-
vidual variation in basal metabolism and metabolic
efficiency must be considered. Not all of these factors
were accounted for in this study.
4.6.3 Discussion
4.6.3.1 Major Assumptions. In this study all of the rel-
evant data (body mass, metabolic balance studies for en-
Table 4-25. Food, Exercise, and Weight Loss Correlations
Variables  Entire mission  First month
Regression Intercept,a Regression  Intercept,a
coefficient kcal/day-kg coefficient            kcal/day-kg
body wgt.  body wgt.
Caloric intakeb as a function of
Change in body wgt.c d0.82  49.5  e0.67      48.9
Change in fatc  0.49  45.7  0.56      44.7
Exerciseb as a function of
Change in body wgt.c e0.70  4.97  -.018      2.97
Change in proteinc d0.85  5.67 -0.28      1.34
aZero weight loss
bkilocalories per day per kilogram body weight
cGrams per day per kilogram body weight
d
 p < 0.01
ep < 0.05
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ergy, water, and nitrogen and postflight determinations of
changes in body water, electrolytes and density) from the
three Skylab missions have been integrated into a series
of newly-developed numerical analyses. This has permit-
ted a much greater in-depth answer, than has been hereto-
fore possible to the question: “Why do astronauts lose weight
in space”?. Such an analysis allows an interpretation of the
weight loss in terms of the major body elements and tissues
and is essential for understanding metabolic processes in
space, for predicting energy requirements, and for amelio-
rating weight losses in future missions.
Two major assumptions were made in this analysis:
a) Changes in body protein for use in Eq. (8) were esti-
mated from the cumulative nitrogen metabolic bal-
ance. This balance was uncorrected for the approxi-
mate 0.5 gm/day of nitrogen lost via shedding of cu-
taneous epithelium, hair, nails, and various skin se-
cretions [73]. This cumulative uncorrected nitrogen
balance has been used by others who have claimed
meaningful results [77,78]. While errors in the nitro-
gen balance method have been hypothesized and dis-
cussed [67,79], sources of methodological errors in
carefully controlled studies (the results of which are
in agreement with the positive preflight nitrogen bal-
ances discussed in this report) are not apparent [68,76].
Other similar analyses ([54] and Chapter 4.5) in which
body protein was estimated from whole-body ex-
changeable potassium, potassium balance, body den-
sity and body water yielded comparable conclusions
to those detailed above and serve to enhance confi-
dence in and to justify the use of uncorrected nitro-
gen metabolic balances as good indicators of changes
in body protein.
b) The daily net energy utilization (Eq. (9)) for each crew
member was constant during each phase of the mis-
sion. This assumption was justified on the basis that
each subject adhered to a fairly strict work and exer-
cise schedule especially throughout the inflight phase
[32]. Although not subject to independent verfication,
it does allow estimates to be calculated of time-vary-
ing changes in body composition which in turn can
be subjected to confirmation or challenge by other
related evidence.
It should also be noted that daily balances for water
and fat were sequentially accumulated without increasing
error. This was accomplished by combining daily balances
with end-points restricted to whole-body measurements
in accord with the suggestions of Hegsted [67]. For ex-
ample, the sequential accumulation of the daily inflight
water balance was forced to agree (by applying correction
factors) with the direct measurements of total body water
which were obtained at the beginning and end of each
mission. Daily weight/mass measurements govern the maxi-
mum weight loss composed of the sum of all the body
components. The inclusion of energy balance in the body
composition analysis ensured that fat losses would be based
on the degree of caloric intake deficit [63].
4.6.3.2 Interpretation of Body Composition
Changes. The considerable variability of body composi-
tion changes between the different crewmembers and their
time course during prolonged spaceflight reflect the com-
plex relationships between diet, exercise, physical condi-
tion, and energy balance that are normally observed in
terrestrial conditions. In addition, other changes were ob-
served that appear to be unique responses to the weight-
less environment. Interpretation of the Skylab data, with
the view of identifying and isolating the zero-g factors, is
made more difficult because each successive crew re-
mained in flight a month longer, exercised longer and
harder, and received a larger caloric intake per kilogram
body weight. Furthermore, each crew comprised a very
small statistical sample. Therefore, differences due to flight
duration, exercise levels and caloric intake may be diffi-
cult to discern since they could be masked by differences
among the particular subjects. Nevertheless, the data does
lend itself to a reasonable interpretation which must even-
tually be verified by more direct measurements.
The results from these analyses can best be discussed
in terms of the various body components:
4.6.3.2.1 Body Water. There appears to be an obligatory
and consistent loss of approximately 1 liter of body water
which occurred within the first 2 days after insertion into
microgravity.  This water deficit was primarily a result of
reduced fluid intake because urine and evaporative water
losses were equal to or below control levels during this
period [9,36].  Where decreased fluid intake and loss of
body water was particularly severe in the first few days of
flight, likely a consequence of space motion sickness (i.e.,
in the crew of the 59-day mission), some repletion of body
water occurred during the days following resumption of
normal drinking.
Over the entire period of 1 to 3 months of flight the
body is very close to maintaining water equilibrium as
shown by the partitional water balance of Table 4-26.  Each
major element of the water balance (see Fig. 4-6) can be
examined in this format.  These results suggest that a
slightly negative mean inflight water balance was main-
tained by means of a decreased fluid intake (–5%) and in
spite of a smaller decrease (–3%) in output. Net water out-
put declined, although there was a small increase in urine
volume (+2%), because of an estimated and unexpected
decrease (–8%) in evaporative water loss (see Chapter 4.2
[14,15]).  Table F-5 (Appendix F) provides details of this
water balance analysis.  Note that the values shown in
Table 4-26 are averaged over the entire mission, and there-
fore, mask the dramatic changes in water balance that oc-
cur near launch and recovery.
The reduction in body water was maintained in spite
of ad libitum drinking throughout a 1 to 3 month period.
This observation supports the concept of fluid-regulating
mechanisms which are continually responding to relieve
an effective central hypervolemia created by the cephalad
fluid shift induced by the reduction of gravitational influ-
ences [80,81,45]. Cephalad shifts of up to 2 liters of fluid
have been reported [10] and could account for the total
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body water losses if, as seems reasonable, such a water
load in the upper body was excessive for normal zero-g
health and was eliminated from the body. (The physiol-
ogy of this feedback pathway is fully described in Chap-
ter 5). Confirmation of a one liter loss of body water was
provided by measured inflight reductions in leg volume
and postflight decreases in body water, blood volume and
intracellular volume [4,45,69].
4.6.3.2.2 Body Tissue. Body tissue loss was directly re-
lated to the difference between net energy utilization and
net caloric intake (Eq. (9) and Fig. 4-23). The results sup-
port the premise that body fat was the tissue component
preferentially used to compensate for energy deficits due
to inadequate caloric intake [63]. On average, approxi-
mately 3 times as much weight in body fat was consumed
than in body protein and the fat provided nearly 6 times as
much energy. The catabolism of fat and protein during
spaceflight were sometimes, but not always, consistent
with predictions of tissue loss based on previous meta-
bolic studies in one-g. On one hand, the preflight period
was characterized by an adequate diet during periods of
exercise training; under these conditions one may have
expected the loss of fat and increase in protein mass that
was actually measured for the nine-man crew as shown
Fig. 4-26 (preflight phase). Also, as expected protein loss
was most severe when inflight dietary intake decreased
the most from preflight levels. On the other hand, the
inflight fat losses did not seem to correlate with the indi-
vidual preflight body fat percentages (i.e., on earth the
more fat one has the easier it is to lose) and whole body
protein losses during flight did not appear to be related to
the amount of exercise performed as they do in one-g (i.e.,
exercise promotes the build up of muscle mass).
4.6.3.2.3 Body Fat. Of all the components examined, the
changes in body fat showed the most variability between
the crews. This undoubtedly reflected the wide range of
caloric intake as modified by the varying degrees of exer-
cise performed. (As mentioned above, the plan for a simi-
lar rigidly controlled diet throughout all Skylab missions
was altered in order to prevent the observed gradual loss
of body mass during the flight phase and because of space
motion sickness induced anorexia during the first few days
of flight). Based on the gradual decline of body fat, ca-
loric intake was probably inadequate for the crews of the
28- and 59-day missions but sufficient for the crew of the
84-day flight whose fat stores were slightly increased de-
spite their higher exercise levels. In general, there is little
evidence to suggest that the body fat changes in space-
flight were influenced by weightlessness; they appear to
be entirely explicable in terms of the balance between
caloric intake and energy expenditure and were predict-
able from experiences in one-g [10].
4.6.3.2.4 Body Protein. It is well known that atrophy of
the body protein embodied in skeletal muscle tissue will
occur in response to disuse, inadequate functional load,
insufficient food intake, and lack of exercise [82,83,84].
The crews of the 3 Skylab missions experienced, to vary-
ing levels and at various times, all of these conditions.
The protein balance analysis dramatically indicates that
protein loss occurred almost immediately after entering
weightlessness, that it continued for most of the first month
after launch, and thereafter stabilized. The inflight shift to
a negative protein balance is supported by other Skylab
data such as potassium balance (see Chapter 4.4), and leg
volume and calf-girth measurements [44,45] and also finds
support from investigations in animals whose hindlimbs
were immobilized by casts [82] or suspended from their
tails [85]. It is also in keeping with the concept that the
large fraction of the body’s musculature devoted to op-
posing gravity is virtually unused in space and disuse at-
rophy will rapidly occur [86].
The protein losses occurred in spite of a high-protein
diet and in the presence of exercise training. This finding
appears, at first, to be in conflict with the conclusions
reached by other Skylab investigators [10,70] who sug-
gested that exercise training during flight may have pre-
vented even more loss of lean body mass. However, these
researchers only measured leg volume and strength (as an
indicator of whole body lean body mass) at the end of the
mission. This obscures the result of the present study that
the rate of total body protein loss during the first month
was similar for all crews and was therefore independent of
exercise. Also, by limiting the previous analysis to leg
muscles for which exercises were specifically employed
to strengthen, losses of body protein external to the legs
were ignored. If, as seems likely, leg muscles were rela-
tively better maintained through exercise [70] and the pro-
tein loss was from the unused postural muscles in the hips,
back and neck, then an analysis based only on leg muscle
would be incomplete.
Nevertheless, because each crew member performed
some exercise it is not possible to quantitatively predict
the zero-g effect of a total lack of exercise. Likewise, it
cannot be determined that the exercise performed by the
crews of the two longest missions contributed to the stabi-
lization of protein losses after one month or if it was due
to a gradual adaptive effect. Furthermore, while a reduced
caloric intake appears to exacerbate the protein loss, the
evidence does not allow such a firm conclusion that an
Table 4-26. Partitional Water Balance in Skylab Crew
       Skylab Average
Water Balance, ml/day Preflight Inflight
Input:
Water ingested (food and drink) 2971 2822
Metabolic water   353   350
Output:
Urine volume 1544 1577
Fecal water     82     68
Evaporative water 1677 1550
Net Water Balance +21 –23
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increased protein intake would ameliorate that loss. There
is no reason to question, however, that exercise does main-
tain strength, muscle tone, and probably mass in the legs
and improves circulation similar to exercise training in
one-g [70].
4.7 Conclusions
The findings presented in this chapter suggest that the
major components of body composition (water, protein,
and fat) undergo significant changes in spaceflight. The
kinetics and direction of these changes were different for
each component, suggesting different influencing mecha-
nisms. Losses of water and body tissues were significantly
greater when temporary anorexia, observed early in flight,
was present. Longer term, the body mass of each component
appeared to converge toward new equilibrium levels appro-
priate for the weightless environment, which were modified
by the caloric intake and level of activity. On average, the
results of this study showed that about 60% of the weight
loss measured during all three Skylab missions can be at-
tributed to a loss of lean body mass, and the remainder is
derived from fat stores. Since diet and exercise increased
with mission length, it was difficult to completely sepa-
rate the effects of these quantities from any adaptive ef-
fects of weightlessness that might have occurred over
longer exposures to space. However, as a working hypoth-
esis, the following scenarios are offered:
a) Water losses are obligatory as a result of a normal physi-
ological response to acute cephalad fluid shifts in
weightlessness; they occurred soon after launch and
were independent of flight duration. They seem to be
exacerbated by a short period of deficit fluid intake
and may or may not be accompanied by a diuresis.
b) Protein losses are primarily a result of disuse atrophy of
postural muscles and may be obligatory in weightless-
ness. Although overall body protein losses were inde-
pendent of exercise levels on Skylab, some data indi-
cate that locally applied exercise may have helped to
maintain protein mass and muscle strength in specific
areas, particularly the legs. Exercise may also have been
a factor in causing protein losses to level off after the
first month in flight, but this needs to be confirmed.
c) Fat losses are more variable and are probably depen-
dent on the usual and well characterized one-g influ-
ences whereby fat stores increase with caloric intake
and decrease with exercise. Also, changes in body fat
depend on the cumulative effects of a positive or nega-
tive energy balance and are therefore, highly time de-
pendent. In contrast to water loss related to cephlad
fluid shifts and protein losses related to postural muscle
atrophy, fat losses are probably preventable by dietary
changes.
d) An anorexia of varying degrees and only partly caused
by overt space motion sickness, appeared to be associ-
ated with the initial period of weightlessness. When
present, the anorexia would augment tissue losses by
virtue of a caloric deficiency and enhance water loss as
a result of reduced fluid intake.
e) Contrary to earlier expectations, energy requirements
for working in space do not appear to be significantly
less than those needed to maintain body weight on the
ground. The analysis suggest that a caloric intake of
46–50 kcal/day/kg body weight would have prevented
significant tissue loss (primarily fat) in the Skylab crew.
This conclusion needs to be confirmed in space using
well-controlled workloads and a direct means of mea-
suring energy expenditure.
The procedures used in this study to analyze the meta-
bolic balance data admittedly provide only indirect esti-
mates of inflight tissue and fluid loss behavior. This
analysis was performed and is being reported because it is
unlikely that direct inflight measurements of body com-
position changes will be accomplished in the near future.
It was not originally envisioned by the Skylab researchers
that the data used here would provide enough information
or resolution to determine time-continuous profiles of
changes in the major body constituents.  The desire to
express body composition changes in this format was
driven by the need to validate computer simulations of
the fluid-electrolyte model.  However, we believe the data
analysis portion of those modeling studies, contained in
this chapter, represents a contribution in its own right.
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Chapter 5
Fluid-Electrolyte Regulation During Long-Term
Spaceflight
Throughout the manned space-flight program, there has
been a continuous interest in response of the fluid regulat-
ing systems of the body to the exposure to weightlessness.
In the context of NASA’s biomedical program and, indeed,
of an integrated view of physiology, the study of body
fluid volumes demands the consideration of other related
subsystems, including electrolyte regulation, circulatory
and renal dynamics, endocrine function, body biochemis-
try, and metabolism. The Skylab program included the
first comprehensive observations performed in space on
these systems, and they were also carried out on the long-
est spaceflight that had been flown up to that time. The
purpose of this section is to integrate and interpret the
most significant findings of the Skylab studies in terms of
the homeostatic relationships that govern body fluid vol-
ume and composition.
The Skylab data were evaluated on the basis of com-
parison with previous spaceflight results and ground-based
studies such as bedrest and water immersion, especially in
terms of the responses expected from the current understand-
ing of fluid-electrolyte physiology. The data base analysis
system (see Chapter 3), and the integrated metabolic bal-
ance analysis (see Chapter 4) permitted quantitative de-
scriptions of body composition changes and established
correlations between important variables. Preliminary
model simulations were also valuable in formulating ten-
tative hypotheses and guiding the data analysis.
One result of the preliminary analysis was identifica-
tion of several groups of physiological quantities which
changed significantly during spaceflight and which could
be used to define the fluid-electrolyte status of the crew-
men. These groups included body weight losses (total body
water, lean body mass); body fluid volumes within the
major compartments (blood, extracellular, intracellular,
upper body, lower body); and major body electrolytes and
their plasma concentrations (sodium and potassium). An-
other group consisted of hormones that control fluid elec-
trolyte balance (angiotensin, aldosterone, ADH, cortisol);
renal excretion of water and electrolytes (rates and con-
centrations); and water and electrolyte balances (intake,
excretion, sweat). The ultimate goal of this analysis was to
determine, insofar as possible, the mechanisms and physi-
ological pathways that produced the observed changes in
these quantities. A mathematical model that proved most
important to this analysis was the modified Guyton model
of fluid and electrolyte regulation (see Chapter 3). The
capability of this model to simulate many of the responses
to weightlessness provided a basis for identifying impor-
tant regulatory mechanisms and testing hypotheses to ex-
plain selected Skylab findings and their apparent
inconsistencies.
5.1 Review of Significant Findings
For convenience, the following review of significant find-
ings in the area of fluid-electrolyte regulation will be di-
vided into two categories: pre-Skylab and Skylab findings.
5.1.1 Pre-Skylab Findings
Prior to Skylab, a limited amount of information had
been accumulated concerning the body’s fluid and bio-
chemical responses to spaceflight. These studies of the
astronauts who participated in the Mercury, Gemini, and
Apollo missions were designed to provide data relative to
the maintenance of flight crew health and safety. The early
flights were characterized by technological constraints
that made the design of valid physiological experiments
nearly impossible. With the exception of two missions,
only preflight and postflight measurements were permit-
ted, and there was limited opportunity to provide experi-
mental controls for diet and activity. Therefore, most of
the information collected was in the form of observations
based on urine and blood analyses and some whole-body
measurements, almost all of which were obtained on the
ground. From these data, only gross changes could be re-
vealed, and inflight aberrations could only be inferred.
The investigation and elucidation of the basic physiologi-
cal mechanisms responsible for these changes were to be
performed on future flights, such as Skylab.
Sufficient data were obtained, however, to demonstrate
that spaceflight is associated with significant weight loss,
substantial deficits in fluid and electrolyte balance, a va-
riety of endocrine responses, demineralization of bone,
and cardiovascular deconditioning [1,2,3,4,5,6]. Water
losses [7] were believed to occur principally on the first or
second day of flight. On the basis of the rate of body weight
recovery during the postflight phase (i.e., the most rapid
gains in postflight weight are attributed to water replen-
ishment) it was estimated that 50 – 85% of the total weight
loss during spaceflight could be attributed to water loss.
The remaining loss was taken to be catabolism of tissue
components (fat and protein), most likely a result of an
inadequate diet [7]. In retrospect, it was suggested that a
decrease in food consumption during the early period af-
ter launch may have been associated with low grade vesti-
bular disturbances and space motion sickness symptoms
[8]. Diminished urinary excretion in the immediate post-
flight period indicates efforts by the body to retain fluid
and electrolytes lost inflight. Signs of musculoskeletal
atrophy and loss of intracellular content was indicated by
decreased total body potassium, a negative nitrogen bal-
ance, and reduced intracellular fluid volume. Preflight and
postflight measurements of hormones related to fluid and
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Table 5-1. Pre-Skylab Hypothesis Concerning Processes Involved in Man’s Adaptation in Zero Gravity
Event Response of Body
Entry into zero gravity. Body attempts to reduce volume. ADH decreases,
Redistribution of circulating blood volume. aldosterone production decreases.
Loss of water, sodium, potassium (loss of body weight). Decrease in plasma volume.
Aldosterone increases (secondary aldosteronism).
Increased sodium retention. Potassium loss continues. Intracellular exchange of potassium and hydrogen ions.
Cell: acidotic—extracellular fluid alkalotic Decrease in bone density, muscle cell potassium,
and muscle mass; possibly including cardiac muscle.
Respiratory and renal compensation. Halt to weight Stabilizes with new effective circulating blood volume.
loss trend. New body fluid and electrolyte balance.
electrolyte balance were also consistent with inflight loss
and postflight retention. In particular, elevated levels were
noted postflight for urinary anti-diuretic hormone (ADH),
aldosterone, catecholamines, and plasma angiotensin. These
hormones are usually secreted when retention of water and
salt is required. Also noted were moderate losses of blood
volume (both plasma and red cells). Cardiovascular alter-
ations were indicated by a postflight decrease in orthos-
tatic tolerance and a reduction in exercise capacity.
Following Apollo and before Skylab, a working hy-
pothesis was proposed which presumably accounted for
the adaptive changes in the fluids, electrolytes, and hor-
mones [9]. Table 5-1 outlines those parts of the proposed
hypothesis related to fluid shifts within the body. Upon
initial entry into the weightless environment, the circulat-
ing blood volume shifts from the legs and lower abdomen
toward the central thoracic regions. This is interpreted by the
body as an increase in total circulating blood volume (since
“volume” receptors are located in the cardiopulmonary
region), which the body attempts to reduce by a decrease
in the production of ADH and aldosterone. The result is a
loss of water, sodium, and potassium. The accompanying
decrease in plasma volume may then produce a secondary
aldosteronism. At this point, the body is believed to enter
a phase of electrolyte and fluid imbalance, in which so-
dium retention increases, while potassium loss continues.
The extracellular alkalosis that results from such a response
may produce an intracellular exchange of potassium and
hydrogen ions. At some point, it has been theorized, respi-
ratory and renal compensation could halt the negative bal-
ance trend and produce a physiological system that is
stabilized. This yields a new effective circulating blood
volume and fluid and electrolyte balance.
Prior to Skylab, little was known about the detailed
nature and time course of these changes during weight-
lessness. Also, it was uncertain as to whether the changes
represented a new adaptive steady-state, or whether they
would progress to the point of adaptive failure somewhere
beyond the two to three weeks exposure to weightlessness
studied in previous flights [10]. Missing from the data
collected on these early missions were data collected over
a period of time sufficient to reflect a reliable baseline for
quantitation of inflight urine excretion, inflight biochemi-
cal analysis of urine and blood, and sufficient postflight
sampling to document the crew’s return to normal. The
Skylab experiments were designed to study, in greater de-
tail, the aspects of biochemical and fluid regulation that
had previously shown the most significant changes. The ex-
periments were also designed to complete, where possible,
the incomplete observations of the prior programs. Accord-
ingly, the studies were designed to investigate the mecha-
nisms involved in weight loss, bone demineralization, and
altered endocrinological status. More specifically, evalua-
tion of the endocrinological adaptation and other homeo-
static mechanisms that control the volume and composition
of the body fluids was needed. These objectives were ac-
complished under the Skylab Bioassay of Body Fluids Ex-
periment by establishing controlled dietary conditions,
collecting metabolic excreta and blood samples inflight, and
by taking whole body measurements of fluid and electrolyte
compartments prior to and after flights. Supporting this study
were other related and overlapping experiments in which
mineral balances, daily body mass, blood volumes, and
leg volume measurements were performed.
5.1.2 Major Skylab Findings
The findings described below summarize the most
important results of the Skylab studies related to fluid-
electrolyte regulation. The original findings, as reported
by the principal investigators, are available to the inter-
ested reader [Refs. 11–19]. New analyses of these data are
presented here to permit a description of both the short
and long-term responses to spaceflight. Obtaining a com-
posite picture of these responses, based on the nine Skylab
crewmen, was preferable in most instances to comparing
each three-man crew to explain the differences between
flights. This data analysis served as a starting point for
defining the scope of the general systems analysis.
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5.1.2.1 Weight Loss. Weight loss has been one of the 
most commonly observed findings in astronauts returning 
from spaceflight, regardless of flight duration. Figure 5-1 
shows the percentage weight loss compared to mission 
duration for all U.S. space crewmen through 1975 [16]. 
The average measured weight loss has been 2.8 kg, or 
3.8% of preflight body weight. Although Fig. 5-1 
suggests that weight loss may diminish for the longest 
flights, this is presumably not caused by any adaptive 
effects. Rather, it is caused by the fact that the dietary 
intake was increased on those flights; hence, fat loss was 
significantly reduced.  
        Skylab permitted the first inflight measurements of 
body mass. The analysis of the components of this weight 
loss (presented in Chapter 4.6), was based both on direct 
whole-body measurements and on indirect metabolic 
balance data. One of the conclusions from that analysis 
was that more than half of the weight loss was derived 
from lean body mass and the remainder from fat stores. 
Inasmuch as lean body mass contains the most significant 
amounts of water and electrolytes, the losses of this tissue 
component are of crucial interest in understanding the 
fluid-electrolyte disturbances which occur in spaceflight. 
Some of the major components of the lean body mass 
loss in the Skylab crew are summarized in Table 5-2. 
        About half the total weight loss occurred within the 
first two days of flight, and it was apparently due to water 
loss.   The remaining loss occurred more gradually over 
the duration of the missions and was attributed to both fat 
and protein depletion. As demonstrated by inflight 
metabolic balances of nitrogen and potassium, the most 
significant losses of protein stores occurred during the 
first several weeks. 
 
5.1.2.2 Body Fluids. The loss of body water was 
studied in considerable detail in Chapter 4, since it 
provides major clues to understanding the headward shift 
of fluids, the fate of electrolytes, renal function, and 
endocrine regulation.   The dynamic behavior of body 
water was derived from consideration of water balance 
data and is shown in Fig. 5-2 for the first 28 days of 
flight. (This time period was examined closely for much 
of the data presented here, because it is the longest 
continuous period in which all crewmen from the three 
missions can be included.) A loss of between 1.0 and 1.4 
liters occurred rapidly and then essentially stabilized at 
the reduced level with a tendency toward partial recovery. 
A greater initial loss of water was associated with the 
crewmen who exhibited space motion sickness and drank 
less fluid.      
        While body water changes could be estimated during 
flight, the fluid compartments of the body were measured 
only after the crewmen returned to earth. This 
information is summarized in the composite analysis of 
Table 5-2. Interpretation of these results is confounded by 
the fact that fluid compartments are labile and probably 
subject to rapid changes as a result of reentry forces. 
Therefore, these results, based primarily upon 
measurements performed on the first day of recovery may 
not truly reflect the magnitude of changes incurred 
inflight. This was exemplified in the detailed water 
balance analysis (see Table 4-4) that indicated that the 
inflight loss of water was probably closer to 1.1 liters 
rather than the 0.8 liter shown in Table 5-2.  This 
discrepancy may be explained by assuming partial 
replenishment of water from drinking prior to the 
postflight isotope dilution studies. 
         Significant postflight decrements were found in 
blood volume (–590 ml), extracellular (–330 ml), and 
intracellular fluid (–480 ml). Interstitial fluid volume did 
not appear to change appreciably. Blood volume loss was 
caused by a combination of plasma volume and red cell 
mass loss.   Hemoglobin concentration measurements, 
performed inflight, indicate that plasma volume losses of 
10 to 15% occurred within the first few days and may have 
been rather stable thereafter. However, red cell mass 
appears to have been lost more gradually (–11%) over the 
course of the entire mission (see Chapter 6). During the 
two-week postflight period, blood volume and intracellular 
fluid volume recovered completely. Blood volume 
replenishment was primarily a result of over-recovery of 
plasma volume, since less than 20% of the red cells lost 
during spaceflight were regained during this time. 
 
5.1.2.3 Fluid Redistribution. Headward shifts of fluid 
in weightlessness were documented for the first time by 
leg volume measurements performed on the crew of the 
84-day Skylab mission. Most, if not all, of the body fluid 
deficit could be attributed to losses in the lower 
limbs.There is growing evidence from ground-based 
studies, such as water immersion, that a significant 
fraction of the fluid shifted headward from the legs is 
excreted from the body. Postural change is usually 
associated with an acute fluid volume shift of 600 to 800 
ml. The fluid volume that shifted from the legs after 
several days of weightlessness appears to be 
Figure 5-1. Percentage weight loss of U.S. space crewmen as a 
function of mission duration, based on preflight (usually the 
mean of multiple values) and immediate postflight weights [16]. 
No correlation exists between weight loss and mission length for 
flights up to two weeks. On the Skylab missions weight loss 
diminished with flight duration but this was likely caused by 
increased dietary intake rather than an effect of weightlessness. 
Data was collected in period 1963-1975. 
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Table 5-2. Changes In Fluid and Electrolyte Compartments In Skylab Crew (N - 9)
Quantity       Inflight Losses* Postflight Gains**
Leg Volume (ml)  -1500       +1500
Blood volume (ml)***    -590        +590
Red Cell Mass (ml)    -230        +240
Plasma Volume (ml)    -360        +550
Intracellular Water (ml)***    -480        +530
Extracellular Water (ml)***    -330        +590
Interstitial Water (ml)***     +30          +50
Total Body Water (ml)    –820      +1120
Exchangeable Body K+ (meq)    -240        +164
Extracellular Na+ (meq)***      -90        +100
Body Mass (gm)  -2630      +1840
    * Measured from preflight to recovery day (average mission length = 57 days)
  ** Measured from recovery day to two weeks postflight
*** Measured indirectly
much greater (about 1.8 liters). This implies that there are
greater reserves of mobilized fluid than previously recog-
nized. A mean leg volume loss of 1.5 liters for all nine
crewmembers was found just after reentry, and this was
almost completely regained within the first postflight week.
There are two important questions that were not com-
pletely resolved from these studies. The contribution of
each major leg compartment (blood, interstitial, intracel-
lular) to the initial loss of leg volume is still undeter-
mined. It was also not determined how much of the fluid
shifted was not excreted from the body and in which com-
partments of the upper body it may have been stored. The
puffy tissues of the face and distended head and neck veins
of the crewmen suggested that these regions were involved
as storage depots. An expanded fluid volume in the upper
body, if sustained and not accommodated, could have ad-
verse consequences on pulmonary function, cardiac func-
tion, and volume receptor pathways.
5.1.2.4 Altered Water Balance. Body fluid loss was ex-
pected to result from increased renal excretion. However,
a diuresis was not recorded in the 24-hour pooled urine
samples obtained for each crewmember early in the mis-
sion (see Chapter 4.2). In fact, urinary excretion was di-
minished for the first ten days of the mission (see Fig. 5-3).
The loss of body water during the first two days primarily
resulted from a deficit intake of fluid. Evaporative water
loss increased significantly for several days during the
first week, mainly as a result of increased ambient tem-
peratures in the orbital workshop when a heat shield mal-
functioned on the first mission. However, due to a
corresponding decrease in excretion this did not result in
further body water losses. The three-month averages as
shown in Fig. 5-3 indicates that essentially a zero water
balance was achieved at new equilibrium levels for intake
(slightly diminished compared to preflight), output
(slightly increased), and evaporative water loss (decreased
10%). During the first few days of the postflight period,
water was regained because of enhanced intake and di-
minished excretion, similar to results found in earlier
flights.
5.1.2.5 Electrolyte Losses. Of all physiological changes
seen during and after spaceflight, probably the most reliable
clues to the mechanisms involved are offered by an examina-
tion of the electrolyte response. Loss of extracellular fluid is
always accompanied by its major cation, sodium. Potassium,
nitrogen, and magnesium are located primarily in the intra-
cellular spaces. Loss of these quantities is assumed to reflect
muscle degradation, a process known to occur during grav-
ity unloading. Calcium and phosphorus losses are useful in-
dicators of bone demineralization.
Of these substances, sodium and potassium were sub-
jected to a more careful analysis (see Chapter 4.3). Ex-
changeable body potassium decreased about 240 meq
(6.4%) from preflight levels, indicating a significant loss
of cellular mass (see Table 5-2). A net loss of approxi-
mately 100 meq of sodium occurred from the extracellular
space, and all of this was regained during the two-week
postflight period. The time course of these changes is sum-
marized in Fig. 5-2. There is an expected correspondence
between total body water and sodium dynamics, since these
quantities are believed to be associated with extracellular
fluids, especially during periods of rapid changes. While
body water and sodium appear to stabilize after the initial
inflight disturbance, body tissue, as exemplified by po-
tassium loss, continues to decline gradually. It was shown
in Chapter 4.5 that potassium and nitrogen losses are es-
sentially parallel. This might be expected for a general-
ized degradation of muscle tissue. Two quantities that were
expected to be highly correlated, but were not, were cell
water loss and potassium loss; more intracellular water
should have accompanied potassium loss if their normal
ratios were maintained.
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The changes in metabolic balance (intake minus ex-
creta) for the major intracellular electrolytes, calcium,
phosphorus, nitrogen, and magnesium are shown in Table
5-3. While the loss of electrolytes represents significant
changes in the body’s physiology, it does not significantly
contribute to the overall loss in body weight. Calcium
metabolism and its loss in spaceflight will be treated in a
separate section of this document (Chapter 4.4).
5.1.2.6 Plasma and Urine Analysis. Analysis of weekly
blood samples and daily urine collections also reflected
disturbances in the fluid-electrolyte system. These repre-
sent the first systematic collection of inflight body fluid
specimens under somewhat controlled conditions during
the space program. Plasma electrolyte concentrations are
very useful in interpreting metabolic and hormonal alter-
ations. Elevations in plasma levels were noted for potas-
Table 5-3. Average Daily Net Metabolic Balances of Intracellular Minerals [20]
Preflight 1st Inflight Month 2nd Inflight Month 3rd Inflight Month
(N = 9)         (N = 9)         (N = 6)          (N = 3)
Nitrogen (g)     3.2          -1.7             0.2             0.2
Potassium (meq)   17.0           4.0             9.3             8.7
Calcium (mg)     8.0        -18.0        -170.0        -168.0
Phosphorus (mg) 180.0        -24.0           64.0           20.0
Magnesium (mg)   26.0         16.0           25.0           15.0
Figure 5-2. Changes in total body water, body sodium and body potassium for the entire Skylab crewmembers during preflight, the first
inflight month, and recovery.  Values shown are changes from morning of launch. Data was obtained by the indirect metabolic balance
method (see Chapter 4).
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Figure 5-3. A composite water balance analysis of the Skylab crew (N = 9). Percent changes from control are indicated for the first 28
days and two weeks postflight. Also shown is the average three-month inflight mean that provides insight into long-term changes of
intake, excreta and evaporative water loss during a time when the water balance is essentially zero. Intake includes drinking water, water
in food and metabolically produced water. Output includes both urine and fecal water. Evaporative water loss was estimated indirectly
(see Chapter 4.2).
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Table 5-4. Changes In Plasma Electrolyte Concentrations In Skylab Crew (N = 9)*
sium, calcium, and phosphate, constituents that are nor-
mally associated with intracellular metabolism (see Table
5-4). The plasma concentration of the major extracellular
salt, sodium chloride, was found to be reduced as was the
plasma osmolarity. Elevated rates of renal excretion were
found for all electrolytes (sodium, potassium, calcium,
phosphates, and magnesium) during the flight period (see
Fig. 5-4); all except calcium were reduced during the pe-
riod following recovery. Loss of body protein is indicated
by elevated urine creatinine and total urinary nitrogen.
Uric acid was one of the few metabolites showing a de-
creased rate of renal excretion. Taken as a whole, these
findings suggest loss of lean body mass constituents and
degradation of tissues. However, unless all the routes of
metabolism are examined, it is not possible to quantita-
tively estimate rates of loss by analyzing either plasma or
urine composition alone.
5.1.2.7 Endocrine Function. Endocrine changes that
reflected alterations in fluid-electrolyte status, physical
stress, and tissue metabolism were observed in analyses of
blood and urine. Examination of the data from the first
month inflight (Fig. 5-5) revealed elevations in plasma
angiotensin, urinary aldosterone, and urinary cortisal
throughout this period; the highest levels were reached
early inflight and on the first or second day of recovery.
Urinary ADH was elevated during the first week inflight,
but was depressed during the latter half of the first month.
All the hormones shown in Fig. 5-5 reached maximum
values on the first or second day of recovery. These sub-
stances are released during periods of general stress, but
they are also sensitive to specific stressors, including
plasma levels of electrolytes and blood pressures.
In many cases, the measured levels of these hormones
can be plausibly correlated with other known changes.
For example, increased angiotensin and aldosterone can
account for the elevated renal potassium rates of excre-
tion. Elevated cortisol levels undoubtedly contributed to
muscle catabolism and increased nitrogen and potassium
loss. The behavior of ADH qualitatively exhibits the ex-
pected inverse correlation with urine output during the
inflight and postflight period (compare Figs. 5-3 and 5-
5(a)). The elevation of the catecholamines (epinephrine
Electrolyte   Preflight     Inflight
Na+ (meq/l) 142.2 ± 2.6 137.7 ± 1.5**
K+ (meq/l)   4.07 ± 0.13   4.23 ± 0.12**
Ca++ (meq/l)   9.52 ± 0.31 10.23 ± 0.23**
PO3= (meq/l)   3.35 ± 0.54   3.96 ± 0.54
Cl– (meq/l)  100.3 ± 5.3   95.7 ± 1.7**
Osmolarity (mosm/l)  291.0 ± 2.8 286.4 ± 3.1**
* Means ± SD
**Inflight significantly different than preflight (p < 0.05 )
and norepinephrine) early in flight and on the day of re-
covery, together with cortisol changes, indicated acute
stress responses.
Complete interpretation of these changes is impeded
because of the multiple competing factors that influence
hormonal secretion rates and the various target sites they
affect. In some cases, paradoxical changes appear to exist
with respect to known concepts of physiology and the
working hypothesis discussed earlier. For example, angio-
tensin is a powerful vasoconstrictor in addition to its ac-
tion as an aldosterone stimulator. It is usually released in
response to hypovolemia, so it is not clear why angio-
tensin is elevated in microgravity (and also bedrest), at a
time when there is a tendency for central blood volume
expansion. ADH is also a potent pressor agent, in addition
to its known effects on water excretion. However, this hor-
mone is depressed, during periods when angiotensin is
elevated. In addition, the behavior of ADH was quite dif-
ferent on the three missions, as indicated in Fig. 5-6. ADH
levels were elevated on the shortest mission, but were re-
duced throughout the other two missions. In another case,
aldosterone is a well-known promoter of renal sodium re-
tention. Therefore, the elevated levels of aldosterone are
inconsistent with the enhanced excretion of sodium. This
is possibly evidence of a previously suggested natriuretic
factor which may be operative in spaceflight.
5.1.2.8 Renal Function. Alterations in renal function
during Skylab were indicated by minor changes in creati-
nine clearance, low levels of uric acid in urine and plasma,
and increased secretion of angiotensin. As discussed
above, the fluid-regulating hormones and the degree of
water and salt excretion all were altered during the entire
three-month period of study. However, there is no firm evi-
dence at present to warrant the belief that renal function
was impaired. Rather, renal function was probably respond-
ing to the demands of removing ordinary waste products
from the body in addition to the extra demands of remov-
ing products created by the adaptive spaceflight processes.
An understanding of renal function in the weightlessness
environment is made more difficult by the necessity to study
the large quantities of biochemical agents which control
and are controlled by the kidneys as well as the complex-
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Figure 5-4. Daily changes in urine electrolytes as measured in 24-hr pooled specimen and expressed as percent change from preflight
mean.  Results for the mean (+SE) of the nine Skylab subjects are provided for the first 28 days inflight and two weeks of postflight
recovery: (a) urinary sodium, (b) urinary potassium, (c) urinary calcium, (d) urinary magnesium, (e) urinary phosphate and (f) urinary
osmolarity.
Figure 5-4 (a). Urinary sodium
Figure 5-4(b). Urinary potassium
  Inflight          Postflight
Time, Days
∆%
 fr
om
 P
re
flig
ht
Figure 5-4(c). Urinary calcium
Inflight         Postflight
Time, Days
∆%
 fr
om
 P
re
flig
ht
Urinary
Sodium
Urinary
Potassium
  Inflight          Postflight
Time, Days
∆%
 fr
om
 P
re
flig
ht
Urinary
Calcium
NASA/CR—2020-220487 168
Figure 5-4(d). Urinary magnesium
Figure 5-4(f). Urinary osmolarity
Figure 5-4 continued. Daily changes in urine electrolytes as measured in 24-hr pooled specimen and expressed as percent change from
preflight mean.  Results for the mean (+SE) of the nine Skylab subjects are provided for the first 28 days inflight and two weeks of
postflight recovery: (a) urinary sodium, (b) urinary potassium, (c) urinary calcium, (d) urinary magnesium, (e) urinary phosphate and (f)
urinary osmolarity.
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Figure 5-5.  Hormone changes in the Skylab crew (N = 9) for the first 28 days inflight and the two weeks of postflight recovery.  Results
are expressed as percent changes from the preflight mean: (a) urinary antidiuretic hormone; (b) urinary aldosterone;
(c) urinary cortisol; (d) plasma angiotensin.
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Figure 5-5 continued.  Hormone changes in the Skylab crew (N = 9) for the first 28 days inflight and the two weeks of postflight
recovery.  Results are expressed as percent changes from the preflight mean: (a) urinary antidiuretic hormone; (b) urinary aldosterone;
(c) urinary cortisol; (d) plasma angiotensin.
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Figure 5-6. Comparison of variation of urinary ADH in the Skylab
crew (N = 3) during first inflight month of each mission. Values
are expressed as percent change from preflight mean.
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hypothesized changes were indeed intensive enough to
produce the expected response. The following section pro-
vides state-of-the-art descriptions of the general control sys-
tems involved. These are related to particular events that are
known or suspected to have occurred during spaceflight. Fi-
nally, there will be a discussion of how conceptual and math-
ematical models were utilized in an attempt to answer the
questions posed in Table 5-5, and to arrive at an inte-
grated hypothesis for explaining the circulatory, fluid, and
electrolyte responses during weightlessness.
5.2 Systems Analysis of Circulatory,
Fluid, and Electrolyte Regulation
This section summarizes the major feedback control mecha-
nisms involved in maintaining body fluid volume homeo-
stasis. The purpose of this analysis was to identify the
physiological pathways that should be considered in the
interpretation of the Skylab data and to suggest which of
those might predominate in the acute and longer-term re-
sponses. This analysis was also designed to suggest hy-
potheses that could be tested with the mathematical model
and to reveal additional mechanisms that were not origi-
nally included in the simulation models. The following
analysis discusses all of the assumptions of the regulatory
system that were the basis for the zero-g hypotheses. The
writings of Dr. A.C. Guyton and co-workers and detailed
examination of the Guyton model were extremely useful
in preparing this study [21,22,23]. However, other view-
points of overall fluid volume control were included to
provide a necessary balance to this still controversial sub-
ject [Refs. 24–32].
5.2.1 Overall Regulation of Water Balance
The water balance of the body depends on volume
control in the several body fluid compartments (see Fig.
5-7) but most importantly, it depends on the control of
blood volume. Blood volume regulation is accomplished
by feedback control of three components: fluid intake,
renal excretion, and transcapillary fluid movement be-
tween plasma and interstitial compartments. (Control of
the red cell volume is deferred to a later chapter.) The
interstitial fluid compartment has been regarded as an ad-
justable segment in the total water content of the body,
capable of receiving large quantities of fluid in cases of
blood volume overload or acting as a reservoir to transfer
fluid to the circulation in cases of dehydration. Evidence
for this regulatory role of interstitial fluid in the long-term
control of overall body water is not as strong as it is in the
acute case, since lymph flow, transcapillary forces, and the
physio-chemical forces of the interstitium tend to return in-
terstitial fluid to normal. The intracellular compartment ap-
pears to maintain a fairly constant volume. However, the
requirement for osmotic equality between intracellular and
extracellular fluid is often accomplished by volume ad-
justments between these two compartments. Increases in
extracellular osmolarity, for example, will cause the os-
motic transfer of intracellular fluid into the extracellular
pool. Neither the volume, total electrolyte content, nor
ity of the regulatory processes associated with that organ.
A major emphasis of the present study was directed toward
the systematic study of these processes.
5.1.3 Identification of Problem Areas. Examination
of the Skylab findings resulted in a comprehensive list of
experimental observations some of which, on the surface,
appeared paradoxical and whose etiology was not obvi-
ous. A representative portion of this list is summarized in
Table 5-5. The subsequent analysis which was necessary
to resolve the critical questions listed in the second col-
umn of Table 5-5 requires addressing various elements of
the circulatory, fluid, electrolyte, hormonal, and renal sys-
tems. It is no longer adequate to answer any one of these
questions without considering the effects on other related
systems. A more specific analysis must include all the fac-
tors known to determine particular physiological responses
and these factors must be put into the context of a total
integrated control network. These pathways must be ana-
lyzed quantitatively to determine if certain observed or
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Table 5-5. Important Observations and Critical Questions Identified In Analysis of Fluid-Electrolyte Systems
Observation   Questions for the Analysis
Significant losses of water, sodium, and i) What was the overall magnitude and time course of the losses?
potassium were measured directly or ii) From what body compartments did these quantities originate?
indirectly in the Skylab crew. iii)What components of the metabolic balance were most significantly
altered: intake, excretion, or sweat losses?
iv)What regulatory mechanisms were predominantly involved in
controlling the initial loss of fluids and electrolytes as well as in the
final approach toward a new homeostatic level?
After the first several days of flight, the inflight i) Does this imply continuous loss of fluids and electrolytes from the
phase was characterized by somewhat higher body, or does it reflect an alteration of intake or sweat components as
excretion rates of fluids and major electrolytes. suggested by metabolic balance studies?
ii) What are the mechanisms required to accomplish this and are they
consistent with observed biochemical changes?
Fluid losses from the legs occurred rapidly at the i) From what compartments does this fluid originate?
onset of zero-g and were unexpectedly large. ii) What are the forces which drive it from the legs?
iii)Is this fluid eventually excreted from the body or is there a residual
volume remaining?
iv)If residual volume is stored in upper body as has been postulated,
does this represent long-term stress with regard to volume receptors
or do these receptors adapt?
Urine volumes were reduced during the first week i) Is the Henry-Gauer reflex which predicts a diminished level of ADH
inflight coincidence with a mean increase in ADH. and a diuresis during acute zero-g stress, not operative in this instance?
ii) What factors are capable of modifying or reversing this reflex and can
they quantitatively account for the observed renal excretion?
Urinary ADH was significantly depressed during i) What are the factors causing the ADH response?
the latter part of the inflight phase, while urine ii) What other competing factors are present, including longer term
volume was only slightly elevated. adaptive mechanisms that maintain reduced ADH levels and that
prevent  urine volumes to be even higher than would be expected
on earth?
The measured body loss ratio of potassium: i) Does this reflect measurement error or are other factors such
intracellular water is not consistent with values as altered extracellular osmolarity involved?
expected from normal cell composition. ii) What are the factors which permit potassium extrusion from the
intracellular compartment to occur.
Aldosterone was increased in spaceflight i) Is this paradoxical relationship (in terms of one-g physiology)
accompanied by an increased sodium excretion. explained by other factors which influence aldosterone release or
sodium excretion?
ii) Is this an instance of sodium escape from aldosterone?
iii)What factors caused excess sodium excretion to occur in the face of
hyponatremia and elevated aldosterone?
Angiotensin was apparently increased during i) What mechanisms are responsible for the elevations in angiotensin in
spaceflight. a situation where there is a tendency toward upper body fluid
congestion and increases in central blood pressures which are usually
associated with depressed angiotensin?
ii) How is it possible to reconcile the increased angiotensin and
aldosterone levels in spaceflight with the findings from water
immersion studies, which show an opposite effect?
Plasma osmolarity and plasma sodium i) How can these findings be reconciled when it would be expected
concentration were slightly reduced, while that a dilute urine would be associated with hypotonic plasma,
urine osmolarity was increased. decreased ADH and increased aldosterone?
ii) What are the factors causing the hypotonic plasma and why does this
phenomena persist when the renal-thirst reflexes are capable of
exerting exquisite control of body fluid osmolarity?
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concentration of intracellular fluid is maintained inde-
pendently of events occurring in extracellular fluid.
A normal total ionic concentration of body fluids is
maintained by renal regulation. Loss of body fluid is al-
ways accompanied by a loss of electrolytes, although the
proportion between these two quantities may vary widely.
In the case of water deficit from inadequate intake, preser-
vation of the normal ionic concentration of body fluids
requires removal of a proportionally greater quantity of
electrolytes than water (i.e., a hypertonic urine). There-
fore, urine volume will be considerably reduced and
hyperosmotic. On the other hand, when electrolytes are
withheld in the diet, an accompanying elimination of hy-
potonic urine is necessary. If a therapeutic correction of
water deficit occurs, it cannot be accomplished by water
alone; the lost electrolyte must also be replaced.
These observations suggest that body fluid regula-
tion cannot be separated from regulation of electrolytes,
and a large part of the Skylab analysis was guided by this
principle. A true understanding of fluid disturbances in
any compartment in the body requires a basic knowledge
of fluid volume and electrolyte content of intake, renal
excretion, fecal excretion, sweat and evaporative water,
and the major body fluid pools (see Fig. 10-2). This, of
course, only provides the minimum information required
to understand the extent of fluid disturbance. It does noth-
ing to suggest the internal mechanisms by which the dis-
turbances are ultimately corrected. These feedback
homeostatic processes will be discussed next.
5.2.2 Control of Extracellular Fluid Volume
The control of extracellular fluid volume is under the
influence of a variety of neural, humoral, and physical
factors. There are no known receptors that respond to vol-
ume change, per se. However, volume changes are detected
indirectly by sensors known to receive and respond to
pressure, distention, or flow signals. While these sensors
are located in various parts of the body, the pressure re-
ceptors in particular are found in the cardiopulmonary re-
gion, and they respond to circulatory pressures. Thus, the
control of extracellular fluid volume, especially in cases
of acute disturbances, can be understood best by examin-
ing the factors associated with blood volume changes.
The sensors for volume disturbances are very power-
ful in their ability to rapidly correct blood pressure by
changing resistance and capacitance elements of the cir-
culation, as well as in their ability to shift fluid between
the vascular and interstitial segments. However, any dis-
turbance of body fluid (i.e., dehydration, infusions, hem-
orrhage) cannot be fully corrected by these mechanisms,
since the total amount of fluid deficit or gain still remains.
The only mechanisms available for ultimate control of
body fluid volume are those that affect drinking and renal
volume excretion (Fig. 5-7). Figure 5-8 illustrates most of
the known pathways by which acute and chronic distur-
bances of extracellular fluid volume are corrected. A more
detailed examination of how these mechanisms affect re-
nal function is shown in Fig. 5-9. References will be made
to both of these illustrations, in order to discuss the most
important thirst and renal mechanisms, as they are related
to volume control.
5.2.2.1 Extrinsic Renal and Thirst Mechanisms. The
body fluid control mechanisms have been divided into
two major groups: a) extrinsic renal and thirst mechanisms,
and b) intrinsic factors. In addition, the transcapillary fluid
shift mechanism and other controllers of blood pressure
are included. The extrinsic factors are discussed next.
(a) Arterial Pressure-Urinary Output Mechanism. In
the view of Guyton [22], arterial blood pressure is the
single most important influence on the long-term level
Figure 5-7. Regulation of body water balance showing factors that determine distribution between fluid compartments. Intracellular
volume is ultimately regulated by feedback regulation of fluid intake and renal excretion. Cell membrane contains active pump which
prevents sodium from entering intracellular compartment. Water moves freely across the cell membrane according to electrolyte osmotic
distribution.
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Figure 5-8. Regulation of extracellular fluid (ECF) volume and sodium by renal function. Control of this system is accomplished by
hemodynamic, neural and hormonal factors that respond to blood volume, oxygen tension, and electrolyte concentration influences.
(ADH = anti-diuretic hormone, EWL = evaporative water loss).
Figure 5-9. Regulation of renal blood flow (RBF) and urine excretion. Blood enters the renal artery and is partially filtered (red cells and plasma
proteins remain in the blood) at the glomerular capillaries (Bowman’s capsule). The remaining blood is passed through the efferent arterioles
into the peritubular capillaries surrounding the renal tubules. Whereas net driving pressure across the glomeruli always favors a positive GFR
(see equation for GFR where PG = glomerular hydrostatic pressure, PB = Bowman’s capsule pressure, πL = plasma colloidal oncotic pressure
and K filtration coefficient) the net driving pressure across the peritubular capillaries always favors net reabsorption. The mechanisms that
depend on hormonal and neural signals are described in the text.
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of urinary volume excretion. An increase in blood
volume is reflected by an increase in circulatory fill-
ing pressure, which has a direct hydraulic effect on
the kidneys (via increased renal blood pressure and
glomerular filtration rate) to increase urinary output
until the pressure and volume have returned to nor-
mal. This mechanism (often called a pressure-diure-
sis) is a powerful controller of long-term blood volume
regulation for several reasons. First, it is highly sensi-
tive to small changes in arterial pressure, and secondly,
the effect appears to be sustained indefinitely. This
means that this mechanism is capable of 100% correc-
tion of any fluid volume disturbance, assuming all
other factors return to normal.
(b) Volume Receptor-Renal Sympathetic Stimulation.
Sympathetic stimulation, which may be evoked by even
small decreases in blood volume by way of central arte-
rial and atrial pressoceptors, has a powerful effect on
constriction of the afferent renal arterioles. It acts rap-
idly to maintain blood pressure in the face of volume
disturbances, and also works more gradually to cor-
rect the volume disturbance by altering transcapillary
filtration in the kidneys and other tissues. Several fea-
tures of this feedback system should be noted:
i) The mechanism for controlling urinary output may be
primarily effective in hypovolemic disturbances rather
than hypervolemia.
ii) Sympathetic activity to the kidney results in a de-
crease in renal blood flow, which is greater than the
decrease in glomerular filtration rate (that is, an in-
crease in filtration fraction occurs). As indicated in
Fig. 5-9, this leads to an enhancement of peritubular
capillary plasma, peritubular oncotic pressure, and in-
creased fluid reabsorption from the tubules.
iii) The volume receptors initiating the sympathetic re-
sponse are capable of adapting to a sustained pressure
stimulus due to elastic creep of the receptor tissue.
This suggests that the volume receptor element may
be ineffective in correcting volume changes that are
maintained longer than 24 to 48 hours duration. This
has important implications in spaceflight where there
is a constant tendency for body fluids to redistribute
in a headward direction.
(c) Volume Receptor-ADH and Thirst Mechanism. Sig-
nals from volume receptors (particularly of the heart atria)
are transmitted to hypothalmic centers that control both
ADH secretion and thirst. Increases in blood volume lead
to decreased ADH release, increased urinary excretion,
and inhibition of the thirst drive. This corrective action
decreases blood volume toward normal. The ADH-renal
pathway is a potent short-term mechanism (Gauer–Henry
reflex) for regulating water excretion in the face of mod-
erate blood volume changes.
(d) Osmoreceptor-ADH and Thirst Mechanism. Plasma
osmotic shifts have been observed to accompany
bedrest, water immersion, and spaceflight. Quantita-
tive evidence recently obtained demonstrates the ex-
treme sensitivity of ADH release to osmolar changes,
compared to relative volume changes [33]. The feed-
back mechanism operates in this manner: increases in
fluid osmolarity are sensed by hypothalamic recep-
tors and ADH is released, causing renal water reabsorp-
tion and normalization of osmolarity. At the same time,
the thirst drive is increased. Interpretation of disturbances
in ADH levels must take into consideration the dual
volume-osmoreceptor pathways affecting ADH, as well
as the ability of the volume receptors to adapt.
(e) Aldosterone-Sodium and Water Reabsorption
Mechanism. In the face of effective blood volume
changes, aldosterone, a steroid secreted from the ad-
renal cortex, will appropriately respond in a direction
to return fluid volumes toward normal. A primary ef-
fect of increased plasma aldosterone levels is an en-
hanced sodium renal reabsorption, accompanied by
an osmotic reabsorption of water, thereby elevating
blood volume levels. There are at least two pathways
known where aldosterone secretion can be affected
by blood volume changes. First, renin release and an-
giotensin formation are increased when blood vol-
ume is diminished to a moderate extent. This comes
about either because of a direct effect of renal arterial
pressure or reflexly by renal sympathetic activity.
Angiotensin is a major factor affecting release of al-
dosterone. Second, there appears to be an inverse rela-
tionship between body fluid volumes and aldosterone
secretion by some unknown mechanisms. Acute
changes in plasma sodium concentration can also af-
fect aldosterone secretion. Decreasing levels of plasma
sodium concentration (hyponatremia) leads to in-
creased aldosterone secretion that in turn promotes
sodium retention and normalization of sodium con-
centration. Since hyponatremia is generally associ-
ated with low body fluid volumes, the aldosterone
induced water and salt retention represents an appro-
priate feedback response. On the other hand, such situ-
ations as depressed sodium concentration resulting
from dilutional overhydration (i.e., blood volume ex-
pansion), present competing stimuli (i.e., decreased
sodium and increased blood pressure), and the net ef-
fect on aldosterone secretion is unclear.
(f) Aldosterone-Potassium Excretion Mechanism.
Renal sodium reabsorption, under the influence of al-
dosterone, is an active process that exchanges sodium
ions for other cations such as potassium, hydrogen,
and magnesium ions. The aldosterone-potassium
mechanism is the basis for a powerful feedback sys-
tem for control of extracellular fluid potassium ion
concentration. An increase in plasma potassium ion
levels causes increased secretion of aldosterone,
which in turn has a powerful effect toward promoting
excess secretion of potassium into the renal tubule.
Therefore, urinary output of potassium increases and
NASA/CR—2020-220487 176
the plasma potassium ion concentration returns to
normal. Of all the mechanisms that influence aldos-
terone secretion, none appear as powerful as changes
in potassium ion concentration. An increase in plasma
potassium of less than one meq/liter will triple the
rate of aldosterone secretion [22].
(g) Renin-Angiotensin Mechanisms. Renin is released
from the juxtaglomerular renal cells. The evidence
suggests that renin secretion is inversely related to
glomerular filtration rate, renal pressure, and sodium
and angiotensin concentrations, and is directly related
to renal sympathetic nerve activity. Renin is the pre-
cursor of angiotensin, which is a powerful vasocon-
strictor of all arteriolar smooth muscle. Therefore, these
substances are appropriately released in situations
when arterial pressure falls (as in hypovolemia or stand-
ing). Its main effect on the kidney is probably associ-
ated with its ability to stimulate the adrenal secretion
of aldosterone.
(h) Natriuretic Hormone and Third Factor. The con-
cept of a “third factor” was originally postulated 20
years ago in order to explain experimental results that
showed that excess sodium excretion could not al-
ways be accounted for by changes in aldosterone and
glomerular filtration rate. It was postulated that the
third factor might be a “natriuretic hormone” that acts
on the renal tubules to turn off sodium reabsorption
and increase renal sodium excretion in contrast to the
action of aldosterone, which acts to increase sodium
reabsorption and reduce renal excretion. Other “third
factor” mechanisms that could theoretically explain
the experimental observations have been either found
or postulated. These other mechanisms include physi-
cal factors relating to peritubular capillary hydrostatic
and oncotic pressures and intrarenal redistribution of
blood flow. The precise contribution of each of the physi-
cal factors is still unclear. The natriuretic factor is of
particular interest to space physiologists, since it is usu-
ally released in association with circulatory volume ex-
pansion. This is an active field of research. UPDATE#1
5.2.2.2 Intrinsic Factors Affecting Renal Function.
The extrarenal neural and hormonal control mechanisms
previously discussed (i.e., sympathetic activity, ADH, and
aldosterone) do not entirely explain why the kidney is
able to reabsorb a very high percentage (about 99%) of
the large quantity of plasma which is filtered through the
glomerulus. This is basically accomplished by a number
of intrinsic autoregulatory features of the kidney that con-
trol blood flow, plasma filtration and glomerulotubular
balance. These mechanisms are briefly identified below:
i) Autoregulation of renal blood flow and glomerular
filtration rate is thought to arise from changes in af-
ferent arteriolar resistance by way of a local feedback
circuit. This mechanism prevents large changes in
glomerular filtration rate during daily variations in
systemic blood pressure.
ii) Glomerulotubular balance insures that most of the
glomerular filtrate is reabsorbed and does not pass
into the urine.
iii) Peritubular capillary hydrostatic and oncotic pressures
can have a marked effect on tubular reabsorption, and
hence on urine volume excretion. Changes in plasma
volume passively adjust peritubular pressures in di-
rections that almost always insure appropriate feed-
back correction of the original volume disturbance.
iv) The well-known countercurrent multiplier mechanism
permits the kidney to form a urine more concentrated
than plasma. From a systems point of view, this mecha-
nism seems to be important only in that it permits
ADH to effectively concentrate the urine.
v) An intra-renal renin-angiotensin mechanism exists
whereby angiotensin is produced within the juxta-
glomerular cells (in distinction to the circulatory for-
mation of angiotensin). It is postulated that by
affecting the vasoactivity of the efferent renal arteri-
oles, intrarenal angiotensin can conserve salt and wa-
ter whenever arterial pressure falls, while still allowing
normal excretion of metabolic waste products.
vi) Redistribution of blood flow between two groups of
nephrons (cortical and medullary nephrons) that re-
absorb sodium to different degrees may provide a
mechanism for controlling sodium and water balance.
Intrarenal blood flow redistribution may be under par-
tial control of sympathetic activity.
These mechanisms are far from understood, and their
importance has not been fully ascertained in certain cases.
In general, their existence permits the basic renal function
of eliminating wastes and conserving nutrients to take
place, while allowing the major control of extracellular
volume and ionic concentration to reside in other factors
previously described such as aldosterone, ADH, and sym-
pathetic stimulation. The spaceflight response involves
controlling unusual volume disturbances as well as elimi-
nating excess waste products from tissue degradation.
Therefore, it was important to be cognizant of both intrin-
sic and extrinsic mechanisms when interpreting the bio-
chemical and body fluid responses. Two very important
non-renal mechanisms for controlling blood volume are
discussed below.
5.2.3 Transcapillary Fluid Shift Mechanism
The fluid shift mechanism refers to the movement of
plasma filtrate across the capillary membrane between the
blood volume and the interstitial fluid compartment (see
Fig. 5-7), and provides temporary and rapid correction of
acute blood volume disturbances. This takes place in ac-
cordance with the so-called Starling forces, whereby
transcapillary gradients of hydrostatic and colloidal
oncotic pressures provide the driving force for fluid ex-
change. Disturbances in blood volume are reflected by
changes in capillary pressure that can either drive plasma
into the interstitium if pressure is increased, or reabsorb
fluid into the vasculature from the interstitial reservoir if
pressure is reduced. If hemodilution or hemoconcentra-
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tion accompanies blood volume changes, colloidal os-
motic gradients will occur which also serve to correct the
volume disturbances. In addition to the transcapillary gra-
dients, other factors that determine this distribution in-
clude compliance of the circulatory system, compliance
of the interstitial compartment, the rate of lymph flow, and
physiochemical relationships between gel and free fluid
in the interstitial spaces [22].
The transcapillary fluid shift mechanism is also di-
rectly related to volume receptor pathways and sympa-
thetic activity. For example, hypervolemia will result in
elevation of capillary pressure, first by a direct effect on
the volume-pressure relationships of the circulation, and
second, by causing a decrease in the pre-/post-capillary
resistance ratio by way of the pressoreceptor-sympathetic
pathway. This ratio, along with arterial and venous pres-
sures, is a major determinant of capillary pressure, and, in
this case, leads to movement of fluid from the plasma into
the interstitium.
5.2.4 Blood Pressure Control
Inasmuch as blood pressure changes are directly (but
non-linearly) related to blood volume changes, the fac-
tors which control blood volume discussed above also
play an important role in controlling blood pressure. How-
ever, there are additional mechanisms operative for blood
pressure control that have only indirect effects on blood
volume. These include both neural and local factors which
control vascular resistance or capacitance. In general, the
neural mechanisms (baroreceptor, chemoreceptor, central
nervous system ischemic control) are sympathetically
mediated and reach maximum effectiveness within seconds
and minutes, while the local factors (stress relaxation, flow
autoregulation, vascularization) act more gradually but main-
tain their effectiveness longer. A reduction in blood pressure
at the cardiopulmonary pressoreceptors initiates a wide-
spread increase in sympathetic activity that increases pe-
ripheral resistance by arteriolar constriction and decreases
venous capacitance. These responses tend to restore mean
blood pressure. Stress relaxation refers to the characteris-
tic of vascular smooth muscle that allows it to slowly
stretch when the pressure rises and to contract slowly (re-
verse stress relaxation) when the pressure falls. Vascular-
ization refers to the opening of existing capillaries or the
creation of new ones in the face of increased blood vol-
umes and pressures; devascularization is a reverse process
that accommodates reduced volumes and pressures. Since
these processes (stress relaxation and vascularization) can
take weeks to fully develop, they represent mechanisms
that can profoundly alter the capacitance of the vascula-
ture and accommodate long-term changes in blood vol-
ume (such as the reduced volumes observed in spaceflight)
without significantly altering mean arterial blood pres-
sure. The specifics of these adaptive processes, including
their time course, are not well understood.
5.2.5 Fluid Volume Regulation in the Guyton Model
Many of the important pathways for fluid-electrolyte
regulation identified in the overall systems analysis of the
preceding discussion are contained in the modified Guyton
model for circulatory, fluid, and electrolyte control. These
include:
i) mechanisms related to fluid distribution among the
major body compartments ( transcapillary transport,
transcellular osmotic diffusion and active transport,
lymph flow and interstitial free fluid-gel equilibrium)
(see Fig. 5-7);
ii) mechanisms related to circulatory control (cardiac con-
trol, blood volume distribution and autonomic, hor-
monal, and local control of blood flow) (see Fig. 5-8);
iii) mechanisms related to fluid-electrolyte controlling
hormones (ADH, aldosterone, renin-angiotensin) (see
Fig. 5-8); and
iv) mechanisms related to renal excretion of fluids and
electrolytes (hormonal and neural control, autoregu-
lation, glomerular tubular balance, colloidal oncotic
forces) (see Fig. 5-9); and
v) mechanisms for the control of arterial blood pressure
(see Fig. 5-10).
Figure 5-10 illustrates the response time and relative
effectiveness for eight arterial pressure control mechanisms
which are included in the model. All of these have been
discussed above.
The most rapidly acting mechanisms are those involv-
ing neural feedback elements (baroreceptors, chemorecep-
tors, and ischemic response). While these mechanisms are
capable of exerting a large degree of control for rapid
disturbances such as postural changes, the effects are not
long lasting, because of receptor adaptation. Control mecha-
nisms of intermediate duration are represented by
stress-relaxation of the vasculature, renin-angiotensin- vaso-
constriction mechanisms, and the capillary fluid shift mecha-
nism. These pathways do not become effective unless the
disturbance persists for more than a minute or so, and they
reach full development within a few hours. The aldoster-
one and renal-fluid pressure control mechanism often re-
quire hours or days to become fully effective; their activity is
probably minimal in many disturbances which are effectively
regulated by the short and intermediate term mechanisms.
Note that the renal-blood volume pressure control mecha-
nism, when it becomes fully activated, has infinite gain
and insures that in the long run, renal volume excretion
comes into balance with the net intake of fluid. In spite of the
somewhat hypothetical nature of the gain curves, they are
useful as a means of categorizing both the relative speed
and effectiveness of the pressure regulating mechanisms
of the body. It also suggests the application of the model
to processes such as spaceflight that include long-term
adaptation to significantly large fluid disturbances.
Figure 5-11 illustrates the particular mechanisms used
in the Guyton model for regulating hormonal response
and the mechanisms’ effects on circulatory control and
the renal excretion function. Comparison of Fig. 5-11 with
Fig. 5-8 indicates the high level of detail that exists in the
model (see Appendix G).
The renal subsystem of the Guyton model is depicted
in Fig. 5-12. Just as in the real system (suggested by Fig.
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5-9) angiotensin exerts its effects at the afferent and effer-
ent renal arterioles, while ADH and aldosterone control
water and salt tubule reabsorption. Glomerular filtration
is realistically controlled by the transcapillary hydrostatic
and oncotic forces.
While a majority of mechanisms affecting circulatory,
fluid, and electrolyte control are included in the model, it
is also apparent that some pathways that exist in the real
system are absent in the model. For example, some of the
intrinsic mechanisms such as peritubular effects, intrarenal
blood redistribution and an intra-renal angiotensin mecha-
nism are absent altogether,  while others such as
glomerulotubular balance are present only in a crude fash-
ion. Third factor effects, including the postulated natri-
uretic hormone, are also missing. In the real system, active
sodium reabsorption permits water to follow osmotically
and this effect is absent. Therefore, this analysis has led to
several specific recommendations for modifying the renal
subsystem of the Guyton model (see Appendix G).
As will be demonstrated, however, the existing model is
capable of predicting generally appropriate responses in
many situations and of testing hypotheses of considerable
complexity. It can be appreciated that the final integration of
these pathways and feedback mechanisms are complex, par-
ticularly when the body is equipped with redundant and
multiple interconnecting pathways. The dynamic charac-
teristics of each pathway and their relative influence in
correcting a particular volume, pressure, or osmolar dis-
turbance are quite different. It is for these reasons that a
careful systems analysis is required and that a large-scale
quantitative simulation model becomes so useful.
5.3 Development of Hypothesis
This section will address the critical areas and questions
identified in Table 5-5. Specifically, this involves account-
ing for the distribution, metabolism, and excretion of wa-
ter, sodium, and potassium during acute and long-term
spaceflight. While the study is limited in this manner, it
does involve an extensive analysis of endocrine, auto-
nomic, and local effects that participate in controlling the
volumes and composition of each body fluid compartment
via renal and blood pressure regulating pathways. The
complexity of the fluid-electrolyte regulatory system sum-
marized in the preceding section implies that any expla-
nation of the spaceflight findings will not be an easy
undertaking. Wherever possible, the hypotheses proposed
in this project have been examined for their quantitative
influence, either by a re-evaluation of the data or by com-
puter simulation. In some cases, because of data, model, or
Figure 5-10. Response times and relative effectiveness of the arterial pressure control mechanisms. Maximum feedback gain is a
measure of the effectiveness of the mechanisms and is defined as the ratio between initial and compensated pressure change. The greater
the feedback gain, the more effective is the mechanism as a pressure (or blood volume) controller. The solid portions of these curves are
based on experimental results while the dashed portions are extrapolations and are somewhat hypothetical. Each of these curves
represents a single system result, that is, all systems except the one in question are presumably not responding to the stimulus. Note that
the time base on the abcissa begins with seconds and then extends to minutes, hours, and days.  (Reproduced from Guyton [34]).
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Figure 5-12. Renal regulation of urine volume excretion in the Guyton model. Renal blood flow and pressure (and hence glomerular
pressure) is controlled by resistances in the afferent and efferent renal arteries that vary according to autonomic, angiotension, viscosity,
and local feedback effects. Twenty percent of tubular reabsorption is under the influence of ADH and aldosterone. Urine exretion is
determined by the difference between glomerular filtration rate and tubular reabsorption.
Figure 5-11. Hormonal control of fluid and electrolyte renal excretion as embodied in the Guyton model. All the factors that influence,
and are influenced by, hormonal excretion are shown. The feedback circuit that permits renal excretion to regulate extracellular fluid
volume nad ionic concentration are not shown here (see Fig. 5-8). Except for renin, all pathways shown are extra-renal. A more detailed
description of the intra-renal subsystems are illustrated in the next figure.
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resource limitations, this could not be done, and the au-
thors accept the risks inherent in setting forth an explicit
but untested hypothesis.
5.3.1 Acute Zero-G Response:
Fluid Redistribution Hypothesis
Central to explanations of the physiological response
to weightlessness is the frequently proposed fluid redistri-
bution hypothesis (also known as the “headward fluid shift”
hypothesis) [35,36,37,38]. Accordingly, exposure to weight-
less spaceflight or its ground-based analogs, bedrest and wa-
ter immersion, results in a reduction of the hydrostatic
gradients in the blood column (see Fig. 5-13). Fluid that is
otherwise pooled in the lower extremities is redistributed
headward by the elastic forces and tone of the tissues. While
the proportions of leg intravascular and extravascular fluids
involved in this translocation have not yet been established,
it is believed that the resultant effect must be an increase in
central blood volume (i.e., thoracic blood volume) and
pressures. There is abundant evidence supporting this in-
ternal fluid shift. Reductions in leg volume have been
observed in bedrest, water immersion, and spaceflight, and
engorgement of neck veins and facial tissues and feelings
of head fullness have been observed inflight [16]. In addi-
tion, significant increases in central blood volume and
pressures have been measured directly during water im-
mersion and head-down bedrest [39,40].
A second part of this hypothesis claims that the ceph-
alad shifts of fluid from the legs is interpreted as an in-
crease in effective blood volume which is appropriatly
corrected by neuro-humoral mechanisms or by more di-
rect hemodynamic influences. These feedback pathways
have been described in general terms in the last section
and are illustrated in Fig. 5-14 to 5-17. The following dis-
cussion concerns the integration of these processes in or-
der to relate them specifically to the regulation of fluid
and sodium imbalance during the early phases of space-
flight. The hypotheses presented are consistent with con-
clusions previously reached by other investigators who
have studied either blood volume expansion effects in
general or the spaceflight responses in particular
[22,36,38,41–44].
An expected inflight reduction in body water and
plasma volume has often been explained by an acute di-
uresis via the volume receptor-ADH and thirst pathway
(Fig. 5-14) [13,25,43,45]. The cephalad redistribution of
fluid at the onset of weightlessness may be sufficient to
reflexly suppress ADH and thereby contribute to a diure-
sis. These events have been demonstrated during acute
water-immersion studies [46,47] and head-down tilt [48],
both stresses causing headward fluid shifts. However, dur-
ing the Skylab missions, no diuresis was observed in the
first 24-hour pooled urine volumes, and ADH levels were
elevated on the average during the first two weeks (ADH
measurements could not be performed on the first day of
flight). However, there was a considerable difference be-
tween the ADH response of the three missions; ADH in-
creased on the shortest mission and decreased on the two
longer missions (see Fig. 5-6). The differences between
these mission observations and the differences between the
mean spaceflight and ground-based responses have not been
explained, but several factors should be considered.
The absence of an early clear-cut diuresis during
spaceflight must be considered in perspective with the
known decrease in fluid intake on the first inflight day.
The state of hydration has been shown to be a significant
factor in eliciting a significant free-water diuresis during
water immersion [49,50]. The depletion of over a liter of
body water by the third day of the Skylab flights can be
attributed almost entirely to deficit drinking. Therefore, it
is possible that additional renal regulation was not re-
quired. The renal response at the onset of zero-g accompa-
nied by a normal fluid intake is not yet known.UPDATE#2
Although volume receptor stimulation on the first day
of weightlessness is a logical assumption, plasma osmo-
larity adjustments could have mitigated the ADH response.
Increases in plasma osmolarity, a powerful activator of
ADH, could have occured as a result of reduced fluid in-
take. However, plasma osmolarity was not measured until
the third or fourth inflight day when it was found not to be
elevated, but reduced.
Figure 5-13. Early effects of hypogravity on body fluids leads to
headward fluid shifts and redistribution of leg fluids.
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(bedrest/water immersion/weightless spaceflight)
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An analysis of preflight water balance and body weight
demonstrated that the crew of the 28-day mission lost
nearly a liter of fluid during the several days prior to launch
compared to a much more normal pre-launch water bal-
ance for the two other crews (see Chapter 4.6). In light of
known effects of dehydration on the volume receptor-
ADH-renal pathway, this observation might explain part
of the early inflight difference in ADH response between
the three Skylab crews (Fig. 5-6).
Space motion sickness, observed in a majority of
Skylab crewmembers during the first week of flight [51]
might account for the simultaneous reduction in fluid in-
take. In addition, anti-motion sickness drugs could have
altered renal and hormonal function in a direction that
contributed to a reduced urine volume [52].
Water immersion studies typically measure hourly
urine excretion over a period of 4-6 hours. This is in con-
trast to the 24-hour pooled sample collected in Skylab. In
addition, operational difficulties prevented total urine col-
lection in some crewmen on the first day inflight. It is
conceivable that void-by-void urine sampling in future
space missions will reveal an early diuresis component of
the first day’s water loss. In addition, ADH measurements
performed during this time will complete the missing ob-
servation of Skylab; ADH would be expected to be re-
duced if hydration is normal.UPDATE#2
As will be shown later, many other pathways besides the
ones shown in Fig. 5-14 may be involved in the renal re-
sponse to headward fluid shifts. Their varied behavior dur-
ing spaceflight or during water immersion may explain the
different responses observed in these two stresses.
Correction of central blood volume expansion by re-
nal excretion of water and salts may be accomplished by a
multiplicity of pathways as suggested in Fig. 5-15. They
may be conveniently categorized into volume receptor
reflex pathways (shown on the right side of Fig. 5-15) con-
sisting of neural and humoral controllers such as ADH,
angiotensin and aldosterone, and direct hydraulic or he-
modynamic effects involving intrarenal mechanisms such
as renal arterial pressure, glomerular filtration and
peritubular capillary pressures. Evidence suggests that the
entire volume receptor component is probably ineffective
in correcting volume changes for longer than 1–2 days
due to adaptation or resetting of the elastic stretch recep-
tors that exhibit creep and fatigue [22]. The direct hemo-
dynamic effects, however, would not be expected to adapt
as rapidly in this fashion. All of these mechanisms are known
to alter urine excretion by adjustments in either glomerular
filtration rate or tubular fluid reabsorption. By acting in-
dividually or in parallel, they can provide rapid short-term
regulation of fluid and sodium imbalance.
A more complete analysis of the pathways that regu-
late sodium excretion following hypervolemic expansion
is shown in Fig. 5-16. Factors influencing glomerular fil-
tration rates and tubular reabsorption may be postulated.
Glomerular filtration may be enhanced directly by in-
creases in central blood pressures, or indirectly by reflex
sympathetic mechanisms. A major factor in altering tubu-
lar sodium reabsorption in a direction favoring increased
renal excretion is suppressed aldosterone secretion (via
the renin-angiotensin pathway). Other mechanisms de-
noted in Fig. 5-16 as “third factor”, are also theoretically
capable of effecting tubular sodium reabsorption
[42,53,54]. These include peritubular effects, intrarenal
blood flow redistribution, and natriuretic factor. The pres-
ence of natriuretic activity in plasma is becoming an in-
creasingly attractive hypothesis to explain acute renal
sodium responses during the hypogravic-water immersion
state and circulatory volume expansion [30,46,50]. Re-
lease of another humoral agent, renal prostaglandin, has
also recently been implicated as contributing to the diure-
sis and natriuresis of volume expansion and water immer-
sion [55]. On Skylab, data regarding natriuretic hormone
or prostaglindin activity had not been collected.UPDATE#1 A
natriuresis was not observed early in the Skylab missions,
but excess sodium excretion did occur following the first
week of flight, even though aldosterone levels were high
(Figs. 5-4 and 5-5). The considerations discussed above
Figure 5-14. Reduction in plasma volume during exposure to
weightlessness by activation of the volume receptor-ADH (Gauer–
Henry) pathway [35]. Some of the factors that might interfere
with this response include plasma osmolarity via dehydration,
and anxiety stress.
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regarding restricted intake and drug usage may also be
relevant to this situation as well and account for body
sodium loss without excess renal excretion.
Although renal excretion is one of the best under-
stood mechanisms for controlling plasma volume, other
factors can be equally as important and undoubtedly
played a part in the spaceflight response. As illustrated in
Fig. 5-17, plasma volume control is under the influence of
three major pathways consisting of renal excretion, thirst
and transcapillary filtration. The factors that reduced fluid
intake during the first days of spaceflight are not clear but
have been related to space motion sickness. Also suggested
in Fig. 5-17 is a secondary pathway by which a reduction
in angiotensin may modify ADH release as well as thirst
drive [24,56]. Transcapillary filtration into the intersti-
tium would be favored during central blood volume ex-
pansion as a result of sympathetic, autoregulatory, and
local pressure effects. In water immersion the diuresis is
attenuated in favor of increased capillary filtration if the
subjects are dehydrated, although the decrements in plasma
volume are similar in magnitude to those found in well-
hydrated subjects. However, a close inspection of the wa-
ter immersion studies suggests that removal of blood pool-
ing forces augments inward filtration from lower limb cap-
illary beds which leads to a transient elevation of plasma
volume [57,58]. The subsequent rapid loss of plasma vol-
ume, by any of the routes available, including outward
filtration in the upper body, can create a concentration of
plasma colloids that limits loss of plasma into the tissues
[59]. Therefore, the net plasma-intersitial exchange result-
ing from differing transcapillary forces in the upper and
lower body is not apparent during a hypogravic maneu-
ver.  In this regard, i t  may be note-
worthy that of all the fluid compartments measured or com-
puted during the Skylab experiments, only the interstial com-
partment failed to exhibit a fluid loss (Table 5-2) as measured
at the end of the mission.
In summary, the onset of weightlessness leads to vol-
ume expansion of the central vasculature. Several reac-
tions may be predicted;
a) stimulation of the volume receptors and decreased
sympathetic activity;
b) increased blood pressures and secondary decreases in
peripheral resistance, promoting enhanced organ
Figure 5-15. Pathways that are postulated to increase urine water and sodium excretion following acute expansion of central blood volume. The degree
of participation of each pathway is not well known, although it is believed that increases in glomerular filtration rate are not significant.
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blood flow including that of the kidneys;
c) altered secretion of the fluid-electrolyte regulating
hormones including, ADH, the renin-angiotensin-
aldosterone triad, catecholamines, and possibly a
natriuretic agent and renal prostaglandins;
d) enhanced renal excretion of fluid and electrolytes as
a result of the alterations in sympathetic activity, hor-
mone secretion and blood pressures and flows;
e) increased transcapillary filtration of plasma into the
interstitium due to resetting of the pre-to postcapillary
resistance ratio and elevated capillary pressures; and
f) a decrease in thirst following reduction in angiotensin lev-
els and augmented by space motion sickness anorexia.
Most, if not all, of these rapidly acting mechanisms
that serve to correct the original central hypervolemia
would most likely be observed most readily during the
first hours of a hypogravic stress. Therefore, it is not sur-
prising that they have not been observed in actual space-
flight when operational constraints precluded early
measurements. Nevertheless, the net result of these con-
trolling mechanisms, that is, the loss of body fluids and
Figure 5-16. Postulated early effects of spaceflight on sodium excretion pathways. Preflight dehydration and reduced dietary intake will
modify the response as shown.
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electrolytes, has been observed frequently during and fol-
lowing weightless spaceflight.
It is not possible to predict from this analysis, or from
the spaceflight findings, which pathways predominate. The
utility of computer models, that incorporate representa-
tions of these mechanisms, can prove valuable in suggest-
ing the relative importance of various pathways and in
testing hypotheses and determining consistencies and dis-
crepancies of measured results. Previously observed phenom-
ena of “escape,” adaptation, and resetting suggest that certain
of these pathways change their effectiveness with time (see
Fig. 5-10). Thus, long-term regulation of fluid-electrolyte
balance, following correction of the initial disturbance,
involves a similar but separate analysis. The greatest wealth
of spaceflight data have been collected during the adap-
tive phase of fluid-electrolyte regulation where theoreti-
cal understanding is more limited. In contrast, spaceflight
data are sparse during the acute stress stage where the con-
ceptual understanding is much more extensive.
The roles of the major fluid-electrolyte regulating
hormones (ADH, aldosterone, and angiotensin) in the
long-term adaptive processes of weightlessness are far from
clear [8,13]. For this reason, they have received special
attention in the next discussion.
5.3.2 Long-term Regulation of Aldosterone and
Potassium
Aldosterone secretion is influenced by a number of
factors including plasma angiotensin levels, plasma so-
dium concentration, and plasma potassium concentration
(see Fig. 5-8). The adrenocorticotrophic hormone (ACTH)
also has a releasing effect on aldosterone. However, ACTH
is activated during periods of emotional stress and its
day-to-day influence on aldosterone has not been estab-
lished. Other unknown factors appear to activate aldoster-
one during stresses related to circulatory insufficiency.
Figure 5-17. Direct and reflex mechanisms that can lead to the acute reduction of plasma volume following the loss of hydrostatic
gradients during weightlessness.
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Aldosterone has potent effects on renal function, permit-
ting potassium excretion and inhibiting sodium excretion.
The effect on sodium results in an osmotically induced
reduction of urine volume. Thus, aldosterone secretion
appears to be controlled by, and has an effect on, factors
related directly to changes in body water, sodium, and
potassium. Due to this multiplicity of feedback pathways,
in which aldosterone is a major control element, it is not
surprising that the role this hormone plays in overall
fluid-electrolyte regulation is not clear. UPDATE#1
Many investigators feel that aldosterone secretion is
primarily under control of circulating angiotensin levels
and that aldosterone plays a major role in the regulation
of extracellular volume and sodium concentration. How-
ever, this may be true only in response to acute distur-
bances. Recent reports suggest that the whole question of
the renin-angiotensin system in the long-term control of
aldosterone and sodium metabolism must be reassessed
[22]. For example, prolonged excess aldosterone secre-
tion (primary aldosteronism) results in renal sodium re-
tention of only a few percent above normal. Similarly,
infusions of aldosterone eventually fail to exhibit their
sodium retaining characteristics; that is, the renal tubules
exhibit an “escape” phenomenon. Apparently, plasma so-
dium concentration is well regulated over the long-term
by multiple non-aldosterone factors (see Fig. 5-16).
On the other hand, a functional aldosterone feedback
system appears to be essential to maintain plasma potas-
sium concentration within normal limits. Aldosterone con-
trol of renal potassium secretion is the only major
mechanism known for controlling the extracellular fluid
potassium ion concentration. In the absence of adequate
aldosterone (that is, adrenocortical insufficiency), plasma
potassium can rise to dangerously high levels. In the pres-
ence of chronic excesses of aldosterone (primary aldoster-
onism), a continued increase in potassium urinary
excretion may result in hypokalemia and eventually
muscle paralysis.
While the phenomenon of aldosterone “escape” men-
tioned previously has not been satisfactorily explained,
the following schema offers one possible solution and also
illustrates the complexity of water and salt regulation. Ex-
cess aldosterone (created experimentally by infusion, or
in patients with primary aldosteronism) causes enhanced
renal salt reabsorption that in turn leads to osmotic reab-
sorption of water. The immediate effect is to decrease urine
volume and salt excretion markedly. Both extracellular
volume and blood volume increase. At this point, other
feedback mechanisms related to controlling excess fluid
volumes come into play (for example, the pressure diure-
sis mechanism, the ADH circuit, or natriuretic factor), and
overbalances the retention of fluid and salt by the kid-
neys. Consequently, both urine volume and sodium ex-
cretion rise until urinary output equals net body intake.
At these new homeostatic levels, extracellular volume
rarely rises more than 5-10%. Thus, aldosterone, working
in concert with other feedback circuits, does not appear to
have major long-term consequences on either fluid vol-
umes or net sodium retention.
In the light of the previous discussion, it is not diffi-
cult to suggest mechanisms that contributed to the elevated
aldosterone levels observed in the Skylab crew. According
to the hypothesis diagram of Fig. 5-18, elevated cortisol and
muscle disuse atrophy result in lean body tissue degradation
and cellular release of potassium. These cell losses, to-
gether with an estimated decrease in potassium sweat losses
(see Chapter 4.4) tend to raise plasma potassium concen-
tration. Hyponatremic plasma and increased circulating
catecholamines are factors known to augment renin-an-
giotensin activity. Accordingly, three of the four factors
known to contribute to increased aldosterone secretion,
(that is, elevated plasma potassium and angiotensin
coupled with decreased plasma sodium levels) were all
observed during the course of spaceflight. While decreases
in ACTH were reported, these are reasons to believe that
these measurements should be interpreted cautiously [13].
The increases in potassium renal excretion that would
be expected to accompany excess aldosterone were also
observed during spaceflight. Potassium renal excretion was
elevated about 10% throughout the flight period (see Fig.
5-4(b)). As indicated in Fig. 5-2, most of the body potas-
sium loss occurs during the first month and the major part
of it during the first week of flight. However, why simulta-
neous decreases in sodium excretion, as suggested in Fig.
5-18, were not detected is unclear [13]. The elements of
sodium “escape” from aldosterone seem to be present.
Competing factors for sodium release, such as “third fac-
tor” natriuretic hormone or prostaglandins, could account
for these results, but laboratory analysis of these agents
was not performed. Future measurements of glomerular
filtration may also reveal changes which are consistent
with renal excretion of excess sodium in combination with
elevated aldosterone.
5.3.3 Long-term Regulation of ADH,
Extracellular Osmolarity, and Volume Control
The role of ADH in overall fluid-electrolyte regula-
tion has not been satisfactorily defined. To a large extent,
the difficulty stems from the occasionally opposing func-
tions that ADH plays in two separate feedback pathways
one of which controls blood volume and the other con-
trolling plasma osmolarity. Gauer and colleagues [25] are
proponents of the hypothesis that ADH is primarily in-
volved in regulating extracellular fluid balance. They be-
lieve that ADH reliably responds to minor disturbances in
central blood volume. Alternatively, Goetz and colleagues
[60] claim that ADH secretion is not sensitive to small
changes in blood volume and that the osmoreceptor-ADH
pathway is sufficient to explain normal regulation of both
extracellular volume and tonicity.
Guyton and co-workers [21,22] attempt to integrate
both these points of view by proposing an integrative
mechanism for fluid-electrolyte balance (see Fig. 5-19). The
elements in this scheme include a volume receptor-ADH path-
way that responds to acute, rather than prolonged, volume dis-
turbances. The lack of long-term response is credited to
receptor adaptation. Guyton’s concept also includes a sen-
sitive osmotic receptor-ADH pathway that can override
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inputs from the volume receptors, and an ADH-thirst drive
that receives inputs from both volume and osmoreceptors.
In this view, the osmo-receptor-ADH-thirst mechanism is
primarily responsible for long-term control of plasma os-
molarity. (Inasmuch as sodium contributes about 95% to
total extracellular osmolarity, this pathway becomes es-
sentially a means for controlling sodium concentration.)
This concept is supported by recent animal studies that
demonstrate that plasma osmolarity exerts a very sensi-
tive effect on ADH secretion compared to the influence of
blood volume changes [33]. The fact that volume recep-
tors can adapt to sustained volume disturbances and that
there are other more powerful mechanisms available for
long-term control of blood volume (see Fig. 5-10) sup-
ports the argument for a minor role of ADH in the long-term
control of body fluid volume. The case for dual volume
and electrolyte control of hormones is addressed more fully
in Chapter 9.8.
As ADH secretion increases, reabsorption of water
from the renal tubules and collecting ducts is enhanced
and smaller volumes of increasingly concentrated urine
are formed. Reduced ADH conversely forms large quanti-
ties of dilute urine. Some investigators feel that the ADH
influence on the kidneys is a mechanism for partially dis-
sociating water excretion from that of salt since a decreased
ADH level may increase water excretion without altering
Figure 5-18. Long-term effects of spaceflight on aldosterone.  This diagram represents an hypothesis for explaining the elevated plasma
aldosterone levels observed in the Skylab crew.
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sodium excretion [24,50]. This separation of function may
be crucial for renal regulation of extracellular osmolarity.
In the light of the previous discussions of ADH feed-
back regulation and the Skylab findings, it is possible to
predict decreased secretion of ADH during spaceflight by
two mechanisms: a) an observed mild decrease in plasma
osmolarity and plasma sodium concentration by the third
inflight day which continued throughout the weightless
phase of the mission, and b) an elevation of central circu-
latory pressures which was not measured, but which may
be postulated from such observations as distended neck
veins and feelings of head fullness. The second of these
influences on ADH would be expected to be operative
early in flight if volume receptor adaptation takes place or
if excess circulatory pressures do not persist. Neverthe-
less, ADH inexplicably did not decrease, on the average,
until after the second week inflight (Fig. 5-5(a)). If each
mission is examined separately (Fig. 5-6), ADH exhibits
the expected decrease throughout the two longer missions.
The elevated ADH on the first mission is still paradoxical
but may be related to preflight dehydration and large in-
creases of inflight sweat losses of that crew.
The average urine excretion of nine men was decreased
during the first week when ADH was elevated; after the
second week of flight, both quantities reversed direction
(Figs. 5-3 and 5-5(a)). The significant correlation between
these quantities during the first month (p < 0.05) is in
agreement with the expected influence of ADH on urinary
volume, with regard to direction of response. However,
based on the data summarized by DeHaven and Shapiro
[61], suppression of ADH to the extent observed should
have resulted in an increase of urine volume much larger
Figure 5-19. Scheme of osmoreceptor (A: upper portion) and volume receptor (B: lower portion) feedback regulation of thirst and ADH
release. (Redrawn from Guyton, et al.[22]). Symbols are defined in Appendix A.
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than that measured, and a urine more dilute than that mea-
sured, assuming all other factors did not change. For ex-
ample, on the longest mission the mean urine volume was
not different from preflight, the urine osomolarity was sig-
nificantly increased, and yet ADH was approximately 30%
below preflight levels.
It is likely that other factors that tend to limit and
concentrate urine output were present. This may involve
alterations in glomerular filtration rate (i.e., decreased re-
nal pressure) or tubule water reabsorption (i.e., prostag-
landins counteract the effect of ADH) [62]. Increased
aldosterone, which can lead to renal sodium and water
reabsorption may also have contributed to this result. A
clearer understanding of acute and long-term control of
ADH and urinary volume excretion should emerge by ob-
taining fluid samples earlier in flight, measuring the fac-
tors contributing to water retention, and recording indices
of renal hemodynamics and circulatory pressures.
5.3.4 Long-Term Angiotensin Response
The elevated levels of angiotensin I, which have been
observed during prolonged spaceflight, have not been sat-
isfactorily explained [13]. The available evidence sug-
gests that an increase in renin-angiotensin would be
expected as a result of depressed glomerular filtration rate,
renal pressure, extracellular sodium concentration,
increased renal sympathetic nerve activity and elevated
catecholamines (see Figs. 5-15 and 5-16) and Appendix
A, Fig. A-3). Angiotensin is a powerful vasoconstrictor
and is appropriately released in situations when arterial
pressure or central blood volume falls [63,64,65,66,67]. If
spaceflight is associated with chronic elevation of central
or renal circulatory pressures, as some believe, then the
angiotensin response is paradoxical unless other stimuli
such as those discussed below in the following section,
can be found which oppose that factor. Similar trends of
angiotensin have also been unexpectedly observed in
long-term bedrest (Chapter 9).
A major effect of angiotensin on renal function is its
ability to stimulate the adrenal secretion of aldosterone.
Elevated levels of aldosterone were apparent during the
Skylab flights [13]. This hormone may also exert a spe-
cific intrarenal effect by conserving salt and water in the
body while still allowing normal excretion of metabolic
waste products [22]. Thus, the combination of elevated
angiotensin and aldosterone can help restore depleted ex-
tracellular fluids and salts.
5.3.5 Effects of Altered Renal Hemodynamics
On earth, reflex adjustments in renal blood flow nor-
mally occur acutely with postural changes. During pro-
longed spaceflights, the major effects of weightlessness
on the renal circulation are unknown and the consequences
of an absence of these reflex adjustments may only be
speculated. Astronauts exposed to long periods of weight-
lessness are likely to have decreased renal sympathetic
nerve activity with a tendency toward vasodilation. In ad-
dition, changes in concentration of a variety of blood-borne
humoral agents, such as angiotensin II, catecholamines,
and certain other hormones and plasma electrolytes are
likely to alter renal excretory function, renal blood flow,
glomerular filtration rate, and renal endocrine function.
Measurements of renal pressure, renal blood flow, or
glomerular filtration rate have not yet been made during space-
flight or after return to earth. Alterations in these parameters
could have profound effects on renal excretion of fluids and
sodium, renin release, prostaglandin release, and peritubular
factors [22,62,67]. A number of observations and anticipated
responses during spaceflight could therefore be attributed
to an altered renal hemodynamic state. These observations
include the postulated diuresis and natriuresis of the acute
stress stage as well as the longer, persistent secretion of
angiotensin and aldosterone. Excess renal excretion can
occur as a result of a simple direct pressure effect at the
glomerulus. While there is evidence to show that ceph-
alad fluid shifts can increase renal flow appreciably [28,41],
the long-term effects as observed in bedrest are unclear.
This evidence will be reviewed in Chapter 9.
5.3.6 Dilution of Body Fluids: Implications for
Fluid Regulation
The engorgement of fluid in the upper body during
weightlessness is believed by some investigators to be
sustained [68]. Reconciling this postulated hypertensive
state with the enhanced renin-angiotensin and aldoster-
one secretion observed during spaceflight is difficult.
These hormones are usually associated with hypotensive
circulatory states [22]. On the other hand, ADH was de-
creased nearly throughout the three-month mission, which
would be in accord with enhanced volume receptor activ-
ity [25]. It has been argued though, that the ADH pathway
becomes insensitive to abnormal pressure changes that
are sustained [21]. However, the whole question of a pro-
longed hypertensive state during spaceflight has not been
experimentally confirmed. Pressures in the capacitance ves-
sels and cardiopulmonary regions have not yet been mea-
sured directly, and the extent of upper body congestion has
not been quantitated. (This also seems to be true with regard
to prolonged water immersion and bedrest.) Resting mean
arterial pressure in the Skylab crew was not above preflight
levels.UPDATE#3
This study has evaluated another piece of evidence
that has not received any attention to date and which may
be related to these circumstances. The Skylab data show
that plasma fluid was slightly hypotonic throughout the
flight, with respect to sodium concentration (and total os-
molarity) and in comparison to the preflight mean. As
shown in Fig. 5-20, hyponatremic plasma has also been
observed in several long-term bedrest studies and even in
short-term water immersion [69]. This condition is puz-
zling for the following reasons: a) the body’s thirst and
renal mechanisms are capable of maintaining normal so-
dium levels within narrow limits; b) the hormones thought
to regulate water and salt were at levels appropriate to
correct decreased plasma sodium, (that is, sodium-
retaining aldosterone was high and water-retaining ADH
was low); and c) urine volume was nearly normal but so-
dium excretion was elevated above preflight levels in spite
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of enhanced aldosterone. An appropriate compensation
for plasma hypotonicity would involve a hypertonic fluid
intake and/or a hypotonic renal output. In fact, the Skylab
data demonstrates quite the opposite for both of these path-
ways, thus indicating how the body fluids maintained their
hypotonicity from a metabolic balance point of view.
Although the etiology of this phenomenon remains
unresolved, the effects of hyponatremic extracellular flu-
ids on fluid-electrolyte regulation must be considered. In
particular, the sodium depleted, hyponatremic state has
been shown to activate the renin-angiotensin system and
induce hypersecretion of sodium-retaining aldosterone
[56]. In addition, hyponatremia is known to depress thirst
drive and ADH secretion, thus promoting renal excretion
of water. All of these effects were noted to varying degrees
on the Skylab crew. Whether or not they were induced by
hyponatremic influences is unknown.
Hyponatremia also indicates that intracellular fluid is
dilute and may be expanded unless accompanied by body
losses of intracellular electrolytes [27]. This follows from the
osmotic theory of water distribution across the cell mem-
brane. The data from Skylab, taken as a whole (including
measured losses in fluid volume and electrolytes), therefore
indicates that all body fluids were dilute and hypovolemia
existed (relative to preflight levels) in both intracellular and
extracellular fluid. It is apparent that more electrolytes were
lost from the body relative to the loss of fluid.
One can only speculate about the adaptive value of
maintaining a hyponatremic body fluid. There appears to
be an effect, similar to that found in chronic sodium deple-
tion studies, in which extracellular volume is protected at
the expense of extracellular osmolarity [31]. In other
words, correction of hyponatremia in spaceflight would
involve excretion of extracellular fluid volumes that are
already significantly reduced. However, while sodium
depletion in one-g invariably leads to both hyponatremia
and hypotensive states, these events may be dissociated
in zero-g, (that is, a hypertensive state of the upper body
circulation may coexist with a condition of hyponatre-
mia). It is unclear how the body is able to sense an abso-
lute hypovolemia when fluid expansion seems to be
prevalent in the regions of the cardiopulmonary mechan-
oreceptors. Thus, a study of the development of decreased
serum sodium and measurement of the degree of upper
body congestion on future flights may help reconcile the
unusual combination of hormone levels (enhanced angio-
tensin and aldosterone and decreased ADH) encountered
during hypogravic stress.
5.3.7 Fluid-Electrolyte Balance During
Prolonged Spaceflight
Most of the major changes in body fluids (especially
extracellular fluids) appear to occur during the first sev-
eral days of flight. Observable losses of 1.8 liters of leg
Figure 5-20. Effect of spaceflight and bedrest on plasma sodium concentration.
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volume and 1.5 kg of body weight were measured during
that time. The physiological mechanisms that could have
led to this result have been presented earlier in this sec-
tion. An hypothesis which remains to be examined is
whether the body establishes a new homeostatic level af-
ter these initial losses with respect to water, sodium, and
potassium. There are several lines of evidence that sug-
gest that water and sodium are in balance while potassium
shows some continued loss. These data have been reviewed
in Chapter 4 and will be re-examined and summarized in
the following section.
A related question that has arisen is the following: if
the body is in relative balance during the adaptive seg-
ment of the flight, why is it that excretion of fluids and
electrolytes is elevated, on the average, during this pe-
riod, compared to preflight? The answer should consider
other metabolic avenues of loss and gain such as fluid intake
and sweat losses. In the next section, the metabolic balance
data will be re-examined to explain the altered pattern of
fluid-electrolyte excretion on the basis of long-term distur-
bances in intake and sweat losses. The simulation model
was valuable in helping to integrate the metabolic bal-
ance data and in determining not only its internal consis-
tency but also in revealing the physiological mechanisms
that play a role in establishing homeostatic levels.
5.4 Subsystems Evaluation of Hypotheses
The previous section discussed in qualitative terms, the
factors that could potentially contribute to the loss of body
water and major electrolytes during spaceflight. The pur-
pose of this section is to discuss the evaluation of those
hypotheses, in quantitative terms, by using actual flight
data and predictions from the mathematical models. This
effort represents the culmination of a wide spectrum of
systems analysis activities, including data processing,
qualitative analysis of physiological control mechanisms,
hypotheses development, and quantitiative hypothesis
testing.
5.4.1 Hypotheses Tested by Computer Simulation
The present analysis has been guided by the overall
hypothesis that the observed changes in the renal, cardio-
vascular, and endocrine subsystems of the Skylab
crewmembers can be attributed, in large part, to the shifts
in fluid volumes and electrolytes that occur as a result of
weightlessness. This concept has been subjected to criti-
cal examination by breaking it into a smaller set of hy-
potheses. These hypotheses can be best understood by
considering the types of fluid shifts that occur in
microgravity and the approach used to simulate them.
The often described acute cephalad intravascular
shift of blood from the lower extremities is only one of
many types of fluid disturbances which must be consid-
ered (see Fig. 5-21). Extravascular fluid in the legs (i.e.,
filtrate) also must contribute to the initial rapid headward
movement. Longer-term migration of fluids from the legs
due to elastic tissue forces or tissue degradation does oc-
cur, but the significance of this effect has not yet been
established. Alterations in plasma/interstitial and intrac-
ellular/extracellular fluid exchange may also be expected,
although quantitative documentation of these effects is
sparse. In addition, the overall water balance of the body
is dependent on factors that modify fluid intake, evapora-
tive water loss, and renal excretion. In all cases, one or
more of the major body electrolytes is associated with the
movement of fluid; sodium is primarily associated with
extracellular fluid and potassium with intracellular fluid.
The challenge to the computer simulation process was
to ensure a correct representation of these diverse fluid
disturbances. Given the mathematical representation of
the stresses encountered in weightless spaceflight, the
model’s responses can be compared to the astronaut data
obtained inflight or immediately postflight. During these
studies, two types of questions were therefore addressed:
a) what are the appropriate zero-g stresses to impose on
the model in order to evoke the observed responses; and
b) does the model contain a complete enough description of
fluid-electrolyte control to allow it to produce a realistic
response? In more than several instances, it was found that
the model lacked certain features such as leg compartments
and orthostatic mechanism. Other sections of this document
describe the modifications that were performed on the
models to correct the deficiencies so that appropriate re-
sponses to bedrest, water immersion, and postural change
could be obtained. In this study of long-term spaceflight,
the only additional effect needed was a natriuretic hor-
mone; otherwise, the model modified with legs performed
surprisingly well (see Chapter 3.2.5.2).
The stimulus for weightlessness that was ultimately
used in the Guyton model for this study took advantage of
the fact that the fluid-electrolyte model is extremely stable
in a “supine” position. The hypogravic simulation was
initiated from this reference state. In order to achieve the
fluid shifts from the legs to the upper body in the supine
position, it was necessary to artificially induce fluid move-
ment from leg extracellular compartments where it was
assumed that fluid was previously pooled. Just as stand-
ing has often been viewed as a functional hemorrhage of
the central blood compartments into the leg vasculature,
these stresses simulating hypogravity would be similar to
an infusion of leg fluid into the upper body’s circulation.
While this approach resulted in successful simulations for
many short-term responses, other acute and most long-term
events observed during spaceflight could not be realisti-
cally simulated by headward fluid shifts alone. Therefore,
other hypotheses were added as the simulation study pro-
ceeded, and as greater fidelity was required.
The specific hypotheses evaluated in this study were
the following:
1) and 2) Acute Headward Fluid Shifts: Do the acute
headward fluid shifts observed in such experiments as
water immersion, head-down tilt, and infusions pro-
duce short-term responses typical of these stresses in-
cluding volume receptor activation, plasma loss,
interstitial/plasma redistribution, diuresis, and natri-
uresis? Can the model help distinguish between
headward shifts of fluid arising from the leg vascula-
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ture (blood) (Hypothesis 1) in contrast to that from
the leg tissues (plasma filtrate) (Hypothesis 2)?
3) Potassium Release From Intracellular Compart-
ment. Can potassium release quantitatively explain
the longer-term changes in loss of body potassium,
elevated plasma potassium, intracellular/extracellu-
lar fluid redistribution, renal excretion of potassium,
and altered endocrine behavior?
4) Natriuretic Factor. Can a natriuretic agent explain
renal excretion of sodium not accounted for by other
mechanisms in the model as well as production of
hyponatremic body fluid?
5) Alteration in Sweat Component. Are sweat compo-
nents altered from control conditions and does this
contribute to observed changes in renal excretion and
electrolyte concentrations in plasma and urine?
6) Alterations in Metabolic Intake. Does the early reduc-
tion in intake observed in the astronauts modify the di-
uresis and natriuresis that are otherwise expected to occur?
An important concept that guided the simulation
analysis was that the mechanisms that participate in the
short-term response (the time during which the most promi-
nent fluid-electrolyte disturbances occur) are different from
those that lead to adaptation during prolonged spaceflight.
Therefore, the hypotheses evaluation study was divided
into acute and chronic phases as a convenient method of
examining the spaceflight data and performing computer
simulations. The circulatory, fluid, and electrolyte model is
capable of simulating both short and long-term responses.
This is not unlike investigators who are interested in the 2 to
4 hour response to water immersion in contrast to other
researchers who perform a 5-day bedrest study.
Two sets of data were most crucial for the simulation
analysis. One of these was related to describing the mag-
nitude and time course of the headward shift of fluids. The
second group of data was that related to the metabolic
balance of water, sodium, and potassium and the related
measurements reflecting whole body changes in these
quantities. It was discovered early in the investigation that
the amounts and ratios of water and electrolytes for the
intake, excreta (including sweat losses), and, body fluids
must be specified in order to produce a realistic simula-
tion for prolonged adaptation.
The final integrative simulation utilized headward fluid
shifts, metabolic intake, and sweat loss as major forcing func-
Figure 5-21. Types of fluid shifts during weightlessness. Consideration of each of these disturbances is necessary in order to realisti-
cally simulate the spaceflight fluid-electrolyte response.
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tions for the model. A critical analysis, summarized in this
section, was performed on each of these groups of data.
For convenience, the hypotheses evaluation discus-
sion has been divided into two parts: a) hypotheses re-
lated to altered fluid distribution including acute headward
shifts, extracellular and intracellular, as well as interstitial
and plasm fluid distribution; and b) hypotheses related to
altered metabolic balance, including altered intake, ex-
cretion and sweat losses. Both groups of hypotheses were
found to be necessary to account for the dynamic behavior of
the fluid-electrolyte regulation during the Skylab missions.
5.4.2 Hypotheses Related to Altered Fluid
Distribution
The redistribution of fluid within the body during
weightlessness includes headward shifts, dehydration of the
legs, extracellular/intracellular shifts, and interstitial plasma
exchange. Spaceflight data related to these effects are quite
sparse and have been summarized in Table 5-2. This next
section begins with a critical examination of the headward
shift phenomenon, which is perhaps the singular most im-
portant physiological event characterizing weightlessness.
This analysis forms the foundation for the subsequent com-
puter simulations of altered fluid distribution.
5.4.2.1 Analysis of Altered Fluid Distribution. For
convenience, this physiological disturbance has been seg-
mented into three phases: a short-term (acute) phase, last-
ing several hours to one day; an intermediate phase, which
appears to stabilize after several days; and a long-term
phase, lasting the remainder of the mission.
5.4.2.1.1 Short-term Fluid Shifts. In one-g, a critical
factor affecting blood distribution is the hydrostatic grav-
ity load on vertical columns of blood causing pooling of
fluid in the legs.. The immediate effect of a reduction in
hydrostatic forces is a rapid shift of blood from the legs
toward the head. Blood volumes are distributed in zero-g
in accordance with any net extravascular tissue forces and
compliances of the blood vessels throughout the body.
Leg volume measurements during acute postural
changes or leg negative pressure studies suggest that 400
to 600 ml of blood is highly mobile and is immediately
transferred between legs and upper body (primarily tho-
racic volume) [71,72]. Muscular contraction during stand-
ing can reduce this amount somewhat [73]. Immersion
studies have demonstrated immediate expansion of cen-
tral blood volume by 700 ml [74] at the expense of pooled
blood in the lower extremeties. During weightlessness, it
would be expected that this pooled blood is the first reser-
voir to be mobilized and shifts rapidly headward. In addi-
tion, there is another approximately 500 ml of plasma that
is normally pooled extravascularly in the leg tissues upon
standing. Tilt studies suggest that this extravasation is
complete within 30 minutes. This fluid is probably re-
turned to the leg vasculature and eventually to the upper
body in a hypogravic environment, and probably moves
headward more slowly than the blood pooled in the leg.
Thus, at least a liter of fluid is normally pooled in the legs
when standing and is available to shift toward the head
during zero-g.
In zero-g, a portion of this volume enters the normally
collapsed head and neck veins until they are full. Any
additional volume beyond this zone of free distensibility
in the upper part of the body contributes toward increas-
ing blood pressures and will initiate renal mechanisms,
which act to reduce the excess volume. In addition, the
increase in circulatory pressures may increase capillary
pressures and provide a driving force for filtration into the
interstitium.
A composite picture of the data obtained from the Skylab
and Apollo–Soyez Test Project crews suggests a time course
of leg volume changes shown in Table 5-6 [16]. Examination
of these data suggests that there is an acute fluid shift of
about 0.7 to 1.0 liters from the legs when entering zero-g,
which is quickly returned when leaving zero-g. This shift is
complete within several hours and appears to be consis-
tent with the quantity of leg interstitial and vascular fluid
mobilized during orthostatic stress tests.
Determining the sources of the leg fluid changes is
made more difficult because of the uncertainty of the pre-
flight reference leg volume measurement. If the reference
position in one-g was the upright state, then the loss of a liter
of fluid from the legs (during the first few hours inflight) can
be easily explained as noted above. However, the actual
reference (control) position was not upright, but was su-
pine for perhaps one-half hour after ambulation. Thus, an
unknown portion of previously pooled fluid (approximately
0.5 to 1.0 liters based on tilt studies in one-g) was probably
removed from the legs by the time the reference measure-
ment was performed. This makes the changes observed
during spaceflight even more dramatic when compared to
ordinary postural changes in one-g [68].
It is possible that the interstitial tissues in the legs
contain a larger amount of readily mobilized fluid than
has been previously recognized. Estimates of fluid pool-
ing in the tissues during one-g orthostasis have come, in
part, indirectly from plasma volume measurements before
and after tilt. There is some indication that, during these
postural changes, outward filtration of plasma in the legs
is accompanied by some inward filtration in the upper
Table 5-6. Leg Volume Changes During Skylab [16]*
Time  Leg Volume
0 0
6 hr. -1 liter
1 day -1.3 liters
4 day -1.8 liters
84 day -2.2 liters
R + 0 -1.5 liters
R + 7 -0.2 liters
* See Fig. 9-10 for a graphical representation of this data
R = Recovery Date
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Table 5-7. Properties of the Upper And Lower Body Compartments*
I. Weights, Volumes, and Water
                             Weight           Volume    Water
Body Segment Kg          %    Liters    %       Liters  %
Upper Body 45.8        65.5     50.5   76.6         32 48.8
Legs 24.2        34.5     15.4   23.4         10 14.9
Total 70.0      100.0     65.9 100.0         42 63.7
II. Fluid Compartments
Compartment         Body Fluid Volume (liters) Leg Fluid Volume (liters)
Plasma 3.0 0.75
Interstitial 16.0 3.75
Intracellular 23.0 5.50
Total 42.0 10.0
(1) Based on 70 kg man, whole body sp. gr. = 1.062
(2) Weight distribution from Bioastronautics Data Book [9]
(3) Leg fluid volumes based on total body proportions.
body [75]. If this is true, then the tissue fluid accumula-
tion in the legs could be the sum of the net change in
plasma volume plus this reabsorbed fluid.
5.4.2.1.2 Intemediate-term Fluid Shifts. At the end of
several days inflight, a total of 1.8 liters of fluid may be
lost from the legs. The idea that this fluid is transferred to
the upper body and then excreted through the kidneys in
accordance with the volume reflex pathway gains credence
from the finding of nearly 1.5 liters reduction in com-
puted total body water by the third or fourth day inflight.
This shift of nearly two liters from the legs is a much larger
volume than is usually associated with acute postural
changes in one-g. This suggests a gradual loss of blood,
interstitial, and perhaps intracellular fluid from the lower
extremities, which is essentially complete within several
days. An attempt was made to estimate the contribution of
each major fluid compartment to this total loss. Volumes
of leg compartments are not known precisely but were
approximated from available data on upper and lower body
weight distributions (see Table 5-7). Accordingly, a loss
of two liters from the legs represents a 13% of total leg
volume, 20% of leg fluid volume, and 45% of leg extra-
cellular volume. Certainly, there is not enough blood in
the legs to account for the total changes observed.
5.4.2.1.3 Long-term Fluid Shifts. Prolonged absence
of hydrostatic forces may result in further depletion of the
leg fluid volumes. By the second and third month inflight,
leg volume decreased by a total of more than two liters.
Eighty percent of this is completed during the first week,
as previously discussed. Beyond the first week inflight,
the data become more difficult to interpret. Loss in leg
volume during this period can be ascribed to further dehy-
dration of the legs (plasma, interstitial, or intracellular
fluid), but most assuredly there is a significant component
due to loss of muscle tissue. Calf girth measurements indi-
cate a clear trend toward decreasing circumference through-
out the entire three-month mission of the 84-day mission
[16]. In addition, nitrogen and potassium balances are
strongly negative during the flight, particularly during
the first month, although it is not possible to determine
from which part of the body these elements are derived
(see Fig. 4-22). Biosteriometric measurements, however,
confirm that at recovery day the greatest relative volume
losses in the body occurred in the calves [76,77]. Loss of
leg strength was also noted following reentry. Perhaps half
of the long-term volume loss in the legs, or approximately
200 ml, was due to increased fluid drainage involving in-
terstitial, lymphatic, vascular, and intracellular compart-
ments and the other half may represent cell solids.
The inflight water balance suggests that after an early
loss of 1.5 liters of body water, total body water did not
decrease further, but remained approximately constant with
a tendency to return toward control (see Fig. 4-26). At
recovery, the data suggest a deficit of 0.8 to 1.1 liters in total
body water. This is smaller than the loss of leg volume (–1.5
liters at recovery), and suggests that of the total fluid shifted
from the legs, a large segment is removed from the body, and
a smaller, but significant portion (perhaps several hun-
dred ml) may be stored in the upper body. The upper body
pooling during zero-g may be considered the reverse of
fluid pooling in the legs during standing. If upper body
fluid storage does occur, it can account for the almost uni-
versal inflight symptoms of head fullness and nasal stuffi-
ness, facial plethora, and distended neck and scalp veins
[16]. It is not clear whether the excess fluid was accepted by
the vascular or extravascular compartments.
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In the face of an expanded central blood volume dur-
ing spaceflight, the circulatory components are capable
of permitting a portion of the excess volume to be ac-
cepted without proportional increases in blood pressures.
This is accomplished by processes such as vascular stress
relaxation and vascularization (i.e., increases in number
of capillaries). There is a possibility that these processes
occurred in the upper body during the prolonged inflight
phase of Skylab, when venous distention and head full-
ness were noted. During the two-week postflight period,
the plasma volume of most all crewmen showed a ten-
dency to increase several hundred ml above preflight con-
trol. Similar overshoot effects have been noted following
bedrest. These effects remain unexplained. However, if
stress relaxation of the veins or vascularization in the up-
per body occurred during prolonged spaceflight, it would
be expected that upon return to one-g, the return of vascu-
lar volume to normal size would take several weeks to be
complete. Until this occurs, the capacitance of the circula-
tion would be expected to be higher than normal. A simi-
lar volume compensatory process, but in reverse (i.e.,
reverse stress relaxation and devascularization) could have
occurred in the legs during zero-g exposure, thus tending
to keep vascular capacity constant or reduced [45]. Little
is known, however, regarding the relative differences in
vascular reactivity between upper and lower body circula-
tory vessels. The possibility exists that leg vessels can
resist high pressures (as in one-g orthostasis) more easily
than the upper body vasculature and that stress relaxation
effects may be more prevalent in the latter region.
5.4.2.1.4 Recovery. The average deficit in leg volume
for the nine crewmen at recovery was 1.5 liters (see Table
5-6). However, inflight data from the 84-day mission sug-
gest this may have been actually as much as 2.2 liters, if
measured immediately prior to reentry. Therefore, nearly
700 ml of fluid enters the legs between the start of reentry
and first recovery measurement, despite the fact that the
crewmen wore leg pressure garments during this interval.
This is approximately the amount of fluid that shifts
toward the head immediately after launch and confirms
the quantity of easily mobilized fluid recorded during pos-
tural changes and water immersion. By the end of the first
week of the postflight period, the leg volume has nearly
returned to normal.
5.4.2.2 Simulation and Hypothesis Testing of Altered
Fluid Distribution. Having developed a quantitative sce-
nario for the progression of headward fluid shifts in
microgravity, it was then possible to simulate these fluid
disturbances and to examine their physiological conse-
quences with computer models. Specifically, the purpose
of these simulations was to test the six hypotheses listed
in Chapter 5.4.1.  Spaceflight data during the acute phase
are incomplete, and reference will therefore be made to
ground-based zero-g analog experiments for determining
the veracity of the computer predictions. A more detailed
description and simulation of these ground-based studies
will be found in Chapter 9.
Hypotheses #1 and #2: Acute Headward Shift of Leg
Blood and Tissue Fluid.  One of the most significant
acute responses to exposure to zero-g is a shift of pooled
fluid from the legs to the upper body. The fluid shifted
headward is assumed to consist of two components: a)
blood originally pooled in the vessels (primarily veins) of
the legs, and b) plasma filtrate pooled in the interstitial
spaces of the legs. This hypothesis was examined in the
model by forcing both blood and tissue fluid from the leg
compartments and recording the simulated response. The
quantity of mobilized fluid from each compartment is im-
precisely known, but for convenience, it was assumed that
one liter of fluid was shifted rapidly from the extracellular
fluid of the legs. Further, it was assumed that half of this
(500 ml blood) was derived from the leg vascular compart-
ment and the other half from the leg interstitial compart-
ment (500 ml plasma filtrate). These agree in general with
changes in leg volume measured during the first few hours
after launch into zero-g and with changes in blood vol-
ume measured during one-g tilt and immersion studies
(see Table 5-6 and Chapter 9).
Although these two volume shifts occur simulta-
neously, it is possible to evaluate their effects separately
using the modified Guyton simulation model, an analysis
not possible by experimental means. The results of this
analysis are shown in Fig. 5-22. The predicted responses
to the simultaneous movement of both blood and filtrate
from the legs are shown in Fig. 5-23. In this figure, the
response has been extended from two days to two weeks to
study long-term behavior.
The simulation of a 500 ml shift of blood (solid line,
in Fig. 5-22) from the leg vasculature was accomplished
by reducing the unstressed volume of the leg venous com-
partment. The other simulation of a 500 ml shift of plasma
filtrate (dashed line in Fig. 5-22) was achieved by increas-
ing the tissue pressure in the legs and allowing tissue fluid
to be reabsorbed into the vasculature through the ordi-
nary routes of capillary exchange. Both of these fluid vol-
umes are, therefore, initially conserved intravascularly,
where they are redistributed according to the compliances
in the seven blood containing compartments of the model.
As the fluid enters the central blood compartments,
there is an increase in blood pressure which initiates the
complex sequence of events suggested in Figs. 5-15 and
5-17. This scenario is reproduced by the simulations shown
in Fig. 5-22 and 5-23. The expected transient diuresis and
natriuresis can be observed, as can be the final reduction
in total body water and body sodium. Figure 5-24 is an
attempt to depict the causal events in these two simula-
tions and to contrast their differences. Accordingly, Fig.
5-24 indicates that during both simulation cases there is a
reduction in leg volume and body water and salts, and
increases in circulatory pressures and urine excretion. How-
ever, other factors, such as the blood volume, interstitial
fluid volume, and hemoconcentration responses are quite
different. These differences, which arise primarily because
whole blood contains colloids and red cells while the
plasma filtrate does not, may be summarized as follows:
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Figure 5-23. Simulation of circulatory, fluid, electrolyte and renal
responses to combined blood (500 ml) and filtrate (500 ml) shifts
from the legs. Note that the timescale is different from Fig. 5-22.
Volume shift from legs, ml
Mean arterial pressure, mmHg
Urine volume, ml/min
Na+ excretion, meq/min
Total body water, liters
Extracellular Na+, meq
Blood volume, liters
Hematocrit, vol. %
Interstitial fluid, liters
Time, day
a) In the case of the filtrate shift, the original blood vol-
ume is initially expanded as leg tissue fluid enters the
circulation. Intravascular red cells and plasma col-
loids are diluted by this filtrate. On the other hand,
the translocation of blood from the legs expands the
central blood volume but the total blood volume does
not initially change; neither does hematocrit, nor col-
loidal osmotic pressure. The eventual reduction in
blood volume occurs only in the case of a blood shift
inasmuch as blood volume (transiently increased) is
restored to normal following the filtrate shift.
b) In both cases there is a tendency for the excess central
blood volume to be eliminated via transcapillary fil-
tration into the upper body and into the renal tubules.
However, in the case of the whole blood shift, this
results in hemoconcentration and an increase in the
concentration of plasma colloids, but in the case of
the filtrate shift, there is no net increase in red cell or
colloidal concentration because the original inward
shift from the legs did not contain these components.
Figure 5-22. Simulation of circulatory, fluid, electrolyte and renal
responses to fluid shifts from the legs: (a) 500 ml blood shift from
legs (solid line), and (b) 500 ml filtrate shift from legs (dashed
line). The bottom graph refers to the upper body interstitial fluid.
Volume shift from legs, ml
Mean arterial pressure, mmHg
Urine volume, ml/min
Na+ excretion, meq/min
Total body water, liters
Extracellular Na+, meq
Blood volume, liters
Hematocrit, vol. %
Interstitial fluid, liters
Time, hr
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Thus, the hematocrit increases for the blood shift but
not for the filtrate shift.
c) Although the total amount of fluid shifted in both
cases is identical, the magnitude of the pressure and
renal response is more dramatic for the shift in blood
than for the shift in filtrate. In these simulations, the
entire blood shift is forced into the upper body ves-
sels and thereby increases central pressures more than
in the case of the filtrate shift, the latter of which has
been allowed to distribute between both upper and
lower body compartments.
d) Outward filtration from the central circulation to the
surrounding tissues of the upper body is enhanced by
the dilution of plasma colloids in the case of the fil-
trate shift and attenuated by hemoconcentration in
the case of the blood shift. Thus, in the former case,
upper body interstitial volume increases, but in the
latter case there is a net decrease in interstitial fluid.
This excess fluid is immediately excreted by the kid-
neys, and therefore, contributes to the diuresis. Thus,
for this reason as well as the one mentioned above,
the magnitude of the blood pressure and renal re-
sponses may be more dramatic for the shift in whole
blood compared to the shift in filtrate. Similar changes
have been reported in infusion studies of blood and
saline in experimental animals [78,79].
These studies have suggested that the total response
will depend in large measure on the total volume of fluid
shifted as well as the ratio of filtrate/whole blood that is
shifted. These factors are undoubtedly different for the
various hypogravic maneuvers in use today, including
Figure 5-24. Hypotheses for simulation of fluid shifts during the first day of weightlessness. This diagram considers two type of
headward fluid transport: (A) a blood shift from the legs to the central circulation, and (B) a plasma filtrate shift from leg tissues to the
vasculature. The dashed boxes contain the events which are common to both events. These pathways were determined from the simulated
behavior of the model during the responses illustrated in the previous two figures.
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water immersion, head-down tilt, bedrest and spaceflight,
because the initial stress on the legs is different. For ex-
ample, total leg volume decrements have been reported to
vary from about 500 ml during supine bedrest, to 900 ml
during head-down tilt, to more than 1500 ml during space-
flight. Therefore, the acute responses of each of these
stresses may be different, not because of some fundamen-
tally different reaction, but merely because of the differ-
ence in tissue fluid volume mobilized compared to that
for whole blood. Unfortunately, there is no practical means
of measuring these differences directly. It may be possible,
however, using parameter estimation techniques, to assess
the filtrate/whole blood shift ratio by comparing model
and experimental responses.
How do these simulations compare with spaceflight
related experiments? The initial simulation responses of
pressure, urine excretion, changes in fluid volumes, electro-
lyte quantities, and hematocrit, (Fig. 5-22) are quite similar
to those observed during a typical 4 to 6 hour water immer-
sion experiment [43,44,57]. The long-term effects predicted
by the model (Fig. 5-23) indicate that all quantities return
toward normal except for total body water and sodium, leg
fluid volume, and blood volume. This is similar to obser-
vations in prolonged bedrest and spaceflight.
The transient changes in total body water and inter-
stitial fluid, which are predicted to occur the first day (Fig.
5-23) have not been reported in space. Special measure-
ment techniques would be required to evaluate the rapid
changes of these quantit ies (including over- and
under-shoots) noted in the simulation. While it has been
previously postulated that the reduction in blood volume
secondary to hypogravic exposure is accomplished both
by renal excretion and transport into the interstitial reser-
voir [45], the role of colloidal oncotic forces has not here-
tofore been seriously considered. The simulation suggests
that the colloidal oncotic forces could be an important
factor in the short-term response, since changes in colloi-
dal forces are equivalent to hydraulic forces with respect
to transcapillary movement. This aspect has been studied
in greater detail as reported in Chapter 9.
This analysis demonstrated that fluid shifts from the
legs could indeed account for some of the important short
and long-term circulatory, renal, hormonal, neural, and
fluid-electrolyte disturbances observed in various studies
of hypogravity. However, many of the responses that were
found in Skylab subjects could not be achieved with the
model by a simple internal shift of fluids. In particular, the
diuresis and natriuresis predicted by ground-based stud-
ies and supported by model results have not been observed
in space, nor can this hypothesis account for intracellular
losses of fluids and electrolytes. For that reason, other
hypotheses were tested.
Hypothesis #3: Release of Potassium and Water
From Cells. Losses of cellular constituents (including
water, electrolytes, and nitrogen) were observed in the
Skylab crewmembers as well as in subjects undergoing
prolonged bedrest. While these losses may contribute to
decrements in musculoskeletal function (i.e., calcium loss
and loss of strength), the full significance of these changes
has not yet been ascertained. However, secondary effects
may be expected from the biochemical products of tissue
catabolism, which are released into extracellular fluids and
the circulation, thereby increasing the excretory load of the
kidneys. These biochemical effects were examined in this
study, and a more realistic simulation of fluid and electrolyte
loss was obtained.
The cell  compartment is represented in the
fluid-electrolyte model by a simplified formulation; po-
tassium and water are its only constituents. However, trans-
fer of water is permitted to take place across the cell
membrane according the osmotic gradient between potas-
sium rich fluid on one side and sodium rich fluid on the
other. In addition, the membrane is impermeable to so-
dium, while a pump mechanism maintains potassium in
the cells. Excess extracellular potassium can be regulated
by either active transport into the cells or excretion by the
kidneys under control of aldosterone.
Figure 5-25 shows the results of a simulation, in which
70 meq of potassium was artificially forced from the cells
in an exponential manner, over a four-week period. As
potassium leaves the cells, plasma potassium concentra-
tion is elevated and renal potassium excretion increases
by approximately 20% before gradually returning to nor-
mal. As expected, water follows potassium from the cells
and extracellular volume expands temporarily at the ex-
pense of intracellular fluid. Renal potassium excretion in-
creases as a result of plasma potassium stimulation of
aldosterone secretion. However, aldosterone’s sodium re-
taining properties reduce renal sodium excretion and the
extracellular sodium concentration increases. This creates
an additional osmotic effect in depleting cellular fluid.
Notice that the decrease in sodium excretion is only tem-
porary, and within several days, it rises slightly above con-
trol. This occurs at a time when aldosterone is still elevated.
Thus, the model exhibits an “escape” phenomenon. The
increase in aldosterone is due to the elevated potassium
level in plasma and not due to angiotensin. In the model
angiotensin is shown to be suppressed. These effects of
the potassium release mechanism are summarized in the
hypothesis diagram of Fig. 5-26.
The combination of hypotheses #1, #2, and #3 is il-
lustrated in the simulation results of Fig. 5-27. The loss of
cell potassium leads to a more realistic prediction of body
water loss, intracellular water loss, plasma potassium con-
centration, angiotensin, and aldosterone levels. One quan-
tity that is not in agreement with experimental findings is
plasma sodium concentration, which is transiently in-
creased before returning to normal. As a result, ADH is
predicted to increase. However, observations on Skylab
indicated that sodium concentration in fact decreases by
about 3% and ADH significantly decreases.
The relative quantities of potassium and water that
are derived from the cell compartment of the model is an-
other apparently questionable result. The simulation study,
shown here, required a release of only 70 meq potassium
in order to effect the transfer of 500 ml intracellular fluid.
In contrast, more than three times this quantity of body
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potassium was lost from the Skylab crew, although the
cell water loss was the same as with the model (see Table
5-2). Another way of looking at this is to assume a nomi-
nal cell potassium concentration of 150 meq/1; then the
loss of 240 meq potassium measured in the human sub-
jects would be expected to result in an iso-osmotic loss of
240/150 = 1.6 liters of water, or three times that measured.
In order to account for the measured losses of cellular
water and potassium, it is necessary to hypothesize that
cell fluid tonicity is below normal. A method of quantify-
ing these losses is presented in Fig. 5-28. This graph pre-
dicts the amount of cell water (or extracellular water) that
osmotically follows a given potassium loss (or sodium
loss) as a function of tonicity of body water. The analysis
is based on the Guyton model formulation of intracellu-
lar/extracellular fluid exchange as well as the osmotic theo-
ries originally proposed by Darrow-Yannet [27]. The as-
sumptions in this model are: a) the osmotic gradient across
the cell membrane is created by a sodium concentration
on the one side and a potassium concentration on the other;
b) any imbalance in osmotic gradient is relieved by water
transfer toward the compartment of greatest electrolyte
concentration so that in the steady-state, the concentra-
tions of extracellular sodium and intracellular potassium
are identical; and c) the normal extracellular (intracellu-
lar) concentration is 142 meq sodium (potassium) per li-
ter. At the measured loss of 6% potassium, the graph
predicts an intracellular water loss of 1.6 liters if performed
isotonically at 142 meq./l., and only about 0.5 liters (the
loss observed in the Skylab crew) if performed hypotoni-
cally at 136 meq./l. It was, therefore, not surprising to find
that the plasma of the Skylab crew was mildly hypotonic
and hyponatremic (see Fig. 5-20), to an extent that the
observed potassium to cell water loss ratio is in almost
perfect agreement with this analysis. The factors that pro-
duce this tonicity effect and its consequences are the sub-
ject of the next hypothesis.
Hypothesis #4: Natriuretic Factor. One of the more in-
triguing experimental observations that was closely exam-
ined was the mild hyponatremia and plasma hypo-osmolarity
which developed early in the missions and continued
Figure 5-25. Simulated fluid, electrolyte, hormonal and renal re-
sponses to the release of cell potassium.
Figure 5-26. Hypothesis derived from simulation showing the
events leading to reduction of lean body mass (cell water and
potassium) during prolonged weightlessness.
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Figure 5-27. Simulation of fluid-electrolyte response showing
the combined effect of three hypotheses: (a) blood shift from legs,
(b) filtrate shift from leg tissues, and (c) potassium release from
cells. Qualitatively, all the responses are appropriate compared to
the spaceflight data except those of plasma sodium concentration
and ADH.
throughout the three Skylab flights [11]. These observations
are puzzling, because few physiological parameters appear
to be as well controlled as plasma sodium concentration,
especially in healthy subjects who have free access to water.
In view of the known effects of hyponatremia on hormonal
secretion levels (see previous section), it was necessary to
consider this phenomenon in the simulation.
Plasma hyponatremia turned out to be a difficult re-
sponse to reproduce with the fluid-electrolyte model, un-
less the net intake of fluids was also hyponatremic.
However, this was not the case on Skylab. While not shown
in the previous simulations of Hypotheses #1 and #2, the
Total body water, liters
Total body sodium, meq
Total body potassium, meq
Intracellular fluid, liters
Blood volume, liters
Plasma [Na+] meq/liter
Plasma [K+] meq/liter
Na+ excretion, meq/min
Aldosterone, × normal
Time, days
Angiotensin, × normal
ADH, × normal
headward shift of fluids resulted in a slight transient in-
crease in plasma sodium concentration before returning to
normal values within 24 hours. In the original version of
the model, several factors affected sodium excretion: aldos-
terone, extracellular sodium concentration, and the volume
rate of urine (see Fig. 5-11). These factors did contribute to a
simulated natriuresis in response to headward fluid shifts.
However, the natriuresis was not strong enough to reduce
plasma sodium. It became obvious that a factor, not pres-
ently included in the model, was required, which would
cause the ratio of sodium to water in urine to increase,
resulting in reduced plasma sodium concentration.
Other so-called “third factors” have been recently iden-
tified (see Fig. 5-16), which can also affect the renal han-
dling of sodium. Therefore, a natriuretic factor was
postulated that would become activated by increases in
upper circulatory pressures, as in the case of expansion of
central blood volume in zero-g. As a result of adding this
modification to the model, a mild hyponatremic plasma
was produced in response to headward shifts of leg fluid.
The reduced extracellular sodium concentrations also pro-
duced secondary effects (Fig. 5-29) that resulted in more
realistic responses including elevated renin-angiotensin
secretion, elevated aldosterone secretion, suppressed ADH
secretion, and osmotic transfer of water into the intracel-
lular compartment. The hormonal effects are consistent
with the previous analysis of the model’s pathways (Fig.
5-11), that revealed these direct effects of sodium concen-
tration. The volume expansion of the intracellular com-
partment is beneficial to the zero-g simulation in that it
permits a larger quantity of cell potassium release to be
postulated without drastically reducing cell water. This
volume effect also could have been predicted as discussed
in the previous section (see Fig. 5-28).
The effect of the natriuretic factor on a zero-g simula-
tion is illustrated in Fig. 5-30. The simulation shown in
Fig. 5-27 was rerun with a natriuretic factor included in
the model, and the results of the two simulations were
compared. The simulation shown in Fig. 5-30, therefore,
includes all of the four hypotheses thus far discussed: blood
shift from the legs; tissue fluid shift from legs; potassium
release from cells; and a natriuretic factor. The reduction
in plasma sodium concentration increased the realism of
the simulated response with respect to the effects men-
tioned in the previous paragraph. The decrease in intrac-
ellular water loss is also apparent. Other quantities such as
body water, body sodium, and blood volume did not ap-
pear to be affected by the natriuretic factor, especially in
the long-term period. Hormonal responses, however, were
significantly affected, particularly the elevations in an-
giotensin and ADH.
It is important to note that all variables predicted by
the model exhibited improved agreement with the Skylab
data when the natriuretic factor was added to the model.
This is unusual in a model as complex as the one em-
ployed here, and supports the belief that a natriuretic fac-
tor should be incorporated on a permanent basis. The
present formulation, however, does not appear to be to-
tally satisfactory. It was difficult, for example, to suppress
NASA/CR—2020-220487 200
Figure 5-28. Equilibrium relationships between changes in fluid volume and electrolytes for the extracellular and intracellular compart-
ments. In this simple model the intracellular concentration of potassium is considered identical to the extracellular concentration of
sodium so as to maintain osmotic balance in the two pools. (Other assumptions are given in text.) In the example shown (dashed line)
a one liter decrease in intracellular water must be accompanied by a 4% reduction in intracellular potassium in order to maintain isosmotic
equilibrim with the extracellular compartment (case A). If body fluids became diluted from the nominal value of 142 meq/liter to 136
meq/liter then the potassium loss must increased to 8% (a doubling of the loss in the previous example) to sustain the same volume loss
and remain in equilibrium in the hypotonic environment (case B). A similar analysis can be performed for changes in extracellular
volume and extracellular sodium.
the plasma sodium concentration to the full extent ob-
served in subjects exposed to hypogravity. A more appro-
priate suppression of plasma sodium would have resulted
in even more realistic responses. Further design and vali-
dation studies are therefore recommended.
5.4.3 Hypotheses Related to Altered Metabolic
Balances
The response to fluid-electrolyte disturbances, such
as headward fluid shifts or intracellular/extracellular ex-
change, can be modified by changes in the components of
metabolic balance. In Skylab, there were measured decre-
ments in dietary intake, particularly during the acute pe-
riod following launch. Increased sweat losses would be
expected to affect the net metabolic balance and renal
behavior in the same manner as decreased intake. These
considerations led to a composite metabolic balance
analysis of the Skylab crew (see Chapter 4.4). Two general
conclusions were reached from that study: during the acute
stress stage early in flight, the fluid and electrolyte losses
from the body could best be explained by a reduced di-
etary intake of those substances, and during the steady-state
portion of the flight, the volume and electrolyte concen-
trations of renal excretion could logically be explained
only by a decrease in sweat losses. However, a traditional
metabolic balance analysis alone cannot account for the
alterations in body fluid volumes and composition, nor
can it specify the mechanisms responsible for these
changes. For this reason, the modified Guyton model was
used to verify the results of the metabolic analysis and ex-
tend them to include an analysis of dynamic regulation in
the face of metabolic disturbances. Hypotheses #5 and #6,
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evaluated below, concern the acute and long-term effects of
decrements in dietary intake and sweat.
Hypothesis #5: Chronic Decrease in Sweat Losses.
Sweat components were not originally incorporated in the
Guyton model. The model was modified by simply in-
cluding a parameter representing the sweat rate in the equa-
tion that determines the rate of change of extracellular
water, extracellular sodium, or extracellular potassium.
During the control period of the simulation (i.e., preflight
phase) these parameters were assigned (normalized) val-
ues similar to those obtained for the Skylab crewmen dur-
ing the preflight period (see Table 5-8). In computing these
values, the model’s dietary intakes for water, sodium, and
potassium were increased by exactly the same amounts as
the sweat losses so that renal excretion and the net body
balance was not changed during the control period.
The effect of decreasing sweat losses on fluid-
electrolyte balance during the “inflight” phase was evalu-
ated merely by reducing these sweat parameters by 10% for
evaporative water loss and 30% for electrolyte sweat losses
while holding intake at control values. These changes are
in general accord with the Skylab estimates for the
long-term portion of spaceflight as derived in Chapter 4.4
and shown in Table 5-9. The results of this simulation are
shown in Fig. 5-31.
Only small or insignificant changes occurred in the
fluid-electrolyte compartments. Aldosterone concentration
rose nearly 10% in response to the small increase in plasma
potassium concentration. However, more significant
changes occurred, as expected, in the quantities and con-
Figure 5-29. Hypotheses derived from the simulation showing
the effect of a postulated natriuretic factor on sodium excretion
during expansion of the central blood volume.
Figure 5-30. The simulated effect of a postulated natriuretic factor
on a zero-g simulation. The solid curves are taken directly from
Fig. 5-27, whereby the combined effects of blood and filtrate
headward shifts and potassium release from cells were simulated.
The dashed curves represent the simulation of the same combined
effects with the addition of a natriuretic factor in the model. The
primary effect of natriuretic factor in the model is to reduce plasma
sodium concentration and ADH levels.
Hydrostqatic
Pressure
Gradient
Central Blood
Volume & Pressures
Natriuretic
Factor
Na+
Excretion
Extracellular [Na+]
Renin–Angiotensin
Aldosterone
ADH
Intracellular Water
Total body water, liters
Total body sodium, meq
Total body potassium, meq
Intracellular fluid, liters
Blood volume, liters
Plasma [Na+] meq/liter
Plasma [K+] meq/liter
Na+ excretion, meq/min
Aldosterone, × normal
Time, days
Angiotensin, × normal
ADH, × normal
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centrations excreted. The steady-state increases for water,
sodium, and potassium renal excretion were 10% (144 ml/
day), 12% (17 meq/d), and 3.5% (3 meq/d), respectively.
These are in basic agreement with the values estimated for
the Skylab crew (see Table 5-9). Predicted water excretion
is nearly double the observed Skylab value because the
long-term reduction in water intake was not accounted for
in this simulation. Similarly, the simulated potassium ex-
cretion is about half of that expected because the cell po-
tassium release hypothesis was not used. In other words,
the effects shown in Fig. 5-31 are the result of sweat sup-
pression only. It is interesting to note that these responses
do not reach their equilibrium levels immediately and the
dynamics of each constituent are somewhat different.
Hypothesis #6: Anorexia and Increased Sweating
Early in Flight. It was postulated that the anorexia of
space motion sickness together with a marked increase in
mean evaporative water loss could account for a large part
of the observed changes in renal excretory patterns early
in flight. In particular, it was anticipated that there would
be a partial suppression of the expected diuresis and natri-
uresis during the early period when the largest losses of
body water, sodium, and potassium occurred. It was rea-
soned that loss of any body constituent could occur by
either increased renal excretion in the face of constant
intake and sweat or, on the other hand, by decreased in-
take and/or increased sweat accompanied by normal or
even reduced renal loss. Water intake was severely reduced
(up to 40%) during the first several days on the second
and third mission, and electrolyte intake did not return to
normal on the second mission until the end of the first
week. Evaporative water loss was near normal or reduced
during the first few days of the last two missions, but on
the first mission (where there was a temporary heat shield
malfunction) sweating rates increased by almost 80% above
control during inflight days 3-5. The average intake and
sweat components for the nine crewmen are shown in Fig.
5-32 for the first ten mission days. Some of the data were
averaged over several days for convenience in simulation.
This data was obtained largely from the analysis of Chap-
ters 4.2 and 4.4. Sodium sweat losses were computed by a
compartmental analysis technique described in Appendix
F (see Fig. F-3). This method permitted a more accurate
assessment of these losses compared to the results obtained
in the metabolic balance analysis of Chapter 4.4. Accord-
ingly, sodium sweat losses, averaged over the first five
days, exhibited an increase similar to the trend shown for
evaporative water losses.
The decrements of body water, sodium, and potassium
as well as the rates of renal excretion predicted by the
model are shown in Fig. 5-33 for two cases: no change in
intake or sweat from preflight control, and changes in in-
take and sweat as shown in Fig. 5-32. In both cases, the
combined hypotheses #1 to #4 were used to provide a
more realistic simulation of weightlessness. The decreases
in body composition were similar in both cases after ten
days, although the shorter term dynamics are somewhat
different. Also, the renal losses of water and sodium in the
case of altered intake and sweat were markedly reduced
for the first several days, following a brief increase in ex-
cretion. Renal potassium was increased above control in
both cases, but the increase was more dramatic when in-
take and sweat were normal. In the simulation, renal po-
tassium increased because of the large loss of cellular
potassium and in spite of alterations in potassium intake
and sweat loss. The model prediction with respect to body
water and electrolyte losses and renal excretion (after the
Table 5-8. Control Values for Modified Guyton Model
 Water    Sodium  Potassium
Intake 2.88 liters/d   200 meq/d   100 meq/d
Excreta 1.44 liters/d   144 meq/d     90 meq/d
Sweat 1.44 liters/d     56 meq/d     10 meq/d
Total Body Amounts 40 liters 2150 meq 3550 meq
Table 5-9. Alterations in Components of Metabolic Balance of the Skylab Crew*
                         First 5 Days               Remainder of Mission
  Cumulative     Diet     Excretion     Sweat   Cumulative     Diet Excretion Sweat
Body Losses Body Losses
Water   -1400 liters      -16%       -21%            +6% -1170 liters         -4%     + 5% -11%
Sodium   - 100 meq        -32%       - 7%            –24% - 143 meq        +2%     +13% -25%
Potassium   - 100 meq        -19%      + 9%            –44% - 234 meq         -2%     + 5% -44%
*Summarized from Chapter 4 (Tables 4-12, 4-13, 4-14, Fig.  4-21)
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1st 12 hours) are in basic agreement with the observed
Skylab results (i.e., see Table 5-9, Figs. 5-2, 5-3, and 5-4).
The renal water loss predicted on the first half-day of
the simulated mission, as shown in Fig. 5-33, is much
higher than control, while the 24-hour pooled samples of
Skylab indicate a depressed excretion. Although these stud-
ies have demonstrated that the state of hydration and in-
take/sweat levels can greatly modify the basic renal
response, the model has consistently demonstrated that a
diuresis and natriuresis is expected for at least the first few
hours during which time 0.5 to 1.0 liters of fluid shifts
rapidly headward. This is predicted to occur whether or
not intake is reduced, and is in agreement with the studies
of Behn and colleagues [49] who showed that dehydra-
tion will attenuate but not abolish the diuresis of water
immersion. However, the model predicts a significant de-
crease below control in renal excretion the latter half of
the first day when intake and sweat were altered. In the
model, renal excretion never diminishes below control
when intake and sweat are normal. Thus, these simula-
tions provide a rational explanation for why a 24-hour
pooled urine sample for the first day inflight would show
little net change from control.
The last two hypotheses, related to long-term effects
of altered sweating (hypothesis #5) and short-term effects
of intake and sweat changes (hypothesis #6) are summa-
rized in Fig. 5-34. The early decrease in intake and the
accompanying increase in sweat losses are postulated to
contribute to the reduction of body fluids and electro-
lytes. However, later in the mission, when dietary intake is
relatively normal, renal excretion must increase in order
to maintain body fluid and electrolyte balance in the face
of decreased sweat losses.
The simulations presented above were devoted to de-
veloping and testing individual hypotheses. A simulation
of the combined set of hypotheses (#1 to #6) will be pre-
sented in Chapter 9.4.
Figure 5-32. Mean changes in dietary intake and sweat losses of
the Skylab crew during the first 10 days of weightlessness. These
normalized values, obtained from crew data, were used directly as
forcing functions in the model to obtain the simulations illustrated
in the next figure.
Figure 5-31. Simulated effect of reducing evaporative water loss
(–10%), sweat sodium (–30%) and sweat potassium (–30%) on
body composition and renal function.
K+ intake, meq/min
H2O intake ml/min
Na+ intake, meq/min
K+ sweat loss, meq/min
Time, days
Evaporative H2O loss ml/min
Na+ sweat loss, meq/min
Total body water, liters
H2O excretion, ml/min
Plasma [Na+] meq/liter
Plasma [K+] meq/liter
Na+ excretion, meq/min
[Aldosterone], × normal
Time, days
K+ excretion, meq/min
Total body Na+, meq
Total body K+ meq
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5.5 Conclusions
Overall, this analysis has identified and quantified a num-
ber of physiological events important to an accurate as-
sessment of fluid-electrolyte disturbances during
spaceflight. These included: a) the redistribution of fluids
between various compartments and locations such as in-
tracellular/extracellular, plasma/interstitium, lower body/
upper body; b) the changes in quantity and concentra-
tions of the body electrolytes as they affect the loss of
fluids from the body and osmotic shifts within the body;
c) the separate effects of short- and long-term neural, hor-
monal and hemodynamic regulators of the circulatory-renal
system as they influence the above processes; and d) the
changes in intake, sweat losses and body tissue metabolism
of not only water, but of the major electrolytes as they effect
the transient and steady-state renal and plasma concentra-
tion responses. The simulation model of Guyton, as modi-
fied by us, demonstrated its usefulness in integrating these
factors and predicting responses that were generally in
accord with observation. Other predictions must await
confirmation by the experimental results of future studies.
The analysis provided an interpretation of many of
the biochemical and fluid changes observed during space-
flight. These are summarized in Table 5-10, and are dis-
cussed more fully in the preceding pages. Measurements
made on the Skylab crew are listed in the middle column
(“observation”). The last column summarizes suggested
physiological pathways to explain the observations based
on the systems analysis. In a sense the analysis summa-
rized in Table 5-10 is a partial answer to the critical ques-
tions posed at the beginning of this chapter in Table 5-5.
Briefly, it was demonstrated that most of the water
and sodium losses occur during the first few days of flight
while potassium was lost more gradually. The acute losses
could have been expected on the basis of known regula-
tory mechanisms responding to headward fluid shifts ob-
served in zero-g. These mechanisms predicted an early
Figure 5-33. Effect of space sickness anorexia and sweat changes
on body composition and renal function during simulated space-
flight. The combined effects of Hypotheses #1 and 4 (that is,
blood shift, filtrate shift, potassium release, natriuretic factor) were
employed in both simulations shown. Dashed curves represent
response using normal intake and sweat losses. Solid curves rep-
resent response using altered intake and sweat losses of the Skylab
crew as shown in the previous figure.
Figure 5-34. Hypotheses for simulation of disturbances in intake and sweating during Skylab missions.
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Table 5-10. Indices of Fluid-Electrolyte Status Observed in Skylab Crew with Interpretations from Present Analysis
VARIABLE                     OBSERVATION                           SUGGESTED ETIOLOGY
Leg Volume Decreased 1.5 liters in two days and Fluid loss derived from vascular, interstitial and possibly
smaller losses thereafter intracellular compartments
Total Body Water Decreased 1.1 - 1.4 liters in 2 days. Fluid lost appears to be derived from legs. Body water falls
Tendency to partially recover in crews by combination of short-term diuresis (not observed) and
that were most dehydrated decreased intake
Extracellular Sodium Decreased about 100 meq in two days Sodium loss accompanies extracellular water loss. Natriuresis
and stable thereafter may occur, but primary loss results from decrease in intake
Exchangeable Body Decreases more gradually than sodium; Loss occurs primarily over first month; derived from
Potassium 240 meq lost throughout mission intracellular fluids; early decreased intake and prolonged
elevation of renal potassium identified as avenues of loss
Intracellular Water Decreased about 0.5 liters Cell fluids and potassium loss associated with gravity
unloading and muscle disuse atrophy; fluid loss proportionally
less than potassium, but can be explained on basis of
hypotonic extracellular fluid
Interstitial Fluid No change Lymph flow and tissue gel tend to return interstitium
to original state after initial loading
Plasma volume Decreases 10-15% Initial loss associated with decrements in total body water;
loss is maintained by mechanisms which regulate
hypervolemia; plasma volume losses may represent nearly
half of body water losses
Hematocrit Increased 10% acutely and diminishes Results from early loss of plasma volume followed by more
slowly gradual decrements of red cell mass
Intake of Fluids and Decreased early in flight; Space sickness anorexia may be responsible for intake
Electrolytes otherwise similar to pre-flight. reductions up to 40% persisting up to a week in a few
crewmembers. Responsible in large part for fluids and
electrolytes lost early in flight
Urine Volume Decreased about 20% first week; No diuresis observed first day, possibly due to lack of
slightly above control thereafter. void-by-void sampling. Decrease associated with reduced
intake of fluids. Long-term response associated with
decreased evaporative water loss
Sodium Excretion Decreased about 10% early inflight and Early decrease associated with reduced intake and aldosterone
increased about 12% above control levels; later increase reflects reduced sweat losses rather than
thereafter continuous body loss. Not clear how excretion increases
when aldosterone is elevated; this “escape from aldosterone”
may be mediated by a natriuretic factor
Potassium Excretion Increased about 10% throughout flight Reflects both cellular loss and perhaps decreased sweat
losses. Governed primarily by increased aldosterone and
increased plasma potassium
Evaporative Water Loss Decreased about 10% Unexpected decrease measured indirectly; possibly
resulting from suppressed sweating
Sodium and Potassium Decreased Measured indirectly; perhaps due to suppressed sweat water
Sweat Losses losses and believed to be of same magnitude (about -30%)
Urine [Na+] Increased about 10% Parodoxical for reduced ADH and elevated aldosterone
combination; however, expected on basis of steady-state
analysis showing net change in sodium intake (diet - sweat)
greater than change in net fluid intake
Plasma [Na+] Decreased about 3% throughout flight Total osmolarity also decreased; cause not known. Natriuretic
factor may be involved in excretion of sodium
Plasma [K+] Increased 2 - 4% Intracellular potassium loss and possibly decreased
sweat losses contribute to these results
Angiotensin Increases about 100% in plasma Etiology not clear in light of suspected hypervolemia of upper
body; decreased plasma sodium concentration can explain
part of increase
Aldosterone Increased about 100% in urine Several factors can explain change: increased plasma
potassium, increased angiotensin, decreased plasma sodium
Anti-diuretic Hormone (ADH) Increased on first mission, decreased on Decreased ADH explained on basis of decreased plasma
last two missions osmolarity; role of volume receptors not clear, but
hypervolemia could have also contributed. Results of first
mission are paradoxical
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diuresis and natriuresis, although neither was observed on
Skylab. The model confirmed that the acute losses could
alternatively be accounted for by an observed decreased
intake of fluid and electrolytes in the early flight period.
However, the model also indicated that with a diminished
intake, the diuresis response during the first few hours of
weightlessness would be attenuated and this would be fol-
lowed by a reduction of urine excretion below control.
Thus, a 24-hour pooled urine sample, the mode of collection
on Skylab, might show little (volume) change from control.
Whatever the mechanism, most of these early whole-body
losses were probably ultimately derived from observed
decrements in leg volume involving a contraction of the
plasma, interstitial, and possibly intracellular fluid spaces
of the lower limbs. At the end of the acute stress stage (1 –
5 days), there was a significant reduction in body water,
body sodium, and body potassium. About half the loss in
body water was derived from plasma volume.
The more prolonged adaptive phase was character-
ized by a new steady-state with respect to water and so-
dium and a slightly negative balance of potassium. The
increased urine and fecal excretion of water and sodium
throughout the adaptive phase did not necessarily reflect
continued body loss inasmuch as the model predicted that
excretion could have been offset by a decreased sweat
component. A steady-state metabolic analysis verified that
the long-term renal losses were consistent with known al-
terations in intake and postulated changes in sweating for
both water and electrolytes.
The regulatory mechanisms that contributed to these
changes were also examined. The failure of the plasma
volume to eventually return to normal in zero-g presum-
ably reflects the presence of blood volume controllers re-
sponding to the tendency of fluids to move headward. The
importance of autonomic, hemodynamic and hormonal
regulators of circulatory and renal function was ascertained
by model simulation. These pathways were influenced by
various types of fluid shifts, potassium loss from the cells,
and plasma electrolyte concentrations. A natriuretic fac-
tor was introduced into the model to explain the other-
wise inexplicable responses of sodium excretion, plasma
sodium concentration, the secretion of other hormones,
and intracellular volume. The model correctly predicted
the observed direction of the long-term response for ADH,
angiotensin and aldosterone. Upon further analysis it ap-
peared that the stimulating factors for these renal-regulat-
ing hormones are likely different for the acute fluid-shift
phase compared to the adaptive phase of flight. Volume
controllers appear to dominate in the former case, while
osmo-controllers (i.e., plasma sodium and potassium con-
centrations) take over control in the latter case. This dual
concept of hormone control is discussed fully in Chapter
9.8. More advanced simulation studies along the lines dis-
cussed here are presented in Chapter 9 and further conclu-
sions are discussed in Chapter 10.
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Update Endnotes
Update #1. Renal-Regulating Hormones (TBD)
Recent research regarding renal-regulating hormones,
including aldosterone, natriuretic factor, and prostaglan-
din activity, how they participate in regulating fluid-elec-
trolyte metabolism and what has been found from
spaceflight experiments.
Update #2. Diuresis in Spaceflight
The concepts and hypotheses developed in this chap-
ter formed the basis for a major spaceflight experiments
which was conducted more recently on the Shuttle
Spacelab. An important aspect of this experiment was an
attempt to detect a spaceflight diuresis by measuring each
urine void and attempting to ensure that astronaut sub-
jects were well hydrated prior to launch. Early measure-
ments of renal-regulating hormones were also obtained.
This experiment was designed in part to confirm or dis-
prove the existence of the Gauer–Henry pathway during
acute adjustment to spaceflight. The results of this experi-
ment [80] and other related studies are summarized in the
Update section of Chapter 9.
Update #3. Venous Pressure in Spaceflight
Measurement of venous pressure during spaceflight
have been made since the time of the analyses summarized in
this chapter [81]. The results of these unexpected findings
are summarized in the Update section of Chapter 9.
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6.1 Introduction
The most obvious and consistent manisfestation of space-
flight on the human hematologic system is a reduction in
the circulating blood volume—including both plasma and
red cell components—during flight. The previous chapter
reviewed the mechanisms by which the plasma volume
decrement may have occurred. In this chapter, the empha-
sis will be on the important factors that may have led to
changes in the red cell component of blood. Inasmuch as
the red cells play a dominant role in the oxygen transport
functions of the body, the importance of tissue oxygen-
ation will also be considered.
Explanations for the reduction in red cell mass (RCM)
have been proposed, but confirmatory evidence was still
lacking until the Shuttle Spacelab era. At the time of the
first Skylab mission, the so-called “anemia of spaceflight”
had been variously ascribed to weightlessness, the rela-
tive immobility of the crew, lack of atmospheric nitrogen,
and a high oxygen partial pressure within the space ve-
hicle. With the exception of weightlessness, these factors
were known to alter rates of red cell production and de-
struction in ground-based experiments using human and
animal subjects and were thought to be operative in space-
flight as well. On Skylab, however, in contrast to previous
space missions, crews moved about freely in gaseous at-
mospheres of oxygen and nitrogen much as on earth. Nev-
ertheless, each of the nine crewmembers exhibited
significant red blood cell loss. This unexpected result pro-
vided the motivation to reexamine the data and current
hypotheses through the lens of systems analysis and com-
puter simulation models.
In support of NASA hematology research, the find-
ings and hypotheses of previous spaceflight and experi-
mental studies were integrated within the framework of a
theoretical model of erythropoiesis regulation. This model,
described in Chapter 3 and Appendix C, was developed
by the GE/NASA team, especially to investigate the agents
responsible for the loss of circulating red blood cells ob-
served in crewmen returning from space missions. The stud-
ies described in this section, based on simulations of the
mathematical model, provided new insights into this phe-
nomenon, which is still under investigation.
The general approach for providing systems analysis
support of the hematology program is illustrated in Fig. 6-
1. The major achievements of the analyses are indicated,
as are the reports and publications that describe them. At
the outset of the study, a suitable model of erythropoiesis
regulation did not exist. In addition, it was uncertain if
the systems analysis approach would be of value in this
particular investigative area. Therefore, a feasibility study
was performed which consisted of a review of the essential
physiology describing erythropoiesis regulation, a sur-
vey of available models of this system, the formulation and
implementation of a preliminary version of a new mathemati-
cal model, a review of the spaceflight findings, and fi-
nally, the development of several simple hypotheses based
on the model’s behavior, which could explain these findings.
This initial study indicated that the modeling approach might
be limited as an investigative tool in the Skylab hemato-
logical experiments because of the paucity of inflight data,
and because of an incomplete understanding of the mecha-
nisms affecting erythropoiesis in general. Nevertheless, it
was concluded that a more advanced model could assist
investigators in several ways that have been previously
enumerated in Chapter 3, that is, it could identify impor-
tant parameters, provide a method by which to test hy-
potheses rapidly, define areas requiring further study, and
predict the time course of difficult-to-measure parameters.
The development of the model proceeded in a system-
atic fashion, as indicated in Fig. 6-1. Verification and vali-
dation of the model are described in Chapter 3, Appendix
B and by Leonard and co-workers [1,2,3,4,5]. Simulations
were performed for experimental stresses related to space-
flight such as red blood cell infusions, descent from alti-
tude, and bedrest. Experimental data for these studies were
taken from the available literature. In addition, collabora-
tions with NASA investigators of bedrest and other zero-g
analogs provided specific data that were needed to define
model parameters and confirm model predictions. Major
improvements were made in the model in order to provide
more realistic simulations of these experiments. These in-
cluded the addition of explicit elements representing eryth-
ropoietin and red blood cell production, bone marrow time
delays, variations in the oxy-hemoglobin dissociation
function curves, and an algorithm for entering experimen-
tal data as time-varying driving functions. Other more gen-
eralized simulation analyses, including sensitivity
analysis provided information regarding the relative im-
portance of model parameters and some basic quantitative
relationships between model parameters that would be
difficult to obtain experimentally. A species-specific model
for the mouse was developed to perform simulations of
dehydration and infusion based on animal experiments
that were currently in progress. At each step of the pro-
gram, additional hypotheses were conceived, expressed
mathematically, tested in the model against experimental
data, then tested once again for their validity in space-
flight simulations. The most promising hypotheses were
then considered for evaluation in the laboratory or for
future space missions.
More than in any other investigative area considered
in this book, the modeling approach served to coordinate
data from various ongoing ground-based experimental pro-
grams, and helped maximize the utilization of the acquired
information.
Chapter 6
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Figure  6-1. Approach for studying erythropoietic regulation during spaceflight. The progressive development in each systems analysis
area such as model development is in the downward direction of the diagram while the horizontal lines indicate the high degree of
interaction between all phases of the study. Hypotheses were formulated based on new insights from the different experimental studies
and ultimately the most promising of these were tested agains the Skylab data. The numbers refer to published reports by the GE/NASA
team (see References).
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6.2 Review of Spaceflight Studies
The hematology experiments performed on Skylab encom-
passed a wide range of objectives, including assessment
of man’s immunological integrity, cytogenetic studies, red
cell metabolism, topographical alterations of red cells, and
blood volume changes. Only a small portion of these data
were deemed directly applicable to describing and explain-
ing overall disturbances in circulating red cell mass. The
most relevant data obtained from human spaceflight stud-
ies, including that from pre-Skylab missions, will be briefly
reviewed here. This information formed the basis for de-
veloping specific hypotheses that guided the systems
analysis study.
6.2.1 Gemini Findings
The loss of red cell mass during spaceflight was first
observed on the Gemini 4 mission. The measured loss (12%
in 4 days) was much higher than could be accounted for
by natural attrition of cells (i.e., about 1% per day), even if
production rates were completely inhibited. This sug-
gested increased red cell destruction as a causative factor.
Subsequent studies on other flights confirmed a decrease
in red cell survival (based on 51Cr half-times), and sug-
gested that a hemolytic process was responsible for the
observed red cell loss. Also noted were increases in cell
membrane fragility and biochemical alterations that are
known to influence red cell integrity [13].
An hypothesis was advanced that was consistent with
most of these observations; it was based on the 100%
breathable oxygen atmosphere of the Gemini space cap-
sules. Compared to a normal earth oxygen partial pressure
of 150 to 160 mmHg, the astronauts of the Gemini (and
later Apollo flights) were exposed to about 260 mmHg
(100% oxygen at 1/3 normal atmospheric pressure). This
atmosphere was found to have a toxic effect on the mem-
branes of red cells and could have accounted for the in-
creased destruction and reduced magnitude of the
circulating red cell mass [14].
A normal feedback compensation for destruction of
cells is a compensatory increase in production rates.
Reticulocyte counts are generally good indicators of bone
marrow production rates. For reasons not understood at
the time, compensatory erythropoiesis was not evident in
these early flights, as reflected by the lack of reticulocyto-
sis until several days after the day of recovery.
6.2.2 Apollo Findings
The Apollo missions were also characterized by a sig-
nificant loss of red cell mass, although its severity was
less than that observed during the Gemini flights. In con-
trast to the Gemini missions, red cell survival was not sig-
nificantly altered during the inflight or postflight phases
of all of the Apollo missions. This indicated that hemolysis
either did not occur or was very slight [15]. Like the Gemini
crewmen, the Apollo astronauts breathed an atmosphere that
was primarily hypobaric oxygen. However, on Apollo, the
atmospheres contained small, but varying amounts of ni-
trogen with extended periods of nearly 100% oxygen. A
qualitative analysis of all space and ground-based cham-
ber studies performed up to that time revealed that the
most severe losses in red cell mass occurred when a 100%
oxygen atmosphere was used (compared to those situa-
tions in which a diluent gas was present) [14,16].
It was proposed that the hyperoxic atmosphere was
not only capable of initiating red cell destruction, but it
was also capable of inhibiting the production of red cells
as well [17]. Hyperoxia is thought to limit erythropoiesis
(even in atmospheres with a diluent gas) by the same feed-
back pathways (operating in an inverse manner) that cause
enhanced production during hypoxia [18]. In order to ac-
count for the losses observed in some of the Apollo flights,
red cell production would have to be totally inhibited for
the duration of the flight, assuming a normal loss of ap-
proximately 1% per day. Taken as a whole, the data sug-
gested that the decrements during Apollo may result not
only from diminished production of red cells, but also
from an increased red cell destruction, as was the case on
Gemini.
Suppression of red cell production on the Apollo
flights was not only inferred by normal red cell survival
times, but also by a reduced reticulocytosis immediately
upon return to earth. In light of the Apollo findings, it
appears that suppressed production may have also oc-
curred in the Gemini crew. This may be inferred from their
reticulocyte counts at recovery, which, while normal,
should have been much higher, based on the amount of
hemolysis measured.
Table 6-1 shows a comparison of the percent changes
in red cell mass and plasma volume in all spaceflight crews
(through the 1975 Apollo–Soyez Test Project) in which these
parameters were measured. For comparison, data for the
ground control subjects are also included. Of these control
studies, the subjects in all except the Skylab Metabolic Ex-
periment Altitude Test (SMEAT) and the Brooks Air Force
studies (both done in hypobaric chambers) were exposed to a
normal earth atmosphere. The SMEAT study used an atmo-
sphere (pressure and composition) similar to that of Skylab,
and Brooks used an atmosphere similar to that of the Gemini
atmospheres. The atmospheres of the Gemini missions were
100% oxygen, and the crewmen were de-nitrogenated prior
to launch. The Apollo 14 to 17 flights were lunar mis-
sions, so that only partial degrees of weightlessness were
encountered. No indications of hemolysis were observed
on these latter Apollo flights. A significant conclusion
that can be drawn from Table 6-1 is that there was a vari-
able decrease in all astronauts, the severity of which was
not seemingly related to the duration of flight.
The limited amount of data collected on these mis-
sions, and the complete lack of inflight observations on
the indices that measured oxygen transport, red cell pro-
duction, and red cell lifespan precluded establishing the
exact mechanisms of the red cell mass loss. Atmospheric oxy-
gen undoubtedly was a contributory agent, but it was prob-
ably not the only one [15,19]. To confound the issue, bedrest
studies (used as ground-based analogs of weightless space-
flight) had demonstrated that significant decrements in
red cell mass could occur in a normoxic terrestrial atmo-
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sphere, thereby implicating factors such as immobiliza-
tion or weightlessness itself [20,21]. Nevertheless, the gen-
eral belief was that the Skylab astronauts would be
protected from red cell mass losses because the oxygen par-
tial pressure would be much more similar to earth’s atmo-
sphere than in previous flights and because of the use of
nitrogen as a diluent in concentrations higher than that
used in any previous flight [22]. The cabin atmosphere of
the Skylab missions differed from that of Apollo flights
by having an oxygen:nitrogen ratio of 70%: 30% (at 1/3
atmospheric pressure). Therefore, it was totally unexpected
when the crew of the first Skylab mission returned with red
cell losses as great as those seen in the Gemini astronauts.
6.2.3 Skylab Findings
Although the common characteristic of all space mis-
sions has been the reduction of red cell mass and plasma
volume, other hematological parameters and influencing
factors did not necessarily exhibit the same uniformity, as
is illustrated in Table 6-2. Thus, measurements of red cell
survival, reticulocytosis, and postflight recovery differed
not only among the Gemini, Apollo, and Skylab series,
but, as the following discussion reveals, among the three
Skylab missions as well. The data summarized in this sec-
Table 6-1. Changes in Vascular Compartments During
Spaceflight*
     Red Cell       Plasma
Mission Duration    Mass       Volume
  (Days)     (%Change)       (%Change)
Gemini 4  4     –12 –9
Gemini  5  8     –21 –7
Gemini  7 14     –14           +11
Apollo  7-8     6–11      –2 –8
Apollo 9 10      –8 –9
Apollo 14-17     9–13     –10 –4
Skylab 2 28     –14   –8
Skylab 3 59     –12 –13
Skylab 4 84       –7 –16
Apollo–Soyuz   9       –7 –11
Ground Controls
Apollo 14-17** 9–13   –1.1 +10
Skylab 2** 28   +0.4 + 8
Skylab 3** 59   +0.8  –2
Skylab 4** 84     0  –3
SMEAT 60   –3  +2
Brooks*** 30  –12  —
Apollo–Soyuz   9   +1  +6
*    Ref [19]
**  Subjects exposed to normal earth  atmosphere
***Subjects exposed to 1/3 atm, 100% oxygen
Table 6-2. Comparison of Major Hematological Findings on
U.S. Manned Spaceflights
Gemini Apollo   Skylab
•  100% oxygen atmosphere    Yes         No             No
•  Red Cell mass decrease    Yes   Yes       Yes
•  Plasma volume decrease    Yes   Yes       Yes
•  Inflight Hb increase    ND   ND       Yes
•  RBC survival decrease    Yes Slight Only 28-day
   mission
•  Reticulocytes on                   No Change Reduced    Reduced
   recovery day
•  Delayed recovery of    Yes     Yes Only 28-day
   red cell mass    mission
•  Flight Duration 4d-14d  l0d-16d    28d-84d
ND = Not Determined
* Hb concentration values were higher when measured inflight, com-
pared to the postflight measurements on samples obtained inflight.
This difference was noted [25], but no cause could be found. How-
ever, it is possible that the somewhat hyperoxic atmosphere (190
mmHg oxygen partial pressure) may have been responsible for in-
creasing oxygen saturation of blood samples (and thus Hb concentra-
tion) measured in vitro by the hemoglobinometer technique.
tion were obtained from the published accounts of the
principal investigators [15,19,23-27].
6.2.3.1 Red Cell Mass and Plasma Volume. The red
cell mass losses on the 28-, 59-, and 84-day missions aver-
aged 14.3, 12.3, and 6.8% respectively, as measured on
the first day of recovery (see Fig. 6-2). Although the mean
change of the second flight was not statistically different
from that of the first flight, the general trend would seem
to imply that the red cell mass loss decreases in severity
with increasing mission duration beyond one to two
months and may thereby be said to be self-limiting.
No inflight plasma volume determinations were per-
formed. The first postflight measurements demonstrated
losses of 8, 13, and 16% in plasma volume for the 28-, 59-,
and 84-day crews, respectively, or an average loss of 360
ml for all crewmen (see Fig. 6-2). However, plasma volume
is known to change rapidly (i.e., 10% variations are seen
during brief postural changes) and the value measured ship-
board on recovery day may not reflect the true volume in
zero-g prior to reentry. (This is in contrast to red cell mass
measurements that in the absence of hemolysis, are rela-
tively constant during acute plasma volume changes).
6.2.3.2 Hemoglobin Concentration. Hemoglobin con-
centrations were measured inflight using a hemoglobin-
ometer in conjunction with each inflight venipuncture.
Postflight, hemoglobin measurements of inflight blood
were made by biochemical analysis of the returned frozen
samples [24]. Inflight data were obtained by these two
procedures only on the crews of the 59- and 84-day mis-
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sions; hemoglobin alterations during the 28-day mission
are, therefore, unknown. The precision of the inflight data
is admittedly less than that associated with pre- and post-
flight determinations.*
Consistent in all the inflight Hb determinations was
an elevated value in the first inflight sample, presumably
due to a loss of plasma volume. If hemoglobin concentration
disturbances are used as an index of plasma volume changes
[28], it would appear that the rate of change of plasma
volume during spaceflight is extremely rapid. The earliest
Hb measurement was obtained on the third inflight day, and
showed an average (N = 6) increase of about 11%. Assuming
red cell mass did not change during this time (which is not
certain), this translates into a plasma volume decrease of
approximately 500 ml, or 18% below control. It is not
valid to use hemoglobin measurements after this point to
estimate plasma volume, since red cell mass is undoubt-
edly also changing at an unknown rate.
As the mission progressed, Hb concentration remained
elevated but there was a gradual reduction in their values
toward normal. The latter trend would indicate a gradual
drop in red cell mass if plasma volumes were stable at a
reduced level. However, plasma volume determinations
were not performed inflight. Figures 6-3, 6-4, and 6-5 sum-
marize all the known Skylab data with respect to Hb con-
centrations, red cell mass, and plasma volume.
6.2.3.3 Lifespan Studies. Indicators of intravascular
hemolysis were provided by both 51Cr red cell halftimes
and 14C-glycine red cell mean lifespans. Treating the en-
tire population of nine crewmembers as a single group,
there were no statistically significant differences between
the preflight and postflight mean values, or between the
Figure  6-2. Changes in plasma volume, red cell mass, and total
blood volume of the Skylab crew.  Each bar represents the mean
(±SD) difference between preflight and postflight measurements
for each three-man mission.  The postflight value was obtained on
the day of recovery.
Figure  6-3. Hematological parameters measured as a function of
time from launch for the inflight and postflight phases of the 28-
day mission. Mean (±SD) values for the three crewmen are ex-
pressed as percent change from preflight control levels. No inflight
measurements were obtained for red cell mass and plasma volume
on any Skylab mission. Plasma hemoglobin was not measured
during the inflight phase on the 28-day mission.
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flight crew and a one-g control group for either of the two
measurement methods [26]. However, the postflight 51Cr half-
times for the crewmen of the 28-day mission were 18% less
than their preflight values (p < 0.05). If their ground con-
trol effects are removed, the net effect due to spaceflight is
a 12% decrease (p < 0.05) in red cell halftime (see Table 6-3).
This indicates that hemolysis may have been a factor on that
mission. The red cell mass loss of this particular flight was
also the largest of the three missions.
6.2.3.4 Reticulocyte Counts. Postflight reticulocyte
counts from all three missions are shown in Table 6-4.
Increases in reticulocytes can be taken as an index of red
cell production. The low values on the first recovery day
suggest suppressed red cell production, and imply that
this is a carry-over from the previous days spent in zero-g.
The general tendency of reticulocyte counts to rise to-
ward and above normal during the following weeks indi-
cates augmented production and regeneration of red cell
mass. The differences between the first crew and the last
two are noteworthy. The postflight reticulocyte counts of
the crew of the 28-day mission rose much more slowly
than those of the two longer missions, and they never rose
above preflight values. Also, each subsequent crew exhib-
ited higher reticulocyte counts on the first day of recovery
and the counts rose fastest for crews that remained in space
longer. These results are generally consistent with the pat-
tern of inflight red cell mass loss and postflight recovery
reflecting zero-g suppression followed by enhanced pro-
duction of erythrocytes in one-g.
Figure  6-4. Hematological parameters measured as a function of
time from launch for the inflight and postflight phases of the 59-
day mission.  See caption for Fig.  6-3.
Figure  6-5. Hematological parameters measured as a function of
time from launch for the inflight and postflight phases of the 84-
day mission. See caption for Fig.  6-3.
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6.2.3.5 Change in Red Cell Shape. Special hemato-
logical studies of the inflight blood samples showed that
during extended exposure to spaceflight, significant al-
terations occur in the distribution of red cell shapes in the
peripheral circulation [15,25]. Severe deformation of cir-
culating red cells can result in their premature sequestra-
tion by the reticuloendothelial system (RES). The
alteration in red cell shape during spaceflight might pro-
vide a sufficient stimulus to the RES to initiate trapping
and eventual removal of these cells from the circulating red
cell mass. Maintenance of normal red cell shape and normal
deformability are essential to survival of the cell in vivo. A
major function of the RES is to remove from circulation,
those cells whose structure is abnormal or whose membrane
is too rigid. It was not possible to substantiate a direct rela-
tionship between the red cell shape alterations during the
Skylab missions and the concomitant loss in red cell mass,
but this is an area that merits further investigation.
6.2.4 Bedrest Findings
Experimental bedrest involving healthy subjects has
been considered an analogous stress to weightlessness be-
cause it minimizes certain effects of gravity (particularly
hydrostatic and load-bearing effects in the longitudinal di-
rection). The earliest of these studies [29], as well as those
conducted more recently [30] (see Fig. 6-6) have invariably
reported blood volume decrements both in the plasma and
red cell components. Typically, for studies lasting less than
one month, red cell mass losses are greater during spaceflight
and plasma volume losses are greater during bedrest [31].
Unlike spaceflight, the time-varying behavior of these
blood volume components is more easily examined during
bedrest. Figure 6-6 illustrates several responses that are typi-
cal of many bedrest studies. As shown in the figure , red cell
mass declines linearly as a function of time [30], while plasma
volume declines in roughly exponential fashion with half
the total loss occurring the first few days and the remainder
lost over several weeks [32,33]. Hematocrit and hemoglobin
concentration increases within several days by 5-10% and
remains elevated despite the loss in red cell mass because
Figure  6-6. Hematological measurements from a two-week and
four-week bedrest study [30,32]. The data are normalized with re-
spect to the computer model’s control values (indicated by the solid
horizontal lines). The symbols designated as “assumed” provide the
most realistic estimates of plasma volume where large fluid shifts are
believed to occur, but were not measured. These assumptions were
necessary to obtain accurate simulations with the computer model
(see Chapter 6.5.3). The rationale for these assumptions is available
elsewhere [9].  During days 13, 14, and 15, each subject received a
one-liter saline solution administered orally as part of an experiment
to test its efficacy against orthostatic intolerance.
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Table 6-3. Percent Change in  51Cr Red Cell Half-Times of
Skylab Crewmembers and Control Subjects [26]
            Difference
              Skylab           Ground         Due To
Mission    N      Crewmembers      Controls       Spaceflight
28-day     3       -17.8 ± 5.0*+     -6.0 ± 3.6          (p < 0.05)
59-day     3         -6.6 ± 1.1*      -5.9 ± 9.8     (NS)
84-day     3        +4.3 ± 10.3      -3.5 ± 4.2     (NS)
Skylab Mean        9         -7.3 ± 11.1      -5.4 ± 6.4     (NS)
*     Different from preflight (p < 0.05)
+    Different from control group (p < 0.05)
NS Not Significant
Table 6-4. Skylab Crews Postflight Reticuloctye Counts
(Percentage of Premission Mean) [26]
     Mission
Day                28 day    59 day         84 day
              mission        mission       mission
R + 0 44         69   88
R + 1 53         — 117
R + 3 67         87   87
R + 7 80       184 143
R + 14 86       227 184
R + 21 93       234 180
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of these observations should be consistent with the fact
that, qualitatively and quantitatively, the first Skylab mis-
sion had a somewhat different response than the two longer
missions (see Table 6-6). In their primary Skylab reports,
Kimzey [25], Johnson et al. [26], and Dietlein [36] offered
several hypotheses to explain the hematological findings;
these are summarized in Table 6-7.
The etiology of the drop in red cell mass and lowered
reticulocyte counts at recovery is unknown. The red cell
mass is the most stable of the various blood constituents,
and rapid changes are only possible in hemorrhaging or
hemolysis. Gradual decreases may be produced by inhibi-
tion of bone marrow activity, ineffective erythropoiesis,
hemolysis, chronic hemorrhage, or sequestration of cells.
The spaceflight experiments appear to rule out all but the
first of these factors. There was no clinical indication of
hemorrhage among the crews, and data collected during
the mission did not support the concept of intravascular
hemolysis as reflected by normal 51Cr halftimes, normal
14C-glycine lifespans, and normal haptoglobins. Iron ki-
netic studies (serum iron, iron turnover, and iron reappear-
ance) tended to rule out ineffective erythropoiesis [15], a
conclusion also reached in bedrest studies [30]. The low
reticulocyte counts at recovery are additional evidence
against ineffective erythropoiesisis. A proposed splenic
trapping of circulating cells was unconfirmed by spleen
and liver scans during the Apollo-Soyuz flight, the first
U.S. manned space mission to be performed after Skylab [37].
Finally, the one-g control subjects showed little change in
either red cell mass or reticulocyte counts, ruling out effects
resulting from the blood drawing schedule. Taken as a whole,
these data suggest, by inference, that the Skylab red cell
mass losses were a result of decreased production rather than
an increase in red cell destruction.
Table 6-5. Summary of Spaceflight Findings
• Red cell mass consistently reduced during spaceflight
• Evidence of hemolysis on Gemini flights
• No consistent evidence of hemolysis on Apollo and
Skylab flights
• Rate of red cell loss in Skylab greater than observed
during bedrest studies of comparable duration
• Reticulocytes reduced immediately after mission
recovery
• Postflight reticulocytosis is often delayed several days
• Hemoconcentration occurs early in spaceflight
• Hemodilution occurs during postflight period
• Plasma volume reduction measured postflight
• Significant alterations in red cell shape
• Hematological responses of the first Skylab mission
different than for second and third missions (see Table 6-6)
Table 6-6. Observations from the 28-Day Skylab Flight that
Differed from the 59- and 84-Day Missions
• Red cell loss was the greatest of the three Skylab missions
• Only crew in which reticulocytosis did not occur postflight
• Rate of postflight recovery of RCM was delayed until after
two weeks from reentry; other Skylab crews did not show
delay
• Plasma volume losses were the smallest, as measured postflight
• Only crew to have statistically different 51Cr halftimes
• Hematocrits and hemoglobin decreased during postflight
period (resulting from plasma refilling) as on other flights,
but was decreased the least (half as much) on the 28-day
flight
• Diet and exercise were the least adequate during the mission
• Crew lost the most weight, suggestive of negative energy
balance
plasma volume is also disappearing from the circulation [20].
Following bedrest, plasma volume increases rapidly (result-
ing in hemodilution), but red cell mass does not begin to
regenerate until after one or two weeks [4].
The fact that these changes are qualitatively similar
to those that are found after spaceflight suggests that simi-
lar mechanisms may be operative in these two hypogravic
stresses. The validity of this assumption has not been
firmly established. Unfortunately, most bedrest studies
have not been directed toward examining the erythropoi-
etic system in detail. Evidence for suppression of erythro-
poietic activity is somewhat stronger for bedrest than it is
for spaceflight, although indications of mild hemolysis
have also been reported in bedrest [20]. Reductions in
reticulocyte counts and erythropoietin levels have been
observed [20,34] but not consistently [35].
Taken together, these data indicate erythro-suppres-
sion, possibly mediated by an excess of oxygen supply
over demand. However, the hypo-metabolism of bedrest
subjects in comparison to the more normal metabolic ac-
tivity of the Skylab subjects makes comparison of these
stresses difficult. Likewise, the normoxic environment in
which bedrest is usually studied is not comparable to the
hyperoxic atmosphere of the earlier Gemini and Apollo
missions. In addition, losses of red cell mass have only
been measured for up to 35 days during bedrest, which
provides few clues to the regenerative behavior suggested
in spaceflights beyond 60 days. These considerations were
examined systematically in the studies described in this
section.
6.2.5 Preliminary Hypotheses
A summary of the major spaceflight findings related
to red cell loss are shown in Table 6-5. Any interpretation
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The initial published accounts of the Skylab experi-
ments left the etiology of the probable decrease in bone
marrow activity unanswered. Johnson et al [26], addressed
the question of why the bone marrow failed to deplete red
cells in spaceflight. They proposed that hemoconcentration
or rightward shifts in the oxy-hemoglobin equilibrium curve
may have maintained oxygen flow to the kidney and pre-
vented erythropoietin secretion. A later paper by Johnson
[27] summarized all the current hypotheses including re-
sults from more advanced analyses of Skylab data and post-
Skylab animal investigations. Also, during this post-Skylab,
pre-Space Shuttle period, the first of the systems analysis
and modeling studies of the erythropoiesis system in
spaceflight conducted by Leonard and associates were pub-
lished [1,2,3,4,6,8].
Whatever the cause of the decreased red cell mass, it
appeared that the losses were self-limiting, since increased
time spent in space did not result in additional loss. Fur-
thermore, the smaller losses of red cell mass on each longer
mission gave rise to a “regeneration” theory by the Skylab
researchers. Accordingly, red cell mass initially decreases
during the first 30 days of flight and this is followed by a
gradual recovery of red cells which begins approximately
60 days after launch [25,26,36,38]. Although no measure-
ments of red cell mass were made inflight, this theory has
a basis of support from a composite time profile of the
postflight red cell mass measurements (Fig. 6-7).
The primary objective of the hematology systems
analysis was to assist in the interpretation of the Skylab
findings. One of the more important post-Skylab summa-
ries [38] emphasized the need to better understand the
erythropoiesis “governor” that prevents the red cell mass
from falling below a certain level; it was suggested such
insight into a previously unknown mechanism may apply
to other disease situations on the ground. Accordingly, an
specific approach was chosen to develop and test hypoth-
eses, using computer simulation techniques, to explain
the loss of red cell mass during spaceflight, and the
self-limiting nature of the Skylab crew’s red cell mass loss,
as well as the difference in recovery kinetics between the
first flight and the last two flights.
Ground-based studies, sponsored by NASA, were per-
formed on human and animal subjects and carried out with
the view of explaining these findings on an experimental
basis. An additional objective of the present analysis was
to colloborate with the ground-based investigators by sug-
gesting experimental objectives, assisting in data inter-
pretation, and using the newly acquired data to modify
the model, if necessary.
6.3 Theoretical Considerations of
Erythropoiesis: Tissue Oxygenation
An important assumption in this study was that the basic
relationship between tissue oxygenation and erythropoie-
sis would provide clues for understanding the loss of red
cell mass during spaceflight.. This assumption was de-
rived from the accepted physiological concept that the
balance between oxygen supply and demand at the tissue
level is the major determinant of bone marrow erythro-
poiesis. Some of the important considerations regarding
tissue oxygenation will be reviewed here to provide a theo-
retical foundation for developing specific hypotheses rel-
evant to the spaceflight findings. A mathematical model
embodying the essential elements of tissue oxygenation and
erythrocyte production is also summarized. This model, es-
pecially its physiological basis and its simulated behavior,
was the basis for interpreting the spaceflight events.
6.3.1 Physiology of Tissue Oxygenation
An adequate supply of oxygen to individual tissues is
dependent on a circulatory system that transports oxygen,
bound reversibly to hemoglobin, from an oxygen-loading
organ (i.e., lungs) to the capillaries of an oxygen-consuming
organ. Oxygen enters the cellular space by diffusion along
an oxygen tension gradient between the capillary and the
cell. Normally, a steady-state exists between the rate of
oxygen consumed by the tissues and the rate of oxygen
delivered to the tissues. The amount of oxygen delivered
to a tissue depends on a number of factors, the most obvi-
ous of which are oxygen tension of inspired air, pulmo-
nary function, hemoglobin concentration [Hb], affinity of
hemoglobin for oxygen, speed of dissociation of oxygen
Table 6-7. Preliminary Hypotheses to Explain
Spaceflight Hematological Findings [25, 26, 36]
• Erythropoiesis is suppressed during exposure to
weightlessness
• Red cell destruction contributed to Gemini red cell losses
and possibly to a smaller extent during Apollo, while red
cell life span was normal on the average in Skylab
• Hyperoxic atmosphere contributory to red cell loss in
Gemini and Apollo
• Red cell mass loss is self-limiting and eventually regenerative
• Kinetics of red cell mass recovery (postflight)
independent of duration of weightlessness exposure
• Hemoconcentration during spaceflight and bedrest a
result of rapid and sustained reduction in plasma volume
• Hemodilution during postflight phase a result of plasma
volume rapidly returning to normal
• Red cell mass loss may be due to splenic trapping of red
cells promoted by alterations in red cell shape
• Rule out hemolysis, splenic trapping of red cells, ineffec-
tive erythropoiesis, blood sampling effects, hemorrhage
• Hemoconcentration and increased O2-Hb affinity contrib-
uted to inadequate erythropoietic response to the loss of
red blood cells during the first month
• Insufficient caloric intake, especially on the 28-day mis-
sion, leads to loss of red cells
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from hemoglobin, cardiac output, and the vascular distri-
bution of circulating blood among the various tissues
[39,40]. A disturbance in any of these factors, or in the rate
of metabolism, will cause a temporary imbalance between
tissue oxygen supply and demand and, thereby, will change
tissue oxygenation.
At the tissue level, the rate of arterial oxygen supply
can be expressed as follows:
Oxygen flow rate = blood flow rate to tissue
x fraction of Hb saturated with oxygen
x Hb concentration in blood
x O2 carrying capacity of Hb
 (normally constant)
The bone marrow elements of the erythropoiesis sys-
tem primarily regulate only one of these factors, the he-
moglobin concentration. Control of blood flow and
hemoglobin saturation may be considered to be under the
domain of the circulatory, respiratory, and blood biochemi-
cal regulatory systems (see Fig. 6-8). These latter systems
are capable of rapid compensatory adjustments in the face
of small changes in the oxygen supply-demand balance.
For example, changes in the number of active tissue capil-
laries and blood flow adjustments are common circulatory
responses to minor local fluctuations in the degree of tis-
sue oxygenation. Under these conditions, the rate of red
cell production and the circulating red cell mass are es-
sentially invariant. However, in more extreme and chronic
situations such as hemorrhage, altitude hypoxia, or pul-
monary disorders, an increase in red cell production and
circulating red cell mass appears to be a major pathway by
which the body compensates for an insufficient tissue oxy-
gen supply [41]. Similarly, conditions that lead to chronic
levels of tissue hyperoxia, such as breathing from an
hyperoxic atmosphere, transfusion-induced polycythemia,
or when the tissue demand for oxygen is decreased as in
hypothyroidism, hypophysectomy, and starvation, there is a
significant decrease in erythropoiesis [42].
In assessing the etiology of the loss of red cells during
spaceflight, it is plausible to look for factors that chroni-
cally disturb the delicate balance between tissue oxygen sup-
ply and demand. Since short-term alterations in tissue
oxygenation can theoretically be corrected by the circula-
tory, respiratory and biochemical systems, it is likely that
disturbances in the erythropoiesis system itself are respon-
sible for the longer-term spaceflight findings. However, the
behavior of the erythropoietic processes must ultimately
be judged in the context of the total oxygen transport
system.
6.3.2 Concept of a Renal pO2 Sensor
A majority of experimental evidence supports the hy-
pothesis that oxygen supply to a renal “detector” site in
relation to the oxygen demand of that region is the pri-
mary stimulus for erythrocyte production via the release
of a renal erythropoietic hormone, erythropoietin
[39,42,43]. Erythropoietin production is believed to be
dependent on renal tissue oxygen tension, a variable re-
flecting the summation of renal oxygen supply and oxy-
gen consumption.
The location of the renal sensing site for monitoring
oxygen tension and releasing erythropoietin has still not
been isolated. However, anatomical and physiological con-
Figure  6-7. Changes in red cell mass in the Skylab crew measured from the day of the launch. Each point represents the mean (±SD)
changes of the three-man crews as measured on subsequent days of the postflight period. The first measurement for each crew was
obtained on the day of recovery. The solid line through the points (calculated by least squares method) support the hypothesis that
regeneration of red cell mass begins after 40 days from launch (Figure  reproduced from Dietlein [36]).
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siderations suggest that the kidney tissue has developed a
specialization that enables it to function as a sensitive
oxygen chemoreceptor. Several important characteristics
of the sensing site have been identified, and they are dis-
cussed in the next paragraphs:
a) While most organs in the body exhibit a blood distribu-
tion pattern that results in an even release of blood
oxygen into the tissues, the kidney has a peculiar mi-
crocirculation that favors a reduced hematocrit in the
smaller vessels and a steep gradient of tissue oxygen
tension along the cortico-medullary axis [42,44]. Thus,
a relative hypoxia is present which may act as a con-
tinual stimulus for daily erythropoietin production.
b) The kidney, and especially the renal cortex, has a
uniquely low arteriovenous oxygen difference. Its cap-
illaries differ from the rest of the capillaries of the body
in that they lie along the flat upper part of the blood
oxygen dissociation curve, where small changes in oxy-
gen concentration are associated with large changes in
pO2. This characteristic amplifies the signal for eryth-
ropoietin production [45,46].
c) The sensors which regulate erythropoietin production
appear to monitor venous or tissue pO2, rather than ar-
terial pO2 [47,48,49].
d) Evidence suggests that the sensing sites are located in
areas where blood flow and oxygen consumption are
held stable over a wide range of oxygen tensions [50]
Autoregulation of blood flow is a recognized feature of
the kidney [46]. In addition, changes in blood flow, if
they did occur, would be expected to have a dampened
effect on tissue pO2 because of the unique coupling in
the kidney of blood flow and oxygen consumption [51].
These characteristics effectively make these renal sites
a sensor of blood hemoglobin levels (or hematocrit).† Since
oxygen delivery to tissue is dependent essentially on blood
flow rate, oxygen hemoglobin affinity, and hemoglobin
concentration (see previous equation), a system that can
keep blood flow and oxyhemoglobin affinity constant will
deliver oxygen at a rate proportional only to hemoglobin
concentration. In addition, by requiring a constant rate of
oxygen consumption, the tissue pO2 will vary in direct
proportion to hemoglobin concentration. Therefore, the
renal oxygen sensor can be construed, under the specified
conditions, as a highly sensitive, high gain hemoglobin-
ometer of the body [52]. When combined with a controller
that can vary the rate of hemoglobin production, this sys-
tem may be capable of regulating hemoglobin levels and
tissue oxygen tension. This view of the erythropoiesis con-
troller has not been fully recognized in the past and may
provide important clues to bedrest and spaceflight hemato-
logical changes, inasmuch as these stresses are often accom-
panied by alterations in hematocrit.UPDATE #1
6.3.3 Effect of Hematocrit Levels on Oxygen Transport
The influence of plasma hemoglobin concentration
on oxygen delivery to the tissues, discussed in the preced-
ing paragraphs, is more complex than the simple linear
effect suggested by the oxygen flow rate equation. This is
true because two of the factors that determine blood oxy-
gen delivery (blood flow and hematocrit) have an interde-
pendent relationship. Blood viscosity increases as the
proportion of red cells in blood increases [53] and blood
Figure  6-8. Regulation of tissue oxygen tension showing the contributions of the cardiovascular, respiratory, biochemical, and
erythropoietic systems.
pO2
pCO2
†
 Hematocrit is directly related to the blood Hb concentration by
the mean corpuscular Hb concentration, MCHC, which is normally
quite constant.
▼
▼
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flow is inversely related to blood viscosity. Thus, a changing
hematocrit can have two opposing effects on oxygen trans-
portability. First, as the hematocrit is increased, the oxygen
content of the blood is increased. Second, as the hemat-
ocrit is increased, the rate of blood flow to the tissues is
decreased because of the increased blood viscosity.
Therefore, it is not apparent in this situation whether
there will be an actual improvement in oxygen supply to
the tissues. In fact, these opposing effects would be ex-
pected to produce a maximum level of oxygen transport at
a specific hematocrit, (i.e., the “optimal” hematocrit). Oxy-
gen transport would be reduced below the optimal level if
hematocrit were reduced (i.e., oxygen concentration ef-
fect) or if hematocrits were increased (i.e., viscosity-flow
effect) away from the optimum. The concept of an “opti-
mum hematocrit” for oxygen transport is supported by
studies of experimentally-induced anemia and poly-
cythemia in both normovolemic and hypervolemic ani-
mals and in man [54,55].
These relationships are shown graphically in Fig. 6-9
(solid lines). The influence of hematocrit on blood oxy-
gen concentration and blood flow are shown in Fig. 6-
9(a). Both of these relationships are essentially linear over
a wide hematocrit range. Oxygen transport, shown in Fig.
6-9(b) is taken as the product of blood flow and oxygen
concentration. The inverse linear relationship between
blood flow and hematocrit has been cited on numerous
occasions [55,56,57,58,59]. Thus, blood with a high he-
matocrit may have a rheologic disadvantage with respect
to oxygen transport in spite of the advantages of an in-
creased oxygen capacity.
An additional effect (shown in Fig. 6-9) is that of blood
volume on blood flow (dashed lines). One effect of an
increased blood volume is a decrease in geometric vascu-
lar resistance (i.e., due to passive distension of blood ves-
sels), and an increase in cardiac output at any given
hematocrit level. The relationships for normo- and
hyper-volemia are shown. The family of parabolic shaped
curves, shown in Fig. 6-9(b), representing the effects of
blood volume, theoretically shifts the optimum hemat-
ocrit to higher levels as blood volume increases. More
important, however, is the fact that hematocrits higher than
the normal optimum do not necessarily result in reduced
oxygen transport when accompanied by hypervolemia.
This upward shift of the oxygen transport-hematocrit rela-
tionship helps explain why, in cases of acute
hypertransfusion or chronic cases of polycythemia vera
(i.e., expanded red cell mass and blood volume), oxygen
transport is not depressed, but may in fact, be enhanced
[59,60]. Also, some important differences between the
hemoconcentrating stresses of either an absolute erythro-
cytosis (i.e., there is an increase in red cell mass such as
occurs with red cell infusion) and a relative erythrocytosis
(i.e., there is no increase in red cell mass but rather a de-
crease in plasma volume such as occurs with dehydration)
are more readily appreciated in light of this analysis (see
Chapter 6.5.4 and Fig. 6-32).
The preceding discussion serves to emphasize that
predicting the level of oxygen transport requires consid-
eration of the independent and opposite influences of blood
viscosity and blood volume on blood flow. During expo-
sure to weightlessness and in ground-based studies related
to spaceflight hematology (i.e., bedrest, dehydration, and
infusions), both the viscosity and volume of blood are
known to change to modest extents. With regard to eryth-
ropoiesis regulation, any disturbance of oxygen transport
needs to be examined in the region of the renal oxygen
sensors. These tissues, which release the erythrocyte-
stimulating factor, are a crucial part of the feedback con-
trol system that corrects long-term changes in oxygen
transport. Unfortunately, the effects of viscous resistance
and passive distention on renal blood flow are not well
established, particularly for this organ, which has unique
Figure  6-9. Effect of hematocrit on oxygen transport: (a) maxi-
mum blood oxygen concentration varies directly and blood flow
varies inversely with hematocrit, (b) maximum oxygen transport,
calculated as the product of blood flow and maximum oxygen
concentration, is a parabolic shaped curve when related to hemat-
ocrit, with an optimum occurring in the normal hematocrit range
for humans. As hematocrit increases, the maximum amount of
oxygen that can be transported to the tissues also increases ini-
tially, but declines at very high hematocrits due to the effects of
viscous flow resistance. The solid line indicates normovolemia;
hypervolemia, indicated by the dashed line, causes the optimum
levels to shift as shown. (Redrawn from Ref.  [53] and  [60])
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autoregulatory flow capabilities. Nevertheless, the rela-
tionship between the factors determining oxygen trans-
port, exemplified in part by the oxygen flow rate equation
and Fig. 6-8), have contributed to formulating a consis-
tent and unified interpretation of many diverse studies,
both in human and in animal subjects.
6.3.4 Tissue Oxygenation and Erythropoiesis:
A Model
The physiologic role of the erythron is to provide an
adequate amount of available oxygen in arterial blood at
a suitable oxygen tension. Therefore, a complete charac-
terization of erythropoiesis must consider the relationship
between tissue oxygenation and the red cell producing
mechanisms. It is generally accepted that this relationship
can be described in terms of a negative feedback control
circuit. Figure 6-10 illustrates the essential physiological
and anatomical elements of such a control system, show-
ing the relationship between blood oxygenation, tissue
oxygenation, erythropoietin, red cell production, and he-
moglobin concentration.
The concept shown in Fig. 6-10 was translated into a
mathematical model for the purposes of quantitatively
simulating the responses to erythropoietic disturbances.
This model, including its mathematical description and
validation, has been fully described elsewhere [5,9] (also
see Chapter 3 and Appendix B). For convenience, the ma-
jor assumptions that were used in formulating the model
are summarized in Table 6-8.
In order to compare the performance of the model to
real-world behavior, an understanding of the model’s limi-
tations is essential. Many of these limitations are discussed
in the sections describing the details of the model. In the
context of the present discussion, several aspects of tissue
oxygenation that have just been described but are not rep-
resented in the model will be discussed next.
The model is restricted to control of the erythropoie-
sis system. It represents a system for controlling levels of
circulating red cell mass, but does not have circulatory,
respiratory, or biochemical feedback elements which de-
scribe the other aspects of tissue oxygenation that are sug-
gested in Fig. 6-8. While user-controlled parameters that
represent these functions are included in the model (i.e.,
blood flow, arterial oxygenation, oxy-hemoglobin affin-
ity), they are not automatically adjusted in closed-loop
autoregulatory fashion.
The anatomical representation of the kidney structure
with respect to intrarenal gradients of oxygen tension are
not included in the model (see Chapter 6.3.2). This formu-
lation must await further experimental description of the
Figure  6-10. Systems diagram of the mmodel for control of erythropoiesis.  Fixed parameters of the model are designated by the bullet-
ended arrows. Numbers in parenthesis refer to the parameters that were used to evaluate hypotheses explaining red cell mass loss during
spaceflight (see Fig.  6-14).
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renal oxygen sensing sites. At present, this does not seem
to be a serious limitation, either in simulating spaceflight
or related experiments.
The effects of viscosity and blood volume on blood
flow and erythropoiesis are not included in the model (see
Chapter 6.3.3). The conditions under which these omis-
sions would lead to serious error are not usually encoun-
tered in hypogravic simulations. However, since blood flow
is an explicit parameter in the model, hypotheses con-
cerning viscosity and volume effects were evaluated.
Development of the model and a study of its simulated
behavior led to identification of several important features
of the control system that are not generally recognized. These
properties, derived from a theoretical model, were especially
useful in interpreting the experimental results examined in
this study, and are summarized as follows:
a) The variable that is under primary control is the renal
tissue oxygen tension. Other time-varying quantities,
including hemoglobin concentration (or hematocrit)
and red cell production rate can be considered feed-
back variables that are adjusted to return tissue pO2
toward normal. Erythropoietin acts as a simple messen-
ger conveying information regarding the changing state
of renal tissue pO2 to the bone marrow.
b) It is assumed that the renal tissue functions as an oxy-
gen sensor that is located at the venous capillaries in a
region of constant blood flow and constant oxygen up-
take. If other parameters affecting oxygen transport
(such as arterial pO2 and hemoglobin saturation) are
non-varying, the sensor may be considered to function
as a hemoglobinometer. In this mode, hemoglobin con-
centration is the major variable to influence, and ulti-
mately to be controlled by, the oxygen sensor.
c) The quantity d(RCM)/dt (i.e., the change of red cell
mass with respect to time) operates as if it were under
integral control so that it always returns to a value of
zero at steady-state, regardless of the type of distur-
bance. This is accomplished by changes in both pro-
duction and destruction rates.
d) The combined renal-bone marrow controller operates
according to the principles of proportional control, at
least in its normal operating range. Under this type of
control, the tissue oxygen tension, if disturbed away
from its control value, will always tend to return to nor-
mal, and in most all cases there will be some steady-state
error (i.e., 100% compensation in the face of a load distur-
bance is normally not possible). Increasing controller gain
(i.e., the sensitivity to tissue pO2) will decrease the time at
which maximum compensation is reached and will de-
crease the steady-state error at the sacrifice of some dy-
namic stability in the formation of erythrocytes.
e) Disappearance of red cells during spaceflight may be
expected to occur under certain conditions at much
slower rates than their subsequent replenishment. The
maximum rate of red cell mass loss (assuming produc-
tion is completely inhibited) is limited by the natural
attrition rate of red cells, which in the human, is 1% per
day or about 20 ml packed red cells per day. In contrast,
the maximum rate of red cell production is governed by
the bone marrow production capacity, usually said to
be about six times normal or about 120 ml packed red
cells per day.‡
One of the first, and potentially the most important,
uses to which the model was applied concerned identifi-
cation of factors which could lead to suppression of circu-
lating red cell mass. In keeping with the emphasis of the
previous discussion on tissue oxygenation, and in accord
with the model shown in Fig. 6-10, it was obvious that
increasing levels of tissue oxygen tension would provide
a diminished stimulus for erythropoietin production. The
steady-state relationship between tissue pO2 and red cell
production may be derived by reducing the formulation
of the model’s erythropoietin and erythrocyte controllers
(Fig. 6-11(a)) to the more compact form of Fig. 6-11(b).
This relationship is shown in detail in Fig. 6-12, in which
Table 6-8. Major Assumptions of Computer Model of Erythropoiesis Control
• Erythropoiesis governed by level of renal tissue oxygen tension
• Decreasing renal oxygen supply in relation to renal oxygen demand results in reduced oxygen tension and increasing rates of
erythropoiesis (and the reverse as well).
• Renal tissue oxygenation is a function of hemoglobin concentration, blood flow, mean corpuscular hemoglobin concentration,
oxygen saturation of arterial hemoglobin, diffusivity of oxygen at renal capillaries, and oxygen uptake of renal tissues
• The hormone, erythropoietin, is released by the kidneys into the blood at a rate inversely related to the renal tissue oxygen
tension
• The rate of red cell production is directly related to the log of the log of the erythropoietin plasma concentration
• The rate of red cell destruction is based on the life span of the cell and is a fixed percentage of the circulating red cell mass
• Changes in circulating red cell mass are determined by the time integral of the production rate minus the destruction rate
‡
 A number of factors that could have caused rates of red cell destruc-
tion in excess of normal during spaceflight are discussed in Chapter
6.4.10.
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only the hyperoxic range of tissue pO2 is shown. It is in
this region that suppression of red cell production is pre-
dicted to occur to a degree dependent not only on tissue
pO2, but also on the overall controller gain, G. Although
neither tissue pO2 nor controller gain is normally mea-
sured directly, these quantities can be determined by pa-
rameter estimation techniques. Using the theoretical
analysis of Fig. 6-12, it is possible to predict a significant
suppression of erythropoiesis due to moderate increases
in tissue oxygen tension.
The factors that are capable of altering tissue oxygen
may also be assessed for their quantitative and dynamic in-
fluence an erythropoiesis using the model. The simulated
model behavior resulting from step changes for six normally
Figure  6-11. Relationship between tissue oxygenation and red cell production. (a) Elements, contained in the computer model showing
the renal-bone marrow controllers which has been simplified in (b) by eliminating the effect of erythropoietin which acts merely as a
signal transmitter of tissue oxygen content. The portion of the graph shown in (b) is presented in detail in Fig.  6-12.   (Ep = rate of
erythropoietin release, EP T1/2 = plasma half-life of erythropoietin,  [E] = erythropoietin plasma concentration, PO2 = tissue oxygen
tension, VD = volume of distribution of erythropoietin, RCP = red cell production rate).
Figure  6-12. Combined renal-bone marrow controller function curves (semi-logarithmic plot) showing depressed erythropoiesis at high
tissue oxygen tensions.  Curves are shown for different assumed values of overall controller gain (G) are shown. A detailed discussion
of the renal gain, G1, and the bone marrow gain, G2, can be found in Appendix B. Scale indicates normalized values (Normal = 1.0).
(a)
(b)
pO2, TISSUE Red CellProduction
▲ ▲ ▲
▲ ▲
▲ ▲
•
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•
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fixed parameters is shown in the sensitivity analysis of
Fig. 6-13. Alterations in the following parameters were
evaluated: oxygen uptake of renal tissue, oxy-hemoglobin
affinity (expressed as P50), renal blood flow, arterial oxygen-
ation, total plasma volume, and size of the marrow pool (in-
dicated in Fig. 6-13 as bone marrow responsiveness). The
values of these quantities were changed prior to simula-
tion by a magnitude of 20% from control and in a direc-
tion that led to a suppression of erythropoiesis and red
cell mass.
The sensitivity analysis provided a basis for deter-
mining the relative importance of parameters and for iden-
tifying likely causal factors for the decrease in red cell
mass observed in spaceflight. These assessments were con-
sidered in the light of known physiological function. For
example, while renal oxygen demand demonstrated the
most significant effect on tissue pO2 and erythrocyte pro-
duction, there was no reason to initially believe that this
parameter was altered during exposure to weightlessness.
On the other hand, decreases in plasma volume are a
well-known occurrence in hypogravity, and the resulting
hemoconcentration is capable, at least according to the
model’s predictions, of producing tissue hyperoxia, sup-
pression of erythropoietin, reduction in erythrocyte pro-
duction, and gradually diminished red cell mass. In this
manner, each of the parameters identified by the systems
analysis were evaluated to determine whether a reduced
gravity environment could cause a change from its pre-
flight value. The results of manned spaceflight experi-
ments were reviewed as well as experimental analogs of
long-term weightlessness, such as human bedrest and ani-
mal dehydration studies. Factors other than those directly
contributing to tissue oxygenation were also considered,
such as increased red cell destruction and altered control-
ler sensitivity. Ground-based experiments, such as descent
from altitude and red cell transfusions, were also exam-
ined by computer simulation and found to have unexpected
relevance to the spaceflight situation. This systematic ap-
proach (see Fig. 6-1) led to the formulation of a series of
hypotheses that could explain zero-g induced red cell loss,
not as some pathological event, but in terms of a normal
response to disturbances in a feedback control system.
These hypotheses and their evaluation using model simu-
lation are discussed in the next section.
6.4 Development of Hypotheses
The most attractive candidate hypotheses for reconciling
the experimental findings can be conveniently grouped
into three categories: a) those relating to disturbances in
the oxygen-supply demand balance and which are ex-
pressed via diminished levels of erythropoietin; b)those
having a direct effect on the bone marrow and thereby
by-passing the erythropoietin mechanism; and c) those
which have an influence on removing red cells from the
circulation. These three groups of hypotheses, illustrated
in Fig. 6-14, attempt to explain the disappearance of cir-
culating erythrocytes by either a decrease in production
or an increase in destruction.
Figure  6-13. A sensitivity analysis showing the behavior of the
computer model resulting from disturbances that lead to suppres-
sion of red cell production. The model’s response is illustrated
for a 20% constant load disturbance (that is, step change) of six
parameters.
Curve 1 = renal oxygen uptake (–);
Curve 2 = oxy-hemoglobin affinity, P50 (+);
Curve 3 = blood flow (+);
Curve 4 = plasma volume (-);
Curve 5 = arterial oxygen tension (+);
Curve 6 = bone marrow responsiveness, P1 (-).
Algebraic sign refers to direction in change of each parameter
((+) = increase, (–) = decrease) from its normal control value in
order to suppress red cell production.
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The mathematical model is particularly well-suited
for identifying and evaluating factors relating to oxygen
supply. These factors included alteration in Hb concentra-
tion, arterial pO2, oxy-hemoglobin affinity (i.e., P50), and
blood flow. Other factors that may influence oxygen de-
mand (i.e., diminished caloric intake, activity, and lean
body mass), or the bone marrow (i.e., ineffective erythro-
poiesis and altered marrow responsiveness), or red cell
destruction (i.e., intravascular hemolysis, hemorrhage, and
splenic sequestration) are not explicitly represented in the
model. Therefore, inferences regarding these mechanisms
were made and tested in the model by adjustments in the
oxygen uptake, bone marrow control function and red cell
lifespan parameters. Most of the hypotheses in Fig. 6-14
are indexed with a number that corresponds to a model
parameter (shown in Fig. 6-10) by which the hypothesis
could be evaluated.
The following discussion will address each major hy-
pothesis in turn, with particular emphasis on the physi-
ological pathways involved, the evidence that supports
the hypothesis, and its plausibility in the context of
weightless spaceflight. Wherever possible, this discussion
will be supplemented by computer simulations in an at-
tempt to provide some notion as to the quantitative im-
portance of each proposed mechanism. Only simple model
disturbances (such as step changes in parameter values)
will be used in this discussion. More complex challenges
to the model,  including multiple,  sequential,  and
time-varying driving functions will be described later when
simulations of laboratory experiments are presented.
6.4.1 Hemoconcentration
Of all the factors which can contribute to an increase
in oxygen delivery to tissues, there appears to be only one
Figure  6-14. Hypothesis diagram showing the various factors considered in the present study to account for red cell mass loss during
weightlessness. The numbers adjacent to each factor indicates the model parameter that was altered (see Fig.  6-10) in order to evaluate
the influence of that factor by simulation techniques. (*) indicates that the designated pathway is not testable in the current model. (●)
indicates that evidence is available supporting the event shown. (BM = bone marrow, Hb = hemoglobin).
↑  O2 Supply
Loss of Red Cell Mass
   During Weightlessness ●
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which has been observed consistently in hypogravic ma-
neuvers in association with loss of red cell mass. That
factor is hemoconcentration and results from an appar-
ently rapid reduction in plasma volume. Modest eleva-
tions in hematocrits up to 15% have been observed during
spaceflight, bedrest, and water immersion [25,61,62].
The idea that hemoconcentration was implicated in
the hypogravic response was first proposed in the inter-
pretation of bedrest data [20,63]. This concept was not
related to the spaceflight situation until much later [1,25].
Other than in bedrest, information relating to the long-term
effects of decreased plasma volume on erythropoiesis is
sparse. However, there is considerable evidence to suggest
that the erythropoietic system is very sensitive to hematocrit
changes in either direction. Significant reductions in eryth-
ropoietic activity have been observed following the increases
in hematocrit induced by red cell infusion in humans [64]
and animals [65,66] thirst dehydration [67,68] and altitude
hypoxia followed by descent to sea level [69,70]. As for de-
creased hematocrit changes, the enhanced erythropoietic re-
sponse of many types of acute and chronic anemia are well
known [71,72]. The studies cited were concerned with
changes lasting several days to many weeks, and they rep-
resent stresses for which the model has been validated (see
Table 3-7). These simulation studies will be summarized
later in this section.
Hemoconcentration is not only associated with an in-
crease in viscosity, but it invariably is produced by events
which alter the blood volume. An increase in hemoglobin
levels can be experimentally or clinically obtained by re-
duction in plasma volume (relative erythrocytosis) or trans-
fusions of red cells (absolute erythrocytosis). The former
case is a hypovolemic maneuver, while the latter case is
hypervolemic, but hemoconcentration is a characteristic
of both.
Both blood volume and viscosity are capable of in-
fluencing tissue oxygenation and erythropoiesis indepen-
dent of hemoconcentration effects, as discussed previously
(see Fig. 6-9). It was necessary to account for these vis-
cous and volume effects to explain some short-term hema-
tological observations involving hypovolemic and
hypervolemic hemocentration (see Chapter 6.5.4). How-
ever, the analysis presented in the following pages as well
as by others [67] suggest that in long-term studies, blood
volume or red cell mass changes by themselves, have much
less influence on erythropoiesis than do moderate changes
in hematocrit.
According to the regulatory concepts outlined previ-
ously, hemoconcentration is capable of reducing bone
marrow erythropoietic activity via tissue hyperoxia and
suppression of erythropoietin release. This effect was il-
lustrated by model simulations already presented (Fig. 6-
13), and is further demonstrated by the parametric analysis
of Fig. 6-15. In this latter study, the plasma volume parameter
was reduced incrementally and simulations were performed
at each level for sixty-day periods. As shown in Fig. 6-15, the
rapid rise in hematocrit initiated, in turn, the more gradual
responses in erythropoietin, erythrocyte production and red
cell mass. The falling red cell mass eventually lowered the
Figure  6-15. The simulated effect of hemoconcentration on eryth-
ropoiesis regulation illustrating the sensitivity of the model to
changes in plasma volume. The plasma volume parameter was
diminished at zero time by the percentage indicated and held at
that level for the entire period shown. Gain of the feedback con-
troller was set to G = 6 for this and all other simulations in this
section unless otherwise indicated. Increasing the gain value would
cause a similar but more intense response leading to even larger
losses of red cell mass. The effect of gain on erythropoiesis is
indicated in Fig.  6-12.
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hematocrit toward control levels, thus diminishing the
stimulus for erythropoiesis suppression.
An idealized simulation of spaceflight or bedrest is
illustrated in Fig. 6-16. The two-phase sequence of
hypogravity and recovery is characterized, in this case,
solely by a period of hemoconcentration, followed by a
period of hemodilution. This simulation was driven by an
idealized plasma volume behavior (derived from a bedrest
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study [20]. Although hemoconcentration causes red cell
mass to fall and hemodilution restores red cell mass, the
recovery period is not an exact mirror image of the treat-
ment (bedrest) phase. Many factors contribute to this
non-symmetrical effect, including non-linear controller
functions, time delays in renal and bone marrow elements,
and the fact that the hemodilution event is initiated from
an erythro-suppressive state in contrast to the normal state
preceding hemoconcentration.
If hemoconcentration is a major factor to consider in
explaining losses in red cell mass, then it is important to
examine the degree and dynamic behavior of the
hemoconcentrating event. In bedrest, hemoglobin levels
tend to rise slowly and then stabilize, while in spaceflight
the rise is relatively more rapid and extreme in magnitude,
and a subsequent prolonged downward trend toward con-
trol is observed (see Figs. 6-4 to 6-6). Comparable changes
in plasma volume losses (10 - 20%) can occur in both
spaceflight and bedrest, but the reduction in volume pro-
ceeds more rapidly in spaceflight. This difference in rate
of plasma loss will, of course, be reflected in the dynamic
behavior of hemoglobin levels,  so that the
hemoconcentrating ability of spaceflight is initially
greater than that for bedrest. The long-term behavior of
hemoglobin levels depends entirely on the relative rates
at which plasma volume and red cell mass disappear. As
will be shown later, the computer model proved to be an
ideal tool to explain these complex dynamics and to ex-
amine the erythrokinetic differences between bedrest and
spaceflight.
Figure  6-16. Simulation of a hypothetical bedrest study in which plasma volume (bottom panel) is reduced 300 ml (–10%) and then
returned to normal after 28 days.
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6.4.2 Arterial Oxygen Tension
While the atmosphere of the Skylab workshop did not
contain oxygen in high enough concentrations to pro-
duce toxic effects on red cells, it did exert a higher than
normal oxygen partial pressure (189 mmHg compared to
160 mmHg). If this resulted in even modest increases in
blood pO2, the possibility exists that red cell production
was partially suppressed because of decreased levels of
erythropoietin secondary to tissue hyperoxia [18,73]. A
second factor present that could contribute toward a higher
than normal oxygen partial pressure in the blood was an
observed resting ventilatory rate (minute volume) that was
about 20% higher inflight compared to preflight [74].
While the inflight pO2 of Skylab’s atmosphere was
approximately 30 mmHg higher than preflight levels, the
effective increase in blood pO2 would be expected to be
much less because of a modulating effect in lung oxygen-
ation. In the absence of direct blood measurements, a for-
mulation for predicting blood pO2 from ambient oxygen
concentrations was employed [75]. The results of apply-
ing this equation to the three Skylab crews are shown in
Table 6-9. On the average, there was an estimated increase
of only 3-4 mmHg in blood pO2 during the flight phase in
comparison to the preflight phase. The crew of the 28-day
mission showed the highest estimated arterial pO2. The
fact that this crew also exhibited the largest losses in red cell
mass may be more than coincidental.
The effect of even small changes in arterial blood oxy-
genation can accumulate over time and eventually lead to
significant changes in total circulating red cell mass, as sug-
gested by the simulations of Fig. 6-17. If atmospheric
hyperoxia is combined with bedrest or spaceflight, a larger
decrement in red cell mass may, therefore, be expected than
for bedrest or spaceflight alone. This has not been con-
firmed experimentally, but the reverse case—altitude hy-
poxia during bedrest—demonstrated that hypoxia can
abolish the erythro-suppressive effects of hemoconcentra-
tion [76].
The evidence reviewed here is indirect and sugges-
tive, so that a strong conclusion regarding the effect of
enhanced arterial pO2 is not warranted. However, it may
have been a contributory factor, especially in the largest
red cell mass losses observed on the first Skylab mission.
6.4.3 Oxy-Hemoglobin Affinity
Displacements of the oxygen-hemoglobin equilibrium
curve (OEC) to the right or left (conventionally character-
ized by the value of P50) reflect decreasing and increasing
affinity, respectively, between oxygen and hemoglobin (see
Fig. B-5). Because of the shape of the curve, any change in
it’s position profoundly affects the amount of oxygen avail-
able at normal tissue oxygen tensions, whereas oxygen up-
take by hemoglobin is little affected [40]. The capability to
alter O2-Hb affinity and oxygen unloading at the tissue level
in response to environmental changes and ultimately influ-
ence erythropoiesis regulation has only recently been appre-
ciated [52,77,78].
Quantitatively, a decrease in oxygen-hemoglobin affin-
ity can be considered comparable to increases in blood flow,
hemoglobin concentration, or arterial pO2 in promoting the
supply of oxygen to tissues. Changes leading to a shift to the
right (increasing values of P50) have been observed in sub-
Table 6-9. Estimates of Partial Pressure of Oxygen in Arterial Blood of the Skylab Crew*
Inflight
Quantity Preflight 28-Day Mission 59-Day Mission 84-Day Mission Skylab Avg
**B  760         252        263        259 258
**PIO2  158         194        185        189 189
**PICO2      0             3.7          5.0            5.1      4.6
   PACO2    40           43.7        45.0          45.1    44.6
**RQ      0.87             0.91          0.90            0.88        0.90
  *PaO2  109.50         117.5      110.4        114.1  113.1
 ∆PaO2      0             8.0          0.9            4.6      3.6
*PaO2  =
where B = total ambient pressure, mmHg  [75]
PH2O  = partial pressure of water vapor in lungs (at body temperature of 37oC, PH2O = 47 mmHg)
PIO2 = ambient partial pressure of oxygen, mmHg
PACO2 = partial pressure of CO2 in alveolar air, mmHg (assumed that PACO2 = 40 + PICO2)
RQ = respiratory quotient
PaO2 = partial pressure of oxygen in arterial blood, mmHg
∆PaO2 = difference in PaO2 between inflight and preflight
** measured
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jects exposed to hypoxic conditions at high altitude, exer-
cising individuals, and patients with anemic and cardiac
impairment [79,80,81,82]. The reverse situation, leftward
shifts in the OEC in response to hyperoxia, may be expected
on theoretical grounds, but supportive evidence is scant. The
outward appearance of a feedback control circuit is, there-
fore, present, whereby tissue hypoxia increases blood P50 that
facilitates oxygen unloading from blood hemoglobin. This
tends to correct the hypoxic disturbance.
The influence of shifts in the OEC on erythrocyte pro-
duction has not been well studied, but this relationship is
suggested from reports relating P50 levels to erythropoi-
etin production [48,78,83]. A pathologically or experi-
mentally induced shift of the equilibrium curve could
conceivably result in anemic or polycythemic conditions
[52]. Simulations using the computer model support the
view that small shifts in P50 cause dramatic short-term
changes in tissue oxygenation and long-term changes in
red cell mass (see Fig. 6-13; Curve 2). Normally, however,
changes in P50 appear to be a response to an hypoxic situ-
ation in a direction that favors oxygen unloading, rather
than a cause of the hypoxia.
It is well known that the position of the OEC is gov-
erned by such blood factors as pH, CO2, and temperature.
An additional factor that has more recently been impli-
cated in alterations in oxygen-hemoglobin affinity are in-
tracellular phosphate compounds, particularly
2,3-diphosphoglycerate (2,3-DPG) [84]. The dissociation
of oxygen appears to be facilitated by 2,3-DPG because it
preferentially and reversibly binds to deoxyhemoglobin.
The shifts in P50 discussed here in relation to hypoxic situ-
ations are believed to be a result of increasing levels of
2,3-DPG [85,86].
There is no conclusive evidence that hemoglobin
changes of this nature can account for the loss of red cell
mass during spaceflight or bedrest. Values of P50 during
ground-based hypogravity maneuvers have not been re-
ported. Skylab measurements were performed on 2,3-DPG
and indicated no significant change inflight [87]. How-
ever, plasma hyperphosphotemia was observed during
spaceflight [88] and the possibility exists that blood pCO2
levels were increased because ambient levels of carbon
dioxide were many times normal concentrations in the
artificial gaseous atmosphere (see Table 6-9). Both of these
may contribute toward a decrease in O2-Hb affinity and a
tendency for unloading additional oxygen at the tissue
level.§ On the other hand, if the feedback concept out-
lined above is valid, the modest degree of predicted
inflight tissue hyperoxia (caused by hemoconcentration)
would have contributed toward an increased O2-Hb affin-
ity. These opposing factors prevent one from reaching a
conclusive prediction regarding alterations of inflight oxy-
hemoglobin affinity. However, during the postflight re-
covery phase, it seems more likely that the hemodilutional
anemia would result in an increase in P50; this is consistent
with the relatively large but non-significant increase in 2,3-
DPG measured during the recovery phase [87].
 
This latter
hypothesis was tested by computer simulation and appears
to be a fruitful area for experimental investigation.
6.4.4 Renal Blood Flow
Renal blood flow could markedly affect the amount
of oxygen delivered to the special oxygen sensing sites. If
tissue oxygenation of renal tissue is similar to that of other
tissues, a reduction of renal flow would decrease tissue
oxygen tension [89]. Moreover, since erythropoietin re-
lease is supposedly a sensitive indicator of renal tissue
oxygenation, increasing amounts of erythropoietin should
be observed in tissue made hypoxic by reductions in renal
arterial flow. (This is a prediction of the computer model
as shown previously in Fig. 3-28. Some experimental stud-
ies using renal artery occlusion support this hypothesis
[90,91] while others do not [42,44,92].
Two factors in particular support a relative insensitiv-
ity of the erythropoietin producing apparatus to renal blood
flow. First, in contrast to all other body organs and tissues,
the oxygen demand or consumption in the kidney is more or
less proportional to blood flow rather than remaining rela-
tively constant at rest [51]. Thus, although moderate reduc-
Figure  6-17. The simulated effect of increasing arterial blood oxy-
gen tension (P
a
O2) on reducing red cell mass.  At zero time the value
of  P
a
O2  was increased from its normal value of 95 mmHg to the
value shown in the graph and it was held at that level for the entire
period shown.  The behavior of other model variables during this
simulation is indicated in Fig.  6-13 (Curve 5).
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§
 Johnson, et al [26] postulated that such a decrease in O2-Hb affin-
ity could, in fact, be responsible for an hyperoxic condition and
thence a suppression of erythropoiesis. Our interpretation of the
existing literature rejects this notion on the grounds that the de-
crease in O2-Hb affinity, if it occurred, would be in response to an
hypoxic condition and would not overcompensate by creating
hyperoxia. It is more likely that inflight hemoconcentration would
favor an increase in O2-Hb affinity.
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tions in renal blood flow do affect oxygen delivery, they may
not alter tissue pO2 and erythropoietin production, presum-
ably because renal oxygen consumption is also decreased.
Secondly, renal blood flow is known to be under a high
degree of autoregulatory control [46]. Both of these con-
siderations suggest that the balance between tissue oxy-
gen supply and demand is not markedly influenced by
moderate blood flow changes in the kidney. Whether the
renal oxygen detector sites exhibit these same character-
istics that may exist for the kidney as a whole is not known.
In order to explain the spaceflight decrease in red cell
production on the basis of blood flow, an increase in renal
blood flow must be postulated. There is some evidence,
based on postural change studies, which suggests an in-
crease in renal blood flow during the acute stress phase of
weightlessness [51,93]. The headward shift of fluid in
microgravity is a volume-expanding event with respect to
the upper body circulation and may enhance renal flow, at
least temporarily. However, there is some indirect evidence
that does not support an increased renal blood flow, or at
best confuses the issue. First, an increased renal blood
flow is not a consistent finding in acute water immersion
studies [94], and second, longer term bedrest studies show
equivocal results with respect to changes in renal blood
flow [95,96], although none of these studies measured
erythropoietin or the direct effect on erythropoiesis. Third,
exercise is known to decrease renal blood flow [46] and
daily exercise of varying levels of intensity was used as a
deconditioning countermeasure on Skylab flights. Fourth,
the hemoconcentration accompanying spaceflight may be
responsible for altering intrarenal blood flow [97] and,
therefore, may affect the renal oxygen sensors in a yet
unknown manner.
In view of the inconclusive evidence relating blood
flow to erythropoiesis and the lack of data describing re-
nal blood flow change during spaceflight, it would seem
prudent to await new experimental evidence before in-
voking this mechanism as a long-term causative factor in
the reduction of red cell production.UPDATE #1
6.4.5 Altered Oxygen Demand
A decrease in red cell mass could conceivably result
from decreased oxygen consumption of the renal tissue
because erythropoietin is supposedly responsive to the
oxygen supply-demand relationship in that tissue. The
major portion of renal oxygen demand is directed toward
active transport processes related to eliminating wastes
and conserving nutrients [51]. Any event that decreases
waste product or nutrient supply to the kidney may be
expected to reduce renal oxygen uptake. Such events might
include the restrictions in dietary intake and reduced meta-
bolic activity in bedrest subjects and in astronauts in physi-
cally confining spacecraft. Although a reduced level of
activity was not believed to have been present during
Skylab, dietary levels were inadequate throughout the
28-day mission, and possibly the 59-day mission, and par-
ticularly for the first week of flight on most other prior
missions because of space sickness [98]. On the other hand,
loss of cellular material resulting from musculoskeletal
atrophy, a common occurrence in both bedrest and space-
flight, might lead to greater demand for renal oxygen up-
take in ridding the body of this waste material. Therefore,
the net effect on renal oxygen consumption is difficult to
predict.
It is also reasonable to examine possible changes in
whole-body oxygen demand, since this parameter is more
easily measured and has been linked to changes in eryth-
ropoietic activity. For example, the decreases in metabolic
rate seen with hypophysectomy, starvation, and hypothy-
roidism reduced the need for oxygen in relation to an un-
altered oxygen supply and were followed by decreased
erythropoiesis until a new steady-state was established
[42]. Decreases in basal metabolism of about 7% have been
noted in bedrest subjects, and even larger decrements
would be expected in total energy metabolism [99].
Weightless spaceflight was thought at one time to pro-
mote effortless activity in performing tasks with an ac-
companying reduction in metabolic demand [100].
Consequently, recommended dietary intake during flight
was usually reduced below preflight levels. However, this
concept has not been borne out and it is now believed that
in a high activity mission like Skylab, total metabolic
expenditure is similar to that on the ground [101]. The
tentative conclusion one draws is that total oxygen con-
sumption is reduced during bedrest and during flights in
small space capsules, but there is probably little change
for subjects in larger space workshops.
Hypotheses regarding altered oxygen demand on
spaceflight erythropoiesis activity were only evaluated to
a limited extent in the present study because there is scant
quantitative information available for statistical analysis,
and there is no information available regarding renal oxy-
gen consumption. Likewise, there is no information pres-
ently available that suggests a mechanism by which
whole-body oxygen demand can influence erythropoiesis
by pathways not related to renal oxygen demand. How-
ever, it was desirable to consider changes in oxygen de-
mand in the particular instance of evaluating the wide
variation in exercise levels recorded by the Skylab crew
(see Chapter 6.4.7).
6.4.6 Reduced Lean Body Mass
Hypogravity, whether induced by bedrest or by space-
flight, often results in a decreased lean body mass, even in
the presence of periodic exercise [33] (also see Chapter
4.5). Among a normal population, there is an excellent
correlation between lean body mass and red cell mass [102].
It is reasonable to speculate that this correlation may be
based on the size of the oxygen-supplying erythron con-
forming to the size of the metabolically active tissue mass
of the body. If this is true, a decrease in lean body mass
may be a causal factor in a reduction in red cell mass. This
influence was statistically evaluated in the Skylab crew-
men (see next section). One might also conjecture that it is
not the size of the lean body mass that is important, but
rather the total amount of oxygen consumption by this
tissue. Since the limited data available suggests that, total
body metabolism is not different in space than on Earth,
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an alternative hypothesis is that proportionately, more work
was being demanded of a diminishing muscle mass [101]
and hence, no change in erythron mass would be expected
as a result of a reduction in lean body mass.
6.4.7 Effect of Physical Activity
Exercise conditioning is known to have major long-
and short-term effects on the oxygen transport systems
[103]. Therefore, it is certainly conceivable that exercise,
or the lack of it, would affect the erythropoietic process
and modify the red cell mass response to both bedrest and
spaceflight. However, the effects of exercise on erythro-
poietic activity and circulating red cell mass are complex
and poorly understood.
No clear picture emerges regarding an exercise effect
from a review of spaceflight and bedrest studies. Simple
bedrest, characterized by a complete absence of physical
activity, is associated with a loss of red cell mass. When
intermittent daily supine exercise was added to a bedrest
protocol, the loss of red cells became more severe, at least
in one study [104]. Spaceflight has been characterized by
varying degrees of metabolic activity ranging from par-
tial immobility during the earliest suborbital flights to
the shirt-sleeve 90-minute daily workouts on treadmill and
bicycle during the 84-day Skylab mission. In Skylab (and
in apparent contrast to the bedrest study cited above) in-
creasing levels of exercise were correlated with smaller
decreases of red cell mass. However, this result is not con-
clusive because of the lack of suitable controls.
The possibility exists that exercise may have an ef-
fect not only during bedrest or spaceflight, but during the
recovery period as well. During recovery from bedrest and
during the first (28-day) Skylab mission, repletion of red
cell mass was observed to be delayed for up to two weeks.
A delay was not observed after the 59-day and 84-day
missions. These observations may be attributed to the in-
crease in physical activity following bedrest [30,104] in
contrast to a reduction in activity following the 59-day
and 84-day Skylab missions.
While most investigators find an increase in blood
volume during simple exercise conditioning, there is as
yet no clear agreement whether this is accompanied by an
increase or decrease in red cell mass [103,105-108]. These
inconclusive results pertain to both comparisons between
athletic versus non-athletic populations and to longitudi-
nal training program studies in the same individual. Most
often, an increase in plasma volume at rest is observed
with exercise training associated with a concomitant de-
crease in hematocrit.
Physiologically, it appears that exercise may have two
opposing effects on the circulating red cell mass that can
account for the varied results. On the one hand, sustained
physical training regimens may be associated with an in-
crease in blood destruction rates manifested by an ob-
served drop in red cell mass and hematocrit. This
phenomenon, first observed in dogs [109] was recently
termed “sports anemia” and has been attributed to me-
chanical hemolysis resulting from heavy muscular work.
It has been observed in both fit and unfit populations,
although the results seem to be exaggerated after pro-
longed confinement or sedentary activity. On the other
hand, exercise may act as a bone marrow stimulant and
increase the production of red cells. This phenomenon has
not been well described, but possibly is a result of the
stimulus of blood loss arising from the hemolysis effect
[109]. It is also plausible to consider the increased need
for oxygen as a causative factor.
Tests with the erythropoiesis model have shown that
increased destruction of cells will reduce the hematocrit,
and this slight anemic condition will, in turn, increase red
cell production. The net result, however, is still a slightly
reduced hematocrit; that is, over-compensation and net in-
creases in red cell mass do not occur in the model system,
contrary to the implication by Broun [109]. The simulation
analysis, illustrated in Fig. 6-18, confirmed the conclu-
sions of Hodgson [47] who showed on theoretical grounds
that large increases in destruction rates will result in rela-
tively small decreases in red cell mass because of an effec-
tive and sensitive controller of bone marrow production.
If exercise, per se, can influence both destruction and
production rates of red cells, then any resulting changes
in red cell mass would be dependent on the delicate bal-
ance between these two rates. Any imbalance would have
a cumulative effect during prolonged training periods.
Mechanical destruction of cells would likely be affected
by the type of exercise, whether it be jogging, skiing, or
swimming. Similarly, if production is based on long-term
oxygen demand, the intensity and duration of exercise
would be crucial factors affecting steady-state rates of
erythropoiesis. These considerations could, in part, ex-
plain why different investigators obtain different results.
Unfortunately, the most precise methods available to mea-
sure rates of red cell production and destruction have yet
to be applied to exercise studies.UPDATE #2
The effect of complete cessation of exercise in previ-
ously athletic individuals, as exemplified in some bedrest
studies and pre-Skylab spaceflights, may lead to effects
opposite to those of exercise training. A decreased meta-
bolic rate, a decrease in lean body mass (see Chapter 6.4.5
and Chapter 6.4.6) and minimal mechanical stress could
increase red cell lifespan (by reducing the rate of hemoly-
sis in previously athletic subjects), and increase the ten-
dency for lower red cell production rates. Without precise
determinations of these opposing factors that influence
red cell mass, it would be difficult to predict the final
effect.
Any theory that exercise, or the lack of it, influences
hematological behavior during hypogravic maneuvers
must be consistent with the following facts: bedrest is char-
acterized by a cessation of exercise and loss of red cell
mass; the Skylab missions were characterized by a loss of
red cell mass that was less severe on each subsequent mis-
sion in association with increasing amounts of exercise;
the degree of exercise on the shortest Skylab flight was
probably less than was performed preflight, and this crew
lost the largest amount of red cells compared to any subse-
quent crew and also exhibited a possible shortening of red
cell lifespan at recovery; and, recovery from bedrest
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(ambulation) and from the 28-day Skylab mission was char-
acterized by increased activity and a delayed recovery of
red cell mass.
The following hypotheses are proposed to account
for these observations:
a) some factor other than exercise, possibly hemocon-
centration, is responsible for the primary fall in red
cell mass during hypogravity maneuvers, but exer-
cise could modify this response;
b) oxygen demand, as reflected by the degree of activity
performed over a long time span during bedrest or space-
flight, ultimately has a controlling influence on promot-
ing red cell production by an unknown mechanism;
c) the type and intensity of exercise performed during
weightlessness does not lend itself to significant lev-
els of red cell destruction; and
d) a lack of exercise in certain hypogravic studies may
conserve fragile red cells (i.e., increased lifespan)
which are more vulnerable to destruction during the
early ambulation period (i.e., decreased lifespan post-
flight) [30].
These hypotheses are aimed primarily at explaining
differences between studies in which exercise levels are
varied. Accordingly, the increasing degree of exercise on
each longer Skylab mission may have limited the severity
of the red cell loss. Also, assuming that a period of high
activity precedes and follows a minimal activity bedrest
phase or a high activity spaceflight phase, the exercise
effect, as such, could cause red cell loss to be more severe
after bedrest than after spaceflight. Finally, the delay in
replenishment of red cells during the recovery period of
both bedrest and low activity spaceflights is in accord
with hypothesis (d).
There are some grounds for questioning this set of
hypotheses. The postulated effect of long-term oxygen
demand on red cell production is not known, but cannot
be ruled out. Such an effect may exist under conditions of
reduced red cell mass (that is, weightlessness), but not
when red cell mass is normal (as in terrestrial studies of
exercise conditioning). Also, evidence for significant de-
struction of red cells during or following bedrest or space-
flight is not strong (except under conditions of pure
atmospheric oxygen). However, only limited data are avail-
able and quantitative techniques for testing these hypoth-
eses suffer from lack of precision.
This discussion of potential exercise effects is pre-
sented, in spite of its speculative nature, because it is one
of three factors that have been identified which might ex-
plain the differences between the red cell losses on each of
three Skylab missions. The other two factors are diet and
mission duration. These will be considered next in the
recent findings on the effect of exercise on erythropoiesis
and red cell destruction.
6.4.8 Effect of Diet
It has been established that animals deprived of food,
protein, or water exhibit a significant suppression of red
cell production [111,112,113,114,115]. The implication
of this finding as a causal factor of the “anemia” of space-
flight was recently suggested on the basis of hematologi-
cal findings in dehydrated mice [66,68]. Restriction of
food and water intake was frequently noted on the Skylab
mission during the first week of flight (see Chapter 4.6).
Also, on at least one Skylab flight and on numerous
Figure  6-18. Simulated steady-state response to a shortened red blood cell lifespan (hemolytic anemia). Predicted hemoglobin levels
and red cell production rates are shown as a function of red cell lifespan and controller gain (G). Dashed line (G = 0) indicates no
feedback control. Results suggest that hemoglobin levels are always below control, but they can be maintained near normal for a large
range of reduced lifespan provided that controller gain is high.
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pre-Skylab missions, the diet was considered significantly
inadequate [100,116]. These factors contributed toward a
negative energy balance and negative water balance in
spaceflight [101,117] both of which are characteristic find-
ings of the original animal studies.
The actual mechanisms whereby food restriction or
dehydration in animals reduce red cell production is not
entirely clear. A resolution of the processes involved is
complicated by the fact that starved mice or rats refuse
water and dehydrated animals refuse food. There appear to
be two components to the erythroid suppression which
follows either food or water restriction: a) a component
related to dehydration and the resulting increase in hema-
tocrit, and b) an energy-balance factor related to the re-
duced food consumption (see Fig. 6-19).
With regard to the first component, water deprivation
induces a state of relative polycythemia that, by increas-
ing oxygen capacity per unit of blood, could lead to tis-
sue hyperoxia and suppression of erythropoietin [66,115].
This is similar to the pathway previously described by
which polycythemia, induced by red cell infusion or
bedrest, reduces erythropoietic activity (see Chapter 6.4.1).
The energy balance component of red cell loss is more
complex and not as well understood. Deprivation of water
and food was shown to result in a depression of oxygen
uptake, reduced radio-iron uptake by red cells, decreased
erythropoietin formation in hypoxia and reduced eryth-
roid responsiveness to exogenous erythropoietin
[115,116,117,118]. In terms of the mathematical model of
erythropoiesis, these findings can be interpreted to mean
that food restriction leads to decreased red cell produc-
tion by at least three separate pathways (see Fig. 6-19):
a) a reduction in oxygen demand, which leads to tissue
hyperoxia if oxygen supply is constant;
b) a direct effect on the erythropoietin producing tissues,
which reduces their sensitivity to changes in oxygen
supply; and
c) a direct effect on the erythrocyte-producing tissues,
which reduces their sensitivity to changes in erythro-
poietin.
The latter two direct effects on the erythropoietic con-
trollers may be a result of deprivation of critical proteins
[112]. The possibility that a disturbance of food intake
can affect the erythropoietic regulatory process at several
distinct entry points as shown in Fig. 6-19 makes the nega-
tive energy balance mechanism a potentially powerful one.
In an effort to distinguish between these different effects,
it has been concluded that both the hematocrit and the
negative energy balance effects are each significantly im-
portant, at least in short-term studies [118].
It is not clear whether the food deprivation mechanism
is operative in humans as it is in animals, and if it is, whether
the magnitudes of dietary intake restriction observed in as-
tronauts can produce a similar erythroid-suppression behav-
ior. Also, it is not likely that a dietary effect can explain the
entire loss of red cell mass in the Skylab astronauts because a
significant loss was noted in the one crew (84-day flight) that
was known to have an entirely adequate diet. However, this
pathway may explain differences in red cell loss between the
different crews inasmuch as the astronauts having the largest
negative energy balance (see Chapter 4.6) also showed the
largest decrease in red cell mass.
6.4.9 Altered Controller Function
The shape and position of the renal and bone marrow
tissue function curves (see Figs. 6-11 and 6-12) have been
found to be crucial elements in the control of erythropoie-
sis. Each curve (which is essentially a dose-response curve
describing erythropoietin or erythrocyte production rates)
may be roughly characterized by its slope (sensitivity or
gain) and by its normal operating point (i.e., the basal or
threshold level of production rate**). The effects of
changes in sensitivity on controller response have been
previously illustrated (see Fig. 6-12 and Appendix B, Figs.
B-2, B-3, and B-4). Figure 6-20 shows the effects on the
bone marrow when both sensitivity (curve A) and operat-
ing point (curve B) are decreased from normal. Combina-
tions of these cases, in which both sensitivity and operating
points change simultaneously, can also be postulated. Dra-
matic changes in erythrocyte production and erythropoi-
etin sensitivity of the marrow are possible by altering the
shapes and position of the controller function. Erythropoi-
etin production (as a function of tissue pO2) is controlled in a
similar manner.
Figure  6-19. Hypotheses that can account for reduced erythropoie-
sis following food and water restriction. These pathways are based
on animal studies.  (Hct = hematocrit; EP = erythropoietin)
** A linear function curve may be simply defined by its slope and
intercept; a non-linear function curve requires other parameters for its
characterization (as illustrated in Appendix B, Fig. B-3).
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The effect of a change in the bone marrow’s normal
operating point on erythropoietic activity was evaluated
by model simulation (Fig. 6-21). In this study, the parameter
controlling the position of the basal production rate of red
cells (P1) was altered (see also Appendix B, Fig. B-3 for pa-
rameter definitions). A decrease in P1 would be analogous
to a primary anemia of bone marrow failure. The initial effect
on production rate is dampened by the bone marrow transit
time delay. The reduction in red cell mass (and hematocrit)
accompanying this case produces a secondary response of
erythropoietin release (not shown), which tends to par-
tially restore production rate to a new, sub-basal,
steady-state level. This process causes the undershoot of
the simulated production rate. A long-term effect of this
stress is also demonstrated, inasmuch as red cell mass does
not appear to have stabilized even by sixty days.
The controller functions have not been well described
in the human, and it is mostly from animal studies that
their general characteristics are known. Comparison of
simulation responses with experimental responses has veri-
fied the accuracy of the functions used in the model, and
has permitted estimation of the parameters that character-
ize their shape and position. If these control functions
behave similarly to those of other physiological systems,
it may be assumed that their characteristic parameters may
be altered during certain stressful conditions, particularly
if the stress is maintained chronically. In fact, shifts in
control function are one important way in which the body
adapts to unusual conditions. There is a growing body of
literature reporting specific instances of these types of adap-
tive changes. These reports have been reviewed in Appen-
dix B, and some are particularly relevant to the present
study of spaceflight anemia accompanied by hemocon-
centration. It  has been noted, for example, that
hypertransfused animals become progressively more sen-
sitive to erythropoietin within one to two days after trans-
fusion of red cells [119,120]. There is indirect evidence to
suggest that prolonged decreases in erythropoietin con-
centration may lead to decreases in bone marrow sensitiv-
ity to erythropoietin [121,122]. Others have shown that
bone marrow responsiveness to exogenous erythropoietin
decreases during restriction of food and water [66,115]. If
the size of the stem cell pool increases, as suggested dur-
ing the response to hemolytic anemia [72], this can be
expressed in the model as an upward shift in operating
point and an increase in sensitivity.
These findings, while limited, provide a rationale for
testing the hypothesis that the renal or bone-marrow func-
tion curves are altered during simulations related to space-
flight studies. One preliminary model analysis suggested
that spaceflight is accompanied by decreases and then in-
creases in the controller operating point [3], although the
mechanism for inducing this change could not be postu-
lated at the time. Since then, evidence has become avail-
able suggesting that negative energy and water balances
(both characteristics of most spaceflights) could reduce
Figure  6-20. The erythropoiesis controller illustrating hypotheti-
cal alterations in bone marrow responsiveness. The normal func-
tion relating erythropoietin concentration to red cell production is
shown as the solid curve. Two distinct types of controller shifts
are indicated by the dashed curves. Curve (A): a simple reduction
in slope (by rotation about the normal operating point) reduces the
sensitivity (gain) of the bone marrow to erythropoietin while main-
taining normal operating levels of red cell production.  Curve (B):
a downward shift in the normal function curve results in reduced
erythrocyte producing activity for any given level of erythropoi-
etin, although the sensitivity of the bone marrow to changes in
erythropoietin are not significantly altered. (P1 = normal red cell
production, P
o
 = basal production rate, E1 = normal erythropoietin
levels).
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Figure  6-21. The simulated response to alterations in the operat-
ing point, P1. At zero time, P1 was adjusted from its normal level(1.0) to the value shown.
Plasma Erythropoietin Concentration
R
ed
 c
el
l p
ro
du
ct
io
n 
ra
te
 (m
l/d
ay
)
R
ed
 c
el
l m
as
s 
(lit
er
s)
30
15
2.2
1.8
0         15 30         45                60
Times (Days)
P1
P1
1.2
1.0
0.8
0.6
1.2
1.0
0.8
0.6
NASA/CR—2020-220487 236
bone marrow sensitivity and responsiveness to erythro-
poietin and thereby be responsible for a reduction in eryth-
rocyte production. Evaluation of this hypothesis is
discussed later in this chapter (6.5.5.1).
6.4.10 Red Cell Destruction
Red cell death normally occurs after about 120 days
by extravascular hemolysis (i.e., sequestration and destruc-
tion of senescent red cells in the reticuloendothelial system
of the spleen and liver), and, less commonly, by intravascular
hemolysis. These pathways account for the normal attri-
tion of about 1% of the circulating red cell mass per day.
Abnormal loss of circulating red cells can occur by in-
creasing the degree of hemolysis, and also by such factors
as hemorrhage (including blood sampling losses) and
splenic trapping. Radio-labeling techniques and analysis
of body fluids for cell breakdown products are useful for
determining if cell death is occurring prematurely.
Using these methods, a shortened red cell lifespan was
detected for Gemini crewmen and astronauts on the 28-day
Skylab mission. Toxicity resulting from a high pO2 cabin
atmosphere was probably responsible for the Gemini find-
ings, but as yet, no cause for the Skylab results has been
found. Table 6-10 lists a number of factors that have been
examined to account for unusual red cell destruction.††
 Factors that have been considered and ruled out in-
clude blood sampling, splenic trapping, exercise, and in-
creases in cell membrane fragility. It is conceivable that
excess hemolysis can be attributed to the stress of launch
and reentry (high G forces and vibration), but a shortened
post-flight lifespan is not a consistent finding on all mis-
sions. Changes in red cell shape have been reported [25]
but they have not been well correlated with the rates of red
cell disappearance. However, since cell surface and shape
changes are known to influence red cell survival, this
mechanism probably deserves further attention. At present,
it is not possible to distinguish between these various
mechanisms of red cell disappearance using the computer
model. A single parameter, the red cell lifespan, can however,
be used to test various hypotheses related to the rate, degree,
and time course of destruction, whatever its origin.
It can be argued that the failure to measure a short-
ened lifespan does not rule out the possibility that excess
hemolysis or removal of cells did occur to an extent that
was beyond the resolution of the techniques employed.
There are two such types of losses to consider: an acute
loss, which may occur soon after launch, and a chronic,
but low level loss which may continue for longer periods
of time. With regard to the first of these, it has been pro-
posed that an age-dependent loss of red cells cannot be
ruled out [26]. In particular, the 14C-glycine lifespan tests
are based on a radio-label injected 30 days prior to flight,
with subsequent measurement during the postflight pe-
riod. Therefore, if red cells greater than 30 days of age at
the time of launch were sequestrated and destroyed selec-
tively during the first few mission days, this event would
not be seen in the 14C-glycine survival curves. While such
a process is conceivable, it must be consistent with ob-
served levels of inflight hemoglobin concentration, inas-
much as any acute loss would lower those levels. Computer
simulations that quantitatively evaluate this hypothesized
route of loss will be presented later in this chapter.
The effect on red cell mass of chronic shortening of
red cell lifespan is illustrated by the computer simulation
of Fig. 6-22 (solid line). In this study the normal lifespan was
reduced by 10% (i.e., the approximate corrected change found
for the crew of the 28-day mission as shown in Table 6-3),
and the predicted effects during the subsequent 60 days
were recorded. The model predicts a decrement in red cell
mass of only several percent, reflecting the sensitivity of
feedback compensation which limits red cell loss by in-
creasing erythropoiesis (see also Fig. 6-18). However, if
production rates had not increased in response to abnor-
mal hemolysis, losses of red cell mass greater than 6% are
predicted (see Fig. 6-22 (dashed line)). This latter case
may have been closer to the spaceflight situation since
erythropoiesis is believed to be inhibited in weightless-
ness. These simulations suggest that a large fraction of the
total red cell mass loss observed an the 28-day mission
may be attributed to a measured 10% decrease in lifespan
assuming there is no compensatory increase in erythro-
poiesis. Smaller changes in lifespan may not be detect-
able (i.e., see control group in Table 6-3), but could still
contribute significantly to the overall loss if the condi-
tion is maintained.
Despite of the lack of extensive spaceflight data, it
appears reasonable to conclude that red cell destruction
was not responsible for all of the measured losses of red
cell mass, even on those missions where a decrease in
lifespan was observed.
6.4.11 Differences Between Missions
Regardless of the cause of red cell mass loss during
spaceflight, the problem of explaining the unexpected dif-
ferences of these losses among the three Skylab missions
remains. Figure 6-2 showed that the severity of red cell
mass loss (as determined on the first recovery day after
flight) was progressively smaller for each subsequent flight
of longer duration. Since red cell mass was not measured
inflight, it is only possible to speculate on inflight behav-
ior. Two alternative hypotheses will be considered here;
they will be termed the “regeneration theory” and the “con-
tinuous loss theory”.
Regeneration Theory. One hypothesis that was offered
to explain red cell mass behavior on Skylab claimed that
regeneration of erythropoiesis occurs during prolonged
spaceflight [15,25,124]. Accordingly, if the three missions
††
 In the most significant spaceflight findings since this chapter was
originally written, Alfrey and co-workers [123], have concluded
from experiments performed on Spacelab crews that a newly re-
vealed process of red cell destruction is taking place during the first
week of spaceflight. Dubbed “neocytolysis”, the red cells most
recently released from the bone marrow are selectively targeted for
destruction apparently in response to the previously noted hemo-
concentration. The Spacelab results and neocytolysis is discussed
more fully at the end of this chapter.UPDATE#3
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Table 6-10. Factors Proposed For Explaining Increased Red Cell Destruction During Spaceflight
Factor Evaluation
Blood sampling Ruled out on basis of ground control studies.
Mechanical stress of launch and reentry Cannot be ruled out; may be responsible for postulated age-dependent
loss early in flight or decreased life span measured on 28-day mission.
Change in red cell shape Morphological changes were observed but were not correlated with red
cell loss; may require further attention.
Increased cell membrane fragility Ruled out on basis of osmotic fragility tests
Exercise hemolysis Ruled out on basis that increasing exercise in space was associated with
less RCM loss.
Splenic trapping Ruled out on basis of spleen and liver scans on Apollo-Soyuz mission.
Oxygen toxicity Probable cause of hemolysis on Gemini and Apollo but not on Skylab.
are considered as a composite, a time-relationship between
the red cell mass change and the time following launch
becomes apparent (Fig. 6-7). This relationship suggests
that “following some initial insult, during the first 2 or 3
weeks of flight, the red cell mass begins to recover, after a
refractory period, at about day 60” [25].
In order for the “regeneration hypothesis” to be cred-
ible, it must include an explanation for three events: the
initial loss of red cells, the refractory period, and the
inflight red cell mass-repletion process. With regard to the
initial loss of cells, the preliminary belief was that it took
place early in the flight due to either hemoconcen-
tration-induced-hyperoxia [1,25] or to splenic trapping of
red cells older than 30 days [26]. The former mechanism is
based on suppressed erythrocyte production, while the
latter mechanism is effectively a form of red cell destruc-
tion. A refractory period, supposedly characterized by a
red cell mass that temporarily stabilized at reduced levels
prior to regeneration, was believed to be a result of contin-
ued hemoconcentration and decreased oxy-hemoglobin af-
finity. The mechanism originally proposed for inflight
regeneration of red cell mass was a transient hemodilution
at about the same time (about 60 days after launch) that
the red cell mass is theorized to begin rising toward con-
trol (Fig. 6-23). The sudden drop in hemoglobin, if real, may
have been due to a rise in plasma volume. It was hypoth-
esized that this event may have triggered the production of
erythropoietin and red cells and provide the basis for a re-
generation phenomenon [25]. The liklihood of regenera-
tion late in fl ight was said to be supported by a
post-mission reticulocytosis, that was apparent soon after
recovery of the longest mission, but which did not appear
after the shortest mission (see Table 6-4).
In spite of the attractiveness of the regeneration theory,
it was based on assumptions that must be critically exam-
ined, particularly in the light of new analyses conducted
in the interim period. The theory might be challenged on
the following grounds:
a) The regeneration curve of Fig. 6-7 was constructed
entirely from postflight measurements, but the impli-
cation is that they reflect the time course of inflight
red cell mass changes. Shipboard data collected on
the first postflight day presumably reflects red cell
mass prior to reentry. However, there is reason to be-
lieve that postflight recovery is not an accurate indi-
cator of a postulated inflight recovery (see (b)).
b) The kinetics of the postflight repletion response ap-
pears similar to that which occurs following any usual
blood loss (i.e., hemorrhage, acute hemolysis, blood
donation), and is likely controlled by similar mecha-
nisms. Although these mechanisms are not completely
understood, there is a good reason to suspect that
hemodilutional anemia (caused by plasma refilling
after blood loss) is a major causative factor in stimu-
lating erythropoiesis [71]. Figure 6-7 suggests that
regeneration during spaceflight is controlled by the
same mechanisms that control postflight recovery.
However, the in-flight period is characterized (with
the exception of one datum) by hemoconcentration
(erythro-suppressing) in contrast to the hemodilution
(erythro-activating) of the postflight period.
c) Splenic trapping, a mechanism advanced in prelimi-
nary analysis to explain the original red cell mass loss,
cannot be supported on the basis of spleen and liver
radio-scans performed on the subsequent Apollo-
Soyuz crew [37]. An age-dependent destruction of cells
by other means cannot, however, be ruled out.
d) While it is possible that a decreased oxy-hemoglobin
affinity could contribute to oxygen unloading at the
tissues and suppression of erythrocyte production, as
proposed [26], there is no strong evidence of this oc-
curring either during spaceflight or bedrest. Further-
more, it is the conventional wisdom that a decreased
oxy-hemoglobin affinity arises in response to tissue
hypoxia and not the hyperoxia that was thought to be
present [125].
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e) A postflight refractory period in the recovery curves
of the crew of the 28-day mission may have been
caused by a lack of hemodilution as suggested by
Kimzey [25]. However, an in-flight refractory period
cannot realistically be postulated based on postflight
recovery kinetics. If, on the other hand, inflight hemo-
concentration and a decreased oxy-hemoglobin affin-
ity contribute to the postulated refractory period by
inhibition of erythrocyte production, it is difficult to
understand why the red cell mass does not continue to
fall during this inflight period rather than stabilize.
f) The mechanism by which regeneration was thought
to take place centered on a single datum showing a
sudden fall in hemoglobin concentration on day 60
of the 84-day mission (Fig. 6-23). Closer inspection
revealed that this value was heavily biased by mea-
surements on one individual on a day when his water
intake was unusually high. Also, an in-flight tech-
nique of questionable accuracy was used (finger stick-
hemoglobinometer method) to obtain that day’s value
in contrast to the other data of Fig. 6-23, in which
results from two techniques have been combined. It is
unlikely that a short period of hemodilution, if it was
real, could have caused a sustained period of erythro-
poietic activity leading to a 10% increase in red cell
mass as suggested by Fig. 6-7. In sum, it is question-
able that hemodilution is a general occurrence (or
occurs at all) during spaceflight and that it was re-
sponsible for inflight regeneration in Skylab.
g) A consequence of the regeneration theory is that ini-
tiation of red cell production is apparently indepen-
dent of the presence or absence of gravity, but rather
is a function of the time after first exposure to weight-
lessness [25]. Absent from the hypothesis, if hemodi-
lution is discounted for the reasons discussed above,
is a suitable explanation of the processes which un-
derlie these unusual kinetics, particularly the stimu-
lus that causes regeneration to occur.
h) The legitimacy of using data from different missions in
the composite diagram of Fig. 6-7 derives in part from
the assumption that the conditions present during space-
flight that affect erythropoiesis were identical on each
flight and that the primary difference between flights
was their duration. However, it is known that at least
two factors were present, diet and exercise, that were
augmented on each subsequent flight. That is, the in-
creasing duration of weightlessness was accompanied
by increasing levels of diet and exercise; also, the
level of diet on the first mission was inadequate to
prevent weight loss. Both of these factors are known
to affect erythropoiesis, as discussed earlier in this
section. They also had a demonstrated effect on other
tissues. It is generally agreed that the crew of the
84-day mission (on which red cell mass loss dimin-
Figure  6-23. Inflight hemoglobin concentration during the 59-day
and 84-day missions expressed as percent of preflight mean. The
first determinations at Day 4 after launch show a 10% hemocon-
centration reflecting plasma loss. Thereafter, hemoglobin levels
decline slowly, presumably due to red cell mass loss. Each point is
the mean of three crewmen. All data, except those marked (*) were
determined by averaging measurements from two different methods
(see Chapter 6.2.3.2). The (*) data was obtained by the finger
stick-hemoglobinometer technique only and its accuracy and mean-
ingfulness is being reassessed (see text). The data in question
were omitted from Fig. 6-5. (Reproduced from Kimzey [25]).
Figure  6-22. Simulation of the effects of hemoysis caused by reduc-
ing the red cell lifespan by 10% in the intact model (solid curves) and
in the case where compensatory increases in red cell production are
prohibited (dashed curves). The model predicts red cell loss of about
3% at the end of 60 days due to a 10% shortened lifespan, but a loss
twice as great if erythropoiesis is completely suppressed.
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ished the least) was successful in preventing significant
muscular and circulatory deconditioning and weight loss
by their superior exercise program and relatively
hypercaloric diet (see Chapter 4.6) [126,127].
The preceding comments are not meant to suggest that
regeneration of red cells in space did not occur. However,
a plausible explanation for its occurence is still lacking.
While hemoconcentration is still highly attractive as a
mechanism contributing to reducing red cell mass, it is
not likely that the transient alterations in inflight hemo-
globin levels can be invoked as a causative factor for re-
generation. In summary, the available evidence does not
appear to support regeneration as a general theory for eryth-
ropoietic activity during weightlessness.
Continuous Loss Theory. An alternative, and more con-
servative, hypothesis that avoids most of the objections
to the regeneration theory, is illustrated in Fig. 6-24. It
takes into account the idea that all missions were not iden-
tical. Therefore, a composite of flight data based on
end-point determinations should not be used to describe
inflight kinetics. The dashed lines in Fig. 6-24 represent
the decline in red cell mass during the inflight phase.
While it is not possible to conclusively define the kinet-
ics of this period, ground-based bedrest studies suggest
that a linear decline (as shown) may, in fact, have occurred.
If true, the rate of decline of red cell mass would be
seen as inversely related to the duration of flight. This is
in contrast to the postflight recovery of red cells (denoted
by solid lines in Fig. 6-24), which appears to have been
achieved at similar rates for all crews, except for the first
two weeks of the shortest mission. This alternative theory
can be termed the “continuous loss” hypothesis because it
proposes that the loss of red cells is primarily a monotonic
function throughout the in-flight phase. While some re-
generation cannot be ruled out, it would not have thought
to occur to the extent predicted by the regeneration theory
as illustrated in Fig. 6-7.
The challenge of the continuous loss theory is to ex-
plain how the loss rates of red cell mass could be different
on each flight. Hemoconcentration is currently the most
plausible factor implicated in suppressing red cell pro-
duction and, as suggested in Fig. 6-23, was presumably
similar on each flight. With this in mind, a rationale for
the behavior described by the three curves of Fig. 6-24
can be hypothesized. Specifically, it can be hypothesized
that some erythro-suppressive phenomenon, common to
all flights and a direct function of the weightless environ-
ment (perhaps hemoconcentration), acts to reduce red cell
mass by inhibiting production, and that other factors that
are different on each mission, e.g., level of caloric intake
and/or exercise, modifies erythropoietic activity. There-
fore, a varying behavior of erythrokinetics would be ex-
pected for each mission. In support of the continuous loss
theory, are several recent findings that were not available
during the immediate post-Skylab period:
a) A composite of bedrest studies indicate a clear linear
decline in red cell mass with no observable regenera-
tion [30]. However, the regeneration theory of space-
flight requires the period of repletion to be delayed
for up to two months after the hypogravic stimuli, and
the bedrest data includes measurements only up to 5
weeks.
b) The studies reviewed in association with Fig. 6-19
showed that both hemoconcentration and negative en-
ergy balance can be responsible for significant
erythro-suppressive effects in mice. These animal stud-
ies are admittedly short-term experiments, but never-
theless, a negative energy balance was reported for
the three crews, and this balance varied directly with
red cell mass loss (see Chapter 4.6).
c) A similar trend for red cell mass among the three crews
was reported for solid tissue loss (see Chapter 4, Fig.
4-24), and this was not thought to result from any
adaptive or regenerative effects of zero-g exposure
time, but rather from diet and exercise differences be-
tween the crews superimposed upon a common loss
due to direct effects of weightlessness. The continu-
ous loss theory becomes more attractive if it can be
assumed that the mass of red cells in space behaves
similarly to other body tissues.
Both theories can explain the different losses of red
cell mass for the three missions; their basic dissimilarity
lies in the postulated in-flight kinetic behavior (mono-
tonic vs. biphasic) of red cell mass and red cell produc-
tion. Repletion of red cell mass would begin, according to
the regeneration hypothesis, approximately two months
after launch, whether or not the crew has returned to earth.
In contrast, the continuous loss hypothesis postulates that
red cell mass begins recovery only after the crew returns to
earth and hemodilution accompanied by normal activity
and diet occurs. The differences among the recovery rates
of the three crews can perhaps be explained by the relative
degree of hemodilution of these crews, in accord with the
suggestion of Kimzey [25]. These and other important dif-
ferences between the two theories are summarized in Table
6-11. Both theories were evaluated by computer simula-
tion as discussed in the Chapter 6.5.
6.4.12 Data Limitations and Experimental Error
The credibility of any hypothesis or set of hypotheses
is only as good as the data on which the interpretations are
based. Most of the experimental studies reviewed in this sec-
tion, whether they be spaceflight or groundbased, are rela-
tively sparse with regard to the type of data collected
compared to the number of important hematological indices
available for examination. For example, the computer
model has identified the following parameters as being
potentially critical to characterizing and interpreting the
spaceflight findings: hemoglobin concentration (or he-
matocrit), red cell mass, plasma volume, red cell production
rate, red cell destruction rate, plasma erythropoietin levels,
and blood P50. Of less importance but equally as pertinent are
arterial pO2, bone marrow sensitivity to erythropoietin, meta-
bolic rate, and adequate control or monitoring of diet and
exercise. Although techniques are available for their mea-
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surement in humans and animals, it is rare that more than
several of these parameters are determined in any single
study. In the Skylab program, for example, data for hemo-
globin concentrations and monitoring of dietary intake
were the only critical inflight measurements performed.
Human bedrest studies and animal studies include addi-
tional measurements, but an overall description of the
erythropoietic response to hypogravity must still be based
on a composite of many studies performed by different
investigators under diverse conditions and on different
animal species. The simulation model is ideally suited to
integrate these data, but without additional experimenta-
tion, hypotheses cannot be suitably evaluated.
In addition to the lack of data, the job of interpreting
and utilizing the data that are available is made difficult
because of some inherent inaccuracies in traditional mea-
surement techniques. Reference is made in particular to
determination of erythropoietin, red cell production rates,
and red cell lifespan studies; these are discussed next.
It is the current belief that red cell production is sup-
pressed in association with reduced erythropoietin levels.
An in vitro fetal mouse liver cell assay has recently been
developed [128] that does claim to have the required sen-
sitivity for measuring low level erythropoietin, and re-
sults using this technique are summarized later in this
section. However, this technique is not yet in wide use,
Figure  6-24. Changes in red cell mass in the Skylab crew measured from the day of launch. Each point represents the mean (±SD)
change of the three-man crew as measured on the first day of recovery and during the subsequent postflight period.  The dashed lines
roughly suggest the time course of inflight behavior while the solid lines connect the measured postflight values. The data shown here
are identical to that shown in Fig. 6-7. Only the lines connecting the points have been altered to emphasize that each mission could be
treated as a separate event rather than as points on a continuum. This representation of the data is termed the “continuous loss theory” in
contrast to the “regeneration theory” of Fig. 6-7.
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and other bioassay techniques currently available are gen-
erally not accurate for measuring sub-basal erythropoi-
etin levels. Data are, therefore, extremely limited in this
regard.UPDATE #4
Red cell production rates are most accurately deter-
mined by the indirect method of radio-iron incorporation
into the erythron. However, this method is often neglected
in favor of the more popular use of the reticulocyte index.
Confusing results have been obtained during the
post-spaceflight and post-bedrest periods in which high
rates of reticulocytosis were not accompanied by simulta-
neous increases in red cell mass [20,35]. However, reticu-
locytes are not a reliable index of red cell production during
periods of strong erythropoietic activity [39], so these data
should be viewed with skepticism.
Red cell lifespan studies are used to determine red cell
destruction rates and to ascertain the presence and degree of
any hemolysis. Most of the procedures involve following the
time course of disappearance of radio-labelled cells. Nor-
mally the tracking of these cells requires many days and if
the subject is not in a hematologically stable state (produc-
tion of cells balancing destruction), or if sequestration of
cells occurs, the method yields inaccurate results. The
changing red cell mass accompanying spaceflight and
bedrest studies indicates a non-stable state and, therefore,
caution must be used in interpreting the findings.
The simulation model can assist in identifying the
accuracy with which various parameters should be deter-
mined. Sensitivity analyses and parameter variation stud-
ies indicate the relative importance of parameters and the
degree to which changes in their values can influence over-
all hematological behavior. It has been found, for example,
that shifts of oxygen-hemoglobin affinity can produce dra-
matic changes in tissue oxygenation and that measurements
of P50 should be made with accuracy better than ±1 mmHg.
Comparison of model behavior with experimental ob-
servations and any resulting interpretation, as discussed
in the next section, should take into account the limited
data available and the experimental error associated with
these data.
6.5 Simulations of Ground-Based and
Spaceflight Studies
The model simulations that have been thus far presented
have exemplified the behavior of the model of erythro-
poiesis regulation. However, they did not demonstrate the
greater capabilities of the modeling approach that arise
out of a more direct involvement with experimentation or
experimental data. Model-to-data comparison is a much
more challenging test of model credibility, and it affords
the opportunity to interpret data, evaluate the relative ef-
fectiveness of different control mechanisms and guide the
experimental process. In this section, a number of experi-
mental studies that have been subjected to simulation
analyses will be described.
These studies were performed using both human and
animal subjects and involved both long- and short-term
events. Both the human and mouse versions of the erythro-
poietic control model were employed. The types of stresses
which were examined can be divided into two major cat-
egories: a) stresses which resulted in a relative erythrocy-
tosis (or polycythemia) such as thirst, dehydration, bedrest
and spaceflight where there is an increase in [Hb] but no
increase in red cell mass and b) stresses which result in an
absolute erythrocytosis (or polycythemia) such as hypoxia
Table 6-11. Comparison of Two Theories To Explain Behavior of Red Cell Loss During Skylab Missions
Regeneration Theory Continuous Loss Theory
1. Behavior of RCM Response Loss curve of RCM is biphasic and Loss curve of RCM is monotonic
proposes inflight recovery.
2. Comparison Between Missions All Skylab missions considered Hemoconcentration behavior assumed similar
identical except for duration. on all missions, but other modifying factors
such as diet and exercise were different.
3. Hemoconcentration Hemoconcentration proposed as a Same
causal factor in loss of RCM
4. Inflight Hemodilution Temporary inflight hemodilution Temporary inflight hemodilution has little
responsible for regeneration effect on long-term erythrokinetics.
5. Refractory Period Refractory period exists during No inflight refractory period proposed;
second month in flight. delayed recovery of 28-day flight due to
minimal postflight hemodilution.
6. Recovery of RCM Recovery of RCM initiated after Recovery of RCM initiated only after return
two months from launch irrespective from space.
of time spent in space.
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and red cell infusions where there is an increase in [Hb] as
well as an increase in red cell mass. Because of the scar-
city of data concerning long-term relative erythrocytosis
(which is directly relevant to spaceflight), it was believed
that useful insights could be obtained by studying cases
of absolute erythrocytosis for which a larger body of lit-
erature existed. All of these experimental maneuvers re-
sult in hemoconcentration and erythro-suppression, factors
identified early in this study as possibly being respon-
sible for the red cell mass loss in spaceflight.
As the study progressed and the number of experiments
that were simulated were increased, it became clear that fac-
tors other than hemoconcentration were involved, to an ex-
tent that remains to be determined. Additional hypotheses
were therefore formulated, and these have been described
individually in the previous section. In the following pages,
the results of applying these hypotheses, both singularly
and in combination, to produce realistic simulations of
human and animal responses will be described.
6.5.1 Simulation of Altitude Hypoxia
A simulation analysis of altitude hypoxia was pre-
sented earlier in this volume to demonstrate validity of
the erythropoietic control model (see Chapter 3, Fig. 3-29
and Ref. [5]). One of the more interesting aspects of this
simulation study turned out to be, not the ascent to alti-
tude, but rather the descent back to sea level. Subjects
returning from prolonged stays at high altitude breathe air
at ordinary oxygen levels, but their red cell mass and he-
matocrit are considerably elevated. In the absence of other
changes that influence oxygen supply and demand, the
model predicted that hemoconcentration would suppress
erythropoietin and red cell production until the red cell
mass and hematocrit returned to the original prealtitude
levels. Experimental data confirms the overall changes
that the model predicts in ex-hypoxic subjects as illus-
trated in Fig. 3-29 [69,129-131]. However, it should be
emphasized that a direct cause and effect between hemo-
concentration and erythro-suppression has not yet been
firmly established, although this seems to be a plausible
mechanism. If an increase in hematocrit resulting from a
previous hypoxic exposure could lead to suppression of
red cell production, it seemed reasonable to presume that
the same type of suppression should occur if hematocrits
were increased merely by infusing additional red cells.
Analysis of this latter stress condition is described next.
6.5.2 Simulation of Red Cell Infusion
Polycythemia, induced by infusing red cells from a
donor, has long been known to suppress erythropoietin
and red cell production of the recipient [65]. Induction of
the erythroid-suppressed state by this procedure in the
mouse forms the basis of an erythropoietin bioassay. One
of the few available studies of the long-term effects of red
cell infusion in humans was reported by Birkhill [64] who
showed that the suppression of red cell production was
directly related to the amount of red cells infused.
A simulation of this experiment is illustrated in Fig.
6-25. At the start of the simulation, 800 ml red cells were
infused. The model was modified so that the infused red
cells could be distinguished from the original circulating
red cell mass and could disappear at a linear rate over a
period of 126 days. Analysis of the model’s response
showed that the increased hematocrit leads to tissue
hyperoxia, decreased release of erythropoietin, and sup-
pression of red cell production. Loss of the recipient’s red
cell mass continues until the hematocrit decreases to a
point where erythropoiesis returns toward normal and is
equal to the destruction of recipient cells. As production
rates continue to rise slightly (due to an hematocrit which
is just below normal), the recipient’s red cell mass reaches
a minimum value and then rises toward its control level.
The results suggest that erythropoiesis is under the con-
trol of hematocrit levels, and the renal oxygen sensor in
this instance is behaving as the “hemoglobinometer” de-
scribed by Beutler [52].
The simulation results compare favorably with the
experimental results, both with regard to magnitude and
time course of the changes in hematocrit, disappearance
of infused blood cells, and suppression and recovery of
the recipient’s red cell mass. Allowance should be made
for the fact that the experimental study used only two sub-
jects, did not have the accuracy that radio-labeled cells
would have afforded, and was performed at a time prior to
the identification of erythropoietin.
The similarity between the infusion response and the
descent-from-altitude response of the previously described
simulation should be apparent. In both cases, the increased
hematocrit  contributed to t issue hyperoxia and
erythro-suppression. The degree of suppression was much
greater for the descent phase than for red cell infusion,
primarily because the hematocrit levels were higher in the
former case. In both simulations, a similar value of con-
troller gain (G = 12) was used to obtain the best fit with
experimental data. This also compared favorably with the
controller gain value obtained from mice data previously
reported by Hodgson [47].
6.5.3 Simulation of Bedrest
Bedrest and spaceflight are the only experimental
maneuvers available at present for studying relative poly-
cythemia in healthy subjects over long periods of time. As
we have discussed, in these situations “down-regulation”
of the erythron (i.e., erythrosuppression) is a potential pow-
erful route for restoring hemoglobin concentration to nor-
mal. However, these stresses have received comparatively
little research attention compared to the situations that
lead to “up-regulation”, such as hypoxia and anemia. This
is undoubtedly a major factor contributing to the lack of
understanding of the present problem. Some of the gen-
eral conclusions from bedrest and their relationship to
spaceflight hematology have been presented earlier (see
Chapter 6.2.4). In the following pages a detailed analysis
will be presented in which the mathematical model of eryth-
ropoiesis control was used to simulate and interpret find-
ings from a 28-day bedrest study [4,9,30].
The results of the Baylor College of Medicine (BCM)
study have been presented previously in Fig. 6-6. As in
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previous studies of this type, a small but significant de-
cline of red cell mass (-7%) was observed. Using the math-
ematical model, various hypotheses were tested to provide
insight into the response of the erythropoiesis system to
bedrest. The principal hypothesis under consideration was
that the red cell mass decrease during bedrest could be
accounted for, in large part, by the observed downward
shift in plasma volume. It was believed that the resulting
hypovolemic polycythemia (i.e., relative erythrocytosis)
would lead secondarily to suppression of erythrocyte pro-
duction in the same manner as was suggested for the
hypervolemic polycythemia (i.e., absolute erythrocyto-
sis) of red cell infusion and post-altitude hypoxia.
The 28-day BCM study is particularly worthy of close
scrutiny for several reasons. First, it was of the same length
as the first Skylab mission during which a 14% decrease
in red cell mass was observed. Secondly, the procedures
used were nearly identical to those for the Skylab hemato-
logic experiments and were conducted by the same princi-
pal investigator.  Furthermore, several important
hematologic measurements were made which were not
available from spaceflight studies. These data are crucial
for maximum utilization of the erythropoiesis model.
A preliminary simulation, performed with an earlier
version of the computer model, showed reasonable agree-
ment with a 35-day bedrest study [2]. However, the data
analyzed since that time, including the BCM studies, re-
vealed two important facets of the red cell loss that previ-
ously were not fully appreciated. First, the combined results
from a number of bedrest studies demonstrate that the red
cell loss is a linear function with time (rather than the
exponential disappearance predicted originally by the
model or the biphasic regenerative behavior as suggested
by Skylab data) [30]. Secondly, the earlier observation by
some investigators that red cell mass continues to decline
following bedrest was confirmed during the 14-day and
28-day BCM studies (Fig. 6-6). It appears that this “refrac-
tory” period can last for up to two weeks after bedrest is
ended [28,29,132,133]. The red cell mass eventually re-
turns to normal during the recovery phase, but the precise
dynamics of this event are not clear because of the spar-
sity of data. The ability to mathematically simulate both
of these phenomena, operative during the supine phase
and the recovery phase of bedrest, was singled out as par-
ticularly desirable for the simulation study.
Details of the bedrest study and of treatment of the
data prior to simulation are provided elsewhere [9,30] Simu-
lations were performed using either the bedrest hemat-
ocrit data as a driving function, or in some cases, using an
idealized plasma volume function as a driver. Where pos-
sible, the simulation responses (i.e., red cell mass, plasma
volume, erythropoietin, red cell production) were com-
pared directly with other experimental data. In addition,
parameters were adjusted as necessary, in accord with pos-
tulated events in order to obtain closer agreement between
model and observed responses. For convenience, the re-
sults will be divided into those related to the supine phase
of bedrest, and the ambulatory recovery phase of bedrest.
6.5.3.1 Supine Phase of Bedrest. Figure 6-26 shows
the results obtained using the experimentally determined
hematocrit as the only driving function (from Fig. 6-6).
The open loop gain of the feedback elements (i.e., G) was
adjusted prior to the simulation until the predicted red
cell mass at day 28 was equal to the measured value on
that day. (The gain factor is described fully in Chapter 3
and in Appendix B, Fig. B-4). The gain was assumed con-
stant throughout the supine and ambulatory phases, and
its value was consistent with prior validation studies of
the model involving descent from altitude and red cell
infusions. The linear change in red cell mass and alter-
ations in plasma volume predicted by the model are in
Figure  6-25. Simulated response to sudden infusion of 800 ml
red blood cells (solid lines). Experimental data from a single sub-
ject are shown as filled circles and dashed lines  [64]. Infused
cells disappear completely at a constant rate, while the recipients
red cell mass decreases to a minimum value as erythropoiesis is
temporarily inhibited. Controller gain, G, was set to a value of 12
throughout the simulation.
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excellent agreement with the measured values during the
supine phase.
The model predicts an average fall in plasma erythro-
poietin levels of about 15% and in red cell production rate of
about 27% during the first 28 days. During the subsequent
recovery phase, both of these indices of erythropoietic ac-
tivity increased above baseline levels. These model pre-
dictions are generally, but not totally, consistent with
bedrest data with respect to direction, magnitude, and time
course of change [20,30,34]. Reticulocyte counts (taken
as a measure of red cell production rate) observed during
bedrest, show either a 20% reduction [20], or no signifi-
cant change [35]. The only measurements of erythropoi-
etin made during bedrest with supposedly accurate assays
for sub-basal levels unexpectedly failed to confirm a de-
cline in erythropoietin [35]. However, post-bedrest eleva-
tions in erythropoietin and reticulocytes have been
reported and were generally consistent with the model re-
sults of Fig. 6-26.UPDATE #5
This portion of the simulation suggests very strongly
that hematocrit changes alone (via erythrosuppression) can
account for the magnitude and time course of the red cell
mass decrements observed during the bedrest study. In
addition, the non-linear plasma volume loss and the time
delays in bone marrow production were important con-
tributory factors in producing the linear nature of the red
cell mass decrease in the model and possibly in the human
subjects as well. The effects of these factors on the dynam-
ics of red cell loss are shown more clearly in Fig. 6-27. The
three simulations in that figure were accomplished by re-
ducing plasma volume to the same extent in each case.
Using only an idealized step decrease in plasma volume
and no time delays, the exponential decline of curve A is
generated. The addition of the four day bone marrow tran-
sit time delay increases the linearity of the red cell mass
response as shown in curve B. Curve C was produced by
assuming a more realistic exponential decline of plasma
volume and leaving the time delay function intact. Curve
C represents the optimal predicted response. Therefore,
the only difference between curves B and C is the dy-
namic behavior of plasma volume loss. In case C, the he-
matocrit declines relatively slowly compared to the other
Figure  6-26. Simulation of a 28-day bedrest study. Hematocrit data was used to drive the model during bedrest and recovery phases.
Dashed lines and solid circles represent experimental data  [30]. The off-normal transient at 14 days is a result of ingestion of saline (see
caption in Fig.  6-6). It appears to have affected erythropoietic activity to a small extent but the long term effect on red cell mass seems
negligible. Controller gain, G, was set to a value of 10 throughout the simulation.
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cases, in spite of an equivalent decrement in red cell mass.
This occurs because the plasma volume continues to de-
crease throughout the four-week period in case C in ac-
cord with the data shown in Fig. 6-6. It is noteworthy that
the model’s responses became more accurate as more real-
istic features were added.
Bedrest studies to date have shown that red cell mass
decreases linearly, without apparent limit, up to at least 35
days. These simulations have replicated this phenomenon
and in the process, have revealed that this is true only as long
as plasma volume continues to decline. If the plasma volume
stabilizes at a reduced level (Figs. 6-16 and 6-28), the hema-
tocrit will fall with continued red cell loss and the depressant
effect on erythropoiesis will be diminished. This process will
continue until red cell production converges toward the now
slightly, reduced destruction rate. (If the lifespan of red
cells are assumed constant, destruction rates in the model
are proportional to the total mass of circulating red cell
mass). A new equilibrium will be established at which time
the red cell mass will be reduced and hematocrit will be
slightly above normal. A steady-state error of this type is
expected for proportional control systems. This down-regu-
lation of red cell mass represents a normal physiological
feedback process. As can be visualized from Fig. 6-28,
this process can take a considerable length of time for
perfect equilibrium to be established.
6.5.3.2 Recovery Phase of Bedrest. The initial model
simulation, driven by experimental hematocrit data, failed
to predict the continued decline in red cell mass for the 14
days following the end of bedrest. Instead, the post-bedrest
simulation (as shown in Fig. 6-26 and repeated in Fig. 6-29
(panel A)), exhibits a delay in red cell mass recovery for
Figure  6-28. Simulation response to a step decrease (300 ml) of
plasma volume showing approach toward equilibrium. The entire
response is due to a hemoconcentration-erythrosuppression effect.
The simulation suggests the self-limiting nature of red cell loss when
plasma volume loss stablizes. Equilibrium is realized when rates of
red cell production and destruction converge.
Figure  6-27. Effect of bone marrow time delay and dynamics of
plasma volume (PV) disappearance on red cell mass and hematocrit
behavior during a bedrest simulation. (A) 300 ml PV step decrease
using model with time delays set to zero, (B) 300 ml PV step de-
crease using model with normal first order time delay of 4 days,
(C) PV decreases exponentially with 300 ml depleted at end of
two days and 200 ml additional loss thereafter, using model with
normal time delay. Gain of model adjusted in each case to provide
the same total red cell loss at the end of 28 days. Curve C most
closely approximates the experimental data shown in Fig. 6-26.
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only several days, a result of the bone marrow delay factor,
which is included in the model. The model was used to
examine hypotheses that could account for the delayed
recovery of red cell mass for the remaining post-bedrest
period. Three specific post-bedrest hypotheses were tested:
a) that plasma volume returns toward control levels more
slowly than was assumed (not shown),
b) that there was a temporary increase in the rate of red
cell destruction (Fig. 6-29, panel B), and
c) that there was a shift in oxygen-hemoglobin affinity in
response to the modest hemodilution at recovery (panel
C).
These will be discussed next.
The sparsity of data for the period immediately fol-
lowing bedrest brings into question the true rate of recov-
ery of the post-bedrest plasma volume and hematocrit. No
measurements of plasma volume or hematocrit were deter-
mined until two weeks after the BCM bedrest study. Since
red cell production has been shown to be sensitive to he-
matocrit shifts, it was reasonable to test the hypothesis
that plasma values at recovery do not return toward nor-
mal as rapidly as had been assumed in the simulation of
Fig. 6-29(A). When the assumption that two weeks were
required to return plasma volume to normal (instead of the
two days previously assumed) was tested, the simulated
red cell mass response during the first recovery week was
substantially improved (not shown) in comparison to the
data; that is, there was a slower replacement of red cell
mass. While it is improbable that plasma volume recovery
was this slow [20,32], this simulation suggests that a more
complete experimental determination of the recovery re-
sponse is desirable. Further demonstration of the impor-
tance of plasma volume and hematocrit on recovery
dynamics will be found in the section devoted to space-
flight simulations.
The model was used to test the hypothesis that de-
creased exercise levels during bedrest conserves fragile
Figure  6-29. Simulation (solid line) of various hypotheses to account for delayed recovery of red cell mass during post-bedrest period.
The prebedrest control values are shown by solid circles in panel (A). The supine phase of bedrest which precedes the recovery period
is given in Fig.  6-26. The hematocrit data were used to drive the simulation in all cases shown. (A) effect of hematocrit drive alone, (B)
effect of hematocrit and 50% reduction in RBC lifespan, (C) effect of hematocrit and P50 shift, (D) effect of hematocrit, lifespan reduction
and P50 shift combined. Dashed lines are experimental data  [30].
0
∆P50 = + mmHg
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red cells which are more vulnerable to destruction during
the early ambulatory period. This hypothesis was tested
by reducing the mean red cell lifespan in the model dur-
ing the recovery period in order to represent the more rapid
destruction of fragile cells. The results (see Fig. 6-29, panel
(B)) indicated that in order to completely account for the
recovery response, the mean cell lifespan had to be in-
creased to values that appear to be unrealistically high (i.e.,
50% reduction in lifespan throughout a 2-week period).
Although evidence is not available to confirm changes
in blood P50 during bedrest or spaceflight, it is interesting to
speculate what effect such a shift might have had on the time
course of red cell mass recovery from these stresses. Based on
findings showing decreased oxy-hemoglobin affinity asso-
ciated with many forms of hypoxic disturbances [85], it was
postulated that increases in P50 could have occurred during
the recovery from bedrest in compensation for the observed
hemodilutional anemia. The simulation results suggested that
only a very small increase in P50 of about 1 mmHg would
account for a large part of the decreased red cell mass during
the two weeks of recovery (i.e., compare panels (A) and (C) in
Fig. 6-29). With the change in P50 (panel C) erythropoietin
release is suppressed along with red cell production in com-
parison to the base case (panel A). The transient increase in
erythropoietin concentration shown in Fig. 6-29 (C) at the
time the P50 shift was activated corresponds to a similar event
reported during the 28-day bedrest [35]. The profound influ-
ence that small changes of P50 had on the response was sur-
prising, although suppressed erythropoietin is not an
unexpected result [52].
The possibility was considered that more than one
mechanism might be simultaneously operative during the
recovery phase. For example, reductions in red cell lifespan
and increases in P50 could have occurred which were small
enough to be experimentally undetectable, but which
could produce measurable effects on red cell mass over a
long enough period. This hypothesis was used in the simu-
lation shown in Fig. 6-29 (D) where the lifespan was de-
creased 10% in combination with a +1 mmHg shift in P50.
This resulted in improved agreement with red cell mass
response although red cell production levels failed to rise
above control.
A peculiarity noted in at least two bedrest studies
[20,30] was a sharp increase in reticulocyte index after
bedrest, in the face of a continued decline of red cell mass.
Morse [20] speculated that this paradox could be ac-
counted for by a “compensated hemolytic syndrome in
which in the rate of production balances the rate of hemoly-
sis.” This is in accord with the recovery simulation of Fig.
6-29(B), if one accepts large values of red cell destruc-
tion. Ineffective erythropoiesis, a mechanism not included
in the model, will also produce reticulocytosis while cir-
culating red cell mass is reduced. However, there is no
strong evidence to suggest significant incidences of inef-
fective erythropoiesis [30], and only sparse data exist sup-
porting hemolytic events [20]. A possibility that remains
to be examined is that red cell production during recovery
is much lower than the reticulocyte index indicates. Un-
der conditions of strong erythropoletic stimuli, it is known
that reticulocytes appear much earlier than usual and are
not a reliable index of red cell production [39]. This effect
is not accounted for in the model. Other hypotheses for the
delay in recovery of red cell mass include hemorrhage, splenic
sequestering, and effects of blood sampling, but as discussed
in Chapter 6.4.10, these have tended to be ruled out [15,30].
The results presented thus far support the hypothesis
that red cell losses during long-term supine bedrest, red
cell infusions, and descent from high altitude are all nor-
mal physiological feedback processes in response to the
sequence: hemoconcentration → enhanced tissue-
oxygenation → suppression of red cell production. This is
not to suggest that other mechanisms do not play a contribu-
tory role, but merely that the data available do not permit
one to distinguish between alternate theories. There have
been other hypotheses proposed to account for the suppres-
sion of the erythropoietic system during bedrest. These have
included: a reduction in oxygen requirements [20,34,134];
age dependent loss of red cells [15]; an increase in plasma
phosphates [26]; increased renal blood flow [1,34,95];
changes in gain and thresholds of the kidney-bone mar-
row controller [3]; and changes in energy balance [66].
Some of these factors will be evaluated in the following
simulations of ground-based animal studies and human
spaceflight studies.
6.5.4 Simulation of the Dehydrated Mouse
In the previous simulation studies, similar responses
were demonstrated for cases involving both an absolute as
well as a relative polycythemia. That is, the model was
unable to distinguish between a hemoconcentation-in-
duced erythrosuppression caused, on the one hand by an
excess of red cells, or on the other hand by a loss of plasma
volume. Also, this similarity was not in opposition to the
available experimental data. However, recent studies us-
ing dehydrated mice as a potential experimental model of
spaceflight, have suggested some previously unrecognized
differences between absolute and relative polycythemia.
Because of the potential importance of these findings to
the simulation analysis task, a collaborative effort was
initiated between the scientific investigators of the ani-
mal experiments and the systems analysis team. The re-
sults of this integrative approach provided clues that
factors in addition to hemoconcentration may be involved
in the spaceflight and bedrest responses.
The experiments which will be discussed have been
described in detail elsewhere [6,7,66,68,118] and the re-
sults are summarized in Fig. 6-30. Briefly, dehydration in
mice by water restriction produces a 22% reduction in
plasma volume within the first 24 hours, and a 39% reduc-
tion within 72 hours. The proportional elevation in hema-
tocrit was accompanied by suppression of erythrocyte
production rates, and by the end of three days, a notice-
able reduction in red cell mass. A decrease in red cell pro-
duction (determined by radio-iron incorporation into
newly formed cells) was measured on each of the first three
days of dehydration, with suppression becoming progres-
sively more severe with time. This trend was also evi-
denced by a decrease in cellularity of hemopoietic tissue.
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These findings could have been expected in light of the
mechanisms previously discussed, involving tissue hyperoxia
and suppression of a humoral regulator, erythropoietin.
Erythropoietin titers were reduced, as expected on the sec-
ond and third days of dehydration, but surprisingly, eryth-
ropoietin levels were normal on the first day. This apparent
temporary dissociation between erythropoietin and red cell
production was partially resolved by the finding that the
splenic tissue became less sensitive to erythropoietin
within 24 hours after dehydration. (In mice, the spleen is
an important erythropoietic organ). The reduced sensitivity
was attributed to a reduced food intake which is found to be
a voluntary response to water restriction. In addition, a small
reduction in oxygen consumption was noted by the third
day of dehydration, which may have been related to the
loss in body weight. It was, therefore, hypothesized that a
food restriction induced-negative energy balance can sup-
press erythropoiesis by direct effects on the hemopoietic
tissue and independent of the hemoconcentrating effects
of dehydration (see Chapter 6.4.8).
By comparing the responses of dehydrated, food-re-
stricted mice to those of red cell-transfused mice, it was
possible to separate the effects of hemoconcentration
(which occurs in both groups) from that of food restriction
(which occurs only in the former group). This is indicated
in Fig. 6-31 where suppression of red cell production is
observed for both dehydrated mice and mice transfused to
a hematocrit similar to that observed in dehydrated ani-
mals. Assuming that the hemoconcentration-related effect
is similar for both groups, the differences between the two
responses can be taken as a reflection of the energy related
(i.e., food restricted)  effect. These results suggest that the
initial suppression of erythropoiesis in dehydrated mice,
e.g., within the first 24 hours, is entirely due to a reduced
food intake (because erythropoietin did not change dur-
ing that period). Thereafter, suppression can be attributed
equally to the hemoconcentration and negative energy
balance.
These findings, while demonstrating that factors other
than hemoconcentration are important, did not reveal the
precise pathways that are operative. For example, the fail-
ure of erythropoietin to become suppressed for the first
day in spite of significant hemoconcentration was not ex-
plained. Other studies suggested that hemoconcentration (of
ex-hypoxic mice) is capable of suppressing erythropoietin
within several hours [129]. In addition, other important
factors were not considered in interpreting the results, such
as the effect of hypovolemia and hypervolemia during
relative and absolute polycythemia, respectively. Blood
volume is an indirect modifying influence on oxygen trans-
port as described earlier (see Chapter 6.3.3). Nevertheless,
the wealth of data from animal experiments such as these
suggested that a more rigorous examination of the data
using systems analysis techniques could help resolve these
issues.
An understanding of the experimental results is fa-
cilitated by a theoretical analysis of the differing effects
of hemoconcentration by either increasing the red cell
mass, for example, by hypertransfusion, or by reducing
the plasma volume, for example, by dehydration (see Fig.
6-32). Both conditions are characterized by hemoconcen-
tration with resulting increases in oxygen delivery, e.g.,
tissue PO2, decreased erythropoietin, and suppressed eryth-
ropoiesis. The increased viscosity accompanying hemo-
concentration provides a resistance to blood flows and
leads to a force that opposes, but apparently does not over-
whelm the direct hemoconcentration effect. Several im-
portant differences also exist  between the two
hemoconcentration stresses: a) dehydration is hypovolemic
while transfusion is hypervolemic; therefore, the effect of
blood volume on blood flow (i.e., the oxygen delivery
rate) is additive to the viscosity effect during dehydra-
tion, but in opposition during transfusion; b) dehydration
in mice results in a decreased oxygen demand which could
have a significant effect if manifested at the renal oxygen
sensing site; c) dehydration in mice also has been found
to be accompanied by reduced ad libitum dietary intake,
and this may be responsible for the reduced responsive-
ness and a decreased time delay in cell maturation ob-
served in hemopoietic tissue. The pathways by which diet,
and especially a negative energy balance, might affect
erythrocyte production was previously discussed in detail
(see Chapter 6.4.8 and Fig. 6-19). The crucial fact here is
that diet restriction can suppress erythrocytes directly, with-
out altering erythropoietin. The individual effects of these
pathways have been studied by model simulation tech-
niques and those analyses suggest that red cell mass would
be expected to decrease more rapidly and to a larger ex-
tent with dehydration (accompanied by food restriction),
than with transfusion.
Simulations of the three-day dehydration experiments
were performed in a version of the erythropoietic control
model that was specifically adapted to the mouse. This
version of the model is described in Chapter 3 and Appen-
dix B. The elements of the original human model which
were modified to formulate a mouse model included pa-
rameters that were based on size (i.e., blood volume, plasma
volume, red cell mass) and total oxygen uptake, and pa-
rameters that were based on values which are known to be
species-specific, irrespective of size, e.g., red cell lifespan
and the oxygen-hemoglobin equilibrium curve. In addi-
tion, validation studies were required to ascertain if the
model could realistically respond to short-term stress con-
ditions as it does to longer-term disturbances. One such
validation study is shown in Fig. 6-33, in which erythro-
cyte production responses to single and multiple injections
of erythropoietin are illustrated. These results compare fa-
vorably to the dynamic behavior of reticulocytosis follow-
ing erythropoietin injections, as measured some years ago
in the mouse [121]. These and other short-term validation
studies [68,118] provided the basis for utilizing the model
for simulating dehydration and infusion experiments.
Two simulations based on the analysis of Fig. 6-32 are
shown in Fig. 6-34. Identical increases in hematocrit were
accomplished by either step increases in red cell mass simu-
lating transfusion or by more gradual reductions in plasma
volume similar to the dehydration maneuver. The transfu-
sion response, which agrees with animal (Fig. 6-31) and
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Figure  6-30. Dehydration response in mice restricted from water for 3 days. Loss of body water is reflected in reduced body weight,
plasma volume and increased hematocrit. The voluntary food restriction that always accompanies water restriction in mice results in
further weight loss and presumably influences changes in splenic sensitivity to erythropoietin, cellularity of the erythron, and oxygen
uptake. A reduction in erythropoietin, erythropoiesis, and red cell mass are the secondary hematological responses to food and water
restriction as suggested by the hypothesis chart of Fig.  6-19. (Data obtained from Dunn and coworkers [66,68,118]).
0     1          2             3
Time (days)
.7
.6
.5
.4
H
em
ac
rit
, v
ol
. %
70
60
50
R
ed
 C
el
l M
as
s,
[vo
lum
e 
(m
l)]
80
60
40
Pl
as
m
a 
Vo
lu
m
e,
 
m
l
25
20
15
Bo
dy
 w
ei
gh
t, 
gm
6
4
2
0
Fo
od
 in
ta
ke
, g
m
/d
ay
.3
.2
.1
0E
ry
th
ro
po
ie
tin
, 
un
its
/m
l
30
20
10
0E
ry
th
ro
po
ie
si
s 
ac
tiv
ity
(%
 59
Fe
 in
co
rp
or
at
io
n)
100
75
50
25S
en
si
tiv
ity
 o
f e
ry
th
ro
n
to
 E
P 
(%
 o
f c
on
tro
l)
100
75
50
25C
el
lu
la
to
ry
 o
f e
ry
th
ro
n,
(%
 o
f c
on
tro
l)
20
15
10
O
2 
u
pt
ak
e,
 m
l/h
r
0     1          2             3
Time (days)
NASA/CR—2020-220487 250
human studies (Fig. 6-25) was produced by using only the
influence of hemoconcentration. If hematocrit changes
alone were the only factors considered in the dehydration
case, its responses would be extremely similar to the trans-
fusion responses because the model responds to the mag-
nitudes of the hematocrit disturbances, regardless of their
causes. However, the analysis discussed above demon-
strates important differences in the erythropoietin and red
blood cell production responses for these two cases. In
order to achieve closer agreement with the animal data
and produce the results shown here, it was necessary to
include the additional factors addressed in Fig. 6-32 in
simulating the dehydration case. These factors included
alterations in blood flow (a decrease of 10% during the
first day which, by an assumed renal autoregulatory effect,
returns to normal thereafter), reduction in maturation time to
25% of that used in the transfusion case, and a decreased
responsiveness of hemopoietic tissue as dictated by experi-
mental results (Fig. 6-30).
With the addition of these hypotheses, the model dem-
onstrated the capability of simulating different responses
for dehydration and transfusions and the model responses
compare favorably with those found experimentally. Physi-
ologically, the two most important aspects of this simula-
tion are a delay in erythropoietin suppression during
dehydration, but not after transfusion, and a delay in sup-
pression of red cell production after transfusion, but not
during dehydration. Thus, the dissociation between eryth-
ropoietin and red cell production during dehydration, ex-
plained by direct action of diet restriction on hemopoietic
tissue which bypasses the erythropoietin pathway, coupled
with a transient decrease in blood flow, was successfully
reproduced in the simulation (see Fig. 6-34).
Simulations that are more detailed were also performed
of the dehydration experiments. Figure 6-35 shows the
response both for the mouse and for the mathematical
model for 3 days of dehydration and 7 subsequent days of
rehydration. The suppression of erythropoietin and red
cell production is similar to that shown in Fig. 6-34. Dur-
ing dehydration, the following parameters were adjusted
in a direction in accord with the hypotheses presented in
Fig. 6-32 and, where possible, in a magnitude dictated by
the experimental results: a) a decrease in plasma volume
as shown; b) a transient decrease in blood flow (-10%) for
the first 24 hours; c) a gradual decrease in responsiveness
of hemopoietic tissue to erythropoietin to 20% of control;
d) a gradual decrease in oxygen uptake to 80% of control;
and e) a reduction of the time (i.e., maturation time) re-
quired for erythrocyte production to respond to influenc-
ing factors. During rehydration, these parameters were
returned to normal and only the plasma volume influence
was used to drive the simulation. These choices of param-
eter adjustments were established by a trial-and-error pro-
cedure, continually testing the model response against the
experimental data.
Once a reasonable simulation is achieved, as demon-
strated in Fig. 6-35, it is then possible and instructive to
determine the relative influence of each major factor on
the final response. This is accomplished easily with a
model by first performing the optimal simulation with all
the required hypotheses and then selectively removing
one or more of the effects (i.e., setting the model param-
eter at its control value) and performing the simulation
again. In this particular case, it is convenient to think of
the dehydration response as being under the influence of
both a negative water balance effect and a negative en-
ergy balance effect. Of the five hypotheses described in
the paragraph above, the first two (plasma volume and
blood flow effects) are related to water balance and the
remaining hypotheses (hemopoietic responsiveness, oxy-
gen uptake, and transit time) are related to energy balance
effects. Two simulations were performed, as shown in Fig.
6-36, to examine the separate influences of these water
Figure  6-31. Rates of erythropoiesis as measured by radio-iron
incorporation in newly formed cells.  Dehydrated mice are shown
by open circles and dashed line and transfused mice are shown by
filled circles and solid line. Vertical bars indicated ±SEM.
(* = P < 0.05 from controls; + = P < 0.05 of dehydrated mice
compared to transfused animals). Since the transfused mice ate and
drank normally and the dehydrated mice were also food restricted,
it is assumed that the difference between the two curves reflect the
erythroid suppression of the energy related component.
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balance and energy balance factors on the red cell mass,
red cell production rate, and erythropoietin levels.
It is clear that the effect of the hypotheses related to a
negative energy balance has a more profound influence
on erythro-suppression than the hypotheses related to a
negative water balance. However, it should be noted that
the suppression of erythrocyte production during the wa-
ter balance simulation, while less acute, is quite similar in
magnitude to that predicted for bedrest (see Fig. 6-26).
And while in the case of bedrest, a negative water balance
is a sufficient stimulus to decrease the red cell mass sig-
nificantly given sufficient time, the three-day dehydra-
tion experiment is far too short to produce a noticeable
effect on red cell mass in this simulation. Most of the de-
crease in red cell mass during short-term dehydration is,
therefore, attributed to the dramatic inhibition of red cell
production as induced by energy balance factors. Also of
interest is the fact that erythropoietin levels for the two
cases considered are similar, when compared to their quite
dissimilar effects on red cell production and red cell mass.
The entire erythropoietin effect in the energy balance simu-
lation is due to the reduction in oxygen uptake.
The computer simulations were particularly valuable
in revealing unusual trends in the data and suggesting
clarifying experiments. A summary of the major problem
areas that were resolved with the assistance of the model
are listed in Table 6-12. The first column represents the
trends in the data that were not easily explained by the
original computer analysis or by intuition. One or more
hypotheses that could resolve the descrepancy, as sug-
gested by the simulation approach, are shown in the sec-
ond column. The last column indicates the results of
second generation experiments which were performed to
test the hypotheses in the laboratory. The model behavior
suggested that all of the hypotheses listed in Table 6-12
were theoretically credible, but, as shown, the experimen-
tal evaluation proved that some of them were “ruled out”
because they were not biologically plausible. The inter-
action between modeling and animal testing demonstrated
that the hemoconcentration effect (i.e., plasma volume
changes) and negative energy balance effects (i.e., reduc-
tions in tissue sensitivity to erythropoietin and metabolic
rate) were the most influential in accounting for the ex-
perimental findings, e.g., Items 1,2 and 6 in Table 6-12.
However, in order to bring all of the simulated variables
into agreement with the experimental findings, several
additional factors need to be considered, which eventu-
ally produced the simulations presented in Fig. 6-35. These
factors, shown in Table 6-12 (Items 3,4 and 5), are dis-
cussed in the next three paragraphs.
The red cell mass decreased more rapidly in vivo than
was predicted by the computer model. The animal data
could be simulated by assuming a 50% increase in the rate
of red cell hemolysis during dehydration. Estimation of
serum bilirubin levels failed to support this concept. Sur-
vival of 51Cr-labelled red cells also failed to support the
concept of increased hemolysis during dehydration. How-
ever, these measurements demonstrated that the normal
red cell lifespan in the particular strain of mice used to
study dehydration was about half the value used initially
in the computer model (which was based on accepted lit-
erature data [135]). Adjustment of the computer parameter
for red cell destruction to 5.3% per day (corresponding to
a life span of 20 days rather than the original value of 40
Figure  6-32.  Hypotheses that explain differences between transfusion and dehydration polycythemia.  (PV=plasma volume, RCM=red cell
mass, HCT=hematocrit, BV=blood volume, BF=blood flow, PO2=renal tissue oxygen tension, EP=plasma erythropoietin concentration).
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days) resulted in a good simulation of the experimentally
determined changes in red cell mass not only during de-
hydration but also during rehydration.
Even when appropriate changes in metabolic rate and
tissue sensitivity to erythropoietin were incorporated into
the computer simulation, the rate of red cell production
did not fall as rapidly as was determined experimentally.
Therefore, the computer simulation shown was obtained
by reducing the transit time for red cell precursors through
hematopoietic tissue to one day from its nominal value of
3 to 5 days [121,136]. Experimental justification for this
maneuver is based on the following evidence: spleen and,
particularly bone marrow cellularities show marked de-
creases within 24 hours of commencing dehydration (see
Fig. 6-30), and proliferation of normal marrow stem cells
in vitro is more rapid for the strains of mice used in these
experiments than in other strains, suggesting a normally
shorter transit delay in red cell production (C.D.R. Dunn,
unpublished observation).
In the computer simulations, an increase in hemat-
ocrit, whether induced by red cell transfusion or a reduc-
tion in plasma volume, resulted in an immediate decrease
in serum titers of erythropoietin (i.e.. see Figs. 6-25 and 6-
26). In contrast, in the dehydrated animal studies, erythro-
poietin remained normal for at least the first 24 hours of
dehydration. Four factors were considered to bring the
computer simulations into agreement with the experimen-
tal findings:
a) a change in the sensitivity of the erythropoietin pro-
ducing system; if the hormone producing system be-
came less sensitive to increases in tissue oxygen then,
theoretically, this might be expected to maintain eryth-
ropoietin titers near normal;
b) a change in erythropoietin half-life (t1/2); if erythropoi-
etin t1/2 is related to marrow erythroid activity [137]
Figure  6-33.  Simulated responses of mouse model to erythro-
poietin injections: (a) bone marrow response to single dose of
erythropoietin. (b) bone marrow resonse to multiple doses of eryth-
ropoietin. Arrows indicate time of injections.
Figure  6-34. Simulated responses to red cell transfusion (solid
line) and dehydration (dashed line) using the mouse model. For
the case of dehydration, the plasma volume was reduced over a
period of one day while in the case of transfusion, red cells were
infused instantaneously, resulting in a similar degree of hemocon-
centration for both cases. In addition, the following parameter
adjustments were made during the dehydration simulation only to
reflect energy balance effects: red cell maturation time reduced
from 2 days to 0.5 days; controller operating point, P1, reduced
from 1.0 to 0.2; blood flow reduced to 90% of control for the first
day and then returned to normal. Controller gain was set at G = 18
for both simulations.
0
12
Pl
as
m
a 
Er
yt
hr
op
oi
et
in
C
on
ce
nt
ra
tio
n
(x 
no
rm
al)
40
70
R
ed
 C
el
l P
ro
du
ct
io
n
(m
l/d
ay
)
0 2  4   6   8   10
Time (days)
0
12
Pl
as
m
a 
Er
yt
hr
op
oi
et
in
C
on
ce
nt
ra
tio
n
 
(x 
no
rm
al)
40
70
R
ed
 C
el
l P
ro
du
ct
io
n
(m
l/d
ay
)
(a)
(b)
Hematocrit
Plasma Erythropoietin
(x Normal)
Red Cell Production
Rate (x Normal)
Transfusion
Dehydration
NASA/CR—2020-220487 253
then suppressed erythropoiesis might be expected to
extend t1/2 which, in turn, would act to maintain serum
erythropoietin titers near normal;
c) a shift in blood P50; a decrease in P50 would diminish
oxy-hemoglobin affinity and the degree of oxygen un-
loading at the tissue level, thus tending to increase
erythropoietin levels;
d) a change in renal blood flow; theoretically, the reduced
plasma volume would be expected to increase blood
viscosity and passively blood vessels to shrink in di-
ameter. Both of these effects would reduce blood flow
and oxygen transport.
The first three assumptions were examined experimen-
tally [7] and found not to change. However, other investi-
gators have shown a reduction in the sensitivity of
erythropoietin release to hypoxia following dehydration
[115]. As far as blood flow is concerned, it was assumed
that a reduction in renal blood flow could occur only dur-
ing the first day in the light of the excellent flow auto-
regulatory capability of the kidney. This remains a
hypothetical but perhaps logical explanation for the main-
tenance of normal erythropoietin titers, despite an in-
creased hematocrit. It was not possible, at the time, to
experimentally test this hypothesis.
These studies illustrate the potential usefulness of the
interaction of experimental and computer studies in the
systematic analysis of alterations in the control systems of
specific biological processes. Thus, the red cell lifespan,
oxygen uptake, sensitivity of the erythropoietin produc-
ing system, erythropoietin half-life, and blood P50 would
probably not have been measured if experimental and com-
puter studies had originally been in agreement. Also, cer-
tain concepts such as the effects of total blood volume
and blood flow on tissue oxygenation, and of red cell
marrow transit times on erythropoietic dynamics would
probably not have been considered to explain the data
obtained in the dehydrated mouse if computer simulations
had not been undertaken.
Figure  6-35.  Simulation and experimental murine hematological
responses to 3 days of dehydration and 7 subsequent days of
rehydration.  The mouse data was taken from a composite of
several different experiments reported by Dunn and co-workers
[7,66,68,118].
Figure  6-36.  Simulated responses of mouse model showing the
separate effects of water balance factors (solid line) and energy
balance factors (dashed line) in producing the combined response
illustrated in the previous figure. Water balance factors consist of
reductions in plasma volume and blood flow. Energy balance fac-
tors include decreases in oxygen demand, marrow responsive-
ness, and cell maturation time. See text for description of parameter
adjustments during each simulation.
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In summary, these animal and computer studies have
shown that hemoconcentration is a major factor in pro-
ducing erythro-suppression in both absolute and relative
erythrocytosis. However, when hemoconcentration is
caused by water-restriction, an additional factor is present
that reduces the responsiveness of hemopoietic tissue to
erythropoietin. The negative energy balance that accom-
panies dehydration in mice was implicated as a causative
agent in this mechanism. The hypovolemia of dehydra-
tion may have contributed to a transient decrease in blood
flow, which together with the reduced insensitivity of he-
mopoietic tissue accounts for a temporary dissociation
between erythropoietic activity and its hormone regula-
tor. Extrapolating to the spaceflight situation, it is sug-
gested that the negative energy balance may contribute to
the loss in red cell mass to a degree that had heretofore not
been appreciated. Food intakes that are lower than neces-
sary to maintain energy balance and body mass have often
been observed in astronauts (see Chapter 4.6).
From the point of view that dehydrated mice and space
travelers have both been observed to experience a nega-
tive water and negative energy balance which leads to
hemoconcentration and reduction in erythropoietic activ-
ity, the dehydrated mouse may be considered to be a suit-
able ground-based analog of the hematological response
to weightlessness. However, there are several important
differences between the humans exposed to zero-g and
their dehydrated animal counterparts:
a) hemoconcentration of astronauts may not necessarily
occur by fluid restriction, but rather by excess renal
excretion secondary to headward fluid shifts;
b) the reduced body fluid volume of space travelers is be-
lieved to be appropriate for health in zero-g while de-
hydrated mice cannot be maintained for more than sev-
eral days because of water and nutritional deficiency;
c) the body fluid composition of astronauts are more likely
to be normal compared to dehydrated mice; and
d) food restriction in human space travelers have typi-
cally been observed in conjunction with space sick-
ness, which is not always present, while food restric-
tion in mice always accompanies fluid restriction.
Therefore, these animals can, at best, represent the
human condition in zero-g for only a brief period of time
and only when both food and water restriction is evident.
6.5.5 Spaceflight Simulations
Many factors have been discussed which could have
contributed to the anemia of spaceflight. The available
inflight data, as sparse as it is, together with the analysis
of human and groundbased studies, does permit specula-
tion to center on several probable pathways. It seems plau-
sible to suggest that the enhanced oxygen carrying
capability of hemoconcentrated blood and the decreased
energy balance of a restricted diet may have limited the
production of erythrocytes. Other factors which cannot
Table 6-12.  Dehydrated Mouse Study: Hypotheses Formulated and Tested To Explain Discrepancy Between Experimental and
Simulation Responses
     Problem Hypothesis Revealed by Simulation Experimental Evaluation
1. Explain reduction in red cell Erythropoietin suppression induced by Hemoconcentration confirmed; tissue
production during dehydration tissue hyperoxia secondary to oxygenation not measured; EP not
hemoconcentration. suppressed on first day. 
2. Explain reduction of Reduction in sensitivity of hemopoietic Confirmed for spleen, but not for bone
erythrocyte production despite  tissue to EP marrow
normal EP titers on first day of
dehydration.
3. Explain normal EP titers on first a) Reduced sensitivity of renal tissue to a) Ruled out
day despite hemoconcentration    tissue oxygenation.
and reduced erythrocyte production b) Increased EP half-life b) Ruled out
rates. c) Increased oxy-hermoglobin affinity c) Ruled out
d) Reduced blood flow d) Not measured; cannot be ruled out
4. Explain larger decrement in Reduction in red cell lifespan Hemolysis ruled out, but normal life span
red cell mass during dehydration found to be shorter than originally believed.
than is predicted by model.
5. Explain rapid fall in erythrocyte Reduced response time of hemopoietic Confirmed for splenic tissue
production on first day of tissue to EP, i.e., shorter time delay,
dehydration despite maturation
time delay
6. Explain more rapid and extreme Delayed reduction in oxygen uptake Confirmed
fall in EP titers after first day of
dehydration than is predicted
by model on basis of
hemoconcentration.
NASA/CR—2020-220487 255
presently be ruled out, but which are believed to be ca-
pable of exerting a secondary influence, include the pos-
sibility of some red cell destruction, the influence of a
slightly hyperoxic environment, shifts in oxygen-
hemoglobin affinity, changes in total blood volume, blood
flow alterations, and the varying levels of exercise per-
formed by the space crews.
The problem which remains is to relate these factors not
only to the absolute fall in red cell mass, but to the varying
degrees to which red cells disappeared in the different Skylab
missions as well as to the non-uniform kinetics of postflight
recovery. Within limits, the techniques of computer simula-
tion have proved valuable in integrating the available data
with current concepts of erythropoietic regulation and choos-
ing between alternative zero-g hypotheses. Simulation stud-
ies will be presented in this section in three broad areas:
suppression of red cell mass during spaceflight; postflight
recovery of red cell mass; and comparison between bedrest
and spaceflight erythrokinetics.
6.5.5.1 Suppression of Red Cell Mass During Space-
flight. The kinetics of red cell mass disappearance during
flight is unknown because of the lack of measurements.
Two theories have been advanced to explain inflight
erythrodynamics and to account for the different net red
cell mass losses observed on the three flights (see Chapter
6.4.11). Evaluation of these two divergent concepts, termed
the “regeneration theory” and the “continuous loss theory”
will be described below.
6.5.5.1.1 Evaluation of Regeneration Theory. The re-
generation theory hypothesizes that red cell mass decre-
ments occur within the first month of flight and that
repletion of cells begins shortly thereafter whether or not
the human subjects return from space. In the previous dis-
cussion of this theory, it was argued that while regenera-
tion is theoretically a possibility, the supporting data are
weak and inconclusive. In particular, the suggestion by
Kimzey [15,25] that a temporary hemodilution (observed
during a single inflight day) could trigger the regenera-
tion of red cells over the next month was deemed unlikely.
The improbability of this event received support, inad-
vertently, from a bedrest study in which a large amount of
ingested saline was tested as a countermeasure for orthos-
tatic intolerance (see Fig. 6-6). The resulting temporary he-
modilution did not appear to alter the course of red cell
disappearance. This conclusion was supported by computer
simulation studies, although a small effect on erythro-
kinetics of the bone marrow was demonstrated (see Fig. 6-
26).
There are factors other than inflight hemodilution
which can be conceived to be responsible for regeneration
of red cell mass. Simulation analysis has suggested sev-
eral guidelines which can be used in formulating hypoth-
eses, for example:
a) regeneration is only possible if production rates of red
cells increase above destruction rates;
b) a biphasic regeneration response (see Fig. 6-7) is not
likely to occur when two competing stimuli, one
erythro-suppressive and the other erythro-active, are
initiated simultaneously, and are maintained for the
same length of time; and
c) a biphasic red cell mass recovery curve becomes more
credible by assuming that an early erythro-suppressive
influence is followed by an erythro-active stimuli.
It can be assumed that one suppressive influence on
red cell production is that of hemoconcentration, which
appears to persist at progressively diminished levels
throughout three months of spaceflight (Fig. 6-23). How-
ever, experimental and simulation studies have shown that
a chronically maintained relative polycythemic condition
will not, by itself, allow production rates to rise to levels
which promote red cell mass regeneration (see Fig. 6-26
and 6-28). Therefore, it is likely that additional factors or
events must be postulated to account for regeneration. Two
scenarios have been postulated. First, a stressor acting
early in flight reduces the red cell mass within the first few
days or weeks and thereafter its influence is greatly dimin-
ished or entirely disappears, thereby permitting normal or
enhanced erythropoiesis. Examples of such a stressor
which would be compatible with spaceflight data may in-
clude hemolytic destruction of cells early in flight or re-
stricted dietary intake early in flight. Secondly, some
stimuli not previously present could increase production
rates late in flight. Such an effect could be induced by
some as yet unknown adaptive influence of zero-g on oxy-
gen transport (i.e., shifts in oxy-hemoglobin affinity) re-
nal blood flow, or the bone marrow. However, there is
currently no evidence of any kind for such a late acting
mechanism during spaceflight or bedrest, and this possi-
bility will not be considered further.
With regard to the first scenario of an early acting
stressor, two hypotheses were examined by simulating the
59-day Skylab mission. In the study illustrated in Fig. 6-
37, it was assumed that the renal-bone marrow controller
exhibited a reduction in responsiveness (i.e., change in
sensitivity and threshold) during the first month in space.
The suppression was removed during the second month
and a small enhancement in responsiveness was assumed
thereafter. A concomitant reduction in plasma volume was
imposed for the first two months before returning to nor-
mal as suggested by hematocrit changes and bedrest stud-
ies. The rationale behind the change in controller
sensitivity was not well formulated at the time this simu-
lation was first performed [3]. Subsequently, the work with
dehydrated mice (see Chapter 6.5.4) suggested that such a
parameter alteration is a somewhat plausible representa-
tion of the influence of the negative energy balance ob-
served in the 59-day Skylab mission [101] (also see
Chapter 4.6). In that flight, the severe symptoms of space
motion sickness impaired normal dietary intake for the
first mission week. Thus, an early reduction in red cell
mass could have occurred on two accounts: hemoconcen-
tration, and reduced dietary intake. Later in flight, the
dietary intake increases toward normal while the hemo-
concentration effect diminishes somewhat, as red cell mass
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is lost. This might favor increases in bone marrow produc-
tion and a partial restoration of red cell mass.
While this simulation of the 59-day mission agrees
with the regeneration curve composed of data from all 3
flight crews, corresponding simulations of the 28-day and
84-day missions did not show similar agreement for two
reasons. First, dietary restriction was not severe on the
shortest flight and almost non-existent on the longest
flight, so that the controller parameters would not be ex-
pected to change to the same extent as shown in Fig. 6-37.
Secondly, plasma volume levels should return one month
sooner than shown for the 28-day flight and one month
later than shown for the 84-day flight. When these changes
were instituted, the inflight red cell mass response curve
departed widely from the regeneration curve based on
postflight crew data.
A second hypothesis to explain regeneration was ex-
amined in which it was assumed that a loss of red cells
took place during the first several days of the mission.
Such a loss could be explained by intravascular hemoly-
sis or splenic sequestration and destruction of cells.
Johnson [26] speculated that if this loss occurred selec-
tively in older cells, it would not necessarily be detected
by lifespan measurements (see Chapter 6.4.10). Figure 6-
38 illustrates the simulated responses for two cases:
a) a short period of hemolysis (10% of cells destroyed in 3
days), and
b) hemoconcentration produced by a sustained reduction
in plasma volume leading to erythrosuppression.
The latter case is similar to previous illustrations of
hemoconcentration (see Fig. 6-28). Hemolysis (solid line)
results in a biphasic regeneration response of red cell mass,
but since hematocrit and erythrocyte production rate re-
sponses are opposite to expected or measured values, it is
not likely that hemolysis by itself can account for either
the entire spaceflight loss of red cell mass or its regenera-
tion. Hemoconcentration alone (dashed line) does account
for loss in red cell mass, but as suggested earlier, a regen-
eration response is not possible by this mechanism.
The simultaneous occurrence of hemoconcentration
and hemolysis is illustrated in Fig. 6-39. Two responses
are shown, the solid line representing the case where
hemolysis destroys 10% of the cells, and the dashed line
representing 20% of cell destruction. A plasma volume
reduction of 500 ml was imposed on both simulations. If
Figure  6-37. Simulation of the 59-day Skylab mission illustrat-
ing the hypothetical conditions under which regeneration of red
cell mass may take place. Plasma volume was assumed to de-
crease during the entire inflight phase and controller responsive-
ness was assumed to decrease only during the first month. This
resulted in the decline of red cell mass. Regeneration took place
following postflight hemodilution (return of plasma volume to
normal) and a postulated increase in controller responsiveness.
The experimental red cell mass is a composite of postflight mea-
surements obtained from the nine Skylab crewmen  [3,124].
Figure  6-38. Simulation analysis comparing loss of red cell mass
by either hemolysis of 10% of the circulating red cells during the
first 3 days (solid line) or plasma volume reduction of 500 ml
maintained throughout the period studied (dashed line).  Acute
hemolysis produces a biphasic regneration response but the hema-
tocrit and red cell production are opposite to the responses expected
for hemoconcentration alone. The effect of both stresses, hemolysis
plus hemoconcentration, acting together are shown in the next figure.
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Figure  6-39.  Simulated analysis of hemolysis as a possible
causative factor of regeneration.  In both cases shown, the plasma
volume was reduced stepwise by 500 ml and this was combined
with an acute 3-day hemolysis simulated by transiently reducing
the red cell lifespan.  Qualitatively different responses are seen
when either 10% (solid line) or 20% (dashed line) of the circulat-
ing red cell mass is destroyed by hemolysis. Note that after hemoly-
sis, the loss of red cells continues in the case of 10% loss, due to
hemocentration effects.
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cell destruction is large (dashed line), a biphasic regen-
eration curve of red cell mass is apparent, as in the case of
hemolysis by itself. However, the accompanying hemat-
ocrit response is triphasic, quite unlike the observed
inflight data. On the other hand, for smaller degrees of
hemolysis that are not large enough to reduce hematocrit
to below control levels (solid line), hemoconcentration is
evident throughout the response period and production
rates are below control as expected. On the other hand, the
red cell mass no longer exhibits regeneration characteris-
tics. In fact, the simulation predicts that the long-term re-
duction in red cell mass is the same whether or not
hemolysis occurs; it is only the short-term response which
results in enhanced red cell mass loss due to the addition
of hemolysis.
It becomes apparent that alterations in hemoglobin
levels consistent with those observed during Skylab could
not by themselves generate computer simulation responses
comparable to the observed changes in red cell mass, if
one accepts a composite (multi-mission) view of the post-
flight data. These analyses suggest that some degree of
regeneration of red cell mass may have occurred in iso-
lated instances such as during the 59-day mission when
severe space motion sickness resulted in large temporary
decrements in food intake. But it is difficult to demonstrate,
on the basis of plausible hypotheses, that regeneration is a
universal phenomenon of space travelers as originally sug-
gested [25]. The simulation and experimental studies have
tended to rule out inflight hemodilution, negative energy
balance, or hemolysis as causative factors in the regenera-
tion phenomenon. However, it has been impossible to rule
out a modest early inflight hemolysis event as a contribu-
tory factor to red cell mass loss (without regeneration)
during spaceflight.UPDATE #3
6.5.5.1.2 Evaluation of Continuous Loss Theory. The
continuous loss theory specifies that red cell mass depletes
gradually as a function of time in weightlessness, similar
to the behavior seen in bedrest. Furthermore, the differ-
ences in red cell mass loss among the Skylab crewmembers
who remained in space for varying time periods is assumed
not to result from any adaptive or regenerative process.
Rather, it is proposed that factors that influence erythro-
poietic activity are present in different degrees in the three
missions. The net result of these factors is presumed to be
a suppression of erythropoiesis that is greatest during the
shortest Skylab flight and least during the longest flight.
The most promising candidates which have been iden-
tified as erythrosuppressive factors and which were known
to be present during spaceflight are those related to hemo-
concentration and negative energy balance. Energy bal-
ance is determined by diet and physical activity, and it
appears that both of these were adequate on the longest
flight and grossly inadequate on the shortest flight [116;
see Chapter 4.6]. It is known that dietary restriction sup-
presses erythrocyte production, and it will be assumed that
a reduced amount of activity has the same effect (see Chap-
ters 6.4.7 and 6.4.8). These three factors, hemoconcentra-
tion, diet, and activity, and an estimate of their varying
presence on the Skylab missions are given in Table 6-13.
Two other factors are also listed, hemolysis and hyperoxic
blood, which could have been present on the 28-day mis-
sion to a modest extent (see Table 6-3 and Table 6-9). The
analysis of Table 6-13 provides a rational basis for quali-
tatively predicting that the greatest red cell mass loss oc-
curred on the shortest mission and the smallest loss
occurred on the longest mission. These factors were sub-
jected to further quantitative examination using simula-
tion and statistical analysis.
Evaluation of the continuous loss theory was accom-
plished in two stages. First, the influence of hemoconcen-
tration (negative water balance) on red cell mass was
ascertained by computer simulation. Secondly, the differ-
ences in energy balance factors were described and tested.
The hematological responses of the Skylab crew that
resulted only from the influence of hematocrit alterations
were estimated by computer simulation. Figures 6-40 and
6-41 illustrate the computer-generated responses for the
59-day and 84-day missions, respectively, using only the
mean inflight plasma hemoglobin concentration data to
drive the model. (The 28-day mission was not simulated
because no inflight hemoglobin data were obtained on
that flight). This procedure is identical to that used in the
bedrest analysis (Fig. 6-26). The postflight values of
plasma volume and red cell mass (no inflight measure-
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ments were determined for these quantities) are indicated
by solid circles. The gain factor, G, was adjusted (and held
constant throughout the simulation) so that the simulated
total inflight red cell mass loss agreed with the measured
value obtained on recovery day. No further gain adjust-
ments were made to simulate the postflight period. Agree-
ment between model and data during the postflight period
for red cell mass and plasma volume is considered good.
These simulations represent the first systematic at-
tempt to predict, on a continuous basis, inflight red cell
mass and quantities associated with its regulation using
actual flight data. The regulatory basis by which decre-
ments in erythropoietin, red cell production, red cell mass,
and plasma volume are produced in the zero-g phase of
the mission are quite similar to that described for the
bedrest study previously discussed. The inflight response
is essentially a response to a relative polycythemia-
induced-hyperoxia, and the postflight recovery response
results from the dilutional anemia-induced-tissue hypoxia.
These simulations suggest, at first glance, that the loss
of plasma volume during spaceflight can account for many
of the changes in erythropoietic activity during flight and
recovery. The similarity between these spaceflight simu-
lations and previously discussed bedrest simulations, all
in basic agreement with measured values, suggests a com-
mon etiology based on normal feedback regulation of
erythropoiesis. It is encouraging that the two spaceflight
simulations exhibited similar trends and that both inflight
and recovery phases could be estimated successfully us-
ing a single parameter adjustment for overall gain.
There was, however, one disturbing aspect of these
simulations. The model, operating as a hemoglobinom-
eter, predicts that the degree of erythro-suppression is pro-
portional to the degree of hemoconcentration. It would,
therefore, be expected that the similar levels of hemoglo-
bin concentrations measured on the 59-day and 84-day
missions (see Fig. 6-23) would result in equal rates of loss
of red cell mass on both flights and that there would be
greater losses at the end of 84 days in space than after 59
days in space. However, the measured red cell mass loss
was almost twice as great for the 59-day mission than for
the 84-day mission. This discrepancy was empirically re-
solved during the simulations shown in Figs. 6-40 and 6-
41 by assuming that the sensitivity of red cell production
to hemoglobin concentration (overall open loop gain, G)
was two and one-half times higher for the longer flight
compared to that of the 59-day flight. The gain factors
required to obtain successful spaceflight simulations was
also quite different for those determined for other stresses
examined, all of which were characterized by hemocon-
centration (Table 6-14). The fact that the spaceflight val-
ues differ by up to 600% compared to bedrest, infusions,
or descent from high altitude, suggests that other factors,
in addition to hemoconcentration, are most likely present
during spaceflight and have not been taken into account
in the modeling analysis. In simulation, it is often pos-
sible to use changes in gain to mimic some other effect
that is not considered explicitly in the model.
Other than hemoconcentration, energy balance fac-
tors appear to offer the most plausible explanation for red
cell mass decrements. Using the results of a previous Skylab
energy balance analysis [101,117] (see Chapter 4.6), it
was found that the largest losses of red cell mass were
associated with the crews who consumed the fewest calo-
ries (r = 0.71, p < 0.05), exercised the least (r = 0.63, p <
0.1) and lost the most tissue mass (r = 0.66; p < 0.05) (see
Tables 6-15 and 6-16). A negative energy balance is a
reflection of decreased intake of calories and/or increased
exercise expenditures, resulting in increasing amounts of
endogenous tissue loss. On Skylab, it was believed that
the increase in diet provided to the crewmen on the longer
missions was greater than the accompanying increase in
exercise, so that net energy balance became less negative,
or even positive, for those crewmen (see Table 4-23). Taken
as a whole, the correlations of Table 6-16 suggest that
energy balance factors may indeed have been a factor in
reducing red cell mass during spaceflight.
These statistical findings must be tempered, however,
by the realization that the experimental design was not
intended to reveal the caloric factors involved in erythro-
poiesis regulation. For example, the fact that diet and ex-
ercise both increased with increasing mission duration calls
for caution in interpreting these results. (A regression of
red cell mass loss vs. mission duration shows as strong a
correlation (r = 0.75, p < 0.05) as that for red cell mass loss
versus diet).
Diet and exercise factors are not included implicitly
in the computer model of erythropoiesis regulation. It was
assumed that alteration of these quantities could be simu-
lated by adjusting either of two model parameters: oxy-
gen uptake (an exercise effect), and the operating position
of the bone marrow controller function curve (possibly an
exercise and dietary effect). Simulations of the three Skylab
missions were accomplished using the influencing factors
in Table 6-13 as a guide in the following manner:
Table 6-13. Relative Importance of Factors Proposed To Be
Responsible For Reduced Red Cell Mass On Skylab*
28-Day     59-Day     84-Day
Factor Mission     Mission    Mission
Hemoconcentration**      1   1    1
Reduced Dietary Intake   2   1    0
Reduced Physical Activity   2   1    0
Hemolysis   1   0    0
Increased Arterial pO2   1   0    0
Relative Erythrosuppression
Effect on Red Cell Mass              3         2             1
* The numbers indicate the estimated effect of reducing RCM due to each factor based
on its relative intensity on the three flights. Factors are ranked horizontally only. A
higher number indicates a greater erythrosuppressive effect for that factor relative to the
other missions. “0” indicates no presumed effect.
** Inflight hemoglobin concentration was not measured on the 28-day mission,
but it is assumed that hemoconcentration was similar to the other flights.
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Figure  6-40.  Simulated hematological
response of the crew of the 59-day mis-
sion. The response of the erythropoietic
model was generated by using the mea-
sured hematocrit-time profile as the pri-
mary driving function. In addition to a
gradual loss in red cell mass, the model
predicts even more rapid decreases in
plasma volume, erythropoietin and red
cell production. Red cell mass and plasma
volume data obtained postflight com-
pares favorably with the simulated re-
sponse. Contoller gain, G, was set to 5
throughout the simulation.
Figure  6-41.  Simulated hematological
response of the crew of the 84-day mis-
sion. See caption of previous figure.
Controller gain, G set to 2 throughout
the simulation. Because G was set to dif-
ferent values in the simulations of this
and the last figure, controller gain should
be thought of as a secondary driving func-
tion perhaps reflecting the different en-
ergy balances between the two missions.
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a) an inflight plasma hemoglobin concentration vs. time
function was constructed from the average of the two flights
for which data were available, and this single function
was used to drive each of the three mission simulations
(i.e., it was assumed that there was no difference in hemo-
concentration among the three missions);
b) differences in dietary and metabolic activity were simu-
lated by adjusting the controller operating point to val-
ues that provided a reasonable agreement between ex-
perimental and predicted red cell mass;
c) a 10% decrease in red blood cell (RBC) lifespan was
assumed for the 28-day flight in accord with the esti-
mates presented in Table 6-3;
d) a 7% increase in arterial oxygen tension was assumed
for the 28-day flight in accord with the estimates pre-
sented in Table 6-9; and
e) controller gain factors were held constant for all simu-
lations (G = 10) in accord with previous estimates for
bedrest shown in Table 6-14.
These parameter adjustments are listed in Table 6-17
(case 1) and the results of the simulations are shown in
Fig. 6-42, which includes the hemoglobin drive function
employed.
Additional simulations were performed, for compara-
tive purposes, that used different parameter combinations
and values. For simplicity, changes in arterial oxygen ten-
sion and red cell lifespan were ignored in these other cases,
which are listed in Table 6-17. Instead, in cases 2 to 4,
overall gain was chosen to be either 10 or 5, and optimal
fits with the data were obtained by adjusting the operat-
ing point and oxygen uptake (case 4). A final simulation
was performed (case 5) in which only the overall gain was
adjusted. The simulated responses of these additional
cases were essentially all similar to case 1, which is illus-
trated in Fig. 6-42.
These simulations demonstrate the plausibility of the
continuous loss theory. In order to account for the ob-
served differences between Skylab missions, it was not
necessary to consider inflight regenerative behavior, nor a
variable controller sensitivity (i.e., G was identical in all
missions for cases (1) to (4)), thus overcoming certain re-
strictions and discrepancies of earlier simulations (see
Table 6-14). Hemoconcentration can explain part of the
loss of red cell mass, but it cannot explain the differences
between missions. These differences may, however, be ex-
plained by other factors such as changes in controller func-
tion, oxygen uptake, arterial oxygen tension, and red cell
lifespan. In each of the cases (2), (3), and (4), the values of
P1 and oxygen uptake which provided good agreement
between model response and data are in ascending order
for the 28-day, 59-day, and 84-day missions, respectively.
This would be expected if their values were somewhat
proportional to average dietary and exercise levels of those
crews. These simulations also indicate that more than one
computer solution (i.e., combination of parameter values)
can account for the observed losses in red cell mass. The
predictive value of the simulation technique is thus lim-
ited by the lack of inflight data. Nevertheless, the addi-
tional information that must be obtained in order to
distinguish between the alternative scenarios is suggested
directly by this study.
6.5.5.2 Postflight Recovery of Red Cell Mass. An ob-
servation, selected for closer examination, was that after
leaving the space environment, replacement of red cells in
the crew of the 28-day mission was delayed for about two
weeks. This “refractory” phenomenon was different from the
more rapid recovery exhibited by the crews of the two longer
missions as evidenced by a reticulocytosis and measured
rise in red cell mass (Table 6-4 and Fig. 6-24). It was shown
previously that bedrest is characterized by a similar delay
in red cell mass recovery as that seen after the 28-day
spaceflight (Fig. 6-6). However, a reticulocytosis was ob-
served much earlier after bedrest than after spaceflights of
similar duration [35] even though red cell mass failed to
show demonstrable repletion in both cases.
In the case of bedrest, the simulation analysis sug-
gested the delay in red cell mass recovery may have re-
sulted from a combination of factors which included a
normal bone marrow transit time delay of several days,
increased destruction of cells, decreased oxy-hemoglobin
affinity, and a delay in plasma volume repletion [9] (see
Chapter 6.5.3). The last of these factors could not be ad-
equately examined because of the sparsity of data relating to
plasma volume recovery. In Skylab, however, a much more
complete description of plasma hemoglobin concentration
changes (from which plasma volume could be inferred) was
available during the postflight period. These data were pre-
sented in Figs. 6-3 to 6-5 and have been redrawn in Fig. 6-43
for convenience in comparing mission differences.
Accordingly, it appears that the hemodilution arising
from plasma refilling was much greater following recovery
day of the two longer missions, compared to the 28-day mis-
sion. This is confirmed, in part, by the less frequent plasma
volume measurements which indicates that maximum reple-
tion of plasma took place almost 6 weeks following recovery
for the 28-day crew compared to two weeks for maximum
recovery for the 59-day and 84-day crews (Figs. 6-3, 6-4, and
6-5). No explanation for this difference in plasma refilling
behavior has yet been advanced, but a tentative hypothesis
is provided in the paragraph below.
Table 6-14. Gain Factors Used In Simulations When Hemocon-
centration Was The Only Driver
Condition  Gain Value Required For
Optimal Fit With Data*
Descent from Altitude 12
Red Cell Infusions 12
Bedrest 10
Skylab: 59-day mission 5
Skylab: 84-day mission 2
*Gain refers to overall renal-bone marrow controller sensitivity relating tissue oxygen-
ation to erythrocyte production rate (see Fig. 6-12).
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Figure  6-42. Simulation of the three Skylab missions: A = 28-day mission, B = 59-day mission, and C = 84-day mission. The
hematocrit-time profile shown in the bottom panel was based on a composite of inflight data and was used to drive the model for the three
simulations. In addition, the parameter adjustments shown in Table 6-17 (Case 1) were used. The dashed portion of the curves are
predicted responses if all missions had continued for 84 days. The predicted end-of-mission values for red cell mass and red cell
production are in good agreement with measured values. The predicted plasma volumes losses are greater than measured at recovery for
the two shorter missions.   However, plasma volume measurements could be expected to be quite erratic at the end of space missions.
Table 6-15. Summary of Inflight Energy Balance Components On Skylab (N = 3)*
            28-Day Mission 59-Day Mission 84-Day Mission
Red Cell Mass Loss:
(total ml)   311 ± 19    247 ± 123     134 ± 39
(ml/day)  11.1 ± 0.6     4.2 ± 2.1      1.6 ± 0.5
Diet (Kcal/d) 2930 ± 90  3225 ± 610   3260 ± 105
Exercise (W-m/d) 1950 ± 315  4690 ± 1620   4890 ± 715
Lean Body Loss (gm/d)   –60 ± 40    –14 ± 26     –10 ± 3
Fat Loss (gm/d)   –41 ± 31    –35 ± 24      + 5 ± 11
Solid Tissue Loss (gm/d)   –52 ± 34    –40 ± 24   + 0.7 ± 9
* Data derived from Chapter 4.6
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If plasma volume changes were similar on all flights, it
would be expected that the crewmembers with the largest
decrements in red cell mass (i.e., the 28-day crew) would
exhibit the greatest amount of postflight plasma volume re-
filling in order to return blood volume to the preflight level.
However, inflight plasma volume changes were apparently
not the same, but rather the least losses occurred on the 28-day
flight and the greatest losses occurred on the 84-day flight.
Also, the amount of postflight plasma volume refilling
(by the end of two weeks postflight) was directly related
to the amount of plasma lost inflight. The overshoot of
plasma volume above control levels, often seen after
bedrest and spaceflight, may be ascribed as a compensa-
tion for the previous losses in red cell mass. From the point
of view that plasma volume is regulated both inflight and
postflight to maintain blood volume appropriate to the
respective gravity environments, the smaller degree of re-
filling on the 28-day mission seems more understandable.
The observation that the greatest losses in red cell
mass were accompanied by the least losses in plasma vol-
ume resulted in a blood volume loss that was essentially
constant regardless of mission duration (Fig. 6-2). This
suggests a regulatory process whereby blood volume is
maintained at reduced levels, appropriate for zero-g, by
control of plasma volume. Accordingly it can be presumed
that downward plasma volume adjustments are required
for the acute upper circulatory overload upon entering
zero-g, and longer term upward adjustments take place in
compensation for the more gradual red cell mass changes
which would otherwise reduce blood volume further (see
Fig. 10-15). Long-term plasma volume regulations in re-
sponse to a primary disturbance in circulating red cell
mass has also been noted in erythremic states such as poly-
cythemia vera [138] and altitude hypoxia [139].
The effect of plasma volume refilling following space-
flight was studied by computer simulation. An idealized
spaceflight simulation was performed by reducing the
plasma volume 500 ml below control and permitting the
model to achieve a new steady-state, at which time 250 ml
of red cell mass had disappeared (see Fig. 6-28). Thereaf-
ter, three idealized postflight cases were examined: a)
plasma volume refilling of 250 ml (undershoot); b) plasma
Table 6-16. Energy Balance Factors Tested for Their Influence
on RCM Change (N = 9)
Factor Correlation Coefficient
Diet1 –0.71***
Bicycle Work1 –0.63**
∆Lean Body Mass2 +0.61**
∆Body Fat2 +0.61**
∆Solid Body Tissue2  +0.66***
1. Total mission calories vs. total mission red cell mass loss
2. Mass of tissue lost per day vs. red cell mass loss per day
** p < 0.10; *** p < 0.05
volume refilling of 500 ml (return to control); and c)
plasma volume refilling of 750 ml (overshoot). The re-
sponses to these volume adjustments are shown in Fig. 6-
44. In each case, the model is responding to the simulated
postflight hemodilution that has different levels of sever-
ity, depending upon the degree of plasma refilling. After
30 simulated days, the red cell mass had only returned to
normal for the case where a plasma refilling overshoot was
postulated (case C). For case A, where plasma refilling was
incomplete but hematocrit was depressed 6% from the last
inflight day (similar to the 28-day mission), recovery of
red cell mass was essentially negligible after two weeks,
and after 30 days, only 33% of the lost red cells had reap-
peared in the circulation. Thus, when combined with the
normal 4-day transit delay for bone marrow production
(included in the model), the diminished recovery of plasma
volume on the 28-day mission compared to that observed
on the other flights seems sufficient to account for the
differences in postflight recovery kinetics of red cell mass
among crewmen. In addition, a small degree of hemolysis
cannot be ruled out following the shortest mission (see
Table 6-3). The available data do not permit any specula-
tion regarding shifts in oxy-hemoglobin affinity, as was
postulated in the bedrest study (see Chapter 6.5.3).
6.5.6 Comparison Between Bedrest and Spaceflight
Erythrokinetics
Comparison of the hematological responses between
bedrest subjects and the crews of Skylab reveals many
similarities including: a) a seemingly gradual decrease in
red cell mass, b) a more rapid decrease in plasma volume,
c) hemoconcentration throughout the stress period, d) de-
struction rates of red cells which are either normal or not
high enough to account for the total red cell mass loss, e)
a depressed reticulocyte count immediately following the
hypogravic stress which subsequently increases to
supra-normal levels upon return to a one-g ambulatory
environment, and f) a return-to-normal of red cell mass
requiring 3-7 weeks. In addition, and as just discussed, a
delay in red cell mass recovery has been found in bedrest
and spaceflights which last less than a month.
Blood volume losses for the first 30 days of space-
flight and bedrest are compared in Fig. 6-45. The bedrest
results are based on two empirical formulations, which
were derived from a large number of studies of different
lengths. First, a predictive equation describing red cell
mass (RCM) loss was given as [30]:
RCM Loss (percent decrease)
= 0.24 x Days of Bedrest + 0.90
This formulation is based on bedrest studies whose
length varied from 2 to 35 days and should not be ex-
trapolated outside this range. Secondly, plasma volume
(PV) losses were fitted by a regression equation which ap-
pears accurate for about 30 days of bedrest [33]:
PV Loss (percent decrease)
= Days of Bedrest/(0.33 + 0.039 x Days of Bedrest)
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The results from Apollo and the 28-day Skylab missions
shown in Fig. 6-45 are taken from direct measurements on
crewmen obtained during the first day of recovery. The other
curves, representing the 59-day and 84-day Skylab mis-
sions, are taken from the computer simulations of Figs. 6-
40 and 6-41. These should be considered unconfirmed
estimates, since no direct measurements of red cell mass
and plasma volume are available in this time period. The
28-day Skylab mission could not be accurately simulated
since no inflight hemoglobin data were obtained.
It is difficult to discern specific differences between
spaceflight and bedrest from the data presented in Fig. 6-
45. Based on a strict interpretation of hard data (i.e., ex-
cluding simulation predictions by Johnson [31]) claims
that in spaceflight, losses of red cell mass are greater, and
plasma volume losses are smaller, compared to bedrest.
However, these conclusions should be stated guardedly
for the following reasons. First, it is believed that some of
the Apollo results included a significant red cell loss due
to oxygen toxicity, a factor that was not present in the
Skylab and bedrest situations. Secondly, if the simulation
results of the 59-day and 84-day missions (i.e., those con-
sistent with the “continuous loss” hypothesis) are tenta-
tively acceptable in place of non-existent data for the first
30 days in space, the red cell mass losses of the two long-
est Skylab missions appear to be less than that of bedrest,
as illustrated in Fig. 6-45. Thirdly, with regard to plasma
volume, measurements of this labile fluid compartment
on the day of recovery are not necessarily representative
of the true inflight loss because of the body’s capacity to
TABLE 6-17. Alternative Scenarios which Produce Nearly Equivalent Simulations of the Three Skylab Missions
      28-Day Mission        59-Day Mission       84-Day Mission
Case 1
Overall Gain, G    10    10    10
*Operating Point, P1 + 20% + 20% + 30%
Arterial Oxygen Tension +  7%    0%    0%
RBC Life Span - 10%    0%    0%
Case 2
Overall Gain, G  10    10    10
*Operating Point, P1 -10% + 20% + 30%
Case 3
Overall Gain, G    5    5    5
*Operating Point, P1 -20%    0% +10%
Case 4
Overall Gain, G   5    5    5
*Operating Point, pi - 2.5%    0% + 1.5%
*Oxygen Uptake - 2.5%    0% + 1.5%
Case 5
*Overall Gain, G  14    5    2.5
Note 1: Percentages in Table refer to changes with respect to normal model parameter value. A value of zero means that the normal value was used.
Note 2: The hematocrit vs. time function that was used in these simulations is a composite of the 59-day and 84-day mission inflight data.
Note 3: (*) designates parameters which were adjusted to obtain optimal fit with data.
rapidly replenish plasma deficits prior to their measure-
ments in one-g. Also, the possibility exists that measured
spaceflight plasma volume losses were under-estimated
because of a diurnal variation [31].
The plasma volume values shown in Fig. 6-45 for bedrest
were obtained by direct measurement while the simulation
results for the two longer Skylab missions were inferred from
inflight hemoglobin measurements. Thus, these latter data,
although indirect may be more reflective of the hypogravic
state than measurements made after the mission because
the complicating factors of recovery are not present. If this is
true, than plasma volume may decline more rapidly in space-
flight than in bedrest. This is supported by the evidence that
hemoconcentration is more extreme in spaceflight than in
bedrest (see Figs. 6-6 and 6-23).
Proponents of the theory that a significant loss of red
cells are destroyed early in a spaceflight mission could
argue that the Skylab simulations for red cell mass shown
in Fig. 6-45 are in error and should diminish more in-line
with the other spaceflight data shown (solid line). If we
assume that a rapid loss of 7% red cells (similar in magni-
tude to that seen in Apollo), then using the observed acute
increase in inflight hematocrit as a guide (10%; see Fig. 6-
23), it is easy to calculate the plasma volume would have
decreased more than 25%. This is thought to be unlikely.
See also the discussion of an acute hemolysis in Chapter
6.5.5.1.1.
One of the more intriguing patterns that emerge from
Fig. 6-45 is that associated with the blood volume data.
Compared to the results of red cell mass and plasma vol-
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constant level, or falls more gradually (as in bedrest) to
the same level. However, the contrary situation seems to
be present in Fig. 6-45; i.e, those studies in which plasma
volume decreased most rapidly were accompanied by the
least changes in red cell mass. This does not negate hemo-
concentration as a causative agent in red cell loss, but
suggests that other factors were present to varying degrees
in the cases examined in Fig. 6-45. In this regard, and in
the light of the previous discussions on the role of energy
balance, the differences between diet and overall meta-
bolic rate between spaceflight and bedrest merits further
attention. Bedrest subjects are often given a decreased
dietary intake thought to be commensurate with the de-
creased metabolic rate. Twenty-four hour metabolic rates
during spaceflight have not been measured, but they un-
doubtedly have varied widely as a result of nearly total
confinement in the earlier missions and the free-ranging
movement in the lunar environment and the Skylab work-
shop. This has been accompanied by a nearly universal
occurrence of inadequate dietary intake in spaceflight,
with the single exception of the 84-day mission.
Figure  6-43.  Postflight blood hemoglobin concentrations of
each Skylab crew expressed as percent of preflight control.
Figure  6-44. Simulation analysis of postflight recovery of red
cell mass showing the influence of different degrees of hemodilu-
tion. The responses shown in this figure  were preceded by a 120
day idealized spaceflight simulation (similar to Fig.  6-28), which
was accomplished by reducing plasma volume by 500 ml. The
pre-spaceflight control values are shown by the solid circles on
the left. At 120 days, recovery was initiated by refilling plasma
volume to varying degrees: 250 ml added (……), 500 ml added
(- - - -)  or 750 ml added (———-). The resulting hemodilution
(indicated by the hematocrit response) then served as the stimulus
for red cell mass recovery.
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Step increase in plasma volume following bedrest simulation
ume, the blood volume losses appear to be more uniform
(i.e., less scatter) for all bedrest and spaceflights exam-
ined. This observation lends support to the concept, stated
in the previous section, that total blood volume is closely
regulated and tends to stabilize in hypogravic environ-
ments at levels approximately 90% of control. Also see
supporting simulation with Guyton model in Chapter 10
(Fig. 10-15).
If hemoconcentration resulting from plasma volume
depletion was the sole cause of red cell mass changes, it
would be expected that those situations in which plasma
volume dropped more rapidly (i.e., 59-day and 84-day
Skylab missions) would be associated with the most rapid
drop in red cell mass. This hypothesis is supported by the
idealized simulation shown in Fig. 6-46 in which plasma
volume decreases either rapidly (as in spaceflight) to a
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The general conclusion appears inescapable that
bedrest and spaceflight have more similarities than differ-
ences with regard to the erythropoietic response. How-
ever, a more complete description of the disturbances in
oxygen transport, bone marrow activity, and red cell
lifespan are required in both situations. Differences be-
tween bedrest and spaceflight may ultimately be explained
by the energy balance factors of diet and metabolic rate,
by the dynamics of plasma volume shifts, and possibly by
selective destruction of an age-related cohort of red cells.
6.5.6 Simulation of Spaceflight Experiment
A very useful application of computer models is to
help define and refine experimental designs and protocols
(see Chapter 11.2). The ability of the model to predict
experiment outcomes allows the researcher to determine
such information as the most important variables for mea-
surement, the frequency of measurement, and the types of
interventions that could test alternative hypotheses. An
important hematology experiment, one that was designed
to address unanswered questions from the Skylab program,
Figure  6-45. Changes in blood volume, plasma vol-
ume, and red cell mass during the first month of space-
flight and bedrest.  Spaceflight results are of two types:
a) direct end-of-mission data  [19] from combined-
Apollo, Apollo–Soyuz and the 28-day Skylab mission
(solid line), and b) predictions from the simulation model
for the first 30 days of the 59-day and 84-day Skylab
missions (small open and filled circles) for which there
is no direct data.  Combined Apollo and Apollo–Soyez
results are included for reference only.  Bedrest data
(dashed line) are derived from regression equations
(see text) for plasma volume and red cell mass based
on multiple studies.
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was conducted on the first Shuttle Spacelab mission (SL-
1). The same model discussed throughout this chapter was
applied to help predict possible outcomes of this experi-
ment with the goal of understanding whether the blood sam-
pling from the human subjects would obscure the effects of
spaceflight that the experiment was designed to measure
[140]. Simply put, the hypothesis of the flight experiment
was that weightless spaceflight would induce a decrease
in red cell production and eventually a measured reduc-
tion in red cell mass. On the other hand, drawing blood for
analysis, would also be expected to reduce blood volume
but could also cause a measurable feedback increase in red
cell production. Would the effects of blood sampling be
large enough to oscure the expected effects of spaceflight
on erythropoiesis?
The experiment, conducted on a 10-day mission,
would measure factors involved in the control of erythro-
poiesis, including red blood cell mass and plasma volume
(pre and postflight) as well as inflight hematocrit, red cell
production and erythropoietin, all variables which are ac-
counted for by the model. Erythropoietin would be mea-
sured for the first time in space; the model had previously
predicted a decrease in erythropoietin for the Skylab as-
tronauts of about 20% (see Figs. 6-40 and 6-41), so it would
be very interesting to test this prediction. Just as impor-
tant, however, was to assess the influence on erythropoie-
sis of the blood sampling protocol. The original plan for
drawing blood consisted of 10 blood draws (from each of
2 crewmen) during the preflight, inflight and postflight
periods, each draw averaging approximately 93 ml blood,
or a total of about 0.93 liter blood during an 8 week pe-
riod. (The blood samples were required for several differ-
ent experiments in addition to the hematology
experiment).
A series of computer simulations, shown in Fig. 6-47,
was conducted using the above information to test the
effect of blood draws on erythropoiesis. All simulations
included a 30-day preflight period, a 10-day inflight pe-
riod and a 2-week postflight period. The first simulation
(dotted line) was a simulation of weightless spaceflight
Figure  6-46. Simulation of an acute drop in plasma volume (representing spaceflight) in comparison to an exponential fall in plasma
volume (representing bedrest).  Erythropoiesis is controlled by the hematocrit-time profile.  On the basis of a hemoconcentration
influence alone, the model predicts a greater erythro-suppression for spaceflight than for bedrest during the first four weeks.  Because
plasma volume decreases to the same level in both cases, convergence of all corresponding variables to the same steady-state value is
predicted by eight weeks.
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without any blood draws. This simulation is similar to
that shown in Fig. 6-16 for the case where the initializing
stimulus (onset of weightlessness) is a sudden decrease in
plasma volume of 10% that is returned to normal 10 days
later. A second simulation (dashed line) was performed
using only the blood draw protocol as the driving func-
tion. Appropriate amounts of red cell mass and plasma
were removed on the days specified in the protocol. A
third simulation (solid line) was simply a combination of
the first two; a simulation of weightlessness combined with
a simulated blood draw protocol. These three simulations
provided a visual assessment of the consequences of space-
flight on erythropoiesis and of a concomitant blood-draw
schedule. The bottom curve of Fig. 9-47 indicates the cu-
mulative blood drawn for sampling.
The overall result indicated that the blood draw pro-
tocol does have a significant impact on the erythropoietic
system, but that in most cases the changes due to space-
flight are much greater. Even with the large blood samples
considered here, the response of the important variables
of the erythropoiesis system in a spaceflight environment
were qualitatively similar whether or not blood is sampled.
Thus, weightlessness is the dominant stress during the
inflight phase. However, during the important early post-
flight period blood sampling appears to obscure two spe-
cific measurements, that of erythropoietin and red cell mass.
Erythropoietin is predicted to remain below control as a
result of weightlessness but may rise above control on the
first or second postflight day as a result of the blood draws.
Similarly, the predicted loss in red cell mass is barely sig-
nificant after only 10 days in space but may exhibit a 10%
loss due to the cumulative effects of blood sampling. Also,
a distinctive “overshoot” is apparent in both cases that
involved blood being sampled but not in the case of a
“pure” weightlessness response.
As a result of this analysis and other ground-based
testing, it was decided to reduce the amount of blood drawn
for sampling purposes to about half of that originally pro-
posed. When the results of the flight experiment became
known, they were compared to the predictions made by
the simulation. The correspondence between simulated
and experimental results were qualitatively and quantita-
tively acceptable as shown in Table 6-18.
An interesting side-note to this analysis was that the
principal investigators of the flight study originally re-
ported a much greater inflight and postflight reduction of
erythropoietin than the values predicted by the model
(–75% vs. –14% inflight; –44% vs. + 2% postflight) [141].
Figure 6-47. Simulated results of the Spacelab-1 (SL-1) hematology investigation using the model of erythropoiesis regulation.
Red Cell Mass (liters)
Plasma Volume (liters)
Erythropoietin (x normal)
Hematocrit (%)
Red Cell Production (ml/day)
Total Blood Drawn (liters)
Zero-g stress only (.....)
SLS-1 blood draw protocol (- - -)
Combined zero-g stresss and SL-1 blood draw protocol (----)
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Also, the model predicted a postflight overshoot of eryth-
ropoietin although this was not measured. Those authors
made a point of faulting the model’s capability to predict
the observed changes (even though they were not statisti-
cally significant) and suggested “a need for continued re-
finement of the computer model” [142]. However, in a
subsequent publication, the same authors reported the re-
sults of a re-analysis of the flight blood samples using a
more sensitive erythropoietin assay [143]. The corrected re-
sults agreed very closely with the simulation results (see Table
6-18), although the authors failed to mention the model’s
veracity. However, gratifying confirmation of model predic-
tions might be, it is worth remembering that the ultimate
usefulness of a model is not in the accuracy of its predic-
tions but in the power of a model to force the user to ask
critical questions and to turn model predictions (good or
bad) into ideas for more probing experiments.
6.6 Summary
The regulation of erythropoiesis during weightless space-
flight was studied using a theoretical model. The model
incorporates the best current understanding of the dynam-
ics of red cell production and the associated feedback regu-
lation based on knowledge current at the time of model
development. Using the techniques of computer simula-
tions, it was possible to apply the model to study candi-
date hypotheses that might explain the loss of circulating
red cell mass during spaceflight.
Both ground-based and spaceflight experiments have
suggested that, in the normoxic environment of Skylab,
this loss was likely a result of suppressed erythropoietic
activity rather than elevated destruction of red cells, al-
though occurrence of the latter to some extent cannot pres-
ently be ruled out. According to current concepts
embodied in the theoretical model, a reduced erythropoi-
etic state can be caused indirectly by hyperoxia of a renal
oxygen sensor via the humoral regulator, erythropoietin,
acting on the bone marrow, or by direct alteration of stem
cell kinetics at the marrow controller. (The presence of
erythropoietin inhibitors was not considered in this analy-
sis). Tissue hyperoxia may be caused by factors that in-
crease oxygen supply (i.e., hemoconcentration, enhanced
blood flow, decreased oxy-hemoglobin affinity and in-
creased arterial oxygen loading) or by factors that decrease
oxygen demand. Proliferation of erythrocytes at the bone
marrow level is affected, not only by erythropoietin, but
also by dietary factors. One can reasonably postulate that
all of these various influences were present to various de-
grees during spaceflight and bedrest, and they contrib-
uted to the eventual reduction in red cell mass.
Evaluation of these hypotheses was accomplished by
several means including: sensitivity analyses of math-
ematical models which revealed the relative influence of
each major hematological parameter on circulating red
cell mass; dynamic simulation of human and animal stud-
ies, whereby the effects of single, multiple, or time-varying
stresses were assessed for their potential to generate com-
puter responses similar to those observed experimentally;
and, collaboration with investigators performing animal
studies to test, in the biological system, those hypotheses
suggested by the computer model. Results from a number
of experimental studies, each characterized by a reduced
red cell mass or suppressed erythropoietic activity, were
examined. These included not only spaceflight investiga-
tions, but also those of bedrest, red cell infusions, dehydra-
tion and descent-from-altitude. The simulation model was
valuable in revealing the pathways which were common to
all of these situations and provided a quantitative basis for
testing whether the same mechanisms were operative in
spaceflight.
This hypothesis testing approach led to the following
conclusions:
a) The shifts in plasma volume accompanying
hypogravic maneuvers results in an observed mild
hemoconcentration which can eventually lead to sig-
nificant decrements in circulating red cell mass. The
model predicts that moderate increases in hematocrit,
if unopposed by other factors involving oxygen de-
livery to tissues, can proportionately increase oxygen
tension at a renal sensing site and exert a sensitive
suppressant effect on erythropoietin and red cell pro-
duction. The erythropoietic regulatory system may
be viewed, when operating in this fashion, as a hemo-
globinometer (i.e., red cell production decreases so as
to eventually relieve the hyperoxic condition). The
final predicted result is a nearly complete restoration
of hemoglobin concentration (or hematocrit) accom-
panied by a diminished red cell mass. ‘The simulation
of bedrest, using the observed non-linear plasma vol-
ume changes as model driving functions, predicted a
qualitatively accurate linear rate of fall in red cell
mass. The model suggests that red cell mass will sta-
bilize as hematocrits normalize; this has not yet been
confirmed experimentally, either in space or on the
ground. Therefore, this overall process can be ex-
plained in large part, in terms of normal feedback regu-
lation of the erythropoietic system in the face of
sustained decreases in plasma volume.
Table 6-18. Comparison of Predictions of the Erythropoiesis
Regulatory Model and Experimental Results from SL-1
[% change from baseline]
Measured Variable              Predicted          Measured*
RBC mass (landing day)     –6  –10
Plasma volume (landing day)   –10    –6
Erythropoietin (FD7)   –14  –20
Erythropoietin (R+1)    +2  +10
Hematocrit (FD7)    +8    +7
Hematocrit (R+1)    –6       0
RBC Production (FD7)  –19  –25
RBC Production (R+8)  +50 +50
* Ref. [143]
FD = flight day; R+ = number of days after landing
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b) Other factors which may have enhanced oxygen de-
livery and produced the same effects as hemoconcen-
tration cannot be ruled out (i.e., shifts in blood flow,
P50 and arterial pO2), but direct data are only available
to support the hemoconcentration effect. In any event,
the model system predicts that even small changes in
a variety of parameters (perhaps smaller than can be
measured experimentally), if sustained for long
enough periods of time, could lead to a progressive
and significant degeneration of red cell mass.
c) The ability of hemoconcentrated blood to suppress
erythropoietic activity was qualitatively similar in all
situations studied, whether it involved red cell infu-
sion, descent from altitude, water deprived dehydra-
tion, bedrest, or spaceflight. However, as revealed by
computer simulation, the quantitative effect was not
always the same. That is, equal degrees of hemocon-
centration did not result in the same degree of
erythro-suppression for bedrest and spaceflight, nor
for the 59-day and 84-day Skylab missions. This sug-
gested that other factors may have been present which
either augmented or opposed the hemoconcentration
effect.
d) Two additional factors were examined in some detail:
diet and exercise. The hypotheses that dietary restric-
tion can reduce, and exercise can enhance, erythro-
poiesis (as reported in animal studies) appeared to
account for the discrepancies noted in (c). An inad-
equate diet, in particular, has been shown to lead to
suppressed erythropoiesis by mechanisms which may
bypass the hormone regulator and act directly on the
bone marrow controller. This could explain the occa-
sional findings that erythropoietic activity decreases
in the presence of normal levels of erythropoietin.
However, both dietary and exercise effects have not
been well defined in the human subject and the lack
of appropriate controls during spaceflight studies does
not permit a definitive conclusion.
e) The simulation analysis failed to rule out some small
degree of acute red cell destruction as contributing to
either the reduced red cell mass during hypogravity
or the delayed recovery of red cells following some
spaceflights and bedrest. Unusual removal of cells from
the circulation could possibly arise from the mechani-
cal stresses of launch, splenic sequestration, exercise
hemolysis during flight, or postflight hemolysis of
cells made more fragile by weightlessness or bedrest.
However, a major role of inflight cell destruction is
unlikely, because this would contradict the observa-
tions that hemoglobin concentrations are significantly
elevated and that overt signs of hemolysis were sel-
dom found.
f) The model erroneously predicts an identical hemato-
logical response to both relative and absolute poly-
cythemia (produced by plasma volume decreases or
red cell mass increases, respectively). While both cases
result in hemoconcentration and reduced erythropoi-
etic activity, the influences of blood volume (i.e., rela-
tive polycythemia is hypovolemic and absolute
polycythemia is hypervolemic) on blood flow, which
is not accounted for in the model, may partially ex-
plain the different experimental responses to these two
stresses.
g) Two theories were examined to explain the Skylab
findings that demonstrated decreasing red cell mass
losses with increased exposure to weightlessness. Ac-
cording to the so-called “regeneration theory,” this
behavior represents an adaptive influence to an ini-
tial insult of weightlessness. Treating the Skylab crew
data from three separate missions as a composite sug-
gested that an early loss of red cells is followed by
regeneration which begins two months after launch.
Acceptance of this hypothesis as a generalized theory
of erythropoietic regulation in weightlessness is con-
founded by the fact that decreasing losses of red cell
mass were associated, not only with longer duration
flights, but also with increasing levels of diet and ex-
ercise. These latter factors had demonstrable effects
on maintenance of body tissue and cardiovascular
condition, and their further involvement in the oxy-
gen transport-erythropoietic system was postulated
herein. As a result, an alternative and more plausible
(“continuous loss”) theory was proposed which sug-
gested that there were two components to the suppres-
sion of red cell production: one related to energy
balance and one related to water balance. Differences
among the crewmen’s red cell mass losses were thereby
considered to be a result of different levels of dietary
intake and exercise, superimposed on a common loss
due to hemoconcentration. According to this concept,
the kinetics of red cell mass disappearance would not
include regenerative behavior, but would be more simi-
lar to the continuous, linear losses observed in bedrest.
Experimental animal studies support this theory.
h) Computer simulation predicted that in most cases the
observed repletion of red cells during the recovery
period from hypogravity can be attributed to
hemodilution-induced hypoxia (i.e., an effective ane-
mia resulting from inflight red cell mass depletion
and followed by postflight plasma refilling). The de-
layed recovery of red cell mass during the 28-day
Skylab mission and the 28-day bedrest simulation of
that mission was attributed in part to a normal 3-4 day
bone marrow transit time and a time-lag in plasma
volume recovery. The presence of an acute reticulo-
cytosis following bedrest and its absence after a
Skylab mission of the same length, suggests some-
what different mechanisms were operative in each case.
The involvement of shifts in oxy-hemoglobin affin-
ity, mild hemolysis, or ineffective erythropoiesis were
suggested as areas of future study.
i) The hematological responses to bedrest and space-
flight were found to be more similar than different.
Common characteristics of both stresses include the
loss of red cell mass, loss of plasma volume, hemo-
concentration, and, in some cases, the kinetics of re-
covery. In addition, the restricted dietary intake and
diminished metabolic demands of bedrest are qualita-
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tively similar to that exhibited on the shorter space-
flights. However, the plasma volume losses may not
occur in bedrest as rapidly as observed in spaceflight
and the dynamics of hemoconcentration are somewhat
different. Also, it is possible that the history of exer-
cise during spaceflight compared to the history of in-
activity during bedrest may be partly responsible for
different kinetics of the recovery response. It is prob-
able that at least two elements, a negative energy bal-
ance and negative water balance, may be important
causative factors in both bedrest and spaceflight.
j) The red cell mass losses on the earlier spaceflights
were attributed to the toxic effects of 100% oxygen
atmosphere and a resulting intravascular hemolysis.
The results of the present study suggest that many of
the factors considered to explain the Skylab and
bedrest observations, particularly, hemoconcentration,
negative energy balance, and decreased physical ac-
tivity undoubtedly also played a contributory role in
the Gemini and Apollo flights. This helps to explain
the large red cell mass losses observed during those
relatively short flights.
The discussion in this section extends the analysis of
the hematological responses originally presented in the
Skylab postflight reports [25,26]. The lack of additional
spaceflight experimentation in the intervening period pre-
cluded testing of newly developed hypotheses in a true
weightless environment. Some of the experimental dis-
crepancies revealed by the quantitative nature of model
simulation analysis suggest approaches for future experi-
mentation. For example, it is crucial to obtain direct
in-flight measurements of erythropoietin and bone mar-
row activity. If reduced erythropoietin levels cannot be
demonstrated during spaceflight, then the hemoconcen-
tration theory may have to be abandoned. Also, the impor-
tance of diet and exercise on erythropoiesis needs to be
studied more carefully in humans with and without ac-
companying hypogravity. The question has been raised
whether moderate and relatively short periods of dietary
or exercise restriction by themselves could alter red cell
production in humans. At the very least, diet and exercise
should be controlled more carefully on future missions in
which the hematological system is under investigation.
Another area that needs clarification is the possibility of
some degree of cell destruction greater than the normal
attrition rate, possibly related to the age of the red cell.
This would require improved techniques to measure cell
life span and biochemical products of cell destruction as
well as inflight red cell mass measurements. The present
analysis has also questioned the occurrence of inflight
regeneration of red cell mass. Testing the regeneration
hypothesis will require inflight measurements of red cell
mass on flights lasting several months. While no U.S.
manned flights of this duration are planned for the near
future, data from the long-term Soviet mission might help
to resolve this issue. In addition to inflight studies, the
question of postflight kinetics was not entirely resolved.
For example, it would be desirable to explain the presence
of a reticulocytosis during the immediate post-bedrest
period in contrast to a delayed reticulocytosis in a space-
flight of comparable duration. Also, the profound influ-
ence that oxygen-hemoglobin affinity might exert on
inflight and postflight tissue oxygenation as predicted by
the model merits additional attention. The reader is re-
ferred to more recent research‡‡ as well as to additional
conclusions in Chapter 10.3.2 and recommendations in
Appendix G.
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Update Endnotes
UPDATE #1. Renal Oxygen Sensing Site (TBD)
Recent research regarding the renal oxygen sensing
site including the influence of renal blood flow.
UPDATE #2. Effect of Exercise (TBD)
Recent findings on the effects of exercise on erythro-
poiesis and red cell destruction.
UPDATE #3. Neocytolysis in Spaceflight (TBD)
Recent findings on SLS-1 (1991 and 1993) have sug-
gested a newly identified process, called “neocytolysis”
by which newly formed red cells are selectively destroyed
in response to a sustained hyperoxic stimulus such as
spaceflight hemoconcentration or descent from altitude
of high altitude dwellers [123].
UPDATE #4. Erythropoietin Assays (TBD)
Recent progress on assays for erythropoietin and their
use in spaceflight research.
UPDATE #5. Recent Bedrest Findings (TBD)
Recent measurements of red cell production and eryth-
ropoietin during bedrest.
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Chapter 7
Cardiovascular Regulation During Spaceflight*
* The author is grateful to Dr. Srini Srinivason, Wyle, Laboratories, Houston, TX for helping to prepare this chapter.
7.1 Introduction
One of the well-known effects of spaceflight in humans is
cardiovascular deconditioning that manifests itself as re-
ductions in orthostatic tolerance and postflight exercise
capacity [1,2]. The alterations are significant and have
consistently been observed in several studies from the early
days of spaceflight in both the US and Russia [3]. A num-
ber of changes in cardiovascular parameters contribute to
these decrements, the loss of blood volume being perhaps
the most central among them [4].
Prior to extensive studies conducted during the Skylab
missions, the assessment of space cardiovascular changes
were inferred mostly from pre- and post-flight measure-
ments. The three manned Skylab missions were the first
attempt to evaluate both acute and adaptive changes that
occur under hypogravic conditions and to understand the
underlying physiologic mechanisms. The constraints of
spaceflight and concern over possible risks in using inva-
sive procedures in a space environment limited the mea-
surements to those that could be readily obtained by
non-invasive means. Still, a wealth of information was
gathered from which a composite picture could be pieced
together and plausible hypotheses could be formulated.
After 30 years the Skylab experiments still stand as the
best long-duration (90-day) space-based study of exercise
and orthostatic tolerance.
The exercise stress test using bicycle ergometry and the
orthostatic stress test with application of pressures below the
ambient level to the lower extremities of the body (known as
lower body negative pressure or LBNP) were two important
Skylab tests designed for examining the ability of the car-
diovascular system to cope with the physiological chal-
lenges of spaceflight. The results of these tests were not
always easy to interpret because of the narrow breadth of
measured variables and led to hypotheses for explanation
rather than definitive conclusions. With inflight studies
for obtaining needed additional data at least a decade
away, the researchers thought that mathematical models
could be helpful for testing the validity of various candi-
date hypotheses through computer simulation.
This chapter describes the effort of the systems analy-
sis project to interpret the data from Skylab cardiovascu-
lar experiments in the context of mathematical modeling
and computer simulation. As in other chapters of this book,
the emphasis is on the utility of mathematical models in
discerning physiologic mechanisms that would lead to
the observed results. In addition to analyses pertaining to
the Skylab results, this study examined orthostatic intol-
erance during the reentry phase of the, then, new Space
Shuttle, and is an example of the systems analysis meth-
odology to help resolve an ongoing medical operational
problem. Also discussed are improvements in cardiovas-
cular modeling needed for testing other candidate mecha-
nisms and more recent model developments aimed at
simplifying the model specifically for simulating orthos-
tatic stress responses.
7.2 Model of Cardiovascular System
The cardiovascular model used in the analyses discussed
in this chapter is a multi-compartment representation of
the cardiovascular system with lumped parameters that
consist mostly of resistances and compliances. It is a beat-
to-beat model built on the assumption of a closed vascu-
lar system, with no provision for fluid filtration into the
extravascular space. The omission of capillary filtration
and endocrine control were justified on the basis that it is
a short-term model intended to simulate responses lasting
less than 30 minutes. The pressure-volume relationships
in many (but not all) of the compartments are non-linear;
this feature will be important in the analysis of LBNP find-
ings. Chapter 3.2.1 contains a detailed description of the
model which was originally developed by Croston [5] for
simulating exercise responses (EXER model). It was later
simplified for simulating responses to head-up tilt and
lower body negative pressure (LBNP model) by excluding
the metabolic control elements and adding the capability
to respond to different compression and gravitational
forces [6]. Thus, the two versions of the model differ mostly
in the way the cardiovascular control is represented.
Figure 3-15 shows the cardiovascular control system
for the EXER model while Fig. 7-1 shows the simplified
cardiovascular control representation associated with the
LBNP model. The latter model consists essentially of the
baroreceptor system with control signals derived from ca-
rotid and aortic pressures for acute regulation of heart rate,
strength of cardiac contraction, venous tone, and some
peripheral resistances. Although admittedly incomplete
in many respects, the pulsatile cardiovascular model has
proven to be an excellent tool to systematically explore
and analyze conceivable underlying physiologic mecha-
nisms and to provide an integrated picture of the observed
cardiovascular changes in microgravity.
The Skylab studies on metabolic activity and LBNP
were specifically aimed at elucidating cardiovascular adap-
tation to weightlessness. The adaptive changes include
reductions in orthostatic tolerance and postflight exercise
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Figure 7-1. Simplified controlling system associated with the LBNP model of the cardiovascular system.
capacity, weight loss, decrements in blood and leg vol-
umes, changes in leg venous compliance, and a reduction
of heart size, among others. We describe below the two
Skylab experiments and discuss the analyses that were
performed using these mathematical models of the cardio-
vascular system to explain some of the observations.
7.3 Skylab Metabolic Activity (Exercise)
Studies
7.3.1 Experimental Observations
The alterations in metabolic activity caused by expo-
sure to weightlessness were assessed with graded levels of
exercise performed by Skylab crewmen while seated on a
bicycle ergometer. In addition to heart rate and blood pres-
sure, oxygen consumption and carbon dioxide output were
monitored with measurements of flow and gas concentra-
tions of inspired and expired breathing mixtures. The pro-
tocol consisted of rest, exercise at 25%, 50%, and 75% of
maximal oxygen consumption, and recovery, each test seg-
ment lasting for 5 min with a total test period of 25 min.
Inflight tests were performed 6 times on Skylab-2 (28-day
mission), 9 times on Skylab-3 (59-day mission), and 12
times on Skylab-4 (84-day mission) on each astronaut at
regular intervals during the mission [7]. Pre- and post-
flight tests included exercise in both supine and sitting
positions for comparison with inflight results.
The cardiovascular response to exercise [7,8,9,10]
showed no change or a slight decrease in inflight heart
rate for a given workload compared to preflight. Also, there
was no change in mean arterial pressure and oxygen up-
take inflight compared to preflight. However, physical de-
conditioning was particularly apparent during postflight
testing. Early postflight measurements showed a signifi-
cant increase in heart rate and a decrease in cardiac output
during exercise. The degradation of cardiovascular per-
formance immediately upon return was consistent with
observations from all earlier spaceflights [3].
Thus, an important finding from the metabolic activ-
ity studies was that exercise capacity, observed to be di-
minished postflight in all spaceflight studies, showed no
appreciable decrease inflight. In addition, the postflight
reduction in exercise capacity was smaller in the crewmen
of Skylab-4 than in those of Skylab-2 and Skylab-3 [2,7].
Skylab-4 astronauts engaged in longer and more strenu-
ous personal exercise throughout their entire mission, be-
tween 150% to 300% greater than on Skylab-2 or
Sklylab-3 [10].   Two hypotheses were suggested to ex-
plain these findings:
a) The resting blood volume, although reduced in
weightlessness, might still be adequate to meet the
inflight metabolic needs, perhaps because plasma he-
moglobin concentration was higher and tissue oxy-
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gen delivery was not greatly altered (see Chapter 6).
b) Crewmen of Skylab-4 might have undergone some
physical conditioning during their spaceflight due to
increased levels of exercise, and this training effect
could be the reason for the observed improvement in
their postflight exercise capacity.
7.3.2 Model Analysis
An analysis of the exercise findings was performed to
determine if the effects of training could account for the
lesser reduction in postflight exercise capacity exhibited
by Skylab-4 crewmen. The approach for accomplishing
this was as follows:
a) identify the physiological effects of one-g exercise
training (conditioning) that could be responsible for
a possible training effect in Skylab-4;
b) identify the physiological effects of zero-g adapta-
tion (deconditioning) that would be expected to in-
fluence the inflight and postflight exercise response
if there were no training effect, i.e., Skylab-2 and –3;
c) determine, through model simulation if there is some
combination of deconditioning and conditioning ef-
fects that can explain the overall Skylab results.
7.3.2.1 Model Validation and Exercise Conditioning.
Validation of the EXER model for simulating simple exer-
cise, uncomplicated by training effects, was accomplished
as part of the model development procedure and was de-
scribed in Chapter 3 (Chapter 3.2.1.4 and Fig. 3-16). As
part of the Whole-Body Algorithm, the EXER model sub-
system was validated for simulating simple exercise (Fig.
3-47) and for simulating supine exercise before and after
28 days of bedrest (see Chapter 9, Fig 9-9).
A special validation study was conducted to determine
if known training effects could be introduced into the model
in order that a simulation of the exercise response of trained
athletes could be accomplished. The following changes, sup-
ported by the data of Ekblom et al. [11], were introduced
in the EXER model by adjusting the values of appropriate
parameters to account for the effects of exercise training
observed in athletes (at rest unless otherwise stated):
(a) reduced sympathetic activity;
(b) decreased arteriolar vasodilation (neurogenic term) dur-
ing exercise, and hence increased peripheral resistance;
(c) a larger heart with increased contractility;
(d) increased leg capillary density, and
(e) increased vagal activity at rest to account for lower
resting heart rate due to training.
Figure 7-2 illustrates the effects of training on oxy-
gen uptake, blood pressure, arterio-venous oxygen differ-
ence, heart rate, stroke volume, and cardiac output. The
simulated results agree reasonably well with experimental
data, showing the ability of the model to reproduce changes
in cardiovascular response due to the physical condition-
ing effects which have been listed above.
7.3.2.2 Hypogravic Deconditioning. Although it is
known that spaceflight induced-cardiovascular decondi-
tioning manifests itself in terms of orthostatic intolerance
and decreased exercise performance, the fundamental
physiological mechanisms that bring about these changes
in microgravity are not well understood and are the sub-
ject of ongoing research, including the current systems
analysis effort. Accordingly, a set of hypotheses was for-
mulated that represents the effects of spaceflight on the
circulatory system, and that could help account for obser-
vations of cardiovascular performance. The following four
hypotheses were identified as occurring during or follow-
ing bedrest or spaceflight:
a) Increased sympathetic activity,
b) Increased peripheral resistance,
c) Decreased total blood volume, and
d) Decreased leg capillary density.
Some of these hypothesis have an experimental basis,
such as a decreased blood volume (Chapter 6); some of
them are inferred from other measurements, such as el-
evated catecholamine and angiotensin levels found in
long-duration spaceflight [12,13] (see Fig. 9-5) suggest-
ing increased sympathetic activity and peripheral resis-
tance, respectively. Changes in vascularization (leg
capillary density) are more speculative because they are
difficult to measure, but are known to increase in indi-
viduals undergoing long-term training [11]. Mathemati-
cally, this would be represented in the model in a similar
fashion to the phenomenon of venous stress relaxation,
i.e., an increase in unstressed volume. In exercise training
such as running or bicycling, the demand of the leg muscle
tissues to increased blood supply causes an adaptive in-
crease in vascularization (increased number of capillar-
ies). For spaceflight, reverse stress relaxation and
devascularization is postulated for the leg circulatory sys-
tem because veins are collapsed at rest in space and leg
postural muscles do not require as robust a circulation as
they do on the ground. Chapter 7.4.3.6.2 describes the
stress relaxation phenomenon with regard to interpreting
LBNP results. These hypotheses for hypogravity decondi-
tioning can be thought of as a companion set of hypoth-
eses to those postulated for exercise conditioning
(identified above); so they parallel each other in a sense,
often having opposite effects.
7.3.2.3 Simulation of Conditioning versus Decon-
ditioning. Model simulations were performed for one-g
exercise (50W) for three cases using the appropriate set of
hypotheses as described above: a) Normal EXER model
representing Preflight exercise, b) EXER model with “de-
conditioning” hypotheses representing an immediate post-
flight exercise test following a long-duration spaceflight,
and c) EXER model with “conditioning” hypotheses rep-
resenting an exercise test following a long-term training
regimen. These model results were then compared to re-
sponses of the Skylab crew during their immediate post-
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Figure 7-2. Comparison of trained and untrained steady-state exercise responses generated by the EXER model with experimental data [11].
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Figure 7-3. Comparison of hemodynamic variables, heart rate and stroke volume, for Skylab astronauts with EXER model responses resulting
from exercise at 50 watts. The Skylab data for the first two missions (Skylab-2 and -3) are grouped together (see text). The first two pairs of
columns in each panel compare preflight (clear bars) with postflight (shaded bars) measurements.  The model responses includes the normal
condition representing preflight (clear bars), weightlessness conditions (shaded bars), and training effects (filled bars).
flight tests. All tests and simulations were performed in
the sitting position.
Figure 7-3 compares the pre- and postflight Skylab
measurements of heart rate and stroke volume in response
to exercise at 50W with simulated responses using the
EXER model. The data from Skylab-2 and Skylab-3 crews
were combined because they were similar compared to the
Skylab-4 crew. Although the increase in heart rate between
preflight and postflight was similar for all crewmembers,
the postflight-to-preflight decrease in stroke volume is
significantly smaller in Skylab-4 astronauts possibly due
to the influence of exercise training. The larger stroke
volume decrease for the Skylab 2 & 3 crews is an indica-
tion of cardiovascular deconditioning. The simulated
“model” responses for weightlessness (hatched bar) and
training effects (filled bar) are also shown separately and
can be compared to the simulation without either weight-
lessness or training effects (clear bar).*
As indicated by the simulation results in Fig. 7-3,
hypogravic deconditioning (model: hatched bar) increases
the heart rate and decreases the stroke volume from the nor-
mal levels, while the opposite is the case with exercise train-
ing (model: filled bar). Thus, the model appears to confirm
that training effects could have been responsible for the im-
proved Skylab-4 crews postflight response to exercise. An
appropriate combination of conditioning and decondition-
ing effects should yield results close to those observed in
Skylab-4 mission, if indeed inflight exercise training is
the reason for the improved postflight exercise capacity.
Accordingly, several hypotheses were formulated that
were designed to test the deconditioning or conditioning
hypotheses or some combination of the two. These hy-
potheses were the basis of a series of simulations, the re-
sults of which were compared to responses of the Skylab-
4 crewmembers. The following hypotheses were formulated
and tested:
0. Normal model (1-g mode)
1. Increased sympathetic activity affecting heart rate
only,
2. Reduced blood volume only (250 ml),
3. Combination of 1 and 2 above,
4. Increased peripheral resistance only, and
5. Increased sympathetic activity on heart rate, in-
creased peripheral resistance, increased heart con-
tractility, and 100 ml of blood volume loss un-
compensated by vascular changes.
The first item on the list is the control hypothesis
representing preflight; #1 through #4 are relatively simple
hypotheses; #5 is a selected complex hypothesis. The un-
compensated blood volume loss in hypothesis #5 refers to
the net blood volume loss (250 ml) less the quantity of
estimated reverse stress relaxation in the legs (150 ml).
Figures 7-4(a) and 7-4(b) compare the average data
from Skylab-4 astronauts with simulation results obtained
by incorporating each hypothesis in the EXER model
through appropriate changes of model parameter values.
Preflight data (A) should be compared with the simulation
with no special effects (0), i.e., the normal 1-g model.
Clearly, a reduction in blood volume, which is known to
occur in spaceflight (hypothesis #2), cannot by itself ex-
plain the observed pattern of changes between preflight
and postflight for stroke volume, systolic blood pressure,
and diastolic blood pressure (supine vs. sitting). This simu-
lation result is consistent with the suggestion noted ear-
lier that a reduced blood volume might not compromise
the inflight metabolic needs. The model and experimental
*Unless otherwise noted, the Skylab data shown in this chapter was
provided by the Skylab investigators J. A. Rummel (Exercise) and G.
W. Hoffler (LBNP).
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Figure 7-4(a). Simulated values of
heart rate and stroke volume compared
to average data from the crewmen of
the 84-day Skylab-4 mission for both
rest and exercise in supine and sitting
positions. Comparisons should be
made of preflight data (A) with simu-
lated values (0) and immediate post-
flight data (B) with simulated results
obtained with each hypothesis tested
(1 through 5). See text for hypothesis
description and interpretation.
Figure 7-4(b). Simulated values of
blood pressure compared to average
data from the crewmen of the 84-day
Skylab-4 mission for both rest and
exercise in supine and sitting posi-
tions. Comparisons should be made
of preflight data (A) with simulated
values (0) and immediate post-flight
data (B) with simulated results ob-
tained with each hypothesis tested (1
through 5). See text for hypothesis
description and interpretation.
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Figure 7-5. Comparison of changes in cardiovascular control pa-
rameters needed to simulate weightlessness (bedrest) and one-g
training effects with those of hypothesis #5 (see text) that best
reproduced the average data of Skylab-4 astronauts.
responses match most closely for hypothesis #5, indicat-
ing this to be the most likely explanation. However, it is
by no means unique, and further theoretical and experi-
mental results are needed to identify the causes of the
altered postflight exercise response.
7.3.2.4 Skylab Exercise Hypotheses. Hypothesis #5,
which gave the best results in terms of matching the ob-
served and simulated values, is in fact a combination of
the changes in cardiovascular parameters brought about
by weightlessness and exercise training. The postflight
increase in blood pressure (Fig 7-4(b)) is possibly due to
increased peripheral resistance as a result of change in the
leg capillary bed; these are features of hypothesis #5. As
suggested in Fig. 7-5, conditioning and deconditioning ef-
fects, according to this analysis, are not complete opposites;
they include some quantities that move in opposite direc-
tions, but some that induce changes in the same direction.
It is questionable if all effects of exercise training occur in
space, but the broad assumption here is that they do but
are mitigated by the deconditioning of spaceflight.
Clearly, we need much more data to identify the presence
or absence of these changes and their relative significance,
but the point we emphasize here is the useful role of math-
ematical modeling in suggesting possible combinations
of mechanisms that would explain the observed changes.
7.4 Skylab Lower Body Negative
Pressure (LBNP) Studies
7.4.1 Introduction
The LBNP stress test consists of applying pressures
below ambient level to the lower part of the body in graded
steps and measuring the resulting changes in cardiovascu-
lar response. Many investigators have used the test in
ground-based studies and have shown it to provide sensi-
t ive indices of cardiovascular performance
[14,15,16,17,18]. It has also been suggested for simulat-
ing the effects of hemorrhage by shifting blood from up-
per to lower parts of the body [19]. It is a highly reproduc-
ible test with a safer methodology compared to clinical
stand and tilt tests for evaluating orthostatic tolerance.
The primary effect of LBNP is a transfer of blood from
the central circulation to the blood vessels in the legs,
reducing effective circulating blood volume. The ensuing
central hypovolemia results in a reduction of central
venous pressure and cardiac output. The decrease in car-
diac output is associated with a decrease in stroke volume
caused by decreased venous return and insufficient car-
diac filling. Heart rate and peripheral resistance are in-
creased by the baroreceptor reflex mechanism to restore
cardiac output and mean arterial pressure. The magnitude
of cardiovascular changes induced by LBNP increases as
the negative pressure applied to the lower limbs increases
because more blood is shifted legward and out of the cen-
tral circulation. Thus, the degree of stress produced de-
pends in large part on the total amount of circulating blood
volume and the pressure-volume (P-V) relationship of the
leg veins, both of which could be significantly affected
by spaceflight. Because in spaceflight there is a well-
known reduction of blood volume (10%-15% loss), inflight
LBNP starts with an already reduced blood volume.
7.4.2 Skylab Observations
The Skylab equipment for performing LBNP tests con-
sisted of a rigid container with an air-tight waist seal that
provided a reduced pressure (maximum of 50 mmHg be-
low ambient or –-50 mmHg) around the legs and lower
torso while the rest of the body remained at ambient pres-
sure [20]. The test protocol included resting supine con-
trol for 5 minutes, five graded levels of LBNP (1 minute at
–-8 mmHg, 1 minute at -16 mmHg, 3 minutes at -30 mmHg,
5 minutes at -40 mmHg, 5 minutes at -50 mmHg), and a
final 5 minutes of recovery at ambient pressure. The num-
ber of daily inflight tests on each crewmember was 7 in the
28-day Skylab mission, 16 in the 59-day mission, and 22
in the 84-day mission. The tests were performed at regular
intervals during the mission but not on the same day as
the exercise tests. The measurements included vectorcar-
diogram from which heart rate was determined, systolic
and diastolic blood pressure, and percent changes in leg
volume using a special leg volume measuring system [21].
Thus, changes in both hemodynamic and electrocardio-
graphic responses to LBNP were assessed. Hoffler [4],
Johnson et al. [22], and Sandler [23] have reviewed in
detail the results of the Skylab LBNP experiment. The
major findings comparing inflight LBNP with preflight
LBNP responses pertinent to analyses discussed here (and
which will be shown later in Figs. 7-6, 7-7 and 7-11) in-
clude the following:
• Inflight elevation of resting heart rate, which tended
to be slightly higher early in flight compared to in-
creases noted later in flight.
• Increased systolic and pulse pressures and decreased
diastolic and mean pressures at rest compared to pre-
flight measurements of the same.
• Decreased orthostatic tolerance as indicated by sig-
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Table 7-1. Simulation studies and analyses performed using the pulsatile cardiovascular model and cardiovascular data from the
Skylab LBNP experiment
    Description of Analysis  Experimental Data Used Results
Simulation of Preflight LBNP Average data from 6 crewmen of Skylab Favorable comparison of simulated and
Response – Model Validation missions 2 and 3 and Average data from observed changes in heart rate and pulse
crewmen of Apollo missions 7, 8, 9, and 15 pressure
Measured heart rate and blood Average data from all Skylab crewmen for Significant increase in orthostatic intolerance
pressure responses to LBNP* the first month inflight. after one week in space.
Influence of Blood Volume Loss on Significant changes in heart rate compared
LBNP Response to only moderate changes in blood pressure
· Parametric Analysis Using the Model None
· Comparison with Experimental Results Average data from all Skylab crewmen for A large fraction of inflight changes in heart
the first month inflight. rate and pulse pressure explained on the basis
of decreased blood volume
Leg Volume Response to LBNP* Average data from all Skylab crewmen Significant inflight increases in percent leg
volume change (PLVC) at lower levels of LBNP.
Effect of Changes in Leg Venous None Leg volume changes in weightlessness cannot
Compliance be explained based on increased leg venous
compliance alone.
Effect of blood volume loss, fluid Data from a single Skylab crewman from Delayed compliance change (reverse stress
shift from legs and delayed early and late in the mission. relaxation) can partly explain difference between
compliance on LBNP response early and late mission LBNP results.
*
 No simulation involved
nificant increases in heart rate at -50 mmHg LBNP
compared to preflight. This occurred as early as the
first inflight measurements 4 to 6 days after launch.
• Significant correlations between orthostatically
stressed heart rates (change from rest to -50 mmHg
LBNP) and decrements in blood volume, the latter
measured on recovery day.
• Greater LBNP-induced leg volume increases inflight
compared to those seen in preflight tests.
• More stable cardiovascular response to LBNP and rela-
tively improving orthostatic tolerance after 5 - 7 weeks
of flight tending toward preflight normals.
7.4.3 Model Analysis
7.4.3.1 Simulation Approach. Hoffler [4] and Johnson
et al. [22] identified a number of possible contributory
factors that would explain the observed changes in car-
diovascular response to LBNP in weightlessness. The most
dominant among these factors was the reduction in blood
volume, and accordingly, our initial analysis focused on
the influence of blood volume loss on LBNP response.
The analysis utilized the LBNP model, a simplified ver-
sion of the EXER model as noted earlier. In addition, the
data on leg volume response to LBNP were examined in
detail to find plausible explanations for the observed
inflight changes. Specifically, the LBNP model was used
to discern the role of leg venous compliance in LBNP-
Figure 7-6. LBNP model validation study showing preflight re-
sponses from spaceflight crews. Simulation results (———) com-
pared with averages of 6 runs from each of 3 subjects in typical
space crews (- - - -). ● Averages of Apollo 7, 8, 9, and 15 crews,
3 runs each; ▲ Average of Skylab crews, 6 runs each.  Redrawn
from Ref [25].
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Figure 7-7. Mean Skylab heart rate (top panel) and blood pressure
(systolic, diastolic, and mean; bottom panel) responses to LBNP
during the first month inflight (N=9; mean ± SE) ). The values at
rest (pre-test) are shown by open circles and the values at maximum
LBNP of -50 mmHg are shown by filled circles. The values at
zero time are the preflight means.
induced leg volume changes, based on the suggestion of
increased leg compliance as a significant factor of leg vol-
ume response in weightlessness [4,24]. Finally, in order to
understand why the LBNP responses that were obtained early
inflight differed so dramatically from those administered
late in the mission, hypotheses were tested associated with
long-term circulatory adaptive changes, such as delayed
compliance. Table 7-1 lists the simulation studies and data
analyses performed and the results obtained.
Prior to these studies the LBNP model was validated
using data obtained in one-g (see next section). For the
analysis of inflight Skylab data, various hypotheses were
tested with the model as described above. These simula-
tion results were compared with the average LBNP data
from the three manned Skylab missions for the common
flight duration of the first 28 days after launch, a period
corresponding to the shortest mission, and where the data
for all nine crewman could be included. Despite the con-
siderable differences among the three missions regarding
diet, exercise, and other crew activities (see Chapter 4.6),
it was deemed reasonable to assume that the overwhelm-
ing effect of weightlessness would tend to minimize other
sources of variability in the measured quantities.
7.4.3.2 Simulation of Preflight LBNP Response —
Model Validation. Validation tests were performed to
demonstrate that the LBNP model could reproduce ob-
served changes under one-g conditions without the un-
known and confounding effects of weightlessness.
Preliminary LBNP validation studies were presented in
Chapter 3.2.1.4 using data from NASA and non-NASA
earth-based laboratories. The techniques for simulating
LBNP were also described as well as a model comparison
between a tilt test and LBNP test for measuring orthostatic
intolerance. The results demonstrated that the model was
able to simulate plausible cardiac and circulatory changes
expected from these maneuvers.
A validation study more relevant to the current analy-
sis was conducted using preflight LBNP tests on the astro-
nauts who flew missions in the Apollo and Skylab programs
(Fig. 7-6). Steady state heart rate and pulse pressure changes
due to applied LBNP were computed and compared with
those obtained in preflight LBNP tests. Values are presented
as percent changes in heart rate and pulse pressure. Normal-
ized parameters are used to provide a basis of comparison
because of the wide range of resting normal values of blood
pressure and heart rate that existed among the Skylab and
Apollo crewmembers. The favorable comparison of simu-
lated and observed changes indicated that the model was
sufficiently accurate for simulating inflight data and com-
paring the results with experimental observations.
7.4.3.3 Influence of Blood Volume Loss on LBNP
Response
7.4.3.3.1 Skylab Measurements. Figure 7-7 shows the
average Skylab heart rate and blood pressure responses in
the resting state and during steady-state LBNP of -50
mmHg. Clearly, the inflight increase in heart rate at -50
mmHg LBNP from the resting level is much larger com-
pared to the corresponding increase prior to flight. On the
other hand, the mean arterial pressure does not appear to
change significantly either from preflight to inflight or
from resting to -50 mmHg LBNP. There is also a slight
tendency for the pulse pressure (systolic minus diastolic)
at rest to increase while the stressed pulse pressure de-
creases slightly over time and compared to preflight.
7.4.3.3.2 Parametric Analysis Using the Model. The
reduction in blood volume as a result of spaceflight is be-
lieved to have a critical influence on the inflight response to
LBNP as well as on the immediate postflight response to
standing [26]. In order to assess the contribution of blood
volume loss to LBNP response, a parametric analysis was
performed using the LBNP model. Figure 7-8 (top panel)
shows the heart rate responses at rest and at the maximum
LBNP level of -50 mmHg produced by the model over a
range of blood volume losses. The response to maximal
LBNP shows that a 20% blood volume loss (approximately
a liter in an average subject) represents a severe stress. The
steep increase in heart rates and decrease in systolic and
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Figure 7-8. Model-simulated heart rate and blood pressure re-
sponses to LBNP as a function of decreases in blood volume. The
values at rest are shown by open circles and the values at maxi-
mum LBNP of -50 mmHg by filled circles.
Figure 7-9. Comparison of measured and simulated values of
heart rate (increases from resting levels) and pulse pressure (PP)
at maximum LBNP of -50 mmHg during the first month of the
Skylab missions. Experimental values were obtained from data in
Fig. 7-7. Simulated values were calculated from Fig. 7-8 using
estimated inflight blood volume changes from Fig. 7-10.  Simu-
lated PP values were further normalized by adding the difference
between the experimental resting PP (Fig. 7-7) and the model’s
resting PP (Fig. 7-8) to the model’s PP at –50 mmHg.
pulse pressures at the larger blood volume losses may be
indicative of initiation of syncope that has been observed
at high LBNP levels. For example, in normal subjects syn-
cope occurs at approximately –70 mmHg LBNP [19], while
it occasionally took place at –50 mmHg during the inflight
phase of Skylab [22]. (No episodes were reported preflight).
At lower levels of blood volume loss, the heart rate in-
creases predicted by the model (Fig. 7-8) are lower com-
pared to available experimental measurements [14].
Figure 7-8 (middle panel) shows the effects of de-
creased blood volumes on the blood pressure response to
LBNP. Significant decrements occur in systolic pressures,
especially at larger blood volume losses. On the other hand,
the changes in diastolic and mean pressures are relatively
small amounting to less than 10%. Most of the changes in
mean arterial pressure results from a decreased systolic
pressure. Also, decreases in systolic pressure result in a
diminished pulse pressure response to LBNP with blood
volume reductions (Fig. 7-8, bottom panel). The differ-
ence between resting and stressed pulse pressures increases
with blood volume loss.
7.4.3.3.3 Comparison with Experimental Results. Re-
ferring to experimental data in Fig. 7-7 (top panel), inflight
heart rates at rest are elevated above preflight control val-
ues and exhibit a tendency to plateau for the duration of
the mission. The factors causing the elevated resting heart
rates, also noted in bedrest studies (see Fig 9-4), whether
mediated by mechanical, neural, hormonal, or local mecha-
nisms are not understood. Because the model was not able
to reproduce this heart rate effect, it is difficult to make
direct comparison between data and model with regard to
absolute values. However, the change in heart rates from
rest to stressed levels can be compared between model and
data. When this is done, the parametric study of Fig. 7-8
can be analyzed and some inferences can be drawn regard-
ing the effect of blood volume.
Using the data from Fig. 7-7, the average change in
heart rate from resting to stress level at -50 mmHg LBNP
for the nine Skylab astronauts was computed as shown in
Fig. 7-9. The change increases from a little over 10 beats/
minute preflight to approximately 25 beats/minute by the
eleventh inflight day and remains elevated throughout
the remaining days of the mission. This implies that, if we
assume blood volume loss as the only causative factor for
the increased heart rate response, the loss is mostly com-
plete by the eleventh day of the flight. Based on the model
analysis shown in Fig. 7-8, an increase of 25 beats/minute
corresponds to a 15% blood volume deficit or approxi-
mately 750 ml for a normal subject. This is comparable to
that reported by Murray et al. [18] who found a heart rate
increase of 25 beats/minute with a blood loss of 500 ml
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Figure 7-10. Blood volume changes during the first month of
Skylab predicted by the erythropoiesis regulatory model (Chapter
6) using measured plasma hemoglobin concentration as a model
driving function.
(acute venesection) at -40 mmHg LBNP. Blood volume
loss for the Skylab crew was measured postflight as 590
ml (see Table 5-2), an amount sufficient to explain the
early increase in stressed heart rate.
A different type of comparison of the experimental
LBNP responses (Fig. 7-7) with simulation results over
the course of the first month can be made by estimating
the inflight changes in blood volume and by assuming
blood volume to be solely responsible for the observed
response to LBNP. No measurements of blood volume were
performed during flight but it had become possible to com-
pute this variable from the erythropoiesis model (see Chap-
ter 6). Specifically, the model was programmed with the
measured changes in plasma hemoglobin concentration
measured in the Skylab crew and was able to predict plasma
volume, red cell mass and total blood volume during the
course of the mission. Although superior methods of simu-
lating the effects of spaceflight on blood volume were
developed later in the project (see Figs. 6-40, 6-45 and 9-
19), Fig. 7-10 shows the blood volume estimate that was
available at the time of these LBNP studies based on he-
moglobin data from the Skylab missions. This data was
used in each of the inflight simulations for Figs. 7-9, 7-14
and 7-15.
Figure 7-9 includes the simulated values of the change
in heart rate from resting control levels to -50 mmHg LBNP
plotted as a function of mission time for comparison with
experimental results. Figure 7-8 was used to determine the
delta heart rate response predicted by the model for the par-
ticular mission day using blood volume estimates from Fig.
7-10. The comparison between model and delta heart rate
data in Fig. 7-9 indicates that approximately 75% of the
observed increase in stressed heart rate from resting levels
can be accounted for by decrements in blood volume re-
sulting from exposure to weightlessness. The bottom panel
of Fig. 7-9 shows a similar comparison of the pulse pres-
sure at –50 mmHg LBNP. The model values show a slight
increase (less than 7 mmHg), while the observed values
exhibit a slight decrease throughout the mission. Although
the trend in the human data does not seem to be reflected
in the model predictions, the data and model agree fairly
closely early in the mission and on an absolute mean ba-
sis. The basic conclusion is the same as for the heart rate
comparison – most of the LBNP response can be associ-
ated with direct effects of a reduced blood volume.
7.4.3.4 Leg Volume Response to LBNP
7.4.3.4.1 Experimental Measurements. The leg vol-
ume was determined both at rest and during LBNP tests in
the Skylab missions by measuring the circumference at a
number of points along the leg and calculating the total
volume as the summation of multiple truncated conical
volumes [21]. The application of LBNP results in an in-
crease in leg volume due to fluid pooling in the lower half
of the body caused by the pressure gradient. Figure 7-11
shows the plot of average percent leg volume change (PLVC),
i.e., deviation from resting control levels during any ses-
sion, as a function of mission time for the nine Skylab
astronauts for all five levels of Skylab LBNP protocol.
7.4.3.4.2 Analysis of Data. The data shows that the per-
centage increase in leg volume during inflight LBNP, i.e.,
PLVC, was greater than the preflight value for any given
level of LBNP. In addition, the difference between inflight
and preflight, as measured by the percent increase in PLVC,
i.e., ∆PLVC, is greater for the lower levels of LBNP. (For
example, for –16 mmHg, the mean inflight change in PLVC
compared to preflight is over 200%, while the correspond-
ing value for –50 mmHg is only 45%). This is consistent
with the observations of the Skylab researchers who noted
that the rate and magnitude of leg volume increase mea-
sured during inflight tests were especially pronounced at
the lower levels LBNP of –8, –16 and –30 mmHg [22].
Presumably, a given increment of negative pressure has a
greater effect in forcing fluids into the legs at lower LBNP
levels.
Figure 7-11. Skylab mean percent leg volume change (PLVC)
response to LBNP (N = 9; mean ±SE). The data at zero time are
mean preflight values.
Days in flight
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Figure 7-12. Analysis of Skylab leg volume changes during LBNP.
The upper panel shows the ratio of change in leg volume to change
in pressure level during LBNP using Skylab data, and the lower
panel shows the same referenced to the preflight mean
Table 7-2. ∆PLVC/∆LBNP Ratios for LBNP Steps of Skylab
Protocol
∆LBNP Level (mmHg)
 Increase in 0-8 8-16 16-30 30-40 40-50
Compliance
    20 0.23 0.28 0.25  0.26  0.24
    40 0.44 0.55 0.49  0.51  0.47
      100 1.07 1.32 1.18  1.22  1.13
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The above observation is more readily seen by calcu-
lating the change in PLVC per unit of applied negative
pressure between protocol levels (∆PLVC/∆LBNP). The re-
sulting ratio can be taken to represent the volume response
of the leg to a unit of negative pressure applied. As such,
∆PLVC /∆LBNP, is an index of leg compliance. Figure 7-
12 shows the results of this transformation for each level
of LBNP protocol. The inflight changes are remarkably
similar (Fig 7-12, top panel) with the exception of the
values for the maximum stress levels of LBNP, i.e., -40 to
-50 mmHg, which show a decrease in leg volume response
to pressure after two weeks of flight. The interpretation of
this finding remains speculative. It could be due to a de-
crease in leg vascular capacity (reverse stress relaxation
or devascularization) or a stronger sympathetic response
to the stress than during preflight; the effect has a greater
influence later in the mission and at higher stress levels.
Another observation of interest is that during preflight,
the compliance indices for the two lowest LBNP levels are
less than the indices at higher levels of LBNP stress (see
Fig. 7-12 for zero time). This becomes evident by replot-
ting the indices with the preflight levels at the origin as
indicated in the lower panel of Fig. 7-12. This plot clearly
shows the compliance index is highest at the lowest levels
of LBNP as well as the dramatic divergence between the
index at the highest and lowest levels of LBNP.
7.4.3.4.3 Hypothesis for Leg Volume Findings. Sev-
eral hypotheses are offered to explain these findings re-
lated to changes in leg volume.
a) Effect of a Diminished Resting Leg Volume. A
partial explanation for this phenomena resides in the
recognition that resting leg volume gradually dimin-
ishes over the course of the mission. Because PLVC is
defined as the ratio of leg volume change to the rest-
ing leg volume, then for the same absolute change in
leg volume, the inflight PLVC would be greater than
the corresponding preflight value. Direct measure-
ments aboard the 84-day mission showed that the rest-
ing leg volume decreased early inflight and contin-
ued to decline very gradually for exposures to
microgravity up to 3-months (see Fig. 9-10). The av-
erage resting leg volume decrement in Skylab was 2.2
liters by the end of the longest mission. For an aver-
age 70 kg man, the combined total leg volume is ap-
proximately 16 liters. Thus, for an identical increase
of 500 ml in leg volume due to LBNP, the PLVC would
be 3.60% inflight compared to 3.13% preflight. This
effect of a gradually diminished resting leg volume
can account for a 15% increase in PLVC inflight as-
suming the same volume of fluid shifted at all levels
of LBNP, but it is not sufficient to explain the ob-
served inflight increases in PLVC obtained at the high-
est LBNP levels, e.g., increase from 3.8 to 5.4 at -50
mmHg LBNP, which is an increase of over 40%.
b) Partial Collapse of Leg Veins. A more complete
explanation for the greater inflight leg volume
changes at lower LBNP levels is based on the partial
collapse of leg veins prior to the beginning of the LBNP
tests. The leg veins are relatively empty in a supine,
resting one-g state but more so during inflight than pre-
flight because of the tendency for fluids to move
headward and the legs to dehydrate. Therefore, the
legs, being less full during flight, can accommodate
more blood volume with the application of small in-
creases in LBNP. Calculations indicate that only 135
ml to 200 ml of fluid would need to be removed from the
one-g supine leg blood volume to completely account
for the effects shown in Figs. 7-11 and 7-12. This hy-
pothesis has been advanced by Skylab investigators
[22]; it has also been used in previous modeling stud-
ies [25]; and will be discussed later in this chapter as
part of an overall hypothesis for LBNP response.
c) Increase in Leg Venous Compliance. Another,
equally plausible hypotheses for inflight increases in
leg volume change is a simple increase in leg compli-
Note: Ratios were calculated using the leg blood volume changes
produced by the LBNP model with increase in leg venous compliance.
The indicated ratios are referenced to that obtained with no change in
compliance corresponding to preflight, as in Fig. 7-12 (bottom).
Days in flight
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Figure 7-13. Model responses to LBNP with increased leg venous
compliance.
ance. This could be caused by the reduction in force
exerted transversely on the leg veins by the surround-
ing muscle and other tissues under weightless condi-
tions. Normally, the weight of tissues acting trans-
versely on the leg veins must be opposed by accumu-
lating venous pressure or by external LBNP forces in
one-g before leg veins can fill. In zero-g the overlying
tissues are weightless, tissues are dehydrated and
muscles have atrophied; there is good reason to be-
lieve that under these conditions LBNP is transmitted
more directly to leg veins. In addition, prolonged
spaceflight may act directly to increase compliance
of the leg veins, reduce tone of supporting muscle and
diminish tissue pressue, all of which may enhance the
leg fluid pooling during LBNP. Thus, the same incre-
ment of LBNP could be more effective in spaceflight
in filling the veins. This translates into an increase of
leg venous compliance (larger change in volume for a
given change in transmural pressure).
Such an altered compliance has been suggested
as the cause of increased leg volume in weightless-
ness during LBNP tests [24]. There is no doubt that
overall resting leg compliance increases in spaceflight
[27]. The real practical question is to what extent an
increased leg venous compliance and the consequent
increase in leg blood volumes under LBNP can ac-
count for the observed changes in total leg volume
and other physiological responses.
The LBNP model was used to evaluate the effect
of changes in leg venous compliance on LBNP re-
sponse. A parametric analysis of the model response
was performed by increasing the compliance of small
veins and venules of the legs up to 100%. The top two
panels in Fig. 7-13 show the results on heart rate and
systolic pressure. The latter was used to represent blood
pressure response because simulation results showed
no appreciable effects on diastolic pressure. Accord-
ingly, changes in systolic pressure reflect all changes
in mean arterial pressure and the pulse pressure. Al-
though these simulations indicate that an increase of
leg venous compliance has no effect on resting heart
rate and systolic pressure, the model predicts eleva-
tions of stressed heart rate and decrements in systolic
blood pressure at all levels of an LBNP protocol.
The bottom panel in Fig. 7-13 shows the simu-
lated results on leg blood volume, which increases
linearly with leg venous compliance at each level of
LBNP. (Note that the model can only predict increases
in leg blood volume rather than total leg volume. For
the purposes of this analysis we assume that changes
in leg blood volume are similar in nature to leg vol-
ume, the latter being the measured variable). At any
venous compliance, leg blood volume increases pro-
gressively from rest to higher LBNP levels. Table 7-2
shows the ∆PLVC/∆LBNP ratios calculated as described
earlier, but using the simulated leg blood volume (from
Fig. 7-13) in place of leg volume and the preflight value
corresponding to zero change in compliance as refer-
ence. The ratios are not significantly different at any
one compliance level, except for the slightly larger
value for the LBNP step from –8 to –16 mmHg. With
this exception, they do not exhibit larger leg volume
increases observed at lower levels of LBNP as was
observed in the Skylab experiment. Also, they increase
with increasing levels of compliance. We cannot as-
sociate increasing compliance with mission duration,
because ∆PLVC/∆LBNP, based on measurements,
showed little change through the mission (Fig. 7-12).
Thus, (within the limitations of the model’s inability
to distinguish between leg volume and leg blood volume
changes) the results on leg volume changes during LBNP
from the Skylab experiment cannot be explained based on
increased leg venous compliance alone. This analysis,
however, does not test other factors that could have con-
tributed to the observed changes in the overall leg pres-
sure/volume relationship. Both the changes in the leg
tissues which surround and support the leg veins and di-
minished tissue pressure that accompanies leg dehydra-
tion may participate to varying degrees in this relationship
and help explain the large inflight leg volumes observed
inflight compared to preflight, especially at the higher
levels of LBNP. (Additional comments about this analysis
are found at the end of the next section).
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Figure 7-14. Comparison of experimental and model responses to LBNP response for a single Skylab crewman. Three hypotheses were
used in the model to account for inflight changes in heart rate and pulse pressure on Inflight Day 52. See text for explanation of
hypotheses (A), (B) and (C).  See Fig. 7-15 for a similar comparison on Inflight Day 20 using a simulation of Hypothesis (A) and data
from the same subject.
7.4.3.6 Hypotheses For LBNP Response In Weight-
lessness. The following key factors emerge from the fore-
going discussion to explain the experimental results: a)
blood volume loss during spaceflight, b) headward fluid
shifts accompanied by blood leaving the legs, resulting in
a partial collapse of leg veins, and a relatively empty
venous system in the legs at the beginning of the LBNP
test, and c) delayed retoning of the legs blood vessels to
accommodate the reduced inflight leg blood volume. The
first two of these may help explain the difference between
preflight and early inflight responses to LBNP while the
third factor may explain the difference between early and
later mission results.
7.4.3.6.1 Hypotheses to Explain Early and Late Re-
sponses. It was clear that LBNP tests soon after launch
were quite different than preflight (see Figs. 7-7 and 7-
11). Model simulations also indicated that the loss of blood
volume could be a major factor in explaining the LBNP
results, at least early inflight (see Figs. 7-8 and 7-9). How-
ever, blood volume changes alone could not explain the
LBNP results later in the missions. A comparison of model
response with inflight data (Fig. 7-9), using blood volume
loss as the only model hypothesis to distinguish between
preflight and inflight conditions, showed the differences
became greater during tests in the later portion of space-
flight. In addition, Skylab findings revealed that the great-
est decrements in orthostatic intolerance occurred during
the first several weeks of flight, but after approximately 5-
7 weeks, cardiovascular responses became more stable and
tended towards preflight normals [22]. A simulation study
was undertaken to answer the question “what hypotheses
are required in the model to obtain reasonable agreement
between model results and Skylab data for both early and
late responses?” Although only a single crewman’s data
was used in this analysis (originally a pilot study) it is a
convenient means of demonstrating an important concept
of cardiovascular adaptation – that of stress relaxation.
Using the data for the selected crewman, Figs. 7-14 and 7-
15 compares experimental and model responses to LBNP
at three phases of the mission: Preflight control (Fig. 7-
14); Inflight Day 20, representing an early mission LBNP
test (Fig. 7-15); and Inflight Day 52, representing a late
mission test (Fig 7-14). Figure 7-14 also summarizes three
hypotheses that were used to improve the agreement be-
tween model and data for the Inflight Day 52 test. The
following hypotheses were evaluated:
The overriding hypothesis tested was that blood vol-
ume changes were responsible for the differences between
inflight and preflight LBNP responses.  Blood volume
changes during the mission were estimated from the model
as noted in Chapter 7.4.3.3 and Fig. 7-10. These changes
were introduced in each of the inflight simulations in Figs.
7-14 and 7-15 in addition to one of the following second-
ary hypotheses.
Hypothesis (A): Blood Migration from the Legs
The absence of gravity allows headward migration of
blood from the legs.  In the absence of a hypothesis for the
physiological mechanism involved, a pressure bias term
was added to the leg vasculature in the model to force
blood from the legs into the upper body prior to initiating
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Figure 7-15. LBNP response on Inflight Day 20 for the selected
crewman (solid line) compared to the simulated response (dashed
line). This graph is from the same series of simulations shown in
Fig. 7-14. As a means of representing the inflight physiological
condition, the model was initialized with a reduced total blood
volume and reduced leg blood volume (see Hypothesis (A) in
text). Although comparison between model and data was reason-
able on Inflight Day 20, the same hypotheses produced a poor fit
on Inflight Day 52 (see Fig. 7-14, Hypothesis (A)).
the LBNP test. The exact quantity of blood that was shifted
was derived from the resting leg volume measurements
made at rest prior to LBNP. Thus, it was possible to com-
pute from these inflight leg volume measurements, a time-
varying estimate of fluid shifts during the mission. The
test of this hypothesis, together with the overriding hy-
pothesis of blood volume loss, is shown in Fig. 7-15 for
Inflight Day 20 and in the second panel of Fig. 7-14 for
Inflight Day 52 (Hypothesis A). Hypothesis (A) resulted
in good agreement for the test early in the flight, but poor
agreement for the later test.
Hypothesis (B): Partial Collapse of Leg Veins
Followed by Reverse Stress Relaxation
The failure of the model to simulate the later mission
LBNP experiments resulted in the generation of another
hypothesis to account for a long-term change in the car-
diovascular system. This hypothesis postulates a retoning
of the partially collapsed leg veins after a headward mi-
gration of blood from the legs has occurred. The long-
term change postulated is called reverse stress relaxation
and has the characteristics of retoning the vasculature to
accommodate the reduced blood volume in the legs and
returning venous pressure toward normal. This hypothesis
was included in the LBNP simulation model by shifting
the leg compliance curve (effectively reducing the un-
stressed volume in the vein). Reverse stress relaxation will
be further explained in a section below. The test of this
hypothesis, together with the overriding hypothesis of
blood volume loss, is shown in the third panel of Fig. 7-14
for Inflight Day 52 (Hypothesis B).
Hypothesis (C): Leg Blood Volume Loss Equal to
Total Blood Volume Loss:
Another hypothesis considered is that the eventual
reduction in total blood volume is equal to the amount
that migrated from the legs to the upper body. In other
words, the upper body somehow sensed the influx of blood
from the legs as excess and moved to reduce the total blood
volume by that amount. This hypothesis was tested by
setting the history of leg blood volume reduction equal to
the history of model-estimated total blood volume reduc-
tion and rerunning the LBNP simulations for the later mis-
sion days. The test of this hypothesis, together with the
overriding hypothesis of blood volume loss and includ-
ing Hypothesis (B) is shown in the fourth panel of Fig. 7-
14 for Inflight Day 52 (Hypothesis C).
In summary, as shown in Fig. 7-15, the loss of blood
volume can account for most of the LBNP response early
in the mission. However, the difference between simulated
and measured responses for a mission day test late in the
flight was poor (Fig. 7-14) if one considered only blood vol-
ume losses and migration of blood from the legs (Hypothesis
A), simulated by forcing blood out of the leg compartments
with a pressure bias term. The agreement improved con-
siderably by allowing the leg venous compartments to
retone after partial collapse (Hypothesis B), or assuming
that the migrated blood from the legs was lost from the
circulation so that it was not available to move to the legs
during LBNP (Hypothesis C).† The best agreement of Hy-
pothesis (C) was achieved without sacrificing the good
agreement for early tests (e.g., Fig. 7-15). In almost every
case the model simulation of late mission tests was im-
proved by the addition of the hypothesis to the model,
giving credence but not conclusiveness to the hypothesis.
By far the greatest improvement was realized by the addition
of the long-term reverse stress relaxation hypothesis.
7.4.3.6.2 Reverse Stress Relaxation and the Impor-
tance of the Compliance Curve. Figure 7-16 illustrates
the concept of reverse stress relaxation with a typical P-V
relationship of a venous segment (representative of data
on vena cava; see Fig. 3-14) with an unstressed volume Vo.
A sudden drop in volume causes point A to shift to point
B on the normal P-V curve (solid line) with a concomitant
drop in transmural pressure. Re-toning of the veins re-
† Whether fluids that shift headward in spaceflight leave the circulation
or are available to supplement circulating blood volume during LBNP
was considered an unanswered question of great importance by the
Skylab investigators [22]. The present analysis preliminarily indicates
that the headward shifted blood is not available.
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Figure 7-16. Normal pressure-volume (P-V) relationship in a
venous segment of the cardiovascular system (solid curve) show-
ing the effect of reverse stress relaxation (dashed curve), by which
reduced transmural pressure due to a reduction in volume (from A
to B) is restored to its original value (from B to A’, as indicated by
the dotted line with an arrow). The normal (one-g) unstressed
volume is V
o
, and the symbols R
o
 and R refer to the resting oper-
ating points in one-g and weightlessness, respectively. Volume
and pressure are small at R due to partial collapse of the vein and
migration of blood out of the vein in zero-g. The volume increase
due to LBNP is ∆V
o
 (from R
o
 to A) in one-g, ∆V (from R to A)
early in flight, and ∆V’ (from R to A’) later in flight with adapta-
tion to weightlessness. Both ∆V and ∆V’ are greater than ∆V
o
,
and ∆V’ is less than ∆V.  Compliance is defined as the inverse of
the slope of these curves at any point.
stores the pressure to its original level as indicated by
point A’ on a P-V curve with a reduced unstressed volume
(dashed line). Movement from point B to point A’ (indi-
cated by a broken line with an arrow) for restoring the
transmural pressure to its original level is not immediate.
In the model simulation described above, the compliance
curve was allowed to shift as a function of the history of
the reduction in leg blood volume (obtained from inflight
measurements) and with a time constant of 14 days, i.e.,
63% of the change occurs in one time constant [Guyton,
A.C., private communication].
Stress relaxation (or delayed compliance) refers to the
additional increase in volume that occurs in response to
continued pressure of the same amount over a long period
of time, this additional volume occurring by slow accre-
tion. Delayed compliance is caused by progressive plastic
stretching of the vasculature with time. During the early
period of spaceflight, there is a large influx of blood from
the legs to the central circulation, which undoubtedly is
accommodated by some degree of stress relaxation in the
large central veins. On the other hand, the venous system
of the legs may experience reverse stress relaxation as the
vessels attempt to accommodate the partially collapsed
veins. A description of this mechanism can also be found
in Chapter 9.7.3.1 and in Guyton [28]. Clearly, stress re-
laxation in the upper body, and reverse stress relaxation in
the legs, is imperfect and does not completely accommo-
date the shifting of blood volume or the net losses of blood
volume that occur in spaceflight. If there was perfect and
instantaneous compensation, i.e., the operating point
shifted from A to A’ in Fig. 7-16, there would be no change
in mean circulatory pressure and provocative stresses such
as LBNP would likely reveal little change from preflight
to inflight as a result of blood volume loss.
The effect of reverse stress relaxation (which will par-
tially reduce the capacitance of the veins) and/or devas-
cularization of the tissues (which accomplishes the same
thing by reducing capillary capacity) is to reduce blood
pooling during LBNP. This is clear from Fig. 7-16 by com-
paring the increases in volume from rest to LBNP early in
flight (from R to A) and later in flight (from R to A’), both
of which are larger than the preflight increase (from Ro to
A). Because the effect has a long time-constant of action,
this mechanism may explain the fact that after 5-7 weeks
of flight, the cardiovascular response became more stable
and evidence of improved orthostatic tolerance appeared.
Another effect that may have aided the partial recovery of
inflight tolerance is a gradual increase in baroreceptors
sensitivity that could lead to more intense vasoconstric-
tion and venomotor function during LBNP [29].
It should be noted that the P-V curves depicted in Fig.
7-16 have a similar compliance, i.e., inverse slope, in the
linear elastic region at high transmural pressures. How-
ever, this may not be true, and the inflight changes in P-V
relationship may be more complex than a simple shift with
reduced volumes, especially with prolonged exposure to
weightlessness.‡ A more rigorous analysis of simulated leg
volume responses during LBNP, i.e., Fig. 7-13, and com-
parison of Skylab data, should take into account changes
in leg compliance due to changes in vasculature, muscle,
and connective tissues of the leg, all of which are influ-
enced in weightlessness by hormonal and neural activi-
ties that control fluid volumes.
The P-V relationships shown in Fig. 7-16 indicate a
non-linear region at transmural pressures slightly above
and below zero, in the vicinity of the collapsible range.
The LBNP model includes this non-linear representation
for the large veins of the upper body (see Fig. 3-14) but a
linear representation has been chosen for the leg veins
(see Fig. 9-32). The linear approximation is adequate if
the transmural pressures stay in the elastic region of low
compliance, but the nonlinearity should not be ignored if
the veins become partially collapsed with pressures close
to or below zero. Specifically, the analysis of compliance
in Chapter 7.4.3.5 revealed a linear relationship between
leg blood volume and compliance (Fig. 7-13 bottom panel)
and was not able to account for the differences in leg vol-
ume increments with successive LBNP steps. We now sus-
pect that the use of a more realistic linear compliance for
leg veins may have changed these results, so that this
should be considered only a preliminary analysis.
‡
 Increases in leg compliance at rest during spaceflight are no longer in
dispute but there is a question of how much this factor contributes to
postflight standing intolerance [27].
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Figure 7-17. Hypotheses for cardiovascular changes that explain the LBNP findings during the early (acute) and late (adaptive) phases
of spaceflight. Late mission results are influenced by factors that either promote greater orthostatic tolerance (+) or oppose it (-).
7.4.3.7 Summary
In summary, the modeling analysis has confirmed the
belief of the importance of blood volume loss in affecting
cardiovascular performance and orthostatic intolerance in
spaceflight. Heart rate and pulse pressure responses to
LBNP can be largely, but not wholly, attributed to this
factor. The increased leg volume pooling during LBNP
(compared to preflight) can be primarily explained by the
partial collapse of leg veins and a reduced leg blood vol-
ume at rest prior to the test. The ability of legs veins to
collapse in space, led to the study of a mechanism (re-
verse stress relaxation) that allows the leg vessels to gradu-
ally retone, thus perhaps explaining the improvement in
orthostatic tolerance as the mission progressed. Simple
passive increases in leg compliance, while theoretically
attractive, did not appear to explain LPNP response but
the analysis may have been flawed by the assumption of a
linear leg vein compliance curve. Leg compliance is in-
fluenced by a number of factors and measurements
strongly suggest that compliance increases in flight at
rest. Figure 7-17 shows the possible sequence of these
mechanisms that could lead to the observed changes in
the cardiovascular response, both in the near-term and in
the long-term.
7.5 Orthostatic Intolerance During
Shuttle Landings
In contrast to all previous manned spaceflights, the up-
right sitting posture of the Shuttle crew during reentry
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Figure 7-18. Comparison of steady-state cardiovascular response to +G
z
 acceleration produced by the LBNP model with experimental
data obtained from centrifugation studies. Simulation (solid line); Lindberg and Wood [30,32] (dashed lines, filled circles); Henry, et al.
[31] (dashed lines, open circles).
into the Earth’s atmosphere exposes them to +Gz accelera-
tion that would reach a maximum of twice the normal ac-
celeration due to gravity at sea level. The pooling of fluid
in the legs at such high g-forces combined with the loss of
blood volume caused by exposure to weightlessness, had
the potential of rendering the crew orthostatically intoler-
ant at a time when their performance level needed to re-
main high. Experimental data showing the combined effect
of the two stresses (blood loss and blood pooling) on car-
diovascular performance were limited, and therefore, the
computer simulation approach was used to generate the
needed results.
In this section, we summarize the results of a study
using the LBNP model that examined the combined effect
of blood volume loss and head-to-foot (+Gz) acceleration
on cardiovascular response. The simulation study was ini-
tiated during the early testing phase of the Space Shuttle
program. It was the first attempt in this project to use a
mathematical model to analyze an ongoing operational
problem concerning astronaut health and safety. The simu-
lations were first designed to explain the high heart rates
that were observed in the crewman returning on the early
shuttle flights. A second goal was to determine the maxi-
mum tolerable +Gz acceleration at any given level of blood
volume loss. Finally, the simulations were extended to
assess the effectiveness of an anti-g garment as a counter-
measure to orthostatic intolerance.
7.5.1 Simulated Response to +Gz: Model Validation
The LBNP model was validated for simulating responses
to +Gz acceleration, which is an orthostatic stress that pro-
duces blood pooling in the legs not unlike LBNP. Accelera-
tions greater than one-g are obtained in the laboratory by
using man-rated centrifuges to obtain forces along which-
ever axis of the body is of interest. The results of a valida-
tion study, using data from both steady-state and dynamic
behavior of the cardiovascular system during centrifuga-
tion of normal human subjects [30,31,32], showed that the
model was capable of producing correct responses.
Figure 7-18 compares the steady-state responses, show-
ing favorable agreement between simulated results and
experimental observations. Figures 7-19(a) and 7-19(b)
compare experimental and simulated pressure waveforms
obtained with a force of 4.5-g lasting for 15 seconds. Re-
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ferring to the experimental waveforms (Fig. 7-19(a)), the pres-
sure measured at the head level decreases rapidly to very
nearly zero with increasing g-force as blood is being forced
away from the heart. Reflex action partially restores head
pressure at the peak acceleration level. There is an in-
crease in waveform frequency during the centrifugation
reflecting an increase in heart rate. While the pressure at
the head level falls, the pressure at the heart level rises.
This latter elevation is both due to baroreceptor reflex
action and due to the measured pressure being just below
the hydrostatic indifference point, below which pressures
increase during standing. The simulated pressure wave-
forms produced by the model (Fig. 7-19(b)) reflect all the
features of the highly dynamic measured waveforms just
mentioned.
Thus, the LBNP model was verified to be capable of
accurately reproducing both steady-state and dynamic
characteristics of the cardiovascular response to centrifu-
gation, and thus, its potential for use in the Shuttle reentry
study. No modification was necessary to extend the model’s
capability, which is attributable to the fact that the model
is based on established physiological concepts and gen-
eral physical principles governing flow of incompressible
fluid in a closed elastic system.
7.5.2 Response to Combined +Gz and Blood
Volume Loss
The validated model was used to evaluate the sensi-
tivity of the response to g-level and blood volume loss.
Figure 7-20 shows the simulated systolic carotid pressure
response to combined +Gz acceleration as a function of
blood volume loss produced by the model. Model re-
sponses are shown for g-forces of 1.0, 1.5 and 2.0-g’s. The
dashed lines represent the threshold pressure levels for
blackout and two types of vision impairment based on
data obtained during centrifugation in normal subjects
[32]. Compared to results in normal subjects at one-g, the
systolic carotid pressure at 2-g’s is about 15% lower with
no blood volume loss, but the decrement increases to
nearly 50% at a blood volume loss of 10%. These simula-
tions predicted that at one-g, blood volume losses some-
what greater than 15% can be tolerated without any vision
impairment. However, the tolerable amount of blood vol-
ume loss is less at higher g-levels. Thus, the model pre-
dicts that with a blood volume loss of 10-15%, the Shuttle
crew could be at some risk during reentry because maxi-
mum g-forces are in the range between 1.5 and 2.0 g’s.
This conclusion, not verifiable with currently available
Figure 7-19(a). Blood pressure waveforms in response to +G
z
acceleration of 4.5 g in normal subjects from two separate cen-
trifugation experiments: Top panel: Lindberg & Wood [32]; Bot-
tom panel: Henry, et al. [31]. Both studies indicate that arterial
pressure at the head level diminishes to about zero. Brain circula-
tion fails when arterial pressure at that point becomes subzero, the
carotid vessels collapse, and blood flow ceases.
Figure 7-19(b). Blood pressure waveforms in response to +G
z
acceleration of 4.5 g produced by the LBNP model. The unique
pulsatile waveform pattern measured in human subjects and shown
in Fig. 7-19(a) is reproduced by the model.
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ground-based data, was substantiated by comparing data
from Shuttle pilots as discussed next.
7.5.3 Simulation of Responses from Shuttle Flight
The model was used to analyze heart rate and blood
pressure data from the crew of the first Shuttle flight, STS-1.
Figure 7-21 shows heart rate data recorded from the two
crewmen of STS-1 during reentry [33] (top panel, dashed
lines). Also shown are the heart rate responses for three
different simulations, using three levels of blood volume
loss (top panel, solid lines). (During the reentry phase, the
only biomedical data measured were the continuously-
monitored values of the crew’s heart rate). Each of the
simulations incorporated the time-varying reentry g-force
profile encountered by the crew as input into the model
(bottom panel). Peak g-forces occur at about 12 minutes
prior to touchdown.  The effect of these peak g-forces on
orthostatic tolerance is suggested by the simulated response
of the carotid blood pressure during reentry (Fig. 7-21,
middle panel).  Accordingly, the threshold of vision im-
pairment (62 mmHg) may have been exceeded if the blood
volume loss was as high as 16%.
The sensitivity of the model to both blood volume
loss and g-forces is evident from these results. For a blood
volume loss of –16% the heart rate curve reflects the g-
profile. Response with a blood volume loss of 8% closely
approximates the measured heart rates, except during the
last 5 minutes of reentry. This discrepancy in the waning
minutes of the flight could be the result of factors not
built into the model, i.e., anticipation and anxiety when
the crew gets ready to assume manual control of the space-
craft. An equally plausible explanation is an increased
blood volume loss due to excess capillary filtration of
plasma into leg tissues during the latter phase of reentry,
as indicated by better agreement between measured and
simulated responses at a blood volume loss of 16% in the
last few minutes before landing. The limited data do not
permit a resolution of these two explanations.
Thus, taking into account the differences between
measured and simulated heart rate responses toward the
end of reentry, the simulation results indicate a blood vol-
ume of loss of 8-16%. This was corroborated during a stand
test that was administered soon after Shuttle landing. The
comparison of the preflight and postflight stand tests in
the two Shuttle crewmen is shown in Fig. 7-22. Blood
pressure and heart rate responses are shown before (su-
pine) and after (standing) approximately 1 minute of stand-
ing. Figure 7-23(left side) repeats this data from Crewman
A which is compared to the results of four simulations of
the stand test, performed using the LBNP model. Each
simulated stand test was performed with a different blood
volume: a normal blood volume (0%) and a 5%, 10% and
15% reduction in blood volume. (The ability of the LBNP
model to reproduce an orthostatic tolerance test using
upright tilt, with a normal blood volume, was validated as
described in Chapter 3.2.1.4).
The first simulation with a normal blood volume, in Fig.
7-23 represents the preflight condition, while the others show-
ing different degrees of blood volume loss are alternative
simulations for the postflight condition. The simulated
data that best approximates the patterns measured in the
human subject are those corresponding to a blood volume
loss of 10-15%; this is consistent with the tentative con-
clusions from the analysis of heart rate measurements dur-
ing reentry (see Fig. 7-21). These results assume that blood
volume loss alone can account for the differences between
pre-and postflight. Interestingly, the postflight response
of the two crewman, shown in Fig. 7-22, are quite different
from one another. The response of Crewman B does not
match the simulation response at any blood volume level.
In particular, Crewman A exhibits postflight diastolic hy-
potension (similar to the model response) as opposed to
diastolic hypertension in Crewman B.
Nevertheless, there are some important common fea-
tures to both crewmen’s responses. Specifically, relative
to preflight, (i) the measured pulse pressure is narrower
postflight, especially in the standing position, and (ii) the
measured changes between supine and standing show an
increase in heart rate, a lowering of systolic pressure, and
a flattening of diastolic pressure. These differences are
reproduced by the model. The differences in the responses
of the two crewman may be explained by considering
changes in factors other than blood volume (i.e., barore-
ceptor sensitivity, venous tone, catecholamine release and
sympathetic activity), that are presumably different in the
two crewmen.§ Although these factors were not tested in
the current model analysis, the ability to discriminate be-
tween individual responses undergoing similar treatments
is a sought-after goal of modeling.
Figure 7-20. Combined effect of +G
z
 acceleration and blood vol-
ume loss on vision. Solid curves are generated by the model.
Horizontal dashed lines are obtained from data reported in Lindberg
and Wood [32].
§
 Orthostatic intolerance with losses of both blood volume and barore-
ceptor sensitivity has been addressed in a subsequent simulation study
using the LBNP model [29].
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Figure 7-21. Comparison of heart rate responses of crewmen
from the first Shuttle flight (STS-1) during re-entry with data
generated using the LBNP model with different amounts of blood
volume loss (top panel).  The fall in carotid blood pressure (middle
panel) could have exceeded the vision impairment threshold (dashed
line). The g-force profile experienced by the crew is shown (bottom
panel) and was used to drive the model. TD = Shuttle touchdown.
Figure 7-22. Blood pressure and heart rate responses for the two
STS-1 crewmen during a one-minute stand test administered pre-
flight and immediately after return from space. Blood pressure is
represented by a bar showing systolic and diastolic levels; the
height of the bar is the pulse pressure. Each stand test consists of
a supine phase (hatched bar) and a stand phase (white bar).
The simulation study, using the LBNP model, helped
substantiate the conclusion based on available data from
bedrest studies [34] (i.e., depending on the severity of
blood volume loss), the reentry acceleration might be det-
rimental to physiologic function and may place the physi-
ologic status of the Shuttle crew near the borderline of
some form of impairment. Model results suggest that mod-
erate blood volume losses (10-15%) may be reason for
medical concern in this situation. It has been emphasized
that the major assumption is that blood volume losses could
account for the observed changes. We have failed to lo-
cate experimental data showing how simple blood vol-
ume loss uncomplicated by weightlessness or similar
conditions can modify the normal circulatory response to
centrifugation. Such data would be highly useful to sepa-
rate the effects of blood volume loss from other aspects of
cardiovascular deconditioning alluded to above.
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Figure 7- 23. Measured (left side) versus simulated responses (right side) of crewmen from the first Shuttle flight (STS-1) to stand test
administered preflight and immediately after return from space. Only the data from Crewman A is shown (repeated from Fig. 7-22). The
first simulated stand test (at normal blood volume) represents preflight condition while the other 3 three simulated tests (at –5%, -10%
and –15% blood volume loss) are alternatives for the postflight condition.
All of these factors taken together increase the likeli-
hood of impaired performance during and after Shuttle
landing. Therefore, it was deemed prudent to initiate some
form of corrective measures prior to or during reentry (fluid
loading, for example) that would increase the margin of
safety, or at the very least, provide emergency coun-
termeasures (anti-g suit, for example) that could be used at
the first sign of impairment. It should be pointed out that
both fluid loading and donning of anti-g garment are now
part of standard operating procedures to be followed dur-
ing the return of the Shuttle from space. An analysis of the
anti-g suit is presented next.
7.5.4 Response with Anti-g Suit as a
Countermeasure
The anti-g suit is one of the countermeasures used by
the Shuttle crew for improving tolerance to headward ac-
celeration during the reentry phase of the flight.** The crew
would inflate the suit at the first sign of acceleration intol-
erance such as difficulty in vision. The positive pressure
of the anti-g suit forces blood and other fluids from the
legs into the central circulation. The resulting increase in
venous return, cardiac output, and total peripheral resis-
tance improves cerebral perfusion. The use of anti-g suit
for improving tolerance to +Gz has long been recognized
for high performance jet fighter pilots [32]. However, its
effectiveness may be reduced in Shuttle flights because of
cardiovascular deconditioning resulting from weightless
exposure. For example, the minimum suit pressure required
for a given level of protection (as judged by the carotid
systolic pressure) may be expected to be higher with in-
creasing loss of blood volume.
The dependency of minimum suit pressure on blood
volume loss was examined using the LBNP model. No
model modification was necessary for this study; applica-
tion of anti-g suit pressure required only assigning a posi-
tive value for the LBNP parameter.  Figure 7-24 shows the
results of a sensitivity analysis of the effect of anti-g suit
pressure on systolic carotid pressure. Results were obtained
at normal blood volume and 3 levels of reduced blood
volume. Operating points below a systolic carotid pres-
sure of 62 mmHg are in a danger zone. All simulations
were conducted using a g-level of 2.0. At g-levels less
than 2.0 the four curves of Fig. 7-24 would shift upwards
to a safer zone (not shown).
The results indicate that, a 10% BV loss can be toler-
ated only up to 2-g without anti-g garment protection.
With a loss of 15%, the suit pressure must be at least 46
mmHg in order for the carotid systolic pressure to stay
above 62 mmHg, and thus above all threshold levels. The
available data from Shuttle flights showed that approxi-
mately 50% of astronauts chose to inflate the anti-g suit
during reentry. The inflation pressure ranged from 26 to
78 mmHg with an average of 52 mmHg, which is close
agreement with the minimum suit pressure determined from
the simulation results.
Figure 7-25 shows the effects of anti-g suit pressure
on cardiovascular response during Shuttle re-entry, using
the STS-1 re-entry g-profile. A high value of 16% was
** Fluid loading is another countermeasure used by the Shuttle crew,
discussed in Chapter 9.7.6.
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Figure 7-24. Changes in systolic carotid pressure with increase
of anti-g suit pressure at different blood volume losses. Results
(solid line) were obtained from the LBNP model with g-level set
at 2.0. The threshold levels for visual symptoms (dashed lines)
are the same as in Fig. 7-20.
assumed for blood volume loss, since incidence of vision
impairment are highly likely for losses of this magnitude
especially if the peak g-force exceeds 2-g. The anti-g suit
inflation to 30 mmHg was assumed to begin at a declining
systolic carotid pressure of 60 mmHg. The simulation re-
sults indicate considerable improvement in cardiovascu-
lar response even at this low inflation pressure. These
results are in basic agreement with a related pressure suit
study [35] with the major exception that the peripheral
resistance decreased in the simulation (not shown) but in-
creased in the human subject. One explanation for this
difference is that the simulations discussed above did not
take into consideration possible mechanical compression
of blood vessels below the trunk with application of lower
body positive pressure. Another possibility is that the
baroreceptor control included in the model is not strong
enough. Nevertheless, the model was sufficiently accurate
to yield plausible lower bounds of suit pressure for given
levels of g-force and blood volume loss.
More detailed discussion of the Shuttle reentry prob-
lem and g-suit analysis using the LBNP model may be
found in previous publications [29,36,37]. These studies
demonstrate the utility of mathematical models in explain-
ing observed responses and formulating hypotheses that
lead to further experimentation, a theme emphasized
throughout this book.
7.6 Cardiovascular Modeling
Considerations
7.6.1 Strengths and Drawbacks of the Present Model
Analyses and simulation results presented in the fore-
going sections amply demonstrate the beneficial role of
mathematical models in assessing the effects of possible
changes to the cardiovascular system brought about by an
exposure to weightlessness. The application of mechanis-
tic models provides a complimentary approach to tradi-
tional statistical analysis. The model may be viewed as
the common background against which data from differ-
ent experiments obtained under varied experimental con-
ditions could be analyzed. However, this requires the
model to be comprehensive and representative of the hu-
man system. Accordingly, our model of the cardiovascular
system is large-scale in its scope with the controlled sys-
tem represented by as many as 28 compartments (see Fig.
3-12). It should be noted that the systemic circulation may
be modeled as elaborately as desired based on anatomical
structure. Models of the arterial tree much more detailed
than the representation in our model have appeared in the
literature [38,39,40].
While the controlled system is modeled with a large
number of compartments to retain close correspondence
to the real system, it was not always necessary to consider
the myriad of physiological factors involved in cardio-
vascular control [41]. For simulating both exercise and
LBNP responses, it was sufficient to consider only the acute
controls exerted by the autonomic nervous system. In the
case of only LBNP responses, the controlling system could
be further simplified by excluding the metabolic control ex-
erted by oxygen requirements. The more gradual changes in
cardiovascular variables, such as blood volume, brought
about by the influence of long-term control mechanisms
Figure 7-25. Simulation of the effect of inflating the anti-g suit on
cardiovascular response during re-entry, assuming a blood volume
loss of 16% and the STS-1 reentry g-profile. The suit was inflated to
30 mmHg when the systolic carotid pressure reached 60 mmHg.
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are readily introduced into the simulation by manual
changes in appropriate fixed model parameters. It is pre-
cisely these changes in model parameters that we seek
when we use the model to explain the observed changes in
LBNP and exercise responses during spaceflight.
The autonomic function is represented in our cardio-
vascular model by a proportional controller that operates
on signals sensed by the baroreceptors located in the aor-
tic arch and the carotid sinuses. No adaptation of the
baroreceptors is considered such as changes in gain or
threshold levels. The effects of sympathetic and parasym-
pathetic neural components are combined into a single
autonomic signal and is used to control flow resistances,
compartmental compliances, and both the strength and
the frequency of cardiac contractions. This representation
of autonomic function was deemed adequate when the
model was developed originally for simulating responses
to submaximal exercise. Its inadequacy is apparent when
one considers simulation of equivalent changes in heart
rate controlled by different proportions of sympathetic
and parasympathetic signals. The poor results of some
simulations are attributable at least in part to this defi-
ciency in the present model. Inclusion of dual autonomic
control in the controlling system will certainly improve
the model’s capabilities.
7.6.2 Model Simplification for Simulating
Orthostatic Stress Response
The approach to building the simplified cardiovascu-
lar models described here is to begin with a detailed large-
scale representation and to remove elements and
mechanisms that are not needed for accurate representa-
tion of the simulations of interest (top-down approach). In
contrast, we can construct a simple model with only the
essential elements that are necessary for simulating the
data on hand and expand the model to satisfactorily simu-
late additional data as they become available (bottoms-up
approach). We can develop a simple model of the cardio-
vascular system starting with our present model by reduc-
ing the number of vascular compartments and ‘fine-tuning’
the controlling system. We describe below such a minimal
representation developed for simulating cardiovascular
responses to orthostatic stress over a wide range.
The effort began with a review of the principles and
data requirements for modeling the cardiovascular system
to simulate its short-term response to orthostatic stresses
[41]. A survey of published models showed that the exist-
ing models could be improved based on current knowl-
edge of the cardiovascular system and recent experimental
data. Three different overall models of the cardiovascular
system, including the one described in the preceding sec-
tions, were compared for their capabilities in reproducing
responses to different stimuli that result in an orthostatic
stress (i.e., LBNP, head-up tilt, and blood volume loss [42]).
These models had a similar structural skeleton, but dif-
fered in the number of compartments, assumptions for solv-
ing the equations relating pressure and flow in the arterial
segments, and representations of the venous system and
the cardiac function. The orthostatic responses simulated
by the models were in qualitative agreement with avail-
able experimental data, but the differences were quantita-
tively significant. Each model produced best agreement
for the stress for which it was designed.
The review and the comparison study brought to light
the considerable variabilities in the observed cardiovas-
cular responses, and pointed to the need for a simple car-
diovascular model with a minimal number of elements,
which would allow one to fit the experimental data from
each individual subject and thus explain the observations.
Such a model has been developed and applied to LBNP
data [43]. It is a steady-state model aimed at simulating
the pulsatile pressure and flow in the cardiovascular sys-
tem following application of LBNP. The model equations
are based on the following processes involved in eliciting
the orthostatic response: (a) blood volume redistribution,
(b) left-ventricular end-diastolic filling, (c) interaction
between left ventricle and peripheral circulation, and (d)
modulation of heart rate and peripheral resistances by ar-
terial and cardiopulmonary baroreflexes.
The simple cardiovascular model and its variants have
been used to simulate LBNP response up to presyncopal
levels [44] as well as LBNP response modified by de-
creased blood volume [45]. Figure 7-26 shows compari-
son of experimental data compiled from a large number of
LBNP studies [46] with model-generated data up to -40
mmHg LBNP. The model has also been shown to repro-
duce well the effects of autonomic blockade [43]. The
model has far fewer number of sensitive parameters than
large overall models of the cardiovascular system. Along
similar lines, a ten-compartment model has been reported
recently [47]. Such simple representations that contain
the essential features of the cardiovascular system, but are
parsimonious in the number of parameters, have the po-
tential for simulating and comparing data from individual
subjects with optimization of parameter values, and de-
riving indicators of cardiovascular performance under or
following altered environmental conditions such as expo-
sure to weightlessness.
7.7 Summary
The pulsatile cardiovascular model, although deficient in
some respects, has proven to be a very useful tool for simu-
lating orthostatic intolerance and exercise responses as-
sociated with spaceflight. This approach is especially
convenient because of the difficulties involved in obtain-
ing measurements during the critical periods of flight. The
simulation results using the model corroborate the find-
ings by other investigators of Skylab data. An extended
analysis demonstrated the capability of the model to pre-
dict physiological responses that were not amenable to
measurement and to generate and evaluate hypotheses to
explain the results. Thus, it was possible to quantitatively
evaluate how exercise conditioning could oppose zero-g
deconditioning, to show how acute headward fluid shifts,
collapsing leg veins and eventual reverse stress relaxation
can help explain short and long-term changes in the car-
diovascular system, and to demonstrate how blood vol-
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Figure 7-26. Results of the model response (solid line) to LBNP up to -40 mmHg compared to experimental data [46] (filled circles). D
denotes change from baseline value at zero LBNP. SAP = systolic arterial pressure; MAP = mean arterial pressure; CVP = central
venous pressure; VLOL = leg volume (compartment representing the lower limbs); HR = heart rate; CO = cardiac output; EDV = end
diastolic volume; RSPL = splanchnic resistance.
ume loss accounts for much, but not all, of the orthostatic
intolerance seen during LBNP and during Shuttle reentry
from space. Other factors, including autonomic control,
catecholamine release, baroreflex adaptation, and venous
tone were identified for future study. An example of coun-
termeasure development to ameliorate orthostatic intoler-
ance, using model analysis, was also described.
In the process, a number of inadequacies of the com-
puter models were identified, including the lack of sepa-
rate sympathetic and parasympathetic pathways, a need
for non-linear compliances for the leg veins modeled after
the upper body veins, representation of adaptive mecha-
nisms for baroreceptors, delayed vessel compliance and
the desirability of an “open” circulation that can filter
plasma into tissues. With appropriate representation of
cardiovascular control, a simplified version of the model
can acceptably reproduce cardiovascular responses to
orthostatic stress. Further expansion of the simplified
model is the next step in the evolutionary development
toward a more comprehensive (albeit minimal) model of
the cardiovascular system, one that can simulate with fi-
delity, results from various experiments. Such a model can
serve as a framework within which the results can be ex-
plained without inconsistencies and the underlying physi-
ologic mechanisms can be elucidated.
In this chapter, the cardiovascular system has been
examined during provocative maneuvers (exercise, LBNP,
Shuttle reentry).  The manner in which weightless space-
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flight effects the cardiovascular system at rest is also of
great interest.  This subject is addressed in Chapter 5 and
9 as part of the response to headward fluid shifts during
spaceflight and ground-based maneuvers such as water
immersion and head-down tilt.  The Guyton model of cir-
culatory control has been very useful in this regard.  A
summary of the resting cardiovascular response to weight-
lessness is provided in Chapter 10.3.3.
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Chapter 8
Musculoskeletal System and Calcium Regulation
Losses in bone and muscle mass were among the many
physiological changes seen in Skylab crewmen during
spaceflight. The losses, first observed in the Gemini and
Apollo crews, [1,2] were not studied extensively until the
Skylab missions. Deficiences identified in the musculo-
skeletal system during hypogravity include: a) muscle and
connective tissue atrophy and localized bone loss; b) re-
ductions in motor performance; and c) increased susceptibil-
ity to injury (fracture, sprains). In addition, muscle atrophy
undoubtedly contributes to (but is not normally implicated
in) the occurrence of orthostatic intolerance observed upon
immediate return from spaceflight. Because the systems
analysis tools that were used to investigate the hypoth-
eses have not yet been as fully developed as in other dis-
ciplines (i.e., Chapters 4 to 7), the analysis presented here
concerning musculoskeletal adaptation in zero-g should
be considered as a preliminary one. If these losses are un-
derstood, perhaps they can be prevented or reversed by
taking the appropriate measures in future missions.
The main emphasis in this chapter will be on calcium
regulation with the aim of using knowledge of this com-
plex feedback system to better understand bone deminer-
alization in spaceflight. A unique contribution to this area
is the application of a mathematical model to simulate the
hypogravity environment. Analysis of muscle atrophy us-
ing metabolic balance techniques has been reported in
Chapter 4. In this chapter there is a brief summary of other
experimental evidence (mostly obtained from Skylab) sup-
porting the findings of muscle atrophy and a discussion of
the underlying mechanisms. Finally, there is a short dis-
cussion of the benefits of exercise and other countermea-
sures to both of these tissue systems.
8.1 Bone and Calcium Regulation
8.1.1 Introduction
Loss of calcium from the body had been observed
during bedrest studies and in short-term spaceflight mis-
sions prior to Skylab [3,4]. One of the most important con-
tributions of the Skylab missions was to show the extent
of calcium loss in a relatively long 3-month mission and
to document biochemical changes related to calcium loss
during flight [5]. In the post-Skylab era, calcium losses
have been noted consistently in both U.S. and Russian
space missions, some of which have lasted more than a
year [6]. At the time of Skylab the prevailing hypothesis
to explain calcium loss was that it was related to the re-
moval of mechanical loading as the originating event. But
it was not clear just how this occurred nor whether there
were some other primary events that originate in the kid-
neys, intestines, or hormonal secretion organs and have
secondary effects on bone demineralization.
The systems analysis of bone loss in space, including
the use of a mathematical model of calcium regulation,
addressed the various hypotheses and interpretations of
spaceflight and bedrest findings. A summary of the analy-
sis will include the following topics: a) a brief review of
physiological considerations that are needed to interpret
the experimental findings and to create a model of cal-
cium regulation; b) the most significant results from the
Skylab missions; c) a summary of a bedrest study not pre-
viously published with comparison to spaceflight results;
d) a description of the computer model and simulations
of hypogravity; and e) development of hypotheses to ex-
plain the spaceflight and bedrest findings. Results from
spaceflight, bedrest and mathematical modeling studies
will be combined to help formulate an overall hypothesis
of calcium metabolism adaptation to long-term spaceflight.
In order to better understand the experimental find-
ings and their role in overall calcium metabolism, a brief
review of the components of the calcium regulating sys-
tem is provided below.
8.1.2 Physiology of Calcium Metabolism
Calcium is a critical element in the composition of
bone, as is suggested from the fact that 98% of the total
body calcium is contained in the skeletal tissue. Calcium
metabolism centers on maintenance of the integrity of the
bone and homeostatic control of extracellular (or plasma)
calcium concentration. There are three major organs re-
sponsible for calcium regulation: bone, kidneys and in-
testines (see Fig. 8-1). Bone can be thought of as a calcium
reservoir for the maintenance of plasma calcium. The in-
testines act as both a source of external calcium via di-
etary intake as well as a means of (fecal) excretion. Blood
calcium is filtered into the kidneys at high rates and most
is reabsorbed back into the circulating plasma; thus small
changes in reabsorption will produce large changes in uri-
nary excretion of calcium. Similarly, there is a great turn-
over of bone calcium under normal conditions; bone
formation and bone reabsorption are both naturally high
flux processes.
Calcium concentration in plasma is exquisitely con-
trolled. The pathways available to correct increases or de-
creases in extracellular calcium concentration are indicated
in Fig. 8-2. Accordingly, if calcium concentration rises
above normal, the excess calcium can be excreted through
the kidneys or intestines or can incorporated into new or
existing bone (known as accretion, deposition, formation,
or mineralization). Conversely, if calcium concentration
falls below normal, calcium sources are activated by in-
creasing the fluxes into the extracellular pool. These
sources include bone resorption (i.e., demineralization),
renal reabsorption and intestinal absorption. Also shown
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Figure 8-1. Simple model of the organ compartments that participate in regulation of extracellular calcium concentration. The calcium
fluxes connecting the Extracellular compartment are under control of the calcitropic hormones (not shown here). Note the confusing
similarities of some of the terms often used to describe “inward” calcium flux: resorption from bone, reabsorption from kidneys, and
absorption from the intestines.
Figure 8-2. Basic physiological responses to a decrease (top figure) or increase (bottom figure) in plasma calcium concentration.
Changes in plasma calcium can be corrected by fluxes into or out of bone, or increases and decreases in renal and intestinal excretion. The
hormone controllers will theoretically change in the directions shown. The relationships between the hormones and their actions on bone,
kidney and intestines are shown in Fig. 8-3. See text and Fig. 8-7 for further clarification. (PTH = parathyroid hormone; CT =
calcitonin).
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in Fig. 8-2 are the expected changes in the three major
calcitropic hormones (parathyroid hormone, metabolites
of vitamin D, and calcitonin) that participate in the feed-
back regulation. (Their modes of action are described be-
low). In experimental studies, including those of bedrest
and spaceflight, the expected changes of these theoretical
pathways are not always observed. The preferred pathways
and the actions of hormone controllers and other possible
regulators under many experimental and clinical condi-
tions are still actively being researched and are not well
understood. Two pathways in particular, filtration into the
kidneys and secretion into the intestines are often consid-
ered to be relatively constant and not under regulatory
control. With little evidence to the contrary, that is the
assumption that was used in the mathematical model.
Figure 8-3 is a rather intricate diagram of the (mostly)
accepted relationships of calcium metabolism as they oc-
cur in the major organs depicted in Fig. 8-1. The interac-
tion of phosphorus, another critical bone mineral, is also
shown. The regulation of calcium metabolism is largely
under the control of three hormones mentioned above:
one secreted by the parathyroid glands (parathyroid hor-
mone; PTH), one from the thyroid gland (calcitonin; CT),
and one derived from vitamin D through activation pro-
cesses by the skin, l iver,  and kidney (1,25
dihydroxycholecalciferol; 1,25-DHC). 1,25-DHC is the
most biologically active metabolite of vitamin D3 [7]. PTH
and CT have opposing effects and are thought to be pri-
marily responsible for regulation of extracellular calcium
levels; PTH mobilizes calcium from the bone and increases
Figure 8-3. Model of calcium metabolism showing the interrelationships between the three major organ systems involved with calcium
homeostasis: intestines, kidneys, and bone tissue. The three calcitropic regulatory hormones, parathyroid hormone (PTH), calcitonin (CT),
and vitamin D (1,25-DHC) are included. Phosphorus (P) is also included because it is a critical element in both bone composition and
calcium regulation. The system functions to regulate extracellular (ECF) calcium concentration. Suggested pathways for gravity effects
are shown. The computer model shown in Fig. 8-7 uses a subset of these pathways. Suggested pathways for gravity effects are shown.
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renal tubular reabsorption in response to a decreased
plasma calcium; CT depresses bone resorption transiently
and thus inhibits the flow of calcium from bone to blood
in response to elevated serum calcium. Less is known
about all the forms and functions of vitamin D, but it has a
major role in enhancing intestinal absorption of calcium
and a lesser role in enhancing renal calcium reabsorption;
both these effects thus tend to raise plasma calcium levels.
The action of Vitamin D on the bone is more complex,
because it appears to both promote bone formation and
calcium mobilization (reabsorption). The actions of these
hormones are complex and interrelated as the overlapping
feedback loops in Fig. 8-3 illustrate.
Although complex, the information in Fig. 8-3 is very
compact and efficiently presented and can be viewed in
various ways. For example, examining the inputs and out-
puts to the box representing the extracellular calcium con-
centration, [Ca+]ECF, indicates that there are four pathways
that can change [Ca+]EFC (GI absorption, renal excretion,
bone resorption, and bone formation) and there are six
different quantities that [Ca+]ECF can influence (PTH, CT
and 1,25-DHC, bone deposition, renal excretion, and in-
testinal absorption). The known affects of each of the
calcitropic hormones are explicitly shown. Also shown
are the postulated direct effects of gravity unloading
(weightlessness) on bone formation and resorption. All of
these are gross effects, only indicating whether one quan-
tity has a positive or negative influence on another. It
does not portray the magnitude of the effects, thresholds,
adaptation to prolonged effects, etc. Many of these rela-
tionships and effects, if well described (and many are not)
are incorporated into the mathematical model that is pre-
sented later in this chapter.
With this rudimentary physiological schema as a con-
text, the primary findings of spaceflight and bedrest stud-
ies will be presented next.
8.1.3 Skylab Mission Results
The Skylab missions presented the first opportunity
to study calcium metabolism and bone demineralization dur-
ing spaceflight. Assumptions of human bone degradation in
space, which are today well accepted, have been based on
several types of Skylab findings: a) negative calcium balances
including excess excretion of calcium in urine and feces,
b) reduction in mineral density of load-bearing bones, c)
increased rates of hydroxyproline excretion rates, and d)
analysis of plasma and urine samples for bone minerals
and hormones known to regulate calcium metabolism [5,8].
These findings will be summarized briefly below:
a) An Increase in Urine and Fecal Calcium. The
first indication of a disturbance in calcium metabo-
lism in microgravity was the immediate increase in
urine calcium excretion rates. Levels of urinary cal-
cium increased progressively the first 18 to 24 days
inflight, after which time they appeared to stabilize at
a new excretory rate (see Fig. 8-4). The plateau oc-
curred at a value approximately 60% higher than the
preflight mean. Excretion of calcium in the feces also
exceeded preflight norms but not until 2-3 weeks af-
ter launch and then the loss became more progressive
(did not plateau) and continued to increase with flight
duration.
b) A Negative Calcium Metabolic Balance. The cal-
cium balances, computed by subtracting renal and fe-
cal excretion rates from dietary intake, confirmed a
consistent and progressive loss in total body calcium
(see Table 4-24 and Fig. 8-5). The inflight calcium
balances during the first month were slightly more
negative than the preflight balances and they became
increasingly more negative with each successive
month in space. The early (first month) losses in total
body calcium can be attributed to the higher urinary
losses of calcium (Fig. 8-4), while losses later in the
mission are a combined result of renal and fecal losses.
The total losses of calcium derived from these studies
(uncorrected for the small amount of losses in perspi-
ration) indicate that an average 20 g of calcium, or
about 0.8% of the total body pool, was lost from each
of the three Skylab crewman on the 84-day mission.
c) A Reduction in Bone Density. Inflight losses of
bone mass were detected by bone density changes in
the heel (calcaneus) which were measured by photon
absorptiometric techniques (x-ray densitomography)
during both the Apollo and Skylab programs [5,9]. On
Skylab, calcaneous losses were not significant during
the 28-day mission; the losses averaged about 2% of
the preflight density on the 59-day mission; on the 84-
day mission the losses averaged 4% of preflight den-
sity. Apparently, a slow but consistent loss in calcaneus
bone density occurs with extended durations in space.
Calcaneal loss of calcium was found to be pro-
portional to that calculated from calcium balance
studies in the Skylab crewmembers (correlation co-
efficient = 0.8), strongly suggesting that loading bear-
ing bones are preferentially losing calcium and are
responsible for the negative calcium metabolic bal-
ance [10]. This conclusion is supported by bone den-
sity measurements of the radius and the ulna bones
(of the arm) which showed no appreciable loss during
any of the Skylab missions. Because the calcaneus only
contains about 0.2% of the total body calcium, other
weight-bearing bones likely contribute to the estimated
total whole-body losses of calcium.
d) Excretion of Hydroxyproline. Indirect support for
bone mass changes were derived from urinary losses
of hydroxyproline and hydroxylycine. These sub-
stances are components of the collagen matrix of the
bone, and their presence in the urine is assumed to be
related to collagen break down, a tissue present in
bone joints and a source of calcium. On Skylab, both
these substances were measured in urine and showed
a gradual increase on each mission [5,11]. Urinary hy-
droxyproline increases progressively the first month and
plateaus at a value 34% higher than the preflight mean.
e) Blood and Urine Biochemistry. Analysis of plasma
and urine revealed inflight increases in calcium and
phosphate that were significant throughout the 3-
month duration in space [12]. Plasma PTH was more
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Figure 8-4. Urine and fecal calcium excretion during the 84-day Skylab mission (mean ± SE). From Rambaut and Johnston [5].
Figure 8-5. Average calcium balance of the three Skylab crews. The preflight, postflight, and first month inflight averages are of nine
crewmembers. The second and third inflight month averages were calculated from six and three subjects, respectively. The data are
plotted in the conventional Albright–Reifenstein style: from the zero baseline, dietary intake is plotted downward. Urinary excretion is
plotted upward from the intake value and fecal excretion is plotted upward from the urinary value. The top of the fecal value indicates the
balance. Values below the zero baseline are positive balances; above are negative balances.
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difficult to interpret; one report showed higher mean
values inflight for all nine crewmembers while another
showed a decrease in mean value for crewmembers
on the 84-day mission. None of these results were sta-
tistically significant. Plasma vitamin D, measured only
after the missions, showed no change. Calcitonin was
below the level required for detection. Another hor-
mone that is capable of influencing calcium metabo-
lism is cortisol, a substance that was found to be
elevated on all Skylab flights [12]. High levels of cor-
tisol are known to cause bone mineral loss in humans
and may have contributed to the changes in calcium
regulation in spaceflight [13].
In summary, the results collected from the Skylab
crews suggested that the integrity of particular bones be-
gan to decay upon long-term exposure to spaceflight. Most
of the Skylab measurements of calcium metabolism indi-
cated negligible calcium losses after the first month
inflight; they showed considerable losses the second
month and some of the indicators showed progressive
losses carrying into the third month in space.
8.1.4 Bedrest
Bedrest is frequently used as a ground-based analog
of the microgravity of spaceflight; it provides a means of
testing and examining microgravity physiology in a one-
g environment. By removing the downward gravitational
forces that occur during erect ambulation, a degradation
effect of bone is produced that may be similar to that
encountered in weightlessness. (In the next chapter it will
be shown how bedrest is used to emulate the circulatory,
fluid and electrolyte responses of microgravity). However,
bedrest does not remove the effects of the gravity vector
completely, it merely reduces the effect of gravity, so the
analogy is imperfect. Because bedrest is ground-based, it
is possible to conduct studies in a laboratory setting, us-
ing superior measurement techniques that would not be
suited for a remote space cabin, with a higher statistical
subject population.
8.1.4.1 Analysis of Results. A collection of bedrest
data, never previously published, was made available to
the systems analysis project for examination [14]. The data
was collected over a 10-year period and included strict
supine bedrest periods lasting up to 36 weeks. During the
analysis, comparisons were made between bedrest and
spaceflight using the Skylab microgravity data. A sum-
mary of the main conclusions of this analysis is provided
below from the original report [15].
a) Comparison of Bedrest and Spaceflight. Figure
8-6 shows a selected portion of the bedrest data in
comparison with Skylab data over a period of 3 months
of hypogravic testing. Many of the bedrest responses
are similar to the spaceflight responses reported by
Figure 8-6. Comparison of bedrest and spaceflight data. Spaceflight is represented by the data from Skylab [5,8,12] while the bedrest
data is taken from a collection of clinical hospital studies [14,15]. Values are shown as mean change from ambulatory control.
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Skylab investigators [5,8,12]. The main differences
are quantitative, and these may be due to the nature of
the mechanical stress forces present during bedrest vs.
spaceflight. Another explanation is the differences in
experimental protocol. For example, during space-
flight there was an increase in dietary calcium both
within a single mission as a function of time and be-
tween successive missions. Dietary calcium was in-
creased on Skylab because of the belief that it might
inhibit some of the calcium loss; thus, an increase in
dietary calcium may be expected to affect the space-
flight data shown in Fig. 8-6 and confound the analy-
sis.
b) Kidney Excretion. Urine excretion of calcium be-
gan to increase almost immediately in both bedrest
and spaceflight. In bedrest, phosphorus excretion fol-
lowed calcium excretion very closely, both elements
probably coming from the same source – skeletal tis-
sue. After several weeks of bedrest, the renal excre-
tion rates of calcium decline (although still remaining
above baseline), but during spaceflight they remain
stable at an elevated level (Fig. 8-6).
c) Hormonal Regulation. PTH is known to cause a de-
crease in renal calcium excretion by virtue of its abil-
ity to enhance tubular reabsorption (see Fig. 8-3). In
bedrest, this hormone gradually increased signifi-
cantly after a month, helping to explain the longer
term renal calcium excretion behavior noted above.
Although the graph in Fig. 8-6 suggests that PTH be-
comes elevated in bedrest and reduced in spaceflight,
the statistical significance of the data in both cases is
rather low. However, based merely on the average long-
term changes (longer than 6 weeks) it is likely that the
reduced plasma calcium levels observed in bedrest
were responsible for the increased PTH levels and
long-term decline of the urine calcium excretion to-
ward control. The reverse process may occur in space-
flight. Although this scenario is consistent with current
theory, it is not clear why bedrest and spaceflight
should exhibit these quite different effects. More spe-
cifically, why is calcium plasma concentration found
to be below control in bedrest and above control in
spaceflight? The experimental results should be con-
firmed in both situations before searching for alterna-
tive explanations. One alternative, for example, is that
in this bedrest study, the correlation of the reduction
in plasma magnesium and increasing PTH levels is
quite high, suggesting a possible causal effect.
The vitamin D data are scant and inconclusive in
this bedrest study and there seems to be little agree-
ment regarding trends in hypogravity [6]. Calcitonin
was not measured during the bedrest study nor has it
been measured in spaceflightUPDATE #1.
d) Intestinal Absorption and Excretion. During
bedrest, the intestinal absorption of calcium gradu-
ally decreases to rates as low as 75% below control.
There is also a more subtle decrease in phosphorus
absorption. These changes are directly related to the
increase in fecal calcium excretion. Similar alterations
in intestinal absorption and fecal loss are apparent in
the Skylab results (Fig 8-4 and 8-6). These changes
are long-term, requiring five or six weeks to be maxi-
mally effective, and are presumably mediated by de-
creases in 1,25-DHC. In Skylab, the effect of 1,25-DHC
on absorption may be partially countered by the in-
creasing dietary intake of calcium over time, which
can cause intestinal absorption to increase by passive
diffusion.
e) Bone Resorption. In these bedrest studies, no direct
bone measurements were made, (i.e., bone density or
osteoclastic activity), but the urine excretion of hy-
droxyproline showed that it paralleled urinary cal-
cium excretion for the first several weeks. This can
indicate that bone resorption is elevated and the prod-
ucts of bone demineralization are being excreted by
the kidneys. An increase in resorption is consistent
with the hypothesis that this is the initiating event in
bone demineralization because of an unknown me-
chanical stress factor. In this regard, bedrest and space-
flight may be similar.
8.1.4.2 Summary of Bedrest. The response to bedrest
is difficult to typify with the existing data, but it can be
categorized as occurring in three distinct time periods:
short, intermediate and long term. The short-term period
(up to two weeks) is characterized by small, recordable
changes in urine excretion rates. Calcium efflux from bone
commences at the onset of hypogravity, but the bone has
such large quantities of calcium, and the calcium regula-
tory system is so effective, that these changes in calcium
efflux may be too small to detect as increases in plasma
calcium concentration. The intermediate period (from 4 to
6 weeks after onset) is characterized by increasing urine
excretion rates of calcium, phosphorus, magnesium, and
hydroxyproline presumably reflecting osteoclastic bone
resorption activity. The kidney filters the excess load of
each substance from the plasma by means of normal renal
regulation (modulated by PTH in the case of calcium) main-
taining the plasma calcium and phosphorus concentra-
tions within a few percent of normal. This period may also
be characterized by the changes in the production and
secretion rates of the calcitropic hormones. The long-term
period (beyond 6 weeks) is characterized by renal excre-
tion rates decreasing toward baseline during bedrest. Net
intestinal absorption rates decrease also, allowing the cal-
cium load to be eliminated preferentially through intesti-
nal excretion. Eventually, the system balances at a new
steady state, with slightly different calcium fluxes into
and out of each compartment. New plasma concentrations
of calcium, phosphorus, PTH and 1,25-DHC are also es-
tablished.
8.1.5 Simulations Studies with the Calcium
Regulatory Model
The Skylab data confirmed the total body losses of
calcium, but did little to expand our understanding of the
physiological processes involved with the altered calcium
state. What are the fundamental drivers for body calcium
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loss in space? What is the behavior of osteoblastic and
osteoclastic activity during long-term adaptation to space-
flight? Is it possible to predict the magnitude and direc-
tion of the calcitropic hormone regulators for long-term
exposure to microgravity? Addressing these types of cal-
cium regulatory issues can sometimes be best addressed
using a model that contains the appropriate calcium path-
ways and the (hormonal) feedback regulatory elements.
As we have shown in earlier chapters mathematical
models can be used to extend the predictive powers of
the physiologist and, by means of simulation, to define
hypotheses and check them against experimental results,
thus gaining insights into processes that are not amenable
to measurement. At the very least, the modeling process
permits the researcher to organize in a systematic way all
of the relationships of this very complex system; the model
then provides a framework to identify gaps in knowledge
and to add new information as it becomes available.
Modeling efforts of calcium metabolism that incor-
porated representations of physiological processes did not
begin until the late 1970’s. It was only at that time that the
role of the excretory organs, regulatory agents and bone
biochemistry had become defined. To further our under-
standing of the alterations of whole-body calcium metabo-
lism upon exposure to reduced gravity conditions, a
mathematical model of calcium metabolism was devel-
oped as part of this project.
8.1.5.1 Model Description. The model is based upon
the interactive and logical characteristics of biological
homeostatic feedback theory and the mathematical repre-
sentation of calcium-related control systems. The central
purpose of the model, as well as the physiological system
that it represents, is the control of extracellular calcium-
ion concentration, [Ca+]ECF which is the controlled vari-
able in the model. Model regulation is achieved using
subsystems that describe urinary excretion, intestinal ab-
sorption, and skeletal handling of calcium. The calcitropic
hormones are included as regulatory agents. Many of the
relationships in the model were discussed earlier in Chap-
ter 8.1.2 (see Fig. 8-3) and an overview of the model was
presented in Chapter 3.2.7.
A schematic form of the basic model is shown in Fig.
8-7. The model consists of four compartments, a central
extracellular fluid compartment, in which the concentra-
tion of calcium is regulated by fluxes to and from the re-
nal, intestinal, and skeletal compartments. The renal
compartment removes calcium from the central compart-
ments, the intestinal compartment adds dietary calcium to
the central compartment, and the bone compartment stores
calcium in an internal reservoir and acts as a buffer to the
central compartment. Calcium enters the intestines in di-
etary form as well as in the secreted digestive juices; part
of the calcium in the intestines is absorbed into the plasma
while the rest is lost in the excreta. In the kidneys, calcium
is filtered; part of it is reabsorbed, the rest excreted.
The routes of calcium in and out of the bone compart-
ment represent net changes that are related to specific cel-
lular and biochemical activity rates. Referring to Fig. 8-7,
the term resorption represents a general degradation, or
loss of calcium out of the solid bone that is assumed to be
caused primarily by cellular osteoclastic activity (or bone
demineralization); accretion represents the buildup, or in-
crease of calcium into the solid bone mineral by osteo-
blastic activity (or bone formation); influx and efflux
represent general gains and losses, respectively, from the
bone fluid. Bone fluid is the fluid between the cells just
exterior to the bone surface and the bone surface itself
(osteocytic lining) and contains recently deposited amor-
phous calcium phosphate. Through the osteocytic lining,
calcium can be rapidly added to or removed from the ex-
tracellular fluid. Thus, the bone fluid is the most impor-
tant short-term buffer system for calcium in the body [16].
The solid bone compartment contains crystallized matri-
ces of calcium (hydroxyapitate) to form the skeletal struc-
ture and probably plays an important role in long-term
regulation. The solid bone may be thought of as provid-
ing a calcium pool for the bone fluid, which, in turn, pro-
vides a calcium pool for the extracellular fluid. The soft
tissue system, particularly the kidneys and bone fluid, and
hormonal glands are capable of rapid response, but the
solid bone system responds much more slowly.
Regulation of calcium homeostasis is under the con-
trol of three hormones that are also shown in Fig. 8-7.
These hormone regulators (parathyroid hormone (PTH),
Vitamin D (1,25-DHC), and calcitonin (CT)) stimulate
or inhibit the calcium fluxes between compartments via
negative feedback control. The secretion rate of these hor-
mones depends on the amount of calcium in the extracel-
lular fluid (the model’s controlled variable) and sometimes
its rate of change. The action of these hormones have been
described earlier in this chapter (see Figs. 8-2 and 8-3) and
their influence in the model is indicated in Fig. 8-7. Basi-
cally, intestinal calcium absorption is under the direct con-
trol of 1,25-DHC, renal excretion is inversely regulated by
PTH, and bone compartment osteoclastic activity (resorp-
tion or destruction) is stimulated by PTH and 1,25-DHC,
and is inhibited by CT.
The first version of this model was proposed by Jaros,
Coleman, and Guyton [17] and, after conducting prelimi-
nary simulations, was modified in this project, to include
detailed representations of some of the subsystems
[18,19,20]. Because of inadequacies in the renal subsystem,
temporary modifications were included in the simulations
as described below. A gravitational term was included in
order to represent the effect of gravity unloading on the
release of calcium from the bone compartment.
Jaros and co-workers demonstrated that their model
was designed for short-term (hours) calcium homeosta-
sis. For example, the model appears to respond properly
to repeated calcium removal from plasma, to short-term
calcium infusion, to injection of calcitonin and parathy-
roid hormone and to parathyroidectomy [16]. But clearly
the model has not been tested, until now, for the weeks
and months of bone demineralization that is seen during
prolonged bedrest and spaceflight. While most of the ele-
ments of long-term calcium homeostasis are grossly con-
tained in the model, they are being validated for the first
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time in the current project. The model’s original authors
have presented their results in two reports [16,17], the lat-
ter containing a more detailed description of major sub-
systems, particularly the role of the bone in calcium
homeostasis, and the addition of a phosphate metabolism
subsystem. Because of the unavailability of the second
publication at the time this project was initiated, the model
and its simulations shown below are based on the original
description. Unfortunately the project was terminated be-
fore the model could be updated and before it could be
fully tested and explored in an equivalent manner to the
other modeling studies described in this volume.
8.1.5.2 Simulation of Gravity Unloading. Simula-
tion of gravity unloading in hypogravic environments was
accomplished in the calcium model by making the fol-
lowing initialization parameter adjustments:
a) The value of a hypothetical gravitational term, repre-
senting mechanical loading of the bone, was reduced
(see Figs. 8-3 and 8-7). This in turn allowed a rise in
calcium loss from the bone compartment. This initial-
ization factor permits a slow, consistent, gravity-in-
duced, mineral loss from bone during the entire
simulation. (This loss is not explicitly represented in
the tables or figures below).
b) Extracellular fluid volume was reduced by one liter in
accord with Skylab measurements, presumably due to
the acute regulatory response to headward fluid shifts.
This will affect the plasma concentration of electro-
lytes and regulatory hormones.
c) A forced increase in urinary calcium excretion pre-
sumably in response to elevated concentrations of cal-
cium in the extracellular fluid. This is an added renal
stimulation to the original model’s renal calcium ex-
cretion algorithm and was necessary to prevent plasma
calcium from rising unrealistically high (see below).
In addition to these initializing parameter changes that
drive the simulation, the following assumptions were made:
i. Calcium sources from the muscle and collagen are as-
sumed to be negligible during exposure to hypogravic
Figure 8-7. Scheme of the calcium regulatory computer model showing major compartments, fluxes and regulatory influences. (CTH =
calcitonin; PTH = parathyroid hormone; 1,25D = active Vitamin D metabolite).
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environments. Therefore, calcium removed from the
body is ultimately derived solely from the bone.
ii. Intestinal secretion rates (calcium flow into the gut)
are assumed to remain constant at the control value.
This is also a common assumption in measuring in-
testinal calcium fluxes [21].
iii. Dietary calcium is constant and set to its control value.
The initializing parameter adjustment that altered uri-
nary calcium excretion (item (c) above) was required to
maintain plasma calcium levels at realistic levels. Urine
calcium excretion, in the original model, is a controlled
variable responding to PTH and [Ca+]PLASMA. However, ini-
tial simulation trials indicated an apparent deficiency in
the renal subsystem, in that calcium excretion rates were
much lower than bedrest findings and too low to prevent
[Ca+]PLASMA from becoming unrealistically high in response
to the stimulus of calcium efflux from the bone (item(a)
above). The model’s original creators indicated that the
renal subsystem was not fully functional [16]. Until new
research provides a basis to improve the renal subsystem,
it was decided to artificially increase the urine excretion
rate by a fixed amount that is maintained throughout the
hypogravic stress. Accordingly, the renal subsystem pro-
vides regulation of calcium excretion, according to the
model’s original formulation, around this “bias”. The bias
was set to one of two values comparable to the experimen-
tally measured excretion rate: 45% above control based
on bedrest findings or 80% above control based on space-
flight findings. Unless otherwise stated, the computer stud-
ies below are simulations of bedrest. Validation data with
which to compare model results came from two sources,
bedrest and spaceflight (see Fig. 8-6).
8.1.5.2.1 Bedrest Simulation. Figure 8-8(a) and 8-8(b)
presents a group of selected variables from the bedrest
simulation performed as described above. The variables
in Fig. 8-8(a) are related to the soft tissue compartments
(kidney, intestines, and plasma) and hormones, while those
in Fig. 8-8(b) relate primarily to the fluxes of calcium into
and out of the solid and fluid bone compartments. The
step increase in urine calcium and release of skeletal cal-
cium efflux at the beginning of simulated bedrest are re-
sponsible for the step decrease in simulated calcium
balance. In this preliminary model simulation, the sudden
onset of these variables is not physiologically correct, and
changes around the onset of bedrest should be ignored
since they reflect the artificially imposed initial condi-
tions. But the longer-term changes of these and other quan-
tities are more reasonable. The results of each figure will
be discussed in sequence.
Many of the variables in Fig. 8-8(a) agree with the
experimental bedrest data of Fig. 8-6 both qualitatively
and quantitatively. In both the model and actual physi-
ological system, rapid renal calcium filtration tends to
compensate for the skeletal unloading of calcium into the
plasma, resulting in the maintenance of relatively stable
plasma calcium levels in spite of the input load. Plasma
calcium is only 4% above control in the simulation while
it fluctuates closely around control value in bedrest. Only
in spaceflight is the plasma calcium level well above con-
trol values (+7%). In the simulation, urine calcium ex-
cretion increases immediately to about 41% above control,
and remains at a high level. However, in bedrest, calcium
excretion rises much more gradually over a 3-week period
to a maximum level (45% above control) and then de-
creases for the duration of the study to about 10% above
the ambulatory mean (see Fig. 8-6). This discrepancy be-
tween simulation and experimental results is attributed to
the deficiencies in the renal subsystem noted above and
the imposed initialization adjustment
The intestinal calcium absorption rate does not change
significantly for the first 5 weeks of simulated bedrest.
But after 5 weeks, it decreases below the ambulatory
baseline value to a rate that is very close to that calcu-
lated from bedrest data [15]. (The data graphed in Fig. 8-6
does not include intestinal absorption but rather fecal ex-
cretion which is inversely related to intestinal absorption).
In the model, the intestinal absorption rate is regulated by
the plasma level of 1,25-DHC. This vitamin is decreased
modestly both in the simulation and in the bedrest study.
Because the calcium levels in the extracellular pool are
higher than normal, the model is apparently reducing the
amount of intestinal calcium secretions that are returned
to the extracellular fluid pool as well as reducing the
amount of dietary calcium absorbed. This reduction in in-
testinal absorption is an appropriate regulatory response
in the face of high plasma calcium levels.
Body calcium decreases after about 20 days of bedrest
(Fig. 8-6). The simulation of Fig. 8-8(b) suggests the
changes in unmeasured calcium fluxes into and out of
bone. Although the rate of calcium resorption decreases
slightly (a maximum of 5%), and thereby reduces the rate of
bone mineral removal, the rate of accretion, by which new
collagen for new mineral formation is deposited, decreases
by 20%. In addition, the rate of calcium efflux is eventu-
ally inhibited by a maximum of 18% while the rate of influx
is stimulated by 6%. This suggests that the bone fluid is
buffering the amount of calcium being lost from the solid
bone mineral and being dumped into the plasma compart-
ment. These skeletal results contribute significantly to the
negative calcium balance shown in Fig. 8-8(a).
The relationship of these long-term bone changes to
the hormone regulators provides some insight into physi-
ological processes. For example, the gradual decline of
skeletal calcium efflux from bone fluid below control is a
response to the simulated rise in calcitonin and decrease
in 1,25-DHC. The decline of bone resorption and the
greater decline in bone formation (accretion) is in part due
to the reduced secretion of PTH in the former case and
1,25-DHC in the latter case.
8.1.5.2.2 Sensitivity Analysis: Effect of PTH on Cal-
cium Metabolism. As a result of a primary increase in
calcium release from bone in hypogravity environments
the model predicts an increase in plasma calcium and this
is supported by a number of studies. In theory this should
cause a suppression in plasma PTH, as is demonstrated
NASA/CR—2020-220487 314
Figure 8-8 (a). Selected variables from the computer model simulation of bedrest: Non-skeletal tissue quantities.
Figure 8-8 (b). Selected variables from the computer model simulation of bedrest: Skeletal tissue fluxes.
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during the simulations of bedrest (see Fig. 8-8(a). How-
ever, findings of depressed PTH are not universal in ei-
ther bedrest or spaceflight as Fig. 8-6 demonstrates.
Alternatively, PTH is reported increased, decreased or not
changed, with no particular trend over time [6,13] although
one reviewer suggests that PTH is normally suppressed in
spaceflight, at least for the short-term [21].
Inasmuch as the direction and magnitude of the plasma
PTH response to hypogravity is not clear, the model was
used to show the influence of this hormone on calcium
metabolism for a range of PTH levels. A sensitivity analy-
sis of PTH was performed by severing the feedback con-
trol loop of PTH and assigning the following values to PTH
plasma concentration: a 30% increase, a 30% decrease or
no change. (Note: This analysis is similar, in the case of
an increase in PTH, to a thyroidectomy which eliminates
PTH secretion followed by an infusion of PTH). Otherwise
the model adjustments were the same as for the bedrest
simulation described above. The results of this open-loop
analysis are shown in Table 8-1.
The results suggest that PTH exerts little influence
on several important calcium metabolic variables. A ± 30%
change from normal in plasma PTH concentration only
slightly affects the urine calcium excretion rate and plasma
calcium concentration. (Reminder: the value for urine cal-
cium has a 45% bias because of the initialization adjust-
ments). The effect on the intestinal absorption rate is more
pronounced because of the increasing influence of 1,25-
DHC. This hormone is inversely related to plasma calcium.
There is also a PTH effect on the four calcium flow
paths into and out of bone. The most dramatic influence
is on calcium reabsorption which, in the model, is regu-
lated directly, and solely, by the plasma concentration of
PTH. Thus, as PTH increases, bone resorption rates in-
creases. And as PTH concentration changes from below
control to above control, bone resorption changes in the
same manner, leading to an elevated bone loss and nega-
tive calcium balance.
In the model, as is believed to exist in the human,
bone formation is influenced by a direct effect of bone
resorption (Fig. 8-7). Thus, as bone resorption increases,
bone formation also increases; apparently bone is con-
stantly losing and gaining mineral – a biological turnover
of bone calcium. However, in the bedrest sensitivity simu-
lation, as resorption increases (with higher levels of PTH),
accretion rates do not continue to increase (or become less
negative) as expected. Rather, there is a disassociation be-
tween resorption and accretion which is due to a second
influence on bone accretion, that of 1,25-DHC. The long-
term decrements in 1,25-DHC (with increasing levels of
PTH) are great enough to slow down the rate of bone for-
mation even further.
In the simulations whose results are shown in Table
8-1, it appears that the skeletal system attempts to main-
tain bone integrity in the face of the slow, consistent, grav-
ity-induced, mineral loss from the solid bone compartment.
A careful examination of the values for the four bone fluxes
suggests that there is a diminished ability to rebuild min-
eral mass despite maintenance of calcium concentrations
in the surrounding bone fluid. Nevertheless, for the case
where PTH is below control (the case most representative
of bedrest) there is an improvement in this diminished
ability. That is, due to changes in the three bone fluxes
where there is active regulatory control, there remains a
net loss of bone, but there is a reduction in the rate of loss.
8.1.5.3 Summary of Model Analysis. Because this
project was forced to end prematurely, the simulation stud-
ies described above are only suggestive of the type of
results that can be achieved with this model, but are not
indicative of the more powerful uses of the model, spe-
cifically the testing of alternative hypotheses, identify-
ing gaps in knowledge, and designing critical experiments.
The model could also help understand the consequences
of certain countermeasures or disturbances in the feed-
back circuitry. For example, what happens if calcium or
vitamin D is increased in the diet? Will this reverse the
decline in intestinal absorption and if so will it worsen
the hypercalcemia that already exists? Will alterations of
hormonal substances be able to reverse the bone loss?
Although model development was not completed, it
was determined that the model did work as expected ac-
cording to accepted feedback relationships and simula-
tions that included plausible responses to parameter
Table 8-1. Influence of Varying Levels of Plasma PTH on Selected Model Variables during Bedrest Simulations
(percent change from baseline).
     Plasma PTH Level
Selected Variable             –30% 0%            +30%
Urine Excretion  45  47 49
Plasma Calcium    4    5   6
Intestinal Absorption              –13              –16              –20
Bone Fluid Calcium Efflux              –18              –17              –15
Bone Fluid Calcium Influx    6    7    9
Solid Bone Calcium Reabsorption – 5    0  +7
Solid Bone Calcium Accretion              –20              –17              –18
Plasma 1,25-DHC                –12                –17               – 22
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disturbances. Deficiencies in the model and recommended
corrections will be discussed in the concluding section
below (see Chapter 8.1.7.2). Most of the insights gleaned
from working with the model were related to the function
and behavior of the soft-tissue elements, the kidney, intes-
tines, and the extracellular fluid. It was found, for example,
that (in spite of the fact that calcium is preferentially ex-
creted via the intestines compared to the kidneys) the kid-
ney was the fastest acting and most influential controller
responsible for the maintenance of short-term plasma cal-
cium homeostasis. This conclusion is strengthened by the
fact that fecal calcium in both bedrest and spaceflight does
not participate with increased calcium excretion until al-
most a month after initiation of hypogravity. Thus, while
there is decreased intestinal absorption of calcium during
hypogravity in both the human and model, the model in-
cludes a built-in delay [16]. This may underlie the obser-
vation that in the Skylab astronauts, gastrointestinal
absorption appears to be relatively insensitive to changes
in bone calcium [5]. In this study, the change in plasma
calcium concentration was found to be much higher dur-
ing spaceflight than during bedrest. This suggests that the
rate of skeletal calcium efflux is greater and is less com-
pensated by the urine calcium excretion rate during space-
flight than during bedrest. Since the concentration of
plasma calcium is the main regulator in most of the sub-
systems of the calcium model, the changes of the simula-
tion variables would be expected to be more dramatic
during spaceflight than bedrest, as seems to be true in the
human subjects (see Fig. 8-6).
8.1.6 Hypothesis Development
What initiates bone loss in microgravity? Any hy-
pothesis attempting to explain the spaceflight observa-
tions of bone loss should first address the primary event
in the process. While there is a general consensus that
the mechanical unloading of stress acting directly on the
bone is a causa ultimata of bone demineralization, the
specific pathways and processes have not been revealed;
certainly nothing definitive was known at the time of the
early Skylab missions. Thus, other alternative hypotheses
should be explored and the most promising of these will
be examined below. The appearance of large quantities of
calcium in the urine immediately upon entering
microgravity needs to be explained either as an initiating
event or as a feedback response. In addition, if fecal cal-
cium excretion really increases progressively as the Skylab
data suggests, then the health of the skeletal system during
long-term spaceflight may be in question. Could some pri-
mary disturbance in the calcitropic hormones cause renal
excretion and bone loss? Finally, what can be postulated
about biological activity in bone tissue, e.g., osteoclastic
and osteoblastic activity, processes which were not mea-
sured directly.
8.1.6.1 Initating and Continuation of Calcium Loss.
The initiation of the bone loss in spaceflight may be due
to a property of the bone itself, as it relates to mechanical
factors, or the loss may be a result of physiological changes
of calcium metabolism external to skeletal tissue (non-
skeletal factors) or to both of these. Mechanical factors
refer to stress induced by gravitational loading and/or mus-
culoskeletal interactions. They can include piezoelectric,
compression, tensile, and shearing forces that may be very
important to bone maintenance as well as to the repair of
bone. However, the effect of the absence of these specific
forces or their absence on bone mineralization had not
been experimentally ascertained during the Skylab era and
has only begun to be addressed more recentlyUPDATE#2. Non-
skeletal factors refer to physiological changes in the ex-
cretory organs or fluid compartments and include
hormonally induced stresses. For example headward fluid
shifts are one of the most notable changes seen upon ex-
posure to zero-g (see Chapter 5). They are thought to pro-
duce diuresis, natriuresis, and have a large dehydration
effect upon the legs. Scenarios that are consistent with the
two main alternative approaches suggested above, a pri-
mary renal calcium leak or a primary bone response, are
provided below:
a) Primary Renal Calcium Leak. In this scenario the
kidneys begin to excrete excess calcium early in space-
flight, perhaps in response to a sodium diuresis (which
is known to promote hypercalciuria) or because of a
primary defect in hormones that lead to the same re-
sult, (i.e., decrease in PTH or increase in calcitonin).
According to Cann [21], the following scenario has
not been definitively ruled out and can theoretically
explain some of the spaceflight findings.
As a result of hypercalcuria, such as is observed
in spaceflight and bedrest, the extracellular fluid com-
partment loses calcium via excretory pathways, and
to compensate, calcium flows from the bone compart-
ment to the extracellular fluid compartment and re-
stores the extracellular fluid calcium concentration
(see Fig. 8-2 bottom). If the intestine does not respond
to the demand for increased calcium input, then the
bone continues to compensate for the calcium losses
by drawing upon normally inaccessible calcium re-
serves and the system becomes negatively balanced.
This theory seems flawed because the kidney does
not appear to initiate these changes but rather seems
to respond to excesses in extracellular fluid. In space-
flight there is an increase, not a decrease in plasma
calcium as would be expected under this scenario. In
addition, PTH seems to decrease in spaceflight, which
inhibits net bone resorption. The decrease in intesti-
nal absorption coupled with the reduced levels of
plasma 1,25-DHC, further support the notion that the
calcium metabolic system is attempting to remove,
rather than restore, calcium from the extracellular fluid.
b) Primary Bone Response to Gravity Unloading.
As noted above, bone is known to be highly sensitive
to changes in its customary amount of intermittent
loading and deformation. Although not completely
understood, mechanical stress and loading generates
increased skeletal mineral content and the removal of
such forces can cause a reversal of this process and an
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increase in skeletal calcium efflux. This has become
the central  idea for bone demineralization in
hypogravity environments. Upon entry into an
hypogravic environment, the skeletal system is as-
sumed to dump, in some undefined manner, calcium
into the extracellular fluid [5,15]. The rise in extra-
cellular calcium concentration, in turn, will force cal-
cium through the kidneys at a higher rate. The calcium
metabolic system then attempts to restore homeosta-
sis to the extracellular fluid with a series of compen-
satory and hormonal feedback responses. These series
of responses were examined in the calcium model,
described in the previous section.
Of these two hypotheses, the first is shown to be theo-
retically possible but likely invalid when compared to ob-
servations. Therefore, the second hypothesis, changes in
gravitational stresses and musculoskeletal interactions,
continue to be the prevailing theory for initiating the ob-
served bone losses, although experimental support is lack-
ing. Not only is a primary effect on the bone thought to
initiate the bone loss, but it is believed that the loss will
continue as long as gravity unloading occurs.
8.1.6.2 Mechanical Forces on the Bone. The nature
of the reduction in the gravitational force on weight-bear-
ing bones is different during bedrest and spaceflight. One
should be cognizant of the differences in mechanical
forces on the different body tissues during bedrest, space-
flight, and the erect ambulatory position. These differ-
ences can be described in terms of externally applied
compression from gravity, and internally-applied torsion,
tension, compression, and shear from muscle-bone inter-
actions. In a one-g upright environment, the gravitational
vector concentrates the force of body weight towards the
feet and provides compression to the long bones. When
the individual is in the horizontal (bedrested) position,
the gravity vector is distributed along the entire length of
the body. In space, the skeletal system is completely re-
lieved of gravitational forces, and therefore, of body
weight loads and impact forces. Consequently, the differ-
ence between bedrest and spaceflight calcium responses
may be due to a different distribution of forces. In this
report, the primary mechanical force is considered to be
externally applied compression from gravity. However,
the relationship of internally applied forces to bone deg-
radation and integrity are poorly understood. The current
hypothesis is that the greater skeletal loss of spaceflight,
in comparison to bedrest, is due to differences in mechani-
cal factors applied to the bone.
8.1.6.3 Control of Renal Calcium Excretion Urine ex-
cretion of calcium begins immediately upon entering
microgravity [5]. As shown in Fig. 8-3, the renal excretion
of calcium can be affected by the plasma concentration of
calcium, calcitonin, parathyroid hormone, 1,25-DHC, and
the rate of sodium excretion during diuresis. Plasma cal-
cium levels were elevated slightly throughout the Skylab
flights, significantly so for the first month [12]. Although
urinary sodium excretion was elevated also for the dura-
tion of the flight, a diuresis was never observed (see Chap-
ter 5). PTH may have been reduced [5]. The rise in renal
calcium excretion can be explained by those factors. Part
of the reason for the plateau of renal calcium excretion in
spaceflight or the decline of calcium excretion toward
baseline during bedrest, after a month or more, (see Fig. 8-
6) is because the intestines are excreting progressively
greater amounts of calcium; this relieves the filtered loads
at the kidney.
8.1.6.4 Control of Intestinal Calcium Excretion. The
intestinal absorption of calcium is primarily a function
of the dietary intake of calcium, the plasma concentra-
tions of calcium, and 1,25-DHC (Fig. 8-3). Dietary levels
of phosphate may also have an effect on the absorption of
calcium. The secretion of calcium into the intestinal tract
does not appear to be a regulated process, although it does
seem to increase slightly as the dietary absorption of cal-
cium increases [22].
The spaceflight measurements indicate that the fecal
excretion continually rose (Fig. 8-4). Based on the simple
diagram of Fig. 8-1 a change in one or more of three path-
ways could explain the fecal increase: increased intesti-
nal calcium secretion, decreased intestinal calcium
absorption, or an increase in dietary calcium. Within each
Skylab mission, as the duration of the flight increased,
both the dietary intake, and the fecal excretion of cal-
cium increased [8]; (see Table 4-24). If the changes in di-
etary loads are subtracted from the quantities of fecal
calcium, no change in fecal calcium excretion, from the
preflight norms, are observed. These results suggest that
the progressive fecal increases result from increases in di-
etary calcium intake that are not absorbed through the in-
testines. (This assumes the intestinal secretion of calcium
is basically the same throughout preflight and inflight pe-
riods). If the excess dietary calcium is not being absorbed,
the most likely reason is that the active transport of intes-
tinal calcium is not being stimulated by 1,25-DHC. The
decrease in intestinal calcium absorption also suggested
that the inflight crew members were in an adequate cal-
cium state, that is, the body was not in need of calcium.
8.1.6.5 Biological Activity in Skeletal Tissue. The
most important organ in the calcium regulatory system is
skeletal tissue (bone), and it is the most difficult to study
in humans. Little is known about the response of bone to
microgravity at the organ level nor about the fundamen-
tal processes of bone remodeling and resorption at the
tissue level [21]. Other than bone density, no direct mea-
surements have been done on humans during spaceflight
because of the invasive nature of these methods. Animal
studies in the late 70’s on Russian biosatellites and U.S.
Spacelabs have formed the basis of our knowledge. These
flights were less than 3 weeks in length. The primary ad-
vantage of using animals as human surrogates is that they
permit the use of invasive and destructive techniques and
provide a true response to microgravity without the con-
founding effects of countermeasures.
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Accordingly, research on rodents and primates in space
have shown decreased bone growth, decreased mineral-
ization, decreased bending strength, and decreased mass
[10,23]. In short-term spaceflights, primates have been
shown to not only increase bone resorption but to decrease
bone formation, amplifying the loss of bone material com-
pared to increased bone resorption alone [10,21]. Similar
results of the effects of microgravity on the bone remodel-
ing system that were found in the primate were also found
in rodents. However, in rodents resorption is not affected
significantly [24].
8.1.6.6 Summary: Hypothesis of Spaceflight Bone
Demineralization. The hypothesis that has emerged
from this analysis for bone demineralization and calcium
regulation during spaceflight is illustrated in Fig. 8-9. It is
assumed that gravity or mechanical unloading initiates
skeletal degradation in some as yet undefined manner and
causes bone mineral to be released into the plasma, result-
ing in an increase in plasma calcium concentration and
increased appearance in the urine of products of bone re-
sorption, such as hydroxyproline. This is interpreted by
the soft tissue regulatory system as an excess of extracel-
lular calcium which must be eliminated. There are nor-
mally three major routes for reversing a rise in plasma
calcium, via renal excretion, intestinal excretion and bone
formation (see Fig. 8-2). If bone is being degraded in space-
flight, the latter route is no longer available for calcium
regulation, so that it falls on renal and intestinal routes to
control blood calcium levels. The calcium control system,
therefore, behaves as if were attempting to reduce the rise
in plasma calcium by excreting calcium, first by the kid-
neys and later by the intestines. Thus, renal and fecal ex-
cretion of calcium eventually rise to high levels resulting
in whole-body loss of calcium, which is reflected as a nega-
tive calcium balance and eventually, as a measured de-
crease in bone density. These actions are mediated by two
hormone regulators (PTH and 1,25-DHC) whose produc-
tion is inversely related to plasma calcium concentration
(the controlled variable). Both of these hormones would
be expected to be depressed at least during the early por-
tion of spaceflight, leading to, in the case of PTH, de-
creased renal reabsorption and enhanced renal excretion
of calcium, and, in the case of 1,25-DHC, a decreased in-
testinal calcium absorption and enhanced fecal calcium
excretion. PTH and 1,25-DHC, if reduced as expected, are
capable of producing secondary feedback effects on the
bone itself, possibly limiting net resorption. A third
calcitropic hormone, calcitonin, is known to be secreted
in response to elevated plasma calcium and can decrease
blood calcium also by blocking bone resorption. How-
ever, calcitonin appears relatively unaffected by either
bedrest or small changes in plasma calcium. In addition
there is a question whether any of these hormones are ca-
pable of reducing or reversing bone resorption in the face
of gravity unloading.
The entire regulatory system functions as if to main-
tain plasma calcium at constant levels. Gravity unload-
ing apparently creates a defect in the system by interfering
with the normal processes of bone remodeling in weight-
bearing bone sites. Until this defect is corrected (by en-
tering a gravitational field, for example), feedback
regulators are not able to cause a net increase in bone
formation and counteract demineralization. However, all
other elements of the control system appear to respond
appropriately to this stress. This scenario appears to ac-
count for the known responses to spaceflight and is con-
sistent with the preliminary computer modeling studies
described above.
8.1.7 Conclusions: Calcium Regulation
8.1.7.1 Critical Questions for Future Research.
From these analyses, a number of critical questions arise
related to what is actually known about the physiological
process of bone demineralization in spaceflight. How does
a reduction in mechanical loading lead to net bone loss?
How do the weight-bearing bones detect the lack of grav-
ity? Is mechanical unloading the sole cause of zero-g in-
duced bone loss? Is the rate of skeletal calcium efflux, in
fact, greater during spaceflight than during bedrest? What
is the nature of the skeletal loss? That is, does it arise from
an increase in bone resorption or calcium efflux in contast
to a decrease in bone formation or calcium influx? Is the
skeleton the only source of calcium elimination from the
body or do soft tissue calcium pools also contribute, and
if so, to what extent? In the study of calcium homeostasis
in microgravity, two effects must be considered: the acute
homeostatic response to the microgravity unloading, and
the adaptation which results from long-term maintenance
of the microgravity stimulus. If bone resorption or forma-
tion is under the influence of gravity unloading, can the
hormone regulators, PTH, calcitonin or 1,25-DHC, still
function in such a way as to reduce or buffer bone loss or
are those routes blocked from hormonal intervention? In
attempting to adapt to continued gravity unloading, does
bone demineralization eventually cease? Does the seem-
ingly progressive elevation of fecal calcium continue un-
abated? What type of countermeasures are available for
reversing the unloading effect on bone? Because of the
lack of controls, the ethical requirement for countermea-
sure use in humans, and the unavailability (until recently)
of a long-term space platform to perform careful scientific
study, no definitive statements can be made about the ef-
fect of microgravity (as opposed to spaceflight) on bone
resorption, intestinal calcium absorption, bone cell regu-
latory factors, or the transduction mechanism by which
microgravity signals bone tissue [21].
8.1.7.2 Future Work with Model. The results of the
bedrest and spaceflight simulations using the Jaros,
Coleman, and Guyton calcium model [16] demonstrate that
the model is capable of simulating calcium metabolic re-
sponses to hypogravic environments. Although not com-
pletely realistic, and unable at this time to distinguish
properly between bedrest and spaceflight, the model is
expected to improve with future modifications. The exact
manner in which bone contributes to the homeostasis of
calcium ions has not yet been agreed upon; therefore sig-
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Figure 8-9. Hypothesis for the physiological responses of the calcium metabolic system to the weightless environment. The events that
have been confirmed experimentally in humans at the time that these modeling studies were performed (early 1980’s) are shown with
solid boxes.
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nificant experimental research will be required to improve
the model sufficiently to represent long-term physiologi-
cal adaptation to spaceflight. Regarding specific improve-
ments to the current version of the model, the renal
subsystem must be modified to respond more appropriately
to plasma calcium loads and the relationship between me-
chanical loads and bone demineralization must be better
understood. Bone regulatory forces, such as piezoelectric
and mechanical stresses, are eventually expected to also
be included. The more advanced model of the original au-
thors contains modifications and expansions of their skel-
etal subsystem so that it is more representative of the actual
physiology and biochemistry of the bone [17]. These modi-
fications were in the process of being incorporated into
the existing model when the project concluded. Thus, con-
tinued development and testing with this model has be-
come a future goal.
As it is being developed, the model will be validated
for a variety of normal and pathological stresses and used,
as with all the other models, as a test bed for identifying
and testing important hypotheses. This should naturally
lead to predict changes which may occur in different, as
yet untested situations, and to design critical experiments.
The model should be developed to the extent that it can
be used to evaluate countermeasures to prevent signifi-
cant bone loss in long-duration spaceflight. This will re-
quire a thorough understanding of the mechanistic and
regulatory factors related to zero-g calcium metabolism.
8.2 Muscle and Lean Body Mass
8.2.1 Spaceflight Findings
Several experimental techniques used in the Skylab
missions supported, either directly or indirectly, the hy-
pothesis of decreased muscle integrity in persons exposed
to long-term zero-gravity. In addition to the losses of pro-
tein documented by metabolic balances (see Chapter 4.5
and 4.6), increases in the concentration of particular uri-
nary amino acids, decreases in muscle mass and strength,
and changes in electromyographic responses all suggested
that muscle mass was lost, and muscle tissue biochemistry
was altered, during spaceflight. Metabolic balance tech-
niques are only an indirect measure of muscle loss be-
cause protein is a molecule found in most other body
tissues. These analyses of the Skylab experiments showed
losses in lean body mass of approximately 1.5 kg on aver-
age for each astronaut [25]. Lean body mass is assumed to
be 19.4% protein; using this percentage and the lean body
mass losses, the total body decrements of protein after
three months were calculated to be 0.3 kg. The losses in
total body protein have been assumed to be derived, pri-
marily, from losses in muscle mass.
A more direct indicator of muscle loss, however, may
lie in the measurements of the urinary excretion of 3-me-
thyl-histidine. Muscle is composed of two main proteins,
actin and myosin, each of which contains the unusual
amino acid, 3-methylhidstidine. Consequently, when
muscle is broken down, this substance is released into
the blood and is subsequently excreted through the kid-
neys. The monthly pattern of the protein losses, as indi-
cated by the urinary excretion of 3-methylhistidine in the
Skylab astronauts, was 60% above control the first month,
32% the second month, and 21% the third month [11].
The major type of muscle lost during spaceflight is
assumed to be skeletal and is assumed to be lost prima-
rily from the legs. Muscular strength was assessed pre-
flight and postflight on all of the Skylab crewmen through
use of the Cyber Isokinetic Dynamometer which recorded
the muscle forces of the limb by repetitive testing. Aver-
age muscle strength was reduced during each of the mis-
sions, with the crew of the 28-day flight showing the
greatest losses in muscle strength [26,27]. This crew
showed losses of muscle strength in the arms and the legs,
approximately 8% and 26% of the preflight means, respec-
tively. This same crew also exhibited a 5% loss in leg vol-
ume and a 4% loss in body weight. The 59-day mission
crew eliminated most of the muscle strength losses in the
arms by increasing the intensity, duration, and type of ex-
ercise to the arms. No such improvement was seen in the
legs. There were fewer changes in leg muscle strength and
volume observed in the crew of the 84-day mission than in
the crews of the two shorter missions although the loss of
strength averaged 8%. This was assumed to be attribut-
able to exercise since additional exercise devices were
included in this mission specifically for improving muscle
strength in the legs [27].
Electromyographic responses of skeletal muscles were
obtained for the legs of the crew members on both the
59-day and 84-day mission [28,29]. The duration and
muscle potential interval of the Achilles reflex was mea-
sured pre- and post-flight. Measurements of the Achilles
reflex may yield indications of muscle fatigue and the type
of muscle fiber affected during spaceflight [30]. The
changes in the duration of the Achilles reflex followed the
same qualitative pattern, as the leg strength measurements;
they decreased after two months inflight compared to pre-
flight, and improved after three months, compared to the
first two months.
Muscles contain two types of fibers, red fibers (type
I) and white fibers (type II). Red fibers are slow-twitch,
fatigue resistant fibers that normally control anti-gravity
or postural functions, and white fibers are fast-twitch, eas-
ily fatigable fibers which control movements. Skeletal
muscles are composed of a combination of these two fi-
bers, and their relative proportions depend upon the use
of the muscle, as well as the subject’s diet. Simple disuse
and high intensity exercise preferentially affects red fi-
bers, while starvation appears to degrade mainly the white
fibers. Crucial to the understanding of muscle losses dur-
ing spaceflight is the question of whether particular
muscle fibers, either the red or the white, are preferen-
tially affected by spaceflight, or whether the losses are
generalized system losses.
Muscle biopsies from the Skylab crews were not col-
lected; however, more recent studies of 5- to 11-day Space
Shuttle flights revealed significant muscle atrophy of both
fiber types [31]. Bedrest studies also revealed a decline in
both fiber types; but after 2 months the Type II fast-twitch
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fibers reached a plateau while atrophy of the Type I slow-
twitch fibers continued [32].
Spaceflight studies of muscular adaptation in rats have
allowed biochemical and histological examination of the
muscle fibers collected through biopsies. Although care
must be taken in relating the animal studies to human
studies (since the muscle groups and fibers between hu-
mans and rats are different), the studies do confirm that
the muscles are affected by exposure to hypogravity. The
animal studies demonstrated that muscle mass diminished
significantly during spaceflight, and the rate of red fiber
break-down especially increased [33,34,35] as one would
expect from a preferential atrophy of postural muscles.
Such consistency with expectations is not universal; in
more than a few studies both red and white fibers showed
the same decrements or greater losses of white fibers. More
recent studies in hind-limb suspended rats and in space-
flown rats and primates indicate that there is a transforma-
tion of slow fibers into fast fibers in leg postural muscles,
especially in the soleus [32]. Another line of recent evi-
dence also suggests that neuromuscular changes (altered re-
cruitment, fiber type composition) occur in space-flown rats
which may help explain the changes in lean body mass.
8.2.2 Hypotheses of Muscle Atrophy
Muscle atrophy is hypothesized to explain the pro-
tein losses and muscular changes observed in the Skylab
crews. It is well known that atrophy of skeletal muscle
occurs in response to disuse, inadequate functional load,
and insufficient dietary intake [36,37,38], and spaceflight
may be associated with more than one of these conditions.
The absence of gravity resulted in diminished use of the
lower limbs for postural support and locomotion, reduced
body weight on weight-bearing tissues, and interference
with proprioreceptor reflexes which can influence muscle
metabolism and function [39,40]. Data from the first month
of Skylab reflect dietary insufficiency, since dietary in-
take was reduced considerably during periods of space mo-
tion sickness [41]. The Skylab data support the hypothesis
of muscle atrophy by demonstrating a consistent loss of
lean body mass,  a consistent loss of urinary 3-
methylhistldine, and decreases in muscular strength.
Although there are several known causes of atrophy, it is
thought to result primarily from disuse rather than dietary
insufficiency. The dietary insufficiency in Skylab crewmen
probably lasted about one week (see Chapter 4, Fig. 4-23),
which was the maximum duration of the motion sickness. In
contrast, the reduced loading and functional disuse lasted
potentially for the duration of the flight, except during
the short periods of exercise. The amount of exercise var-
ied among the three Skylab crews, ranging from what could
be considered minimal to intensive work [42]. However,
while leg muscle strength decreased less with leg exer-
cise, the losses of whole-body protein (which is derived
from both postural and non-postural muscles) were not
reversed, but neither did they get worse.
Disuse muscle atrophy is associated with diminished
muscle mass and contractile strength, as well as with in-
creased muscle stiffness and fatigability. Histologically,
disuse atrophy is characterized by shrinkage of the con-
nective tissue; increase in collagen in the connective tis-
sues; decrease in the cross-sectional size and size of the
individual muscle fibers; increase in the extracellular space
in the muscle; and decrease in the water and solid compo-
nents of muscle tissue [43]. Consequently, muscles sub-
jected to disuse atrophy appear histologically normal. The
fibers are simply smaller and further apart than normal
fibers and the muscle is stiffer and cross-sectionally smaller.
Spaceflight adaptation in rats reflected such changes. Con-
sequently, the hypothesis of disuse atrophy appears to be
supported by experimental observations.
Because the red fibers are the main fibers affected by
spaceflight, and the red fibers are mainly postural fibers,
the main groups of muscles which are subject to disuse
atrophy are hypothesized to be postural muscles. Postural
muscles in the human are found mainly in the neck, trunk,
and calves [43,44]; but the only postural muscles studied
directly in Skylab were those in the calves. More recent
studies in Space Shuttle astronauts do indeed demonstrate
atrophy of muscles of the anti-gravity muscles in the lower
extremities, back and neck [31]. Individual losses in some
muscle groups for some Shuttle astronauts (and in space-
flown rats) exceeded 50%. The atrophy in the calves de-
creased as exercise, directed toward the legs, became more
intense and more posturally oriented. The altered elec-
tromyographic responses and the decreases in the cross-
sectional area of the calves support the hypothesis of
atrophy of the postural muscles; of course, these altered
responses do not exclude atrophy of other muscles that
were not examined.
8.2.3 Conclusions: Muscle Atrophy
The Skylab data showed definite losses in whole-body
protein and suggested that the protein losses were a result
of muscle atrophy, which appears to mainly affect the pos-
tural muscles. In zero-g, such muscles are no longer re-
quired to support the body weight, and the one-g
locomotive function is reduced or eliminated because the
legs are not required to support or even to provide loco-
motion for the body. Exercise may have reversed or inhib-
ited muscle atrophy in the legs, and although the atrophy
was not completely eliminated, adherence to an appropri-
ate exercise regimen might possibly result in complete
reversal.
8.3 Integrated Musculoskeletal System
The term “musculoskeletal system” is used very loosely
by NASA biomedical research managers as if it repre-
sents a single integrated discipline. However, it is ex-
tremely rare to find researchers who have deviated from
their own specialty as “muscle” researchers or “bone”
researchers. Nevertheless, there are reasons to maintain
the goal of integrating these two components. First, the
musculoskeletal system, can be treated as a functional
unit, providing the means for humans to easily adapt to
moving about and working in a one-g environment. Sec-
ondly, eliminating gravity causes both muscle and bone
NASA/CR—2020-220487 322
tissue to degrade for similar reasons – reduced loading
and disuse. In both cases, the losses are most significant in
the lower extremities, in anti-gravity muscles and weight
bearing bones. Third, similar experimental techniques can
be used for gathering information about muscle atrophy
and bone demineralization including collecting blood and
urine samples, metabolic balances, performance measures,
and imaging techniques. Finally, exercise may prove to be
a common countermeasure for ameliorating or reversing
the long-term effects of weightlessness. In fact, it may be
preferable to maintain musculoskeletal tissue as a system
rather than to provide individual countermeasures effec-
tive for only muscle or only bone.
Functionally, muscle and bone are highly interrelated.
A contracting muscle is capable of providing high inter-
nal loading on the bones to which it attached, although
the nature of this loading is not well understood. Because
of the interaction between the two tissues, the contribu-
tion of the atrophy of muscle toward the skeletal losses
must be considered. Unfortunately, data with which this
contribution could be assessed is severely limited. One
of the few demonstrations of a direct relationship between
muscle atrophy and skeletal loss was shown in immobi-
lized rhesus monkeys [45]. In that study enhanced bone
resorption was found to occur at the site of muscle inser-
tion and on the periosteal surfaces, resulting in a loss of
30% of the force required to pull the tendon from the bone.
A similar and even more striking finding in humans was
made in 1981 after a long-term flight on a Russian space
station [21]. Using computer tomography, the researchers
were able to show that bony projections of the spine to
which (non-exercised) anti-gravity muscles were attached,
lost about 8% of its mass which correlated well with a 4%
decrease in the mass of muscles attached to the bone. The
vertebrae itself, which was exercised by simulated gravi-
tational loading, did not lose bone. One type of proof of
the relationship between muscle atrophy and bone losses
would require demonstrating that the prevention of muscle
atrophy will also lead to the prevention or retardation of
bone losses. This has not yet been demonstrated.
Attempts to identify an exercise regimen that would
reduce or prevent bone loss during bedrest have shown
mixed results. An early bedrest study (6-month) indicated
that an hour per day of exercise designed to duplicate
muscular, one-g, compressional, and tensile forces, failed
to change mineral balances, bone density losses, or hor-
monal plasma concentrations [46]. However, if the sub-
jects stood stationary for three hours a day, bone
demineralization was prevented. Potentially, the impor-
tant differences between the exercise program and quiet
standing are the amount of force applied to the calcaneus,
the muscle groups involved, and the duration of the stress.
The exercises provided particular muscles with much
movement and very little force; the standing provided more
force, little movement and probably affected a different
set of muscles (postural muscles). Therefore, the impor-
tant preventative factor appears to be the amount of force
applied to the bones, and may include the types of muscles
used, as well as the duration of the stress.
Prevention of bone demineralization in space crews
might require a system that can provide mechanical loads
to each area of the body representative of the loads seen
in one-g. If this is true, then a needed area of research is
to characterize actual bone strains and loading patterns
at clinically relevant sites in humans during specific types
of movement and exercise in one-g. This will help deter-
mine the mechanical loading thresholds for bone mass
maintenance and engineer the types of devices to provide
the appropriate loads. More fundamental research along
these lines would determine the specific manner in which
external loads are translated into the molecular and cellu-
lar signals that activates or suppresses osteocytic activity.
What will likely evolve is a protocol involving a multi-
faceted exercise prescription perhaps together with drugs,
(i.e., diphosphonates), growth hormones, and dietary
supplements (i.e., calcium, vitamin D) to maintain the func-
tional integrity of the musculoskeletal system in a weight-
less environment.
A recent review of musculoskeletal countermeasure
programs has concluded that current exercise paradigms
and other countermeasure strategies typically used during
spaceflight are inadequate to prevent or reduce deficien-
cies in the musculoskeletal system [47]. While loss of
muscle mass in space is diminished but not prevented by
exercise, exercise alone has not had the same partial suc-
cess on bone loss. It may be preferable to maintain muscu-
loskeletal tissue as a system rather than to provide
individual countermeasures effective for only muscle or
only bone However, aerobic modes of exercise (high fre-
quency, low force), the type most commonly used by as-
tronauts, are far more suited to maintaining cardiovascular
condition rather than musculoskeletal health. In contrast,
resistive exercise (high force, low frequency) is the most
promising countermeasure at present to maintain bone and
muscle tissue. Three possible countermeasure approaches
were suggested: a) intermittent artificial gravity, b) resis-
tive exercise, c) pharmacoloigc and/or dietary supplement.
Combinations of these may also be useful. In summary,
the development of successful countermeasures for muscle
atrophy and bone demineralization remains an unresolved
issue.
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Update Endnotes
Update #1
Hormonal Control (TBD). Recent research on
calcitrophic hormones in bedrest and spaceflight.
Update #2
Bone Activity (TBD). Recent research on direct mea-
surements of bone activity (osteoblastic and osteoclastic)
during hypogravic maneuver.
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Chapter 9
Integrated Systems Analysis: Simulations of Hypogravity
9.1 Introduction
In previous chapters the systems analysis emphasized the
development and testing of hypotheses to explain the ob-
served physiological changes during spaceflight in a va-
riety of body systems. These hypotheses and their effects
were demonstrated using relatively simple simulations
involving a single regulatory system. This section will
examine the application of multiple hypotheses applied
simultaneously to multiple systems to study the
hypogravic environment. In addition, simulations of space-
flight will be augmented by simulations of ground-based
analogs of microgravity. In one instance, our large inte-
grated subsystem model, the Whole-Body Algorithm, will
be used to perform the simulations. Thus, this chapter will
bring together, or integrate, data from multiple subsystems,
multiple subsystem models, multiple hypotheses and mul-
tiple types of microgravity stresses.
In order to create realistic simulations of the biomedi-
cal changes in spaceflight, it is critical to have available
accurate data from spaceflight with which to compare the
model responses. Unfortunately, this requirement is prob-
lematic because of the operational limitations of collect-
ing data early in flight or in making invasive measurements
even on a major mission such as Skylab. The simulation
studies described in Chapter 5, for example, indicate that
some of the most rapid changes in a host of fluid-related
mechanisms occur within the first few hours of spaceflight.
This was not fully appreciated during the design of the
Skylab experiments; even if it were, it would have been
operational unfeasible to gather data so early and so fre-
quently as would be needed to measure these changes.
It became obvious that if realistic simulations of
microgravity were to be accomplished, it would be neces-
sary to supplement the spaceflight data with the more ex-
tensive data sets from experimental ground-based analogs
of microgravity. Specifically, the ground-based hypogravic
maneuvers that were considered the most useful included
postural changes, water immersion, supine bedrest, short-
term head-down tilt and long-term head-down bedrest. All
of these approaches have in common a redistribution of
blood volume involving a partial emptying of the periph-
eral vessels in the legs and an engorgement of the headward
regions of the circulation. Because the analogs are ground-
based and were performed in well-equipped research labo-
ratories, they are capable of providing more subjects, more
detailed examination of difficult to measure quantities
and examination of the effect of environmental or other
external factors.
The simulation model used in the first study described
in this chapter is the Whole-Body Algorithm. In the re-
maining studies the Guyton model of circulatory, fluid
and electrolyte control, which is the keystone subsystem
of the Whole-Body Algorithm, was used. This approach
was taken because the Guyton model was quite suitable
for the fluid-related changes that were of interest. In addi-
tion, it was less unwieldy to use one model, however com-
plex, rather than an integrated set of models. The simulation
models offer a means not only of examining the experi-
mental results and evaluating hypotheses, but also of po-
tentially determining the differences between the various
one-g analogs and spaceflight events. After all, all of the
analogs are characterized by alterations in fluid (blood)
shifts toward the head, but they are not functionally iden-
tical. In one aspect, they may be distinguished from each
other by the time course and magnitude of fluid move-
ment. Table 9-1 indicates some of the differences of these
ground-based analogs and spaceflight, while Fig. 9-1 shows
the approximate durations of currently available experi-
mental studies. If we make the tentative assumption that it
is possible to simulate reduced gravity by any maneuver
that creates headward fluid shifts, Fig. 9-1 suggests that,
taken in the aggregate, these analog experiments provide
a wide time span with which to provide reduced-gravity
validation data for the models.
Our primary interest in these model simulations was to
achieve an accurate assessment of fluid disturbances in the
hypogravic environment. Such an assessment is character-
ized by the following quantities: the redistribution of fluid
between various compartments and locations such as intrac-
ellular/extracellular, plasma/interstitial and lower body/up-
per body; the changes in electrolyte concentrations
associated with these compartments; the changes that oc-
curred in intake and sweat losses of water and electrolytes;
and the regulatory mechanisms (renal, hormonal, cardiovas-
cular) which control acute fluid-electrolyte disturbances and
long-term adaptive influences. Secondarily, there was an
emphasis in examining the circulatory and hemodynamic
changes including responses to tilt, exercise and fluid-
loading. These areas are readily accounted for by the
Guyton model; in addition it was possible to indirectly
study some of the other important effects of microgravity
such as muscle atrophy and bone demineralization.
Our basic thesis governing the analysis of the space-
flight results is that the physiological changes that occur
during weightlessness can best be appreciated by under-
standing the mechanisms that are necessary to protect the
body from the effects of gravity. Therefore, an ideal model
with which to analyze the zero-g data would be one that
contains all of the gravitational protective mechanisms that
are present in normal, ambulatory man. The advantage of
such a model is that the simulation of hypogravity could be
initiated by simply altering or removing the gravity vec-
tor. The hypothesis that would be tested, then, would be
that the hypogravic state, if chronically maintained, would
lead to the gradual readaptation of those mechanisms that
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Figure 9-1. Duration of typical hypogravic fluid shift studies in the Skylab era. The length of typical studies are indicated by the bars.
The times during which data is typically collected is shown by the solid circles. Data collection is generally sparse during the first day
of supine bedrest and spaceflight studies when many dramatic changes occur. Results from other analog studies are therefore necessary
to estimate early physiological changes.
Table 9-1. Characteristics of Various Hypogravic and Fluid-Shift States 
Normogravic or Hypogravic State External Forces Time Phase* Influence on Body Fluids
Postural Change Full effect of gravity gradient Short term Fluids pooled in legs
during erect posture
Water Immersion External pressure gradient Short term Fluids forced cephalad by
equal to blood hydrostatic gradient external forces
Supine Bedrest Partial removal of erect gravity Long term Elastic forces of tissues
gradient redistribute fluids
Head-down tilt & Removal and partial reversal Short term Elastic forces of tissues
Head-down bedrest of gravity gradient Long term redistribute fluids and
leg tissues dehydrate
Spaceflight Complete removal of gravity Long term Redistribution of fluids and
gradient in all body positions dehydration of leg tissues
* Short-term is considered < 24 hrs.
have been developed to protect man from his normal am-
bulatory, relatively unstable, upright position. Unfortu-
nately, a model that can be initialized in the ambulatory
state and maintain stability has not yet been designed. An
attempt to accomplish this is described later in this sec-
tion but it was only partially successful.
Consequently, investigation of the thesis through mod-
eling must be approached in a different manner. The simu-
lations of supine bedrest were initiated in the supine model
by forcing a redistribution of fluids in a manner that was
hypothesized to occur as a result of gravity unloading. In
the case of head-down tilt, the introduction of the gravity
vector allowed a more realistic simulation of fluid redis-
tributions by simply changing the angle of tilt. In this
case, the overall hypothesis being tested was whether the
dynamic changes in fluid volumes that occur because of
gravity unloading were responsible for many of the ob-
served renal, cardiovascular and hormonal responses. Other
hypotheses, reflective of gravity unloading, were also in-
cluded in the initiation of the simulation. For example,
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variations between the physiological stresses shown in
Table 9-1 may be explained, in part, by differences in the
metabolic activity, the diet and the degree of musculosk-
eletal degradation of the subjects. Therefore, the investi-
gation of the spaceflight responses, through modeling, has
been done as a series of trials based on discrete physi-
ological alterations that are hypothesized to occur upon
exposure to hypogravic stresses.
In this chapter the testing of the zero-g hypotheses
using a mathematical model and various ground-based
analogs is discussed. A summary of the specific hypoth-
eses examined is given in Table 9-2. To test the hypoth-
eses, the long-term circulatory model (Guyton) was
modified by incorporating ever-increasing complex pro-
cesses related to gravity. Hypogravity was first simulated
in the unmodified Guyton model without a leg compart-
ment (Chapter 9.2). These simulations demonstrated a need
for a leg compartment in the model. Supine bed-rest stud-
ies provided data to validate and improve the simulations
(Chapter 9.3). Since the model was originally designed as
a supine model, it was only possible to simulate supine
bedrest by artificially forcing fluids from the leg toward
the head and then allowing the model’s normal regulatory
processes to take over. This approach was extended to simu-
late the long-term Skylab spaceflight missions (Chapter
9.4). Water immersion was simulated in the same model by
providing an external compressive force on the leg fluid
compartments that provided a cephaled fluid shift (Chap-
ter 9.5). Water immersion studies were especially useful in
providing information on early events of hypogravity.
Further modification of the model was undertaken to in-
clude gravity, particular the action of the gravity vector
on hydrostatic blood columns. This permitted a range of
postural tilt studies to be simulated (orthostasis in Chap-
ter 9.6, head-down tilt and head-down bedrest in Chapter
9.7) using a more natural forcing function. In each case,
the knowledge gained from one set of studies was applied
to the subsequent studies. Data of increasing complexity
was examined, interpreted and organized in a way to as-
sist in model validations and hypothesis testing. In the
iterative process of performing these functions, the hy-
potheses addressing spaceflight physiology can be con-
tinually examined and reevaluated.
9.2 Supine Bedrest Simulation with a
Legless Circulatory Model (Whole-Body
Algorithm)
The first simulations of hypogravity were performed with
the Whole-Body Algorithm, with the long-term circula-
tory portion (Guyton model), playing the central role. It
was noted that the primary event accompanying a reduced
hydrostatic effect is a shift of blood from the legs to the
central regions of the vasculature. The resulting increase
in blood pressures in this region coupled with the fact that
this area contains the major pressure sensors of the body
was generally believed to be the causal factor for many of
the physiological changes to follow. However, in an at-
tempt to simulate supine bedrest with a legless model ini-
tialized in the supine position, some important questions
had to be addressed at the outset. First, in a model that
does not directly account for gravity, what physiologi-
cally acceptable stimulus or forcing function would cause
the model to simulate the reduction in hydrostatic effect
that accompanies bedrest? Secondly, how could hydro-
static effects be accounted for in a model without legs? At
this point in these studies it was not feasible to devote the
time necessary to add a leg compartments and explicit
gravity components (this would be done at a later time);
therefore, some artificial but plausible forcing function
was needed.
The approach eventually used was to approximate the
headward fluid shift by shifting a portion of blood from
the unstressed blood volume to the stressed blood vol-
ume. The broad outline of this approach is shown in Fig.
9-2 in which the entire circulatory volume is approximated
by a single compartment divided into stressed and un-
stressed volumes.* The reader should note that only
changes in the stressed blood volume (which is a small
fraction of the total blood volume) is responsible for
changes in vascular pressure. At the start of the simula-
tion, fluid would be suddenly shifted from the unstressed
to the stressed volume, keeping the total blood volume
constant. The amount of fluid shifted would be approxi-
mately the same as that observed to be displaced from the
legs when changing from the erect to the supine posture
(about 300 ml). The increase in stressed blood volume
would initiate the model simulation by increasing the pres-
sure on the pressure receptors, which would in turn, ini-
tiate pressure-receptor effects. The fact that the unstressed
volume has been reduced is of no consequence since, math-
ematically, it contributes nothing toward changes in blood
pressure. Only the stressed volume is the critical factor
affecting pressures, pressure receptors and most all aspects
of fluid-electrolyte regulation. In this method total blood
volume remains constant while the step change in stressed
volume takes place.
In summary, the fluid alterations of bedrest were as-
sumed to be simulated by forcing an amount of fluid equal
to that mobilized from the legs during an acute erect-to-
supine position from the unstressed to the stressed vol-
ume of the circulation. This is similar to an infusion of
blood into the central circulation with the exception that
it is accomplished at constant blood volume. Once this
forcing function was complete (over a period of less than
1-minute) the model would then run on its own and re-
spond to this “blood infusion” into the stressed volume
by activation of the model’s controller mechanisms. These
studies with the legless model only simulated the acute
movement of blood from the legs; there was no attempt to
simulate the slower migration of fluid from the leg tissues
*
 Consider the circulation to be represented by an empty deflated
balloon. The amount of fluid volume that must be introduced into the
balloon to just inflate the balloon without increasing the internal pres-
sure is called the unstressed volume. Introduction of any further fluid
(stressed volume) will cause the balloon to expand with increasing
internal pressure. A graphical representation of this concept is shown
later in Fig. 9-32.
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Table 9-2. Hypotheses Tested during Integrated Systems Analyses
Classification Question Hypotheses
Body fluid shifts and What conditions are necessary or • Loss of plasma volume and total body water initiated
distribution sufficient to simulate a realistic by rapid headward shift of blood and extravascular
dynamic behavior of: fluid from legs
a) total body water • Headward shift of blood results in an immediate
b) blood volume diuresis which may be modified by state of hydration
c) intracellular/extracellular • Losses of body fluid can primarily be attributed to
d) intravascular distribution changes that occur in legs. Short-term losses are due
e) fluid loss from legs? to acute fluid shifts, while long-term losses are due to
long-term tissue losses, metabolic factors and circulatory
adjutments.
Loss of electrolytes What conditions are necessary • Primary loss of sodium occurs early in flight due to
from body or sufficient to simulate realistic extracellular fluid loss
behavior of major electrolyte loss • Loss of potassium due to muscle disuse atrophy,
from body of occurring gradually.
a) sodium
b) potassium?
Loss of red cell mass What conditions are necessary • Increase in hematocrit due to early plasma volume
or sufficient to simulate the loss is responsible for increased oxygen supply and
increase in hematocrit? decrease in erythropoietic activity.
Change in renal function What factors controls renal • Headward shift of body fluids triggers renal
function as defined by: mechanisms (neural, hormonal, and hemodynamic)
a) urine volume which produce acute losses of electrolytes and fluids.
b) sodium excretion • Continued gradual loss of intracellular and
c) potassium excretion extracellular fluid coupled with changes in sweat
d) glomerular filtration rate losses and dietary intake of fluid and electrolytes can
e) renal blood flow? explain longer-term renal response.
Hormonal regulation What factors controls the major • Initial headward fluid shift results in increased
renal and cardiovascular hormonal stimulation of cardiopulmonary presso-receptor
regulators: pathways resulting in depression of ADH, angiotensin,
a) ADH and aldosterone at the beginning of flight
b) renin-angiotensin • Longer term changes in hormone can be partly
c) aldosterone? attributed to changes in plasma electrolyte levels
Changes in cardiovascular What conditions are necessary or • Acute cardiovascular changes can be attributed to
system at rest sufficient to simulate cardio- rapid expansion of central blood volume resulting
vascular behavior as defined by: in alterations of flows, pressures, autonomic stimulation,
a) cardiac output and vasoconstrictor agents (angiotensin, catecholemines)
b) heart rate • Longer term changes may be attributed to circulatory
c) stroke volume system adjusting to: a) continued decrease of gravity
d) peripheral resistance load on mechanoreceptors, and b) downward
e) blood flows to legs, viscera, adjustment of blood capacitance affecting retoning
    kidneys of blood vessels and blood volume.
f) blood pressures in arteries, veins,
    atria, pulmonary circulation?
Changes in provocative Can the changes in performance of • Inflight reduction in blood volume can explain most of
metabolic and orthostatic these tests be explained by deviation of LBNP responses at the beginning of flight,
stress tests (includes a) fluid shifts and the decrements in exercise performance at
LBNP and bicycle b) reduced blood volume recovery
ergometry exercise) c) exercise conditioning • History of exercise conditioning inflight determines in
d) vascular retoning? part the immediate postflight exercise response and
rate of recovery toward normal
• Longer term changes in LBNP during flight is partly
attributable to retoning of vascular elements. Other factors
not well known.
Overall Hypotheses
1. The dynamic changes in fluid volumes and electrolytes that occur as a result of gravity unloading are responsible for many of the observed renal,
cardiovascular, and hormonal responses as well as the decrements in performance of provocative metabolic and orthostatic stresses.
2. Similar types of fluid shifts occur in all stresses considered here (i.e., spaceflight and its analogs), but differ in magnitude and dynamic behavior.
Differences in metabolic activity, diet, and degrees of musculoskeletal degradation also exist in these situations. These differences can explain, in part, the
variations in overall physiological responses between these stresses, particularly between long-term bedrest and spaceflight.
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and further “drying” of the leg vasculature. These pro-
cesses, which were addressed in more advanced simula-
tions, could remove another 200–300 ml from the legs
(see Chapter 9.3). Also later in this chapter, simulations
will be described using models with upper and lower body
segments that are capable of shifting fluids between these
compartments in a more realistic manner.
One other modification that was suggested for simu-
lating bedrest was a cardiovascular effect. The effect was
an increase in heart rate by 0.4 beats per minute for each
day of simulated bedrest. The cardiovascular effect had
been suggested from abundant data of different bedrest
studies [1]. Although the modification was added to the
model, it did not appear to be critical to the simulations.
Simulations were run with and without the cardiovascular
effect and the only difference was an increase in heart rate
and a corresponding decrease in stroke volume. No other
differences in behavior of any other variable, including
cardiac output, were observed.
Simulations of the events that occur during supine
bedrest were performed with the whole-body algorithm
using the legless Guyton model. Before and after simu-
lated bedrest, an additional series of stresses were auto-
matically performed utilizing the short-term subsystem
models of the Whole-Body Algorithm. These additional
studies consisted of 70°  tilt, lower body negative pressure
(LBNP) and 50-watt supine exercise. In experimental stud-
ies, these tests help to reveal physiological changes that
occurred during bedrest that were not always apparent in
the resting supine state. These simulations of bedrest and
special stress studies will be described next.
9.2.1 Comparison of Simulation with Bedrest Data
The responses of the model to a 28-day bedrest simu-
lation are shown in Figs. 9-3(a) to 9-3(d) using the forcing
function described above. Twenty-four variables are de-
picted. The simulation revealed that many new quasi
steady-state conditions were reached at the end of 4 weeks.
However, most of the significant changes in the variables
had occurred by the end of the first day. Consequently, the
model’s behavior is shown in more detail for the first 24-
hours. While many of these variables have not been mea-
sured simultaneously during any single bedrest study,
many of the results shown in Fig. 9-3 have been confirmed in
different hypogravic maneuevers either during bedrest, wa-
ter immersion, or spaceflight. The experimental bedrest re-
sults, for many of the same variables, are shown in Figs. 9-4
to 9-7. Unfortunately, bedrest investigators fail to measure
physiological variables during the first day when many
interesting physiological parameters are changing. It was,
therefore, only possible to compare the longer term results
of the simulation with experimental data.
Based on the simulation data, the physiological ad-
justments to gravitational stress appear to be quite rapid.
Central blood volume is not shown but its value will be
parallel to that of the pressures within the circulation.
Within the first few simulated minutes, the blood pres-
sures in both the atrial and the arterial segments rose, caus-
ing an increase in stroke volume and cardiac output (Fig.
9-3(a)). Heart rate reflexively decreased because of barore-
ceptor influence and a rapid rise in blood pressure yielded
a transient decline in aldosterone and renin (Fig. 9-3(b)).
Because of the changes in aldosterone, the urine rate and
Figure 9-2. Idealized approach for simulating blood volume distribution during bedrest using the Guyton model. The model is initially
in the control position (a); bedrest is initiated by forcing function (b); model response shown in (c).
(A) Control Position: “Erect”
Total blood volume = Vs + Vo
where Vs = stressed blood volume
Vo = unstressed blood volume
5 compartments of the model are represented here
by a single compartment. Leg blood volume is
considered to be included in Vs + Vo
(B) Acute Shift to Supine
(i)  ∆V ~ 300 ml shifted from unstressed to stressed volume
(ii) ∆V represents easily moblized fluid from legs being
     infused into central compartment at constant blood volume
(C) Physiological Response
(i)   Increased pressures lead to reflex diuresis, i.e., approx.. ∆V is excreted.
(ii)  Stressed blood volume reduced to approx. normal
(iii) Total blood volume eventually reduced by ~∆V
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urine sodium increased (Fig. 9-3(c)). The increase in uri-
nary fluid loss led to decreases in blood volume, extracel-
lular fluid volume, total body water and vascular
hemoconcentration (Fig. 9-3(d)). Because of the changes
in central blood volume and pressure, changes in the
plasma concentrations of anti-diuretic hormone (ADH),
aldosterone, angiotensin and renin occurred. Anti-diuretic
hormone is shown to decrease for the first half-hour of the
simulation, after which it transiently rises and then de-
clines in a biphasic response. Transient decreases in al-
dosterone, angiotensin and renin were predicted whereas
sodium and potassium plasma concentrations remained es-
sentially unchanged. Many of these variables were not pre-
dicted to return to their pre-bed-rest values at the end of 28-
days, the most notable of these being blood volume, extra-
cellular fluid volume, total body water, hematocrit, cardiac
output, heart rate, stroke volume, blood pressure, peripheral
resistance, renal flow, angiotensin and aldosterone.
An unexpected result was the decrease below control
of the right atrial pressure (which is similar to central
venous pressure) that occurred within a few hours. The
only analogous data at this time was from water immer-
sion studies that showed clearly that central venous pres-
sure increases dramatically immediately upon immersion
and is maintained at high levels for several hours [9]. This
observation, in fact, is the basis for Gauer’s theory of cen-
Figure 9-3(a). Simulated responses to 28-days of bedrest, using
Guyton model without legs: Cardiovascular function.
Figure 9-3(b). Simulated responses to 28-days of bedrest, using
Guyton model without legs: Plasma concentration of hormones
and electrolytes.
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tral blood volume regulation via ADH and renal pathways
[10]. The reasons for the model’s behavior will be reported
later (see Chapter 9.7.5), but at this time it should be noted
that it was not until some years later that head-down tilt
studies showed that venous pressure falls back toward nor-
mal much faster than with water immersion and it was even
later that spaceflight studies confirmed that central venous
pressure can fall below control almost immediately upon
entering microgravity (without even showing an earlier
increase) UPDATE#1.
The long-term effects of bedrest were simulated rea-
sonably well with this model. Further examination of the
autoregulatory segments of the model were made by re-
moval of all of the autoregulatory components, except for
those that were long-term (i.e., time constants greater than
one week). Simulations with these changes resulted in al-
most identical values for all variables at the end of 28-
days indicating that very short-term autoregulatory
mechanisms are not significant in longer-term studies –
an expected result.
The model’s long-term hemodynamic changes were
compared with the results from several bedrest studies of 2
to 7 weeks duration (Fig. 9-4). Although hemodynamic
agreement between model and data was generally good,
variation of experimental data among all the studies was
very wide. The cause of the experimental variation was
unknown, but it was not necessarily related to the length
of the bedrest.
Seemingly conflicting data that showed both increases
and decreases in certain hormones, as a result of reduced-
gravity effects were reconciled by the model. Figure 9-5
Figure 9-3(c). Simulated responses to 28-days of bedrest, using
Guyton model without legs: Renal function.
Figure 9-3(d). Simulated responses to 28-days of bedrest, using
Guyton model without legs: Body fluid volumes.
Intracellular fluid, liters
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represents the only bedrest data available (at the time of this
analysis) showing the prolonged effects of bedrest on plasma
renin and urinary aldosterone. No data on angiotensin activ-
ity were located. However, since renin is a precursor to
angiotensin, the renin data were compared with results of
the angiotensin simulation. The pattern predicted by the
model, of an initial decrease followed by an increase in
plasma concentrations of aldosterone and angiotensin, is
supported by the published accounts shown in Fig. 9-5
and in short-term immersion studies (not shown) [11].
The decrease in ADH during the first day of simula-
tion appears to be contrary to the belief of many reviewers
of bedrest studies [12,13]; however, no experimental data
could be located that would conclusively demonstrate that
ADH is below control levels after 1-hour of bedrest. In a
recent review on ADH control, it is concluded that al-
though ADH may decrease temporarily during postural
change (upright to supine), because of changes in atrial
pressure, this effect does not appear to be long lasting
[14]. The longer term simulated effects show an increase
in ADH, which will almost return to normal after 1-day. An
explanation for the simulated ADH bedrest responses may
be found in the concept that ADH is under the dual con-
trol of osmo- and volume-regulators. Accordingly, the in-
crease in central blood volume may initially decrease the
plasma ADH concentration, but the long-term control is
probably regulated by the osmolarity of the extracellular
fluid and thereby the plasma ADH concentration is raised.
The model embodies the dual control mechanism which is
described in detail in Chapter 9.8.4.
Data on the body fluid volume changes during 28-
days of experimental bedrest are presented in Fig. 9-6.
There was generally good agreement between the simula-
tion and experimental results of these variables. Although
the model yielded higher hemoconcentration than the ex-
perimental data (i.e., compare Figs. 9-3(d) and 9-6)), the
difference may be explained by two factors. First, this par-
ticular study used frequent blood draws, which diminished
red cell volume and the draws were not accounted for in
the simulation; and, second, these data and other experi-
mental studies strongly suggest a diminution of red cell
mass due to inhibition or cessation of red cell production.
The simulation did not predict significant changes in red
cell mass; however, the simulation did not use the im-
proved red cell production subsystem that was produced
during the course of the systems analysis project (see Chap-
ters 3,6 and Appendix B). This subsystem probably would
have predicted the changes observed in red-cell mass more
accurately. More advanced simulations, discussed later in
this chapter, will demonstrate this effect.
Some experimentally determined changes in renal func-
tion during bedrest are shown in Fig. 9-7. Comparison of
changes in urine and sodium excretion with the simulation
results (Fig. 9-3(c)) indicates reasonably good agreement.
9.2.2 Comparison of Simulations with
Post-Bedrest Tilt and Exercise Data
Researchers interested in bedrest as an analog to space-
flight have developed several procedures for testing the
Figure 9-4. Hemodynamic response due to prolonged bedrest.
Percent change from control. Model vs. data [2,3,4,5,6].
   Reference Days bedrest   No. subjects
A 2          14          15
B 3          21            5
C 4          28            6
D 1          42            3
E 5          14            6
F 6          21            6
 Guyton model          28           ----
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effects of bedrest on cardiovascular behavior. These tests
include exercise and tilt-table studies. The former is a
metabolic stress and the latter is an orthostatic stress; both
tests will reveal physiological changes that are not ob-
servable at rest. On occasion LBNP will be used instead of
the tilt-table to test orthostasis. The ability of the short-
term cardiovascular model (Croston’s model) to simulate
exercise, tilt and LBNP was presented in Chapter 3 (see
Chapter 3.2.1.4). Here we will examine the simulated re-
sponses to the same stresses, but in the context of the
Whole-Body Algorithm. In this case the four week bedrest
discussed in the current section was simulated using the
long-term circulatory model and then control was passed
to the short-term models where tilt and exercise were simu-
lated. Results will be compared with experimental data.
The results of the short-term simulations of 70°
head-up tilt and supine exercise, before and after a bed-rest
simulation, are shown in Figs. 9-8 and 9-9, respectively.
Simulation results are compared to corresponding experi-
mental data from 4-week bedrest studies [3,15]. All results
labeled “tilt” or “exercise” are shown as changes from the
resting supine position immediately preceding tilt or ex-
ercise. These simulated results were produced by the short-
term group of models of the Whole-Body Algorithm before
and after the long-term model provided a simulation of
bedrest. Results labeled “supine” or “rest” in these figures
represent the changes in supine resting values because of
bedrest alone (long-term model vs. data).
The differences in the initial conditions of the short-
term models, between the pre- and post-bedrest states, were
based on changes obtained from the long-term model’s
bedrest simulation. Only total blood volume changes, vas-
cular resistances and local cardiovascular changes were
transferred from long-term to short-term models. This is an
admittedly simplistic set of hypothesis to allow differen-
tiation between the pre- and post-bedrest physiological
states. Other changes observed at the end of the long-term
Figure 9-5. Experimental data on the effect of bedrest on (a) aldosterone [2] and (b) renin [7] responses.
bedrest simulation included hormonal changes, unstressed
volume changes, pulmonary resistance and blood viscos-
ity effects. These changes were not used in the short-term
subsystem to simulate tilt and exercise.
Model and experiment agreement in the case of su-
pine exercise was better than in the case of tilt. This result
was not unexpected, since the head-up tilt simulations
should have been highly affected by physiological
changes in the legs during bedrest that would influence
fluid pooling upon standing and the model lacked a leg
compartment. Some of the changes that might be expected
in the lower extremities include leg tissue dehydration,
reverse stress relaxation (retoning) and compliance
changes during bedrest as well as extravasation of plasma
into an altered interstitium during standing. These poten-
tial effects indicated that a leg compartment would be
important in simulating head-up tilt particularly if excess
pooling occurs. This may be one reason why experimental
data during tilt is so time-dependent. An example of this
can be seen in Fig. 9-8 where experimental values for heart
rate are shown at the end of 1-minute and at 5-minutes.
The short-term models that simulated tilt do not contain
an interstitial compartment that can promote time-depen-
dent pooling. These leg factors would not be expected to
influence the simulated exercise results as much, since in
supine exercise, pooling of blood in the legs does not
occur. If it had, cardiac performance during exercise would
be greatly affected.
9.2.3 Summary: Supine Bedrest with a Legless
Model
In summary, this preliminary attempt to simulate the
effects produced by upper and lower body fluid shifts has
demonstrated the capability of the Whole-Body Algorithm
to perform a sequential series of short- and long-term
stresses automatically and somewhat accurately. No major
structural changes in any of the subsystem models were
19th min
40 mmHg
LBNP
(a) (b)
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necessary to perform these simulations. This study should
be considered a validation of the structure and function of
the Whole-Body Algorithm. Also encouraging was the
notion that the response to a simple increase in stressed
blood volume could explain many of the fluid and circu-
latory findings from bedrest studies.
However, some aspects of the model’s behavior have sug-
gested that certain modifications would be useful. Some of
these include a superior erythropoiesis regulatory system
that would predict decreases in red cell mass in long-term
hypogravity, inclusion of a leg compartment in the long-
term model and inclusion of an extravascular compart-
ment in the short-term models. In addition, further analysis
and understanding is needed in the areas of autoregula-
tion of blood flow, stress relaxation and ADH regulation.
Furthermore, the simulations had to be artificially in-
duced by forcing fluids into or out of the stressed fluid
compartment. As such, the simulations did not represent
physiological changes induced directly by the postural
change but those induced indirectly by changes in the
stressed fluid volume. In an attempt to make the long-term
model capable of initiating its own fluid shifts, a leg com-
partment and the addition of a gravity vector was consid-
ered to be essential additions to the model. The modeling
studies with such a modification are presented in the fol-
lowing section.
9.3 Supine Bedrest Simulation Using a
Circulatory Model with Legs
9.3.1 Introduction
The addition of leg compartments to the Guyton model
was motivated by the need to simulate hypogravic ma-
neuvers more realistically. A number of critical processes
occur in the legs in spaceflight including acute fluid shifts,
gradual dehydration of the leg tissues and musculoskel-
etal degradation. The long-range goal to simulate space-
flight by initializing the model in the erect position and
then remove the gravity effect was planned to be accom-
plished in several stages: a) addition of leg compartments,
b) addition of gravity effects, c) testing the leg compart-
ment modifications with supine bedrest simulation, d) test-
ing of the gravity effects with postural simulations, e)
creation of a model referenced in the erect position and f)
simulation of spaceflight by removing the gravity effect
from the reference model. The first four of these steps was
completed in the course of this project and they are docu-
mented in the remainder of this chapter. The project ended,
unfortunately, before it was possible to develop an erect
reference model. This section will report on the use of a
model with legs to simulate long-term supine bedrest. Test-
ing the model for gravity related stresses such as postural
changes and head-down tilt will be the subject of subse-
quent sections.
9.3.2 Model Modifications and Simulation Strategy
The path towards a realistic simulation of postural
change and gravity dependency necessitates that the cir-
culatory compartments should be divided into upper and
Figure 9-6. Experimental data of body fluid volume changes dur-
ing a four-week period of bedrest [2].
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lower body segments. The Croston model of cardiovascu-
lar regulation was designed from the outset with leg com-
partments and gravity elements but it is considered a model
for short-term events. The more comprehensive Guyton
model contains elements that lend themselves to the more
desirable behavior of long-term adaptation. Redesigning
Guyton’s circulatory model so that elements of the leg
(lower body) compartments could be specified required
the modification of several components of the model as-
sociated with fluid volumes and flows. These modifica-
tions involved separating or redistributing:
1) the pressures, flows and volumes of the upper and lower
circulatory compartments;
Figure 9-7. Experimental data of renal function during bedrest [8].
2) the flow paths between upper and lower circulatory com-
partments perfusing muscle and non-muscle, non-renal
tissues;
3) the levels of pressure and volume of the upper and lower
body interstitial (and intracellular) compartments;
4) the basal capillary filtration and lymph flow between
the upper and lower body compartments;
5) the pressure-volume function curves (compliance rela-
tionships) of the upper and lower circulatory compart-
ments for arterial and venous segments; and
6) the pressure-volume function curves (compliance rela-
tionships) for the interstitial component of the upper
and lower body compartments.
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Figure 9-9. Response to 50 Watt supine exercise: Before and after bedrest comparison of model and data [3].
Figure 9-8. Response to 70° tilt from supine: Before and after bedrest comparison of model and data [15].
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Another critical modification was to add gravity ef-
fects to the new circulatory compartments so that removal
or adjustment of the gravity vector is explicitly represented
in the model. See Chapter 3.2.5, Appendix C.1 and Leonard
& Grounds [16] for details of the recompartmentation and
gravity related modifications to the model. Chapter 9.6
also reviews special issues associated with these modifi-
cations. Figures 3-35 and 3-36 show a schematic of the
Guyton model before and after recompartmentation. Taken
as whole, this redesign would allow changes to occur in
the leg compartments themselves and fluid shifts to occur
between the lower and the upper body compartments subse-
quent to simulated postural changes. After the modifications
were made, it was verified that the recompartmented model
could reproduce the stability and responses to simple stresses
almost identical to the original model.
If the Guyton model, modified with leg compartments,
could be initialized in the erect position, a simulation of
supine bedrest could be initiated by simply changing the
gravity vector from vertical to horizontal position (allow-
ing pooled fluids in the legs to move to the upper body
propelled by natural tissue compressive forces) and turn-
ing off any position-defined orthostatic defense mecha-
nisms, e.g., proprioceptor. Because such an erect initial
state was not available, the problem became that of deter-
mining how to simulate a supine bedrest state starting from
a supine initial state. Inasmuch as both states are supine, it
would not be possible for fluids to move headward in a
natural manner. Therefore, it was decided to move fluids
artificially without actually changing postural position.
This “forced-fluid stimulus” is similar to that presented
earlier in Fig. 9-2 using the “legless” Guyton model. Al-
though this is an unnatural forcing function, the studies
that emerged, especially regarding mechanisms of leg de-
hydration, are considered to have value in understanding
an important aspect of the hypogravic response.
In this study, our main interest was in the fluid vol-
ume responses during supine bedrest, specifically in leg
volume. About 400–600 ml of blood are easily mobilized
and rapidly transferred between legs and upper body dur-
ing postural maneuvers. Another 300–500 ml of plasma
was normally pooled extravascularly in the leg tissue upon
standing. Thus, it appears that up to a liter of fluid is nor-
mally pooled in the legs when standing and some or all of
it is available to shift cephaled when gravity vectors are
removed. The working hypothesis is that fluid shifts from
the legs during supine bedrest are the major driving force
for many of the observed changes regarding fluid volumes
(blood and interstitial), urine excretion and regulators (au-
tonomic and hormonal) of renal and blood pressure con-
trol. It appears that the amount of blood originally pooled
in the legs is very close to the eventual reduction in blood
volume in hypogravity. For that reason special attention
is paid, in this section, of the factors that cause leg dehy-
dration in hypogravity.
9.3.3 Experimental Data
9.3.3.1 Bedrest Data. There are relatively few published
studies which deal with all aspects of bedrest on the human
physiological system, or which attempt to integrate the many
major studies which have been conducted in the years prior
to the current modeling studies, i.e., [6,17,18,19]. One pos-
sible explanation for this fact is that differences in scope and
methodology, especially as regards the degree and duration
of immobilization, make quantitative comparisons between
studies difficult or impossible. So rather than attempt to de-
termine a “typical” bedrest response, a specific bedrest study
was chosen for simulation.
The study which was used as a baseline for the current
set of horizontal bedrest simulations is the Baylor Col-
lege of Medicine (BCM) 28-day bedrest study [20]. That
study was designed as a bedrest control for the first 28-
days of the Skylab missions; one can use this data to draw
comparisons between microgravity and bedrest. This data
was augmented with two other bedrest studies, a 14-day
BCM study [17] and a 28-day study of Hyatt [2]. Results
of certain fluid volume measurements (total body water,
intracellular fluid, interstitial fluid) which were the em-
phasis of the simulation study, were quite variable as will
be shown. However, plasma volume and leg volume
changes are more consistent and these data will allow us
to examine the processes that control them.
9.3.3.2 Leg Volume Changes in Bedrest and Space-
flight. One of the important objectives of this effort was
to create the ability to simulate the prolonged dehydra-
tion effects in the legs that are observed during bedrest
and weightlessness. Figure 9-10 shows the change in total
leg volume during the first month of bedrest and space-
flight. The most dramatic aspect of this data is the four-
fold difference in the magnitude of the leg volume changes
between spaceflight and supine bedrest. One feature that
is common, however, is the rapid decrease within the first
few days followed by a more gradual decline that does not
stabilize during the time period observed. The leg volume
data from spaceflight does not level out even up to 84-
days. Recovery is also very rapid, but bedrest yields the
most rapid recovery. A critical analysis of the time-course
of leg dehydration in spaceflight has been presented in Chap-
ter 5.4.2. (The head-down bedrest and spaceflight data will
be scrutinized more closely in later sections of this chapter;
here we will concentrate on the supine bedrest data).
If one examines the data more carefully, it can be pre-
sumed that the changes that occur the most rapidly are
probably due to the easily mobilized fluid in the legs, that
of blood and the interstitial fluid that is pooled in the legs
upon standing. By measuring the leg volume changes dur-
ing the first few minutes of the supine position (from erect),
approximately 400 ml of blood are inferred to pool in the
legs. Judging from volume change on the 28th-day of
bedrest (Fig. 9-10) there is probably another 300 ml vol-
ume that can be attributed to extravascular sources. This
undoubtedly consists of easily mobilized interstitial fluid
and of muscle tissues that atrophy from disuse during
bedrest. If we acknowledge that recovery of the atrophied
tissue takes longer than that of fluid recovery, it is pos-
sible to infer from the recovery data that much more tissue
is lost during spaceflight than is lost during bedrest.
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9.3.4 Model Parameters Affecting Leg Dehydration
As was made clear previously in this book, a maneu-
ver from the erect to supine position will result in a rapid
headward movement of easily mobilized fluid in the legs.
This leg fluid is derived from fluids in the leg vessels and
leg interstitium, previously pooled during standing. (See
Fig. 5-24 for details of this concept and Fig. 9-11 (bold
lines) for a summary). Following this rapid fluid shift there
appears to be a more gradual and less significant decrease
in leg volume. The continual losses of leg volume, after
the first day in the supine position, suggest that mecha-
nisms beyond simple fluid shifts from the leg vasculature
are important to understand long-term changes observed
during bedrest. The components of the Guyton model were
examined for various factors which could help explain the
exponential-like decrease in leg volume. Once identified,
these factors could be used to test hypotheses regarding
fluid shifts and fluid volume changes during bedrest. Table
9-3 addresses the model factors that could influence the
long-term dehydration of the legs.
9.3.5 Simulation Hypotheses
Based on the factors in Table 9-3 several promising
hypotheses were identified and tested in the model as part
of a bedrest simulation. The onset of bedrest simulation
would be performed in a manner that will cause the blood
pooled in the legs to rapidly shift headward. The hypoth-
eses discussed below are designed to produce a more
gradual loss of fluids from the legs over the 4 weeks of
bedrest. Most of the factors in Table 9-3 were tested in the
model but eventually only the first four were deemed im-
portant to achieve the desired result.
9.3.5.1 Hypothesis #1 – Decreased O2 Demand and
Autoregulation of Flow. The first hypothesis is based
on the fact that bedrest subjects are relatively inactive,
compared to ambulatory subjects. Thus, oxygen demand
would be reduced. In addition, muscle tissue atrophy which
accompanies bedrest or spaceflight will lead to a smaller
and more gradual reduction in whole-body oxygen de-
mand, but especially in the legs where the postural muscles
primarily reside. In the Guyton model oxygen demand is
linked to local blood flow  autoregulation, so that a de-
crease in demand would reduce blood flow through the
local tissues as well as reduce local capillary pressure. As
shown in the hypothesis diagram of Fig. 9-11 this would
lead to an increase in fluid reabsorption as predicted by
the Starling forces and ultimately a decrease in interstitial
fluid volume.
This “disuse” hypothesis was tested in the model by
decreasing the value of oxygen consumption by 7% be-
low the control level. This value is the same as that mea-
sured in subjects immobilized with plaster hip casts [25].
There are no comparable values measured directly during
a bedrest study. A simulation to demonstrate the hypoth-
esis was performed with the oxygen demand being low-
ered both by a step decrease of the whole value and by a
linear decrease of the value over 28-days; both scenarios
seemed plausible. For example, there is probably a rapid
decrease in oxygen consumption at the very start of bedrest
but also slower changes as metabolism processes change
and as tissue wasting occurs.
The response of the model to the step decrease, shown
in Fig. 9-12, was an autoregulatory-induced increase in
peripheral resistance (not shown) with an associated de-
Figure 9-10. Effect of spaceflight and bedrest on total leg volume. Ref.: Supine bedrest [20]; Head-down tilt/bedrest ■ [21], ? [22];
Spaceflight ▲ Apollo Soyez Test Project [23], Skylab, SL4 mean ● [24].
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Figure 9-11. Hypotheses for explaining fluid volume changes during supine bedrest. Proposed mechanisms for short-term fluid shifts
are shown with bold lines. The other branches of the diagram are for longer-term fluid shifts based on inactivity (Hypothesis #1), reverse
stress relaxation of leg veins (Hypothesis #2). and muscle atrophy (Hypothesis #3).
Table 9-3. Model Factors Which Influence Leg Dehydration
     Name of Process Model Component Description of Process
a) Decrease in oxygen demand Effect of O2 metabolic rate on Bedrest inactivity diminishes oxygen demand.  Local
autoregulation autoregulation responds by increasing resistance to flow
and lowering capillary pressure which favors increased fluid
reabsorption from the interstitial fluid.
b) Reverse stress relaxation Unstressed (filling) volume of Leg veins empty due to headward fluid shifts.  Leads to
leg vein (Vo) reverse stress relaxation (decreased Vo) of veins until
pressure is restored, thereby further emptying the veins.
c) Muscle atrophy Decreased intracellular fluid Inactivity leads to muscle atrophy. Model’s cellular
and loss of vascularization compartment can be diminished by leaking potassium causing
water to follow. Blood vessels associated with muscles
are diminished by reducing Vo.
d) Drying of interstitial gel Amount of hyaluronic acid in Decrease in hyaluronic acid will decrease gel that contains
the interstitium. the largest portion of interstitial fluid. Can also be simulated
by decreasing set point of interstitial volume.
e) Compliance of leg blood Venous compliance Relationship of pressure and volume of stressed volume
      vessels in the leg veins. A decrease in compliance will increase leg
blood pressure and decrease stressed volume.
g) Tilting to supine position Angle of tilt Negative values will simulate head-down tilt and pool
blood from legs into upper body.
d) External pressure on leg External pressure bias on leg Represents natural compressive forces of tissue that force
blood vessels and leg tissue fluids headward upon reclining. Also used for muscle
compartment pump on standing or external pressure in water immersion.
Effect is to drive fluid from legs.
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crease in cardiac output and muscle blood flow. Leg vol-
ume decreased by a small amount, 65 ml, with most of the
fluid coming from the interstitium. Modest decreases in
plasma volume reflected the increased arterial pressure
(not shown). The decreases in plasma volume and intersti-
tial fluid accounted for the losses in total body water.
9.3.5.2 Hypothesis #2 – Reverse Stress Relaxation
of the Leg Vasculature. The second hypothesis is based
on the knowledge that veins act as viscoelastic materials.
When a vein is subjected to a mechanical strain, part of
the strain is immediately reversible (the elastic part) and
part of the strain is not (plastic deformation, creep, or stress
relaxation). The amount of elastic stretch is measured by
the compliance, which describes the relationship between
pressure changes and volume changes. The filling volume
of the venous compartment (Vo) is the volume that can be
filled (starting from an empty “flabby” vessel) before pres-
sure changes occur. This is also called the unstressed vol-
ume and is capable of non-elastic deformation [26b](see
Fig. 9-32 for a graphical illustration of these concepts).
During ambulatory periods, the leg veins are often dis-
tended and, as a result, a certain amount of stress relax-
ation occurs (i.e., a gradual increase in Vo at constant pres-
sure). During bedrest, however, the leg veins are not dis-
tended, but are rather empty and the reverse process, reverse
stress relaxation occurs. The filling volume of the leg veins
decreases and the transmural pressures increase until trans-
mural pressure across the vein reaches a steady-state con-
dition. As the transmural pressures are gradually increased
during reverse stress relaxation, additional blood will leave
the leg vascular compartment and shift headward. The ef-
fects of bedrest on fluid volume changes, based on reverse
stress relaxation in the legs, are shown in Fig. 9-11 (Hy-
pothesis #2).
Reverse stress relaxation in the Guyton model is an
automatic mechanism of the large central veins in the body.
However, the leg veins of the modified Guyton model were
not designed with an inherent function for reverse stress
relaxation. Therefore, the unstressed volume of the leg
veins was changed manually. The total magnitude used
for the stress relaxation effect was 280 ml, the value esti-
mated for the change in leg blood volume because of bedrest.
The unstressed volume change was accomplished at an
exponential rate (1st order time constant) over 28-days.
The major effect of this process was a small gradual rise in
arterial pressure that eventually led to a renal-induced re-
duction in plasma volume of the same magnitude.
9.3.5.3 Hypothesis #3 – Loss of Muscle Tissue and
Tissue Vasculature. The third hypothesis is that muscle
atrophy due to gravity unloading was responsible for a
portion of the long-term changes in leg volume. Muscle
atrophy implies losses of skeletal muscle cellular contents
and the associated capillary vasculature of the muscle tis-
sue. Figure 9-11 indicates that muscle tissue losses, largely
due to inactivity, would decrease interstitial fluid volumes
(Hypothesis #1), as well as intracellular volume and the
volume of blood normally associated with the lost tissue
(Hypothesis #3). To the extent that these losses occur in
the legs, leg volume will also gradually decrease.
Is it possible to estimate the amount of leg volume
loss due to muscle atrophy? One approach is to note from
Fig. 9-10, that the total reduction in leg volume measured
at the end of 28-days of supine bedrest was 600 ml. Sub-
tracting the 280 ml of easily mobilized leg fluid measured
during postural change from 600 ml yields 320 ml as our
estimate for extravascular tissue (interstitial plus intracel-
lular) losses in the legs. Another gross estimate of leg tis-
sue loss would be to use the information that 46% of the
decrease in maximum calf circumference was recovered
by the end of the first post-bedrest day and then remained
constant. If the remaining 54% represents muscle tissue
loss and further if this proportion is constant for the total
leg loss, than about 320 ml (54% of 600ml) of loss were
from extravascular sources, in excellent agreement with
the first approach. Using a demonstrated correlation be-
tween lean body mass and blood volume [27] and noting
the observed blood volume to lean body mass ratio of 89
ml/kg during bedrest [20], a blood volume of 29 ml is
calculated representing the blood lost from the body with
320 ml (~0.320 kg) of muscle tissue. (This amount is in
Figure 9-12. Simulation of the effect of a step reduction in oxy-
gen demand in muscles.
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addition to the rapid loss of vascular fluid from the legs at
the onset of bedrest).
Which parameters of the model should be altered to
simulate the leg volume losses from muscle atrophy just
calculated? In the model, the legs do not include a sepa-
rate cellular compartment but they do contain an intersti-
tial fluid compartment. Therefore, in order to simulate
muscle tissue loss, the leg interstitial fluid volume is re-
duced by 320 ml, the amount previously calculated. An-
other 30 ml of blood will be “squeezed” from the legs due
to devascularization (i.e., the volume associated with the
atrophied tissue) by reducing the filling volume (i.e., un-
stressed volume, Vo) of the leg veins. This is equivalent to
invoking reverse stress relaxation. In addition, a small por-
tion of the intracellular volume will be slowly depleted
by allowing 10% of intracellular potassium to leak across
the cell membrane. This represents the gradual wasting of
muscle tissue. Since the intracellular compartment is not a
part of the leg structure in the model, this loss is not re-
flected in leg volume changes, but rather in total body
water.
9.3.6 Supine Bedrest Simulation: Overview and
Approach
The Guyton model, modified with leg compartments,
was used to simulate supine bedrest using the scheme
shown in Fig. 9-13. In order to overcome the disadvantage
of simulating supine bedrest with a model initialized in
the supine position (as discussed in the introduction to
this study, Chapter 9.3.1), fluids were forced from the leg
compartments and allowed to shift headward. Prior to start-
ing the simulation, the leg veins and leg interstitial com-
partments were “preloaded” with an amount of fluid
believed to be pooled in the legs when erect (see Fig. 9-
13(a). It was as if the model were allowed to stand upright
for about 30-minutes; about 400 ml excess blood pools in
the lower limbs and 300 ml pools in the leg interstitium
(see Chapter 9.7.3.2.1). If then, the model was suddenly
brought supine, the leg fluid compartments would be
“preloaded” at the moment the simulation begins. The leg
vein compartment was preloaded by increasing the un-
stressed volume (Vo) by 400 ml and the leg interstitial
compartment was preloaded by increasing the interstitial
volume set point (VI) by 300 ml.
“Release” of these volume excesses provided the ini-
tial stimulus for shifting fluid headward and was accom-
plished by simply reversing the “loading” parameters, Vo
and VI by the same magnitude as the preload amount. The
duration of the Vo shift was about 30-minutes since it rep-
resents the highly mobilized fraction of blood available
for shifting between upper and lower body segments dur-
ing postural change. The duration of the VI shift was set as
a first order exponential change, decreasing 63% of the
full value within the first 3.7-days and the remaining 37%
over the remaining 24.3-days of the bedrest study (see
Fig. 9-13(b and c). The tissue fraction of fluid is reab-
sorbed across the leg capillary beds into the leg vascula-
ture and then is automatically shifted headward by
compliance forces. Two other hypotheses were tested in
this simulation as described in Chapter 9.3.5 (but not ex-
plicitly shown in Fig. 9-13): the decrease in oxygen de-
mand due to inactivity (Hypothesis #1) and a small amount
(30 ml) of devascularization (i.e., further decrease in Vo)
due to muscle atrophy (Hypothesis #3).
The fourth cartoon in Fig. 9-13(d) represents the re-
sponse of the model’s control system to the headward fluid
load. As described fully in Chapter 5 (and summarized in
Fig. 9-11), a relative hypervolemia occurs in the upper
body and is relieved by a reduction in plasma volume, i.e.,
Gauer–Henry mechanism. That is, the physiological vol-
ume control mechanisms will maintain the central blood
volume at a normal level by renal excretion of excess fluid.
This is the belief of a number of researchers and is con-
firmed by the Guyton model. Prolonged bedrest results in
further leg dehydration as suggested by the time profile of
leg volume changes. It is suggested that this is due to the
hypotheses discussed in Chapter 9.3.4 (see Fig. 9-13(e)).
9.3.7 Supine Bedrest Simulations: Simulation
Results
9.3.7.1 Plasma Volume. The model simulation shows a
decreasing plasma volume that compares favorably with all
three bed-rest studies (Fig. 9-14). The recovery of the model
is slower than that indicated by the data. There is a distinct
overshoot of the control level in two of the studies, but not in
the simulation.
9.3.7.2 Leg Volume. The model output of leg volume
compared to data from the 28-day Johnson and Mitchell
study is shown in Fig. 9-15. Several factors prevent pre-
cise comparison between model and experimental re-
sponse. The experimental data represent changes in total
leg volume including those due to decrements in fluid
volume (intravascular and extravascular) and solid tissue.
The model response, on the other hand, includes only those
changes due to leg intravascular and interstitial fluid
shifts. The rapid initial decline of plasma volume in the
simulation was due to: a) the pooled blood in the leg veins
being “released” and propelled toward the central venous
compartment by the compressive forces of the leg veins
and b) an intravasation of 300 ml of leg tissue fluid into
the leg veins which then shift the fluid headward by the
same compressive forces as in (a). The continuing slower
decrease in leg volume was a result of the tail-end of the
1st order decreases of (a) and (b), (c) a decreased oxygen
demand and d) the devascularization mechanism.
Changes in tissue volume as a result of muscle atro-
phy could not be measured during the bedrest study and
were not considered in the simulation. However, this fac-
tor could alter the time course of the response. Recovery
results indicated that the model recovers leg volume less
quickly than the human subjects. All forcing functions used
to create the changes were made symmetrically for either
decreases or increases in fluid volumes. It has been suggested
that this may not be the case in the real system [26a].
9.3.7.3 Extracellular Fluid Volume. In Fig. 9-16 the
differences in the extracellular fluid volume of the simu-
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Figure 9-13. Idealized concept for fluid shifts from legs during supine bedrest. This diagram shows the initial preloaded state (a); the
forcing stimulus for initiating supine bedrest simulation (b) and (c); the acute response of the model is (d); and the long-term dehydration
of the leg (e) as tested by the three hypotheses.
lation and the experimental data from the 28-day BCM
study, the 14-day BCM study and the 28-day study of
Hyat, are compared. The model’s response of extracellular
fluid coupled with the leg volume response shown previ-
ously suggest that the decrease of the extravascular vol-
ume of the legs is excessively rapid and that a volume
decrease of less than the 300 ml used for this simulation
might be more appropriate. The recovery of human sub-
jects shows an overshoot response which is not duplicated
by the simulation. The notation of extrapolated and 30-
minute values on the 28-day BCM study indicate two tech-
niques which were used to interpret the isotopic tracer
data.
9.3.7.4 Total Body Water. In Fig. 9-17 the total body
water response of the simulation is compared to the data
from the three experimental studies. The total body water
changes include the net changes in both the extracellular
and the intracellular fluid compartments. Intracellular fluid
was depleted in accord with Hypothesis #3 (see Chapter
9.3.5.3). The simulation predicts both a rapid and then a
gradual decline in total body water throughout the dura-
tion of the bedrest. The longer term simulation response is
in agreement with the data.
9.3.7.5 Other Results. The results of the simulation also
show good agreement in other areas of experimental ob-
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Figure 9-14. Comparison of changes in plasma volume during
bedrest: Model vs. data. Figure 9-15. Comparison of leg volume changes during bedrest:Model vs. data. Left leg volume data is from 28-day BCM bedrest
study. The spike in the data at the end of two weeks of bedrest
coincides with the LBNP + saline ingestion crossover study, a
factor not accounted for in these simulations.
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Figure 9-16. Comparison of extracellular fluid volume changes
during bedrest: Model vs. data. The notation of extrapolated and
30-minute values for the 28-day bedrest study indicate two tech-
niques which were used to interpret the isotopic tracer data [20].
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Figure 9-17. Comparison of change in total body water during
bedrest and recovery: Model vs. data. ? - 28-day study;  ? -14-
day study;  ∆ - Hyatt.
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servations including red cell mass, cardiac output, arterial
pressure and total peripheral resistance. A 6.7% decrease
in red cell mass compared well to the observed value of
6% decrease at the end of bedrest as measured by Kimzey,
et al. [28]. This favorable comparison indicated the sound-
ness of the improved erythropoiesis algorithm which had
been inserted in the model [16,29]; (see Appendix C). Some
of the model’s hemodynamic parameters which showed a
change at the end of 4 weeks simulated bedrest are a 4.2%
decrease in cardiac output, a 2.5% increase in arterial pres-
sure and a 7.1% increase in total peripheral resistance.
These values show reasonably good correspondence to
studies by others [1,3,4,5,6]. The only parameter that was
not simulated well was resting heart rate. An increased
resting heart rate has been a consistent finding in almost
every bedrest study to date. Yet, without additional
changes to the autonomic elements, the Guyton model
predicts practically no change in resting heart rate for 28-
days of bedrest. An empirical algorithm has been applied
to the heart rate function to provide realistic heart rate and
stroke volume responses for bedrest simulations. The
mechanisms that may be responsible for this effect are not
presently known.
9.3.8 Summary: Supine Bedrest
 Despite the crude approximations that were made,
reasonable results have been obtained in simulating the
fluid shifts of bedrest. Although it was necessary to use an
unnatural forcing function to allow leg fluids to shift
headward, the resulting changes in plasma volume, extra-
cellular volume and leg volume were similar to those seen
in bedrest. The addition of leg fluid compartments to the
model have permitted testing of hypotheses to account for
the time course of leg dehydration. The magnitude of 400
ml of shifted blood and a time constant of slightly less
than 4-days give good correspondence to experimentally
observed losses in plasma volume. The extravascular fluid
from the legs, originally estimated to be around 300 ml,
leaves the tissue too quickly and may represent an exces-
sively large volume. A decrease in resting oxygen demand
of muscle seems warranted and this decrease has positive
effects on leg volume changes and hemodynamic parameters.
Overall, these simulations provided some insights into the
interpretation of the observed fluid volume changes whereby
an initial large and rapid decline in the volumes of plasma,
interstitium and legs gives way to a smaller and more
gradual decrement in these compartments. Most of these
changes appear to be explained by fluid and tissue changes
in the legs, i.e., leg dehydration and muscle atrophy.
As indicated in Fig. 9-10, the fluid shifts accompany-
ing spaceflight are much larger than those associated with
postural changes or supine bedrest. It is possible that the
interstitial tissues in the legs contain a larger amount of
readily mobilized fluid than has been heretofore recog-
nized under normal terrestrial surroundings. The most prom-
ising ground-based, experimental stresses for examining
the larger zero-g fluid shifts are water immersion and
antiorthostatic bedrest (head-down tilt). These will be ex-
amined in the following sections after a simulation study
of spaceflight is presented. All of the remaining studies in
this chapter were performed using the Guyton model modi-
fied with leg compartments.
9.4 Spaceflight Simulation
9.4.1 Hypothesis Development
An overall goal of the modeling project was to achieve
an accurate computer model simulation of the physiologi-
cal changes observed during spaceflight. Several major
obstacles had to be surmounted to accomplish this goal:
a) identify the physiological areas of concern, b) develop
or acquire the models for studying this area, c) using the
model as a guide, identify the experimental variables of
interest, d) formulate hypotheses to account for the ob-
served zero-g changes and d) determine how these vari-
ables are altered in spaceflight by testing the hypotheses
in the model. This approach was used throughout Chapter
5 to analyze the fluid, electrolyte and circulatory responses
to spaceflight.
As part of the analysis of Chapter 5 a set of six hy-
potheses were developed (see Chapter 5.4). Each hypoth-
esis was designed to explain a specific known or suspected
physiological change(s) in the Skylab astronauts. Table
9-4 lists these hypotheses and summarizes their major
short-term and long-term physiological effects on the simu-
lation. Each item listed is a quantity which has either been
measured or postulated to occur in spaceflight. The list
taken as a whole represents a comprehensive fluid-elec-
trolyte response pattern to weightlessness. In Chapter 5.4
these hypotheses are analyzed individually and the reader
is referred there for a complete discussion of each of them.
In this section, we shall report the predicted responses for
the case where all of these hypotheses have been com-
bined during a single simulation.
9.4.2 Simulation Approach and Model Modifications
The most important hypothesis considered was the
acute shift of fluids toward the head (Hypotheses #1 and
#2 in Table 9-4). This was a common characteristic of vari-
ous hypogravic situations including postural changes,
bedrest, water immersion and head-down tilt. Consider-
ation was given to various techniques that would provide
the appropriate stimulus for simulating this initial re-
sponse. Since weightlessness appears, in many respects,
to be merely the absence of orthostasis in one-g, it seemed
desirable to initialize the model in a steady-state upright
position and proceed to remove the gravity vector. This
approach was not feasible since the physiological mecha-
nisms that protect man from long-term orthostatic collapse
are not known well enough to include in a quantitative
model, especially as a reference state [16]. The successful
use of six-degree head-down tilt as an experimental
ground-based analog to weightlessness suggested another
direction. For reasons that were then unknown, the model
exhibited instabilities and mathematical discontinuities
during a simulated head-down tilt. Neither of these ap-
proaches were sufficiently developed at the time to be
used in the present study, however, they subsequently re-
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ceived additional attention and were somewhat success-
ful (see Chapter 9.6 and 9.7).
A third technique was briefly attempted with little
success. This involved using the values for fluid intake,
evaporative water loss and renal volume excretion that
were observed in the Skylab crew (see Chapter 4.4) as forc-
ing functions for the Guyton model. This was done in an
attempt to drive the internal physiological mechanisms.
Controlling both intake and output proved unsuccessful
as a zero-g simulation, but it did demonstrate that the nega-
tive water balance which appears appropriate for main-
taining normal function in zero-g is a severe stress in one-g
and a knowledge of electrolyte balance is as important as
water balance for simulating an individual’s response to
any long-term stress.
The stimulus for weightlessness that was ultimately
used in this study took advantage of the fact that the
fluid-electrolyte model is extremely stable in a “supine”
position. The hypogravic simulation was initialized from
this reference state, just as it was in the supine bedrest
simulations described in Chapter 9.2 (without “legs”) and
9.3 (with “legs”). The following programming was introduced
into the Guyton model (modified with legs) in order to per-
form this Skylab simulation and test the hypotheses:
1. An acute headward shift of leg fluid was accomplished
by forcing fluids from the leg blood (Hypotheses
 
#1)and
tissue (Hypotheses
 
#2) compartments. See Fig. 9-13
(items a, b and c) for the concept of fluid shifting
headward in the model. In this case, however, a greater
amount of fluid was shifted than for supine bedrest (i.e.,
500 ml of blood and 500 ml of filtrate were forced acutely
from the leg compartments) in accordance with observa-
tion (Fig. 9-10). For convenience, the longer-term de-
hydration of the legs was not considered. The leg dehy-
dration phenomena will be revisited in the head-down
bedrest study later in this chapter.
2. Potassium was gradually released from the cell com-
partment in an effort to mimic some of the effects of
muscle atrophy (Hypotheses
 
#3). The manner in which
this was accomplished is described in Chapter 5.4.2.2.
3. The model was structurally modified to include the
natriuretic factor (Hypotheses
 
#4). See Figs. 5-16 and
Table 9-4. Hypotheses and Their Effects on the Simulation of Circulatory, Fluid and Electrolyte Responses to Spaceflight (Skylab)
Hypothesis Short Term Effects Long Term Effects
#1 Blood shift from legs • Transient decrease in interstitial fluid • Increased hematocrit
• Decreased red cell mass
#1 and #2 #1 and #2
• Circulatory hyperdynamia • Decreased leg volume
#2 Filtrate shift from leg • Diuresis • Decreased plasma volume
tissues • Natriuresis • Decreased body water
• Decreased sympathetic activity • Decreased body sodium
• Decreased angiotensin, aldosterone,
   and ADH
• Transient increase in interstitial fluid • Decreased interstitial fluid
#3 Potassium release from • Increased K+ excretion
cells • Decreased body K+
• Decreased intracellular fluid
• Increased plasma [K+]
• Increased Aldosterone
#4 Natriuretic factor • Increased urine Na+ excretion • Decreased extracellular [Na+]
• Decreased extracellular [Na+] • Increased aldosterone
• Decreased intracellular osmolarity • Increased angiotensin
• Decreased loss of intracellular fluid • Decreased ADH
#5 Chronic decrease in • Increased renal excretion of water,
sweat losses    sodium, and potassium
• Increased urine osmolarity
#6 Anorexia and increased • Decreased body water
sweating early inflight • Decreased body potassium
• Decreased body sodium
• Partial suppression of diuresis & natriuresis
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5-29 and the associated discussions.
4. Dietary intake and sweat rates for water, sodium and
potassium were entered into the model according to a
previous analysis of a composite Skylab crewman as
illustrated in Fig. 9-18 (see also Chapter 4.4 and Table
5-9). This programming was sufficient to test Hypoth-
eses
 
#5 and Hypotheses
 
#6 that deal with short and long
term influences of intake and sweat rates.
With regard to the last item, the Guyton model con-
tained no sweat loss mechanism, so a simple formulation
was inserted into the model as described in Chapter 5
(Chapter 5.4.2.2). The Guyton model, of course, contains
a kidney with renal excretion of water, sodium and potas-
sium as computed variables. Therefore, the urine excre-
tion data shown in Fig. 9-18 was not used as data for
programming the model, but rather as data for comparison
with the model output. Because the Guyton model con-
tained no representation of fecal output, urine and fecal
quantities have been combined. However, fecal excretion
is only a small fraction of urine excretion.
9.4.3 Spaceflight Simulation Results
The simulated flight period was 57-days (the length
of the average Skylab flight). It was preceded by a 4-day
control period and followed by a 14-day recovery period.
Recovery periods have not received a great deal of atten-
tion during these simulations and hypotheses which might
improve their response have not been evaluated. There-
fore, the recovery period is not included in all figures.
Some of the most important responses in this simulation
are presented in Figs. 9-19(a) to 9-19(d).
Figure 9-18. Total intake, total excreta and total skin losses for water, sodium, and potassium in the average Skylab crew and for the
average mission length. Changes have been partitioned into acute and long-term segments for ease in model use. Total Intake includes
dietary intake and metabolic water; Total Excreta combines urine and fecal quantities; Total Skin Losses includes insensible evaporative
and sweat losses. For the Skylab simulations in this section, the modified Guyton model was programmed with Total Intake and Total
Skin Losses which are fixed parameters. The excreta data was used to compare with model output. Data in this figure was derived from
metabolic balances (see Chapter 4) and from a special modeling technique (see Appendix F.3.3). C= preflight control period, R =
postflight recovery period.
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Figure 9-19(a): The headward shift of a liter of fluid
from the legs (blood plus filtrate) results in a rapid loss of
plasma. There is a more gradual decline in red cell mass.
The model predicts this response as being secondary to
hemoconcentration-hyperoxia effects. Hematocrit declines
from its initial elevated levels as red cells are lost from the
circulation. However, blood volume remains relatively
stable at a reduced level due to a compensatory increase
in plasma volume. The model also predicts that intersti-
tial fluid volumes (in the upper body) return to normal
within several days. Recovery is characterized by a return
to control levels for leg volume and blood volume, while
hematocrit falls below normal. Discontinuities appear at
the end of the fifth inflight day in some cases because this
point separated the two-stages (acute and chronic) of di-
etary/sweat module inputs.
Figure 9-19(b). This figure shows the behavior of some
important fluid-electrolyte variables. Total body water and
extracellular sodium decrease rapidly because of the fall
in extracellular fluid (not shown) and then more slowly as
intracellular fluid decreases. The rate at which fluid leaves
the intracellular compartment is controlled completely by
transcellular osmotic forces. However, this is a complex
function of extracellular sodium concentration that is regu-
lated by renal excretion and the release rate of potassium
from the cell. The influence of the natriuretic factor caused
the plasma sodium concentration to fall, although not as
far as observed in spaceflight. Plasma potassium concen-
tration increases primarily because the loss of cell potas-
sium; the concentration would have been higher if not for
good renal regulation. The loss (after launch) and even-
tual recovery (during postflight) of body water, body so-
dium and body potassium proceed at different rates. These
rates were similar to those found for the Skylab crew (see
Fig. 5-2).
With the exception of plasma electrolyte concentra-
tions, hematocrit and leg volume, none of the variables
shown in Figs. 9-19(a) and 9-19(b) was measured directly
during the weightless portion of flight. Using traditional
and novel modeling techniques it has been possible to
develop independent estimates of many of these quanti-
ties. The results shown here are in good agreement with
those predictions.
Figure 9-19(c): The renal responses of fluids and elec-
trolytes during simulated spaceflight are shown in this
figure. Excretions of water and sodium have similar
time-courses. After a short period of rapid excretion, the
first 5-days of flight are characterized by a loss rate much
less than that shown during control. The model is appear-
ing to conserve fluids in the face of decreased drinking and
increased sweating. This is followed by a much more con-
stant output slightly higher than control. Steady-state values
for water and sodium excretion are elevated by +4% and
+12%, respectively. These changes are in excellent agree-
ment with Skylab values. Potassium excretion remains el-
evated, however, throughout the inflight period by about
4%. This value is lower than that observed during space-
flight because of a potassium loss rate from the cells which
was set too low in the model. The predicted steady-state
urine concentration of sodium is about 10% above con-
trol, also similar to experimental findings. This occurs at a
time when aldosterone is elevated; thus the model exhibits a
“sodium escape from aldosterone” phenomenon similar to
other studies of chronic hyperaldosteronism.
The dietary and sweat changes programmed into the
model (Fig. 9-18) had a significant influence on the outcome
of the simulation, particularly the renal responses of Fig. 9-
19(c). It is worthwhile summarizing the important aspects of
these metabolic events. The early decrease in intake was
ascribed to space motion sickness induced anorexia while
the early increases in sweat losses were due to unusual
heat and work loads. Both of these early changes had
marked effects in causing a fall in the simulated renal ex-
cretion of water and sodium; thereby modulating the ex-
pected diuresis. During the prolonged phase of flight, mean
intake of fluid and electrolytes was not identical with pre-
flight values, but was within ± 5% of control conditions.
This small change together with the larger decreases in
evaporative loss was also reflected in the both the volume
and electrolyte concentration of urine excretion.
Excretion of water and electrolytes is partly under the
influence of the hormones shown in Fig. 9-19(c) (ADH,
aldosterone and angiotensin). Some dramatic transient ef-
fects are predicted early inflight as well as significant de-
partures from preflight levels during the long-term
steady-state. Circulatory pressures and plasma electrolyte
concentrations are the predominate influences on those
hormones. Mean arterial pressure (Fig. 9-19(d)) is elevated
by about 2%. Similarly, small changes exist for sodium and
potassium concentrations. Yet, the changes in plasma con-
centrations of ADH, aldosterone and angiotensin (-40%,
+16% and +24%, respectively) are significantly larger. If
spaceflight is associated with the chronic elevation of cen-
tral or renal circulatory pressures, then the angiotensin
response is paradoxical unless other competing stimuli
can be found which oppose that factor. The predicted re-
sponses of ADH and angiotensin follow intuitively con-
sistent trends.
Figure 19(d): Although the emphasis of this chapter
is on fluid-electrolyte regulation, the Guyton model is
capable of simulating hemodynamic events. Figure 19(d)
illustrates a variety of common cardiovascular parameters.
The first few hours of the simulation do not portray a true
picture because of the compressed time scale. The reader
is referred to Fig. 9-3 where a similar type of simulation
was performed for the first 24-hours of supine bedrest.
There you can see that during the first hour or so, the
cardiac output, arterial pressure, central venous pressure
and renal blood flow actually increase before declining
below control. Over the next few weeks these cardiovas-
cular parameters gradually return to normal. There are no
comparable measurements from the Skylab missions (in
resting subjects) to validate these predictions with the
exception of mean arterial blood pressure which indicates
only a very slight decline from preflight on average over
the mission. Because of the lack of inflight measurements,
there was no attempt to develop hypotheses to optimize
the simulation response as was done for the fluid,
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Figure 9-19(b). Simulation of average Skylab mission: Fluid and
electrolytes [see caption Fig. 9-19(a)].
electrolye, renal and hormone responses, i.e., Table 9.4.
However, hemodynamics will be revisited in the section
on head-down tilt bedrest (Chapter 9.7) where experimen-
tal data is available.
9.4.4 Summary: Spaceflight Simulation
The responses shown here represent the most accurate
simulations performed to date with regard to circulatory,
fluid and electrolyte changes. Predictions for the acute,
long-term and recovery phases of spaceflight have been
compared to the measured spaceflight data for a diverse
number of parameters. Table 9-5 lists the parameters that
were simulated in this specific study and references the
tables and figures in this book that show confirmatory
Skylab findings. Other simulations in this book empha-
sized a number of other physiological functions, includ-
ing those involved with circulatory, orthostatic, exercise,
hematological and metabolic responses. These are cov-
ered in other chapters and other sections of this chapter. In
almost all cases reasonable results have been obtained.
This was achieved by considering a number of hypotheses
as well as a variety of experimental data. Most important,
however, these simulations could not have been possible
without an accurate model representation of the highly
complex physiological system. Taken as a whole, the hy-
potheses tested have produced a reasonably accurate fluid
electrolyte response pattern to weightlessness and these
results do account for findings that have been heretofore
difficult to explain.
9.5 Water Immersion Simulation
9.5.1 Introduction
Water immersion has proven to be a useful tool for
studying fluid volume homeostasis and renal physiology
in man [30]. Physiologically, it is characterized by a cepha-
lic redistribution of blood volume from the legs, which is
also a seminal event in spaceflight. As such, it has been
Figure 9-19(a). Simulation of average Skylab mission: Blood
and tissue volume. The preflight duration is 4-days; inflight dura-
tion is 57-days; and postflight is 14-days. The simulation in-
cluded all of the proposed hypotheses listed in Table 9-4.
Total body water, liters
Intracellular volume, liters
Total body sodium, meq
Total body potassium, meq
Plasma [Na+], meq/liters
Plasma [K+], meq/liters
 Change in total leg fluid volume, liters
Blood volume, liters
Plasma volume, liters
Red cell mass, liters
Hematocrit, volume percent
Interstitial fluid, liters
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used as an excellent means of simulating and examining
the details of the circulatory, renal and fluid-electrolyte
responses to weightlessness. Because water immersion
studies are technically difficult to conduct for periods of
longer than 3 to 6-hours, it has been used to help under-
stand the events occurring at the onset of weightlessness.
In fact, it is primarily from water immersion investigations
that most of the theories (during the 1970’s and 80’s) re-
garding the very early effects of zero-g on fluid balance
and blood volume control have been obtained [10].
Fluid is shifted from the legs in water immersion due
to external water pressures, in contrast to the natural elas-
tic tissue forces which are the primary drivers in weight-
lessness. The redistribution of blood during water
immersion is mediated primarily by an external hydro-
static pressure gradient acting on the body surface (and by
innuendo, on vascular columns of the body) which in-
creases by 22.4 mmHg/foot of water depth. This increase
in transmural pressure forces blood from the vessels of the
lower extremities toward the cephaled region and central
Figure 9-19(d). Simulation of average Skylab mission: Renal and
endocrines [see caption Fig. 9-19(a)].
Total leg volume
Central blood volume
Cardiac output
Mean arterial pressure
Central venous pressure
Renal blood flow
Total peripheral resistance
Figure 9-19(d). Simulation of average Skylab mission: Hemody-
namics [see caption Fig. 9-19(a)].
Urine volume, ml/min
Sodium excretion, meq/min
Potassium excretion, meq/min
Urine [Na+], meq/liter
Plasma [ADH], x normal
Plasma [aldosterone], x normal
Plasma [angiotensin], x normal
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Table 9-5. Variables of the Skylab Simulation and their Experi-
mental Confirmation*
Simulated Variable                Confirmation    Confirmation
                                                Table Number   Figure Number
Fluid Compartments:
Total body water 5-2           5-2
Intracellular volume 5-2
Interstitial fluid 5-2
Blood volume 5-2           6-2
Plasma volume 5-2           6-2
Red cell mass 5-2           6-2
Total leg volume 5-2           9-10
Body Electrolytes:
Total body sodium 5-2           5-2
Total body potassium 4-15, 5-2           5-2
Plasma Concentrations:
Plasma [Na+] 5-5           5-20
Plasma [K+] 5-5
Hematocrit           6-4, 6-5
Plasma ADH           5-5
Plasma aldosterone           5-5(b)
Plasma angiotensin           5-5(d)
Renal Function:
Urine excretion 4-14            9-22
Sodium excretion 4-14            5-4(a),9-22
Potassium excretion 4-14            5-4(b)
Urine [Na+] 4-14
* Skylab simulation refers to Fig. 9-19
venous pool. Although this type of external force does
not exist during spaceflight or bedrest, the nature of the
fluid redistribution itself is probably similar for all three
stresses. Quantitatively, the degree of fluid shift during
water immersiont appears to be in between that seen in
bedrest and in spaceflight [31].
There are certain facets of the water immersion pro-
cess that make this maneuver inherently different from the
acute response to weightless spaceflight. Several major
considerations that may limit the usefulness of water im-
mersion as a zero-g analog are:
1. Water immersion studies are usually limited to periods
of less than 6 hours.
2. Immersing a subject to the neck or chin results in nega-
tive pressure breathing because the force exerted by the
water on the surface of the body has no counterbalance in
the airways. Negative pressure breathing, or the posi-
tive pressure breathing equipment used to counteract
this effect, may interfere with the circulatory, renal and
hormonal responses that are under examination [30].
3. During immersion, there is a marked decrease in evapo-
rative water loss. While this simplifies the interpreta-
tion of water balance and renal alterations (for example,
the predominant route for fluid losses is by way of kid-
ney excretion), it does not permit exact extrapolation of
renal responses to the weightless condition where skin
water loss is a significant fraction of overall water balance
(see Chapter 4). The total quantity of urine voided dur-
ing immersion might, therefore, be expected to be some-
what higher than that achieved during weightlessness.
4. The pressure on the walls of the thorax, due to the hy-
drostatic forces of water external to the body, is an ef-
fect that is not present in weightlessness and can lead
to higher intrathoracic pressure than would be observed
in spaceflight. This transthoracic pressure gradient and
compression of submerged tissues is probably respon-
sible for the sustained hyperkinetic circulatory state
reported during immersion studies [32,33]. As a result,
immersion may lead to higher venous pressures, a larger
reduction in blood volume than would be expected in
zero-g and to a masking of any reflex relaxation effects
of peripheral capacitance vessels [34].
In terms of fluid volume regulation, the two most sig-
nificant responses to the blood redistribution resulting
from water immersion are an acute diuresis and a reduc-
tion in the plasma volume. At the time of this analysis
(early 1980’s) there has been no attempt to measure plasma
volume during spaceflight, but plasma volume loss has
been a consistent finding immediately after spaceflight
Also, the expected diuresis has not yet been measured
during any flights, although 24-hour pooled samples were
taken on 9 subjects in the Skylab program. One of the
questions addressed during the present analysis was to
examine the factors which may have led the apparent dis-
crepancy between the observed and expected urinary vol-
ume responses, particularly the effect of dehydration.
The physiological events thought to occur during wa-
ter immersion have been summarized in Chapter 5.3.1. In
the following description of simulation and experimental
results, reference will be made to that section. A set of
baseline simulations of a normally hydrated subject will
be presented first. This is followed by studies of the ef-
fects of dehydration on the water immersion response.
9.5.2 Simulation of Normally Hydrated Subjects
Simulations of water immersion were performed using
the Guyton model with leg compartments, as modified for
the bedrest simulations. The simulation was initiated by
forcing 500 ml of intravascular and 500 ml of interstitial
fluid from the leg compartments. At the time of this study,
no data was available to define the magnitude or time
course of leg volume shifts during immersion, but the shifts
that were imposed in simulation are supported by data
from bedrest and orthostatic maneuvers [13,35,36]. Also,
it has been shown that central blood volume increases by
700 ml immediately following immersion [37]. The simu-
lations were run for 10-minutes with all short-term auto-
regulatory components removed and for 6-hours with all
autoregulatory components intact. The simulation results
are shown in Figs. 9-20 and 9-21. The experimentally de-
termined effects of water immersion are presented in Table
9-6, Figs. 9-22 to 9-25.
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Figure 9-22. Percent changes of plasma volume during water
immersion. A composite of ten studies, derived from Greenleaf et
al. [41].
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Table 9-6. Experimentally Determined Short-Term (10 min – 6-hour) Immersion Response
9.5.2.1 Fluid Shifts. The primary effect of water immer-
sion can be characterized by an acute translocation of fluid
from the leg to the upper body, primarily the intrathoracic
compartment. This primary effect was the basis of the
model initialization. In addition to the translocaton of
blood, there appears to be a significant increment in plasma
volume, demonstrated by a transient decrease in hemat-
ocrit. This augmented plasma volume resulted from the
external water pressure forcing leg interstitial fluids into
the capillaries. Within 1 to 2-hours, however, a significant
portion of plasma from the engorged central blood vol-
ume finds its way out of the vasculature via renal excre-
tion and via filtration into the interstitium of the upper
body (see hypothesis diagram, Fig. 5-17). The result is an
interesting biphasic response of the plasma volume, first
increasing and then showing a greater net depletion. Ex-
perimental findings that depict these changes are shown
in Table 9-6, Figs. 9-22 (plasma volume) and 9-23 (hemo-
globin); they are also faithfully reproduced in the simula-
tion (Fig. 9-20).
9.5.2.2 Hemodynamic Responses. With the initial
acute shift of fluids, an increase in central blood volume,
heart volume and blood pressures in the central veins and
Primary Effects:             Reference           Change from Control
Central Blood Volume (A) +700 ml
Heart Volume (G) +180 ml
Central Venous Pressure (G,A) +12 to +18 mmHg
Intrathoracic Pressure (G,A) +4 to +5 mmHg
Transmural Pressure (G,A) +8 to +13 mmHg
Plasma Volume (Gr) +10%
Secondary Effects:
Circulation
Stroke Volume (A) +35%
Cardiac Output (A) +32%
Total Peripheral Resistance (A) –30%
Peripheral Venous Tone (G) –30%
Arterial Pressure (A) +10 mmHg
Endocrines
Anti-diuretic Hormone (E,G) –50% to –88%
Renin (E) –75%
Aldosterone (E) –70%
Renal
Urine Volume Rate (G) +200%, peak flow +500%
Sodium Excretion Rate (G) +50 to 125%
Potassium Excretion Rate (G) +30%
Volume
Plasma Volume (G) –10 to –15%
Total Body Water (G) –1.5 liters/8 hrs
A   = Arborelius and co-workers [37]
G   = Gauer and co-workers [10,38]
E    = Epstein and co-workers [11,30,39,40]
Gr  = Greenleaf, et al. [41]
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pulmonary vessels occur (Table 9-6, Figs. 9-20, 9-21, 9-
23). Total peripheral resistance and venous tone decreased,
a probable result of autonomic reflexes. These responses
have been observed to reach their full magnitude within
the first 10-15-minutes of immersion. The simulation results
shown in Figs. 9-20 and 9-21 and the experimental data in
Figs. 9-21 and 9-23 support the immediate increase in car-
diac output and mean arterial pressure. Cardiac output di-
minishes somewhat but remains elevated over the
remaining hours of the simulated and actual immersion
test. Central venous pressure, on the other hand, slowly
diminishes toward control levels during the simulation
(Fig. 9-20) but remains at very high levels during the hu-
man study. Furthermore, the increase in magnitude of
venous pressure due to water immersion is several hun-
dred-fold (from 4 mmHg to 15 mmHg) in the human (Fig.
9-23) but rises only 15% in the simulation (Fig. 9-20).
The short-term (10-minute) hemodynamic responses
to the fluid shifts were further investigated. As shown in
Fig. 9-21 a superior simulation was obtained by removing
the short-term autoregulatory function of the model. (This
function is intended to permit arteriolar resistance ele-
ments to respond to short-term fluctuations in local (rather
than central) blood pressures). The only variable in Fig. 9-
21 that yielded a change that was not reproduced in the
simulation was the increase in right atrial pressure. Aside
from this shortcoming, the simulation of this very
short-term response must be considered reasonable, espe-
cially since the circulatory, fluid and electrolyte model
was designed primarily to describe long-term events.
As noted above, there are serious discrepancies in cen-
tral venous pressure between model simulation and ex-
periment, with regard to magnitude and time course of
response. The same increase in central blood volume that
was measured experimentally (about 700 ml) was seen
during the simulation. Yet, the venous pressure rose only
a fraction in the Guyton model compared to the experi-
mentally reported results. In this case, it is our belief that
the experimental blood pressure data is misleading for the
following reason. The normal cardiac function curve, in
which cardiac output is plotted against right atrial pres-
sure (RAP, similar to central venous pressure), indicates
that an increase in RAP by only 2 to 3 mmHg can double
the cardiac output [26b]. Increasing RAP by 10 mmHg, as
reported by Echt, et al. [9] and shown in Fig. 9-23, will
cause cardiac output to reach maximum values – about
200% above control. But it has been shown that cardiac
output only increases by about 20% in water immersion
[32] (see Fig. 9-23). There appears to be a discrepancy
between the measured value of venous pressure and the
much lower value derived from the accepted cardiac func-
tion curve. It is unlikely that venous pressures as large
and long lasting as that shown in Fig. 9-23 could occur.
A reasonable explanation for this conflict was alluded
to in the introductory discussion where a unique aspect of
water immersion was stated to be an increase in intratho-
racic pressure due to the external hydrostatic pressure at
the level of the heart. During immersion to the neck, the
transthoracic pressure gradient in the region of the heart
has been estimated to be 20 cm H2O [32], the same value
that was “coincidentally” measured in the central veins.
Thus, the rise in central pressure may be an artifact of the
measurement; there is an increase in transthoracic pres-
sure (pressure outside the large veins minus pressure in-
side the veins), but not such a large increase in central
venous pressure itself. This condition could be simulated,
by introducing into the model, a transthoracic pressure
gradient in the region of the heart.
9.5.2.3 Renal and Endocrine Responses. Within the
first hour of experimental immersion, there is a significant
rise in the urinary excretion of fluid and salts (the latter
consisting primarily of sodium), which was reproduced by
the simulation (i.e., compare urine and sodium excretion
in Figs. 9-20 and 9-24). The urine formed was consider-
ably dilute, demonstrating free-water rather than an os-
motic diuresis. In most studies, the peak urine flow
occurred within the first hour whereas the natriuresis
reached a maximum somewhat later (see Fig. 9-24). This
finding suggests independent mechanisms mediating re-
nal sodium and water handling.
Numerous mechanisms are available that can poten-
tially contribute to the diuresis and natriuresis of water
Figure 9-23. Experimentally determined hemodynamic changes
during water immersion. Data obtained from (top to bottom) Be-
gin, et al. [32], Echt, et al. [9], and McCalley et al. [42].
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immersion. These have been discussed previously in Chap-
ter 5 (see Figs. 5-15 to 5-17). In a review of the renal ef-
fects of immersion, Epstein [30] suggested that the factors
that were primarily responsible for the diuresis were sup-
pressed ADH, increased prostaglandins (which inhibit the
action of ADH) and decreased sympathetic activity. The
natriuresis was attributed to suppressed renin-
angiotensin-aldosterone, increased prostaglandins, reduced
sympathetic activity and release of a natriuretic factor.
There is also a lesser role played by hemodynamic effects
within the kidney that are observed during expansion of
the blood volume [43]. The mechanisms and role of each
of these factors are clearly described in Chapter 5. The
Guyton model accounts for all these factors except for
prostaglandins and intrarenal hemodynamics.
A comparison of endocrine changes during immer-
sion, between a 6-hour simulation and experimental study
of similar duration, is shown in Figs. 9-20 and 9-25. In all
cases, there is a suppression of renin/angiotensin (one is a
precursor of the other), aldosterone and ADH. This is com-
pletely in accord with the expected mechanisms based on
the analyses of Chapter 5.3.1. While the first two hormones
remain suppressed in both simulation and experiment,
ADH responded somewhat differently in the human sub-
jects compared to the simulation. Although ADH decreased
in both cases, it remained suppressed in experimental stud-
ies but returned toward normal in the simulation. This lat-
ter behavior in the model was attributed to a decreasing
central venous pressure, which effects ADH in an inverse
manner. In addition, ADH is also under the influence of
plasma osmolarity; it is the interplay of these dual con-
trollers, venous pressure and plasma osmolarity, that de-
termines the resulting ADH response. This analysis,
described by Leonard [44,45], suggests the difficulty in
Figure 9-25. Experimentally determined endocrine changes dur-
ing water immersion (expressed as percent change from control)
Data obtained from Epstein and co-workers [11,39].
Time from Immersion, hr
Figure 9-24. Experimentally determined diuresis and natriuresis
of water immersion in normal and dehydrated subjects [46].
- - - -  Dehydration plus immersion
——   Immersion (normal)
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Table 9-7. Contribution of Plasma and Interstitial Volumes to
Body Water Loss During 4-hours Water Immersion*
Compartment  Experiment        Model
Plasma Volume –75 ml (15%) –123 ml (16%)
Interstital Volume
Upper Body Not measured –194 ml (25%)
Lower Limbs Not measured –473 ml (59%)
Total –425 ml (85%) –667 ml (84%)
Total Body Water –500 ml (100%) –790 ml (100%)
*Experimental data from Greenleaf, et al., [47].
predicting the time-course of ADH in weightlessness. It
also suggests the importance of making careful measure-
ments of blood pressure, serum osmolarity, ADH and vol-
ume shifts during water immersion or spaceflight in order
to distinguish between the possible alternate scenarios.
9.5.2.4 Plasma and Interstitial Fluid. The net effect of
the diuresis and natriuresis on body fluid volume was a
reduction in total body water (Table 9-6, Fig. 9-20). Ap-
proximately 20 to 25% of the total fluid loss from the
body was derived from plasma. This proportion was ex-
pected inasmuch as the normal ratio of plasma/interstitial
fluid is about 1:4. The increase in plasma volume at the
onset of immersion, mentioned earlier, was therefore fol-
lowed by a gradual decline below control as volume regu-
lator mechanisms reversed the engorgement of the
intrathoracic compartment. These observations from ex-
perimental studies were faithfully reproduced by the model
simulations.
Plasma volume reduction following water immersion
may be a result of two independent effects: a diuresis of
primarily extracellular fluid and a movement of fluid from
the intravascular compartment into the interstitium of the
upper body due to normal transcapillary filtration (see
Fig. 5-17). The latter of these effects has been difficult to
quantify because it is not possible to experimentally dis-
tinguish between decreased interstitial volume loss in the
lower limbs and any increased interstitial volume in the
upper body. However, it is possible to accomplish this feat
using computer simulation. This topic has been covered
in a detailed manner in Chapter 5 (see Chapter 5.4.2.2,
Figs. 5-17, 5-22 to 5-24). Additional analyses of these
phenomena were performed in connection with the water
immersion study and are presented below.
If one considers the first 4-hours of immersion, a pe-
riod during which plasma volume may not be significantly
changing [47], it is possible to compute the decline in
body water and the contribution to this loss from the plasma
and interstitial compartments. The results from the com-
puter model and from one immersion experiment are shown
in Table 9-7.
Although the absolute values of fluid losses derived
experimentally are not identical to those predicted by the
model, the percentage contributions of plasma and total
interstitial volumes to total body water losses are quite
similar to the observed values. In addition, the experi-
mental data and the simulation responses indicate that
substantial amounts of water are removed from the inter-
stitial fluid before plasma volume is largely affected. Fur-
thermore, while the model predicts that most of the
interstitial fluid loss originates from the lower limbs as
expected, a significant fraction of fluid (25% of the total
body water loss) is derived from the upper body intersti-
tial fluid. This appears paradoxical in the sense that it is
normally believed that plasma is filtered into these tissues
and there is a net gain of tissue fluid (in the upper body) at
the expense of plasma volume. However, while the model
indicates that outward filtration into tissues does occur
(see “upper body interstitial fluid” Fig. 9-20), it is limited
in time (about 3-hours) and in magnitude (about 300 ml).
The process quickly reverses because of increased plasma
colloidal concentration as plasma is filtered through the
renal tubules and the upper body capillaries. The model
further predicts that if immersion were to continue be-
yond 4-hours, the upper body interstitial fluid compart-
ment would exhibit a net depletion of nearly the same
volume lost from the leg tissues (about 500 ml), but would
return to normal within 48-hours. Lymph flow return plays
a part in this normalization as well. (See simulation in Fig.
5-23, bottom curve, which represents the upper body in-
terstitial fluid.) For this reason, the role of transcapillary
filtration in plasma volume regulation is effective in the
short-term but not for long-term control.
This self-limiting feature of transcapillary filtration
effectiveness may be blunted if proteins are not perfectly
filtered by the capillary membrane and can leak to some
extent as a result of pressure distention effects on the mem-
brane pores. This effective increase in protein permeabil-
ity would permit greater quantities of plasma filtrate to
enter the tissue spaces.
This possibility was examined by computer simula-
tion with the results illustrated in Fig. 9-26. Two cases
were examined: a) a normal water immersion simulation
identical to that shown in Fig. 9-20 and b) an immersion
simulation in which protein permeability of the capillary
membrane was increased by a factor of ten. Qualitatively,
the two primary effects of increasing protein permeability
are a reduced plasma colloidal concentration and a nor-
malized (rather than a decreased) upper body interstitial
fluid volume throughout the period of study. This study
also demonstrated that plasma volume reduction was nearly
double for the case of increased protein permeability.
Taken as a whole, the assumption of increased protein
permeability resulted in a more realistic simulation of the
immersion experiments of Greenleaf and co-workers
[41,47]. In particular, a reduction in plasma protein con-
centration, predicted by the analysis, was reported by
Greenleaf et al., [47] in their water immersion study. Of
even more relevance, a recent spaceflight study has also
suggested that there was an increase in the rate of
transcapillary protein transport [UPDATE#2]. A similar analy-
sis was conducted during head-down tilt simulation (see
Fig. 9-40). Further details can be found in Ref. [44].
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9.5.3 Effect of Dehydration
The preceding characterization of the immersion re-
sponse was based on well-hydrated and otherwise normal
subjects. However, the state of dehydration of the subject,
during immersion, is an important determinant of the re-
nal response, of fluid distribution and of the ultimate loss
of body water [10]. The effect of dehydration during water
immersion was studied experimentally and by computer
simulation. The purpose of these studies was to ascertain
if the lack of an observed acute diuresis on the Skylab
mission could be ascribed to the generally agreed on no-
tion that the crewmembers were dehydrated before the
mission and dramatically so, in some cases, during the
first week of spaceflight. Some of the results of these analy-
ses are shown in Fig. 9-27 and Table 9-8.
For the simulation analyses, intake of fluid was as-
sumed to be either normal or zero during the 24-hours
preceding immersion and the 24-hours during immersion.
During the first 6-hours of simulated immersion, the urine
volume response for the cases of normal and reduced in-
take was predicted to be similar. However, increasingly
significant differences between these two cases were ob-
served for each succeeding 6-hour period. As a result, the
cumulative losses of body water (taken as the balance be-
tween renal excretion and drinking) were nearly twice as
great for the dehydrated case as for the normally hydrated
case at the end of 24-hours (Fig. 9-27).
These simulation studies generally confirmed the ex-
perimental results established by Gauer and co-workers
[10,33] with regard to renal excretion and plasma regula-
tion when challenged by immersion and dehydration (see
Table 9-8 and Fig. 9-24). Specific differences in immer-
sion responses to a normal and a dehydrated state were: a)
the absolute increase in water and sodium excretion was
smaller (compared to normal immersion controls) whereas
the percent urine increase was larger (compared to
preimmersion controls); b) immersion was characterized
by a larger decrease in free water clearance in the dehy-
drated subjects than in the hydrated subjects; c) the de-
crease in plasma volume was more severe in dehydrated
subjects; and d) the contribution of plasma volume reduc-
tion to excess urine volume excreted during immersion
was greater for the dehydrated subjects than for the hy-
drated subjects.
The effect of salt intake was also studied. It was found
that urine flow decreases with reduced sodium intake both
prior to immersion and during immersion. This was true
for any given level of water intake, both above and below
normal. In all cases studied, the urine flow during immer-
Figure 9-27. Effect of dehydration (via suppressed intake) on
simulated immersion response.
Figure 9-26. Simulation of water immersion: Effect of increasing
capillary permeability on transcapillary fluid exchange. Normal
simulation (—); Capillary protein permability increased 10 times
normal (- - -).
Plasma Volume
(liters)
Interstitial Fluid
Volume,
Upper Body
(liters)
Plasma Colloidal
Osmotic
Pressure (mmHg)
Total Body Water
(liters)
Normal Simulation - - - - - - Capillary Protein Permeability
Increased 10x normal
Time, hours
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sion increased in relation to its pre-immersion diet con-
trol; i.e., there was a relative diuresis.
Despite the general agreement between simulations
and experiments, it was not possible to replicate the mag-
nitude of the fall in urine excretion during dehydration
that was seen in the human subject (see Fig. 9-24). In that
case, it can be seen that dehydration caused the absolute
quantity of urine flow to be blunted, the peak diuresis to
be delayed and the peak of the naturesis to be reached
after the peak diuresis, although the natriuresis response
itself is unaffected. These simulations did not consider
the effects of evaporative water loss, which are reduced to
a minimum during immersion, or the difference in the de-
gree of headward fluid shift between the hydrated and de-
hydrated cases. It can be argued that the magnitude of the
fluid shift from the legs in response to immersion would
be less in previously dehydrated subjects compared to well-
hydrated subjects. We would expect the divergence in the
theoretical response between hydrated and dehydrated
cases to be even more marked if these factors were consid-
ered in the simulation, placing the results in closer agree-
ment with experimental data.
9.5.4 Summary: Water Immersion
Agreement between observed and simulated responses
was quite reasonable. The basic characteristics of water
immersion were replicated in the model’s response, i.e.,
the translocation of fluid from the legs into the central
blood volume and the resulting diuresis and reduction in
plasma volume. The realistic behavior of the responses
attested to the basic validity of the model and the manner
in which the controlling mechanisms were represented.
However, the simulation studies of the effects of dehydra-
tion on immersion revealed several limitations in model
behavior that must await future modifications: a) the ex-
perimental results suggest a much greater decrement in
immersion diuresis volume as a result of dehydration than
is indicated by the model and b) experimental results show
a greater dissociation between the immersion diuresis and
natriuresis response than could be simulated. The analy-
sis also demonstrated several areas of discrepancy that
deserve more research, including: a) the question of
whether the 6-hour ADH immersion response is solely un-
der the influence of volume receptor control [47,48], or, as
the model indicates, the osmoreceptors as well; b) the role of
transcapillary filtration during immersion was shown to be
effective in acute studies but not for the longer-term, con-
trary to the conclusions of some investigators [33]; c) whether
transcapillary protein leaks play an important role in re-
ducing plasma volume following immersion as shown by
the model simulation; and d) whether central venous pres-
sure measurements during water immersion are as high
and sustained as reported in seeming opposition to the
traditional operating range for cardiac function.
As a result of the analysis, one can predict that a di-
uresis should be observable during the first several hours
of spaceflight and the probability of demonstrating this
response decreases as subjects become dehydrated, as their
fluid intake diminishes and/or if urine voids are pooled
during the first 24-hours [UPDATE#3]. The nature of the water
immersion technique may tend to overestimate the pre-
dicted zero-g diuresis because of reduced evaporative water
Table 9-8. Effect of Dehydration on Pre-Immersion and Immersion Response
Experiment* Simulation**
Pre-   Immersion Pre-   Immersion
Urine Volume, V                    
∆ % V from pre-immersion                
Urine Sodium, UNaV                    ?
∆ % UNaV from pre-immersion                
Osmolar Clearance, Cosm          ?          
Free Water Clearance, CH2O                  
∆ Plasma Volume, ∆ PVimmersion               
(∆ PV/V)immersion               
KEY:
 Increase compared to hydrated controls * Behn, Gauer, Kirsh and Eckert [33]
 Large increase compared to hydrated controls
 Decrease compared to hydrated controls ** Guyton’s model of Circulatory, Fluid, and Electrolyte Regulation
 Large decrease compared to hydrated controls
? No change
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loss and increased transthoracic pressure gradient. These
factors are present in immersion but do not occur in true
weightlessness.
9.6 Postural Simulations
The capability of the Guyton model to account for gravity’s
influence on the fluid columns of the body is described in
Chapter 9.3 and Appendix C.2. Much more is known about
standing, or orthostasis, than about hypogravity, even
though they may be considered inverse physiological
stresses. So it is natural to validate a model capable of
postural changes by first performing simulations of stand-
ing or head-up tilt than for hypogravic situations. A study of
head-down tilt, which is a natural adjunct to examining head-
up tilt, is reported in the following section.
Earlier in this book the capability of the short-term
cardiovascular model (Croston) to perform tilt was dem-
onstrated. Why do we need this capability in the long-
term circulatory model (Guyton)? The Croston model is
certainly adequate for our purposes of simulating a short-
term (10-minute) postural tilt. But it does not contain many
of the elements outside of the circulation that ultimately
control blood volume, pressure and flows over the longer
term as does the Guyton model. We believe that the up-
right position, like bedrest, does not achieve steady-state
within 10–30-minutes; the stationary, erect body contin-
ues to adjust probably for hours or days, even though these
types of measurements are not made for ethical reasons.
The Guyton model’s comprehensive inherent capabilities
might allow us to determine the factors necessary to simu-
late long-term orthostasis. The advantage of creating a valid
orthostatic model was alluded to earlier, i.e., such a model
could more realistically simulate hypogravity by simply
changing the angle of tilt from erect to supine (or slightly
head-down). This would provide a much more natural simu-
lation. The following postural studies with the Guyton
model are preliminary attempts in this direction.
9.6.1 Physiology of Orthostasis
Upon shifting from a supine to an erect position, ex-
perimental data reveal physiological changes in the cir-
culatory pressures, flows and blood volume distribution.
About 10% of the blood volume is shifted from the upper
part of the body (mainly from the thoracic cavity) to the
legs, where it is pooled, primarily in the distensible venous
segments [27]. Due to hydrostatic pressure on the blood
column, the arterial, capillary and venous pressures be-
come markedly elevated in the lower extremities, causing
a net capillary filtration into the tissues. This filtration
can result in a loss of 5 to 10% of the supine blood volume
[13]. In response to the decrease in central blood volume,
compensatory pressure regulating mechanisms come into
play, preventing a fall in the effective central venous pres-
sure below that of the heart, insufficient cardiac pumping
and orthostatic hypotension.
The defenses of the body against orthostatic hypoten-
sion consist of both passive and active elements [13,49,50].
Ultrafiltration into the tissues is minimized by increasing
tissue fluid pressure and increasing lymphatic flow, reducing
the hydrostatic columns in veins by “pumping” blood past
leg venous valves and transiently venoconstricting the ex-
tremity venules. Systemic arterial pressure is maintained
and even elevated, because of activation of intrathoracic
and carotid baroreceptors. The reduction in effective blood
volume, caused by a shift of blood from the upper to the
lower part of the body, is associated with a sustained in-
crease in sympathetic activity to the resistance vessels in
muscles and visceral organs and to the heart. Thus, car-
diac output and arterial blood pressure are maintained,
despite reduced cardiac filling pressure.
The increase in leg vascular resistance also helps mini-
mize venous pooling. Central venous pressure must be
maintained to promote adequate right ventricular filling.
Although the exact mechanisms controlling this adjust-
ment have not yet been agreed upon, certain factors are
important in preventing a debilitating fall in central
venous blood volume and pressure. These factors include
contraction of large venous channels and venous reser-
voirs, such as those that exist in the visceral organs; exter-
nal compression of veins by skeletal muscles in the legs;
and an external pressure on the large abdominal veins ex-
erted by both the increased hydrostatic column of abdomi-
nal organs and an increase in abdominal muscular
contraction, i.e., abdominal reflex [49,52,53,54,55]. De-
spite the influence of the orthostatic defense mechanisms,
the net result of the effects induced by standing is a reduc-
tion in central blood volume by leg fluid pooling, a de-
crease in cardiac output due to reduced stroke volume
despite an increase in heart rate and an increase in periph-
eral resistance which acts to elevate the mean systemic
blood pressure [56]. In many individuals the peripheral
resistance does not increase sufficiently and blood pres-
sure is not maintained; the ultimate consequence is syn-
cope or fainting. The modeling of syncope was not an
objective of the current study.
In order to validate the new features of the modified
Guyton model, simulations were performed of both pas-
sive tilt experiments and LBNP experiments. These vali-
dations offered a relatively simple means of determining
that the new gravity-dependent components functioned
appropriately and that the controllers in the model were
sufficient to face an orthostatic challenge.
9.6.2 Simulation of Tilt and Recovery
Having modified the Guyton model as described above,
the main question to be addressed was “are the simple changes
made to the model sufficient to simulate a head-up tilt-from-
supine response”? The orthostatic maneuver causes a wide-
spread body response that includes: a) baroreceptors; b)
autonomic function; c) pressures, flows and volumes of the
upper and lower circulatory compartments; d) pre- and post-
capillary resistances in muscle and non-muscle tissues in the
upper and lower circulatory compartments; e) venous tone in
both upper and lower body segments; f) renal blood flow and
renal function; g) capillary filtration and lymph flow in both
upper and lower compartments; h) secretion of blood pres-
sure and renal regulating hormones; and i) metabolic rate.
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These are the responses we wish to replicate. Inasmuch as
the major changes of the modified model were associated
with the controlled system (i.e., adding new circulatory
compartments), it was important to assure that the control-
lers in the model (autonomic, local and hormonal) were
sufficient to regulate orthostasis. The goal was to produce
a response that was more qualitatively than quantitatively
correct by identifying gross mechanisms that are required
not only for short-term and long-term tilt, but for bedrest
and weightlessness, these latter situations being the ulti-
mate objective.
The simulation of tilt was initiated by changing the
angle of tilt of the gravity vector. The response of the
modified Guyton model to a 90° head-upward tilt is shown
in Fig. 9-28. The hydrostatic forces produced by the tilt
resulted in fluid pooling almost instantaneously in the
leg blood vessels and more gradually in the leg tissues.
The leg fluid pooling reduced the central blood volume
and thereby lowered cardiac output and arterial blood pres-
sure. Blood flows through the legs, upper body and renal
pathways were also reduced.
Although the model’s responses were generally in the
appropriate direction, neither the magnitude nor the dy-
namic behavior of the responses was consistent with ob-
servations of the real system. Pressures and flows would
have been reduced even further if compensatory feedback
mechanisms, decreasing venous capacitance and increas-
ing peripheral resistance had not been present in the
model. However, these feedback mechanisms were not as
effective in the model as in the real system. The reduction
in arterial pressure and cardiac output, as seen in the simu-
lation, was greater than typically observed in man.
Another shortcoming of the model was related to the
blood volume response. Although blood pooling in the
legs and fluid shifting into the leg interstitium were ap-
propriate with regard to direction and dynamic behavior,
the blood volume only decreased transiently, by about 50
ml, instead of showing a net sustained loss of several hun-
dred ml. On further examination, it was found that fluid
was being absorbed from the capillaries in the upper body
nearly as rapidly as it was filtering from the leg capillar-
ies. Obviously, further modifications of the model’s struc-
ture were required.
9.6.2.1 Additional Modifications. It became apparent
that any single mechanism added to the model to allow
blood volume to fall would make the blood pressure and
cardiac output responses worse. Therefore, a combination
of mechanisms was necessary that would inhibit inward
fluid absorption in the upper body capillaries and increase
venous return and, therefore, the blood flow and arterial
pressures. The following modifications were added to the
model with the objective of improving the tilt simulation.
a) Enhanced Venoconstriction. The sensitivity (gain)
of the venous resistance element to efferent barorecep-
tor signals was increased. This change increased the
postcapillary resistance in the upper body capillaries
(the major blood flow pathway) in the face of a de-
creased baroreceptor pressure and thereby permitted an
increase in capillary filtration pressure and limited the
inward filtration that would have otherwise occurred.
b) Enhanced Reverse Stress Relaxation. The origi-
nal Guyton model contained a stress relaxation element
that causes gradual reduction of venous capacitance in
the face of a reduced blood volume. A term was added
to produce an instantaneous effect that reduces upper
body venous capacitance to approximately half the re-
Figure 9-28. Simulation of a 90o head-up tilt from supine using
the basic gravity-dependent model without further modification.
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Figure 9-29(a). Simulated 90° tilt response: Effect of instanta-
neous reverse stress relaxation.  Solid lines represents basic model
simulaton (Fig. 9-28); dashed lines represents model with modifi-
cation (see text for meaning of “+” or “–”).
duction in central blood volume. This effect, which had
been recommended by Guyton in a recent unpublished
version of his model, was simulated by reducing the
unstressed venous volume at the moment of tilt. Its ef-
fect is to increase venous return, cardiac output and
systemic blood pressures.
c) Reduced Area Available for Capillary Filtration.
The filtration coefficient for the upper body capillaries
was reduced in value at the time of tilt. The direct effect
was to limit the rate at which interstitial fluid enters the
circulation and thereby produce a reduced blood vol-
ume.
d) Muscle Contraction Effect in Legs. A parameter was
added which would provide a pressure, external to the
leg blood vessels, simulating the muscle contraction
effect that occurs during tilting and, to a much greater
extent, during standing. The effect is to reduce leg
venous pressure, reduce the amount of fluid pooled in
the legs and increase venous return.
These modifications appear reasonable and are sup-
ported by tilt-table experiments to be discussed later. The
first three modifications are in accord with the general-
ized splanchnic venoconstriction that has been observed
following reduction in central blood volume as a result of
either hemorrhage or tilting [53,54]. The first two modifi-
cations could also be a result of abdominal compression,
autonomic control, or local metabolic effect. The evidence
for a decrease in capillary coefficient (item 3) has been
inferred from studies of hemorrhage, infusions and stand-
ing [57,58]. The last modification (4) could represent a
proprioceptive tilt reflex which was simulated as a small
increase in external pressure (~10 mmHg).
9.6.2.2 Model Responses After Modification. The four
modifications mentioned above were applied individu-
ally and in combination to the simulation of tilt. The re-
sults are shown in Figs. 9-29(a) to 9-29(e) (dashed curves).
The first two mechanisms listed above resulted in the great-
est improvements and Fig. 9-30 shows the tilt response as
well as recovery from tilt during a simulation in which
these effects have been added. The solid curves in Fig. 9-
29 represents the simulated response to tilt of the gravity-
dependent model without the modifications (as shown in
Fig. 9-28). The symbols at the right margin of Fig. 9-29
(“+” or “–“) indicate responses that have been improved
or made worse, respectively, due to the additional mecha-
nisms. (A plus sign signifies that the modified simulated
response is closer to the expected response). The transient
“spike” effect at the start of each tilt simulation is an arti-
fact that would not be present if the tilt had not been per-
formed instantaneously. Each of the four modifications
resulted in an overall improvement of the model’s response
to tilt that was reflected in almost all of the variables moni-
tored during this series of simulations.
The Guyton model’s responses have provided a com-
prehensive view of orthostasis. The response of a wide
range of model variables obtained during a simulation
incorporating all four modifications is illustrated in Figs.
9-31(a) to 9-31(d). Qualitatively, the model variables agree
with experimental data. The following is a discussion of
the relevant physiology, explaining the responses shown
in these figures and including the results of experiments.
Although it is desirable to validate the model for much
longer periods of time than the 30-minutes of this simula-
tion, there have been no reported data with which to com-
pare an extended time period.
9.6.2.2.1 Fluid Volume Shifts. The vertical orientation
creates a long hydrostatic column of blood that greatly
increases the arterial and venous pressures in the legs (Fig.
9-31(a)). Both of these pressures are increased to the same
extent; therefore there is no change in the driving force to
flow. However, these high pressures do cause distention of
the leg vessels; about 400 to 600 ml of blood rapidly pool
in the leg vessels, primarily in the veins [27,51]. A slight
muscle contraction effect will reduce by 15% the amount
of fluid that otherwise would pool in the leg [49]. The
accompanying increase in leg capillary pressures creates
a driving force for filtration. At the end of 30-minutes,
approximately 500 ml of plasma will have left the circula-
tion and entered the leg interstitial compartment [36]. Con-
comitantly about 100 to 200 ml of fluid will have entered
the circulation through absorption from the upper body
capillaries. (This quantity has never been measured ex-
perimentally). This results in a net reduction in total blood
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Figure 9-29(c). Simulated 90° tilt response: Effect of muscle pump.
See caption for Fig. 9-29(a).
Figure 9-29(d). Simulated 90° tilt response: Effect of reduced capil-
lary filtration coefficient. See caption for Fig. 9-29(a).
Figure 9-29(b). Simulated 90° tilt response: Effect of enhanced
splanchnic venoconstriction. See caption for Fig. 9-29(a).
Figure 9-29(e). Simulated 90° tilt response: Effect of combina-
tion of four orthostatic mechanisms. See caption for Fig. 9-29(a).
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Figure 9-31(a). Simulated 90° tilt response with added orthos-
tatic mechanisms: Fluid shifts and leg blood pressures. Values on
right side of graph are changes in value from control at end of 30-
minutes.
Figure 9-30. Simulated 90° tilt response and recovery with en-
hanced reverse stress relaxation and splanchnic venoconstriction.
volume of about 300 ml [52,59]. Since this represents a
change in plasma only, the hematocrit increases accord-
ingly [60]. The net deficit of fluid in the upper body (ef-
fective central blood volume) is approximately 700 ml:
400 ml due to limb pooling and 300 ml due to net ex-
travascular filtration [36,61].
9.6.2.2.2 Major Circulatory and Cardiac Changes.
At the end of the 30-minutes of simulated tilting, the mean
arterial pressures have returned to near normal, whereas
central venous pressure has remained relatively depressed
(Fig. 9-31(b)). The magnitudes of these changes, includ-
ing the initial reduction in pressures, are appropriate. The
time course, however, is in error, because these events are
known to occur more rapidly. Cardiac output is decreased
by approximately 15%, primarily because of a reduction
in stroke volume and despite an increase in heart rate
[50,62]. The reduction in stroke volume is a result of a
decreased venous return created by the large reduction in
central blood volume. The heart rate changes reflect in-
creased autonomic stimulation. Total peripheral resistance
increases sharply at first [63] as a result of intense
autonomic-baroreceptor activity [64] that later is augmented
by angiotensin release and attenuated by autoregulatory ef-
fects (see Fig. 9-31(d)). Blood flow to each of the three
major tissue segments in the model (renal flow, leg muscle
flow and non-muscle, non-renal flow) decreases because
of the general decrease in cardiac output as well as vaso-
constriction [50,65,66]. The renal and leg blood flows
appear to stabilize at lower levels, but the splanchnic flow
tends to return toward normal.
9.6.2.2.3 Capillary Filtration. The filtration of nearly
500 ml of plasma into the leg interstitium, is basically
complete within 20 to 30-minutes [63] (see Fig. 9-31(a)).
The driving force for this event is an increase in leg capil-
lary pressure of nearly 60 mmHg, equivalent to the hydro-
static column from the heart to the midpoint of the legs.
This vascular pressure is opposed by the leg tissue pres-
sure which increases gradually as fluid enters the intersti-
tial spaces [58].
While leg filtration is occurring, the capillaries in the
upper body are undergoing a more complex process (Fig.
9-31(c)). At the beginning of the tilt response, the fall in
capillary pressure and the rise in colloidal oncotic pres-
sure favor the absorption of fluid from the extravascular
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space into the bloodstream. While colloidal pressures con-
tinue to rise, the pre/post capillary resistance ratio de-
creases because of a rise in venule resistance [61] thus
favoring a rise in capillary pressure as well. Capillary pres-
sure rises until the transcapillary forces slows absorption
and even reverses it at about 15-minutes following tilt. It
is quite remarkable that there may be net transcapillary
filtration at a time when arterial and venous pressures are
below normal. However, this same behavior, a result of
adjustments in the pre/post capillary resistance ratio, has
been reported in studies of moderate hemorrhage, another
hypovolemic stress [58]. This effect has also been sug-
gested during LBNP studies [67] and not unexpectedly,
opposite changes have been suggested during plasma in-
fusions [68]. However, no documentation exists to con-
firm whether the same phenomena seen in these simulations
Figure 9-31(b). Simulated 90° tilt response with added orthostatic
mechanisms: Major circulatory parameters. Values on right side of
graph are changes in value from control at end of 30-minutes.
Figure 9-31(d). Simulated 90° tilt response with added orthostatic
mechanisms: Autonomic and hormonal responses. Values on right
side of graph are changes in value from control at end of 30-minutes.
Figure 9-31(c). Simulated 90° tilt response with added orthostatic
mechanisms: Upper body capillary filtration parameters.
 Total peripheral resistance, mmHg-min/liter
Effect on
blood vessels
Effect
on heart
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occurs during human tilt. Thus, the fall in blood volume
due to extravasation of fluid from the legs is partly com-
pensated, hypothetically, by a self-limiting intravasation
of fluid from the tissues of the upper body.
9.6.2.2.4 Neural and Humoral Orthostatic Protec-
tive Mechanisms. Several of the major neural and hu-
moral reflex pathways that are activated during the tilt
simulation are shown in Fig. 9-31(d). The autonomic in-
fluences include those that produce vasoconstriction, car-
dioacceleration and contractility and reduction in venous
capacitance [49]. The dual effects of venoconstriction and
reduced venous capacitance was noted to be among the
most potent defense mechanisms for orthostasis. The hu-
moral mechanisms are seen to be slower acting and in-
clude angiotensin release,  which produces
vasoconstriction [69], aldosterone release, which inhibits
sodium and water excretion [70] and ADH release, which
decreases urinary output and preserves body fluid vol-
umes [14]. All of these mechanisms are mediated in the
model by reflex pathways originating at pressoreceptors
in the cardiopulmonary, arterial, or renal areas. The realis-
tic time course of these reflexes should be noted; auto-
nomic reflexes are fully operative within a few minutes
whereas hormonal responses are slower acting.
9.6.3 Summary: Head-Up Tilt
Validation was accomplished for simulations of 30-
minutes head-up tilt. The general agreement between the
experimental observations and the model simulations of
the many physiological parameters in response to passive
tilt attests to the basic soundness of the original Guyton
formulation and the new modifications.
An additional set of simulations was undertaken for lower
body negative pressure (LBNP) using the modified Guyton
model [16]. LBNP was shown, in Chapters 3 and 7, to be an
orthostatic-like stress capable of being simulated by a model
with a representation of the circulation more detailed than
the Guyton model. However, the results with the Guyton
model, while not reported here, demonstrated a new capabil-
ity to simulate fluid shifts along the long body axis [16].
Although other computer models have been capable
of simulating a tilt response with greater fidelity with re-
gard to circulatory flows and pressures (especially during
the first 10-minutes following tilt), they did not include
the wide range of physiological subsystems found in the
Guyton model [71,72,73] Thus, the responses shown here
are representative of the circulatory, fluid, renal, autonomic
and endocrine responses to tilt that have been described
by many investigators, each observing only a portion of
these physiological reactions.
Longer-term standing using the Guyton model could
not be validated at this time because of the absence of
experimental data. The model was able to simulate short-term
90° head-up tilt (standing), but it did not achieve a
steady-state in this position. The Guyton model was designed
from data gathered in the supine, resting position and it
would be difficult to redesign the model based on ambula-
tory initial conditions. Even defining ambulatory initial
conditions would not be easy, because these conditions
would depend on the history of average activity (stand-
ing, walking, or sitting) of the subjects from which the
data were gathered. Sufficient data of this type is not avail-
able. Furthermore, standing is a complex stress and all the
mechanisms that participate in creating orthostatic toler-
ance are not yet quantitatively understood [49,50].
9.7 Head-Down Tilt and Head-Down
Bedrest Simulations
9.7.1 Introduction
Exposure of human subjects to a moderate degree of
head-down tilt (anti-orthostasis or negative tilt) for sev-
eral hours to more than a week, has been used as a ground-
based analog of weightless spaceflight [74,75,76].‡
Head-down tilt has been shown to mimic the major fluid,
renal and cardiovascular characteristics of the weightless-
ness response in a more reliable and reproducible fashion
than supine bedrest [77]. An anti-orthostatic animal model
has also been used with some success to study cardiovas-
cular deconditioning and musculoskeletal atrophy simi-
lar to that which occurs in spaceflight [78,79,80]. The
objective of the present analysis is to: a) demonstrate the
capabilities of the Guyton model to simulate postural
changes and particularly, the short-term and long-term re-
sponses of head-down tilt,§ and b) help interpret the still
poorly understood experimental head-down tilt findings.
These studies are described more fully in the original re-
ports [81,82].
Although it may appear logical to believe that head-
down tilt leads merely to opposite responses to that of a
head-up tilt, this is not necessarily so. In the upright posi-
tion the physiological defense mechanisms must counter
the tendency for loss of brain blood flow, while in the
head-down position the physiological problem is that of
reducing fluid pooling in the fragile thoracic regions which
could lead to pulmonary congestion. The body appears
better adapted for immediate protection against gravity in
the orthostatic position compared to the anti-orthostatic
position, the latter case seeming to require longer-term
adjustments. It also needs to be noted that in the context
of our discussion, orthostasis implies a completely erect
upright individual (+90°) while anti-orthostasis represents
a much smaller angle to the horizontal (–4 to –6°); the hy-
drostatic forces are, therefore, not as great in the head-
down position as in the upright position.
‡ Head-down tilt was a relatively new technique at the time this analysis
was completed in 1982 and these citations were the extent of the avail-
able experimental reports. The more numerous studies conducted since
then will not be included in this book, except as a brief update.
§
 
The angle of tilt (with the horizontal) for human anti-orthostatic studies
has varied from -4 to -12°. Eventually, the science community seems to
have settled on a 6° angle of tilt as a standard to simulate microgravity.
The present analysis was conducted prior to the establishment of this
standard and so considers other angles of tilt as well.
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9.7.2 Changes in Leg Fluid and Tissue
We have found that one of the keys to achieving a
realistic simulation of supine bedrest or head-down tilt, is
a better understanding of events which occur in the legs
during alterations of hydrostatic gradients. As was shown
in Chapter 9.3 the initial response to a hypogravic stress
is an acute movement of blood out of the legs and this is
followed by a more chronic condition of gradual leg de-
hydration. These changes were described graphically in
Fig. 9-10. It was shown there that the reduction in leg
volume accompanying supine bedrest is much less than
that of spaceflight; therefore, most of the fluid regulatory
parameters (that respond to headward fluid shifts) change
to a lesser degree during supine bedrest than spaceflight.
It also was shown in Fig. 9-10 that anti-orthostatic bedrest
is associated with leg volume decrements between those
of spaceflight and supine bedrest.
It is worth considering that the body fluid losses dur-
ing spaceflight are primarily derived from leg fluid and
tissue losses. This notion is supported by data from Skylab.
Those studies reveal a loss of approximately 1.8 liters in
leg volume at the end of several days inflight and this was
associated with a total body water loss of nearly 1.5 liters
(see Chapter 5.4.2.1). The more gradual loss in leg volume
during periods beyond a week or so can be ascribed to
further leg dehydration as a results of: a) elastic forces,
influenced by devascularization and tissue and vessel
retoning, which squeeze additional fluid headward and b)
loss of solid tissue, mostly muscle, due to disuse atrophy.
Altering a human’s posture from supine to -4° head-
down tilt allows fluids to shift from the feet to the head. It
is easy to understand how blood can flow “downhill” from
the leg veins to the veins of the upper body – similar to a
horizontal cylinder partially filled with fluid being tipped
a few degrees. It is not so easy to visualize how leg blood
flow would be affected. As the leg veins lose fluid and pres-
sure, the pressure outside the veins is now unopposed and
the vessels collapse or partially collapse; when this happens
the resistance to flow should increase. It is also not obvious
how leg interstitial fluid drains out of the legs. There is a
good deal more leg tissue fluid than there is blood stored in
the leg vasculature, as we can infer from comparing leg
volume changes measured during short-term lower body
negative pressure tests (which affect primarily the blood
compartment) with that after long-term head-down bedrest
and spaceflight (which affect total leg fluid). Aside from a
small contribution of lymph flow, the major portion of leg
tissue fluid leaves the legs by crossing the capillary mem-
brane of the leg vasculature and then draining into the upper
body. What alterations occur during head-down tilt in the
Starling forces that control transcapillary fluid movement?
How would these forces be different between the leg capil-
lary beds and those in the upper body during postural ma-
neuvers? To further complicate the picture, long term
changes are likely to occur in both the leg veins and leg
tissue compartment such as reverse stress relaxation and
retoning as well as loss of tissue due to muscle atrophy; these
should effect dehydration in the legs as was discussed in
Chapter 9.3.3. The Guyton model was not designed with
legs and certainly did not account for postural maneuvers,
either short-term or long-term . Therefore, the challenge in
this analysis was to account for these processes that are sel-
dom addressed and not well understood, by the use of the
mathematical model of the circulation.
9.7.3 Modifications to the Circulatory Model
The direct effect of gravity forces was introduced in
three locations in the model: at the inflow to the leg arte-
rial compartment, at the outflow of the leg venous com-
partments and at the carotid baroreceptors. Hydrostatic
forces were computed for any angle of tilt as a function of
the vertical distance to the midpoint of the legs or to the neck
baroreceptors as measured from the heart (see Appendix
C.1). These hydrostatic pressures are algebraically added
to the usual dynamic fluid pressures of the circulation.
With the model so modified it was possible to exam-
ine by simulation techniques the two postural maneuvers
described above which have been most useful for study-
ing fluid responses to gravitational disturbances: head-up
tilt (orthostasis) and head-down tilt (anti-orthostasis). By
simply specifying any angle of tilt, either head-up, su-
pine, or head-down, it is possible to create a large range of
hydrostatic forces in the model, from maximal (at the feet)
in the erect position, to zero in the supine position, to
negative in the head-down position. Simulations of head-
up tilt were examined in Chapter 9.6; in this section we
will focus on head-down tilt.
The initial simulations that were performed of head-
down tilt (by simply changing the angle of the gravity vec-
tor) resulted in leg blood flows and in leg tissue drainage that
were not plausible and produced instabilities in the simu-
lated responses, especially at extreme degrees of negative
tilt. It was discovered that a more realistic simulation of head-
down tilt would be achieved by modeling collapsible leg
veins and accounting for dehydration of extravascular leg
tissue. This effort is an extension of the analysis of factors
affecting long term leg dehydration that were described in
relationship to supine bedrest (Chapter 9.3).
9.7.3.1 Modeling Collapsible Veins. The most conve-
nient representation of the elastic properties of arteries
and veins is the pressure-volume relationship as illustrated
in Fig. 9-32. The volume to the right and left of Vo is
“stressed” and “unstressed” volume, respectively. The un-
stressed volume, or zone of distensibility, is the region in
which the vein is in a state of collapse. Notice the non-
linear characteristic shape of the pressure-volume curve.
It is convenient in mathematical models to “linearize” this
relationship in the “stressed” region as indicated by the
dashed line A. This “constant compliance” representation
is used in the Guyton model. However, in the original for-
mulation of the Guyton model, the collapsible range was
represented by a horizontal line at zero transmural pres-
sure. This simplification is sufficient for many applica-
tions of the model. However, this is not an adequate
description of collapsible segments and does not permit
the model to achieve a full range of unstressed volumes
necessary for simulating head-down tilt.
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Figure 9-32. Pressure-volume relationships of the veins.. The
solid line shows an idealized non-linear “compliance” curve. The
dashed lines are linear representations as used in the Guyton model.
The unstressed volume, Vo , is the X-intercept of the pressure-
volume curve. The region to the right of Vo is the elastic range;
vessel compliance is the inverse of the slope. The region to the left
of Vo is the area of vessel collapse. The collapsible region can be
modeled by using one or more straight lines. The line denoted by
“A” shows the normal linear compliance. The normal operating point
is shown as “1”. If the vessel empties, retoning can take place whereby
the compliance line shifts to the left (i.e., “B”) and pressure is par-
tially restored; operating point moves to “3”. For complete resto-
ration of pressure, the operating point moves to “2”.
A superior representation is depicted by the dashed
line below the volume axis, either as a single straight line
or else broken into linear segments as shown. Modeling in
this manner permits the pressure inside the vessel to de-
crease gradually as the veins empty and collapse. (Other-
wise the value of unstressed volume could oscillate
between 0 and Vo and the model could be unstable). The
decreasing pressure drop for flow as the vein collapses,
will cause a decrease in flow [83]. It is also possible to
increase resistance to flow using a formulation for col-
lapsible tubes [73] although the data to implement this
latter approach was not available.
The normal operating point of a vein is shown in Fig.
9-32 as Point 1. Normally as the volume of the vein gradu-
ally is increased or decreased, the elastic property of the
veins allows the operation point to move up or down on
the solid line. However, if the vein is partially drained of
fluid, (as in leg veins during head-down tilt) the vessel
can also retone, given enough time (Point 2 or 3). The
compliance curve has thus shifted from A to B in Fig. 9-
32. This passive mechanism is called reverse stress relax-
ation (or “retoning”). Stress relaxation (or “delayed com-
pliance”) is movement of the compliance curve to the right
and is activated to accommodate over-inflated veins.
These processes, derived from the plasticity properties of
blood vessels, have been incorporated into Guyton’s model
as one means of controlling venous blood pressure [26b].
This is a different mechanism than active control of venous
tone mediated through the sympathetic nervous system.
The modifications of venous collapse were made in
only the leg veins of the model, inasmuch as the larger
upper body veins do not collapse during head-down tilt,
but rather they are engorged. In hypogravic situations, the
central veins could act as a large depot for leg fluid. Any
additional volume beyond the zone of free distensibility
contributes toward increasing venous pressures; this would
presumably initiate renal mechanism, which acts to re-
duce the excess stressed volume. In addition, adaptive
mechanisms exist that can accommodate excess fluids.
These influences include stress relaxation, vasculariza-
tion (i.e., increases in number of open capillaries) and al-
tered volume receptor sensitivity.
9.7.3.2 Modeling the Leg Interstitial Compartment.
9.7.3.2.1 Transcapillary Fluid Movement. In Chapter
5.4.2.2 the importance and processes of capillary fluid
exchange during the acute stage of weightlessness were
discussed. The new configuration of the leg filtration
mechanisms in the modified computer model is shown in
Appendix C (Fig. C-2). Tissue fluid pressure is determined
by the elastic characteristics of the tissue (see below) and
its state of hydration and acts to oppose capillary pres-
sure. During standing capillary pressures in the feet will
increase by 60–75 mmHg. As much as 500 ml plasma may
filter into the tissues within 30-minutes; after that this
effect is limited by the opposing tissue pressure, a reflex
reduction in capillary surface area and by concentration
of plasma colloids which are not easily filterable. Little is
known about the Starling forces and their dynamics for
the reverse situation of head-down tilt[UPDATE#4]. Capillary
pressure certainly will be expected to decrease (as a result
of diminihsed hydrostatic pressures in the leg) and favor
movement from the leg tissues into the leg vasculature.
But what is the intensity and time-course of this process
and what factors influence it? One of the keys for answer-
ing this is a better understanding of the factors that influ-
ence leg tissue pressure. This is addressed next.
9.7.3.2.2 Pressure-Volume Relationship of the
Tissues. Guyton has proposed a composite diagram show-
ing the relationship of interstitial fluid pressure to total
interstitial fluid volume (Fig. 9-33; solid curve). Also
shown is the relationship between free fluid and non-mo-
bile fluid in the interstitium (dashed line). According to
experimental observation, normal interstital fluid is in the
negative interstitial fluid pressure range. As can be seen
by Fig. 9-33, normal tissues have essentially zero free fluid.
However, as the interstitial fluid pressure rises into the
positive range, the compliance (slope of the solid curve)
increases dramatically and large quantities of free fluid
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begin to appear. This non-linear compliance of the tissues
is potentially significant to the quantitative understand-
ing and simulation of head-down tilt and weightlessness.
During postural change from supine to erect, a large
quantity of free tissue fluid is mobilized and the operating
point shifts to the high compliance range where tissue
pressures are positive. Conversely, during head-down tilt
or prolonged weightlessness, when leg tissues become de-
hydrated, little free fluid is present and tissue compliances
are much lower. Although the interstitial compartment of
the upper body includes a non-linear compliance relation-
ship, this feature was introduced in the model’s leg com-
partments as a manual change in tissue compliance to
achieve the desired degree of leg dehydration. In the simu-
lation studies, it was found, in fact, that in order to achieve
the proper degree of leg tissue dehydration during head-
down tilt, it was necessary to decrease leg tissue compli-
ance several fold compared to the simulation of standing.
The change in tissue compliance was one of the more sig-
nificant modifications considered for the simulation of
head-down tilt; it initiated the driving forces of the model,
rather than the forced volume shift initiations required for
the supine bedrest simulations (Chapter 9.3).
Like the veins, the interstitial matrix is not entirely
elastic in structure because it exhibits the phenomenon of
stress relaxation and reverse stress relaxation. One may
expect that during acute head-down tilt, free fluids leave
the leg tissues quite readily due to the elasticity of the
interstitium and the falling capillary pressure. However,
loss of tissue fluid is self-limiting as tissue pressure falls.
Eventually, reverse stress relaxation partially restores the
tissue pressure and this in turn permits further dehydra-
tion of the leg tissues. Thus, a greater degree of fluid from
leg tissues may be lost during head-down bedrest from
subjects who have been previously ambulatory or stand-
ing for long periods of time and who are well hydrated.
9.7.4 Verification Studies
Preliminary simulations were performed to test the can-
didate approaches for modeling the leg elements. Two types
of verification studies were performed: a) a postural study
demonstrating the model’s fluid shift capability between
erect, supine and head-down maneuvers and b) a sensitiv-
ity analysis demonstrating the ability of the model to simu-
late various angles of head-down tilt.
9.7.4.1 Simulation of Postural Maneuvers. The capa-
bility of the modified model to predict fluid volume
changes for a variety of postural changes and gravity vec-
tors are shown in Fig. 9-34. In these simulations, consecu-
tive short-term postural changes were performed, from the
supine (initialization) to the erect, back to the supine and
followed by an anti-orthostatic position (–4°). The head-
down tilt was then allowed to continue for a longer period
(48-hour). The forcing function in all of these cases and
for the remainder of the simulations in this chapter was the
angle of tilt; there were no artificial forcing functions used
to move fluid as was done in previous sections of this
chapter for supine bedrest and water immersion. However,
as mentioned above, the compliance of the leg tissue com-
partment was set to a value that would ensure inward fil-
tration when the hydrostatic forces of standing were
removed.
Two important kinds of fluid shifts are examined in
Fig. 9-34: a) movement of blood between upper and lower
body and b) plasma exchange between intravascular and
extravascular compartments. The model realistically dem-
onstrates the rapid blood volume shift of about 400–600
ml that occurs during normal short-term postural changes
and the somewhat slower shift of an additional 500 ml
plasma that is normally pooled in the leg extravascular
tissues upon standing. This implies that in the erect pos-
ture about a liter of fluid is pooled in the leg compart-
ments (veins and interstitium) partially at the expense of a
large reduction in central blood volume and total blood
volume. Tilting to the supine position returns fluid to the
upper body and essentially reverses the previous changes.
Tilting head-down -4° for a short period merely accentu-
ates the magnitude of the fluid shifts that were already
observed in changing posture from erect to supine. How-
ever, longer exposure to head-down tilt (right half of Fig.
9-34) dramatically reverses many of the short-term head-
Figure 9-33. Estimated tissue pressure-volume relationship of
entire human body. Redrawn from Guyton, et al. [26a].
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Figure 9-34. Simulation of fluid shifts during acute postural changes followed by bedrest. The angle of tilt with respect to the horizontal
is shown at the top.
down shifts, except for the drainage of fluid from the legs,
which becomes more severe. Therefore, although the model
predicts that almost a liter of leg fluid has shifted cephaled
by 2-days of anti-orthostasis (as measured from the initial
supine reference), central blood volume has returned to
nearly normal, due to the reduction in total blood volume.
In the model, the loss of blood volume (and total body
water) during prolonged head-down tilt is due primarily
to feedback renal excretion pathways, while blood vol-
ume loss in the short-term erect position arises from filtra-
tion into the leg interstitium. In both cases, the loss of
plasma is reflected by a hemoconcentration that is more
severe in the anti-orthostatic position.
The simulations of Fig. 9-34 also demonstrate that
measurements of leg volume changes during bedrest (or
spaceflight) studies can be quite misleading unless the
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reference posture is clearly defined. For example at the
end of 48-hours of head-down tilt, the simulation results
indicate a decrement of total leg volume (leg blood vol-
ume plus leg tissue volume) of about one liter if measured
from the supine position and about two liters if measured
from the erect position. It should be also clear that the
time at which subjects remain either in the erect or supine
position before the reference (or control) measurements
are made is also crucial.
9.7.4.2 Sensitivity Analysis. The results of a series of
simulations at –4°, –8° and –12° tilt are shown in Fig. 9-
35. The objective of this study was to show that increas-
ing the angle of tilt increases the severity of leg fluid shifts
and to examine related physiological aspects. In so doing,
the simulation will serve as a verification of the model’s
ability to account for negative tilt. The manner in which
the legs are modeled will influence the amount of total
fluid shifted from the legs. Therefore, the predictions
shown in Fig. 9-35 will presumably be modified as more
realistic leg elements are developed and as data becomes
available.
As the angle of tilt increases, the effect on shifting fluids
from the interstitium is proportionately greater than the shift
of leg blood. This result may be expected in that most of the
fluid from the leg vasculature drains out for only small nega-
tive angles, similar to the effect seen during LBNP when the
greatest amount of leg pooling occurs during the lowest pres-
sure differentials. In previous simulations of supine
bedrest, the blood volume changes were nearly equiva-
lent to the losses of blood from the legs. These anti-ortho-
static simulations, by contrast, indicate that blood volume
losses are always greater than that shifted from the legs.
This condition arises because of an excess hydrostatic pres-
sure at the volume receptors, which is maintained through-
out negative tilt. This is a situation not previously
encountered in the supine position. It may be expected
that a similar phenomena is present in human subjects.
Our analysis suggests that at –4°, leg capillary pres-
sures decrease only about 5 mmHg as measured from su-
pine, compared to a 60–75 mmHg increase in the erect
position. This suggests a much slower dynamic response
during a slight head-down tilt than during a more severe
head-up tilt. In addition to the decrease in capillary pres-
sure, the model simulation reveals alterations in plasma
colloidal pressure,  t issue pressure and pre- and
postcapillary resistances (not shown), all of which favor
inward filtration through the capillaries. Absorption of
tissue fluid would be expected to continue until the tissue
pressures declined and a balance of Starling transcapillary
forces was again achieved. The model presently predicts
the resulting leg tissue fluid losses over 24-hours, in the
4° head-down position, to be nearly equivalent to that
gained by the tissues in 30-minutes of standing.
9.7.5 Simulation of Head-Down Tilt
At the time these model analyses were performed (1978
to 1982), there were only a few published experimental
studies on head-down tilt using human subjects. Two of
Figure 9-35. Sensitivity analysis of anti-orthostatic simulation:
Influence of angle of tilt.
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Figure 9-36. Simulation of head-down tilt (-5° ) using the modi-
fied circulatory model. Values have been omitted from the ordi-
nate for clarity and in order to emphasize the general behavior of
the dynamic response for a variety of variables. Comparison should
be made with experimental results of Figs. 9-37(a) and 9-37(b).
Quantitative values are provided in Table 9-9.
these investigations were useful for validating the tech-
nique for simulating head-down tilt. The first of these
[34,74] concerned a 24-hour tilt (–5°) and the second study
[84] was a head-down bedrest (–6°) for 7-days. Thus, it
was possible to study both a short-term and long-term anti-
orthostatic bedrest response by comparing model behav-
ior with experimental data. All of the results shown here
were performed with the modified version of the Guyton
model.
As was true in the studies of supine bedrest and water
immersion, head-down tilt is characterized by an acute shift
of blood from the legs into the central circulation. The physi-
ological response that accompanies this maneuver, the fluid-
shift hypothesis, has been discussed in detail in Chapter 5 (in
particular see Figs. 5-15 to 5-17). While most of the acute
changes predicted by theory are reflected in the model
simulations, they had been difficult to verify experimen-
tally until the studies of Nixon and Blomqvist [34,74].
9.7.5.1 24-Hour Head-Down Tilt Study
9.7.5.1.1 Simulation. Computer simulations of the first
24-hours of 5° head-down tilt are shown in Fig. 9-36. These
results demonstrate an expected behavior for a variety of
fluid volume, hemodynamic and renal-endocrine param-
eters based on the fluid-shift hypothesis. The initial re-
sponse (the “acute stress phase”) is in accord with the
predictions in Fig. 5-15. The loss of fluids from the legs
during head-down tilt is closer to that seen in spaceflight
than was the case for supine bedrest (see Fig. 9-10). Ac-
companying the headward shift of leg fluid, there are in-
creases in central blood volume which leads to increases
in circulatory pressures, stroke volume and cardiac out-
put, a decrease in heart rate (demonstrating the altered
sympathetic outflow) and alterations of the renal-regulat-
ing hormones (including ADH, aldosterone, angiotensin
and natriuretic factors). The increase in renal water and
salt excretion is ultimately expressed as a decline in ex-
tracellular fluid, blood volume and total body water.
An interesting aspect of this simulation is the so-called
“rebound” effect, after the first hour or two, in which most
of the circulatory variables reverse direction. Except for
fluid volume changes, which remain depressed, all other
variables examined in Fig. 9-36 exhibit a transient biphasic
behavior, with a return to baseline. It is particularly note-
worthy that in several instances these quantities are pre-
dicted to eventually overshoot (or undershoot) baseline
conditions. For example, venous pressure, stroke volume,
cardiac output, ADH, angiotension and aldosterone ap-
pear to reverse direction at the end of the 24-hour period
compared to their values during the acute stress phase.
Therefore, during the first few hours of head-down tilt, the
model predicts a situation similar to that predicted by the
fluid-shift hypothesis (Fig. 5-15). But after about 12-hours,
while one might find a reduced blood volume as predicted,
most of the other elements of that hypothesis might show
measured values in opposite directions to that predicted
on theoretical grounds (see Figs. 5-15 and 5-17).
The simulation analysis, therefore, demonstrates the
importance of considering the dynamic properties of regu-
latory systems in order to explain otherwise unexpected
or counterintuitive results. For example, if measurements
during head-down tilt were performed only after 12-hours,
the model predicts that an investigator would find angio-
tensin levels elevated, renal excretion stable, or venous
pressures below normal. These results might appear para-
doxical in the face of presumed central hypervolemia and
at odds with the concepts outlined earlier. Such “para-
doxical” findings, have in fact characterized many previ-
ous bedrest and spaceflight studies [85,86]. The simulation
analysis suggests that rather than invalidating the theo-
retical expectations, these types of results merely indicate
that earlier and more frequent measurements should have
been performed in order to capture the acute biphasic phe-
nomena. In other words, the hypothesis diagrams of Figs.
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5-15 to 5-17 (typical of those found in the literature) are
really a static picture representing only the acute primary
responses to headward fluid shifts; a more realistic dy-
namic analysis would allow for secondary changes that
may cause a reversal of direction in various parameters.
9.7.5.1.2 Comparison of Model and Data. Validity of
the computer simulations was assessed by comparing the
model responses with the experimental studies of
Blomqvist and co-workers [34]. A graphical schematic sum-
mary of that study has been reproduced from a published
report [74] in Fig. 9-37(a) (fluid-shifts and renal-endocrine
responses) and Fig. 9-37(b) (hemodynamic responses).
Comparing Figs. 9-36 and 9-37, it can be observed that
the general behavior of the model’s responses is remark-
ably similar to the experimental findings.
The experimental response to head-down tilt confirms
the simulation results for the major hemodynamic, renal
and endocrine parameters, in that most of the changes re-
turn to control levels within a 24-hour period. It appears
that cardiovascular and blood volume regulation was
achieved in the human subjects in a manner suggested by
a more detailed analysis of the model; that is, by a combi-
nation of renal diuresis, transcapillary filtration, accom-
Figure 9-37(a). Experimental fluid-shift and renal-endocrine  re-
sponses of human subjects to 5° head-down tilt. Idealized re-
sponses reproduced from Blomqvist and co-workers [74]. The
abscissa has a logarithmic-like scale.
Hours
Figure 9-37(b). Experimental hemodynamic responses of human subjects to 5° head-down tilt. Data from Ref. [74]. Compare with
model response in Figs. 9-36 and 9-38 (for peripheral resistance).
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modation by vascular capacitance elements and a reduc-
tion in blood volume, associated with a transient suppres-
sion of volume-regulating hormones. At the end of the
experimental period, many of the observed quantities ex-
hibited a deviation from control values and these changes
were similar to those predicted by the simulation, at least
in direction if not in magnitude (see Table 9-9).
The early rise in urinary excretion noted in the ex-
perimental study was also observed in the simulation (i.e.,
compare Figs. 9-36 and 9-37(a)). Also, the model suc-
ceeded in differentiating between the eventual fall below
control in venous pressure at a time when arterial pressure
was elevated (at 24-hours). Finally, the interesting
biphasic behavior of the ADH, aldosterone and angiotensin
hormones was seen in both experimental and simulation
studies (see Chapter 9.8 for a detailed analysis). The en-
hanced activity of a natriuretic factor, predicted by the
simulation, was not measured experimentally.
Blomqvist’s studies were the first reported observa-
tion, during a hypogravic type of maneuver, that the re-
nal-regulating hormones return to and overshoot, their
control values during a 24-hour period. It was gratifying
to us to note that this phenomenon of suppression, recov-
ery and overshoot was predicted by computer-model simu-
lations a number of years prior to these validation
experiments [87]; (see Chapter 9.2.1). It is our belief that
understanding such a transitory response to central hyper-
volemia is essential to reconcile data from short-term and
long-term hypogravic studies [88]. Specifically, short-term
studies such as water immersion indicated hormone sup-
pression, while results from Skylab and certain longer-
term bedrest studies demonstrate that angiotensin and
aldosterone become elevated over days or weeks. Rather
than viewing this as conficting results, the model behav-
ior suggests they are simply highly dynamic points on a
time-continuum.
In preliminary simulations of head-down tilt, the
model predicted that ADH suppression was short-lived (i.e.,
less than 30-minutes) before increasing above control in
response to a rising plasma sodium concentration(see Fig.
9-3(b). An elevation in either ADH or sodium concentra-
tion is unrealistic during acute hypogravic stress in light
of more recent studies [11,34,41,48] which indicate that
both quantities diminish, for at least a number of hours.
Two model modifications were introduced that produced
a more realistic response. First, a renal-natriuretic factor
was introduced which permitted plasma sodium concen-
tration to be maintained near or below normal levels (see
Fig. 5-30). Secondly, the sensitivity of ADH to venous
pressure was increased by a factor of 15 relative to that of
plasma sodium concentration, as suggested by recent stud-
ies [26a, 89] (see Chapter 9.8). As a result of these modifi-
cations, in response to head-down tilt, ADH diminished
for several hours until central venous pressure returns 
Table 9-9. Comparison of Simulation and Experimental Response for 24-hour Head-Down Tilt (-5°)
Study.
Quanitity    Value @ 24-hours Compared to Control
Head-down tilt* Model
Fluid shifts:
Total body water –1300 ml –1130 ml
Leg volume  – 900 ml  – 710 ml
  Leg blood volume     nd  – 256 ml
  Leg interstitial volume     nd  – 454 ml
Total blood volume  –425 ml  – 563 ml
Hematocrit  + 7.5%    +12.5%
Urine rate, 1st 8hr/24 hr  127%     190%
Hemodynamics:
Cardiac output –7.8% –11.1%
Stroke volume –8.5% –9.8%
Heart rate 0% +1.4%
Arterial pressure       +3.7 mmHg (+ 4%)     +2.6 mmHg (+3%)
Central venous pressure      –2.4 cm H2O (–49%)    –0.5 cm H2O (–9%)
Left atrial pressure    nd    –0.7 cm H2O (–49%)
Peripheral resistance +11.3% +16%
Hormones:
Angiotensin +25% +27%
Aldosterone +35% +17%
ADH +57% +  3%
Natriuretic factor    nd +14%
nd = not determined
* Data from [Refs. 34,74]
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to normal (Fig. 9-36) in agreement with the experimental 
data (Fig. 9-37(b)).
The longer-term changes in all of the measured hemo-
dynamic variables were identical in direction and close to
the magnitude predicted by the model (compare Fig. 9-36
with 9-37(b)). In most cases, the short-term changes were
predicted by the model as well. The simulated peripheral
resistance is not shown in Fig. 9-36 but rather in Fig. 9-
38(bottom); there is close agreement with the experimen-
tal findings shown in Fig. 9-37(b). However, a transient
dip in arterial pressure and the failure of cardiac output to
rise, during the first several hours in the human subjects,
could not be explained by the researchers and was not
predicted during the simulation. Several of the hemody-
namic responses are particularly intriguing. At 24-hours
after head-down tilt, both the model and experimental re-
sults demonstrate an elevated arterial pressure and periph-
eral resistance and a diminished cardiac output and venous
pressure (Table 9-9, Figs. 9-36, 9-37(b) and 9-38). A de-
tailed model analysis was conducted to determine the cause
of these changes (especially the fall in venous pressure)
that were not immediately apparent or expected [82]. The
following conclusions were drawn from that analysis:
a) The main cause of the net reduction in venous pressure
back to the baseline is the loss of blood volume
b) The main cause of the venous pressure declining below
the baseline is a rise in peripheral resistance
c) Stress relaxation of the large veins modulated the rise
in venous pressure but was not a major contributing
factor to the fall in venous pressure.
These conclusions led to a more detailed examina-
tion of the factors that caused peripheral resistance to in-
crease. Total peripheral resistance in the Guyton model is
proportional to four factors: a) an autoregulatory factor
which attempts to regulate blood flow according to the
oxygen needs of the tissue, b) a viscosity factor which
increases frictional resistance to flow, c) an angiotensin
factor which is proportional to angiotensin levels (angio-
tensin is a potent vasoconstrictor) and d) an autonomic
factor which is a signal from the baroreceptors. The dy-
namic influence of these various factors on resistance dur-
ing a head-down tilt simulation is shown in Fig. 9-38.
Note that different factors appear to dominate the control
of resistance at different time periods. The autoregulatory
factor and the autonomic factor respond in opposite direc-
tions to the increased flow to the tissues and increased
arterial pressure immediately following head-down tilt;
they essentially cancel out each other’s influence. The
hemoconcentration, which develops during head-down tilt
secondary to rapid plasma volume losses, alters the oxy-
gen supply-demand balance at the tissue level to favor
tissue hyperoxia. This in turn causes an autoregulatory
increase in resistance, thereby reducing blood flow and
returning the tissue oxygen supply toward normal. An ad-
ditional influence of hemoconcentration on resistance is
due to the viscosity effect that increases frictional resis-
tance. Angiotensin increases above normal following 12-
hours of simulated head-down tilt and this has a vasocon-
strictor effect as noted above.
Whether or not the responses in Fig. 9-38 are quanti-
tatively accurate is not of major concern at this juncture.
It is certainly relevant that increases in hematocrit, angio-
tensin and total peripheral resistance have been noted in
supine bedrest and head-down tilt [34,84]. Peripheral re-
sistance has been measured to increase 15–20% in these
cases in excellent agreement with the model predictions.
Although no definitive explanation for the resistance
changes had been offered (at the time) it is well known
that exercise conditioning decreases resting total periph-
eral resistance, so one might infer the opposite effect dur-
ing hypokinesia or deconditioning.
9.7.5.2 One Week Head-Down Bedrest
9.7.5.2.1 Simulation. As indicated above, both the simu-
lation and experimental results of head-down tilt indicate
that many of the physiological disturbances and regula-
tory influences have not stabilized at the end of 24-hours.
In order to determine the behavior of these parameters over
longer periods, simulations of a 7-day head-down tilt were
performed and were then compared to the experimental
findings [84]. Simulations of the 7-day head-down bedrest
study were performed in a similar manner to the 24-hour
study. That is, the angle of tilt with respect to the horizon-
tal was set to –6° (rather than –5°) and the responses were
observed over a period of 7 simulated days. In addition, a
decrease in dietary intake similar to the ad libum human
diet was imposed in the simulation. The average reduc-
tion in dietary intake was close to 28%. (The actual reduc-
Figure 9-38. Simulation of 5° head-down tilt showing the total
peripheral resistance response. Peripheral resistance in the Guyton
model is computed as being proportional to the four factors shown
in the top graph.
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Figure 9-39. Simulation responses of f luid shifts  and
hemodyamics during head-down bedrest.
tion for water, sodium and potassium in the diet, by weight,
was 24%, 29% and 30% respectively). Model parameters
controlling dietary water, sodium and potassium were re-
duced by these amounts.
9.7.5.2.2 Overall Response. Table 9-10 lists a number
of important physiological parameters (similar to those
presented in Table 9-9 for the 24-hour study) and their
simulated changes from control measured at the end of 7-
days. Also shown, for comparison, are the corresponding
experimentally measured changes. The simulated re-
sponses are in reasonable qualitative agreement with ob-
servations in the human subject. Other than using the
initial parameters mentioned above, there was no attempt
to optimize the simulated response.
9.7.5.2.3 Fluid Volumes and Hemodynamics. The
acute shift of blood and tissue fluid from the legs to the
central circulatory region leads to regulatory changes and
produces the long-term fluid and hemodynamic responses
shown in Fig. 9-39. The model predicts that most of these
disturbances stabilize after the second day. At this time,
the legs have lost about 650 ml from both intravascular
and interstitial sources while the plasma volume decreases
by about 550 ml. Associated with these fluid losses is an
almost complete correction of central blood volume. Car-
diac output and venous pressure (reflected by end-dias-
tolic volume) eventually reach a level that is below control
levels while arterial pressure essentially shows no change.
These responses are a continuation of the trend observed
at the end of the 24-hour head-down tilt study (compare
Figs. 9-36 and 9-39).
During head-down tilt, the model predicts that a sig-
nificant fraction of the fluid in the interstitial compart-
ment of the leg is drained into the circulation (see Fig.
9-35, bottom curve). However, an unexpected prediction
was the loss in upper body interstitial fluid (Fig. 9-40,
second from top, solid line). Conventional wisdom sug-
gests that headward fluid shifts should promote
transcapillary filtration and thereby an increase in central
interstitial fluid. (This is based in part on the reports of
puffy faces and head congestion during spaceflight). How-
ever, computer analysis of this event suggests that as
plasma volume diminishes, plasma protein concentration
becomes elevated which favors transcapillary fluid ab-
sorption from the interstitium. This phenomena is only
partially offset by the tendency of the heightened blood
pressure to filter fluids in the opposite direction. The re-
sultant of these two opposing transcapillary forces is not
easy to predict intuitively and one should use this model
prediction of a temporary net inward filtration to encour-
age experimental verification. However, it is not possible
to experimentally measure interstitial fluid of the upper
body separately from that of the legs in the human sub-
ject. Therefore, the model was used to examine these quan-
tities in greater detail. Model analysis of this phenomenon
was first conducted in the simulation of water immersion
where it was followed for only 8-hours (see Fig. 9-26) while
in Fig. 9-40 the simulation duration is 7-days. By extend-
Table 9-10. Comparison of Simulation and Experimental
Responses for 7-Day Head-Down (-6°) Bedrest Study
Quantity       Value @ 7-days Compared to Control
    Head-down Bedrest* Model
Fluid Shifts
 Total Body Water –600 ml –805 ml
 Blood Volume –400 ml –650 ml
 Plasma Volume –240 ml –550 ml
 Red Cell Mass –180 ml –100 ml
 Leg Volume –460 ml –650 ml
Hemodynamics
 Cardiac Output –9.5% –10.7%
 Arterial Pressure +9.5%     0%
 Venous Pressure –2.0% (EDV) –  8.6%
 Peripheral Resistance +14.0% +11.0%
Renal Function
 Water Excretion –39% –31%
 Sodium Excretion –39% –33%
 Potassium Excretion –13% –16%
Electrolytes:
 Plasma [Na+] –3.0 meq/l         –6.7 meq/l
 Plasma [K+] –0.5 meq/l         –0.5 meq/l
 Total Body Potassium ND –4%
Plasma Endocrines:
 Angiotensin +116% +55%
 Aldosterone –28% –24%
 ADH –65% –37%
*Data from Ref. [84]
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ing the time period a 700 ml decline followed by a dra-
matic rebound of upper body interstitial fluid is revealed
which restores that compartment’s fluid volume before
settling at a normal stable level. The rebound occurs as a
result of a reduction in lymph flow, normalization of plasma
colloids and readjustments of the pre/post capillary resis-
tances to favor filtration.
There is no evidence to confirm the veracity of this
simulation, but such swings in fluid volumes have never
been reported. Also, it has been shown that water immer-
sion results in dilution of plasma colloids [47] and not
their concentration. (No such measurement was available
for head-down bedrest). Therefore, a hypothesis was for-
mulated that suggested that plasma colloids would not
concentrate and upper body interstitial fluid would not
deplete so readily, if transcapillary protein permeability
were increased. The rational for this hypothesis is pro-
vided in a previous section (Chapter 9.5.2.4). The hypoth-
esis was evaluated by permitting the protein permeability
in the capillaries to increase 10-fold from its resting value
during the first 8-hours of head-down bedrest (when pores
in the capillary wall would most likely be stretched open);
thereafter it was returned to normal. The most obvious
difference due to this hypothesis is to significantly mini-
mize the large swings in interstitial fluid volume and
plasma colloids, thereby reducing the magnitude of total
body water depletion. These changes affected the response
during the first two days. After that time the effects of the
early permeability changes had disappeared. In addition
to producing a more plausible simulation of water immer-
sion and head-down bedrest, a transient increase in pro-
tein permeability of the capillaries was claimed to be re-
sponsible for the reduction in plasma volume during
spaceflight.[UPDATE#2]
9.7.5.2.4 Endocrines and Electrolytes. Alterations of
renal-endocrine function and electrolyte metabolism have
been the subject of various spaceflight investigations be-
cause they provide important clues about fluid volume con-
trol during weightlessness. A number of these quantities
measured during the 7-day head-down bedrest are indi-
cated on the left side of Fig. 9-41. They have been placed
in the categories: plasma electrolytes, plasma endocrines
and renal excretion. The plasma electrolytes are impor-
tant determinants of the secretion rates of renal-regulating
hormones (ADH, angiotensin and aldosterone) which in turn
are capable of exerting a powerful influence on renal excre-
tion of fluids and electrolytes. For example, ADH is influ-
enced by and provides renal control of, plasma sodium
concentration. These cause and effect relationships are dis-
cussed in Chapter 5 and are indicated in Figs. 5-8 and 5-11.
The data shown in Fig. 9-41 indicate several changes,
which at first glance, appear paradoxical. For example,
there is a decrease in aldosterone, which is associated with
a diminished plasma sodium concentration and with a sig-
nificantly elevated angiotensin level. In addition, urine
flow is diminished in spite of a reduced level of ADH.
There is also a reduction in sodium excretion, which is
associated with a decrease in aldosterone. In each case,
the normal relationships between hormone, electrolyte and
renal excretion appear to be violated (see Fig. 5-11). Nev-
ertheless, these effects, observed in the human (Fig. 9-41,
left side), have all been reproduced in the simulation of
head-down bedrest (Fig. 9-41, right side).
When a model is able to predict an unexpected event
that turns out to be observable, examination of the model
is warranted to help identify the true causal factors. Such
an analysis has suggested that in the face of competing
factors the following mechanisms prevail [82]:
a) Of the two factors that can normally reduce ADH (an
increase in atrial pressure and a decrease in plasma so-
dium), the most plausible candidate during long-term
head-down bedrest is the measured decline in plasma
sodium.
b) Plasma potassium was the only one of three aldoster-
one-controlling factors in the model to change in the
appropriate direction to explain the measured decline
in aldosterone.
c) The decline in plasma sodium can also explain, in
theory, the increases of angiotensin observed in the
study.
Thus, this analysis is able to suggest how changes in
plasma electrolytes can account for, both qualitatively and
quantitatively, the long-term changes in renal-regulating
hormones observed during one week of head-down bedrest.
9.7.5.2.5 Renal Excretion. The fluid and sodium renal
output responses of the model, as shown in Fig. 9-41, can
Figure 9-40. Effect of acute increase in capillary protein perme-
ability on head-down bedrest response.
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be conveniently separated into an acute response and a
longer-term response. Urine measurements were pooled
over 24-hours; thus, the models acute response cannot be
confirmed directly but can only be inferred from the 24-
hour pooled samples. Accordingly, the distinct diuresis
does not appear to be confirmed in the human subjects,
but a natriuresis was measured. After 2-days of bedrest, the
longer-term phase indicates that a near steady-state pla-
teau is reached during the simulation at a reduced level
for the three renal substances shown, in complete agree-
ment with the data. These results collectively indicate that
the model’s prediction of the acute response was not as
valid as its prediction of the longer-term response.
Renal excretion, it appears, cannot be explained on the
basis of hormonal mechanisms. The measured (and simulated)
decreases in both ADH and aldosterone would normally be
expected to enhance the excretion of water and sodium
and not the reverse as shown in Fig. 9-41. In order to cor-
rectly simulate the experimental plasma electrolytes, hor-
mone levels and renal excretion data, it was necessary to
impose the dietary restrictions for fluid, sodium and po-
tassium that were measured for the human subjects (see
Chapter 9.7.5.2.1). The steady-state renal excretion of the
model exactly balances dietary intake. Thus, in chronic
situations when dietary factors have been altered, renal
regulation of water, sodium and potassium in the math-
ematical model is controlled by non-hormonal mechanisms,
such as plasma electrolytes and renal hemodynamics.
9.7.5.2.6 Effect of Diet. The model results have, there-
fore, suggested the importance of dietary intake in caus-
ing the observed long-term changes in renal-endocrine
behavior and fluid-electrolyte metabolism during the
bedrest study. Figure 9-42 demonstrates this effect more
clearly. The effect of dietary changes alone can account
for the changes seen at the end of 7-days of head-down tilt
with dietary restriction. On the other hand, the acute ef-
fects of the first 2-days predicted by the model are pecu-
liar to head-down tilt and are not affected by alterations in
diet. It is common to find significant reductions in dietary
allotment during bedrest studies, so this conclusion may
have applicability that is more general.
Figure 9-41. Electrolytes, hormones, and renal excretion during head-down bedrest. Left side shows experimental data. Right side
shows simulation.  In the simulation, like in the human subjects, the water, sodiumk, and potassium dietary intake was reduced 24%,
29%, and 30% respectively.  In addition, a potassium “leak” from the cells (20% of the pre-bedrest dietary potassium), was imposed,
representing muscle atrophy.
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9.7.5.2.7 Potassium Metabolism. A interesting feature
of the renal excretion data shown in Fig. 9-41 (left side) is
that renal potassium losses in the human are relatively
unaltered in comparison to water and sodium excretion.
This occurs in spite of the fact that the dietary intake of all
three substances was reduced in the human subjects by
approximately the same amount, i.e., 25 to 30%. (Nor-
mally, if a substance that is normally excreted in the urine
has its intake reduced, the urine excretion at steady-state
is reduced by a similar amount). It is also interesting that,
when the true change of –30% dietary potassium was first
imposed on the model, it led to reductions in potassium
excretion that were unacceptably low (not shown) com-
pared to the data. What can be responsible for this behav-
ior? One likely possibility is that, in the human studies,
intracellular stores of potassium have been mobilized be-
cause of muscle atrophy induced by bedrest inactivity.
Cell potassium could thereby, “leak” into the extracellu-
lar fluids and eventually be excreted via the kidneys. Thus,
there are two effective routes of potassium input into the
extracellular fluids: from the diet and the cell. The effec-
tive sum of these two sources would influence the renal
excretion of potassium.
This hypothesis was examined in the model. It was
important to first estimate the magnitude of the contribu-
tion of cell potassium to renal excretion in the human
subjects. This was done by solving a mass balance equa-
tion for potassium entering and leaving the extracellular
fluid compartment. At steady-state, the net potassium bal-
ance must be zero, thus:
K+ Balance (extracellular) = 0
 = Kdiet + Kcell – Krenal– – Kfecal+sweat
where Kdiet is the daily amount of dietary potassium, Krenal
is the daily potassium renal excretion amount, Kfecal+sweat is
the daily amount of potassium leaving the body from fe-
cal and sweat routes and K
cell is the daily amount of potas-
sium leaking from the cellular compartment due to muscle
atrophy. In the pre-bedrest control period, Kdiet and Krenal
are known while K
cell
 is assumed to have a zero value; this
allows a calculation for Kfecal+sweat. The equation is again
solved for the steady-state bedrest period in which diet
and renal potassium values are measured quantities and
Kfecal+sweat is assumed to have the same value as pre-bedrest;
thus, a value for K
cell may be computed. This value of Kcell
was calculated to be 20% of the pre-bedrest dietary intake
of potassium per day. By multiplying this value by 7-days
a total cell potassium loss was derived. This value was
then used in the model to simulate the consequences of
muscle atrophy.
A “potassium leak” was applied in the model, which
allowed the total cell potassium loss calculated, as de-
scribed above, to be removed from the cell compartment
over the 7-day bedrest period in an exponential manner.
In Chapter 5.4.2.2, the simulated release of cell potassium
was examined in detail, revealing sequential changes in
plasma potassium concentrations, hormones, excretion and
fluid volumes (see Figs. 5-25 and 5-26). The net long-term
effect of this sequela, in the model, is a permanent loss of
body potassium and a reduction of intracellular water. Body
potassium was not measured during the head-down tilt
study, but a loss of about 400 ml intracellular fluid could
be inferred from the human data.
In terms of the model simulation, the total amounts
from the two routes for changing extracellular potassium
(dietary and cellular) can be lumped together into the di-
etary input. Thus, if dietary potassium were normally 100
meq/day, the value during bedrest would fall by 30% or
30meq (as measured in the humans). If cellular potassium
achieved the value of 20 meq/day (as calculated above), a
dietary change of –10 meq/day (i.e., –30 + 20 = –10) would
“effectively” represent both potassium pathways. For con-
venience, this is the approach used in the simulations
shown in Figs. 9-41 and 9-42. The alternative approach of
having a true cellular potassium leak was later examined
and appeared to be even more realistic. Primarily, it per-
mits the potassium dietary intake of the model to be re-
duced to more realistic levels without significantly
Figure 9-42. Effect of dietary change on head-down bedrest. Solid
lines indicates head-down simulation including dietary changes.
Dashed lines indicate simulation of dietary changes alone. Dietary
changes consisted of: fluid intake (-30%), sodium intake (-30%)
and potassium intake (-15%).
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changing the plasma potassium levels or potassium excre-
tion rates which were already in good agreement with the
data in the original simulations. Also, intracellular fluid
volume becomes more stable in its dynamic behavior.
In summary, the invocation of a muscle atrophy-induced
potasium loss from the intracellular compartment resulted in
a more accurate simulation of long-term head-down bedrest
(see Ref. [82] for further details of this analysis).
9.7.5.3 Summary: Head-Down Tilt. Once the modifica-
tions were made to the model regarding the venous and
leg tissue compartments, short-term head-down tilt was
adequately simulated by simply adjusting the angle of
tilt. Longer-term head-down bedrest was more complicated
and required the addition of several other factors that were
hypothesized to have an important influence. Figure 9-43
illustrates the model hypotheses that were invoked in the
head-down bedrest study (bottom of figure) in order to
reproduce the set of experimental findings (top of figure).
These hypotheses included accounting for a natriuretic
factor, a restricted dietary intake and muscle atrophy in
addition to the simple fluid shifts of the acute phase.
The study of short-term and long-term head-down tilt
provided the most useful picture of the dynamic nature of
the hypogravic adaptation processes that we have found
to-date. According to the model and experimental re-
sponses, during the first hour or so of head-down tilt, there
are significant disturbances in the fluid-regulating sys-
tems which are exemplified by internal fluid shifts and
elevated pressures and flows in the thoracic circulation.
This is followed by a short period in which feedback
mechanism (both active and passive) act to correct these
disturbances. Thus, with the exception of the fluid com-
Figure 9-43. Hypothesis for head-down bedrest observations. Experimental findings of interest are shown at top. Acute phase can be
explained by fluid shifts (left box), while long-term phase involves accounting for factors shown in the three boxes to the right.
partments which remain suppressed (i.e., leg volume and
total blood volume), all other variables examined exhibit
a transient biphasic behavior during the first 24-hours,
with a return toward baseline. However, it has also become
clear that the body appears to be seeking a new baseline,
that is, the head-down position seems to alter the “nor-
mal” physiological state. This is demonstrated by the fact
that the longer-term head-down bedrest does not result in
a state identical to the original pre-tilt state. Offsets from
normal were noted for blood pressures, flow resistances,
plasma electrolytes, hormone levels, renal excretion and
so on. The underlying causes of a number of these long-
term biphasic changes were not always obvious and were
in fact counterintuitive. They have become more under-
standable by examining the intricate model relationships
and by testing hypotheses that often required altering these
relationships.
In particular, much of the data can be explained by a
shift from short-term volume control to long-term meta-
bolic control. Volume control refers, in general to regula-
tion of extracellular fluid volume by thirst and renal
mechanisms and in particular, to the vascular control sys-
tems that respond to acute headward fluid shifts. Meta-
bolic control, in this case, is taken to mean those events
that directly influence the metabolism of dietary sub-
stances and are affected by physical activity. In these model
simulations, the definition of metabolic control becomes
more specific and refers to the consequences of alterations
in dietary intake, sweat rates, oxygen uptake and intracel-
lular loss of electrolytes resulting from muscle atrophy. A
secondary effect includes the elevated hematocrit and re-
sulting enhancement of oxygen supply. These phenom-
ena are offered as explanations to account for some of the
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reported differences between acute and chronic zero-g ana-
log studies as suggested by Fig. 9-43. This thesis is ex-
plored in greater detail in Chapter 9.8.
A number of recommendations for improving the simu-
lations of head-down tilt can be found in Appendix G.
Because the modified Guyton model has been validated
for hypogravic stress, it can be used for more advanced
studies, including development of countermeasures, as
described below.
9.7.6 Fluid-Loading Countermeasure Simulation
9.7.6.1 Introduction. One of the most clinically signifi-
cant concerns about spaceflight is the orthostatic intoler-
ance that develops during flight and becomes manifest
during the return to Earth and subsequent early postflight
period. Orthostatic intolerance resulting from bedrest and
spaceflight has been addressed in various part of this book
(see Chapters 3.2.6.6(a), 7.4, 7.5, 9.2.2 and 9.6). The capa-
bilities of the two cardiovascular models (Croston and
Guyton) for simulating orthostasis, providing insight into
the mechanisms of orthostatic intolerance and in helping
to design a lower-body pressure garment countermeasure
have been demonstrated. Also, the impact of orthostatic
intolerance on human health and mission success, during
reentry from space, has been described in Chapter 7. In this
section, the analysis of another countermeasure for amelio-
rating orthostatic intolerance will be presented – this one
based on oral fluid-loading of the circulatory system. Fluid
loads will be imposed on the model following a simula-
tion of head-down tilt, mimicking a spaceflight mission.
The replacement of fluids and electrolytes lost during
the course of spaceflight using oral fluid-loading is now a
common practice for astronauts about to return from space.
An improvement in orthostatic tolerance is brought about by
a partial reversal of some of the adaptive changes that oc-
curred in weightlessness, especially changes in cardiovascu-
lar parameters such as blood volume and blood pressure. The
effects are transitory and therefore, fluid loading is generally
administered just a few hours prior to re-entry to achieve
peak beneficial effects during the re-entry phase. Data from
bedrest [91,92], acceleration studies [93] and Shuttle flights
[94] provide some evidence of its effectiveness as a coun-
termeasure to cardiovascular deconditioning.
It was demonstrated in Chapter 7 that the loss of blood
volume is often a key factor involved in the reduction of
orthostatic tolerance observed following exposure to
weightlessness or similar one-g conditions such as bedrest.
Other factors contributing to this condition include a de-
graded baroreceptor responsiveness, increased venous
compliance and impairment of autonomic signals and
catecholemines release, but the extent of their contribu-
tions is only recently becoming understood [90]. Orthos-
tatic intolerance can occur, clinically, without loss of blood
volume, but blood volume loss always exacerbates the
problem.
The simulation model can be effective in examining
this countermeasure, especially since the physiology of
fluid loading is not completely understood. Although data
is available to show the intercompartment distribution of
fluid loads under normal conditions (see Chapter 3.2.5.3),
it is not known how circulatory status is specifically af-
fected by the volume and salt concentration of the fluid
load in the presence of re-entry g-forces. As emphasized in
Chapter 7.5, it is during the high-g phase of Shuttle reen-
try where the debilitating effects of orthostatic intoler-
ance are most likely to occur. During administration of
fluid loads preceding reentry, it is not known how much of
the ingested fluid remains in the circulation and for how
long under these conditions. It is also desirable to know
the optimum time to administer the fluid load prior to re-
entry, as well as the effective combination of fluid volume
and salt concentration that will maximize blood volume
and presumably minimize orthostatic intolerance. The
computer simulation studies presented below were under-
taken to obtain theoretical answers to questions that were
difficult to address experimentally in an operationally-
oriented environment.
9.7.6.2 Simulations of Fluid-Loading. Simulations of
fluid-loading were performed with the modified Guyton
model [95]. This model is superior to the Croston pulsa-
tile model for this purpose because of two reasons: a) it
has the capability of realistically adjusting circulatory
fluid loads by fluid exchange between the vascular and
extravascular compartments and by renal excretion and b)
it has been validated to simulate the cardiovascular ef-
fects of prolonged hypogravity, a necessary prerequisite
for studying fluid loads during postmission return to Earth.
Weightless conditions were simulated by placing the
Guyton model in a head-down tilt position of –6°s, identi-
cal to the simulations shown previously in Chapter 9.7.5.2.
The physiological parameters were allowed to attain new
steady levels relative to preflight values by running the
model for a period of 3-days. (Although most Shuttle mis-
sions last about a week, it was shown that the hemody-
namic response does not change significantly after 3-days–
see Fig. 9-39). The STS-1 re-entry g-profile with a peak g-
force of approximately 1.5 G was used to simulate re-entry
g-stress (see Fig. 7-21). The time course of parameter varia-
tions was tracked from the beginning of re-entry to touch-
down (TD) and 25-minutes thereafter under one-g
conditions. The results presented here are limited to the
cardiovascular response (although fluid-electrolyte and
hormonal systems responses are also generated) since it is
the primary determinant of orthostatic intolerance.
The time of ingestion prior to re-entry and the salt
concentration of the fluid-load were varied and their in-
fluence upon the parameter changes was examined. The
volume of fluid-load in all circumstances was one liter,
ingested at a constant rate over a period of 10-minutes.
This is the maximal amount of fluid-load used by the
Shuttle crewmembers. It was not necessary to vary the vol-
ume to understand the response patterns as a function of
time produced by fluid-loading, since varying the volume
has the effect of only amplifying or attenuating the elic-
ited changes in physiological parameters. Thus, the per-
centage of fluid ingested that remains in the circulation
during reentry is a critical quantity that the simulation
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Figure 9-44  Effect of varying the salt concentration of the fluid-load
on cardiovascular response during re-entry.  Ingestion time is 2-
hours prior to re-entry (not shown on these charts).  The preflight
control level is indicated by the solid square on the ordinate.  The
level without any countermeasure is shown by the solid line.
provides and it is independent of the total fluid volume
ingested.
9.7.6.3 Simulation Results. Simulations were performed
with and without fluid-loading. Ingested fluids with three
different tonicities were simulated: isotonic, hypotonic
and hypertonic, referring respectively to, fluid-load with
normal plasma concentration of sodium, fluid-load with
no sodium and fluid-load with twice the normal plasma
sodium concentration. Figure 9-44 shows the effect of in-
creasing the salt concentration of the fluid ingested 2-
hours prior to re-entry.  The effectiveness of the
countermeasure is judged from this simulation by the
amount by which blood volume is restored towards nor-
mal. Note that blood volume prior to the simulated mis-
sion is 5.0 liters and that after 3-days of simulated
hypogravity the blood volume falls to 4.5 liters. During
reentry, the blood volume falls approximately another 0.5
liters as a result of capillary filtration in the interstitial
compartment of the lower limbs. It is this loss of nearly
one liter blood volume from its normal value that leads to
orthostatic intolerance during and following reentry. In-
gestion of pure water does little to reverse this effect but
the effect with hypertonic fluid is much greater.
It is also possible to visualize the effect of the coun-
termeasure on other indices of cardiovascular status such
as heart rate, cardiac output and blood pressure. The effec-
tiveness of the countermeasure improved with increasing
salt content in terms of restoring the cardiovascular pa-
rameters toward preflight levels. Also note that the time
course of changes for different salt concentrations was simi-
lar for most responses. Since the loss of fluids is not the
only causative factor behind spaceflight-induced cardio-
vascular deconditioning, compensation for fluid loss alone
cannot be expected to reverse completely the adaptive
manifestation of weightless exposure.
An analysis was conducted to understand the effect of
varying the time of ingestion prior to reentry [96]. Mov-
ing the fluid intake closer to reentry (less than 2-hours)
had the effect of improving the effectiveness of the coun-
termeasure (especially for hypertonic fluids) by moving
the responses closer to preflight levels, but the differences
were only slight. Ingestion times longer than 12-hours prior
to reentry have little impact on the reentry response.
An additional analysis was performed to simulate the
addition of a powerful anti-diuretic agent simultaneous
with the fluid load [97]. This agent has the effect of blunt-
ing the increased renal glomerular filtration rate that fol-
lows the fluid load and retain the ingested fluid in the
body rather than allowing it to be excreted. This was in-
deed found to be the case (Fig. 9-45). For example, if blood
volume is reduced by 500 ml due to several days of
hypogravity, the ingestion of a liter of isotonic saline in-
creases total blood volume by about 150 ml (at the end of
2-hours) and the addition of an anti-diuretic agent can
increase this amount by an additional 150 ml. The in-
crease in plasma volume is not greater even if renal excre-
tion is inhibited, because of transcapillary filtration (see
Fig. 3-38). While the restoration of plasma volume is not
large, even 200 ml increase in blood volume has been
shown to dramatically restore circulatory parameters to-
wards baseline levels [92]. Thus, as much as 60% of the
blood-volume loss can be restored by using fluid-loading
in combination with an anti-diuretic.
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9.7.6.4 Summary: Fluid-Loading Countermeasure.
Inasmuch as fluid-loading affords some measure of pro-
tection against orthostatic intolerance during re-entry it
has been made an operational requirement for Shuttle as-
tronauts. The recommended fluid-load is one liter of iso-
tonic saline, administered 2-hours prior to re-entry. The
simulations study presented here favors increasing the salt
concentration of the fluid-load administered perhaps with
an anti-diuretic. This conclusion is supported by the re-
sults of bedrest studies [93]. These authors used a hyper-
tonic electrolyte drink with approximately twice the
normal osmolarity to restore 2/3 of the loss in +G toler-
ance noted in normal subjects following a 2-week bedrest
with no countermeasures. It has been shown that the effect
of fluid-loading on ameliorating orthostatic intolerance
at the end of Shuttle flights decreases with the duration of
spaceflight [94]. Evidently, fluid-loading does little to
reverse such adaptive manifestations of weighlessness as
changes in baroreceptors gain setting or autonomic signal
that are believed to occur in spaceflights lasting longer
than a few days. The present study also demonstrated the
usefulness of modeling and computer simulation in ad-
dressing questions of operational interest.
9.8 Integrated Analysis of Hormonal
Regulation
9.8.1 Introduction
A group of renal-regulating hormones, consisting of
anti-diuretic hormone (ADH), aldosterone and renin-an-
giotensin, has been the focus of many spaceflight related
studies [19,30,47,74,98]. These hormones regulate the
ionic composition of body fluids, particularly the plasma
concentrations of sodium and potassium (see Fig. 5-8). A
knowledge of inflight hormone disturbances should, there-
fore, provide insight into the status of the fluid-electro-
lyte systems and in revealing the mechanisms that control
renal excretion during weightlessness.
However, the findings from spaceflight have been dif-
ficult to interpret or to reconcile with endocrine data ob-
tained from one-g analogs of weightlessness such as water
immersion, head-down tilt and bedrest. The results often
appear inconsistent, conflicting and paradoxical in rela-
tionship to known concepts of endocrine control.
For example, the Skylab studies have revealed the
following: wide differences between individual crewmen’s
ADH responses, reductions in ADH accompanied by nor-
mal or decreased urine flow, increases in sodium-retaining
aldosterone in the face of a developing natriuresis and
elevated levels of angiotensin (known to be stimulated by
hypovolemia) at a time when there is an accumulation of
fluid in the upper body. Also, the expectation that water
immersion studies would predict the direction of endo-
crine changes in spaceflight was never realized. Support-
ing evidence, that might help explain this seemingly
anomalous behavior, such as measurements made during
the onset of weightlessness, are entirely lacking. At least,
this was the situation during the early 1980’s when the
current analysis was conducted. The purpose of the fol-
lowing study was to subject the data that had accumulated
during the early years of human spaceflight to the rigor-
ous analysis provided by mathematical and computer simu-
lation. The desired result was to unravel the ambiguities
and arrive at a common testable hypothesis. A more com-
plete report on this analysis is available [99,100].
9.8.2 Endocrine Response Data
The analysis began with an examination of the endo-
crine data from a variety of hypogravic experimental stud-
ies whose common characteristic was a reduction in
hydrostatic gradients of the blood column resulting in an
acute headward shift of fluid. A guiding hypothesis in this
study was that all stresses that induce headward fluid shifts
may be presumed, in the absence of other influences, to
lead to similar responses. It is well known that these ma-
neuvers lead to reductions in body water, plasma volume
and electrolytes. Accordingly, it appears reasonable to
compare results from such diverse stresses as water immer-
sion, head-down tilt, supine bedrest, head-down bedrest
and spaceflight. This argument, in fact, is one basis for
utilizing the ground-based studies just mentioned, as ana-
logs of spaceflight and making inferences from them re-
garding the physiological responses to weightlessness.
Figure 9-46 organizes the endocrine data for the three
major renal-regulating hormones, taken from a number of
hypogravic studies, whether performed in one-g or zero-g,
whether short-term or long-term, into a qualitative, com-
posite description. In the process of integrating this data
one must be aware of the fact that each of the hypogravic
maneuvers presented here has been studied over a differ-
ent time-frame (see Fig. 9-1). Thus, at the time this study
was conducted, the acute responses to the initial zero-g
headward fluid shifts can be inferred only from data col-
lected during water immersion and short-term head-down
tilt maneuvers. Other experiments such as bedrest contrib-
Figure 9-45.  Time course of changes in blood volume due to
lysine vasopressin (LVP), an anti-diuretic and fluid loading (FL).
The baseline blood volume before head-down tilt is 5 liters, which
was decreased, after 3-days of head-down bedrest, by 11.2% with
no countermeasure (control – dashed line).  Of this loss, 2.9%
(11.2% less 8.3%) was restored by one liter isotonic saline fluid
load (FL – solid line) and an additional 2.7% (8.3% less 5.6%) by
LVP (LVP + FL — dotted line).  Reproduced from Ref. [96].
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Figure 9-47.  Influence of volume (——) and electrolyte (----) controllers on hormonal secretion.  The stimuli are shown in the direction
that causes each of the hormones to increase in value.
ute data primarily for long-term changes. Based on the
above argument we assume that the data in Fig. 9-46 is
truly part of a time continuum for a general hypogravic
condition and not dependent on the particular stress.
Based on water immersion and head-down tilt stud-
ies, all three hormones exhibited suppression during the
acute period where spaceflight data are lacking [39,41,74].
Following this acute phase, renin-angiotensin is the only
hormone system that demonstrates a consistent behavior,
i.e., a significant elevation in plasma concentration. Dur-
ing spaceflights lasting more than one-month aldosterone
was found to be elevated and ADH suppressed [86], al-
though during intermediate periods, data from various
bedrest studies and spaceflight are not always in agree-
ment (blank areas in Fig. 9-46). It is the general behavior
shown in Fig. 9-46 that needs to be understood. In particu-
lar, it is desired to reconcile the differences between
theacute and chronic responses as well as the differences
among the separate experimental studies.
9.8.3 Analysis of Hormone Controllers
Guyton and co-workers [26a] have incorporated into
their model a schema for understanding endocrine regula-
tion and fluid-electrolyte control. This has been presented
earlier in this book (Chapters 3.2.5 and 5.0; see Figs. 5-8
and 5-11) and will be summarized below.
A schematic description of the factors which influ-
ence the three hormones (as they are represented in the
mathematical model of Guyton) reveal that each hormone
is responsive to two general types of controlling stimuli:
volume disturbances and electrolyte disturbances (Fig. 9-
47). The volume stimuli (as reflected by atrial, renal, or
arterial pressures) may provide control only during acute
disturbances, because of the existence of several types of
adaptive mechanisms indicated in Fig. 9-47 and because
the volume disturbances are often corrected by other non-
endocrine related volume-regulating mechanisms. Three
different types of pressure-related adaptive mechanisms
are indicated, including receptor adaptation (i.e., adaptation
of pressure receptors by increasing receptor tissue compli-
ance or decreasing tissue tension), renal autoregulation (i.e.,
automatic adjustment of renal artery resistance to main-
tain blood flow reasonably constant) and baroreceptor re-
setting (i.e., adjustment of the set point to accommodate
chronic changes in pressure). However, the influence of
the electrolyte disturbances (as reflected by plasma so-
dium and potassium concentrations) is not known to adapt
over time. Therefore, these electrolyte-sensing systems may
Figure 9-46.   Hormonal changes found in plasma or urine during
hypogravic studies: a composite.  Chart was based on studies
from Ref [19,30,47,74,98].  Blank horizontal columns indicate
that different studies reported either both an increase or decrease
in the same variable.  Bars on top of graph indicate typical time
periods associated with the hypogravic maneuver.
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be the primary basis for the long-term control of these
hormones in comparison to the volume sensors.
All of the hormone stimulating factors shown in Fig.
9-47 are known to change at one time or another during
hypogravic maneuvers. For example, during the onset of
hypogravity, headward fluid shifts cause blood pressures
to become elevated leading to an initial suppression of
hormone levels which aids the renal-correction of the vol-
ume disturbance (see Chapters 5.2 and 5.3). However, the
long-term response is variable and appears to depend upon
metabolic factors (such as diet, sweat loss, physical activ-
ity and muscle atrophy) that can alter the plasma electro-
lytes. Thus, the hyponatremia and hyperkalemia observed
in the Skylab crew help explain the elevations of angio-
tensin and aldosterone and suppression of ADH which were
also observed (Chapter 5.3). Discrepancies in hormone
levels reported between different hypogravic studies can
perhaps be explained by the fact that hormones normally
exhibit a highly dynamic behavior which can be obscured
by failing to monitor their levels at appropriate times and
which can be altered by changes in diet, exercise levels,
muscle atrophy and other test conditions. These various
changes, occurring simultaneously, complicate any attempt
to perform an integrated analysis of hormone behavior.
9.8.4 Analysis of ADH Control
An example of how computer modeling may be useful
in accounting for the dynamics of endocrine control dur-
ing spaceflight is presented below for the case of ADH
changes. Two different approaches to understanding ADH
control have been proposed, one based on the control of
blood volume and the other controlling plasma osmolar-
ity. In the first case, ADH would respond to minor distur-
bances in central blood volume as reflected by pressure
changes in the cardiac atria [101]. In the second case,
changes in plasma osmolarity would influence the secre-
tion of ADH [14]. In both cases, the action of ADH on
renal water and salt excretion are proposed to bring the
stimulating variable under control.
Control of ADH according to these two different path-
ways is shown in Fig. 9-48, based directly on experimen-
tal evidence in the rodent. Specifically, it has been shown
that ADH has a sensitive, linear dependency on plasma
osmolarity while the corresponding sensitivity on blood
volume is highly non-linear, showing little influence at
small volume changes and a larger influence (larger than
the sensitivity to osmolarity) at volume changes greater
than 15 to 20% of total blood volume. Therefore, it ap-
pears that under certain stressful conditions, large, acute
changes in blood volume can become the dominant factor
controlling ADH secretion, while under most normal physi-
ological conditions ADH responds to and regulates,
changes in plasma osmolarity.
Guyton and co-workers [26a] have attempted to inte-
grate both these points of view by proposing an integra-
tive mechanism for fluid-electrolyte balance. See Fig. 5-19
for a detailed description and Fig. 9-49 for a simplified
schematic. The elements in this scheme include a volume
receptor-ADH pathway that responds to acute, rather than
prolonged volume (and, therefore, atrial pressure) distur-
bances. The lack of long-term effectiveness of this path-
way is credited to receptor adaptation. This is consistent
with the concept that volume receptor tissues are elastic
and adapt to changing pressures within reasonable peri-
ods of time. Thus, pressure changes, if maintained, exert a
smaller and smaller influence on ADH. Guyton’s concept
also includes a sensitive osmotic receptor-ADH pathway
Figure 9-48.  Effect on ADH caused by changes in plasma osmo-
larity or blood volume. Solid line: Effect on ADH due to blood
volume depletion. Dashed line: Effect on ADH due to increase in
plasma osmolarity. Redrawn from Ref. [89].
Figure 9-49.  Dual control concept for ADH release:  osmo vs. volume control.  This is the basic concept embodied in the Guyton model.
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Figure 9-50.  Hypothesis for ADH control during spaceflight.
Idealized changes in venous pressure and plasma sodium concen-
tration are based on space-based and ground-based data.   The
stimulus-response behavior shown here was obtained from com-
puter simulation of head-down tilt using the Guyton model.
that can override inputs from the volume receptors and an
ADH-thirst drive which receives inputs from both volume
and osmoreceptors. In this view, ADH has a short-term role in
contributing to the correction of large changes in blood
volume, but it has an even more important responsibility
(together with thirst-drive) for long-term control of plasma
osmolarity. The ability of volume receptors to adapt to
sustained volume disturbances, the decreased effectiveness
of ADH on urine output over long periods of time and the
fact that there are other more powerful mechanisms avail-
able for long-term control of blood volume (see Fig. 5-10)
support the argument for a minor role of ADH in the long-
term control of body fluid volume. Interpretation of distur-
bances in ADH levels must, therefore, take into consideration
the dual volume osmoreceptors pathways affecting ADH, the
relative sensitivities of these volume receptors and their abil-
ity to adapt.
Modeling and computer simulation studies have sug-
gested that ADH secretion could respond to weightless-
ness according to the schematic of Fig. 9-50. ADH is
assumed to be under dual control of venous pressure and
plasma sodium concentration, as outlined above. The fol-
lowing assumptions are made regarding these stimuli un-
der hypogravic conditions: (a) the central venous pressure
response is similar to that found during head-down tilt
(see Chapter 9.7.5), (b) hyponatremia develops within sev-
eral days (see below) and (c) ADH is primarily pressure/
volume sensitive during the acute phase which may last
until pressures begin to decline toward control levels, af-
ter which time the sensitivity gradually shifts to favor
osmo-control due to some form of volume-receptor adap-
tation or pressure normalization.
Although based on several untested assumptions, this
hypothesis appears to explain the average ADH response
as measured in the Skylab crew and illustrated in Fig.
5.5(a). The complex triphasic response of Fig. 9-50 in-
cludes the early decrease in ADH (data during the first day
was not collected but is inferred from water immersion,
head-down tilt and the inverse of the first postflight day),
a diminished ADH during the last two-months of space-
flight and the equivocal responses between these two points
in time (see Fig. 9-46) due to competition between pres-
sure and osmo-control.
The ADH waveform shown in Fig. 9-50 is not the only
possible response as indicated in the complete report [99].
For example, the peak formed between the early and later
phases of the response may not occur if adaptation occurs
quickly and/or if osmotic stimuli exert a consistent, pre-
dominant influence. Also, under certain dietary regimes
(or other metabolic influences) plasma sodium may in-
crease, rather than decrease as considered in the above
analysis. Consistent with this would be a long-term eleva-
tion (rather than suppression) of ADH.
9.8.5 Simulation of Endocrine Responses to
Hypogravity
The control of the three renal-regulating hormones
shown in Fig. 9-47 are part of a much larger feedback sys-
tem that can apparently regulate circulatory and extracel-
lular disturbances of various kinds. Figure 5-8 illustrates
three distinct types of control mechanisms, including hor-
mones, autonomics and hemodynamics which act to main-
tain extracellular volume and composition, as well as blood
pressure and renal excretion. Thus, the resultant behavior
of the hormones of interest for a hypogravic stress is likely
beyond intuition and computer model analysis would be
useful to understand the totality of the response.
Figure 9-51 illustrates the hormonal responses of
ADH, aldosterone and angiotensin obtained in the math-
ematical simulation of a 7-day head-down (–6 deg) bedrest
study (see Chapter 9.7.5.2). A similar set of simulated re-
sults were presented in Fig. 9-41 but in that case, the simu-
lation included dietary changes in water and salt based on
the intake of human subjects. In Fig. 9-51 there are no
changes in dietary intake from control levels, although, as
in Fig. 9-41, there is a release of a small amount of potas-
sium from the cellular compartment that represents an ef-
fect of muscle atrophy (see Chapter 9.7.5.2.7)). The most
notably characteristic observed in Fig. 9-51 is the tripha-
sic nature of each response. The behavior of aldosterone
and angiotensin appears to be similar to the ADH response
that was presented in Fig. 9-50. In the light of this analysis
it is proposed that the short-term suppression of the renal-
regulating hormones are a result of volume control fol-
lowing headward fluid shifts in hypogravity while the
long-term behavior can be explained as chronic adapta-
tion to metabolic factors. The long-term trend was clearly
not due to pressure effects because at 7-days venous pres-
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sure was depressed and arterial pressure was nearly normal
(see Table 9-10 and Fig. 9-39). The specific changes in
plasma electrolytes that could be responsible for the long-
term hormone behavior were reviewed in Chapter 9.7.5.2.4.
In most cases the model could account for the observed
changes. However, the magnitude of the increase in angio-
tensin levels in either spaceflight or bedrest seems to be
much greater than can be explained by the measured dec-
rements in sodium. The possible involvement of renal pres-
sure and renal hemodynamics should be explored to further
elucidate other explanations of angiotensin release.
9.8.6 Summary: Hormone Regulation
This analysis suggests that the renal-regulating hor-
mones represents a tightly coupled system that responds
acutely to volume disturbances and chronically to elec-
trolyte disturbances. During hypogravic maneuvers this
leads to an initial suppression of hormone levels and a
long-term effect which varies depending on metabolic fac-
tors. This shift from volume-control to osmo-control may
be postulated to derive from an inherent sensitivity of
hormones for electrolyte stimuli and/or from a gradual
adaptation of pressure disturbances. In addition, the simu-
lations reveal that if pressure effects rapidly normalize, a
transition phase may exist which leads to a dynamic multi-
phasic endocrine response waveform. This hypothesis can
qualitatively account for the observed changes in these
hormones during Skylab and ground-based analog stud-
ies. Where discrepancies between different studies are
found, this may be a result of competing and time-varying
stimuli which differ between subjects and test conditions.
Confirmation of the above hypothesis will require
careful measurements, throughout the time range of inter-
est, of competing factors such as blood pressure, serum
electrolytes and fluid volume shifts which must be ob-
tained simultaneously with endocrine levels. These measure-
ments need to be made not only in space but in ground-based
analogs such as water immersion and head-down bedrest.
Particular attention should be given to obtaining mea-
surements at the onset of hypogravity. Because various
metabolic factors such as sweating, muscle atrophy and
diet can have a strong modifying effect on hormone be-
havior, they should be carefully controlled and monitored.
9.9 Conclusions
The studies described in this chapter represent an exami-
nation of integrated hypotheses proposed to explain many
of the physiological changes observed during exposure to
hypogravity. A key approach of these studies was the use
of mathematical models and their ability to simulate a num-
ber of ground-based analogues of zero-g as well as space-
flight. Data from these hypogravic maneuvers were used to
modify the simulation models and to validate simulation
results. The simulations presented here build directly upon
the subsystem hypothesis development and data analysis
of the previous chapters. The studies of this chapter dif-
fered from those of the previous chapters in that hypoth-
eses were tested as an integrated set rather than
individually, in models that are complex representation
of human physiology. The Guyton model, used through-
out these studies, became the common framework upon
which to integrate and compare diverse stresses and hy-
potheses. This powerful contribution of the modeling ap-
proach is not one that can be easily replicated by human
thought and intuition.
9.9.1 Summary of Physiological Findings
A listing of the important physiological responses to
weightlessness that have been simulated in this chapter
are given in Table 9-11. The broad conclusions drawn from
these studies concerning the physiology of hypogravity
are shown in Table 9-12 and Fig. 9-52. It is not easy to
encapsulate in one diagram the numerous insights derived
from examining the experimental findings and perform-
ing model simulations. Nevertheless, Fig. 9-52 suggests
that there are three broad consequences of gravity unload-
ing: altered hydrostatic gradients leading to headward fluid
shifts, unloading of musculoskeletal tissues leading to dis-
use atrophy and altered metabolism derived from an al-
tered diet and exercise regime. All of these combine to
create disturbances in many interrelated body systems, with
some universally observed consequences that include loss
of body mass and tissues and upon return to one-g a de-
crease in orthostatic tolerance and work performance. With
the exception of a few physiological areas that were not
covered in this project (notably vestibular processes) the
concepts implied by the simple diagram of Fig. 9-52 can
arguably be said to be the basis of space physiology re-
search since the 1970’s.
Figure 9-51.  Hormone responses during simulation of (-6 deg)
head-down bedrest
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Table 9-11. Important Physiological Responses to Weightlessness Which Have Been Simulated
• Acute fluid shifts from legs
• Longer term leg dehydration
• Redistribution of blood towards head
• Changes in blood flow and pressures
• Changes in cardiac output, heart rate and stroke volume at rest
• Altered secretion of hormones: ADH, angiotensin, aldosterone
• Acute increase in urine water, sodium, and potassium
• Influence of suppressed fluid intake on acute response
• Redistribution of intracellular/extracellular fluid
• Redistribution of intravascular/interstitial fluid
• Effect of protein permeability on capillary filtration
• Altered sympathetic discharge to heart, vessels, and kidneys
• Decreased plasma volume and increased hematocrit
• Suppressed erythrocytosis and decreased red cell mass
• Influence of natriuretic factor on renal function
• Change in osmotic concentration of body fluids
• Influence of diet and sweat losses on long-term hypogravic response
• Fluids, electrolytes and hormonal consequences of muscle atrophy
• Decreased body water, sodium, and potassium
• Cardiovascular adaptation to long-term spaceflight
• Cardiovascular and fluid volume responses to postural maneuvers
• Decreased orthostatic tolerance upon recovery
• Decreased exercise performance upon recovery
Table 9-12. Conclusions About Spaceflight Physiological Adaptation Derived from Modeling Studies
These studies have:
• Shown that weightlessness can be better understood by partitioning the response into short-term (about 5-days) and longer term segments
• Resulted in a generalized hypothesis of the fluid-electrolyte weightlessness response; confirmed by simulation and experimental findings.
• Demonstrated that headward shifts of fluid from the legs are primarily responsible for acute body losses of extracellular fluid and electrolytes.
Also muscle atrophy, primarily in legs, is responsible for long-term loss of intracellular tissue, nitrogen and potassium.
• Suggested that of the three routes for depletion of plasma volume (renal, deficit drinking, transcapillary filtration), the last two are not likely to
have long-lasting effects. Renal excretion is a high gain mechanism for correcting central blood volume excesses.
• Shown that early fluid losses occur by deficit intake, but suggested that losses would have occurred anyway by renal regulation if intake were
normal
• Predicted diuresis during first several hours of spaceflight which may be obscured by reduced fluid-electrolyte intake secondary to space
sickness early in flight
• Predicted hemoconcentration during flight contributes to suppression of red cell production
• Suggested a reduction in evaporative water and sweat electrolyte losses rather than an expected increase can help explain patterns of renal
excretion; evaporative water loss changes confirmed by analysis
• Suggested that observed reduction in plasma osmolarity can partially explain measured losses of electrolytes and changes in hormonal levels
• Suggested hypotheses to explain “paradoxical” changes in hormonal levels: During long-term spaceflight ADH may be influenced primarily
by sodium levels (rather than central blood volume), and aldosterone may be influenced more by plasma potassium levels (rather than sodium).
• Suggested presence of natriuretic factor opposing the sodium retaining influence of aldosterone
• Demonstrated loss of potassium from cellular compartment can account for many long-term effects including enhanced aldosterone, increased
K+ excretion, elevated plasma K+, decreased intracellular fluid, and decreased body K+
• Predicted that acute blood volume losses which are maintained cause long-term adaptive adjustments in circulatory flows, pressures, and
capacitances including: flow autoregulation, baroreceptor adaptation, and stress relaxation of blood vessels
• Suggested that the failure of blood volume to return to normal in hypogravity, even after long periods, is indirect evidence of the presence of
volume receptors in the upper body and perhaps their resetting to new thresholds
• Suggested a concept for the behavior of renal-regulating hormones in hypogravity based on acute control of blood volume and longer term
control of plasma electrolyte concentrations
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The simulation studies also highlighted the follow-
ing differences and limitations of the one-g analogs:
a) Each stress provides a picture of hypogravity over a
different slice of time. Thus, water immersion results
are obtained normally over a 4 to 6-hour period, short-
term head-down tilt for 24-hours, long-term head-down
bedrest for up to 7-days and Skylab data represents a
mean response during a 3-month interval. It is normally
the case that the longer the time frame of any particular
study, the less energy the researchers invest in measur-
ing acute changes. While a simulation model can ex-
amine both acute and chronic segments equally, the
data for comparison must come from different types of
studies. The lack of a common time frame of study and
inconsistent methodological procedures in each case
makes true comparison difficult.
b) There are unique aspects of each analog. In water immer-
sion, hydrostatic forces compress the tissue fluids from
outside the body and in supine bedrest or head-down tilt
there is little or no physical activity. Dietary intake, espe-
cially of fluids, electrolytes and calories can also be con-
siderably different. It was shown in these studies that it
is possible to account for a number of physiological
observations on the basis of dietary change alone.
c) With bedrest in particular, it is difficult to separate the
effects of gravity unloading with that of a reduction in
metabolic activity. Exercise conditioning alters many
of these same systems, often in opposing ways as
hypogravic stress. In addition, it is difficult to experi-
mentally dissociate the effects of hydrostatic forces on
the one hand and deformation forces on the other. The
use of model simulations, where cause and effect can
eventually be teased out, allows the researcher to more
easily separate out these different factors.
d) It was observed that all of the hypogravic stresses, when
simulated with the Guyton model, were more qualita-
tively similar than different in the short term. This was
ascribed to the observation that the volume of leg flu-
ids that are shifted headward are different in each case:
they are minimal with supine bedrest, maximal in space-
flight and somewhere in-between for head-down tilt.
Quantitative differences in the acute circulatory re-
sponses appeared to be dependent in large part because
of the magnitude and time course of the headward fluid
shift. These acute fluid shifts are strong enough to mask
out other concurrent effects. However, the longer term
responses could be considerably different from each
other, depending on factors such as the degree of activ-
ity, diet and fluid intake. In an analysis of body compo-
sition (Chapter 4.6), an observed negative energy bal-
ance is thought to have had a great effect on the meta-
bolic systems of the body during spaceflight.
e) Finally, there are differences concerning some critical
measurements. Central venous pressure was predicted
to trend below control in the simulations following a
short upward spike; this finding was observed experi-
Figure 9-52. Physiological effects of hypogravity. Major effects of gravity unloading as discerned from the analyses of Skylab and zero-g
analog findings.
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mentally in head-down tilt (but not supine bedrest) and
the decrease in venous pressure was later confirmed in
spaceflight. In water immersion, the CVP rose so high
as to become suspicious – perhaps an artifact of the
external water pressure. A diuresis was observed in su-
pine bedrest, head-down tilt and water immersion but,
oddly, never during spaceflight. The simulations pre-
dict that a diuresis might be attenuated due to body
dehydration (lack of drinking, space motion sickness)
and by transcapillary filtration, but it would not be
eliminated.
While these differences might be clear to the careful
observer, they became more apparent when viewed through
the prism of a comprehensive modeling analysis.
9.9.2 Summary of Simulation Techniques
The first study in this chapter was a simulation of su-
pine bedrest and associated tilt and exercise tests using
the Whole-Body Algorithm. These tests essentially vali-
dated this highly integrated model for hypogravic envi-
ronments. A wide spectrum of physiological responses
were achieved with the Whole-Body Algorithm, includ-
ing the resting bedrest responses and the post-bedrest
orthostatic and exercise responses. However, for the re-
maining studies in this chapter, the model of choice was
the Guyton model, modified for examining gravitational
maneuvers by the addition of leg compartments and grav-
ity induced hydrostatic pressures, as well as other changes
described more fully in Chapter 3 and Appendix C. The
stand-alone Guyton model was much more convenient to
work with than the much larger Whole-Body Algorithm, pri-
marily because of computer limitations. Although the Guyton
model was limited to a narrower range of physiology than
the Whole-Body Algorithm, it was an excellent vehicle to
study one of our major areas of interest, that is, circulatory,
fluid and electrolyte regulation. It is a testament to the wis-
dom of the creator of the Guyton model that it proved to
be adaptable for gravitationally related stresses including
weightlessness, situations for which it was never intended.
A useful result of this study is the demonstration that
various types of maneuvers, which have been used as ex-
perimental analogs of weightlessness, can all be simulated
by a common mathematical model. The analogs that have
been discussed in this chapter include supine bedrest, head-
down tilt (short-term), head-down bedrest (long-term) and
water immersion. Head-up tilt or standing was also empha-
sized because of its obvious relationship to gravitational
influences and because there is a larger body of knowl-
edge about this maneuver than the others. In all cases the
same quantitative model was used which embodies elabo-
rate but essential relationships describing circulatory, fluid
and electrolyte regulation. Thus, a conclusion of this se-
ries of studies is that adaptation to weightlessness is a
normal response of the feedback control circuits of the
body to gravitational disturbances. Furthermore, the mod-
eling process has confirmed the belief of other researchers
that one-g analogs truly seem to affect many of the same
physiological mechanisms that are activated during space-
flight. The mathematical model can be thought of as func-
tioning as an analog to zero-g physiology in the same way
as water immersion does, or the manner in which animals
are used as surrogates for human studies.
The original Guyton model did not contain the capa-
bility of recognizing changes in gravity or responses to
postural maneuvers (Chapters 9.2). Therefore, one of the
first important modifications included the addition of leg
vascular and extravascular compartments, so that the fluid
redistribution characteristic of weightlessness could be
reproduced and studied (see Chapter 9.3.2 and Appendix
C). During the simulations of supine bedrest (Chapter 9.3),
spaceflight (Chapter 9.4) and water immersion (Chapter
9.5) early in this project, the effects of gravity were not
included and it was only possible to initiate headward
fluid shifts by some artificial means (Figs. 9-2 and 9-13).
In order to more realistically portray the shifts of fluid
between the leg compartments and the head, it was neces-
sary to model both external forces (the gravity vector) and
internal forces (tissue elasticity) that contribute to this
fluid shift. Therefore, the next logical stage of model de-
velopment included a representation of the gravity vector
as it affects the fluid columns of the body. Further modifi-
cations of the model were necessary during simulation of
the erect posture to account for orthostatic defense mecha-
nism that were not originally present in the model (Chap-
ter 9.6 and Appendix C). Finally, the most realistic
simulation of weightlessness was achieved by performing
head-down tilt and head-down bedrest (Chapter 9.7).
The successful simulation of each stress that was stud-
ied was not achieved with the basic model alone; rather
some additional functionality was required to be included
in the model or it was necessary to test some new hypoth-
esis. Thus, supine bedrest presented an opportunity to ex-
amine the gradual dehydration of the legs as a result of
tissue and vessel retoning and unloading and atrophy of
muscle tissue. Head-down tilt simulations required addi-
tional modifications to the leg vasculature in order to pre-
vent venous collapse in the face of negative body angles
and to allow fluid drainage from the leg tissues. Problems
in these areas were not apparent during previous simula-
tions of simple supine bedrest. Realistic simulations of
head-up tilt (orthostasis) required additional assumptions
reflecting leg muscle pumps, abdominal compression and
reduced venous capacitance by stress relaxation. In order
to provide more realistic simulations of water immersion
and head-down tilt, transient changes in the capillary
membrane’s permeability to protein were invoked. The
acute response of hypogravity was simulated in water im-
mersion and head-down tilt by simple fluid volume shifts.
But longer-term, chronic changes exemplified by the
spaceflight and head-down bedrest simulations required
metabolic changes including those associated with diet,
sweating, exercise and muscle tissue loss. An example was
provided that demonstrated how the model could be used
to evaluate and design countermeasures to reverse some
of the untoward effects of microgravity. Validation of the
model for each new situation, therefore, required struc-
tural and programming changes in the model that eventu-
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ally would enhance the range of model capabilities and
lead to improved simulations of weightlessness. In all cases
the modification was plausible and realistic, often being
based on quantitative experimental evidence. The fact that
modifications were required should not necessarily be con-
strued as evidence of model inadequacy because this is
the normal approach in modeling research. The end result
is hopefully an improved model and an enhanced under-
standing of the underlying basis of zero-g adaptation.
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Update Endnotes
UPDATE #1. Central Venous Pressure
The analysis in the water immersion section revealed a
suspected problem with the high and sustained measure-
ments of central venous pressure during water immersion
reported by researchers. The magnitude of the reported val-
ues are well outside the range of right atrial pressures which
are generally accepted in the control of cardiac function
and are in disagreement with the model of Guyton as well.
In this case, rather than indicting the model, it is sug-
gested that the measurements are skewed by an artifact of
the immersion technique. That is, the external hydrostatic
pressure at the level of the heart during immersion is trans-
mitted to the circulation and the pressure transducers. If
this is true, the value of water immersion in understand-
ing the spaceflight response becomes questionable. In
spaceflight, recent findings (years after the above simula-
tion analysis was performed) indicate that central venous
pressure falls rather than increases [103]. While this ap-
pears to agree with head-down tilt studies and the Guyton
model computer simulation, spaceflight measurements
found no increase in venous pressure, even at the onset of
microgravity. The reasons for the changes in space seem
to be different than those found in one-g or computer
studies. Current hypotheses have been subjected to com-
puter modeling [104] and critically reviewed [105].
UPDATE #2. Transcapillary Fluid Movement
(Related to Chapters 9.5.2 and 9.7.5.2) In the water
immersion and head-down tilt studies, an analysis was
performed in which the model predicted an increase in
transcapillary protein permeability in the upper body pos-
sibly as a result of headward fluid shifts. Relevant to this
model prediction made many years ago, is a recent space-
flight study of body fluid regulation, that has shown a
decrease in plasma protein concentration (including albu-
min) [102]. Those investigators suggested that an increased
rate of transcapillary protein transport into the intersti-
tium might account not only for the decreased plasma pro-
teins but was a cause of the reduction in plasma volume.
UPDATE #3. Early Diuresis
In the spaceflight experiment of Leach, et al. [102]
the diuresis at the onset of microgravity was not observed
even though it was an important objective of the research
and inspite of an expectation that it should occur. The
astronaut subjects were requested to maintain their hydra-
tion at normal levels but this could not be guaranteed
because there is a desire on their parts to minimize their
intake of fluid prior to launch. In addition, astronauts wait-
ing on the launch pad (often for several hours) are in a
sitting position, on their back, with their feet and knees
above their head. Inasmuch as this position should pro-
duce many of the fluid distribution and renal effects as
head-down tilt, there is a likelihood that the diuresis ex-
pected upon insertion into weightlessness could be con-
siderably blunted.
In the same study, the plasma volume was shown to
decline within 2-days. It was hypothesized by the research-
ers that plasma volume decreased, not because of the ex-
pected diuresis, but because of fluid transport into the
interstitium presumably due to an increase in upper body
transcapillary protein permeability.
UPDATE #4. Transcapillary Starling Forces During
Head-Down Tilt.
(Related to 9.7.3.2.1) The earliest  studies of
transcapillary fluid shifts during head-down tilt indicated
that dehydration of lower leg tissues resulted from inward
filtration due to a decreased capillary blood pressure. In-
terstitial fluid pressure in leg muscles decreased, fluid col-
loidal concentrations did not change and capillary pressure
was not measured; therefore, the results were not conclu-
sive [106]. But these researchers believed that there is a
drop in capillary blood pressure in tisssues below the heart
that is responsible for tissue dehydration. More recent stud-
ies of the head and neck areas suggested that facial edema
during head-down tilt is caused primarily transcapillary
filtration mediated by elevated capillary pressures and de-
creased plasma colloid osmotic pressure and attenuated
somewha by elevated interstitial fluid. Support was pro-
vided in this study for the Guyton model’s behavior
whereby there is a transition from inward capillary filtra-
tion in the legs and outward filtration above the heart
duriing head-down tilt [107].
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Chapter 10
Discussion and Conclusions
10.1 Introduction
The goals of this project were to apply new analytical
methods to analyze the major medical experiments of
Skylab, to develop and test individual physiological sub-
system hypotheses using computer models, and to inte-
grate these hypotheses into a unified and internally
consistent understanding of the physiological adaptation
to weightlessness. The systems analysis effort has yielded
two major kinds of results or end-products. First, is an
array of systems analysis methods, tools, and techniques
that have proven valuable for the processing and interpre-
tation of experimental data in general, and spaceflight
data in particular. Second, is an improved understanding
of the physiological events that occur during human ad-
aptation to weightlessness, and the concomitant identifi-
cation of areas suitable for future study. Both of these
perspectives will be summarized in this chapter.
The systems analysis methodology, particularly the
use of mathematical models, holds much promise as an
analytical tool and continues to be of great interest to a
portion of the space research community. In contrast, many
of the conclusions, interpretations, and recommendations
developed in the project regarding spaceflight physiol-
ogy are likely, because of the passage of time, to have
been superceded by research that is more recent. However,
because of the limited pool of researchers and flight op-
portunities, the field of space medicine has moved slowly
relative to its earth-based cousin. Thus, while there are
likely to be some physiological insights that are still
worthwhile to present day researchers, the conclusions pre-
sented here, while not necessarily outdated, are not meant
to represent current thinking in the field. Rather, this book
represents, as was stated at the outset, an historic record of
a unique project in NASA’s life science program.
A major contribution of the systems analysis approach
was the organization and integration of various functions
that were not previously available to the space life sciences
program on a systematic basis. Integration was applied to
such categories as multiple physiological disciplines, mul-
tiple models and subsystems, multiple control systems
within those models, multiple environmental and meta-
bolic stresses on the body, multiple hypotheses, and mul-
tiple sources of ground-based and spaceflight data (Fig.
10-1). The most important of these integrating functions
and activities include the following:
a. integration of multiple data sets from different inves-
tigative areas (i.e., cardiovascular, musculoskeletal)
into a common database and analysis system to pro-
vide an interdisciplinary cross correlation capability;
b. integration of multiple physiological and environmen-
tal stresses (i.e., bedrest, water immersion, spaceflight)
to construct an acceptable description of the weight-
lessness response;
c. integration of experimental data with concepts of
physiological control (i.e., biosystem models) in or-
der to compare real-world and theoretical behavior
and generate verifiable predictions;
d. integration of physiological mechanisms relating to
homeostatic control of an organ system within the
framework of a mathematical model, i.e., regulation
of blood pressure by integrating baroreceptors,
chemoreceptors, hormonal control and renal control;
e. integration of physiological subsystem models into a
larger, more complex “whole-body model” to study theo-
retical interactive effects, i.e., integrate cardiovascular,
respiratory, thermal, and fluid volume regulation; and
f. integration of subsystem hypotheses related to zero-g ad-
aptation into a unified theory showing overlapping and
interactive effects between subsystems, i.e., gravity unload-
ing, fluid shifts, metabolism, short and long term effects.
Figure 10-1. Systems analysis is ideally suited for integrating a variety of categories in complex research projects.
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Why is “integration” of such great value? Integration
permits one to systematically examine all the elements
associated with a particular function or activity. Integra-
tion provides a “big picture” perspective from which it is
easier to discern the commonalities and differences of the
subelements and to look for synergies, especially in com-
plex research projects. Systems analysis provided the tools
for integration and resulted in a comprehensive approach
to these complex problems. In NASA life sciences, there
was no other group specifically engaged in an interdisci-
plinary or integrative analysis of a large portion of the
Skylab database.
Of the two categories of end-products mentioned
above, major accomplishments in the first of these, devel-
opment of systems analysis technology, include (see Chap-
ter 3 and Table 10-1):
a) The Skylab Integrated Medical Data Analysis System
(SIMDAS) for interdisciplinary analysis using data-
bases, statistical analysis and modeling systems,
b) The suite of individual subsystem models describing
cardiovascular, fluid-electrolyte, erythropoietic, res-
piratory, thermal, and calcium regulation,
c) Development and validation of a first generation
Whole-Body Algorithm for simulating spaceflight ad-
aptation, and
d) An Integrated Metabolic Balance Analysis System for
reexamining the unique Skylab metabolic balance and
body composition data.
The most notable accomplishments in the second cat-
egory, an improved understanding of the physiological
processes in microgravity, include:
a) A new interpretation of the extensive metabolic and
whole-body measurements from Skylab (Chapter 4);
b) An analysis and interpretation of all data related to
disturbances in body fluid volumes (Chapter 5),
c) Development of hypotheses to explain the loss of red
cells in spaceflight (Chapter 6);
d) Development of hypotheses of the mechanisms lead-
ing to orthostatic intolerance and decreased aerobic
capacity following spaceflight (Chapter 7); and
e) Differentiation between fluid-shift effects of zero-g,
water immersion, supine bedrest and head-down tilt/
bedrest (Chapter 9), and
f) Limited progress was achieved with the more recent
development of a calcium model and analysis of mus-
culoskeletal data (Chapter 8).
As in most large scale studies composed of many com-
ponent parts, there was a flexible approach to each area of
analysis, the path chosen being dependent on the ques-
tions being asked, the models and data available, and the
resolution required for the results. Nevertheless, there were
certain common elements in the approach that can be sum-
marized (below), now that all phases of the project have
been addressed.
Table 10-1. Systems Analysis Technology Developed to Analyze Spaceflight Data
Skylab Integrated Medical
Data Analysis System
Subsystem Simulation
Models
Whole-Body Algorithm
Integrated Metabolic
Balance Analysis System
System Function Significance
? Contains data from spaceflight and
ground-based studies
? Analysis system includes statistical
programs, special purpose programs and
simulation models
• Validated mathematical models for:
− Cardiovascular regulation
− Fluid-electrolyte regulation
− Respiratory regulation
− Thermoregulation
− Erythropoiesis regulation
− Calcium regulation
• Integrates cardiovascular, fluid-electrolyte,
respiratory, thermal, and erythropoietic
regulatory models into one large model
representing the major organ functions of
the body
• Computes metabolic balances for fluids,
electrolytes, nutrients, and energy
• Uses Skylab metabolic balance and
whole-body data
? A database/analysis system that permits automated
interdisciplinary analysis
• Permits a large array of quantitative models to
be applied to solving problems in space physiology
• Permits multi-organ simulation of prolonged flight
adaptation interspersed with environmental (tempera-
ture, gas composition) and clinical (LBNP, exercise)
tests, similar to the Sklylab protocol
• Permits study of interactive effects between
subsystems
• Provides description of time-varying changes in body
composition during zero-g adaptation.
• Estimates dietary and exercise requirements for zero-g
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10.2 Important Factors of the Systems
Analysis Approach
10.2.1 Critical Questions
Certain features of the systems analysis approach were
particularly useful in guiding the evaluation of spaceflight
data. Most importantly, the context of the analysis was
established by the desire to answer several critical ques-
tions that were stated in the Introduction (Chapter 2), which
can be briefly summarized as follows: a) Can the space-
flight findings be explained in terms of disturbances and
responses of well-known homeostatic systems?; b)What
are the common elements in the spaceflight response?; c)
Is there a typical “zero-g response” as revealed by data
from space and ground-based analogs of zero-g?; d) How
can the differences between the responses of the crewmen
from the three Skylab missions be explained?; and f) Can
a unified theory of physiological adaptation to weight-
lessness be formulated?
10.2.2 Critical Subsystem Issues
As a starting point in the analysis of each physiologi-
cal subsystem, an in-depth review was performed to reveal
those “critical issues” in the observed responses that might
become fruitful for more detailed analysis. This review
not only consisted of examining the spaceflight data and
complementary ground-based information but also the
physiological processes and feedback control mechanisms
involved in each physiological area. The mathematical
models were useful in this latter task to help understand
system behavior. A selection of these areas of unusual or
unexplained events that were singled out for special at-
tention in this project are listed in Table 10-2. Many of
the most significant issues that were raised by researchers
prior to and following Skylab are included in this list.
10.2.3 Hypothesis Formulation
These issues were systematically addressed by formu-
lating and evaluating physiological hypotheses. Formu-
lation of hypotheses was facilitated by examining each
physiological system in terms of its regulating features
and model behavior. Critical disturbance points of the feed-
back system could be tentatively singled out for detailed
quantitative analysis by simulation. Spaceflight and
ground-based data were reexamined for evidence to sup-
port the candidate hypothesis. All hypotheses that were
eventually considered were not usually identified at the
start of each analysis, but as part of the iterative cycle of
model simulation and comparison with data as suggested
by the process flow diagrams of Fig. 2-6 and 3-1. With
each reiteration, the model pointed the way to new areas
that lacked clarity. The hypotheses considered and evalu-
ated in each investigative area are summarized in Table
10-3. The detailed analysis of these hypotheses and ef-
fects constituted a major portion of the total effort and led
to the conclusions discussed subsequently in this section.
10.2.4 Integration of Hypotheses
An important objective of these studies was to search
for basic phenomena common to the major physiological
events in space and to determine areas of overlap ripe for
interdisciplinary analysis. In many cases, a hypothesis or
an effect of exposure to weightlessness that was important
in one subsystem was later found to be useful to explain
events in other subsystems. An example of one such over-
lapping area was the reduction in blood volume that was
found to be of central importance in the behavior of the
cardiovascular system, the fluid volume control system,
the erythropoietic system and the metabolic systems. The
most important of these overlapping areas are shown in
Table 10-4. Where a particular effect is not associated with
a specific physiological subsystem in this table, there is
no implication that an association does not exist, only
that it was not examined in this study. Also, certain effects
such as insufficient exercise, inadequate diet, or thermal
disturbances, all of which were present to varying degrees
in the Skylab missions, may not be present on future
flights, so this table is not of general value. Nevertheless,
this tabulation does indicate the degree of hypothesis in-
tegration that was accomplished.
10.2.5 Hypotheses Testing
Evaluation of the hypotheses was accomplished by
several means, including model simulation analysis, sta-
tistical analysis, and, in only a few cases, experimenta-
tion. The use of models was, by far, the most prevalent
technique and the most unique in this project. Hypothesis
testing is normally accomplished, in the case of simula-
tion analysis, by comparison of the computer predicted
responses with those observed experimentally. Models
could predict the consequences of a particular hypothesis
whose plausibility might be questioned if these conse-
quences did not agree with known measurements. Models
could also qualitatively distinguish between alternative
hypotheses. Examples of this type of test include the hy-
pothesis whether red cells that disappeared during space-
flight were regenerated or not while in space or whether or
not exercise training could counteract the degraded exer-
cise performance otherwise seen in microgravity?
Some hypotheses could be tested by simply altering a
parameter value. In other cases new feedback pathways,
such as a naturetic factor, were tested and found to en-
hance the simulation response. Still another approach was
to clamp the value of a normally time-varying quantity to
test its importance in producing certain effects. A number
of useful modeling techniques were used for studying sys-
tem behavior as altered by an hypothesis including sensi-
tivity analysis, dynamic and steady-state responses, and
examination of feedback mechanisms. Once a simulation
was produced with the desired outcome it was easy to as-
sess the relative contribution of individual mechanisms,
thus providing a basis for generating new hypothesis.
The ability of a model to reproduce, in a qualitative
manner, the behavior of a dozen or so measured variables,
added to the robustness of the simulation and the prob-
ability that the hypothesis could be correct. This was much
more useful to this project than quantitatively estimating
the value of a particular parameter, i.e., parameter estima-
tion or curve-fitting. Good agreement between model and
data was not always essential. That is, it is not always
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Table 10-2. Selected Observations from Skylab Experiments Addressed by Systems Analysis
Fluid-Electrolyte System
• Rapid loss of water early in flight
• Much larger decrease in leg fluid volume compared to bedrest
• Absence of measurable diuresis following headward fluid shifts contrary to expectations
• Unusual combination of hormonal changes compared to bedrest and water immersion
• Presence of hyponatremic plasma maintained throughout flight
• Increased water and sodium excretion throughout mission without continuous body losses
• Differences in ADH response between missions
• Decreased evaporative water loss in presence of hypobaric atmosphere
• Disproportionate losses of potassium and cell water
Cardiovascular System
• Absence of acute cardiovascular disturbances expected from headward fluid shifts
• Decreased orthostatic tolerance as measured by LPNP tests during flight and recovery
• Maintained aerobic capacity during flight despite decreased blood volume and decreased orthostatic tolerance
• Decreased aerobic capacity immediately following flight
• Differences in aerobic capacity among the three Skylab missions
Erythropoietic System
• Blood volume loss, as measured by plasma volume and red cell mass losses, not related to mission duration
• Inflight loss of red cell mass despite normoxic environment
• Delay in postflight recovery of red cell mass on shortest mission
• Significant differences in rates of red cell loss among the three Skylab crews
Musculoskeletal System
• Progressive loss of calcium from body
• Urinary calcium stabilizes at elevated level while fecal calcium increases progressively with flight duration
• Changes in PTH during spaceflight dissimilar to changes in bedrest
• Apparent decreases in rates of nitrogen losses as a function of flight duration and increasing levels of exercise
Body Composition
• Apparent disproportion in rates of water, muscle, and fat losses in relation to their normal ratio in body tissues
• Decreases in body mass losses with flight duration
• Water losses in astronauts apparently independent of flight duration
• Large differences in body composition changes between the crews of the three Skylab missions
• Body composition changes related to differences in diet and exercise on each mission
• Apparent similar energy requirements in zero-g and one-g contrary to prior belief
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Cardiovascular System
1. Acute cardiovascular disturbances expected from headward
fluid shifts
2. Long-term adaptation of blood volume, pressures, and
flows expected from:
a) stress relaxation
b) baroreceptor and volume receptor resetting
c) autoregulation of blood flow
d) changes in metabolic activity
3. Decreased orthostatic tolerance and maintained aerobic
performance during flight due to:
a) reduced blood volume
b) collapse of leg veins
c) increased compliance of leg veins early in flight
d) retoning of leg veins and reduction of unstressed volume
late in flight
e) altered sensitivity of baroreceptors
f) continued activity from cardiopulmonary volume
receptors
g) hemoconcentration opposing blood loss to maintain
oxygen delivery
4. Effects of inflight exercise training:
a) enlarged heart
b) increased contractility of the heart
c) reduced sympathetic activity
d) decreased arteriolar vasodilation during exercise
e) increased leg capillary density
f) increased vagal activity at rest
5. Postflight decreased aerobic performance and orthostatic
tolerance:
a) reduced blood volume
b) increased sympathetic activity affecting heart and
peripheral vessels
c) incomplete compensation of venous capacitance for
reduced blood volume
Fluid-Electrolyte System
1. Changes in renal excretion, hormone secretion, body fluid
volumes, and fluid composition observed in flight due to:
a) headward fluid shifts
b) loss of extracellular fluid and sodium
c) loss of cellular electrolytes
d) presence of a natriuretic factor
e) decreased evaporative water and electrolyte sweat
losses
f) anorexia early in flight
g) altered ratio of fluid/electrolytes in diet
h) preflight dehydration
i) hyponatremia of extracellular fluid
Table 10-3. Hypotheses Tested by Simulation, Metabolic, or Statistical Models
Erythropoietic System
1. Inflight loss of red cell mass resulting from:
a) hemoconcentration
b) increased arterial oxygen tension
c) shifts in oxy-hemoglobin affinity
d) increased renal blood flow
e) inadequate diet
f) inadequate exercise
g) altered bone-marrow responsiveness
h) hemolysis early in flight
i) loss of lean body mass
j) regeneration theory vs. continuous loss theory
2. Postflight recovery kinetics affected by:
a) hemodilution
b) delay in plasma volume recovery
c) hemolysis
d) bone marrow transit time delay
e) increased oxy-hemoglobin affinity
f) ineffective erythropoiesis
Musculoskeletal System
1. Atrophy of muscles and bone induced by:
a) gravitational unloading
b) postural disuse
c) exercise disuse
d) inadequate diet
e) high levels of cortisol
f) muscle-bone interaction
2. Loss of calcium caused by:
a) decreased intestinal absorption
b) inhibited vitamin D production
3. Increased fecal calcium results from decreased intestinal
absorption mediated by inhibited vitamin D production.
4. Feedback influence of parathyroid hormone may limit
calcium loss.
5. Calcium loss does not stabilize and may become
progressive.
6. Muscle loss stabilizes with increasing flight duration.
Body Composition and Energy Metabolism
1. Are rates of water, muscle, and fat losses proportionate to
ratio in body tissues?
2. Can body fat losses be predicted from energy balance
considerations?
3. Is water loss independent of flight duration?
4. Are the various methods for estimating lean body mass losses
(total body water, total body potassium, biostereophotometry,
nitrogen balance, potassium balance) in agreement?
5. Is muscle loss dependent on the level of inflight exercise?
6. Does the anorexia of motion sickness significantly influence
body composition changes?
7. Are energy requirements in zero-g and one-g similar?
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necessary that the model be an exact description of real-
ity. The most valuable results occurred when simulations
did not match expectations and when there were surprises.
The heuristic characteristics of modeling added value by
suggesting improvements to the models, new hypotheses,
and new experiments even if agreement was poor.
In most laboratories, hypotheses are tested by design-
ing new experiments on the back of the results of the last
experiment. This was not a feature of the current project
because it was planned as being a more theoretical study
and experiments in space were many years apart. However,
collaborations with several investigators who performed
human and animal studies led to the ability for systems
analysis to contribute to new experiments, in one case this
consisted of erythropoiesis studies in the mouse (see Chap-
ter 6.5.4) and in another case, to a head-down bedrest study
in humans (see Chapter 9.7). Results of those studies, in
turn, led to refinements in hypotheses and modeling stud-
ies. Modeling was also useful in designing protocols for
advanced flight experiments on the Shuttle Spacelab. In
the only case highlighted in this book, the erythropoiesis
model helped formulate the blood draw protocol for a he-
matology experiment so that blood sampling would not
skew the results (see Chapter 6.5.6). Recommendations
for the next generation of flight experiments were gener-
ated in most areas studied (the reader is referred to Appen-
dix G for more detail). In addition to hypothesis testing
and recommendations for future experiments, there are a
couple of examples in which the models were utilized to
evaluate the plausibility and efficacy of countermeasures
against orthostatic intolerance (see Chapters 7.5.4 and
9.7.6). Taken together, these capabilities for hypothesis
testing resulted in a greater utilization of valuable infor-
mation acquired from spaceflight.
10.2.6 How Models Shaped Data Analysis
Models were very useful in indicating which data was
most crucial. The hypothesis testing approach often re-
quired dietary, metabolic rate, or environmental data to
drive the simulation, and still other types of data with
which to compare the model responses. This often led to
reexamining data that was not readily obtainable or that
had already been analyzed by more traditional, e.g., sta-
tistical, methods. Satisfying these data requirements led,
in one instance, to the integrated metabolic balance analy-
sis for describing body composition changes during space-
flight. In another situation, the study that led to an analysis
of evaporative water loss in the Skylab crew was suggested
originally by the need to validate the sweating mecha-
nism in the thermoregulatory model for weightlessness.
Both of these unanticipated analyses provided results that
proved useful in their own right as well as contributing to
improved simulations.
10.2.7 Simulation of Analog Studies
An important part of the analysis was the simulation
of a number of different ground-based studies, each re-
lated to the spaceflight stresses in some important manner.
These one-g studies often provided more abundant data
than were available from spaceflight investigations. In ad-
dition, they were helpful in understanding the basic re-
sponses, both in the human and in the model, to simple or
well-known environmental and metabolic disturbances
without the confounding influence of spaceflight. Thus,
in the case of studying acute fluid shifts in spaceflight
and upon recovery, some important experimental situa-
tions examined included the responses to fluid loading,
hemorrhage, and postural changes. Similarly, in the analysis
of erythropoietic regulation during weightlessness, it was
found useful to review the results from red blood cell infu-
sions, dehydration, and descent-from-altitude studies.
Some ground-based studies were specifically designed to
simulate weightlessness. These hypogravic stresses in-
cluded supine and head-down bedrest and water immer-
sion. These stresses have some common characteristics of
spaceflight, namely, a reduction in hydrostatic gradients
Table 10-4. Examples of Integrated Quantitative Hypotheses Testing
Body
Skylab Hypothesis or Effect
       System
1. Effect of Gravity Vector Per Se X X X X
2. Effect of Headward Fluid Shifts X X X
3. Effect of Blood Volume Loss X X X
4. Effect of Atrophy and Cell Demineralization X X   X
5. Effect of Exercise Conditioning X X X   X
6. Effect of Metabolic Rate X X X X   X
7. Effect of Diet X X X   X
8. Effect of Thermal Disturbance X X   X
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and a rapid headward shift of fluid. Some of these studies
emphasized the short-term phase of hypogravity while
others described the longer-term processes. Taken together
these analog studies provided a better understanding of
the complete temporal spectrum of hypogravic responses.
Confidence in the computer simulations were achieved
by validating the models for such a wide variety of experi-
mental and clinical conditions. A partial list of these simu-
lations is presented in Table 10-5. The simulation models
helped to reveal the regulatory processes operative in these
situations and provided a quantitative basis for testing
whether the same mechanisms were operative in spaceflight.
10.2.8 Testing Differences Between Missions
The goal of much of the analyses was to isolate and
identify the effects of microgravity, but this was not al-
ways possible because of the confounding effects of varia-
tions in diet, exercise and flight duration among the
Skylab crewmembers. In cases where these factors seemed
important (such as in studying body composition, eryth-
ropoiesis regulation, or cardiovascular responses to exer-
cise) each mission was examined separately. A considerable
effort was made to account for diet and exercise in as quan-
titative a manner as possible. For example, a systematic
study was undertaken to document a composite or aver-
age level of crew diet on a daily basis, including the ca-
loric (i.e., fat, carbohydrate, and protein) and non-caloric
(water, electrolytes) components. These data were then
utilized as model forcing functions to obtain more realis-
tic simulations of the fluid-electrolyte regulatory response.
In the case of erythropoiesis regulation, the interpretation
of the differences between red cell mass loss on the three
missions was accomplished, in part, on the basis of exer-
cise and dietary considerations using both statistical and
mathematical modeling techniques. Similarly, the cardio-
vascular stress test results suggested an involvement of
exercise conditioning effects that was examined by devel-
oping “physically trained” and “physically untrained”
cardiovascular models. These analyses all pointed toward
specific hypotheses implicating dietary and exercise fac-
tors and recommendations for controlling these factors in
future flight experiments.
In addition to the effects of duration, exercise and
diet, there were other differences between spaceflight and
ground-controls. The Skylab environment also included
reduced ambient pressures, increased oxygen and carbon
dioxide ambient gas tensions, isolated instances of el-
evated temperatures, and transient but large variations in
gravitational stress forces at launch and re-entry. In some
cases it was possible to reassess the Skylab data by ac-
counting for these known changes, especially for the eryth-
ropoiesis analysis. Just like diet and exercise, the models,
especially the Whole-Body Algorithm, included param-
eters that could adjust for these changes. While several of
the individual models were useful in this regard, the analy-
sis, unfortunately, did not progress to the point where the
Whole-Body Algorithm was utilized for a more compre-
hensive analysis.
10.2.9 Time-Dependent Analysis
It proved advantageous in a number of cases to seg-
ment the analysis into short-term (or acute) and long-term
(or chronic) response periods. This concept was based on
the suggestion from modeling studies, that showed that
the mechanisms that participate in the short-term response
(the time during which the most prominent fluid and cir-
culatory disturbances occur) are different from those that
lead to adaptation during prolonged spaceflight. Also, the
most dramatic disturbances in the body seem to occur dur-
ing the first several days following launch and reentry.
This suggested a logical division of the spaceflight pe-
riod into acute and chronic segments as a convenient
method of examining the spaceflight data and performing
computer simulations. (Also, in general, physiological pro-
cesses appear to be much better understood for acute
changes, than for long-term adaptation). The models ca-
Table 10-5. Stresses Related to Spaceflight that were Studied Using Simulation Models
• HYPOGRAVIC STRESS
- Supine Bedrest
- Head-down Tilt/Bedrest
- Water Immersion
- Spaceflight
• ENVIRONMENTAL DISTURBANCES
- Hypoxia
- Hypercapnia
- Temperature
-  Ambient Pressure
•  ORTHOSTATIC STRESS
- LBNP
- Tilt Table
- Postural Change
- Centrifugation
- Shuttle Reentry
•  FLUID SHIFTS (NON-GRAVIC)
- Hemorrhage
- Fluid Infusions
- Water and Salt Loading
- Dehydration
• METABOLIC STRESS
- Exercise (Trained & Untrained)
· Diet Restriction
•  ERYTHROPOIETIC STRESS
- Altitude Hypoxia and Descent
- Red Cell Infusion
- Erythropoietic Injection
- Anemia
- Polycythemia
- Hemoglobin disorders
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pable of simulating both short and long-term responses
are the circulatory, fluid, and electrolyte model, the eryth-
ropoiesis model and the calcium regulation model; the
remaining models, the pulsatile cardiovascular model, the
respiratory model and the thermoregulatory model are ca-
pable of simulating only short-term responses.
10.3 Major Conclusions from
Physiological Systems Analysis
This study addressed most of the physiological systems
that have been extensively examined during previous
spaceflights, particularly during the Skylab program. For
purposes of summation, the investigative areas will be
grouped into the same five categories used throughout
this volume: fluid-electrolyte regulation, erythropoiesis
regulation, cardiopulmonary function, musculoskeletal
function, and body metabolism and composition (see Table
2-1). Table 10-2 indicates the broad spectrum of physi-
ological issues and adaptive processes that were consid-
ered in each area, although these did not always coincide
with the original objectives of the corresponding Skylab
experiments.
As shown in Table 10-6, the study of the fluid-electrolyte
system emphasized the regulation by renal and endocrine
controllers, of fluid volume compartments and electrolyte
composition as well as differentiating between acute and
chronic responses. The cardiopulmonary systems analysis
was directed at the study of circulatory regulation during
rest in zero-g and as a result of orthostatic challenges and
exercise stress testing. The analysis of the erythropoiesis
regulatory system covered one major issue, that is, the
loss of red cell mass during exposure to zero-g. In order to
address this issue, however, the entire schema of erythro-
poietic, blood volume, and oxygen transport regulation
had to be considered as well as energy balance effects. Of
concern in the musculoskeletal area was the precise de-
scription of hard and soft tissue loss. In the case of bone
demineralization, formulation of a quantitative model of
calcium regulation was in its initial stages of validation.
“Why do astronauts lose weight in space?” was the central
question addressed by the extensive analysis of metabolic
balance and body composition. A more detailed list of
topics and accomplishments in each area can be found in
Appendix G. The major conclusions and the interpreta-
tion of the spaceflight findings emanating from this study
are summarized in the sections that follow, first in terms of
the individual physiological subsystems and then as an
integrated hypothesis.
Conclusions drawn from the interpretation of the
spaceflight data should be accepted with caution, as they
are limited, in large part, by a number of constraints im-
posed on the collection of data. For example, with regard
to the Skylab missions:
a) There were a relatively small number of subjects on each
flight, making statistical treatment of the data difficult,
especially for findings beyond the first 28 days.
b) The restriction on invasive measurements, as well as
on measurements collected early in the mission lim-
ited the amount of useful data that could be collected.
That is why simulation models and supplementary data
from zero-g analogs became so critical.
c) Conclusions drawn from the data need to be limited
to the relatively homogeneous population of the as-
tronaut subjects – i.e., physically fit men in their late
thirties. Generalization to broader populations in terms
of age, sex and physical training involves some addi-
tional uncertainty.
d) There were differences between the three Skylab mis-
sions (such as ambient temperature excursions, space
motion sickness, daily caloric intake, and levels of
personal exercise) that undoubtedly increased the vari-
ance of the data for the combined crewmembers.
e) A number of factors were present in spaceflight in ad-
dition to weightlessness (see last section) but experi-
mental controls to account for these were not
completely successful. Thus, it is not possible to offer
definitive conclusions regarding a spaceflight effect
as arising solely because of gravitational changes.
In addition, there are limitations and errors associated
with the methods of analysis used in this project. These
will be discussed later in this chapter. The physiological
processes described below are gleaned from three sources:
Fluid-Electrolyte System
Body FIuid VoIume Regulation
Body Fluid Electrolyte Regulation
Renal and Endocrine Control
Acute vs Chronic Responses
Cardiopulmonary System
Circulatory Status at Rest in Zero-g
Response to Orthostatic Tolerance Test (LBNP)
Response to Shuttle Reentry
Response to Metabolic Stress (Exercise)
Exercise Training Effect
Erythropoiesis Regulation
Blood Volume Loss
Erythropoiesis Regulation
Renal vs Bone Marrow Effects
Musculoskeletal System
Soft Tissue Losses (Lean Body Mass)
Bone Demineralization and Calcium Regulation
Body Composition
Energy Balance (diet and exercise)
Water and Electrolyte Balance
Dynamics of Body Composition Changes
Components of body mass loss
Table 10-6. Investigative Areas and Issues Considered in Study
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spaceflight data, primarily from Skylab; ground-based data,
largely from studies of water immersion, head-down tilt
and bedrest; and simulation studies, principally using the
appropriate subsystem (stand-alone) mathematical model.
The analyses on which these descriptions are based are
described in detail in the previous chapters (Chapters 4 to
9). These summaries serve as the conclusions of those chap-
ters. While today, many of the tentative conclusions dis-
cussed in the next sections may appear either well-accepted
or outdated, they were considered to be novel when the
original research was completed 20 years ago.
10.3.1 Fluid-Electrolyte Response
to Weightlessness
A major emphasis of this project was an understand-
ing of the control of whole-body fluid-electrolyte metabo-
lism during the acute and adaptive phases of spaceflight.
Figure 10-2 is a schematic of the body’s fluid compart-
ments and all the routes of fluids and electrolytes entering
and leaving these compartments and the body itself. A
knowledge of the alteration of the body’s fluid volumes is
central to an understanding of weightlessness by virtue of
its influence on the circulation. Therefore, identifying the
status of the body’s fluid systems in spaceflight, and how it
changes over time, became an important goal in this project.
As indicated in Fig. 10-2, this would include knowledge of
the volume and electrolyte composition of several fluid com-
partments (plasma, interstitial, intracellular) and the major
flow paths for water and electrolytes (dietary inputs, meta-
bolic water, fecal loss, urine excretion, and evaporative
water) into and out these compartments.
Although this approach was not part of the original
experimental design on Skylab, it was thought that inno-
vative data analysis techniques combined with judicious
use of the simulation models could identify most of these
compartments and pathways and thus, an approximation
of the fluid volume status during spaceflight. In addition,
the mathematical models, containing the physiological
control systems (hemodynamic, neural, hormonal) that
regulate the quantities shown in Fig. 10-2, could provide
critical insight about the regulatory behavior of the entire
system. A fundamental analysis of fluid control in space
can be found in Chapter 5 while the application of these
principles to simulation studies of different types of
hypogravity are presented in Chapter 9.
Analysis of this disciplinary area, including circula-
tory adjustements, benefited from separating the regula-
tory behavior  into an acute phase and a chronic, adaptive
phase. The Guyton model was well suited for this two-
pronged approach, because, it, more than any other model
in our repertoire, included a number of long-term adap-
tive mechanisms that appeared to have as significant a
role in spaceflight as they do on earth.
10.3.1.1 Acute Response. There is unequivocal evidence
that hypogravic stresses such as bedrest, water immersion,
and spaceflight result in significant fluid redistribution
within the body. The removal or reduction of the hydro-
static pressure in the blood column, coupled with the normal
tissue elastic forces and muscle tone of the lower body, re-
sults in shifts of blood and tissue fluid from the lower body
to the intrathoracic circulation. The consequences of this
event are widespread and long lasting, as suggested by Fig.
10-3, which is based on water immersion and head-down tilt
studies as well as model simulations. As a result of acute
central volume expansion, the following complex sequela
of neuro-humoral reactions occur with rapid secondary
changes in the cardiovascular and renal systems:
a) Decreased sympathetic outflow to the kidneys, pe-
ripheral vessels, and heart leading to peripheral
vasodilation
b) Increased venous return leads to enhanced cardiac
output,
c) Reduced secretions of renin, angiotensin, aldoster-
one and ADH promoting vasodilation and elimina-
tion of water and salt,
d) enhanced renal excretion of fluid and electrolytes as
Figure 10-2. Fluid-electrolyte characteristics of the human body. Assessing the values of all the volumes and flow rates indicated here
and how they changed during the course of a long spaceflight became an important goal of this project.
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a result of the alterations in sympathetic activity, hor-
mone secretion, and blood pressures and flows;
e) increased transcapillary filtration of plasma into the
interstitium favored by increased hydrostatic pres-
sures, and
f) a decrease in thirst following reduction in angiotensin
levels and augmented by space motion sickness
anorexia.
Thus, the volume controllers near the heart interpret
the headward shifted fluids as excess volume and activate
three potential pathways to reduce the blood volume in-
cluding capillary filtration, renal excretion and a thirst
mechanism. Of these, the renal mechanisms are the most
complex and powerful and can be further separated into
three groups, mediated by neural, hormonal, and hemody-
namic factors. The net result of these processes is the loss
of extracellular fluid and electrolytes, which has been ob-
served frequently following weightless spaceflight. Ac-
cording to model simulations these fluid adjustments tend
to reduce central blood volume to normal levels, thus op-
posing the notion that central hypervolemia may lead to
cardiopulmonary fluid congestion.
Measurements were not possible on Skylab during the
first few hours, but based on 24-hour pooled urine voids,
urine flow in the Skylab crew was not increased during the
first several days. Does this invalidate the fluid-shift theory
described above? Although experimental evidence for this
theory is sparse during spaceflight, it is possible to make
generalizations concerning the contribution of the three
major pathways shown in Fig. 10-3.
a) Transcapillary Filtration. Simulations predict that
the role of transcapillary filtration is minor and self-
limiting as a means of relieving central hypervolemia
unless transcapillary protein permeability increases
dramatically. Modeling studies showed that hemocon-
centration results from the shift of blood from the legs
but not from the shift of previously pooled leg tissue
fluid, although both fluid pools are mobilized. If
plasma colloids are also concentrated by the same
mechanisms, the model predicts a dramatic attenua-
tion of filtration into the tissues of the upper body
early in flight. Alternatively, the model allows for the
possibility of an increase in capillary protein perme-
ability that actually enhances filtration and further
depletion of plasma volume. In either case, the simu-
lations predict that, in the absence of edema, the total
amount of fluid that can be accepted into the intersti-
tium is limited.*
b) Thirst Mechanism and Drinking. It can be easily
computed from the measurements of water balance,
that the entire loss of body fluids observed in the
Skylab crew could be accounted for by deficit fluid
intake (possibly as a result of space motion sickness,
a volunteer curb on fluid intake, or some mechanism
peculiar to hypogravity) rather than renal excretion.
c) Renal Mechanism. Model and ground-based stud-
ies suggest that if thirst is not a factor, a renal diuresis
is likely to be the preferred pathway of fluid regula-
tion in the well-hydrated subject. Computer simula-
tion analysis of the early flight period agrees with the
findings from daily-pooled inflight urine samples that
there is a suppression of renal excretion of water and
sodium during the first several days. However the model
also predicts a distinct diuresis during the first six hours
that follow acute heardward fluid shifts, and that this
diuresis is reduced but not abolished with a decrease in
fluid intake, i.e., dehydration. It is postulated that a di-
uresis was not observed because void-by-void urine
samples could not be obtained and because an early
diuresis would be masked in a 24-hour pooled sample
in the presence of diminished fluid intake. The
short-term renal response to spaceflight in well-hy-
drated subjects has only recently been studied.*
Based on model analysis and postflight measurements,
plasma volume is depressed about 0.5 liters throughout
the flight (see Figs. 10-5 and 10-15). The failure of plasma
volume to return to normal during prolonged flight (even
with ad libum fluid intake) is presumptive evidence of the
fluid-shift hypothesis of Fig. 10-3 involving blood vol-
ume controllers and perhaps a change in volume set-point.
Failure to demonstrate any of the particular mechanisms
such as reduced ADH or a diuresis during the acute stress
phase does not necessarily invalidate the overall theory,
because alternative pathways can be activated to achieve
the predicted plasma volume loss. Thus, although an ex-
pected diuresis has not yet been observed early in flight,
volume receptors and renal excretion pathways may be
continually responding to the tendency for fluids to pool
headward and thereby act to maintain a reduced blood
volume. The renal pathway for controlling blood pressure
(and thereby controlling blood volume) has been shown
by Guyton to be the only mechanism in the body to have
infinite gain, meaning it is capable of 100% correction of
any deviation from control values (see Chapter 5).
Whatever the mechanism, most of these early fluid losses
from the blood and from the body, appear to be ultimately
derived from observed decrements in leg volume involving a
contraction of the plasma, interstitial, and possibly intrac-
ellular fluid spaces of the lower limbs. Almost the entire
decrement of body water and sodium that occurs during
the flight, representing extracellular losses occurs within
the first two days after the onset of weightlessness. At the
end of this period, the legs and the body will have lost
nearly 1.5 liters of fluid. Symptoms of distention of neck
and head veins, facial puffiness, and a feeling of conges-
tion in the head indicate the tendency of fluids to con-
tinue to pool in the upper body. In addition, during the
early stages of flight, it can be deduced that significant
quantities of potassium are escaping from intracellular
compartments, bringing with it cell fluid. These early losses
* Recent flight experiments on the Shuttle Spacelab could not confirm either
a microgravity-entry diuresis nor an increase in central blood pressures. See
Chapter 9 endnotes and Chapter 7 for more recent findings on the acute phase
of fluid and circulatory changes during spaceflight.
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of intracellular fluids may also be derived, in large part,
from the legs, i.e., muscle atrophy of lower limb postural
muscles. The leg compartments, therefore, would seem to
play a critical and broad role in the acute fluid response.
10.3.1.2 Longer-Term Response. The long-term adap-
tive phase can be considered to begin after the initial loss
in body fluids. This phase is characterized by maintenance
of extracellular volume and electrolyte composition at new
homeostatic levels, a return to body water balance although
the components of that balance (i.e., intake, sweat, excre-
tion) are reset to new levels, and a continued loss of intra-
cellular material in response to reduced zero-g mechanical
loading effects. Nitrogen and potassium balances demon-
strate that the greatest cellular losses occur during the first
month in space, undoubtedly a result from disuse atrophy
of the musculoskeletal organs. Hormonal agents, especially
those affecting circulatory and renal function, are disturbed
from their preflight levels and undoubtedly participate
importantly in the adaptive processes. For example, an-
Figure 10-3. Hypothesis diagram to illustrate how headward fluid shifts induced by weightlessness lead to a decrease in plasma volume.
The three major pathways that lead to decreased plasma volume, thirst mechanism, renal mechanisms and transcapillary filtration are
discussed in the text. While most of the neural-endocrine-hemodynamic mechanisms shown here are short-lasting, certain quantities,
such as decreased leg volume, head-fullness, and decreased plasma volume are observed over long periods. Enclosed quantities were
measured during flight or postflight on Skylab crew.
WEIGHTLESSNESS ON ONE-G ANALOG
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giotensin and aldosterone have reversed direction from
the acute stress phase and are now elevated, although ADH
remains suppressed.
A number of important observations during this pe-
riod (from Skylab) are indicated in Fig. 10-4 (top). At the
bottom of the illustration are five hypotheses that were
formulated and evaluated in the modified Guyton model
(see Chapter 5.4.2) in order to reproduce the observations.
The connecting lines show the hypotheses that are associ-
ated with a particular physiological change. In a few cases,
indicated by lines that join each other, there are multiple
factors underlying a particular observation. Figure 10-5
shows a number of computer simulations of spaceflight,
illustrating most of the quantities shown in Fig. 10-4. The
dynamic changes in both short and long-term phases of
flight are reasonable representations of the observed find-
ings that may have occurred in the Skylab crew (compare
with data in Chapter 5.1.2). The most significant conclu-
sions that were obtained from these simulations, especially
those related to the long-term fluid-electrolyte response
in hypogravity are discussed below:
a) As noted above, plasma volume does not appear to
return to normal but rather is reduced by about 500 ml
throughout prolonged spaceflight; the resulting hemo-
concentration profoundly effects the oxygen supply-
demand balance leading to erythrosuppression.
b) Metabolic balance studies indicate that sodium losses
stabilize within several days of flight (see Fig. 10-10).
This implies that extracellular fluid volumes also reach
a new equilibrium level.
c) Longer-term intracellular fluid losses may be expected
to occur because of cellular degradation (i.e., from
muscle disuse atrophy) augmented by high circulat-
ing levels of cortisol and from osmotic loss of water
following a primary release of osmolar substances, e.g.,
potassium, from cells.
d) A release of potassium from the intracellular compart-
ment (and from the body – see Fig.10-10) continues
throughout the flight and can help account for many
long-term effects observed in the Skylab crew. These
effects include increased renal excretion of potassium,
decreased body potassium, decreased intracellular
fluid, increased plasma potassium, and enhanced al-
dosterone secretion.
e) The proportion of potassium loss to intracellular wa-
ter loss measured in the Skylab crew was successfully
simulated only when body fluids were allowed to be-
come mildly hypo-osmotic. Plasma hypo-osmolarity
and hyponatremia were consistently observed in the
Skylab crew and also in some bedrest studies. It was
necessary to postulate a natriuretic factor not previ-
ously included in the model, in order to reduce plasma
sodium concentrations in accord with Skylab mea-
surements.
f) Without the presence of a naturetic factor is it not
clear why hyponatremia persists during prolonged
hypogravity inasmuch as ADH and aldosterone are
normally capable of correcting this condition. Dilu-
tion of body fluids may be considered a sacrifice of
osmo-control for fluid volume control. Excreting a
dilute urine, the normal response to reflexly correct
hyponatremia, may not be possible in spaceflight be-
cause of the additional loads on the kidney resulting
from dietary and sweat alterations and musculoskel-
etal degradation. However, chronically maintained
hyponatremia was shown in model simulations to ex-
ert a long-term suppressant effect on ADH and cause
hypersection of renin-angiotensin and aldosterone, as
well as a depressed thirst drive, all of which are in
accord with the Skylab findings.
g) Aldosterone secretion is increased not only due to
hyponatremia, but also to hyperkalemia, the latter re-
sulting in large part from release of cellular potas-
sium. Also, aldosterone appears to be exerting its main
effect on potassium rather than sodium excretion. In
addition, the model also predicts that the observed
increase in angiotensin levels exerts a long-term
hyper-secretory effect on aldosterone.
h) Several lines of indirect evidence strongly suggest
that inflight evaporative water losses and electrolyte
sweat losses were reduced from preflight levels. This
is significant, since it was previously expected that
evaporative water losses would be greater in the hy-
pobaric environment of Skylab. Although respiratory
and skin diffusion losses may have been increased
during sedentary activity, it was postulated that the
magnitude of sweat loss reduction was even greater,
leading to a net daily reduction in evaporative water
loss. An analysis of factors directly associated with
weightlessness (i.e., lack of sweat drippage, absence
of natural convection, and biochemical effects) sug-
gest a sweat suppression effect secondary to a high
degree of skin wetness.
i) Renal losses of water and sodium were somewhat in-
creased during the adaptive phase of flight. However,
this did not indicate continued loss of these substances
from the body inasmuch as sweat losses may have been
correspondingly reduced, as suggested from metabolic
balance studies. The simulation model demonstrated
that renal excretion of water and salts could be accu-
rately predicted from a knowledge of dietary intake
and estimated sweat losses.
j) Interstitial fluid volume (not including the leg tis-
sues) tends to return to normal within several days
after a major volume disturbance such as that which
occurs during the onset of weightlessness. The factors
involved in this adjustment include: lymph flow, el-
evated plasma colloidal osmotic pressures, and
physio-chemical forces between gel and free fluid in
the interstitium. The simulation model (Guyton) does
not include a separate head compartment and there-
fore did not assess the degree of tissue swelling in this
region as was noted in the Skylab crew.
k) The systems analysis suggests that the major renal-
regulating hormones (aldosterone, angiotensin, and
ADH) represent a tightly coupled system that responds
acutely to volume (i.e., pressure disturbances) and
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chronically to electrolyte disturbances. During
hypogravic maneuvers, this leads to an initial sup-
pression of hormone levels (resulting from headward
fluid shifts and central blood volume expansion) and
a long-term effect that varies depending on metabolic
factors, e.g., diet, sweat loss, physical activity, and
muscle atrophy, that can alter the plasma electrolytes
and thus influence hormone behavior. This shift from
volume/pressure control to osmo-control creates com-
plex and often competing stimulating factors that can
result in a multi-phasic pattern of hormone response
(see Fig. 10-5, bottom graph). The computer simula-
tion of the Skylab missions revealed that the combi-
nation of hyperkalemia and hyponatremia can account
for the levels of these hormones during the chronic
phase of flight.
The reader is also referred to Table 5-10 for a com-
prehensive summary of observed changes in various
indices of fluid-electrolyte status observed in the
Skylab crew together with interpretations from the
present analysis.
10.3.2 Hematology
The most important hematological finding during
Skylab was a reduction in the circulating blood volume
and red cell mass (RCM) during the inflight period. Be-
fore Skylab, the working hypothesis was that the pure oxy-
gen gaseous atmospheres in the Gemini and Apollo space
capsules represented a toxic stimulus and resulted in early
destruction of significant numbers (as great as 20% loss)
Figure 10-4. Schematic illustration of the special hypotheses (bottom) that were introduced into the Guyton model in order to simulate
the set of observations (top) obtained during the Skylab experiments. All of the observations and hypotheses considered here are
associated with the chronic phase of spaceflight, with the exception of anorexia that refers to the reduced dietary intake resulting during
the first few days of flight. In the first Skylab mission, however, reduced dietary intake persisted throughout the mission. Refer to
Chapter 9.4 for details. Suppressed red cell mass is discussed in Chapter 10.3.2.
Figure 10-5. Simulations of the Skylab mission using the Guyton
model. The model incorporated the hypotheses indicated in Fig.
10-4. This is a composite of the simulations shown and discussed
in Chapter 9.4, using fluid and electrolyte balance data from the
nine Skylab astronauts. All of the quantities shown, except for
blood volume, were measured directly or indirectly during space-
flight and they agree with observations (see Table 9-5).
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of red cells. For the Skylab crewmen who lived in a
normoxic environment, this hypothesis was no longer ten-
able to explain their (11%) loss of red cell mass. In the
absence of a consistent finding of increased red cell de-
struction, it was assumed that this loss was likely a result
of suppressed erythropoietic activity. However, no con-
clusive proof of this theory is available and no one mecha-
nism has been identified which is consistent with all the
data. Therefore, examination of this issue was included in
the systems analysis project (see Chapter 6).
10.3.2.1 Approach. In the absence of inflight measure-
ments (only pre- and postflight measurements were made),
the time course of blood volume, plasma volume and red
cell mass changes during the Skylab missions were pre-
dicted by the modified Guyton model (see previous sec-
tion and Chapter 5) and the model of erythropoiesis
regulation (see Chapter 6). Several approaches were uti-
lized using the theoretical model of erythropoiesis regu-
lation to help understand the mechanisms that were likely
to have produced these changes. These approaches in-
cluded: (a) parameter sensitivity analyses, which helped
identify the factors most likely to have a sensitive influ-
ence on erythropoiesis; (b) dynamic simulation of experi-
mental studies such as altitude hypoxia, descent from
altitude, and red cell infusions which validated the model
and helped reveal behavior of the real system; and, (c)
collaboration with investigators, performing human bedrest
and food-deprived rodent studies, to test in the biological
system those hypotheses suggested by the computer
model. Examination of this relatively simple model re-
vealed that diminished erythropoiesis activity (the pre-
vailing hypothesis for spaceflight RCM loss) can be caused
indirectly by hyperoxia of a renal oxygen sensor via eryth-
ropoietin, acting on the bone marrow, or by direct alter-
ation of stem cell kinetics at the marrow controller. Both
of these pathways were examined.
10.3.2.2 Renal Hyperoxia. A central finding from these
theoretical and experimental studies was that moderate
increases in hematocrit (11.5% on Skylab) resulting from
an acute loss of plasma volume, if unopposed by other
factors involving oxygen delivery to tissues, can propor-
tionately increase oxygen tension at a renal sensing site
(i.e., tissue hyperoxia) and exert a sensitive suppressant
effect on erythropoietin and red cell production (Fig. 10-
6). The erythropoietic regulatory system may be viewed,
when operating in this fashion, as a hemoglobinometer;
i.e., red cell production and hemoglobin concentration
decreases to eventually relieve the hyperoxic condition.
According to this notion, the suppressive effect on eryth-
ropoiesis lessens with flight duration as the hematocrit
approaches preflight levels; this is accompanied by a di-
minished red cell mass. The accuracy of the prediction of
the degree and time course of red cell loss was improved
by insuring model agreement with the spaceflight obtained
hemoglobin measurements. Nevertheless, the lack of cor-
roborating inflight plasma volume measurements makes
the prediction problematic. In any event, modeling and
bedrest studies suggest that RCM during spaceflight will
decline in a linear fashion and stabilize as hematocrit nor-
malizes. Therefore, the Skylab finding of red cell loss can
be tentatively explained in terms of normal feedback regu-
lation of the erythropoietic system in the face of sustained
decreases in plasma volume.
The ability of hemoconcentrated blood to suppress
erythropoietic activity was qualitatively similar in a num-
ber of quite different situations, including red cell infu-
sion, descent from altitude, water deprived dehydration,
bedrest, or spaceflight. However, as revealed by computer
simulation, the quantitative effect was not always the same.
Some of the differences between the spaceflight and bedrest
responses could be attributed to differences in the time-
course and magnitude of plasma volume loss. More im-
portantly, however, it was found that, equal degrees of
hemoconcentration did not result in the same degree of
erythro-suppression for bedrest and spaceflight, nor for
the 59-day and 84-day Skylab missions. This suggested
that other factors may have been present which either aug-
mented or opposed the hemoconcentration effect.
10.3.2.3 Bone Marrow Effects. Two additional factors
were therefore examined: diet and exercise. Findings from
animal studies suggesting that dietary restriction can re-
duce, and exercise can enhance, erythropoiesis appear to
account for the above noted discrepancies in a number of
cases. An inadequate diet (negative energy balance), has
been shown to lead to suppressed erythropoiesis by mecha-
nisms that may bypass the hormone regulator and act di-
rectly on the bone marrow controller (see Fig. 10-6). This
could explain the occasional findings that erythropoietic
activity decreases in the presence of normal levels of eryth-
ropoietin. However, both dietary and exercise effects on
erythropoietic activity have not been well defined in the
human subject and the lack of appropriate controls during
spaceflight studies does not permit a definitive conclu-
sion. Nevertheless, these effects appear capable of explain-
ing some of the unusual findings on Skylab as noted below.
Two theories were examined to explain the findings
that as the Skylab missions increased their duration, the
returning crews were found to have smaller average losses
of red cell mass. The time course of red cell loss in space-
flight is not known because of difficulties of performing
this measurement inflight. However, according to the “re-
generation theory” postulated by the Skylab research team,
and based on a composite of postflight measurement of all
crewmembers, it was thought that red cells disappear by
some yet unknown mechanism during the first month and
then begin to replenish (or regenerate) during the second
and third months. This notion would predict that after du-
rations in space longer than 3 months, the RCM might
return to normal. However, it was not possible to repro-
duce these events in the model using any plausible hy-
pothesis, as a generalized theory of erythropoietic
regulation in weightlessness.
An alternate theory was proposed based on the obser-
vation that decreasing losses of RCM in Skylab were asso-
ciated not only with longer flight duration but also with
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Figure 10-6. Hypotheses for spaceflight induced loss of red cell mass. The most likely pathway is dominated by fluid regulation and
reduced erythropoietin. Metabolic mechanisms induced by negative energy balance that act directly on bone marrow stem cells can be a
contributing factor. Hemolysis has not been a consistent finding although selected destruction of young cells (apoptosis) has recently
been proposed. Other possible pathways are speculative.
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increasing levels of diet and exercise. These metabolic
factors had demonstrable effects on changes of body tis-
sue and cardiovascular condition during flight, and, as
noted above, their further involvement in maintaining the
oxygen transport-erythropoietic system was postulated. A
more plausible “continuous loss” theory was proposed
which suggested that there are two components to the sup-
pression of red cell production: one related to energy bal-
ance (diet and exercise) and one related to water balance
(hemoconcentration). Differences among the crewmen’s
RCM losses were thereby considered a result of different
levels of dietary intake and exercise, superimposed on a
common loss due to hemoconcentration. According to this
concept, the kinetics of RCM disappearance would not
include regenerative behavior as postulated by NASA in-
vestigators, but would be more similar to the continuous,
linear losses observed in bedrest. Statistical correlations
between diet levels and red cell losses on Skylab, as well
as model analysis, also tend to support this theory. Thus,
it is not necessary to invoke the occurrence of red cell
regeneration to explain the Skylab data. If this theory is
correct it could also explain the unusually large RCM
losses observed during the relatively short Gemini and
Apollo flights. It those cases, the combined influence of
hemoconcentration, negative energy balance and de-
creased physical exercise may have been additive to the
destructive effects of 100% oxygen which has already been
implicated as the primary cause of red cell loss.
10.3.2.4 Other Factors. Other factors that may have en-
hanced oxygen delivery and produced similar effects as
hemoconcentration cannot be ruled out (i.e., shifts in blood
flow, P50, and arterial pO2) but direct data are only avail-
able to support the hemoconcentration effect. Neverthe-
less, the model system predicts that even small changes in
a variety of parameters (perhaps smaller than can be mea-
sured experimentally), if sustained for long enough peri-
ods of time, could lead to a progressive and significant
degeneration of red cell mass.
The simulation analysis failed to rule out some small
degree of acute red cell destruction as contributing to ei-
ther the reduced RCM during hypogravity or the delayed
recovery of red cells following some spaceflights and
bedrest. Unusual removal of cells from the circulation
could possibly arise from the mechanical stresses of
launch, splenic sequestration, exercise hemolysis during
flight, or postflight hemolysis of cells made more fragile
by weightlessness or bedrest.† However, a major role of
inflight cell destruction is unlikely on Skylab, because
this would contradict the observations that hemoglobin
concentration is significantly elevated and that overt signs
of hemolysis were found only on the shortest flight.
10.3.2.5 Recovery. Computer simulation predicted that
in most cases the observed repletion of red cells during the
period of recovery from hypogravity could be attributed to
hemodilution-induced hypoxia, i.e., an effective anemia re-
sulting from inflight RCM depletion and followed by post-
flight plasma refilling. The delayed recovery of RCM during
the 28-day Skylab mission and the 28-day bedrest simula-
tion of that mission was attributed in part to a normal 3-4 day
bone marrow transit time and a time-lag in plasma volume
recovery. The presence of an acute reticulocytosis follow-
ing bedrest and its absence after a Skylab mission of the
same length suggests somewhat different mechanisms were
operative in each case. The involvement of shifts in
oxy-hemoglobin affinity, mild hemolysis, or ineffective
erythropoiesis were suggested as areas of future study.
Also, it is possible that the history of exercise during space-
flight compared to the history of inactivity during bedrest
may account for some of the observed differences.
10.3.3 Cardiovascular Regulation
Of all the physiological systems of interest, the car-
diovascular system has been studied for the longest pe-
riod of time in the spaceflight program. However, because
of the complexity of this system, and because of opera-
tional constraints limiting the collection of crucial data, a
good description of cardiovascular adaptation to zero-g
was still lacking even following the Skylab missions. Most
of the earlier spaceflight experiments and measurements
were appropriately designed to reveal possible pathophysi-
ological aberrations that would limit the capacity of man
to work in zero-g and prevent normal function upon return
to earth. These tests provided a gross clinical description
of the system under orthostatic and exercise stresses and
demonstrated that spaceflight does not impair crew health
or performance. However, some fundamental measurements
of the systemic circulation, including blood flows, venous
pressures, vascular resistances and tone as well as possible
alterations in the neural and hormonal controllers, would
not be made for a decade or longer after the Skylab experi-
ments. Acute changes of the cardiovascular system upon
entering space could only be inferred from ground-based
hypogravic maneuvers. Also, longer-term adaptive changes
undoubtedly occur but were obscured by limited knowl-
edge of these aspects of cardiovascular physiology even
in one-g environments. For example, the effects of exer-
cise conditioning on circulatory parameters is a subject
still under intensive study. Therefore, the analysis of these
short and long-term events has resulted in a description of
cardiovascular alterations that is somewhat incomplete and
somewhat speculative.
Three broad areas of cardiovascular regulation in
weightlessness have been considered: the resting (un-
stressed) cardiovascular system, orthostatic testing, and
exercise testing. These three areas are discussed next and
are illustrated in Fig. 10-7. See also Chapter 7 for a de-
tailed presentation.
10.3.3.1 The Resting Cardiovascular Response to
Weightlessness. The most dramatic changes in the rest-
ing cardiovascular system probably occurred early in
flight, long before the first Skylab measurements could be
†
 Recent flight experiments on the Shuttle Spacelab support the notion that
younger erythrocytes are selectively marked for early destruction at the
bone marrow level in the presence of hemoconcentration. See endnotes
of Chapter 6 for a discussion of recent findings.
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performed. As simulated by the modified Guyton model and
demonstrated by one-g experimental analogs of weightless-
ness, the following scenario is postulated. At the onset of
microgravity, the primary event of the headward fluid shift
leads to central blood volume expansion, increased venous
and arterial pressures, increased stroke volume, and el-
evated cardiac output. Secondary reflexive reactions fol-
lowing stimulation of central mechanoreceptors include a
decrease in heart rate and decreased peripheral resistance.
These reflexes, together with enhanced transcapillary filtra-
tion and excess renal excretion, tend to correct both the cen-
tral blood volume and associated pressures. The Guyton model
predicts a complete normalization of central blood volume
within several hours, and as this occurs the circulatory and
cardiac variables also return to normal and some eventually
over- or undershoot. Thus, while arterial pressure may return
to normal, peripheral resistance and heart rate increases, and
cardiac output and venous pressure decreases compared to
control; as indicated in the previous sections, total blood
volume is ultimately reduced at the expense of fluid leav-
ing the lower limbs (see Chapter 9.7.5.1).
Whether this entire scenario occurs is still a matter of
controversy inasmuch as it has not been possible to per-
form a complete cardiovascular assessment very early
inflight. Those measurements that are possible are com-
plicated by emotional stresses resulting from launch ac-
tivity. Also, some of the headward fluid shift may have
occurred while the crew is preparing for launch in the feet-
up position. Inflight measurements taken some hours after
launch, some of more recent vintage, confirm a decrease
in leg volume, plasma volume, and central venous pres-
sure; a modest increase in heart rate, and no change in
mean arterial pressure. Measurements of resting cardiac
output and peripheral resistance have yielded inconsis-
tent results. Only the CVP measurements were obtained
just after entering zero-g; the others some hours later. En-
gorgement of neck veins and facial tissues and feelings of
head fullness that continue throughout the flight are symp-
tomatic of the continued tendency of fluids to pool in the
upper body in zero-g.
Final adjustment of circulatory parameters (flows, pres-
sures, resistances), in order to accommodate the redistri-
Figure 10-7. Hypotheses of the major events and mechanisms in the cardiovascular system during spaceflight. These postulated effects
can explain the findings at rest and from provocative LBNP and exercise testing relatively early in the flight period. During prolonged
flight (not shown), adaptive effects that lead to retoning of the leg vessels and resetting of the baroreceptors, permits orthostatic tolerance
to return towards normal. Immediately, postflight, orthostatic tolerance is degraded (compared to preflight) largely because the reduced
blood volume tends to pool in the legs. Exercise performance is also degraded during the first postflight day as body water increases
causing a relative anemia and poorer oxygen delivery to the tissues.
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bution of fluids, appears to occur much more slowly than
the initial fluid volume adjustments. Although arterial pres-
sures return close to normal, there may exist a residual
central blood volume expansion. Therefore, one of the
long-term effects of spaceflight may be a decreasing influ-
ence of high-pressure baroreceptors and an increasing in-
fluence of low-pressure volume receptors. Whether volume
receptor adaptation occurs is unknown. A residual excess
volume in the vicinity of the low pressure cardiopulmo-
nary receptors may account for the longer term increase in
resting heart rates noted in the majority of the Skylab crew
(and in bed-rest subjects) as well as a possible increase in
stroke volume, e.g., Bainbridge reflex and Starling effect.
Both of these factors argue in favor of a long-term increase
in cardiac output by influences acting directly on the heart.
However, there are also general systemic influences
that must be considered in an assessment of long-term
blood flow alterations. As indicated in Figs. 10-6 and 10-
7, the hemoconcentration (secondary to reflex reduction
of plasma volume) together with a possible reduction in
metabolism of certain organ systems (such as postural
muscles) could lead to a relative increase of oxygen deliv-
ery at the tissue level. As a result, local autoregulatory
(resistive) elements may reduce blood flow so that oxygen
delivery coincides with oxygen demand.
Other long-term mechanisms are capable of assisting
the circulation adapt to reduced total blood volume, an
emptying of leg veins and blood pooling in the upper
body. Over time, the circulatory system attempts to adjust
the capacity of the blood vessels to the actual blood vol-
ume, thereby maintaining mean circulatory pressures.
Blood volume adjustments, if maintained chronically and
if they effect the pressure within the vessels, can lead to
changes in vascular compliance via poorly understood
local (delayed compliance) and central (autonomic influ-
ence on venous compliance) pathways. Thus, it may be
expected that in zero-g, a retoning or devascularization of
leg vessels occurs to accommodate the reduced blood vol-
ume in that segment of the circulation while stress relax-
ation of veins in the upper body may occur to accommodate
fluid expansion in central regions. The actual role of these
long-term mechanoreceptor, autoregulatory, and stress re-
laxation mechanisms have not been well studied. Also,
their net effect is unknown because accurate measurements
of flow, volume, and pressure have not been simulta-
neously performed in the space environment. Some of these
adaptive trends may be interpreted as the removal or re-
versal of orthostatic defense mechanisms no longer needed
in spaceflight.
Cardiovascular function was evaluated during the Skylab
missions by an orthostatic stress test (lower body negative
pressure, LBNP), and by an exercise stress test (bicycle
ergometry). The most prominent findings from these tests
were a decrease in orthostatic tolerance during and follow-
ing flight and a post-flight decrease in aerobic capacity.
Hypotheses to explain these findings were formulated and
tested in the pulsatile cardiovascular model. It was conve-
nient and useful that the same model for the cardiovascu-
lar system be used to analyze both LBNP and exercise,
each of which present different challenges to the cardio-
vascular system with significantly different responses.
10.3.3.2 Analysis of Orthostatic Testing. The observed
decrease in orthostatic tolerance is not unexpected in the
light of significant loss of blood volume (500–600 ml).
Upon application of lower body negative pressure (one-g
or zero-g) or standing (one-g), the increase in leg pooling
coupled with a reduced blood volume significantly low-
ers central blood volume and venous return to the heart.
The model simulations quite accurately predicted the in-
creased heart rates and decreased pulse pressures charac-
teristic of the Skylab crews’ intolerance to orthostasis. The
inflight heart rate response to maximal LBNP (50 mmHg)
was shown to be nearly equivalent to a 15% hemorrhage.
However, blood volume loss alone was not sufficient to
explain all of the observed findings. For example, an in-
crease in leg volume pooling during LBNP (compared to
the degree of pre-flight LBNP pooling) was noted during
spaceflight. The most promising explanation of this phe-
nomenon, as suggested by simulation analysis, was the
partial collapse of leg veins in association with a reduced
leg blood volume during the pre-LBNP control period.
Small increments of LBNP would be expected to draw sig-
nificant quantities of blood into the empty leg veins, more
so in zero-g than in one-g.
The response to orthostasis was observed to stabilize
and even improve in some subjects during the latter part
of the mission. One of the more promising hypotheses to
explain these findings was a long-term downward adjust-
ment of vascular capacity in the legs (in response to the
reduced leg fluid volume) that could be manifested physi-
ologically by retoning, devascularization, or reverse stress
relaxation. Changes in plasma electrolyte concentrations
(increased potassium and calcium, decreased sodium) may
also be involved in altering vascular tone. Little is known
concerning autonomic influences on venous tone during
long-term adaptation to hypogravity.
One of the keys to understanding the circulatory
changes in zero-g may be better description of the vascular
and extravascular compartments in the legs. Simulations of
headward movement of fluid upon entering zero-g and the
subsequent repooling of fluid in the legs upon application of
LBNP or one-g recovery can be made more realistic by in-
cluding more accurate descriptions of collapsible leg veins,
non-linear leg tissue pressure-volume relationships, tone
of extravascular muscle, peripheral transcapillary filtra-
tion, and the active and passive control mechanisms which
influence these elements. Differentiating the upper and lower
body capillary beds with respect to regulation of the pre- and
post-capillary resistances and the elastic character of the in-
terstitial tissues surrounding these beds is not yet possible
from available data. The loss of tone of supporting muscles
surrounding deep leg veins during prolonged weightless-
ness is an additional complicating factor in modeling both
intravascular and extravascular leg elements. A number of
these effects have been included in the modifications to
the Guyton model, but many of the details are poorly un-
derstood. The pulsatile cardiovascular model is limited to
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short-term events because it is a closed system and does
not contain capillary leaks. The lack of data in these areas
of circulatory regulation, while discouraging, still permits
the models to be used for hypothesis testing and suggest-
ing new experimental approaches.
10.3.3.3 Analysis of Shuttle Reentry. During the early
testing phase of the Space Shuttle program, there was con-
cern of circulatory dysfunction during the Shuttle atmo-
spheric reentry phase. In contrast to all previous manned
spaceflights (where crewmembers descended by parachute
in a semi-reclining position with hands-off control), the
crew of the Shuttle orbiter was to be exposed to accelera-
tion forces in the head-to-foot direction (sitting position)
after having also suffered a weightlessness induced-blood
volume loss. Acceleration forces were known to reach a
maximum of twice the normal sea-level g-forces and blood
volume losses in spaceflight have been measured at about
500 ml. The pooling of fluid in the legs at such high g-
forces combined with a loss of blood volume had the po-
tential to render the crew orthostatically intolerant at a
time their performance level needed to remain high for a
hands-on landing. Simulations were performed with the
short-term cardiovascular model (LBNP version) to study
the combined behavior of the two stresses – high g-forces
and blood volume loss – on the circulatory system. The
operational question of immediate concern was “what is
the maximum tolerable +Gz at any given level of blood
volume loss?”
The model was first validated for its ability to respond
to high g-forces and blood volume losses by simulations
of centrifuge and hemorrhage experiments respectively.
The validated model was then used to study the dual ef-
fects of blood volume loss and levels of g-force on carotid
blood pressure. Previously obtained data have related ca-
rotid pressure to vision impairment as reflection of ortho-
static intolerance. It was thus determined that even with
modest blood volume losses of 10–15%, the tolerance to
increased gravitational loading is reduced significantly.
Evidence from Shuttle flight crews, both during reentry
and in tilt studies immediately following reentry, con-
firmed a tendency for syncope; the model was able to rep-
licate these results and show that they could be ascribed
to blood volume loss and reentry g-forces. Finally, more
advanced simulation studies were used to design two coun-
termeasures for “reentry intolerance”. In one of these, the
lower limb external pressure required for an anti-g com-
pression suit was determined (Chapter 7), and in the other
the volume and timing of a fluid-loading protocol was
established (Chapter 9). This entire study, including simu-
lations of basic changes on the circulatory system, simu-
lations of operational conditions, and model-aided
development of countermeasures, indicates the versatility
of these mathematical models.
10.3.3.4 Analysis of Exercise Response. Tolerance
to exercise was essentially maintained during the flight
period. It was only after return to earth that aerobic capac-
ity was found to diminish. This is similar to results re-
ported for bedrest.  Analyses performed with the
whole-body algorithm permitted the circulatory adapta-
tions of long-term bedrest to initialize the short-term LBNP
and exercise model so that pre- and post-bedrest stress
tests could be simulated. Results from these studies sug-
gested that decrements in blood volume in association
with some reduction in unstressed volume in the legs could
quantitively account for most of the observed changes in
post-bedrest exercise (and LBNP) and postflight exercise
in the crews of the two shortest Skylab missions. These
changes, reflecting what has been termed circulatory de-
conditioning of zero-g, included increased heart rate, de-
creased stroke volume, and decreased cardiac output
during postflight sitting exercise compared to preflight
testing.
However, there was a notable qualitative difference be-
tween the degraded post-flight exercise responses of the dif-
ferent crews. For example, heart rate was lower, stroke volume
was smaller and blood pressure was higher during exercise
testing of the 84-day crew compared to the 28-day and 59-day
crews. This was tentatively ascribed to an inflight exercise
training effect since the level of personal daily exercise in-
creased on each longer flight. A systems analysis task was
therefore devoted to developing the most feasible explana-
tion of the interaction of zero-g adaptive changes (decondi-
tioning) and exercise training (conditioning).
In this regard, the cardiovascular exercise model was
modified and validated to represent the simulation of a
highly trained subject’s response to bicycle exercise in
one-g. These “training” modifications included a larger
heart, increased contractility of the heart, reduced sym-
pathetic activity, decreased arteriolar vasodilation (neu-
rogenic) during exercise, increased leg capillary density,
and increased vagal activity at rest. This model was used
in the “trained” and “untrained” mode to simulate the
postflight bicycle ergometry experiments. The results led
to the conclusion that a training effect was quantitatively
consistent with the exercise responses for the crew that
trained the hardest.
The most acceptable hypothesis tested to explain this
crew’s response was a combination of effects that included
increased sympathetic activity on heart rate, increased pe-
ripheral resistance, increased contractility, a reduction in
blood volume, and a reduction in unstressed volume in
the legs. Each of these influences acting alone was not
sufficient to explain the totality of situations examined
which consisted of resting in the supine and sitting posi-
tions and exercise in both positions. (The supine exercise
position tends to minimize the effect of blood volume
loss on exercise performance). The combined set of hy-
potheses is not a unique set of cardiovascular changes but
at this time represents a feasible combination of condi-
tioning and deconditioning effects.
The absence of any notable decrease for inflight exer-
cise capacity for all crewmembers indicates that the con-
tracted blood volume is an appropriate adaptation to
zero-gravity. Nevertheless, the nature of the adaptation is
not clear. The current analysis suggested that normal oxy-
gen delivery was maintained in the face of diminished
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blood volume by the hemoconcentration of weightless-
ness, and by the tendency of fluid to pool in the upper
circulation, thereby augmenting venous return to the heart.
Conversely, the hemodilution upon recovery would be
expected to contribute to the postflight degradation in
exercise performance.
10.3.4 Musculoskeletal Responses to
Weightlessness
The Skylab findings support the concept of a general-
ized atrophic response of the total musculoskeletal sys-
tem during extended exposure to hypogravity. Losses in
bone and muscle mass were among the more significant
physiological changes observed in the astronaut subjects
(see Fig. 10-8).
10.3.4.1 Muscle Atrophy. The losses in muscular tissue
were particularly well documented in the Skylab crew (see
Chapter 4). One of the systems analysis projects demon-
strated that lean body mass was reduced by approximately
1.5 kg (N = 9) over the inflight period. This was revealed
by several independent methods that showed losses in body
water, potassium, nitrogen, and body volume. More direct
evidence of muscle and collogen breakdown was provided
by the measured increase in renal excretion of urinary
3-methylhistidine, hydroxylycine, and hydroxyproline.
Also, excesses of intracellular electrolytes and amino ac-
ids appeared in the plasma and urine. Further analysis of
spaceflight data indicated a significant degree of local
muscle loss in the legs and perhaps in the skeletal muscle
groups that normally control anti-gravity or posture. The
data supporting these contentions come from spaceflight
studies showing a gradual loss of leg volume, decreased
leg strength, a reduction in duration of the Achilles reflex,
and, in animals, diminished mass and response of red fiber
groups.
It is well known that atrophy of skeletal muscle oc-
curs in response to disuse, inadequate functional load,
and insufficient food intake. Spaceflight may be associ-
ated with more than one of these conditions. The absence
of gravity results in diminished use of the lower limbs for
postural support and locomotion, reduced body weight
loading on weight-bearing tissues, and perhaps interfer-
ence with proprioceptor reflexes which can influence
muscle metabolism and function. A reduced caloric in-
take appears to be capable of increasing the loss of body
protein, but increased caloric intake may not prevent this
loss. The muscle disuse atrophy hypothesis receives sup-
port from the finding that the more intensive exercise per-
formed by the crew of the longest flight (mainly exercise
of the leg muscles) was associated with the smallest de-
creases in leg volume and strength. Little is known, how-
ever, about the changes occurring in other muscle groups,
particularly those used for postural support in the upper
body. If postural muscles are the primary targets of loss
induced by zero-g, appropriate locally applied exercise
might reverse this trend. Because each Skylab crewmember
exercised, it is not possible to quantitatively predict the
zero-g effect of complete lack of exercise. There is no rea-
son to question, however, that exercise does maintain
strength, muscle tone, and probably mass in the legs and
improves circulatory condition similar to one-g training.
10.3.4.2 Bone Demineralization. Evidence for inflight
loss of bone mass comes primarily from observations of
calcium metabolic balance and bone density. Inflight cal-
cium balances were consistently negative on all flights, a
result of excess urine excretion throughout the missions
and a progressive increase in fecal calcium loss as a func-
tion of mission duration. Bone densitometric data indi-
cated losses in the calcaneus (of the heel), but not in the
radius and ulna (of the arm), suggesting that losses are
concentrated in load-bearing bones. A significant correla-
tion between changes in calcaneus bone density and cal-
cium balance for the nine crewmen was demonstrated.
Additional evidence of demineralization is suggested by
increases in urinary hydroxyproline and hydroxylycine
which may indicate breakdowns of the collagen matrix in
the bone. As expected, plasma and urine biochemistry
showed significant increases in calcium and phosphate,
but the calcium regulatory hormones did not reveal a con-
sistent trend. Analysis of all these data suggest that bone
losses became progressively more severe on each longer
mission, in contrast to the trend toward stabilized losses
noted for muscle.
The initiation of bone loss is assumed to come from a
reduction of mechanical forces induced by gravitational
unloading, and/or reduced musculoskeletal interactions.
These forces (piezoelectrical, compressional, tensile, and
shearing forces) are known to be important in the normal
maintenance and repair of bone. It appears logical that
external forces, appropriately applied, might reverse the
decalcification process. However, the search for suitable
countermeasures has not met with notable success. The ef-
fect of exercise on bone demineralization remains unresolved.
Current understanding of the physiology of calcium
metabolism, including the systems analysis, provides a
partial explanation of the biomedical findings. Upon re-
lease from the bone into the extracellular pool, calcium
and its concentration in plasma is under the control of a
feedback system which is mediated by a hormonal system
which influences renal excretion and gastrointestinal ab-
sorption as well as new bone formation. The observed el-
evation of urinary calcium may have been a result of
increased plasma calcium concentration decreased par-
athyroid hormone, and increased renal tubular sodium (see
Fig. 10-8). Progressive losses of fecal calcium have been
tentatively attributed to a net decrease in dietary absorp-
tion of calcium from the gastrointestinal tract. The active
metabolite of vitamin D (1, 25 dihydroxycholecalciferol)
is an important regulator of GI tract absorption, and a de-
crease in circulating levels of this substance could ex-
plain the fecal data. As suggested in Fig. 10-8, a depression
of parathyroid hormone and Vitamin D could have a nega-
tive feedback effect on demineralization and limit the
losses of calcium from the bone. These preliminary hy-
potheses have been incorporated into proposals for future
flight experiments that will examine several features of
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Figure 10-8. Highly simplified schematic indicating the postulated effects of spaceflight on the musculoskeletal system. For a more
detailed hypothesis of bone demineralization, see Fig. 8-9.
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calcium regulation, including fluxes into and out of the
bone and GI tract, hormonal regulation, and the effect of
exercise as a countermeasure.
The systems analysis approach for understanding bone
demineralization in space centered on understanding the
complex feedback systems of calcium regulation includ-
ing the development of a mathematical model. Various
interpretations of spaceflight and bedrest findings were
addressed which helped formulate the hypothesis of cal-
cium metabolism adaptation to long-term spaceflight that
is summarized above. Although the model is not yet com-
plete, formulation of the model was instrumental in unify-
ing spaceflight and bedrest data and in identifying critical
areas in the regulatory system that might become altered
in zero-g. When fully developed the model should be able
to provide guidance in understanding these mechanisms.
Can the acute renal calcium excretion be explained as an
initiating event or as a feedback response? Can some pri-
mary disturbance in the calcitropic hormones cause renal
excretion and bone loss or is there a primary event at the
bone level due to alterations in mechanical forces? What
biological activity is occurring in the bone tissue during
these events?
10.3.5 Body Composition Changes
The analysis of body composition changes during
spaceflight, performed during this project (see Chapter 4),
offered a more complete answer to the question of “why
do astronauts lose weight during spaceflight?” than was
heretofore available. Figure 10-9 shows the relationship
of the compartments associated with body composition.
Accordingly, the body mass can change in accord with
alterations in three major substances: muscle (dry), fat (nor-
mally low water content), and body water. The changes in
body water, in turn, can be said to be caused by changes in
one or more components of the water balance, or alterna-
tively, by changes in the major fluid compartments of the
body. From an energy balance perspective, the loss of body
tissue (muscle and fat) implies an imbalance between ca-
loric intake (diet) and caloric output (work + heat). All of
these quantities were examined by an integrative analysis
of the energy balance, mass balance, water balance, and
body fluid volume of the Skylab astronauts to formulate
estimates of body composition changes.
While the original Skylab experiments were designed
to measure body composition changes only at the begin-
ning and end of flights, a method was developed to com-
bine pre- and postflight data with daily inflight metabolic
data so that cumulative changes of body composition dur-
ing flight could be estimated. The changes in several of
these body composition compartments, as computed in
this project, are shown in Fig. 10-10 for the first month in
space. Some of the changes reflect the same complex rela-
tionships between diet, exercise, physical condition, and
energy balance that are normally observed in terrestrial
conditions. In addition, certain changes in the fluid and
musculoskeletal compartments can be directly attribut-
able to the weightless environment. Interpretation of the
Skylab data, with the view of identifying and isolating
the zero-g factors, is made more difficult because each
successive crew remained in flight a month longer, exer-
cised longer and harder, and received a larger caloric in-
take per kilogram of body weight. Nevertheless, the data
obtained from indirect metabolic balance techniques does
lend itself to a reasonable interpretation that must eventu-
ally be verified by measurements that are more direct. For
purposes of summation, it is convenient to consider each
major body constituent separately:
10.3.5.1 Body Water. There appears to be an obligatory
loss of at least one liter of body water that occurs during
the first two days of spaceflight (Fig. 10-10(a)). Each of
the crewmembers lost varying amounts of water early
inflight, some less and some more than a liter, but at the
end of one-month inflight, the body water response ap-
peared to converge toward a one-liter loss. The initial body
water deficit was primarily a result of reduced fluid intake
since urine and evaporative water losses, on the average,
were below control during this period. Those crewmembers
exhibiting severe space motion sickness symptoms reduced
their intake by the greatest amount and lost the greatest
amount of body water. When normal intake was resumed
following severe bouts of motion sickness, some body
water repletion was evident. The reduction in body water
is maintained throughout the flight in spite of ad libitum
drinking. Shifts of up to two liters of fluid from the legs,
Figure 10-9. The compartments which make up the metabolic
systems of the body. Assessing the values of these quantities was
required in order to understand why astronauts lose weight dur-
ing the course of a long spaceflight.
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observed on Skylab, can easily account for these body
water losses.
10.3.1.2 Body Electrolytes. Upon entering weightless-
ness, metabolic balances shifted in the negative direction
for all of the electrolytes studied including sodium, potas-
sium, calcium, phosphate, magnesium, and nitrogen. The
rates of loss were most severe for the first month of flight.
Cumulative estimates of loss computed for sodium, potas-
sium and nitrogen indicated that the sodium losses were
rapid and then stabilized after several days similar to the
behavior of body water, while potassium and nitrogen
losses were more gradual and did not stabilize until the
second month (Fig.10-10(a)). Electrolyte losses from both
intracellular and extracellular compartments were signifi-
cant compared to their total body amounts, but contrib-
uted negligibly to changes in body mass. Nevertheless,
Figure 10-10. Body composition changes for all mission phases
(including first month inflight) for all Skylab crewman (N=9;
mean ± SE). Values are shown as change from morning of launch.
Body mass was measured directly; all other quantities were de-
rived using daily metabolic balance measurements. a) Body Water
and electrolytes: Because sodium and potassium are the major
cations of the extracellular and intracellular compartments respec-
tively they reflect fluid changes in those compartments. b) Body
weight and tissues: Tissue weight (dry) consists of fat and pro-
tein. Changes in lean body mass are approximately five times
those shown for protein.
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they reveal other more significant changes. For example,
sodium losses reflect reductions in extracellular water,
while potassium losses are indicative of intracellular fluid
losses (primarily muscle). Taken as a whole, these data
indicate that spaceflight induces a rapid loss of extracel-
lular fluids and salts, while disappearance of intracellular
constituents takes considerably longer.
10.3.1.3 Body Weight (Mass). Body mass was the only
whole body component measured directly during flight
(Fig 10-10(b)). A weight loss of 3.8% (2.7 kg) was ob-
served in the nine Skylab crewmembers during their
inflight period. This was attributed to a 2.5% loss (1.5 kg)
in lean body mass and a 10.4% loss (1.2 kg) in body fat.
Water, fat and protein contributed approximately 48%, 39%
and 13% respectively, toward the total body mass loss by
the end of the mission. Body mass, measured daily during
(b)
Days from launch Days from
recovery
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spaceflight, decreased most rapidly at launch and recov-
ery, reflecting changes in body water. After the initial rapid
inflight decline, body mass either continued to decline,
stabilized, or recovered somewhat depending on the ef-
fects of diet, exercise, and weightlessness on major tissue
compartments such as fat, muscle, and water. There were
significant differences between the three Skylab missions
(see Chapter 4), which could be attributed to differences
in diet and exercise.
10.3.1.4 Body Tissue. The loss of body tissue (dry weight
of fat and muscle), particularly fat, appeared to be directly
related to the difference between net energy utilization
and net caloric intake (Fig. 10-10(b)). The results support
the premise that body fat is the substance preferentially
used to compensate for energy deficits that result from
inadequate energy intake. A negative energy balance was
observed on the first two Skylab missions. An adequate
diet, in relation to the workload, was present only on the
third and longest mission. Three generalizations can be
made regarding the effects of exercise and diet on tissue stor-
age. First, an inadequate diet will result in fat and muscle
losses. Second, when diet is adequate to maintain body mass,
but exercise is insufficient, the muscles will atrophy and fat
will be deposited. This seems to have occurred in the crew
of the 84-day mission. Third, with an adequate diet during
periods of exercise training a loss of fat and increases in
lean body mass will occur. This situation was observed on
all missions during the preflight control period.
10.3.1.5 Body Fat. Of all the components examined, the
changes in fat stores appeared to vary the most between crews.
This undoubtedly reflected the wide range of caloric intakes
in the controlled diets and the varying degrees of exercise
performed. Fat losses have been observed consistently in
association with inadequate food intake in crews of Gemini
and Apollo missions. On the other hand, the crew of the
longest Skylab flight exhibited a mean gain in body fat,
implying a more than sufficient diet despite their higher
workloads during exercise. On average for the nine Skylab
crew, there was a small loss of body fat (Fig. 10-10(b)).
Caloric intake was less than adequate for the two short-
est Skylab flights, for two reasons. First, the caloric con-
tent of a strictly controlled diet was based on the erroneous
assumption that inflight energy requirements were less than
those of a one-g environment. Second, almost all of the
crewmen experienced space motion sickness during the
first week of flight, and this resulted in anorexia of some
significance. Because of the second of these effects, fat
losses were particularly rapid during the week following
launch. In general, the changes in body fat appear to be
explained by the balance between caloric intake and en-
ergy expenditure and do not appear to have been influ-
enced by weightlessness.
10.3.1.6 Body Protein. According to an analysis of meta-
bolic balance studies of nitrogen and potassium, it was
determined that protein losses are initiated almost imme-
diately after entering weightlessness and then decrease
exponentially with time during the first month (Fig. 10-
10(b)). It is only after the first month of flight that protein
losses appear to stabilize. These losses occurred in spite
of a high protein diet and in the presence of exercise train-
ing. The lack of suitable controls makes it difficult to as-
sess whether the stabilization of protein loss results from
increasing exercise, increasing diet, or from some long-term
adaptive influence. All of these findings are consistent
with the hypothesis that the postural muscles are virtually
unused in weightlessness and that they therefore atrophy
from disuse.
10.3.1.7 Caloric Requirements for Spaceflight. The
food intake for the nine crewmen ranged from 39.6 to 48.5
kcal/d-kg Bwgt while the caloric value of the tissue lost
varied from -4% (a gain in tissue mass) to 26% of caloric
intake. On the basis of a regression analysis of the body
mass loss in relation to the caloric intake, it was estimated
that a caloric intake of 46-50 kcal/d-kg Bwgt would have
prevented significant tissue loss (primarily fat) for the
Skylab astronauts.
10.4 Integration of Subsystem Hypotheses
10.4.1 Overall Hypothesis
Although the separation into individual physiologi-
cal subsystems has been convenient and has yielded a
number of new insights as shwon above in Chapter 10.3,
the central approach of systems analysis is to eventually
integrate this information and view the behavior of the
body as a whole. Figure 10-11 is offered as an integrated
hypothesis for the human physiological response to weight-
lessness. Most of the major systems of the body are repre-
sented except for those that were not part of the current
analysis, such as the vestibular and immunological sys-
tems. This scenerio was generated primarily from the sys-
tems approach that has been presented in this book and
outlined in the beginning of this chapter. Considerable
detail has been omitted for the sake of clarity so that gen-
eralization can be made about the interactions between
subsystems and the behavior of the combined systems.
The following broad picture has emerged.
Disturbances in the cardiovascular, fluid-electrolyte,
erythropoietic, musculoskeletal, and metabolic systems
that are found during and after flights of varying duration
appear to be attributed to two, and possibly three, major
effects of weightlessness. These are, first, the absence of
hydrostatic forces, resulting in acute fluid shifts within
the body, and second, the absence of deformation forces,
resulting in disuse and degradation of normally
load-bearing tissues. The first of these effects leads to a
rapid series of events, including redistribution of circulat-
ing blood, emptying of the leg vessels, and eventually a
reduction in extracellular body fluids, the most important
of which is blood volume. The consequences of the second
effect are a more chronic reduction in bone and muscle mass.
Thus, most of the intracellular and extracellular losses of
fluid, salts and musculoskeletal tissues can be explained by
these two mechanisms. Many of these changes can be ob-
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served during spaceflight itself, while others manifest them-
selves more clearly after return to Earth. As suggested by
the diagram, these two effects are not completely separate,
and probably converge to some common pathway by
mechanisms much more complicated than indicated here.
In addition, a third factor, alteration of metabolic state,
reflected by changes in dietary intake and exercise, was
found to play an important role in the physiological ad-
justments of the Skylab crew. An inadequate intake of fluid
and food, resulting in negative energy balance, whether
brought on early in flight as the result of space motion
sickness, or more chronically because of a controlled but
deficient diet as occurred in the first 2 Skylab crews, con-
tributed substantially to the loss of body water and elec-
trolytes during the first week and to the gradual loss of
body fat, body protein and perhaps to the suppression of
erythropoiesis in the ensuing weeks. Similar processes may
have occurred in astronauts of Gemini and Apollo mis-
sions because of the inadequate caloric content of their
diet. Also, the lack of an expected diuresis could have
been influenced by the deficit intake of water just prior to
launch. Finally, the seemingly obligatory degradation of
musculoskeletal tissue creates a pool of circulating me-
tabolites that adds to the load of waste products that must
be processed by the kidneys, thereby altering plasma bio-
chemistry, hormonal secretion and renal function. To the
extent that these metabolic factors are under voluntary
control (i.e., diet and exercise), they may not be part of a
generalized zero-g response but rather specific to Skylab.
The circulatory and renal systems are central to many of
these processes, both acute and long-term, because of the
need to maintain a hypovolemic state in weightlessness
and to eliminate the waste-products of tissue atrophy.
These three primary effects of spaceflight have both
acute and long-term effects which lead to the notable and
consistent findings of a loss in weight, a change in body
composition, redistribution of fluid volumes, new homeo-
static levels of renal, cardiovascular, and endocrine pa-
rameters, a decreased tolerance for orthostasis, and
additionally, upon return to a one-g environment, a de-
creased aerobic capacity. Figure 10-11 also indicates a
direct effect on the neurovestibular system, particularly
the unweighting of the otolith organs that (together with
other orientation cues) is believed to contribute to space
motion sickness. It is this latter effect that contributes to
the negative energy balance of susceptible crewmembers.
Figure 10-11. Integrated hypothesis of physiological adaptation to prolonged spaceflight.
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Adaptation to weightlessness is said to occur when
the body adjusts to these changes and reaches a new ho-
meostatic level. Figures 10-12 and 10-13 are an attempt to
show the relative time course of adaptation for each major
physiological system or for loss of body tissue, respec-
tively. The return to new baseline values in Fig. 10-12
reflects the establishment of a new homeostatic level ap-
propriate to weightlessness. The most rapid effects are
observed in the vestibular system and the systems that
respond to fluid volume regulation, i.e., headward fluid
shifts. The significant decrements in body water, plasma
volume, and sodium that have been observed in crewmen
returning from space can be attributed to losses that oc-
curred during the first several days of flight (Fig. 10-13).
At the other extreme are the body structures that respond
to slower acting processes and which manifest their zero-g
response by gross losses in red cell mass and bone cal-
cium. However, even a slowly responding system such as
that which controls bone demineralization is under the
influence of rapidly acting hormonal regulators. Muscle
tissue appears to degrade at an intermediate rate, as exem-
plified by nitrogen and potassium losses. Depending on
the degree to which caloric intake matches energy require-
ments, fat stores can be included in this intermediate group
as well (see Fig, 10-13). The time course of adaptation, or
the rates of disappearance from the body, depends on the
nature of the disturbance and on the time constant of the
correcting homeostatic system.
10.4.2 Homeostatic Control
At the time of the Skylab program, it was not known
whether the changes observed in spaceflight were dys-
functional responses (pathological) or based on commonly
accepted feedback mechanisms (adaptive). The studies
discussed in this volume have supported the concept that,
within the time span which man has so far been studied in
space, most of these responses to weightlessness can be
explained in terms of normal feedback regulatory pro-
cesses.* But it was not always possible to explain the long-
term adaptation phase of spaceflight in terms of regulatory
Figure 10-12. A highly idealized view showing the approach toward homeostasis of physiological systems during spaceflight. Each
physiological subsystem has a different time course of adaptation and appears to be driving towards a new homeostatic level. Note that
the time scale is exponential.
Figure 10-13. Various substances disappear from the body dur-
ing weightlessness adaptation leading to a change in body compo-
sition. This figure, like the previous one, illustrates the different
time courses of these substances.
*
 The few instances of possible pathology might include a minor
degree of erythrocyte hemolysis and development of motion sickness.
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feedback mechanisms more suited to corrective action of
acute disturbances. This suggested a logical division of
the spaceflight response into acute and chronic segments
for purposes of systems analysis. A classical example of
the temporal range of feedback processes concerns the
blood volume and pressure controllers that reduce plasma
volume when challenged by the acute cephaled shifts of
peripheral fluid. These controllers include fast acting
baroreceptors-sympathetic pathways, slower acting renal
mechanisms, and long-term adaptive effects that retone
the blood vessels to accommodate more or less blood vol-
ume. Another of many examples concerns the behavior of
the renal regulating hormones, such as ADH or aldosterone,
whose acute response to hypogravity could be explained by
volume/pressure controllers but whose long-term response
could only be accounted for by controllers responding to
electrolyte concentration. In order to determine the extent
of feedback involvement in each case, it was necessary to
develop the appropriate model of the system under inves-
tigation, to identify plausible disturbance points in the
regulatory pathways that would produce the response of
interest, and then to perform simulations of the system to
verify that the predicted responses are quantitatively in
agreement with observed responses.
10.4.3 Central Importance of Blood Volume
Regulation
A concept that clearly emerges from the model simu-
lation studies is the primacy of the circulatory system.
From a systems point of view, it was known that the gen-
eral behavior of many organs, including the renal, respira-
tory, thermoregulatory, hormonal, erythropoietic, and fluid
control systems, depends largely, on normal function of
the circulation. Because of the initial headward fluid shifts
and subsequent downward blood volume regulation, the
control of blood volume and pressure has turned out to be
central to the understanding of the responses to weight-
lessness and the return to Earth. The ability to assess the
causes and consequences of blood volume loss during
spaceflight was facilitated by the fact that the circulatory
system was represented, at varying levels of detail, in our
entire repertoire of models, and in three particularly use-
ful models, those of fluid-electrolyte, erythropoiesis, and
cardiovascular regulation.
The cartoon in Fig. 10-14 illustrates the shift of blood
and leg tissue fluids that are normally pooled in the legs
in one-g into the central circulatory compartments in zero-
g. The consequences of this fluid shift phenomenon are
widespread, as suggested throughout this book and sum-
marized in Fig. 10-14. Not only do they activate the nu-
merous blood volume and renal-endocrine controllers as
indicated in Fig. 10-3, but they affect the hematological,
pulmonary, cardiovascular, and perhaps the vestibular sys-
tem as well as the physical characteristics of the astro-
nauts. The usefulness of ground-based analogs to simulate
spaceflight is often judged by the number of such effects
that can be reproduced. The homeostatic reduction in
plasma volume that is thought to occur (see Fig. 10-5)
returns central blood volume towards normal, reduces the
total plasma volume and produces a mild hemoconcentra-
tion. This event has the following consequences:
a) Hemoconcentration results in enhanced oxygen de-
livery to the tissues, causing a reduction in red cell
production and red cell mass, due in part from sup-
pression of erythropoietin (see Fig. 10-6). Thus,
plasma volume and red cell mass are regulated by in-
dependent mechanisms. Red cell mass is ultimately
under the control of an oxygen regulator which bal-
ances oxygen supply and demand while plasma vol-
ume is under control of a volume regulator sensing
central fluid pressures. Although not measured directly
during flight, the blood volume reduction can, argu-
ably, be attributed to an acute plasma volume loss,
followed by a more gradual loss of red cell mass, a
scenario simulated by the modified Guyton model
(Fig. 10-15). A potentially significant insight from
this model simulation is the prediction that as red cells
are depleted, volume regulators replenish the plasma
component just enough to maintain total blood vol-
ume at a new and reduced level. This inverse relation-
ship between plasma volume and red cell mass was, in
fact, observed in the Skylab crew (see Fig. 6-2. This
supports the notion of a tightly controlled blood vol-
ume level with an altered zero-g setpoint.
b) An increase in peripheral flow resistance also results
from the increased viscosity of the hemoconcentrated
blood, as well as from autoregulatory controllers re-
sponding to tissue hyperoxia. The circulatory effects
of increased resistance, as predicted by our models
are to suppress venous pressures and cardiac output
below control levels.
c) Other circulatory adaptive effects, such as blood ves-
sel retoning, are likely to occur in prolonged flight as
the body attempts to reduce the capacitance of the
circulation to accommodate a reduced blood volume.
The Guyton model is one of the few models in exist-
ence that accounts for this and other similar mecha-
nisms in the long-term adaptation of the circulation.
d) The effect of blood volume loss (and postflight he-
modilution) are believed to be largely (but not wholly)
responsible for the impaired circulatory responses dur-
ing exercise and orthostatic tests noted in astronauts
returning from space. During flight the increase in he-
moglobin concentration likely helps maintain exer-
cise performance in the face of a depleted blood
volume.
10.4.4 Summary of Integrated Hypothesis
The integrated hypothesis has emphasized several
critical ideas:
a) there are only a few direct effects of weightlessness on
the body from which a cascade of physiological re-
sponses ensue,
b) there are both acute and longer-term (adaptive) com-
ponents to the weightlessness response,
c) a number of physiological systems participate in this
response,
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Figure 10-14. The wide-spread effects of headward fluid shifts. The cartoon on top indicates that blood and fluid normally pooled in the
legs in one-g are shifted headward in zero-g. During spaceflight adaptation, volume controllers normalize central fluid volumes. Upon
return to earth, the reduced blood volume is believed to play an important role in causing orthostatic intolerance and reduced exercise
performance. There are widespread and measurable consequences at every stage of this scenario, including the recovery period, as
indicated by the lower portion of the figure. The vestibular effects are uncertain but have been proposed by various researchers.
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d) the response is highly dynamic and interactive be-
tween all of the major systems, suggesting the impor-
tance of an interdisciplinary approach,
e) the responses to weightlessness do not appear to be
pathological but can be explained in terms of normal
feedback regulatory processes that are also operative
on earth,
f) the time course to achieve a new homeostatic state for
zero-g is different for each major physiological sys-
tem, and
g) the most significant and consistent consequences of
these fundamental changes include a change of body
composition, blood volume loss, alteration of blood
biochemistry (hormones, electrolytes), cardiovascu-
lar deconditioning, atrophy of musculoskeletal tissue
and short-term vestibular disturbances.
This broad view of adaptation to spaceflight, together
with the more detailed subsystem hypotheses, is the cul-
mination of the systems analysis effort, and represents a
response to the critical questions posed earlier in this chap-
ter. The approach taken here was designed to mine the
lucrative Skylab database during a time when spaceflight
was inaccessible. Whether or not the effort was worthwhile
should be evaluated in an historical context; i.e., prior to
Skylab a generally agreed upon overall hypothesis for
adaptation to weightlessness was lacking. Like any theo-
retical analysis, these ideas need to be treated with appro-
priate caution. Any ideas that conflict with irrefutable data
that were somehow not considered should be discarded, of
course. More likely, there will be conflicting viewpoints
based on other hypotheses or weak data. In these circum-
stances, the obvious course is to provide the crucial ex-
periments that will provide a factual basis for a more cor-
rect view. In many cases, we have proposed such an
experimental program.
10.5 Effectiveness and Limitations of the
Modeling Approach
10.5.1 General Modeling Process
In general, it was the consensus of those working on
this project that mathematical models are useful and ef-
fective tools for testing physiological system hypotheses
in an interdisciplinary context especially where experi-
mental opportunities are limited as in human space re-
search. Nevertheless, there were limitations to the modeling
process and lessons to be learned for future studies. Some
general conclusions, lessons learned and recommendations
are discussed below, first regarding the general modeling
process, and then, because of its special nature, the Whole-
Body Algorithm.
a) Models Should Complement Research Environ-
ment. The state of the art in mathematical modeling
in the early 1970’s (when this project was underway)
was the representation of entire organ systems or
multi-organ systems. At the same time, biomedical
spaceflight research was in its embryonic form and
consisted almost entirely of identifying gross changes
of different organ systems. Thus, there was good align-
ment between the type of data being collected by
NASA and the level of detail in currently available
physiological models. Had the nature of the research
been concerned more with changes at the biochemi-
cal and cellular level, as it is today, these same models
would have been much less effective.
A large scale modeling program becomes cost ef-
fective when it is difficult or expensive to collect
worthwhile data. The current project took place dur-
ing the 10 year hiatus in spaceflight operations be-
tween the end of the Skylab biomedical program (Feb.
1974) and the start of the Shuttle Spacelab research
program (Nov. 1983). If Space Station science opera-
tions truly became routine, there may be less incen-
tive for science program managers to invest in an
extensive modeling program. However, development
of an advanced whole-body model would be extremely
useful in preparing for NASA’s long-term goal of the
exploration of Mars.
b) Models Limit the Analysis. It was obvious from the
outset that the models currently available or those
that could be developed would be restricted to the
analysis of only a subset of the experimental measure-
ments in the extensive Skylab database. Models, by
their very nature, do not include all the details of the
real system. The approach taken for data collection in
the Skylab missions was to measure a large number of
variables, not merely those that had previously been
shown to be disturbed during spaceflight, nor neces-
sarily fundamental factors in each physiological sys-
Figure 10-15. Plasma volume, red blood cell mass and blood
volume changes during a head-down tilt simulation by the Guyton
model modified by the inclusion of a more accurate erythropoiesis
subsystem (Appendix X). Plasma volume rapidly declines by the
amount Y, and then gradually rebounds by an amount, X, to com-
pensate for the loss of red cells. This results in a constant blood
volume at a reduced level, Y.
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tem. Thus, there were large quantities of data that could
not fit within the framework of the predictive simula-
tion models. In some cases, as in the study of body
composition, it was still possible to create simple
metabolic models that yielded extremely useful re-
sults of a descriptive rather than a predictive nature.
In other cases, the models, however complex, simply
did not include many potentially important effects.
Thus, in the area of fluid-electrolyte and hormonal
regulation, data concerning such substances as growth
hormone, thyroxine, insulin, and catecholamines were
not considered in a quantitative manner. Similarly,
the evaluation of the electromechanical properties of
the heart and the immunological responses of the crew-
men, although studied in space, did not lend them-
selves to a rigorous simulation analysis. Models were
also not available at the time to study such poten-
tially important factors as acid-base balance, cell me-
tabolism, or vestibular function. In the time since this
study began, however, many promising developments
in modeling these systems have taken place and these
ought to be considered if further work is planned in
spaceflight systems analysis.
c) Data Limits the Analysis. Notwithstanding the
above comments concerning the abundance of data
relative to model complexity, another limitation in
the approach resulted from a scarcity of data in those
areas where the models were well suited for analysis.
Measurements were limited, in the Skylab study, to
non-invasive collection procedures, but most of the
model parameters and variables reflect invasively ob-
tained quantities. Data collection was also severely
restricted during the first 24 hours of each flight, dur-
ing the time that dramatic physiological change took
place. Unfortunately, the predictive accuracy of the
majority of models used in this study is much greater
for short-term or acute stress conditions compared to
longer-term events. Therefore, it was not possible to
verify the model predictions in a variety of circum-
stances. Table 10-7 lists examples of the more com-
mon quantities measured during spaceflight that could
be simulated with the current suite of models (left col-
umn); also shown are an equal number of very useful
quantities that were not measured in Skylab but that
were within the capabilities of model prediction. Be-
cause of the unavailability of this data, the modeling
approach, with its predictive capabilities, was able to
make a more significant contribution.
d) Importance of Experimental Program. The im-
portance of using models for data interpretation within
the framework of an active experimental program has
been emphasized throughout this book. This demands,
first, an active involvement of experienced research-
ers and, secondly, the ability to influence new experi-
mental studies. Indeed, we found that the strongest
outcome was generally achieved when the system
modelers and the subject-matter expert scientists op-
erated as a team. This was not always the case and it
was necessary at those times for the modelers to de-
velop a firm foundation of the physiology. Research-
ers who do not make the effort to appreciate the use-
fulness of modeling usually are too skeptical of this
tool, e.g., it is incomplete, it is too quantitative, to
trust the potential insights and benefits. Also, there
was limited opportunity in this project to become in-
volved with new experimental studies, the exceptions
being a U.S.–Russian bedrest study (Chapter 9.7) and
the hematological studies in dehydrated mice (Chap-
ter 6.5.4). However, the modeling project did provide
the basis for a number of ideas that were incorporated
into proposals for future flight experiments (see Ap-
pendix G).
e) Not All Models Useful. Not all of the models used
in the project were equally useful. For example, the
thermoregulatory and respiratory models, although
important elements in the whole-body algorithm, re-
ceived relatively little attention in the task of space-
flight data evaluation. These models were originally
included (prior to the first Skylab flight) because of
the belief that disturbances in environmental tempera-
tures and ambient gas compositions, if they occurred,
would be important factors in interpreting the crew’s
responses. However, there were only isolated instances
of environmental disturbances and for the most part
there were no unusual thermoregulatory and respira-
tory problems. The models that proved most useful
for hypothesis testing were the modified Guyton
model, the pulsatile cardiovascular model (in both
LBNP and exercise modes), and the erythropoiesis
model. The former of these was the most complex and
the latter the least complex of all the models used in
the project, emphasizing the notion that even simple
models can be extremely useful. Nevertheless, the
lesser used stand-alone models were critical compo-
nents of the Whole-Body Algorithm.
f) A New Reference State Needed. One of the con-
clusions of this study is that it is not an easy task to
mathematically simulate the true nature of zero-g. The
two major characteristics of weightlessness are the
elimination of hydrostatic gradients on blood columns
and the elimination of loading on weight-bearing tis-
sues. The human body, altered by these two character-
istics in zero-g, is usually contrasted with that found
in the upright ambulatory position in one-g, for the
latter is the position in which the effects of gravity are
most prominent. It may, therefore, be argued that a
true simulation of weightlessness should begin with a
model referenced in the upright position and should
contain hydrostatic and tissue elements which respond
to gravity. In such a model, removal of the gravity
vector might then automatically promote the headward
redistribution of circulating fluids (in response to the
absence of hydrostatic gradients) and the degradation
of atrophy of musculoskeletal tissues (in response to
the absence of load). This rationale is conceptually
identical to that which underlies experimental simu-
lation of weightlessness by bedrest. However, the ex-
isting mathematical models are initialized in the
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supine, not the upright, position, and do not contain
all of the mechanisms that are representative of ambula-
tory man. The fallacy of the supine reference position is
made clearer by realizing that the supine condition, if
extended, is not much different from the weightlessness
adapted state. (This is the basis for using supine bedrest
as a spaceflight analog). It is our belief that if one
begins with a model referenced in the erect position,
long-term spaceflight could be approximated by simu-
lating the chronic supine position.
Most of the crucial mechanisms that allow man to
remain in the upright position are those that protect
against orthostatic collapse and those that maintain
integrity of musculoskeletal tissue in the face of down-
ward weight loading. Unfortunately, many of these
mechanisms are not yet known or quantified, so that
mathematical simulations using this approach are not
yet feasible. Nevertheless, it was still possible to ap-
proximate some of these gravitational effects in the
current modeling effort in a somewhat artificial man-
ner. For example, headward fluid shifts were accom-
plished either by mathematically forcing fluids from
the legs, applying external pressures on the extremi-
ties, or by tilting the model in a head-downward posi-
tion. Similarly, the effects of muscle atrophy were
simulated, in part, by allowing the release of cellular
electrolytes into the extracellular compartments. This
approach avoided the problem of modeling the pri-
Table 10-7. Selected Quantities Predicted by Simulation Models
PARAMETERS FOR WHICH PARAMETERS FOR WHICH
INFLIGHT DATA EXISTS INFLIGHT DATA DOES NOT EXIST*
Total body water Extracellular water
Leg volume Intracellular water
Body potassium Interstitial water
Extracellular sodium Plasma volume
Plasma sodium Red cell mass
Plasma potassium Red cell production rate
Plasma proteins Plasma erythropoietin
Plasma hemoglobin Tissue oxygenation
Plasma angiotensin Autonomic activity
Plasma aldosterone Volume receptor stimulation
Plasma ADH Natriuretic factor
Capillary filtration
Urine volume Cardiac output
Urine sodium Peripheral resistance
Urine potassium Venous pressure
Evaporative water loss Local blood flows
Blood pressure Body temperature
Leg blood flow Circulatory, renal, fluid, and hormonal
   changes on first inflight day
LBNP heart rate LBNP cardiac output
LBNP blood pressure LBNP venous pressures
LBNP leg volume LBNP blood volume and flow
   distribution
Exercise heart rate Exercise cardiac output
Exercise oxygen uptake Exercise stroke volume
Exercise minute ventilation Exercise blood gases
*Skylab era
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mary physio-chemical-mechanical forces that occur
with the loss of gravity, and it was successful in repro-
ducing many short-and long-term effects observed in
hypogravity environments. The task of identifying
more basic model forcing functions was begun with
the studies of orthostatic mechanisms, cardiovascular
deconditioning, and gravity loading effects on bone
demineralization. Simulations of weightlessness with
greater realism will most likely be achieved by more
fully appreciating and quantifying the mechanisms that
permit man to function in his normal upright position.
Such an approach would necessitate a deeper under-
standing of gravitational and spaceflight physiology.
10.5.2 Whole-Body Algorithm
10.5.2.1 Accomplishments. A great deal has been
learned in the design and development of the Whole-Body
Algorithm (Chapter 3). The WBA was conceived as a means
to study multiple system physiological processes and in-
teractions, multiple and sequential stresses, and overall
system hypotheses including zero-g effects. A number of
diverse stresses (over a range of stress levels) have been
simulated including environmental disturbances (ambi-
ent temperature changes, hypoxic and hypercapnic gas
mixtures), metabolic changes (supine and sitting exercise),
and special experimental situations (tilt-table studies,
LBNP, and bedrest). Simulation of short-term stresses re-
sulted in simultaneous and integrated responses from the
cardiovascular, respiratory, and thermoregulatory sub-
systems and the accuracy of a large number of responding
variables were verified. The capability of each subsystem
model was extended by adding functionality not in the
original model (Appendix D). In all cases, whenever a par-
ticular subsystem model had been previously tested on a
stand-alone basis, its performance as part of the WBA
proved to be at least as good and in some cases better, with
respect to agreement with available data and stability of
response.
The versatility of the WBA was illustrated by its abil-
ity to combine these stresses and automatically sequence
between the long and short-term model subsystems. This
capability was demonstrated by a 4-week bedrest study
preceded and followed by tilt and exercise stress tests
(Chapter 9). In this case the long-term subsystem model
was found to reproduce many experimentally observed
changes in circulatory dynamics, body fluid-electrolyte
regulation and renal function as the body adapts to
hypogravity. The shorter-term components of the WBA
successfully reproduced differences in tilt and exercise
tests before and after bedrest. Both steady-state and tran-
sient responses were found to be reasonably accurate. A
myriad of operational and computer-related problems were
solved during its development. Taken together these are
significant accomplishments.
10.5.2.2 Lessons Learned and Recommendations.
Although a measurable degree of success has been
achieved, the WBA is by no means complete and it really
represents a stage of development. Many aspects and ca-
pabilities of the model have yet to be tested. The valida-
tion process has uncovered inadequacies in the response
to many of the stresses and suggestions for correcting these
have been discussed in earlier chapters (also see Appen-
dix G). Some of the most useful insights gained from the
experience with developing and using the Whole-Body
Algorithm include the following:
a) Greater Stability. In the course of running simula-
tions with the WBA it was observed that the model was
extremely stable from an operational perspective. In
some models, especially in the initial simulation trials,
there is a tendency for the output variable (signal) to
oscillate and eventually become unstable. Guyton
(private communication) made a similar observation
concerning the development of his model and attrib-
uted this phenomenon to the extreme stability of the
real system because of redundant feedback pathways.
This suggests that interacting subsystem models, if prop-
erly formulated, inherits some the innate stability and
compensatory characteristics of the real system.
b) WBA Too Cumbersome. Complexity may have lim-
ited the usefulness of the whole-body algorithm, which
contains well over a thousand parameters and vari-
ables and a large number of physiological subsystems.
A model of this size is somewhat cumbersome and
unwieldy, and simulations take a relatively long time
to perform. This was due, in large part, to the limita-
tions of the computer systems that were in use 25 years
ago. In addition, the WBA turned out to be not as well
suited for studying a single subsystem response, as
were the individual subsystem models on a
stand-alone basis. For example, often only a small por-
tion of the Whole-Body Algorithm was needed to test
the erythropoiesis response to a hypoxic stress. It was
much more convenient, in those cases, to use the stand-
alone model for erythropoiesis regulation. Perhaps for
these reasons, most of the systems analyses performed
in this project and the most useful results were
achieved with the individual stand-alone models
rather than with the Whole-Body Algorithm.
c) WBA Not Fully Utilized. The WBA, as developed in
this project, is very versatile, capable of simulating
many different conditions. Limited resources permit-
ted the examination of only a few specific conditions,
all related to spaceflight. It was not possible to ad-
dress numerous other applications. Thus, even before
developing a more advanced model, it may be useful
to put the current model to more complete use. For
example, simulation of exercise (with or without si-
multaneous environmental stresses) is one of the areas
in which this model may be superior to all others.
Although exercise was an experimental procedure dur-
ing Skylab, measurements were confined to the car-
diovascular responses to this stress. Therefore, the
model’s capability to integrate thermal, respiratory,
and cardiovascular responses to exercise could not be
used to advantage. In general, there is a scarcity of
data describing multi-subsystem responses to almost
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any stress and when this fact is combined with a diffi-
culty in performing rapid experimental iterations, the
utility of such a complex model as the WBA becomes
questionable.
d) WBA Should Integrate Spaceflight Hypotheses.
The full potential of the whole-body algorithm has
not yet been realized, not only due to insufficient data,
but also because the present effort has largely empha-
sized the subsystem analysis in the stand-alone mod-
els. The analysis of subsystem hypotheses is now
largely complete in several important investigative
areas. The next phase of application will be to incorpo-
rate descriptions of these subsystem hypotheses into the
whole-body algorithm. When this is accomplished, then
that model will serve its main function as a central re-
pository of a detailed integrated, multi-system hypoth-
esis of zero-g adaptation. In this way it will be possible
to discover how the hypotheses developed for one sys-
tem could have important consequences on another sys-
tem. Thus, the WBA can then be used to study
interactive effects between subsystems, responses to
multiple stresses, and the dynamic behavior of
short-term and long-term regulators, capabilities
which the present model contains but which have not
been fully explored.
e) Top-down or Bottoms-up? A major question at the
outset of developing a large-scale multi-subsystem
model is whether the design should be “bottoms-up”
or “top-down”. The first approach consists of combin-
ing previously existing subsystem models so that they
function together, while the second approach is to de-
sign each subsystem to function as a part of a single
model from the outset. In spite of some obvious limi-
tations, the Whole-Body Algorithm was designed with
a “bottoms-up” approach and the reasons for doing so
were discussed in Chapter 3 (Chapter 3.2.6.2). Briefly,
the bottom-up approach can lead to a working model
more swiftly but there are operational, structural, and
conceptual problems. On the other hand, the top-down
approach is a more logical and natural one, but re-
quires a large investment in talent, time and money. In
the end, there was general agreement that a top-down
approach would result in a superior model (see sec-
tion below and Chapter 11).
10.5.2.3 Future Directions of the WBA. Work on the
WBA essentially stopped once the concept was demon-
strated. This was a result of limited resources and changes
in priorities rather than in belief that the basic approach
was incorrect and should be abandoned. Thus it was ap-
parent at the time that many voids existed in the inte-
grated model that was created. Much work is needed in the
areas of modeling metabolic and biochemical processes,
renal function, vestibular function and a host of others.
An advanced model that integrates these systems may prove
to be very useful for evaluating countermeasures and pre-
dicting crew health during spaceflight. Developing mod-
els that mimic a particular individual’s unique physiology
is an even more far-reaching goal. There has been little
modeling of disease processes on a subsystem or system
level. These voids should be among the objectives ad-
dressed by an advanced total body system model.
However, in designing an advanced total body system
model, one must consider an even more basic problem
than simply filling the voids of these models. It almost
seems like a contradiction in terms, but the model must be
simplified before a more complex model can be devel-
oped; this may require a totally different approach than
building a total body model by connecting subsystem
models together. At the heart of the systems analysis ap-
proach is the identification of the essential details of a
system and to discard or reduce in size, the non-essential
elements. Several of the essential elements identified for
an improved Whole-Body Algorithm include: a) a top-
down design approach, b) the need for a single central
nervous system and a circulatory system, c) an associated
research program for developing a model validation data-
base and a interdisciplinary spaceflight database, and d)
developing a central repository and communication sys-
tem that will allow modelers from many laboratories to
participate in building a large-scale physiological model.
These and other recommendations are discussed further in
Chapter 11 and listed in Appendix G.
10.6 Concluding Remarks
The project, on which this book is based, set out to de-
velop and utilize a general systems approach for conduct-
ing and analyzing research on the human adaptation to
weightlessness. The approach discussed herein has been
valuable in evaluating hypotheses and important mecha-
nisms, identifying elements requiring further experimen-
tal description, providing a basis for analysis of selected
data, and assisting in the development of a general hy-
pothesis for gravity unloading. Specifically, all of the ob-
jectives originally established at the outset of this project
(see Introduction, Chapter 2.1.2) have been addressed and
realized to a large extent, as described below:
1. The objective of “developing new and improved math-
ematical approaches for solution of problems in
spaceflight life sciences” was achieved with the de-
velopment of an integrated database and analysis sys-
tem including statistical capabilities, special purpose
programs and simulation models including the devel-
opment of a preliminary large-scale model of the hu-
man (see Chapter 3 and Table 10-1).
2. The objective of “organizing, integrating and ana-
lyzing spaceflight and supportive ground-based re-
search data across interdisciplinary lines” has been
realized in each of the areas addressed including
fluid-electrolyte regulation, body composition, eryth-
ropoietic regulation, cardiovascular regulation and
musculoskeletal function. This effort has resulted in
an advanced, but more narrowly focused, analysis of
spaceflight data than was previously available from
the original Skylab reports. A major data analysis ac-
tivity was the interpretation of the vast quantity of
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Skylab metabolic data (see Chapter 4). Data that had
previously been published was reevaluated and rein-
terpreted with the systems analysis tools in the light
of recent findings from ground-based studies and So-
viet missions.
3. The objective of “attempting to explain the experi-
mental findings” by “testing individual physiologi-
cal subsystem hypotheses using quantitative
approaches” was perhaps the unique contribution of
this project and was described at length in Chapters 5
through 9 and summarized in the current chapter. Hy-
potheses were contributed by spaceflight investiga-
tors and were naturally generated by the systems
analysis process. Because the models embodied cur-
rent theories of homeostatic control in the requisite
organ systems, it was possible to use computer simu-
lation as the basis of a hypothesis testing approach.
Comparing model results with the spaceflight find-
ings led to insights about the behavior of the system
under weightlessness conditions and to the veracity
of the hypothesis.
4. A fourth, and highly ambitious, objective was
to“integrate these hypotheses into a unified and in-
ternally consistent understanding of physiological
adaptation to weightlessness”. The process of identi-
fying what appear to be fundamental influences of
gravity on each physiological system and then exam-
ining interactions between systems has led to the rec-
ognition of several common pathways (see Fig. 10-11).
These pathways have suggested clues for a tentative
integrated physiological hypothesis for spaceflight
adaptation that is consistent with the Skylab data.
Feedback pathways that regulate acute changes in
flight eventually give way to less understood adap-
tive (or chronic) processes. In order to solidify these
tentative conclusions more data must be collected
under various conditions, including spaceflight and
ground-based studies and using human and animal
subjects.
5. The final objective listed at the outset was to apply
the experience gleaned from this project “to improve
experimental design and data analysis”. Because of
the capability of the models used in this project to
test hypotheses and predict quantities or processes
that were not examined directly in space, the poten-
tial exists for proposing confirmatory experiments.
During the latter phases of the project, the systems
analysis team formed collaborations with researchers
who were engaged in animal research, human bedrest
studies, operational medicine, and proposal prepara-
tion for experiments on the new Space Shuttle. The
systems analysis approach helped to solidify the hy-
potheses, to provide the research rationale, and to simu-
late the proposed experimental protocols. Many of
these proposed experiments have already been real-
ized. As was emphasized more than once, full poten-
tial of the systems analysis method will best be realized
by maintaining an iterative cycle between model de-
velopment and experimental research.
In spite of the limitations in the modeling process and
the difficulty in achieving a rapid iterative experimental
process, these studies have resulted in an improved under-
standing of the physiological events that occur during
human adaptation to weightlessness. When this under-
standing is enhanced, it should be possible to use advanced
models to define appropriate indices of health (normal
adaptation) during spaceflight, to predict individual re-
sponses to weightlessness, and to develop countermea-
sures to the deleterious effects of spaceflight and
subsequent recovery.
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Chapter 11
Advanced Applications and Future Directions
11.1 Introduction
We have demonstrated, in some detail in this book, the
advantages of mathematical modeling. These include the
identification of system structure, simulation of intact sys-
tem behavior, estimation of quantities which are normally
not measurable, and hypothesis testing to understand spe-
cific mechanisms and help interpret experimental find-
ings. The next step in the NASA Life Sciences program is
to put these newly developed tools to work in support of
the current and future spaceflight programs. A balanced
program is envisioned for applying the current simulation
and analysis systems to new areas and filling the gaps in
the current capability by developing new systems. This
should be complemented by an appropriate experimental
research program. As we have seen from experience, a syn-
ergy of melding experimental and theoretical activities is
crucial for a successful outcome.
Based on the results of the current program we would
expect model applications in several specific areas. Among
these is the use of the models with the zero-g hypothesis
mechanisms incorporated in them for more advanced stud-
ies of integrated physiology. Such a model system would
also be suitable for assisting with the design and interpre-
tation of flight experiments and for continuing the inte-
gration of ground-based and spaceflights studies. The
preliminary effort in developing an erythropoietin mouse
model should be extended in developing multi-species
models for all appropriate physiological systems where
animal experiments play a critical role.
The innovative project of combining subsystem mod-
els that was begun in the current project (i.e., whole-body
algorithm) should be continued. An advanced large sys-
tem model that utilizes a top-down design approach should
have considerable promise in helping to understand inter-
actions between major body systems and long-duration
adaptive phenomena. Also customizing this model so that
it can differentiate between individual subjects or classes
of subjects is a more realistic strategy of accounting for
the nuances in physiological responses than a one-size-
fits-all approach.
A major role of models is also is seen in the develop-
ment of computer-assisted health care systems. Simula-
tion models can be developed for understanding the
pathophysiology of a disease state and evaluating alter-
native therapies and countermeasures. Pharmacokinetic
models are becoming more common for helping to under-
stand drug distribution and behavior in the body with the
purpose of optimizing drug dosing schedules. Models can
be oriented toward such clinical problems as minimizing
the amount of blood drawn from a patient or optimizing
expensive imaging tests. Other types of computational
methods and biomedical databases can be added to de-
velop a system which serves as an adjunct to space medi-
cal operations,  including real-t ime physiological
monitoring of the spaceflight crews, diagnosing medical
conditions, and selecting treatment regimes. Beyond these
space applications, a number of recent innovations in
medicine and physiology have shown much promise in-
cluding expert systems and teaching models.
The general systems analysis approach that provided
the foundation and structure to the current project is also
being applied to managing portions of the space life sci-
ences research program. This is especially true for activi-
ties where decisions by mission planners must be made to
allocate limited resources for science experiments and
ensure safety of space crews. A systematic approach to
resource allocation has been used in managing science
during the Shuttle Spacelab era and in planning for explo-
ration-class missions.
These ideas for advanced applications and future di-
rections of systems analysis and modeling will be explored
below.
11.2 Systems Analysis as an Aid
for Designing Spaceflight Medical
Experiment
An important use of simulation models has been to predict
experimental results or stress responses that cannot be
determined directly because of excessive risk, cost, or de-
lay. The more highly developed the model, the greater the
predictive capabilities. However, a powerful use of simu-
lation models is, as a research tool, to aid in designing and
interpreting experiments rather than to take the place of
experimentation. An example of this approach is provided
in Chapter 6.5.7 where the use of the model for erythro-
poiesis regulation in developing a flight experiment is
described. When used for these purposes, it is not always
necessary that the model be an exact description of real-
ity; a gross approximation will often be sufficient. Certain
special techniques, such as sensitivity analysis, error analy-
sis, and parameter estimation, have been developed that
greatly enhance the use of simulation models in this re-
gard. The following outline briefly discusses many of the
uses that simulation models afford the scientist/planner in
designing experiments (details have been omitted in the
interest of brevity only; the techniques discussed have
been developed sufficiently to begin applying them im-
mediately to any physiological system which is not well
understood and for which a gross descriptive model has
been formulated):
a) Models can be used to rapidly simulate long-term ex-
periments in relatively brief periods. The simulation
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would help establish the exact conditions that are de-
sired for the upcoming experiment.
b) Models that predict unsteady state responses can be
used to indicate the times when variables are chang-
ing more rapidly and thus suggest the time protocol
for making data measurements.
c) Traditional methods of stressing systems, such as in-
ducing single step changes in a system parameter, of-
ten do not produce as much insight into a system as
more unusual types of stresses such as multiple, se-
quential or time varying stresses. Models can usually
predict, better than human intuition, the effects and
advantages of using these types of experimental
stresses.
d) Sensitivity analysis is a systematic and quantitative
method of identifying the most important parameters
of a system; i.e., those that have the greatest influence
on given response variables. This method would pro-
vide a rational basis for deciding priority of experi-
mental measurements and cost allocations.
e) Error analysis, when combined with sensitivity analy-
sis, can lead to an even more powerful ordering of
priorities. This technique provides an estimate of the
relative contribution of errors of the major system pa-
rameters to the final system response. This informa-
tion can be used to define the limits of allowable
experimental error and hence suggest acceptable mea-
surement techniques.
f) Simulation may be used to design decisive experi-
ments by determining those conditions under which
competing theories or hypotheses predict the most
divergent experimental results.
g) Physiological function of particular systems is often
evaluated clinically by measuring only a few system
variables (such as heart rate and blood pressure for
cardiovascular evaluation). As more knowledge is
gained, these “performance criteria” are reevaluated
and improved (e.g., the use of exercise stress and non-
invasive measurements to evaluate cardiorespiratory
function). Simulation can be used to aid in this pro-
cess of developing performance criteria that are sensi-
tive to deteriorating physiological function. This can
be done by testing complex combinations of param-
eters and correlating them with simulated stress and
pathological states. This in turn would suggest ex-
periments to test any favorable simulated results.
h) The interpretation of experimental results can also be
aided and extended by modeling. Parameter estima-
tion procedures involve adjusting parameter values
in a model until certain simulated responses compare
favorably with experimental measurements. This re-
sults in estimating values for parameters and responses
of the system that would otherwise be difficult or im-
possible to measure directly.
An analogy can be made for relating computer simu-
lation using math models to help understand experimen-
tal research in the same way as animal models are used to
help understand the human response to experimental in-
tervention. However, the analogy becomes more complex
because we have shown that the computer model can be
used to simulate the spaceflight response of both the ani-
mal and the human. A major portion of NASA’s life sci-
ence research is devoted to animal studies which often
serve as a surrogate for the human in both ground-based
and space-based research. Figure 11-1 attempts to show
these relationships between math models, animal models
and human studies as used for gravitational studies. Also
shown are the various functions, described above, that
models contribute to this interaction. The models provide
a framework for coordinating and interpreting a diversity
of biological studies whose ultimate objective is the un-
derstanding of human responses to weightlessness.
Figure 11-1 also shows a concept that has been stressed
throughout this book, that modeling is an integral part of the
research cycle. Full potential of the systems analysis method
is realized when there exists an iterative cycle between model
development and experimental observation.
11.3 Advanced Total Body System Models
The research reported in this book has revealed that the
adaptive response to spaceflight is manifested in all of the
body systems that have been studied. It has also become
apparent that many unresolved biomedical problems still
exist and that our understanding of physiological adap-
tive mechanisms is incomplete under either earth-bound
or space conditions. Therefore, a useful strategy to study
spaceflight adaptation would be to examine the human
body as a total system. This was the underlying motiva-
tion for creating the whole-body algorithm. We can no
longer treat the human body as if it were divided into
academically defined organ systems (i.e., cardiovascular
system, neural system) acting independently. It is not
enough to only address the problems caused by the loss of
bone or exposure to space radiation. Rather, a more opti-
mal approach is to develop a fully integrated view of the
body, with all parts connected and fully interacting in a
realistic manner.
As was discussed in the last chapter, the whole-body
algorithm was a preliminary effort, almost a computer ex-
ercise; it was meant to be followed by more advanced
models. The first version of the whole-body algorithm is
already unwieldy and difficult to work with as well as
being time consuming to operate. It is already apparent
that much work is needed in the areas of modeling meta-
bolic and biochemical processes, renal function, vestibu-
lar function, calcium regulation, and pharmacokinetics
among others. There has been little done in the area of
modeling to understand disease processes on a subsystem
or system level. Some of the more important recommenda-
tions for improvements to the current whole body algo-
rithm is provided in Appendix G. There is also a
compelling rationale to begin this type of effort from a
clean slate, as discussed below.
After nearly 3 decades of inactivity in the area of large-
scale physiological models, NASA is beginning to com-
mit resources to the development of a “digital human” – a
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quantitative description of a healthy human being that
contains state-of-the-art information on each component
of the body and how these components relate to each other
[1]. The digital human will contain virtually everything
known about human physiology, from biochemical to cel-
lular to organ to system information (vertical integration)
and then to interactions among the body’s system (hori-
zontal integration). A concept for integrating components
in this manner was presented in Chapter 2 (Fig. 2-1). Such
a representation of the human body through digital infor-
mation will be the backbone of a new approach to integra-
tive physiology and medicine. This approach capitalizes
on the investment that has been and continues to be made
in the molecular approach to biology, and at the same
time on the new and emerging capabilities in computing,
information storage, modeling, and fast, parallel process-
ing that characterize today’s technology (Fig. 11-2). It is
envisioned that the payoff from the digital human will be
great. This model will allow us to understand the function
of the healthy body as we never have before, and to iden-
tify the knowledge gaps that are hidden from our view
today when we look at the many parallel and interacting
proceses at work within the body. It will enable us to probe
into the causes and mechanisms responsible for the many
changes that occur when the environment changes, as it
does during spaceflight, or when some pathway or compo-
nent within the body becomes dysfunctional, as it does
Figure 11-1. Interaction of biological and computer models in support of human experimentation in the space program.
during injury or disease.
The following cross-cutting themes will be central to
the approach to be taken because they represent funda-
mental physical, chemical, and biological processes that
govern system behavior across vertical and horizontal lev-
els of integration:
· biochemical and electrical signaling;
· biomechanics and movement;
· energetics and metabolism;
· fluid, electrolyte and acid-base balances;
· mass and energy transport and conservation;
· hierarchical organization of function from molecule
to cell to organ;
· homeostatic regulation, multi-level control in hierar-
chical systems, and their dependence on the functional
state of the person; and
· adaptation and limits to achieve steady states in con-
tinuous environmental stresses.
Integration across systems (similar to the current
whole-body algorithm) is key to the success of the model-
ing approach because the loss of stability and homeosta-
sis under stress likely involves the interaction of varied
human responses, biological functions, and mechanisms
at all levels. Because of genetic and experiential differ-
ences among individuals, this integration needs simulta-
neously to address generic human responses and individual
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functional characteristics. The research necessary to de-
velop the digital human encompasses “classical” medical
disciplines (i.e., cardiovascular, renal, endocrinology)
as well as “cross-cutting” disciplines such as immunol-
ogy, neurobiology, nutrition, aerospace engineering,
bioengineering, bioinformatics, molecular biology, and
biotechnology.
The proposed model is envisioned to embody a wide
range of human function. Some of those under consider-
ation include movement, repair and healing, homeostatic
regulation and control, environmental adaptation, and sen-
sory perception. This will necessitate the integration of a
variety of specific models and simulations of anatomical
and physiological attributes including, among others,
models of membranes, cells, neurons, sensory processes,
circulation, respiration, hemodynamics, metabolism, en-
docrine function, organs, reproduction, skeleton, muscles,
digestion, and movement control.
Developing such an ambitious model will require time,
resources, and proper planning. We must first develop ap-
propriate strategies and themes for defining, organizing
and integrating human function; then we must identify
the critical research necessary to gather the data and infor-
mation that is lacking. We should begin by consolidating
existing knowledge of physiological function, but we must
determine whether incorporating this information into
model simulations leads to instabilities and a breakdown
in homeostasis.
The creation of this complex model will necessitate a
modular approach for combining mechanism–based com-
putational models. Synthesis and integration of these com-
ponents,  each created by teams of researchers in
geographically diverse laboratories, and with different
computer languages, will be not only a technological chal-
lenge, but scientifically we must understand how these
individual units work together, as they do in the real func-
tioning human. Such software modules should be exten-
sible, reusable, interoperable, and retargetable, and they
need to be based on cellular, tissue, and organ-level mecha-
nisms. Not all of the specific models may be required for a
particular simulation; only those modules needed would
be integrated. The resulting integrated simulation would
probably be executed over a distributed network. It should
be possible to exploit WEB-supported models and data-
bases such as the High Level Architecture (HLA) for simu-
lations of the Department of Defense, the Common Object
Request Broker Architecture (CORBA), the designs incor-
porated in the Physiome Project and the National Library
of Medicine’s Visible Human, and the Department of
Energy’s nascent program on the Virtual Human.
The goal of this modeling research is to provide a tool
for planning an exploration-class manned space mission.
A typical Mars-type mission might involve trips of six
months to one year each way, with a stay on Mars of one to
two years. The digital human, personalized for each
crewmember, could provide the ability to simulate this
mission, understand the physiological adaptation, support
the development of appropriate countermeasures, and ad-
dress the critical questions for increased safety, better health
and improved performance on such a prolonged and gravi-
tationally-varied journey. This would not be an exercise
in descriptive mathematics and programming, but a more
comprehensive effort to organize factual and conceptual
information to make it ultimately useful during long-term
space travel within the solar system.
11.4 Computer Assisted Health Care
Systems
The concept of a whole-body representation of human
physiology and function can lead to applications in dis-
ease states and health care issues. For example, large-scale
Figure 11-2. Major elements that are needed to create a digital human.
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models could be used for real-time monitoring of patients,
providing extrapolations of trends in important health pa-
rameters, identifying the critical parameters to monitor for
patient care, aiding in diagnosis, and indicating patient
response to simulated therapy. This has obvious implica-
tions for space-based medicine, that is, in situations where
resources are limited and patients are treated from remote
locations.
Models also lend themselves to establishing normal
health status of crewmembers and predicting deviations
from the reference state. The “classic” symptoms from
which diseases are normally diagnosed on earth may be
significantly altered by the zero-g environment. In the same
way, earthbound treatment procedures may be inadequate
or inaccurate when applied to the space bound patient. An
appropriately validated model could become a powerful
tool for translating these “classic” terrestrial symptoms
and treatments into spaceflight environment symptoms
and treatments. The use of models in a predictive mode
assumes that the models have been verified for the re-
sponse of interest in the environment of interest and
“tuned” for the individual being observed. Once this has
been accomplished, it would be possible to define a
“redline” safety boundary and determine when these lim-
its have been exceeded. Also, models can help identify
the manner in which diseases develop by simply altering
one or more of the normal pathways of the physiological
system. Once a mathematical model of a pathology is vali-
dated, the human system’s response to the disease can be
simulated and therapies can be identified and evaluated.
In this regard, the utility of models to help design coun-
termeasures for orthostatic intolerance has been demon-
strated in Chapters 7 and 9.
A concept for a computerized real-time biomedical
monitoring and health care system is shown in Figure 11-
3. The system envisioned would have the capability to: a)
automatically integrate spaceflight health monitoring
data, including measurements of physiological, psycho-
logical, performance and environmental status, b) detect
acute or chronic off-nominal conditions, c) predict future
health status assuming no remedial action is taken, and d)
search for appropriate treatments. This capability would
be provided by a computer software system consisting of
an extensive biomedical database and programs for data
processing, pattern recognition, Monte Carlo searches, and
statistical and trend analysis. In addition, the utilization
of mathematical models of major physiological systems
should provide significant advantage in this biomedical
monitoring process. Models envisioned for this system
would have such uses as: a) establishing indices most sen-
sitive to particular changes in body function, b) establish-
ing acceptable tolerance limits for monitoring instruments,
and c) helping to distinguish between normal adaptive
changes as a result of weightlessness and pathological
conditions that might be modified by the space environ-
ment. Furthermore, the simulation models have a capabil-
ity to be used in a real-time mode for such purposes as: a)
predicting difficult to measure parameters from non-inva-
sive measurements, b) predicting trends for pathological
conditions, and c) prediction of effects of alternative thera-
Figure 11-3. Concept for a computer-assisted remote health care system originally proposed for use in the Space Shuttle.
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pies for pathological states as well as countermeasures for
normal adaptive states. Special modeling techniques such
as sensitivity analysis, error analysis, and parameter esti-
mation, are well developed for identifying critical param-
eters and indices of system performance when applied to
integrated subsystem model simulations of environmen-
tal and metabolic stresses. Extensive medical textbook
information would also be included in this proposed sys-
tem that could be rapidly searched for symptoms, diseases
and alternative therapies with prediction of possible con-
sequences and probabilities of success attached to each
treatment or countermeasure. A total system approach such
as this could be designed as an adjunct to the needs of a
flight surgeon or physician, whether remote or on-site.
The above concepts for a computer assisted health
care system were proposed in the mid-1970’s for use on
the then-future Space Shuttle [2]. In the ensuing years, the
capabilities of mathematical models have improved but
they have not fully developed their potential in space-
based health care as originally envisioned. On the other
hand, we have witnessed great strides in the related fields
of remote medical sensing, telemedicine and
bioinformatics for earth-based purposes. While modeling
is still not a vital part of these new paradigms of medical
administration, there is great promise. Pilot projects have
shown that medical care can be administered in a distrib-
uted manner by using the Internet to feed patient data to
specialists from different medical centers. These teams
could then use appropriate mathematical models to aid in
monitoring and diagnosing, providing therapeutic modali-
ties and actual drug dosing recommendations. The patients
data can be entered into a nationwide database and statis-
tical models could be used to formulate the most current
relationships between sign/symptom, disease/treatment,
and treatment/side effect. Standing in the way of creating
truly deterministic predictive models capable of simulat-
ing both normal and pathological events is the lack of
understanding of long-term adaptive processes and dis-
ease states. A systematic approach is needed to organize
and integrate such information from space and earth-based
laboratories.
11.5 Bioinformatics
Bioinformatics is a relatively new term that refers to the
cataloging of biological information and the computa-
tional methods for manipulating this information. Math-
ematical models and their use obviously falls under this
characterization. It should have become evident to the
reader of this volume that the process of modeling feeds
on data. Data is used to determine the values of model
parameters, special data sets are used to validate a model,
and when models are used in a predictive mode, data is
used to both drive the model and more importantly as a
basis for judging the accuracy of model response. NASA
has been on the forefront of insuring the availability of
biological data and the development of advanced compu-
tational technology as demonstrated by the four facilities
or organizations discussed below. The first two of them
are related to archiving research data and the last two are
organizational units for developing innovative modeling
applications.
11.5.1 NASA’s Life Sciences Data Archive
The idea of providing a depository of life sciences
data collected in spaceflight to be used by the scientific
community and mission planners is an old one, but it was
not until the early 1990’s that the concept became a real-
ity. NASA’s Life Sciences Data Archive (LSDA) contains
information and data from spaceflight experiments con-
ducted from 1961 to the present, and includes human, ani-
mal and plant studies. The goal of LSDA is to archive and
distribute life sciences data from the last 40 years via a
web site [3], and to also archive life sciences data from
future Shuttle missions and the International Space Sta-
tion. A major purpose of the LSDA is to help researchers in
preparing for future flight experiments. The authors of this
book all played major roles in planning and managing
this potentially important program.
In its ideal form, each flight experiment (and limited
number of ground-based experiments) will contain an over-
view of the experimental objectives, approach and results;
names and backgrounds of all investigators; descriptions
of all parameters measured, experimental protocols and
hardware; experiment data; and bibliographic information
for NASA project documents and scientific publications.
There is a complete search capability for locating infor-
mation by keywords and cross-searching techniques. This
capability allows users to compare data across missions, ex-
periments, and disciplines and perform queries for locating,
retrieving, or requesting data. At the time of its inception,
this was one of the first life sciences database on the World
Wide Web Internet. Some issues and recommendations
concerning the LSDA’s policy on limiting data access due
to privacy concerns can be found in Appendix G
11.5.2 SPACELINE Bibliographic Data Base
SPACELINE is a NASA sponsored library-style archive
containing documents and publications describing the sci-
entific results of all projects funded by NASA’s Life Sci-
ences Division. This includes ground-based and flight
research and human, animal and plant studies. It includes
not only peer reviewed publications but all other research
documents published by NASA, its contractors and grant-
ees. Most of SPACELINE’s holdings can be retrieved via
the National Library of Medicine’s PubMed (Internet) fea-
ture [4,5]. Dissemination of this information is designed
for the scientific and educational communities and the
public.
11.5.3 NASA Center for Bioinformatics
The NASA Center for Bioinformatics at Ames Research
Center (Moffett Field, CA) and Stanford University School
of Medicine recently established a National Biocomputation
Center on the university’s campus in Palo Alto, CA [6]. The
new center is a national resource to further the use of vir-
tual reality in medicine.
The purpose of the Center is to apply advanced com-
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puter technology to the study of biological systems. The
Center is dedicated to the development and application of
advanced visualization, 3D imaging, and computation and
simulation technologies to support the NASA mission for
the human exploration and development of space.
Researchers at the Centre are working on a variety of
virtual reality computer tools to aid in complex recon-
structive surgery and other procedures. Surgeons can use
the big-screen workbench, special gloves, as well as com-
puter tracking wands and other devices to manipulate 3-D
computer images of patients. This technology will enable
surgeons to plan complex surgical procedures and to visu-
alize the potential results of reconstructive surgery in a
three-dimensional virtual environment simulator.
In the future, virtual reality will allow surgeons to re-
hearse a great many complex procedures before operations.
The team expects that, eventually, virtual reality will be a
powerful teaching tool for medical students. A digital library
of computerized “virtual patients” will be created that physi-
cians can use to share information about uncommon proce-
dures. Some biocomputation researchers envision a virtual
hospital could be established which may eventually link the
best medical minds worldwide as well as treat patients.
11.5.4 Integrated Human Function
The National Space Biomedical Research Institute
(NSBRI) [7] in collaboration with NASA is leading an effort
to develop an overall understanding of the human body’s
response to spaceflight by integrating across research ar-
eas in specific body systems. Working from the principal
that the body needs to be studied in an integrated fashion,
they hope to create analytical and predictive models that
answer questions involving multiple human subsystems.
Such models will integrate human function across mul-
tiple scales of organiztion and widely varying time scales,
using both vertical (hierarchical) and horizontal integra-
tion involving such diverse organizational scales as mol-
ecule, cell, tissue, organ, and organism.
If this description sounds similar to the description
provided earlier to describe the digital human it is be-
cause the Integrated Human Function program of NSBRI
has been created to begin creating this advanced integrated
system model. One of the first applications will be a hu-
man exercise model, involving cardiovascular, respiratory
and thermoregulatory subsystems. This integrated ap-
proach will eventually allow researchers to predict poten-
tial problems, simulate health conditions and plan adequate
responses to situations that might occur on a long-dura-
tion mission. Understanding how the body’s systems in-
teract from the molecular and cellular level to the whole
human will enable medical planning and therapy that can
benefit space and ground research and patient care.
11.6 Systems Analysis and Science
Management
The great expense of spaceflights and the limitations on
payloads and personnel make it incumbent for space mis-
sion planners to choose carefully those experiments that
offer the greatest return. With the probability of explora-
tion-class space missions on the horizon, there are also
great biomedical risks for the safety of space crews. There
is a necessity for a process for optimizing risk manage-
ment decisions based on immediate and long term scien-
tific goals as well as political and economic realities.
Scientists and planners should be provided with as much
information as possible for this task as well as analysis
techniques that will help assimilate and integrate this in-
formation. The broad area of systems analysis has proven
to be a valuable approach for systematically organizing
information and in deducing from this network the conse-
quences of alternative plans.
11.6.1 Science Planning During the Space Shuttle Era
The systems analysis team that produced the research
results discussed in this book also developed the process
of selecting and managing the life sciences research pay-
loads (i.e., experiments) for the Shuttle Spacelab. The
Spacelab missions are, in one sense, simply a collection of
separate experiments that would be performed in space. In
reality, they are highly complex, integrated research
projects, that use the same astronauts as subjects and in-
vestigators and a common pool of resources, to be pre-
cisely implemented in a one to two week period. Selection
of scientific experiments are conducted, first by a scien-
tific peer review, and then by NASA project and mission
management teams who recommend an integrated experi-
ment payload package. Figure 11-4 summarizes the pro-
cess for achieving a recommended payload. The approach
is a systems analysis one, whereby the problem is broken
down into component parts and the decisions of one com-
ponent feed into other parts in such a manner that an opti-
mum payload can be formulated based on well defined
criteria. Some of the more important steps in this process
include:
a) Identification of critical hypotheses in each major dis-
cipline as determined by principal investigators, NASA
advisory panels, National Academy of Sciences, and
systems analysis.
b) Identification of critical measurements and hardware
for obtaining data;
c) Analysis of probability of scientific success based on
achieving optimal data collection (i.e., minimum sub-
ject population, access to critical time periods);
d) Identification of experimental commonalities and re-
dundancies with other experiments; analysis of syn-
ergies gained by combining similar experiments;
e) Determining resource needs for each experiment, in-
cluding crewtime, power, money, and hardware;
f) Estimation of mission resource allocation; and
g) Evaluation of feasibility of experimental protocols
with respect to resources.
In this scenario, computer models of physiological
systems are used to identify critical hypotheses and mea-
surement protocols. These models are also instructive in
demonstrating the synergy of similar experiment proposals.
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Other types of management models are then called into play
to identify various experiment options and support the de-
velopment of enhanced payloads with the end-goal of opti-
mizing science return. A similar approach is also used by
NASA to guide ground-based research programs.
11.6.2 Science Planning for Exploration-Class
Space Missions
The systems analysis process has also been called upon
by life science planners to develop an approach to iden-
tify and mitigate risks to crew health, safety, and perfor-
mance during more advanced exploration-class missions
such as a Mars journey. The main objectives of this ap-
proach are to provide information for defining acceptable
levels of risks, assess progress toward effective risk miti-
gation, and to provide a guide for prioritization of research
and technology. The major processes and functions of this
approach, known as the critical path roadmap [8] is shown
in Figure 11-5, and includes the following:
• Identify the mission requirements to set the context
for the risks to be addressed;
• Identify the most mission-critical risks to human
safety, health, and performance;
• Identify the risk factors associated with each risk, i.e.,
conditions which increase the risk;
• Prioritize the risks by assessing their significance and
severity with and without countermeasures employed;
• Identify the critical questions that must be addressed
to understand and mitigate the risk. These critical
questions provide the basis for underlying research
projects, and address issues involving risk assessment
and acceptability, physiological mechanisms and pro-
cesses, countermeasure development and validation,
and medical diagnosis and treatment;
• Define the deliverables, i.e., specific end-items that
include scientific knowledge about underlying mecha-
nisms, risk characterization and assessment, counter-
measure protocols, strategies, or procedures for risk
reduction, or technology development. Tasks for
achieving the deliverable can then be established;
• Determine the level of readiness of each countermea-
sure or technology item and the criteria for their evalu-
ation (i.e., risk mitigation requirements); and
• Analyze the costs and benefits associated with the
risk and its possible mitigation; is the cost accept-
able?, is the risk acceptable?
An example of the risks, risk factors and their conse-
quences are shown in Figure 11-6 for the area of Cardio-
vascular Alterations. The risk mitigation approaches (i.e.,
countermeasures) are shown at the bottom of this figure
with a connecting dashed lines indicating that they are
capable of blocking risk factors, risks/outcomes or final
consequences. Charts like these were prepared for all dis-
cipline areas to help managers and researchers understand
these relationships and the purpose of the highly directed
research program. There is an obvious role for simulation
modeling in this schema. Potential risks can be assessed
by studying the simulated response of individual
crewmembers to the spaceflight environment and deter-
mining if it passes a clinically significant threshold of
safety. Models can also be used to evaluate countermea-
sures and other risk mitigation procedures. An example of
such an assessment of risk and risk mitigation was shown
in Chapter 7, where orthostatic intolerance thresholds were
simulated in the face of Shuttle reentry g-stresses, and it
was shown how pressure-suit garments could alleviate the
tendency to faint.
Figure 11-4. Systems approach to develop Shuttle experimental payloads.
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Figure 11-5. Key elements of the Critical Path Roadmap for iden-
tifying risk mitigation requirements.
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The purpose of this Appendix is to explain the basic vo-
cabulary and principles of model development so that the
reader may better grasp the description of the simulation
models. Examples that describe the steps leading to the
development of a computer algorithm of a model subsystem
are provided, and the simulation techniques used to assess
model behavior and accuracy will be discussed.
A.1 Definitions of Terms and Concepts
A.1.1 Parameters and Variables
Two general types of quantities are used in mathemati-
cal models: parameters and variables. The value of a pa-
rameter is generally constant with respect to time, whereas
the value of a variable changes with time (i.e., is time-
varying). Biological parameters often vary slowly with time
but may be assumed to be constant in the mathematical
model.
Parameters may be considered independent of system
actions. Variables may also be considered independent if
they influence the system from the outside, i.e., ambient
temperature. Parameters and independent variables are also
called input functions, or forcing functions. More often,
variables are dependent (also called output functions), since
they vary according to the relationships within the sys-
tem. An objective of a systems analysis is to specify the
state of the system; that is, to specify the values of all
dependent variables at every instant of time.
A.1.2 Classification of Mathematical Model Systems
Mathematical models are classified according to the
types of equations they employ [1].
A.1.2.1 Distributed and Lumped Parameter Systems.
In distributed parameter systems, the values of variables
depend on time as well as space coordinates, and the sys-
tem must be analyzed by solving partial differential equa-
tions. In a lumped parameter system, each element is treated
as if it were concentrated (“lumped”) at one particular point,
which is called a node or a compartment. The use of lumped
parameters greatly simplifies the analysis because ordi-
nary differential equations are used to describe the changes
with time. To account for spatial changes that occur in
such a system (e.g., the value of blood pressure is different
in arteries, capillaries, and veins), compartments are added
for each major space location until one reaches the level
of compartmentalization (lumping) commensurate with the
basic purpose of the model being designed.
Generally, as subdivisions are included in a model,
the fidelity and accuracy of the model’s response increases.
For example, in this project, two circulatory models were
employed, one composed of 7 compartments and the other
of 28 compartments. The 7 compartment model can only
simulate mean blood pressures in arteries and veins,
whereas the 28 compartment model can simulate pulsatile
flow and provide systolic and diastolic pressure for all
anatomical portions of the vasculature (i.e., aorta, arter-
ies, arterioles, capillaries, venules, veins, and vena cava).
All models described in this publication are lumped
parameter systems. Whether the lumping of components
and the simplifying of input–output relationships are ap-
propriate depends entirely on the intended purpose of the
model. Lumped, compartmental modeling is in keeping
with a basic facet of the systems approach: to simplify the
problem and define the essentials of its solution.
A.1.2.2 Linear and Nonlinear Systems. In modeling,
systems generally consist of components with a known (or
assumed) relationship. In a broad sense, a component of a
system may be thought of as having the property to trans-
form certain inputs into certain outputs. Such relation-
ships are often (loosely) termed transfer functions
(although transfer function has a rigorous meaning only
in terms of Laplace transforms).
Mathematically, the components of a system may be
represented by several operators, which transform one
function into another. If all the operators for the system
are linear, in the loose sense that their operation on two
independent functions produces two independent results,
then the system itself is said to be linear. Otherwise, the
system is said to be nonlinear. Mathematically, much more
is known about the behavior of linear systems.
Unfortunately, most biological systems—with their
threshold and saturation behavior, sigmoidal dose-response
relationship, and dead time—are nonlinear; analysis of such
systems revolves around numerical methods and the use
of computers. Obtaining rapid, accurate, numerical solu-
tions of nonlinear system equations is absolutely essential
in biological modeling and often represents a separate chal-
lenge. Solutions of nonlinear models are more likely to
yield counter intuitive results than those of linear models.
Most of the models used in this project can be classified as
nonlinear.
A.1.2.3 Other Classifications and Nomenclature.
Models can be developed for either predictive or descrip-
tive purposes. A predictive model must only produce ac-
curate predictions of the output variables in the system.
For example, a single equation may be used to predict the
fractional saturation of hemoglobin with oxygen at differ-
ent levels of oxygen partial pressure. In this case, the mod-
eler is not concerned with a relative replication in the
model of the interactions between the variables in the sys-
tem. The relationships employed in the predictive model to
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generate the predicted output need not conform to the mecha-
nisms in the real system that lead to the same outputs. In
contrast, descriptive models not only must generate pre-
dictions in agreement with real system output but also
must employ intermediate relationships that are realistic
representations of the true processes that generate the ob-
served outputs.
The vast majority of biological systems are continu-
ous systems, in which values are always changing with
time, and they are best described by differential equations.
These equations are typically solved with numerical pro-
cedures on digital computers by transforming them into
finite-difference equations. In this process, the variables
actually appear to be constant for the duration of the inte-
gration step size and, therefore, more properly belong to a
discrete system. This approximation of continuous biologi-
cal systems by discrete numerical systems can produce
inaccuracies and instabilities in the solution, unless ap-
propriate care is taken and the system is carefully verified.
The models described in this project can also be said
to be deterministic, since the input–output relationships
for each component are based on simple physical laws
(i.e., flow-pressure, diffusion, mass action) and are there-
fore fixed, predictable, and reproducible. In reality, most
biological systems are stochastic, in the sense they are
subject to random noise, and their responses can be de-
scribed by statistical laws and in terms of probabilities
and expected values.
Riggs [1] makes the observation that “all naturally-
occurring systems are, in the final analysis, time-varying
distributed-parameter, quantized, stochastic, nonlinear sys-
tems. That we can sometimes obtain useful information by
treating these wayward creatures as if they were fixed
lumped-parameter, continuous, deterministic, linear sys-
tems is little short of miraculous.”
A.1.3 Biological Control Systems
It is difficult to conceive of any biological quantity
that is not controlled or influenced by one or more factors.
For example, blood pressure influences and controls the
rate of baroreceptor neural firing. In this situation, barore-
ceptor neural firing is controlled, or regulated, within nar-
row limits at the expense of the other system quantities,
the limits of which may vary widely. The relationship be-
tween blood pressure and baroreceptor neural firing would
be construed as an open-loop system for controlling barore-
ceptor neural firing. Further examination of the process
shows that the baroreceptor afferent signal is processed
by the central nervous system (CNS) and results in an ef-
ferent neural signal that controls peripheral resistance. This
relationship between baroreceptor firing and peripheral
resistance is an open-loop system for controlling periph-
eral resistance. However, it is known that peripheral resis-
tance directly regulates blood pressure. Once this control
is added to the system, the complete loop of physical
changes (blood pressure, peripheral resistance) and infor-
mation transmission (afferent and efferent signals) forms
a closed-loop control system. The difference between the
closed-loop and open-loop systems is obviously the pres-
ence of the relationship of peripheral resistance to blood
pressure. Blood pressure in the closed-loop system is called
the feedback variable.
A feedback control system, as described previously,
is composed of two major elements, or components: the
controlled system and the controlling system or control-
ler. Figure A-1 is a diagram illustrating the relationships
of these elements. The purpose of the controlled system is
to transform inputs from the outside (load inputs, distur-
bances, or stress stimuli) and inputs from the controller
(controlling signals) into responses (outputs). The refer-
ence input of Fig. A-1 is also referred to as a set-point, and
it represents a normal or desired value of a feedback vari-
able. Differences between the set-point and the actual feed-
back variable result in corrective action by the controller;
this correction permits the output to revert toward normal
values in the face of the disturbance. Consequently, the
presence of feedback control in biological systems allows
important quantities to fluctuate within limits necessary
for maintaining life in the face of many metabolic and en-
vironmental disturbances encountered by the organism.
In man-made technological control systems, the set-
point is a physical quantity that can be varied at will (e.g.,
a thermostat setting for a home heating system). Biologi-
cal systems, however, often have neither a reference input
not an error detector. The establishment of a set-point, or
an operating point, in mathematical models of biological
systems is often included for convenience, only because
the real system behaves as if it were controlled by such a
reference value [1,2].
In terms of the example described previously, blood
pressure is the controlled feedback variable (Yo) and pe-
ripheral resistance can be considered the controlling vari-
able (Yc). The controlled system consists of components
that transform changes in blood pressure into changes in
peripheral resistance (i.e., baroreceptor afferent signals,
CNS processing, efferent signals, effect of autonomics on
vasculature resistance). A typical blood pressure load dis-
turbance (Yi) might be an infusion of blood into the circu-
latory system (which implies that a description of the
volume-pressure relationships of the circulation must be
included in the controlled system) or the introduction of
an upright tilt disturbance (which implies that a descrip-
tion of gravity effects on blood volume distribution must
Figure A-1. A generalized feedback control system. Most biological
homeostatic systems can be reduced to these basic components.
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▲
▲
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be included in the controlled system). The set point (R1) is
the “normal” value for blood pressure.
A.2 Formulation of a Computer Model
It would be instructive to review the steps that lead from
conceptualization of a model to digital computer imple-
mentation. Model systems can be graphically represented
by some combination of boxes that represent the elements
of the system. Such a representation is called a block dia-
gram, which includes logic diagrams, schematics, flow
diagrams, and system diagrams. An important step in con-
structing a model of any system is to draw a block diagram
representing the blocks and their interconnections. This
type of diagram, or series of block diagrams, becomes a
“roadmap” or a “key” for taking a system apart and put-
ting it back together. Some of the most common basic
symbols used in a special form of block diagram, called an
analog diagram, are shown in Fig. A-2. The analog dia-
gram is an adaptation of the diagrammatic method so use-
ful with linear systems. The mathematical operations are
self-explanatory. As an example of the loosely termed
“transfer function,” the graphical transfer function in the
figure might represent the relationship between cardiac
output x and right arterial pressure y. This transfer function
can then represent a measured cardiac function curve.
As a specific example of the programming process,
the subsystem of the circulatory, fluid, and electrolyte
model that deals with angiotensin formation has been cho-
sen. Figure A-3(a) can be construed as a hypothesis dia-
gram for the open-loop control of renin-angiotensin. This
diagram indicates the major factors that control angiotensin
formation and the many effects of angiotensin on other
subsystems. It is generally agreed that two of the major
influences on renin release (a precursor to angiotensin for-
mation) from the juxtaglomerular cells of the kidneys are
renal perfusion pressure and the load of sodium filtered
through the tubules (i.e., glomerular filtration times plasma
sodium concentration). Renin enters the circulation and
forms angiotensin, which has a slight negative feedback
effect on renin formation (see dashed line in Fig. A-3(a)).
The final effect of angiotensin is considered to be wide-
spread, affecting vascular resistance, renal resistance, al-
dosterone secretion rate, thirst and drinking, and the rate
of tubular fluid reabsorption.
To progress to a computer model of this system, each
of the pathways connecting any two variables must be de-
scribed in as much detail as necessary, commensurate with
the objectives of the model design. Therefore, the next
level of detail is shown in the block diagram of Fig. A-
3(b), in which the relationships between variables are quali-
tatively organized. Functional relationships are identified
wherever data describing hormonal secretion rates or hor-
monal effects are available. This diagram was developed
from some very general algebraic relationships, and the
mathematical operations of summation, division, multipli-
cation, and integration are indicated.
Figure A-3(c) is the same diagram as Fig. A-3(d), re-
organized to reflect the computer program names for each
variable and the quantitative transfer functions for each
element. It was common at one time to simulate models
on analog computers, and Fig. A-3(c) is known as an ana-
log diagram because it represents a circuit diagram for pro-
gramming this segment of the model on an analog computer.
However, a digital computer requires a different program-
ming language, and Fig. A-3(d) is the Fortran version of
the renin-angiotensin subsystem. The reader should be
able to identify the meaning of the Fortran expressions
from the previous diagrams. Note that the first statement
represents a function relating renal pressure and renin se-
cretion. In the analog computer, this function would be
represented by a function generator; in the digital com-
puter, it is represented by a table of x–y values (not shown)
from which the desired operating points are interpolated.
The exponential functions (e.g., EXP(–I/RNK)) in Fig. A-
3(d) are numerical approximations for integration, in which
“I” is the integration step size.
It can be appreciated that the discipline of translating
an ordinary physiological hypothesis diagram into a quan-
titative computer representation can lead to a better un-
derstanding of the biological system. Available data from
diverse sources are integrated into a common framework;
other data are excluded as being nonessential for the given
level of detail (i.e., importance of data can be ranked), and
missing information, which suggests the need for new ex-
periments, is quickly identified.
Figure A-2. Symbols used in block diagrams representing math-
ematical operations.
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Figure A-3. Formulation of a control system algorithm (a) Hypothesis diagram showing factors which influence renin-angiotensin
production and the quantities which they influence. These represent the assumptions for one of the hormonal subsystems in the Guyton
model. (b) A more detailed block diagram of the hypothesis diagram of Fig. A-3(a) showing the mathematical operators relating each
quantity. (c) An analog computer diagram of the renin-angiotensin system. This diagram contains sufficient information to wire a patch
panel for programming an analog computer. (d) A Fortan algorithm for the renin-angiotensin control system as it appears in the Guyton
model. The symbols can be interpreted from the preceding diagrams.
CALL FUNCTN:(PAR, RNS, FUN8)
RSR = 300.*REK*RNS*(1.–ANGS–B*(GFR*CNA–17.75))
IF (RSR.LT.0.)) RSR = 0.0
RT – RT * (RSR–CRA*RT)*1.–EXP(–I/RNK))
RC = RT/VP
AN1 = CAIV + CAS*RC
AN2 = AN2 + (AN1 – CAA*AN2)*(1.–EXP(–I/AKA)
ANC = AN2/VP/ANCN
ANM = ANMM–AN3*EXP(–ANC/ANTC)
IF (ANM.LT.0.5) ANM = 0.5
ANSS = A*(ANC–1.)
ANGS = ANGS+(ANSS–ANGS)*I/ANGT
ANK = ANM
IF (ANK.LT.1.)ANK = 1.
ANU = ANM
IF (ANU.LT.0.6) ANU = 0.6(d)
(c)
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A.3 Simulation Techniques
Once a model is implemented on a computer and verifica-
tion procedures ensure that it is operating appropriately,
the model is ready to be tested for accuracy. A model that
is deemed credible can be used to describe the behavior of
the system in terms familiar to control engineers and can
be used to predict system responses in terms that can be
tested by biological experimentation. Some of the more
important techniques used to produce model credibility and
to predict system behavior are discussed below.
A.3.1 Dynamic Simulation
In the context of this study, obtaining the solution to
a model means introducing some type of load disturbance
(i.e., a parameter perturbation) and solving the model’s
differential equations iteratively, using numerical tech-
niques. This process, known as dynamic simulation, is ac-
complished using high-speed digital computers and results
in time-varying values of the dependent variables. These
responses are examined in qualitative terms for their rea-
sonableness by analysts who are familiar with the physi-
ological system or, more often, they are compared
quantitatively with experimental data. In this project, simu-
lation responses were available from digital computers in
tabular and graphical form and could be compared with
previously stored data.
A.3.2 Sensitivity Analysis
Sensitivity analysis is a method for studying system
responses due to variation in parameter value [3]. The con-
ceptual basis of sensitivity analysis is simple; small varia-
tions are made in the values of the system parameters of a
model, and the effects of these changes are observed indi-
vidually in the solution (see Appendix E). Sensitivity func-
tions that describe the observed effects may be computed,
and these are interpreted to extract information about the
dynamic system that could not be obtained from simply
finding solutions with a particular set of input conditions.
Sensitivity analysis provides the following.
1. A quantitative means of comparing the relative impor-
tance of individual parameters on any system variable;
2. A means of determining interactive effects of two or
more parameters on model behavior;
3. A tool to help assess the validity of a particular model
without the need to collect and use extensive measure-
ments from the real system;
4. Information in a form that can be easily interpreted by
those familiar with the subject matter of the model but not
necessarily knowledgeable of simulation techniques;
5. A means of assigning relative importance to all pa-
rameters, a process that can be valuable both to the
simulator in performing parameter estimation or sta-
bility analysis and to the experimenter in allocating
resources for data collection;
6. A practical method of analyzing and comparing two
different models designed to represent the same physi-
cal system.
A sensitivity analysis is very useful when performed
early in model development, before model validation. This
analysis is particularly important to the experimenter, who
can help evaluate the model based on the relative sensi-
tivities of the parameters without really knowing much
about the model. The technique also is useful for involv-
ing the experimenter early in the modeling process, an-
other important factor for eventual model acceptance [6].
The results of the sensitivity analysis must be evaluated
in the light of other known information about the real
system. For example, the fact that a parameter has a very
significant effect on a particular variable of the model is
of little importance if it is known that the parameter in the
real system is relatively constant or that changes in other
parameters are capable of canceling the original effects.
Although sensitivity analysis can be considered to a
be a special case of dynamic simulation, there are several
important differences between these two procedures.
1. Sensitivity analyses are characterized by compara-
tively small perturbations.
2. Sensitivity analyses often are performed by varying
one parameter at a time.
3. Sensitivity analyses often are performed to obtain sen-
sitivity functions rather than solutions of the depen-
dent variable.
4. Sensitivity analyses usually entail comparisons be-
tween two or more simulation runs rather than between
model results and experimental data.
Examples of sensitivity analysis are provided in the
descriptions of the erythropoietic model (Chapter 3.2.4.2)
and of the thermoregulatory model (see Appendix E).
A.3.3 Variation of Parameters
Once a parameter has been identified as being par-
ticularly influential, either by sensitivity analysis or from
direct knowledge of the real system, it is often desirable to
determine the effect of different parameter values on spe-
cific variables. For example, the volume of blood is known
to be important in the blood flow/pressure response to up-
right tilt from the supine position. It is reasonable to ask,
“How does the response change as more and more blood is
removed?” Another way to pose this question is, “What is
the effect of hemorrhage on standing?” Documenting this
effect with a simulation model of circulatory control is
relatively straightforward; the parameter representing
blood volume is assigned a series of values (i.e., a percent-
age of the control or normal value) and, at each level, a
dynamic simulation is performed. The resulting time-vary-
ing responses (of, for example, heart rate, cardiac output,
or blood pressure) can be plotted as overlays on the same
graph. If steady-state responses are desired, the graph of-
ten is constructed with blood volume on the abscissa and
the response variable on the ordinate (see Fig. 7-8).
A.3.4 Error Analysis
Parameters values are never known with 100% accu-
racy. If the standard deviation (SD) around the mean value
can be estimated for each parameter, it is possible to place
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statistical confidence limits on a model’s behavior. For the
example discussed previously, assume an experiment is per-
formed in which blood volume reduction is measured as –
10% + 1.5% (SD). Dynamic simulations can be performed
for three values of blood volume: –8.5%, –10%, and –
11.5%, corresponding to the mean minus SD, the mean,
and the mean plus SD, respectively. The response, for ex-
ample, for heart rate could also be expressed in terms of a
mean and a deviation. This expression would represent a
prediction of the minimum error interval in the response
variable, because of the inherent design of the system and
the uncertainty in measuring blood volume, but would
not include any experimental errors that could occur in
measuring the response variables. Conversely, if a decrease
in the confidence interval of a response variable to a given
width was desired, it would be possible, using these tech-
niques, to determine the minimum experimental accuracy
required in measuring the independent parameter.
Error analysis becomes especially desirable in large-
scale systems containing many parameters that promul-
gate errors through the model, and in certain nonlinear
systems in which the interactive effects of different pa-
rameters lead to amplification of individual errors. Unfor-
tunately, even though the techniques to accomplish this
analysis are rather straightforward, there are few examples
in the literature of physiological systems.
A related problem that has application to error and
sensitivity analysis is the effect of noise on the behavior
of the system. Noise can be described as a statistical dis-
turbance of a particular variable, and it is characterized by
statistical properties such as mean value, probability dis-
tribution, or spectral density. Model output variation which
results from noise can be found by including a distribu-
tion function for each parameter or variable that exhibits
noisy behavior. This problem becomes extremely relevant
in parameter estimation analysis when model output is
compared to data having a significant noise level [4].
A.3.5 Stability Analysis
At this point it is appropriate to mention stability
analysis of dynamic systems because of the inverse rela-
tionship between sensitivity and stability in negative feed-
back systems. In general, sensitivity to disturbing factors
can be reduced by an increase in feedback gain (in tech-
nological systems at least). However, instability occurs as
a consequence of this gain increase. Thus, systems with
high gain may have low sensitivity to external perturba-
tions but may also be operating on the borderline of insta-
bility. Most biological systems are normally stable, and
they do exhibit low sensitivity. Whether they are working
somewhere near the stability limit by way of high gain
factors is not known but should be studied on a case-by-case
basis [5]. An analysis of stability can become an important
measure of the competence of a model, in that if both model
and actual system can be thrown into instability due to
the same parametric changes, there is reason for having
greater confidence in the mathematical representation.
Little practical work has been done on stability analy-
sis of complex physiological systems. Formal techniques
for investigating stability in linear systems and in simple
nonlinear systems have been reported [4,6]; but, for the
most part, studying large-scale nonlinear models is a trial-
and-error experience. Systems that exhibit oscillatory or
periodic behavior in normal operation (e.g., eye move-
ment, respiration) can often be made unstable more easily
than systems that behave monotonically. Inherent insta-
bility is dependent on the properties of the system and is
normally not a function of the specific disturbance. If the
system is inherently stable, all transients will ultimately
disappear regardless of the disturbance causing them. Con-
versely, any disturbance to an unstable system will ini-
tiate oscillations that increase in amplitude with time.
Stability can arise from either inherent features of the
real system or from structural features of the mathemati-
cal model (such as a long integration interval). The tech-
niques of sensitivity analysis can reveal both types,
although it is not always possible to distinguish between
the two. Like sensitivity, stability is a function of the oper-
ating point; therefore, all possible operating points must
be tested for stability. A careful, systematic sensitivity
analysis may often reveal not only points of instability but
their causes as well.
A.3.6 Parameter Estimation
The object of parameter estimation (or identification)
analysis is to determine the value of one or more param-
eters in a model. The parameters selected for estimation
are usually impossible or difficult to measure directly in
the real system. In practice, the technique involves repeti-
tive adjustment of the parameter values until some objec-
tive judgment of acceptable correlation between model
output and corresponding measurements in the system pro-
totype has been satisfied (see Fig. A-4). The automatic
optimization of parameters has been the object of consid-
erable attention [7], consequently, there is a large body of
literature on parameter estimation in physiological sys-
tems and algorithms.
The error criterion used in parameter estimation is usu-
ally a difference function of the form
e(t) = y(t) – y* (t)
where y* is a dependent variable that has been measured
in the real system, y is the corresponding model variable,
and t is time. The error criterion E is a function of e, usu-
ally |e| or e2, integrated over a specified time interval; e.g.,
dteE T ∫= 0
Since y is dependent on the system parameters qi, e
can be expressed as e(t) = e(t, q1, q2, …, qm). The criterion
for the best fit between data and model is achieved when E
reaches a minimum value.
Not every parameter can be estimated with the same
degree of accuracy. Parameter estimation is used most ef-
fectively on parameters exerting a strong influence on a
particular model variable that can be easily measured in
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the real system. A useful technique for determining which
parameters can be estimated with greatest precision is sen-
sitivity analysis, discussed earlier in this Appendix. If sen-
sitivity analysis is used before parameter estimation, it is
possible to select those parameters with the highest sensi-
tivity coefficients as the best candidates for parameter esti-
mation analysis. When the parameter sensitivity is low, then
that parameter value cannot be estimated with as much cer-
tainty. The low-sensitivity parameter should be set at a rea-
sonable constant value determined from other sources.
If the problem of sensitivity analysis is expressed as
determining the behavior of a model given all the param-
eter variations, then the inverse problem would be to de-
termine (or identify) the parameter variations capable of
producing a given behavior of the real system. Unlike sen-
sitivity analysis, variation of parameters, error analysis,
and stability analysis, parameter estimation requires data
measurements from the real system. This inverse problem
may not have a unique solution. Nevertheless, it would be
valuable to know the various solutions possible, since this
knowledge would be a great aid in hypothesis testing. If
several different parameter perturbations could produce
similar model results, it might be possible to accept the
most reasonable, based on physiological plausibility; al-
ternatively, this information could provide the basis for
further experimental testing.
A.4 Model Validation
The validation process is primarily concerned with dem-
onstrating the accuracy and the capability of simulation
models. Two general criteria must be met before model
credibility can be established. First, a quantitative vari-
able or parameter validity criterion must be met, and, sec-
ond, a qualitative “plausibility” criterion must be met. The
first condition refers to tests in which model output is com-
pared directly to experimental data, whereas the second
condition includes all other tests in which only the general
behavior of the model is examined on a more subjective
basis. In the first case, a high degree of fidelity in model
response is expected, whereas in the second, the model
responses need only be “reasonable.” No validation pro-
cedure is appropriate for all models. Rather, validation
depends on the nature of the model and the goals and ob-
jectives of the modeling study.
A.4.1 Quantitative Tests
An important aspect of validation involves compar-
ing the behavior of the model’s dependent variables with
that of their experimental counterparts for the same stress.
Differences between model behavior and experimental data
can often be corrected or minimized either by introducing
new, previously omitted elements into the model’s struc-
ture or by modifying the existing structure (i.e., adjusting
the value parameters that are not well known).
The extent to which the validation process can be
carried is often limited by data availability. Thus, if only
steady-state data are available, validation in the dynamic,
or transient, mode cannot be performed, even though the
model has that capability. Similarly, if only a relatively
small number of experimental variables have been mea-
sured during a particular stress, then it is possible to vali-
date the model for the responses of only those measured
variables; simulated values of all other variables can be
Figure A-4. Simulation procedure for parameter estimation. This method of fitting model output to experimental results can produce
values for system parameters that are difficult to measure directly.
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obtained but should be considered as predictions requir-
ing experimental verification. The response of the body
to a given stress is almost always related to the level or
intensity of that stress, and more often than not, the rela-
tionship is nonlinear. Therefore, to validate the model
properly, it is desirable to obtain data not merely for a
given stress but for a range of intensities of that stress. If it
is important to simulate more than one type of stress, the
validation process will result in a more accurate model if
the experimental response of the same variable is known
for each of the desired stresses. Thus, an idealized set of
experimental data suitable for complete validation of a
complex model should include the following.
1. Steady-state data
2. Transient data
3. Data for a wide range of stress intensities
4. Data for all major dependent variables of interest or
importance
5. Data for a variety of stresses
In addition, since experimental protocol, measurement
techniques, and number and type of subjects may vary
widely from one investigation to another, even when study-
ing the same stress, it is desirable to obtain many of these
data from the same experimental study.
The data used to validate the model should meet sev-
eral conditions:
1. The data used for model validation should be differ-
ent than that used in model development. The model
must be capable of predicting beyond the data from
which the model was generated.
2. The data must be of sufficient precision to make the
test meaningful. The data should cover the range of
interest and should have a minimum level of noise.
The latter condition is best assured by including data
representing a large subject population.
3. The data should be gathered under conditions similar to
those represented in the model. Not all data are appro-
priate for use in validation. The assumptions about the
biological system being studied are often reflected in the
experimental protocol used to gather the data, and these
are often not the same assumptions used in the model.
Obtaining good agreement between a simulation re-
sponse and data is especially important when trying to
simulate a diverse number of variables having constantly
changing values. Agreement between simulation response
and data is often improved by adjusting parameter values.
This procedure is the same as that described under param-
eter estimation techniques. More than one combination of
parameter values may lead to a good “fit.” In these cases,
it is important that all changes be reasonable and consis-
tent with known physiological processes.
A.4.2 Qualitative Tests
The purpose of modeling and simulation, in the con-
text of the current study, is not necessarily to produce an
optimal fit between experimental data and model output,
although this result would not be undesirable. Rather, the
objectives are to help understand the behavior and interac-
tions of the system and its components and to assist in new
experimental approaches. Model credibility, in this case, can
also be established by performing fewer quantitative tests.
Often, the model analyst is content to verify initially
that the “shape” of the data and model output agree. This
situation would occur if the modeler were primarily inter-
ested in the validation of model dynamics as contrasted to
the exact fit of model output and data. In this case, it is not
considered critical that the absolute magnitude of the re-
sponse be without error; this type of discrepancy can of-
ten be remedied by the adjustment of a system parameter.
An important criterion for indicating whether a model
is good enough to be used for forming conclusions about
the real system is that a one-to-one correspondence and
similarity of form must exist between model and real sys-
tem. So-called “black box models” (i.e., models which
represent overall behavior of systems without represent-
ing their underlying mechanisms) are not good models for
making predictions regarding general system behavior; at
best, they may be used as descriptions of data. Thus, there
is always some model that can fit a particular set of ex-
perimental data (usually by adjusting one or more param-
eters), but only the biological plausibility of a particular
model justifies preferring it to all others. Therefore, the
inclusion of a greater number of adjustable parameters in
a model, although perhaps providing a better agreement
with the data, does not necessarily add insight into the
physiological mechanisms.
The techniques described earlier in this Appendix—
sensitivity analysis, error analysis, stability analysis, and
variation of parameters—do not require extensive data sets.
They can be very useful in establishing the plausibility of
a model without necessitating excessive analysis of the
mathematics of the model and all the explicit and implicit
assumptions. Sensitivity analysis, in particular, can be im-
portant in this regard by quickly and systematically ana-
lyzing these component relationships without the need of
actual subject data. This capability is particularly useful
in comparing two different models.
For a model to contribute to a particular investigative
field, it must ultimately be judged by scientists familiar
with that area. When these scientists are not the people
who developed and validated the model, it is important
that lines of communication between them be established
as early in the modeling process as possible. Model vali-
dation, ideally, should be an interdisciplinary process.
During this project, the experience has been that general
simulations, sensitivity analyses, or parameter variation
studies performed without comparison to good experimen-
tal data appear to make less of an impact on experimenters
not familiar with systems analysis than the same work
supplemented with at least a single simulation showing
reasonably good agreement with experimental data.
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Appendix B
Detailed Description of the Model for Regulation of
Erythropoiesis
This Appendix contains the complete mathematical de-
scription of the erythropoiesis regulatory model.  As this
is the simplest of all models considered in this project, it
provides a convenient example of how a physiological
model is constructed.  Reference should also be made to
the overall description of the model provided in Chapter
3.2.4 and a diagrammatic view of the model in Fig. 6-10,
as well as simulations of the model throughout Chapter 6.
The model developed for the spaceflight hematologi-
cal program was designed to examine the relative influ-
ence of the controlling factors of erythropoiesis on total
red blood cell (RBC) mass. The formulation was based on
the generally accepted concept that the overall balance
between oxygen supply and demand regulates the release
of a hormone, erythropoietin, from renal tissues sensitive
to oxygen tension levels and that this substance in turn
controls bone marrow red cell production [1,2,3].
The amount of oxygen delivered to the tissue is ac-
counted for in the model by the combined influence of
several factors: hemoglobin concentration, lung oxygen-
ation of hemoglobin, blood flow, and oxygen-hemoglo-
bin affinity [4]. From this amount of oxygen, a certain
fraction is extracted by the tissue depending on the oxy-
gen demand parameter. Oxygen enters the cellular spaces
by diffusion along an oxygen tension gradient between
the venous capillaries and the cell [5]. Decreasing the oxy-
gen supply in relation to the demand reduces tissue oxy-
gen tension that is, in effect, monitored by a local oxygen
detector [6] and results in increased rates of erythropoi-
etin release [7]. Erythropoietin is released into the general
circulation, and its final plasma concentration is deter-
mined by its rate of release, its volume of distribution, and
the rate at which it is metabolized [8], the latter being
represented in the model by the hormone plasma half-life.
The target organ for erythropoietin is the bone marrow.
The production rate and release of red cells in the model
are determined by the plasma erythropoietin concentra-
tion [9]. A time delay exists between marrow stimulation
and red cell release [10]. Destruction of cells is represented
in the model by a lifespan parameter. Hemoglobin con-
centration in blood is based on the addition of new cells
to existing cells and plasma.
It is known that red cell production is modulated by
factors other than those considered in the model. These
include iron levels [11], hormones other than erythropoi-
etin [12], neural stimulation [13], as well as inhibitors and
activators of erythropoietin [14]. Although it may be de-
sirable to include these effects in future model applica-
tions, quantitative information regarding them is presently
lacking or the need for their inclusion is not yet warranted.
Overall oxygen transport is under the control of ho-
meostatic mechanisms in addition to the erythropoiesis
system. Thus, some of the fixed parameters of the model
such as blood flow, capillary diffusivity, arterial oxygen
tension, plasma volume, and oxygen-hemoglobin affinity
can be considered variable elements of circulatory, venti-
latory, biochemical, and fluid regulatory feedback mecha-
nisms that are beyond the scope of the current model’s
design objectives. Larger models that incorporate many
of these features are available and these have been shown
to be compatible with an erythropoiesis subsystem model
[15]. Although these mechanisms are not included explic-
itly in the present erythropoiesis model, their influence
can be tested, in most cases, by manual alteration of exist-
ing model parameters.
B .1 Mathematical Description of Model
B.1.1 Oxygenation of Blood
The oxygen concentration of arterial blood (neglect-
ing oxygen dissolved in plasma) after passage through the
lungs can be expressed as the product of the carrying ca-
pacity of a gram of hemoglobin (CHbO; i.e., 4 moles O2
per mole Hb), times the hemoglobin concentration (Hb),
times the fractional degree of oxygen-hemoglobin satura-
tion (SaO). It is convenient to use hematocrit rather than
hemoglobin concentration as an index of red cell concen-
tration in blood. These quantities are related by the mean
corpuscular hemoglobin concentration, such that MCHC
= Hb/Hct. Therefore, for arterial blood [1]
CaO = SaO × Hb × CHbO
= SaO × Hct × MCHC × CHbO
(B1)
At full hemoglobin saturation, SaO = 1.0, and Eq. (B1)
then represents the maximum oxygen-carrying capacity
of blood at a given hematocrit. In most instances, the pa-
rameters MCHC and CHbO will be invariant, so that the
arterial oxygen concentration is influenced only by the
hematocrit and hemoglobin saturation. In practice, the ar-
terial oxygen tension (PaO) is assigned a value,* and a cor-
responding value of SaO  is  determined from the
oxygen-hemoglobin equilibrium curve (OEC), an opera-
tion that can be expressed in functional form as
      SaO = OEC(PaO) (B2)
*
 See Table B-1 for symbol definitions, units, and normal values.
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Fjgure B-1. Two-compartment steady-state model of renal tissue
oxygenation. 
B.1.2 Oxygen Delivery atTissues
Oxygen transport at the tissue level is schematically rep­
resented in Fig. B-1. In the present model, the tissue of con­
cern is taken to be the erythropoietin-producing cells known 
to be located primarily within the kidneys. It is assumed that 
the oxygen sensor as well as sites of erythropoietin produc­
tion, is responsive to the mean oxygen tension of the kid­
neys. This assumption permits tissue oxygen tension to J?e 
derived from an oxygen balance using blood flows, arterio­
venous oxygen concentrations, oxygen consumption, and 
transcapillary diffusion resistances common to the kidneys, 
which are considered to be a homogenous tissue. 
The elements of tissue oxygenation were determined 
using a two-phase model consisting of capillary blood 
and tissue fluid [ 16). It is assumed that the blood compart­
ment is well mixed with an oxygen partial pressure (P.0) 
equal to that in the venous outflow. Oxygen diffuses from 
blood to tissue along a gradient of oxygen partial pressure 
(P.0-P,0), whereP,0 is the oxygen tension of the homog­
enous tissue. The amount of oxygen unloaded from the 
blood is given by the difference in oxygen concentration 
between arterial and venous blood (CaO - C.O). At equi­
librium, the rate of oxygen transfer to the tissues is identi­
cal to the tissue oxygen consumption (Vm) and to the 
unloading of blood oxygen as determined by the arterio­
venous oxygen concentration. In other words, 
Q x ( cp- cp) = K" x (PP- P,O) 
Rate of oxygen unlo.iding Rate of oxygen diffusion (B3) 
where Q is the rate of regional blood flow and Kd is the 
diffusive transfer coefficient between blood and tissue. 
The venous partial pressure may be obtained by solv­
ing Eq. (B3) for C"O 
(B4) 
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Figure B-2. Renal controller function for erythropoietin produc­
tion rate showing effect of gain G1 • 
then computing venous hemoglobin saturation from a for­
mulation analogous to Eq. (B 1) 
S,0 = C.Ol(Hct x MCHC x CHbO) (BS) 
and determining P.O from the OEC, expressed in func­
tional fonn as 
PVO = OEC(S,0) (B6) 
Tissue oxygen tension can now be derived from Eq. 
(B3) as 
(B7) 
The assumption of steady state in this formulation 
implies rapid equilibration of oxygen in the fluid phase 
and is not meant to suggest a constant tissue oxygen ten­
sion during the simulation of an erythropoietic distur­
bance. Since the erythropoietic process itself has been 
modeled dynamically, the hematocrit will be time-vary­
ing until red cell production achieves its own steady state. 
In this model, the hematocrit is a major influence on alter­
ations in tissue oxygen tension. In addition, other quanti­
ties in this algorithm (Pao, vn., Kd, P50, Q) are non-regulatory 
parameters and can also influence tissue oxygen tension 
if they are manually altered. 
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B.1.3 Erythropoietin Production and Distribution
Erythropoietin release is assumed to be governed by
the tissue oxygen tension. A limited number of studies
[5,17,18,19] suggest a relationship of the form†
( )OPGEE top 1exp −= (B8)
where pE  is the rate of erythropoietin production, OPt  is
the tissue oxygen partial pressure, G1 is the gain or slope
of the function plotted linearly as the natural log of pE
vs. OPt , and Eo is the pE  intercept at  OPt = 0. Setting Eo =
exp(G1) ensures that Eq. (B8) will always pass through the
normal operating point ( pE  = 1.0, OPt = 1.0) irrespective
of values of G1. In certain cases, it may be desirable to
postulate a shift in the normal operating point as well as
gain, and in those cases, Eo and G1 may be adjusted sepa-
rately. Figure B-2 illustrates the semi-logarithmic relation-
ship between tissue oxygen tension and erythropoietin
production and shows the influence of G1.
The concentration of erythropoietin in the plasma (E)
is a function of the rate of production (Ep), the rate of clear-
ance or destruction (Ed), and the volume of distribution (Ve).
If it is assumed that the rate of disappearance is proportional
to the plasma concentration (i.e., Ed = Ke ×  Ve ×  E, where Ke =
clearance constant = loge 2/plasma halflife), then the follow-
ing first-order differential equation can be written for the
rate of change of erythropoietin concentration [8,17]:
dE
dt
=
Ep
Ve
− KeE (B9)
The steady-state concentration of E (at dE/dt = 0) is,
therefore
E(o) = Ep (o) KeVe (B10)
Eq. (B9) can be normalized by letting = E/E(o) and
 = Ep/E(o) and substituting Eq. (B1) into Eq. (B9):
dE
dt
= Ke Ep − E( )
=
loge 2
TE1/ 2
Ep − E( ) (B11)
a form that has the advantage of being independent of distri-
bution volume and, further, independent of erythropoietin
half-life (TE1/2) at steady state, since (o) = (o). The value
of TE1/2 = 12 hours was chosen for humans, but this does not
appear to be well established for normal subjects [20].
B.1.4 Red Blood Cell Production
An equation expressing the semilogarithmic dose-re-
sponse relationship between red cell production (RCP)
and erythropoietin concentration (E) can be given as
RCP = G2 loge E + P1 (B12)
As has been the convention, RCP and E have been nor-
malized with respect to their steady-state control values, G2
is the gain or slope of the response curve, and P1 is the value
of RCP  when E  = 1.0 and is normally taken as unity.
The accuracy of Eq. (B12) may diminish considerably
at very low and very high values of erythropoietin levels.
For example, at decreasing values of  approaching zero,
the production rate tends toward minus infinity rather than
zero, whereas at high  values, the relationship does not
exhibit a maximal production rate that is known to exist.
Therefore, two additional equations were formulated and
piecewise fitted to Eq. (B12) to account for suppressed and
maximal erythropoiesis (see Fig. B-3). Their precise descrip-
tion is somewhat speculative, although this bone marrow
function curve closely corresponds to the sigmoid shape
of most biological dose-response relationships [21] and
to those observed by others for the bone marrow [22,23,24].
In the present study, it was assumed that there is no
basal production of red cells unless erythropoietin is present
(i.e., Po = 0). Maximal red cell production is assumed to be six
times normal [17] (Pm = 6) and the upper limit of accuracy of
Eq. (B12) was arbitrarily chosen at  = 5.
Iron uptake studies of red cells indicate a bone mar-
row transit time for red cell production of 3.5 to 4.5 days
[10]. This effect was included in the model using a simple
first-order time delay‡ with a time constant TBM. The inclu-
sion of this transit delay clearly improved the realism of
the dynamic response of the model, especially following
sudden changes in tissue oxygen tension.
B.1.5 Red Cell Destruction and Red Cell Mass
The lifespan of the red cell dictates the destruction
rate of cells. A model of red cell destruction was assumed
in which cells are destroyed randomly and no cells sur-
vive past a given lifespan [25]. In that case, the rate of
destruction (RCD) is simply proportional to the amount of
cells present at any time. If that amount is given as RCM,
then the rate of red blood cell destruction will be
RCD = Kr • RCM
= loge 2 • RCM TRC1/ 2
(B13)
where TRC1/2 = red cell half-life and Kr = red cell clearance
constant = loge 2/TRC1/2. At normal values used in the
†
 The bar over the symbols represents normalized values. Thus, X =
X/X(o) where X(o) is the control or pretreatment condition and X is
a value during the post-control or treatment phase. The use of
normalized values simplified comparison of model response with
data from various laboratories.
‡
 If Y is the steady-state value predicted from a dose-response relation-
ship, then the response delayed with a time constant T is obtained by
the solution of the differential equation T dy/dt + y = Y. In finite
difference form, suitable for iterative computer solution, this becomes
y2 = y1 + (Y – y1) (H/T) where H = integration step size, y1 = value of y at
the ith iteration, and y2 = value of y at the i + 1th iteration.
pE
RCP
E
E
E
E
pE
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model, the rate of red cell destruction is 1.1% of the total
amount present or 22 ml of packed cells/day.
The instantaneous change in total circulating red cell
mass is the net difference between red cell production and
red cell destruction rates:
d(RCM)
dt
= RCP − RCD (B14)
The quantity RCP is obtained from Eq. (B12) using
the transformation RCP = RCP  ×  RCP(o), where RCP(o) =
RCD(o) = Kr · RCM(o).
Finally, the current value of RCM, obtained by inte-
gration of Eq. (B14), is combined with the plasma volume
to obtain the whole-body-hematocrit of the circulation:
Hct =
RCM
PV + RCM
(B15)
and the feedback loop begun in Eq. (B1) is closed.
B.1.6 The Renal/Bone-Marrow Axis as a
Proportional Controller
A more visual understanding of the relationships for
renal and bone marrow function can be obtained by deter-
mining the overall dose-response curve of the combined
kidney/bone marrow axis; that is, the relationship between
tissue oxygen tension and red cell production. The results
are shown here only for the midrange of erythropoietin pro-
duction and were obtained by mathematically combining
the renal function (Eq. (B9)) with the steady-state plasma
distribution function of erythropoietin (Eq. (B11); E = Ep)
and the bone marrow function (Eq. (B12)). In this way,
erythropoietin is eliminated as an explicit variable; i.e.,
RCP = G 1 − PtO( ) forPtO <1( ) (B16)
where G = G1 ×  G2. This is a simple inverse linear relation-
ship that has previously been used in the models of Guyton
and co-workers [15] and Hodgson [5]. In this form, the
gain of the renal/bonemarrow (open loop) system is seen
to be the product of the two gain factors, G1 and G2. Simi-
lar (although nonlinear) gain-product relationships were
obtained for the extreme of hyperoxia and maximal hy-
poxia. The results of this analysis have been plotted in Fig.
B-4 for a range of values of G. This function represents the
entire controller circuit of the erythropoiesis model. In gen-
eral, hypoxic tissue is predicted to have a greater effect on
red cell production than hyperoxic tissue, as indicated by
the relative slopes. However, at higher gain factors, the
suppression of erythropoiesis can be considerable for rela-
tively small increases in tissue oxygenation.
Equation (B16) is a typical controller function for a
linear proportional control system in which the actuating
error signal is the deviation of  from its control value
(unity) and G is the constant of proportionality or control-
ler gain. The control value of OPt  is taken as an arbitrary
reference standard and is not meant to imply that there is
an internal set-point. It becomes clear from this control
function that the primary controlled variable is tissue oxy-
gen tension rather than red cell production, red cell mass,
or hematocrit, which can be considered controller vari-
ables. The control system always adjusts the controller
variables in a direction that returns the controlled vari-
able toward normal after an initial load disturbance (see
Fig. A-1 in Appendix A).
The controller gain is a major determinant of the final
feedback compensation following a disturbance and,
within limits, the speed at which a disturbance is corrected.
Figure B-3. Bone marrow controller function for red cell production rate showing equations used to piecewise fit the dose-response
curve and demonstrating effect of gain G2 (semi-log plot).
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Figure B-4. Combined renal/bone-marrow controller function showing effect of tissue oxygen tension on erythropoiesis for various
values of overall gain G.
Although increasing the gain increases the feedback ef-
fect, it may be at the sacrifice of an oscillatory approach to
the steady state. Systems of higher order than this one will
tend to become unstable as controller gain increases. Os-
cillations in the erythropoiesis system are known to occur
in special cases, and analysis of these systems in terms of
control system theory has proved to be rewarding [26,27].
B.1.7 Model Operation
The system of Eqs. (Bl), (B2), (B4) through (B8), and
(B11) through (B15) are solved by computer simulation
using an iterative procedure. Equations (B11) and (B14)
are integrated numerically using a simple Euler algorithm
[28] and initial conditions E(o) and RCM(o), respectively.
The program is currently implemented on a Univac 1110
and a PDP 11/40 using Fortran language. Remote termi-
nals including graphic display of the simulation responses
(and experimental data simultaneously, when desired) have
greatly facilitated user interaction and have enhanced the
convenience of model validation.
Perturbing the model away from its normal steady state
(initial conditions) is accomplished by altering one of the
model parameters.§ These quantities are normally constant
§
   The term “parameter” is used to denote time-invariant quantities
that are not altered by the dynamic properties of the model as
opposed to “dependent variables” that are time-varying and form
the connecting links of the feedback circuit, i.e., P
t
O, E, RCP, Hct,
etc. (see Appendix A).
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in value but can be altered during a run to simulate either
independent stress stimuli or long-term regulatory adjust-
ments. Thus, hypoxia may be simulated by decreasing ar-
terial oxygen partial pressure (PaO), and hemolysis may be
simulated by decreasing the red cell lifespan. In some
cases, alteration of more than one parameter may be de-
sired as in the simulation of altitude hypoxia that involves
a primary change in arterial pO2 and a compensatory shift
in oxygen-hemoglobin affinity (P50). Parameter values may
be time-invariant with values fixed before a simulation
run or they may be entered as a function that varies with
time as the run progresses. Experimental data may be used
to drive the model in this fashion. Thus, it is possible to
simulate a wide variety of stresses and to test a large num-
ber of hypotheses regarding regulating mechanisms.
B.1.8 Parameter Estimation
Table B-1 lists the values of the system parameters,
chosen as representative of the human system. Also shown
are the steady-state control values (i.e., initial conditions)
of the major dependent (output) variables. The precise val-
ues of most of the quantities shown in Table B-1 are not
critical, however, to the general behavior of the model’s re-
sponse when expressed in percent deviation from control.
An exception to this occurs for the highly nonlinear func-
tions such as the oxygen equilibrium curves and the renal
and bone marrow function curves. The location of the oper-
ating point on these curves can change the nature of the
output response. Also, the shapes of these curves, as defined
by the gains and threshold parameters, are critical to the
magnitude of the response. These will be discussed next.
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Table B-1. Parameters and Initial Conditions
 Symbol Definition Value Units
Parameters
CHbO Carrying capacity of hemoglobin   1.34 ml O2/g Hb
Eo Intercept of erythropoietin function 20.09 x normal
G1 Gain of erythropoietin function   3 Nondimensional
G2 Gain of red cell production function   2 Nondimensional
Kd Capillary diffusivity   0.567 ml O2 min–1 mmHg–1
  4.25 mI O2 min–1 kPa–1
MCHC Mean corpuscular hemoglobin concentration   0.375 g Hb/ml RBC
PaO Oxygen tension in arterial blood 95.0 mmHg
PV Plasma volume   3.0 Liters
Pm Maximum production rate of red cells   6 x normal
Po Minimum production rate of red cells   0 x normal
P1 Normal production rate of red cells   1 x normal
P50 Oxygen tension of hemoglobin at 50% saturation 26.7 MmHg
Q Renal blood flow   1.2 Liters/min
TBM Bone marrow transit time   4 Days
TE1/2 Plasma half-life of erythropoietin 12 Hours
TRC1/2 Red cell half-life 63 Days
Vm Oxygen uptake of kidneys 20 ml O2/min
Initial Conditions
CaO Oxygen content of arterial blood  19.6 mI O2/100 ml blood
CvO Oxygen content of venous blood 17.9 ml O2/100 ml blood
E Erythropoietin concentration in plasma  1.0 x normal
Erythropoietin production rate  1.0 x normal
Hct Hematocrit 40 ml packed RBC/100 ml blood
PtO Oxygen tension in renal tissue fluid 20 mmHg
PvO Oxygen tension in venous blood 55.3 mmHg
RCM Red cell mass   2.0 Liters
RCP Production rate of new red blood cells 22 ml of packed cells/day
SaO Saturation of arterial hemoglobin with oxygen 97.6 Percent
SvO Saturation of venous hemoglobin with oxygen 89.3 Percent
An equation for the oxygen equilibrium curve was
obtained from Aberman and co-workers [29]. Their study
included a computer algorithm that converts oxygen ten-
sion to saturation and, with iteration, oxygen saturation
to tension. The agreement between measured and com-
puted values is claimed to be better than 0.2%. In addi-
tion, the algorithm includes the capability of altering P50
values (see Fig. B-5).
Analysis of Adamson’s data [18] from which the eryth-
ropoietin release function was obtained, leads to an esti-
mated value of G1 = 2.8. In simulation studies of bedrest
and hypoxia [30,31] values of G2 were determined by pa-
rameter estimation to range from 2 to 5. No data exist to
confirm these estimates directly. It is permissible to use
the gain factors as adjustable parameters, within reason-
able limits, in order to test hypotheses and possibly pro-
vide improved agreement between model and experiment
data. In addition to the gains or sensitivities, the other
parameters of these functions (Eo, Po, P1) that can be thought
of as threshold indices are also not well known and are
available for parameter estimation during a simulation.
Changing these latter quantities implies a shift of the nor-
mal rating points (( pE  = 1, OPt  = 1) for Fig. B-2; ( RCP  =
1, E  = 1) for Fig. B-3). The value of Kd was obtained from
Eq. (B7) by dividing the oxygen uptake by PvO – PtO. The
value of PtO was arbitrarily assumed to be 20 mmHg, and
PvO was computed from Eqs. (B1), (B2), and (B4) through
(B6).
B.1.9 Steady-State Errors
It is an inherent property of most biological homeo-
static mechanisms in general and proportional control sys-
tems in particular that there will be at least some residual
steady-state deviation from the normal operating point
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when the system is disturbed by a constant load. This “steady-
state error” will vary in size depending on the gain of the
system and the magnitude of the load disturbance. The sensi-
tivity coefficients of Table 3-6, for example, indicate the
steady-state errors of red cell production resulting from small
changes in parameter disturbances.
A basis for understanding steady-state errors in the
current model is as follows. At any equilibrium state, the
term dRCM/dt in Eq. (B14) must be identically zero. There-
fore Eqs. (B13) and (B14) imply that, at steady state, daily
red cell production and destruction rates are equal. Further-
more, if red cell lifespan is constant, a steady-state alteration
in red cell mass implies a proportionate change in red cell
production. Most load disturbances are accompanied by
changes in circulating red cell mass (Fig. 6-13). This im-
plies that red cell production and one or more of the fac-
tors that affect red cell production (including tissue
oxygen tension, erythropoietin, hematocrit, controller
gain, and set-point) must have incurred a steady-state error,
however small. It can be appreciated from Fig. 6-13, that
steady-state errors in tissue oxygen tension are reduced at
the expense of larger errors in red cell mass and hematocrit.
Steady-state analysis may also provide insight into
the independent determinants of the controlled variable
[32]. Figure B-6(a) shows the effect of tissue oxygen ten-
sion on red cell production (the controller function of Fig.
B-4) and the balance between red cell production and de-
struction. Feedback control ensures that the various ele-
ments of the model are adjusted until the rate of red cell
mass change, dRCM/dt, becomes zero and that steady state
is defined by this condition. It is mathematically permis-
sible to set dRCM/dt to equal zero and work backward
from this point to visualize those factors that determine
tissue oxygen tension (Fig. B-6(b)). There are only two
such factors in our model: red cell destruction (which de-
termines production rate) and the relationship between
tissue oxygen tension and red cell production. Only these
factors and those quantities that affect these factors will
ultimately determine tissue oxygen tension. Experimen-
tal evidence is severely lacking on the determinants of the
shape of the controller function curve, although it appears
that it may be under the influence of neural and biochemi-
cal factors (see Chapter B.2.2). The factors that are respon-
sible for normal red cell destruction are also not apparent
[10]. Except for overt pathology, rates of destruction are
generally considered to be a constant fraction of total cir-
culating red cell mass.
Aside from these experimental shortcomings, it is im-
portant to note that the factors usually agreed to play a
role in acute changes of tissue oxygenation (i.e., blood
flow, capillary diffusivity, oxygen uptake, P50, hematocrit)
are not represented between the zero point and the tissue
oxygen point in Fig. B-6. Although they may be consid-
ered dependent variables in the system, none of them, from
a mathematical point of view, are independent determi-
nants of the final level at which the tissue oxygen tension
will stabilize in the steady state. Although dRCM/dt will
always return to its initial zero value, the tissue oxygen
tension may exhibit a steady-state error due to the inher-
ent properties of the control system in the face of a con-
stant disturbance. However, based on the preceding
analysis, the authors believe that even tissue oxygen ten-
sion will return to its initial value (zero steady-state error)
when both of the following conditions are satisfied: (1) a
constant daily rate of red cell destruction and (2) a con-
stant controller relationship between tissue oxygen ten-
sion and red cell production.
Figure B-6. Steady-state analysis of long-term determinants of
tissue oxygen tension. (a) Segment of feedback circuit that results
in the term dRCM/dt becoming zero at steady state when destruc-
tion and production rates are equal. (b) Reversal of diagram in
Fig. B-6(a) starting from the zero point and showing mathemati-
cally equivalent influences on tissue oxygen tension.
Figure B-5. Oxygen-hemoglobin equilibrium curves drawn di-
rectly from computer model output showing effect of changing
the P50 parameter. The P50 value is the oxygen tension at which
50% of the hemoglobin is saturated and is, therefore, an index of
oxyhemoglobin affinity. The position of the OEC may vary in
accordance with known effects of hydrogen ion, CO2, tempera-
ture, or 2,3DPG (diphosphoglycerate). The effects of DPG are of
interest because of its possible contribution to erythrokinetic
changes during bedrest or weightlessness.
P50 (-4 mmHg)
P50 (normal)
P50 (+4 mmHg)
P50o
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As an example of the last point, a simulation of hy-
poxia was performed (Fig. B-7b) in which arterial oxygen
tension (PaO) was set at some low value for the entire run
and red cell destruction was clamped at its control value
of 22 ml of packed cells/day. Tissue oxygen tension de-
creased and then began to return toward normal as red cell
production and hematocrit rose, similar to the simulations
with the intact system shown in Fig. B-7(a). However, since
the destruction rate was not permitted to increase, a greater
net rate of red cells entered the circulation than would
have occurred had destruction rate rose in accord with the
mass action law of Eq. (B13). As a result, tissue oxygen ten-
sion continued to rise and red cell production rates declined.
When the system reached its new steady state, red cell pro-
duction and tissue oxygen tension returned exactly to the
prehypoxic control conditions in accord with the concepts
discussed in the previous paragraph. This was despite an
arterial oxygen tension that was still significantly de-
pressed and at the expense of hematocrit and circulating
red cell mass that were considerably above normal.
It is perhaps easy to visualize that a primary change in
destruction rate, as in hemolytic anemia, leads to second-
ary changes in tissue oxygen tension. It is more difficult
to conceive of destruction rate being a determining factor
of tissue oxygenation in a stress like hypoxia in which it
appears, at first, that the decreased oxygen loading of ar-
terial hemoglobin is the primary stimulus for hypoxia.
However, it is important to distinguish between the initial
stimulus of the acute phase, where blood pO2 is control-
ling, and the ultimate stimulus of the steady-state condi-
tion, where destruction rate (and controller function) is
controlling. These conclusions from a theoretical model
may warrant further experimental examination. The simu-
lation of hemolytic anemia presented in Chapter 6 (see
Fig. 6-18) illustrates the capability of the control system
to minimize steady-state errors.
B.2 Discussion
B.2.1 Renal pO2 Sensor
A major assumption in the controlled system is the
description of the renal oxygen detector. The evidence
strongly indicates that the balance between oxygen sup-
ply and demand at intrarenal sites is the primary stimulus
for erythropoietin release [33]. Furthermore, these detec-
tor sites must monitor venous or tissue pO2 rather than
arterial pO2 since anemia or increased oxygen-hemoglo-
bin affinity lead to increased erythropoietin production
without significantly altering arterial blood oxygen ten-
sion [5,34,35]. The receptors sensitive to tissue pO2 may
be those cells that excrete erythropoietin or its precursor
[13]. The present model is in accord with these concepts.
It has been suggested that the kidney has unique char-
acteristics that enable it to function as a sensitive oxygen
chemoreceptor and, in particular, be responsive to chang-
ing hemoglobin levels. The peculiar renal microcircula-
tion and the uniquely low arteriovenous oxygen difference
provide a gradient of tissue oxygen tension that amplifies
changes in blood oxygen delivery [14,35]. In addition,
the auto-regulatory features of the kidney ensure that
Figure B-7. Effect of destruction rate on long-term control of tissue oxygen tension. (a) Normal simulation response to hypoxic stress.
(b) Hypoxic simulation with destruction rate clamped at control value and showing regulation of tissue pO2 back to normal despite
reduced PaO.
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blood flow and oxygen uptake are effectively stable over
a wide range of oxygen tensions and blood pressures
[36,37] Moreover, if blood flows should be altered, the
kidney, in contrast to other organs, will exhibit propor-
tionate changes in oxygen uptake [38]. This means that
the ratio Vm/Q (the only term in which blood flow appears
in the model (Eq. (B4)) may be relatively constant, and
renal blood flow would not be expected to markedly in-
fluence tissue oxygenation.
The preceding discussion suggests that the powerful
influence which oxygen uptake, per se, was found to have
in the model (Fig. B-1 and Fig. 6-13) may be mitigated in
the real system by concurrent changes in blood flow. Simi-
larly, it is possible that an elevation of Vm, by whatever
cause, promotes tissue hypoxia and results in local regu-
latory increases of Kd, the effective capillary diffusivity.
This is now known to be true for skeletal muscle [39] but
has not been confirmed for the kidney. Such regulation
would, however, further dampen the effect of oxygen up-
take because Kd appears only in the ratio Vm/Kd in Eq. (B7).
It may be desirable to add these local regulatory effects—
between oxygen uptake, blood flow, and capillary
diffusivity—to the model. A current alternate approach is
to assume they are constant and to examine their influ-
ence, if the data so suggest, in improving the accuracy of
simulation. Under these circumstances, and in accord with
Eqs. (B1) to (B7), tissue pO2 would be a function of the
hemoglobin concentration of the blood, the arterial oxy-
gen saturation of hemoglobin, and the shape and position
of the OEC [6].
It should be emphasized that the site of the intrarenal
detector has not yet been confirmed and that the quantita-
tive aspects of its oxygen supply-demand balance (includ-
ing direct measurement of PtO) remain unknown.
Justification of this segment of the model is based on indi-
rect evidence, gross characteristics of the kidney as a
whole, and determinants of tissue oxygenation derived
from other tissues.
The use of a steady-state formulation for tissue oxy-
genation (Eqs. (B1) to (B7)) in a dynamic model is justi-
fied because, in the well-perfused kidney, equilibrium of
oxygen tension due to pure convection and diffusion may be
achieved in the order of seconds to minutes following a load
disturbance. This can be compared to the much slower changes
of the erythropoietin distribution or bone marrow red cell
production process. Estimates of true equilibration times were
obtained from the non-steady-state version of this algorithm
[16,40] that was originally employed in the NASA stud-
ies. The steady-state description permitted the use of a
larger integration step size in the numerical algorithms
and increased the solution speed significantly without de-
creasing the accuracy of the response for the long periods
of time in which the investigators were interested.
B.2.2 Bone Marrow Controller System
An accurate description of the relationship governing
erythropoietin release is not yet available, presumably be-
cause of the difficulty in measuring intrarenal oxygen lev-
els and the uncertainty surrounding the specific location
of the receptor cells. The formulation used to relate tissue
oxygen tension to erythropoietin release is in accord with
the study of Adamson [18], who found a semilogarithmic
inverse relationship between daily urinary erythropoietin
excretion and hematocrit in humans. A parallel between
urinary and plasma erythropoietin [7] as well as between
hematocrit and tissue [41] pO2 was assumed in deriving
Eq. (B8). A similar relationship has been used by Hodgson
[5], whereas Parer [42] has derived a linear relationship,
and Mylrea and Abbrecht [17] have used arterial oxygen-
hemoglobin concentration (i.e., Hb ×  SaO) rather than tis-
sue oxygen tension as the independent variable. At the
present time, sufficient data do not exist to reveal the pre-
cise shape of this function.
Measurement of plasma erythropoietin has, until re-
cently, been restricted to levels above basal [1]. Therefore,
no data are available to confirm the relationship to reduced
release rates of erythropoietin. This region is of particular
interest because of its application of simulation to bedrest,
spaceflight, and related disturbances in which chronic el-
evation of hematocrit follows plasma volume shifts.
There is an abundance of information demonstrating
that in experimental animals, a linear relationship exists
between red cell production and the log of erythropoietin
concentration (Eq. (B12)). This has been observed, for
example, in bioassay animals in which doses of erythro-
poietin are injected either singularly with iron uptake used
as the index of erythropoietic activity [2,24] or adminis-
tered at frequent intervals for up to several weeks with
production rate expressed in terms of increased red cell
mass [9,23]. It is reasonable to assume that a similar dose
response relationship exists for the human, although con-
firmatory evidence is lacking. In vivo estimates of the
human function curve, especially for the suppressed eryth-
ropoiesis range, will be possible as erythropoietin becomes
available in large quantities and as more sensitive assay
methods for this hormone are developed.
The shape and position of the renal and bone marrow
function curves have been found to be crucial elements in
the control of erythropoiesis in general and in the long-
term control of tissue oxygenation in particular. Model
parameters have been incorporated to allow for shifts in
sensitivities and thresholds away from the normal operat-
ing points. Values of controller sensitivities have not been
well established in the human by direct methods and only
to a limited extent in experimental animals [5] Several
studies suggest that alterations in these parameters occur
during certain physiological stresses such as dehydration
and hypoxia [43,44] and during pathological disturbances
such as abnormal hemoglobin [34], erythrocytosis [18]
and hemolytic anemia [45]. It appears that the rate of red
cell production is determined not only by the concentra-
tion of erythropoietin but also by the size of the stem cell
pool [46]. If the pool size increases, the bone marrow re-
sponse to a given dose of erythropoietin should be greater
than normal (i.e., an effective increase in G1). The avail-
ability of iron to the erythron may also influence this func-
tion [11]. Certain hormones, such as androgens, as well as
neural stimuli are assumed to exert their effect on erythro-
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poiesis by their modification of erythropoietin release
[12,13] (i.e., an effective change in G1). It is possible, us-
ing the current model, to predict these parameters within
narrow limits provided both the dynamic behavior of eryth-
ropoietin and red cell production rates are measured si-
multaneously during hematologic stress. Unfortunately,
such data are seldom available, especially for humans.
B.2.3 General Comments
Feedback regulation of tissue oxygen tension is ac-
complished solely by adjustments of hemoglobin levels
resulting from the output of a renal/bone-marrow control-
ler. Other parameters that are known to effect acute changes
in tissue oxygenation are incorporated explicitly in the
model but are non-regulatory in nature and can be altered
manually to test various hypotheses. Similarly, the char-
acteristics of the controller can also be adjusted to test
their effect on long-term control of tissue pO2 and red cell
mass. Such parameter adjustment (other than for the pri-
mary disturbance) has not been found to be essential, in
most cases, to simulate the basic behavior of the dynamic
and steady-state response. However, fine-tuning of param-
eters is required to scale the model output and achieve
closer agreement with experimental values. In some cases,
these studies indicate the need to propose additional regu-
latory elements to provide, for example, a more realistic
simulation of the erythropoietin response to hypoxia. Other
features of a general nature have also been identified that
will increase the utility of the model even further, includ-
ing (1) the effect of blood volume and viscosity on oxy-
gen transport and (2) a description of stem cell kinetics
and reticulocytosis [47,57].
B.3 Formulation of Mouse Model
B.3.1 System Parameters
The computer model for erythropoietic control was
adapted to the mouse system by altering the system pa-
rameters originally given for the human, to those that more
realistically represent the mouse [48]. Parameter values
were obtained from a variety of literature sources as indi-
cated in Table B-2. The immediate application of the
mouse model was the study of the mouse as a potential
experimental model for spaceflight. Data for the simula-
Table B-2. System Parameters for Erythropoiesis Control Model
Parameter        Model symbol       Parameter value     Reference            Units
Human Mouse
Red cell mass* RCM 2000   0.63 B-49 ml
Plasma volume* PV 3000   0.77 B-49 ml
Blood volume BV 5000   1.40 B-49 ml
Whole-body hematocrit Hct     40.0 45.0 B-49 ml of packed RBC/100 ml blood
Mean corpuscular hemoglobin MCHC       0.375   0.300 B-50 g Hb/ml RBC
   concentration*
Hemoglobin concentration Hb     15.0 13.5 B-50, B-51 g Hb/100 ml blood
O2 capacity of blood* CaO     20.1 19.0 B-51 mI O2/100 ml blood
O2 capacity of hemoglobin CHbO       1.34   1.41 B-50, B-51 mI O2/g Hb
pO2 tension at one-half Hb P50     27 39 B-52 MmHg
   saturation*
Arterial pO2* PaO     95 78 B-53 mmHg
Arterial Hb saturation SaO       0.97   0.99 B-52 Percent
Renal metabolic rate* Vm     20   0.04 B-54 ml O2/min
Renal blood flow* Q 1200   1.83 B-55 ml/min
Normal tissue pO2* PtO     20 20 MmHg
Erythropoietin half-life* TE1/2     12   3.25 B-56 Hours
Red cell lifespan* TRC   126 20 B-17 Days
Erythrocyte maturation time* TBM TE1/2      4   3.5 Days
Normal RBC production rate* RCP    22   0.0437 B-49 ml RBC/day
RBC turnover rate RKC      1.1   6.93 B-49 Percent/day
*  Fundamental value from which other parameter values may be derived. Relationships used in deriving these other parameters are as follows:
    Blood volume: BV = RCM + PV = 0.63 + 0.77 = 1.4 ml
    Whole-body hematocrit: Hct = RCM/BV = 0.63/1.4 = 0.45 ml packed RBC/ml blood
    Hemoglobin concentration: Hb = Hct x MCHC = 45 x 0.3 = 13.5 g Hb/100 ml blood
    Capacity of hemoglobin: CHbO = CaO/Hb = 19.0/13.5 = 1.41 ml O2/g Hb
    Arterial Hb saturation: SaO = function (PaO) (See oxygen-hemoglobin dissociation curve (Fig. B-8).)
    RBC turnover: RKC = turnover rate/100 = 0.693/RBC half-life 0.693/20/2 = 0.0693 per day = 6.93% per day
    Steady-state destruction rate = RCM x RKC = 0.63 x 0.0693 0.0437 ml/day
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Figure B-8. Oxygen-hemoglobin equilibrium curves for human and mouse: experimental versus theoretical values.
Table B-3. Absolute Versus Specific Parameter Values
Parameter                            Absolute units        Specific units*
Human Mouse Units Human Mouse          Units
Red cell mass 2000 0.63 ml 28.6 25.2 ml/kg body wt.
Plasma volume 3000 0.77 ml 42.9 30.8 ml/kg body wt.
Blood volume 5000 1.40 ml 71.4 56.0 ml/kg body wt.
Renal blood flow 1200 1.83 ml/min   4.28   6.10 ml/min–1 g–1 tissue
Renal O2 consumption     20 0.04 ml/min   0.73   0.133 ml/min–1 g–1 tissue
Body O2 consumption   250 0.51 ml/min   0.00357   0.0255 ml/min–1 g–1 tissue
*Based on
Body weight = 70 kg man and 25 g mouse
Renal mass = 280 g (0.4% body wt.) in man and 0.3 g (1.2% body wt.) in mouse
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tions were obtained from C. D. R. Dunn (University of
Tennessee Memorial Research Center) and included stud-
ies of dehydration and hypoxia. The strain of mice used in
these studies was C3H with an approximate weight of 25
grams. Parameter values were chosen for this strain where
possible. In certain cases, the literature values were super-
seded by values obtained directly from Dunn’s studies. In
a few cases, mouse data were not available and data for the
rat were substituted. A comparison of system parameters
for the mouse and human models is shown in Table B-2.
Aside from the obvious differences expected in fluid vol-
umes, blood flows, and metabolic rates, large differences were
observed in the following: erythrocyte lifespan (126 days vs.
20 days)** erythropoietin half-life (12 hours vs. 3.25 hours),
and normal arterial pO2 (95 mmHg vs. 78 mmHg). The shorter
lifespan of the mouse red blood cells implies a turnover of
erythrocytes that is six-fold faster. That is, the daily rates
of red cell production and destruction (as well as reticulo-
cyte index) are approximately six times higher in the C3H
mouse than the human.†† Other parameters that were found
to be more similar between the two species were as follows:
hematocrit (40 vs. 45), mean corpuscular hemoglobin con-
centration (0.375 vs. 0.30), and maximum oxygen-carrying
capacity of hemoglobin (1.34 vs. 1.41).
Table B-4. Oxygen Balance at Kidney
O2 supply equals
BF x O2 concentration         Kidney           O2 venous
   O2 demand
Parameter  Human  Mouse Units
Oxygen demand      20.0     0.04 ml O2/min
       0.073     0.153 ml O2 min–1 g–1
Oxygen supply
    PaO, arterial      95.0   78 mmHG
    SaO, arterial      97.4   98.6 Percent saturation
    O2 concentration   196.0 188 ml O2/liter blood
    BF, blood flow 1200 .0     1.83 ml
blood/min
    O2 supply   235.0     0.343 ml O2/min
      0.839     1.143 ml O2/min–1 g–1
Oxygen venous
    PvO, venous     56.0   57 mmHG
    SvO, venous     89.0   86 Percent saturation
    pO2, tissue     20.0   20 mmHg
Percent oxygen       8.7  13.4 Percent
    extraction =
    (O2 demand)/(O2 supply)
Although the arterial pO2 in the mouse is much lower
than in the human, the oxygen saturation of hemoglobin
of both species is nearly identical (97% vs. 99%). This is a
result of the distinctly different oxygen-hemoglobin dis-
sociation curves shown in Fig. B-8 and reflected in the
different P50 values (26.5 mmHg vs. 39.0 mmHg). The P50
differences imply that, at the same level of tissue oxygen
tension, oxygen is more easily unloaded in the mouse than
in the human. It should be noted that the normal pO2 of
arterial blood assumed here (78 mmHg)) was obtained from
rat data [51,56] and has been used in a previous model
validated for the mouse with reasonably good results [17].
No corresponding mouse data could be located. Values for
renal blood flow of the mouse were not available, and data
from rats were used (6 ml min–1 g–1 tissue).
B.3.2 Scaled Parameters
Some parameters of the mouse model differ consider-
ably from the human model because of scaling factors
alone. The values used in the model are given on an abso-
lute basis for the whole animal rather than as a specific
property in terms of “per gram of tissue.” In terms of spe-
cific units, the differences between the mouse and human
system are much smaller, as shown in Table B-3.
B.3.3 Oxygen Balance
The balance of oxygen supply versus oxygen demand
is crucial to the feedback regulation of erythropoiesis.
A parameter reflecting this complex balance is the tissue
oxygen tension that is believed to govern the release
of erythropoietin. The oxygen balances for the human
and mouse systems as used in the model are given in Table
B-4.
Oxygen consumption per gram of renal tissue in the
mouse is approximately twice that for the human. (Overall
total oxygen consumption per gram body weight is nearly
seven times greater in the mouse.) This higher oxygen
demand of the mouse is satisfied in two ways in the model.
First, there is a 50% greater efficiency in oxygen extrac-
tion as indicated in Table B-4. (Note that, in both species,
the amount of oxygen delivered at rest is more than suffi-
cient; i.e., roughly 10 times that required by the tissues.)
Second, there is a 30% higher blood oxygen supply per
gram of tissue because of greater tissue blood flow in the
mouse.
The normal tissue oxygen tension is arbitrarily assumed
to be identical in both model systems; i.e., 20 mmHg. The
equation describing oxygen diffusivity to the tissues from
venous capillaries is given in the steady state as
    Net oxygen delivery = tissue oxygen consumption
          = (pO2 vein − pO2 tisue ) x K (B17)
where K = conductivity coefficient = O2 diffusivity times
the capillary surface area. The ratio Kman/Kmouse would be
expected to reflect the surface area ratio between species
if diffusivity is assumed similar in mouse and man. There-
fore, if S is capillary surface area, then
▲
▲
▲
**
 First and second numbers in parentheses refer to human and
mouse, respectively.
††
 Typical values for mice red cell lifespan found in the literature
indicate only a threefold increase. Values used here were found by
Dunn to be much different in the C3H strain.
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Sman
Smouse
=
Kman
Kmouse
=
(O2 consumption)man
(O2 consumption)mouse
×
( pO2,vein − pO2, tissue)mouse
( pO2,vein − pO2, tissue)man
=
20ml/min
0.04ml/min
×
(57.5− 20)mmHg
(56.4− 20)mmHg
= 515
This is in good agreement with the surface area ratio
of 650 of the glomerulus derived from data in Ref. 54 (p.
174), lending support to the general representation of the
kidney in the computer model.
B.3.4 Functional Relationships
Three functional relationships are included in the com-
puter model: (1) oxygen-hemoglobin equilibrium curve
(OEC), (2) erythropoietin release as a function of tissue
pO2, and (3) erythrocyte production rate as a function of
erythropoietin concentration. The first of these is shown
in Fig. B-8 and will subsequently be described in detail.
The form of the function curves for erythropoietin and red
cell release will be assumed identical in the mouse and
human models. There is no reason at the present time to
take issue with this assumption, particularly since the bone
marrow function was originally obtained from the mouse.
These curves (as shown in Figs. B-2 and B-3 and as used in
the models) are represented in normalized form (i.e., per-
cent of control) so that any species may be represented.
The gain factors G1 and G2, representing the slope of the
relationships, may be different between species. This is of
little concern in the basic design of the model because
these parameters will be adjusted during the simulation
process and their actual values will be estimated by “fit-
ting” the model output to the experimental data.
The equation describing the sigmoidal OEC is a form
of the Hill equation and is shown in the insert of Fig. B-8.
The two solid lines represent human and mouse blood,
respectively, and were recently obtained from blood
samples of the C3H mouse [49]. The value of P50 is explic-
it ly stated in the equation so that shifts in
oxygenhemoglobin affinity may be easily described. The
value of the exponent k, found from the best fit of the
mouse curve, also provides a good fit of the human curve
as shown in Fig. B-8. Thus, the only difference between
the equation describing the human and mouse OEC is the
value of P50.
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Appendix C
Guyton Model for Circulatory, Fluid, and Electrolyte Control:
Modifications and Recommendations
The original version of the model developed by Arthur
Guyton and used extensively as a basis for much of this
work was built as a general-purpose model of overall cir-
culatory regulation and was used by the authors to simu-
late a wide variety of real situations, including congestive
heart failure, various types of hypertension, fistula, and
hypoproteinemia [1,2]. Despite these successes, the model,
as originally constructed, did not have the level of detail
required to respond to the challenge of the microgravity
environment. Modifications were made to the model to
rectify this limitation and expand its capabilities. These
modifications are available in report form [3,4], but they
are presented and summarized here for the convenience of
the interested reader.
The original version of the Guyton model is presented
in Fig. C-1. A legend of symbols, definitions, and units is
included. In addition, Fortran language versions of both
the original and the modified model are obtainable [5,6].
There are two parts to this appendix. The first part
summarizes the modifications that were concerned prima-
rily with recompartmenting the circulatory subsystem to
include leg volume and controller elements; adding grav-
ity-dependent functions to the controlled and controller
systems; and revising and updating the baroreceptor block,
red blood cell block, and the angiotensin block. These
modifications have extended the capability of the origi-
nal model so that the effects of gravity and its removal on
fluid distribution may be simulated more realistically. The
second part is a set of recommendations for improving the
capability of the model to simulate orthostatic (tilt and
standing) maneuvers.
C.1 Modifications to the Guyton Model
C.1.1. Leg Circulatory Compartment
Two additional compartments have been added to the
model of the circulatory system, one to represent the arteries
in both legs and the other to represent the veins (see Fig. 3-
36). Each compartment is characterized by a total blood vol-
ume, blood pressure, and compliance (see Table C-1). The
values for volumes and compliances of the leg compartments
were derived from the model of the 28-compartment pulsa-
tile cardiovascular sub-system of the Whole-Body Algorithm.
The blood volumes and compliances of the upper circula-
tory compartments were adjusted to keep the total volume
and compliance of the arterial and venous vessels nearly
identical to those in the original Guyton model.
C.1.2 Blood Flow Pathways and Metabolic Rates
The original Guyton model contained three blood flow
pathways: renal, muscle, and the remainder of the circula-
tion. In the modified version, these three pathways remain
intact; however, the muscle flow pathway represents the
entire leg flow, and the non-muscle, non-renal pathway
together with the renal flow represents total upper body
flow. In this modified model, leg blood flow and total body
muscle blood flow are identical. Muscle and non-muscle,
non-renal flows were readjusted by changing their basic
resistances so that cardiac output was similar to that of the
unmodified version of the Guyton model and leg flow was
similar to that of the leg blood flow of the short-term pul-
satile cardiovascular model of the Whole-Body Algorithm.
Metabolic demand in terms of oxygen consumption was
also readjusted in proportion to the new blood flow rates.
C.1.3 Resistances of the Leg Blood Vessels
The single resistance in the muscle blood flow path-
way of the original version was replaced by two variables
in series to allow capillary filtration to occur in the
muscles. These represent a precapillary arteriolar resis-
tance and a postcapillary venular resistance, the values of
each being dependent on autonomic and angiotensin ef-
fects. In addition, the venular resistance responds to pas-
sive distention due to hydrostatic pressure, whereas the
arteriolar resistance includes autoregulatory and viscos-
ity effects. These formulations for the leg muscle tissue
are similar to that of the non-muscle, non-renal precapil-
lary and postcapillary resistances in the original Guyton
model with the following exceptions.
First, the passive distention effect resulting from hy-
drostatic pressure was not included as a determinant of the
leg arteriolar resistance. This exclusion was based on the
belief that, upon standing, a strong myogenic local reflex
acts to constrict arteriolar vessels (as well as capillary
sphincters) in response to the high hydrostatic load. The
myogenic reflex opposes the passive distention effect. It
was felt that the passive distention effect should be re-
moved until the myogenic effect is included in the model.
Otherwise, the effect of standing would create arteriolar
distention great enough to overcome autonomic vasocon-
striction, a condition that does not normally exist in the
real physiological system.
Second, the veins are not known to participate in the
myogenic response but, rather, should be highly respon-
sive to passive distention under the high hydrostatic pres-
sures of standing. Consequently, a passive distention effect
was added to the leg venule resistance. This formulation per-
mitted a 1 mmHg change in pressure to cause a 1% change in
resistance in accordance with data reviewed by McDonald
[7]. The net effect of excluding the passive distention effect
in the leg arterioles and adding this effect to the leg venules
is to favor a higher precapillary/postcapillary resistance ra-
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Figure C-1 Key
AAR afferent arteriolar resistance
AHM antidiuretic hormone multiplier, ratio of normal effect
AM aldosterone multiplier, ratio of normal effect
AMC aldosterone concentration
AMM muscle vascular constriction caused by local tissue control, ratio to resting state
AMP effect of arterial pressure on rate of aldosterone secretion
AMR effect of sodium to potassium ratio on aldosterone secretion rate
AMT time constant of aldosterone accumulation and destruction
ANC angiotensin concentration
ANM angiotensin multiplier effect on vascular resistance, ratio to normal
ANN effect of sodium concentration on rate of angiotensin formation
ANP effect of renal blood flow on angiotensin formation
ANT time constant of angiotensin accumulation and destruction
ANU nonrenal effect of angiotensin
AOM autonomic effect on tissue oxygen utilization
APD afferent arteriolar pressure drop
ARF intensity of sympathetic effects on renal function
ARM vasoconstrictor effect of all types of autoregulation
ARI vasoconstrictor effect of rapid autoregulation
AR2 vasoconstrictor effects of intermediate autoregulation
AR3 vasoconstrictor effect of long-term autoregulation
AU overall activity of autonomic system, ratio to normal
AUB effect of baroreceptors on autoregulation
AUC effect of chemoreceptors on autonomic stimulation
AUH autonomic stimulation of heart, ratio to normal
AUK time constant of baroreceptor adaptation
AUL sensitivity of sympathetic control of vascular capacitance
AUM sympathetic vasoconstrictor effect on arteries
AUN effect of CNS ischemic reflex on autoregulation
AUV sensitivity control of autonomics on heart function
AUY sensitivity of sympathetic control of veins
AUZ overall sensitivity of autonomic control
AVE sympathetic vasoconstrictor effect on veins
A1K time constant of rapid autoregulation
A2K time constant of intermediate autoregulation
A3K time constant of long-term autoregulation
A4K time constant for muscle local vascular response to metabolic activity
BFM muscle blood flow
BFN blood flow in nonmuscle, nonrenal tissues
CA capacitance of systemic arteries
CCD concentration gradient across cell membrane
CHY concentration of hyaluronic acid in tissue fluids
CKE extracellular potassium concentration
CKI intracellular potassium concentration
CAN extracellular sodium concentration
CNE sodium concentration abnormality causing third factor effect
CPG concentration of protein in tissue gel
CPIconcentration of protein in free interstitial fluid
CPN concentration of protein in pulmonary fluids
CPP plasma protein concentration
CV venous capacitance
DAS rate of volume increase of systemic arteries
DFP rate of increase in pulmonary free fluid
DHM rate of cardiac deterioration caused by hypoxia
DLA rate of volume increase in pulmonary veins and left atrium
DLP rate of formation of plasma protein by liver
DOB rate of oxygen delivery to nonmuscle cells
DPA rate of increase in pulmonary volume
DPC rate of loss of plasma proteins through systemic capillaries
DPI rate of change of protein in free interstitial fluid
DPL rate of systemic lymphatic return of protein
DPO rate of loss of plasma protein
DRA rate of increase in right atrial volume
DVS rate of increase in venous vascular volume
EVR postglomerular resistance
EXC exercise activity, ratio to activity at rest
EXE exercise effect on autonomic stimulation
GFN glomerular filtration rate of undamaged kidney
GFR glomerular filtration rate
GLP glomerular pressure
GPD rate of increase of protein in gel
GPR total protein in gel
HM hematocrit
HMD cardiac depressant effect of hypoxia
HPL hypertrophy effect on left ventricle
HPR hypertrophy effect on heart, ratio to normal
HR heart rate
HSL basic left ventricular strength
HSR basic strength of right ventricle
HYL quantity of hyaluronic acid in tissues
IFP interstitial fluid protein
KCD rate of change of potassium concentration
KE total extracellular fluid potassium
KED rate of change of extracellular fluid concentration
KI total intracellular potassium concentration
KID rate of potassium intake
KOD rate of renal loss of potassium
LVM effect of aortic pressure on left ventricular output
MMO rate of oxygen utilization by muscle cells
MO2 rate of oxygen utilization by nonmuscle cells
NAE total extracellular sodium
NED rate of change of sodium in intracellular fluids
NID rate of sodium intake
NOD rate of renal excretion of sodium
OMM muscle oxygen utilization at rest
OSA aortic oxygen saturation
OSV nonmuscle venous oxygen saturation
OVA oxygen volume in aortic blood
OVS muscle venous oxygen saturation
O2M basic oxygen utilization in nonmuscle body tissues
PA aortic pressure
PAM effect of arterial pressure in distending arteries, ratio to normal
PC capillary pressure
PCD net pressure gradient across capillary membrane
PCP pulmonary capillary pressure
PDO difference between muscle venous oxygen pO2 and normal venous oxygen pO2
PFI rate of transfer of fluid across pulmonary capillaries
PFL renal filtration pressure
PGC colloid osmotic pressure of tissue gel
PGH absorbency effect of gel caused by recoil of gel reticulum
PGL pressure gradient in lungs
PGP colloid osmotic pressure of tissue gel caused by entrapped protein
PGR colloid osmotic pressure of interstitial gel caused by Donnan equilibrium
PGV pressure from veins to right atrium
PIF interstitial fluid pressure
PLA left atrial pressure
PLD pressure gradient to cause lymphatic flow
PLF pulmonary lymphatic flow
PMO muscle cell pO2
POD nonmuscle venous pO2 minus normal value
POK sensitivity of rapid system of autoregulation
PON sensitivity of intermediate autoregulation
POS pulmonary interstitial fluid colloid osmotic pressure
POT nonmuscle cell pO2
POV nonmuscle venous pO2
POY sensitivity of red cell production
POZ sensitivity of long-term autoregulation
pO2 oxygen deficit factor causing red cell production
PPA pulmonary arterial pressure
PPC plasma colloid osmotic pressure
PPD rate of change of protein in pulmonary fluids
PPI pulmonary interstitial fluid pressure
PPN rate of pulmonary capillary protein loss
PPO pulmonary lymph protein flow
PPR total protein in pulmonary fluids
PRA right atrial pressure
PRM pressure caused by compression of interstitial fluid gel reticulum
PRP total plasma protein
PTC interstitial fluid colloid osmotic pressure
PTS solid tissue pressure
PTT total tissue pressure
PVG venous pressure gradient
PVO muscle venous pO2
PVS average venous pressure
QAO blood flow in the systemic arterial system
QLN basic left ventricular output
QLO output of left ventricle
QOM total volume of oxygen in muscle cells
QO2 nonmuscle total cellular oxygen
QPO rate of blood flow into pulmonary veins and left atrium
QRF feedback effect of left ventricular function on right ventricular function
QRN basic right ventricular output
QRO actual right ventricular output
QVO rate of blood flow from veins into right atrium
RAM basic vascular resistance of muscles
RAR basic resistance of nonmuscular and nonrenal arteries
RBF renal blood flow
RC1 red cell production rate
RC2 red cell destruction rate
RCD rate of change of red cell mass
REK percent of normal renal function
RFN renal blood flow if kidney is not damaged
RKC rate factor for red cell destruction
RMO rate of oxygen transport to muscle cells
RPA pulmonary arterial resistance
RPT pulmonary vascular resistance
RPV pulmonary venous resistance
RR renal resistance
RSM vascular resistance in muscles
RSN vascular resistance in nonmuscle, nonrenal tissues
RVG resistance from veins to right atrium
RVM depressing effect on right ventricle of pulmonary arterial pressure
RVS venous resistance
SR intensity factor for stress relaxation
SRK time constant for stress relaxation
STH effect of tissue hypoxia on salt and water intake
SVO stroke volume output
TRR tubular reabsorption rate
TVD rate of drinking
VAS volume in systemic arteries
VB blood volume
VEC extracellular fluid volume
VG volume of interstitial fluid gel
VGD rate of change of tissue gel volumes
VIB blood viscosity, ratio to that of water
VIC cell volume
VID rate of fluid transfer between interstitial fluid and cells
VIE portion of blood viscosity caused by red blood cells
VIF volume of free interstitial fluid
VIM blood viscosity, ratio to normal blood
VLA volume in left atrium
VP plasma volume
VPA volume in pulmonary arteries
VPD rate of change of plasma volume
VPF pulmonary free fluid volume
VRA right atrial volume
VRC volume of red blood cells
VTC rate of fluid transfer across systemic capillary membranes
VTD rate of volume change in total interstitial fluid
VTL rate of systemic lymph flow
VTS total interstitial fluid volume
VTW total body water
VUD rate of urinary output
VV7 increased vascular volume caused by stress relaxation
VVR diminished vascular volume caused by sympathetic stimulation
VVS venous vascular volume
Z8 time constant of autonomic response
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tio upon standing which tends to reduce leg capillary pres-
sure towards leg venous pressure. According to Mellander
[8], this is an appropriate response to limit outward filtration
of plasma in the erect posture.
C.2 Effect of Gravity on Pressure Gradients
The average hydrostatic pressure gradient in the legs (PGL)
due to gravity has been expressed as
 φ××= sinFHPG LL (C1)
where HL is taken as the distance (in centimeters) from the
heart to the knees. (The knee was used as a convenient
reference point to find the average hydrostatic effect in a
lumped leg compartment.) The term F converts pressure
from centimeters water to millimeters mercury, whereas φ
is the angle (in radians) of body tilt measured from the
horizontal. The pressure gradient PGL is introduced into
the formulation for leg flow at the input to the leg arterial
compartment, where it aids flow, and at the output of the
leg venous compartment, where it opposes flow.
The gravity effect on the carotid baroreceptors must
also be included since the tilt angle changes the hydro-
static pressure at these important sensors. The hydrostatic
gradient at the baroreceptors is given by an equation simi-
lar to Eq. (C1) except that the term HL is taken to be the
distance between the heart and the carotid receptor. The
     Parameter     Value Parameter    Value
Blood volume, liters
Right heart     0.109
Pulmonary     0.413
Left heart     0.431
   Total cardiopulmonary     0.953
Upper artery     0.714
Leg artery     0.146
   Total artery     0.860
Upper veins     2.750
Leg veins     0.440
   Total veins     3.190
Total stressed volume     0.877
Total unstressed volume     4.126
Total upper body volume     4.417
Total leg volume     0.586
Total blood volume     5.003
Blood pressure, mmHg
Upper arterial 100.1
Leg arterial   99.3
Upper venous     4.55
Leg venous     4.89
Right heart     0.63
Pulmonary   18.87
Left heart     0.97
Compliances, liter/mmHg
Upper arteries     0.00265
Leg arteries     0.00112
Upper viens     0.07905
Leg veins     0.00772
Blood flow, liters/min
Cardiac output     6.47
Renal     1.20
Leg (muscle)     0.98
Nonrenal, nonmuscle     4.30
Table C-1. Steady-State Values of Major Physiological Parameters in Modified Guyton Model
Flow Resistances, mmHg/liter/min
Total peripheral   15.60
Renal   83.39
Leg (muscle)   96.31
Non-renal, non-muscle   22.20
Large veins     0.60
Leg arteries (fixed)     0.95
Leg veins (fixed)     0.35
Pulmonary     2.76
Body fluid volume, liters
Blood     5.003
Plasma     3.007
Red cell     1.999
Interstitial   12.013
   Free fluid     0.545
   Gel   11.467
Total body water   40.038
   Extracellular   15.042
   Intracellular   24.996
Metabolic rate, ml O2/min
Nonmuscle, nonrenal 252.0
Leg (muscle)   58.0
Total 310.0
Concentration, meq/liter
Plasma sodium 142.0
Plasma potassium     5.00
Plasma protein   70.1
Hematocrit, vol.%   39.95
Stroke volume, liters     0.088
Heart rate, beats/min   73.3
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pressure gradient so calculated is subtracted from the ef-
fective blood pressure sensed at the carotid body during a
tilt simulation. Any angle of tilt may be simulated by ad-
justing φ, and other postures such as sitting may be stud-
ied by reducing the height HL.
C.3 Venous Valves
The effect of venous valves has been added by permitting
blood flow from the venous leg compartment to assume
only positive values. Because this leg compartment can
only be filled by arterial blood (rather than reverse venous
flow from upper body veins), transient conditions can ex-
ist in which outflow to the veins is extremely low. This
occurs, for example, during the onset of lower body nega-
tive pressure simulation. This situation was not possible
in the original Guyton formulation.
C.4 Leg Plasma/Interstitial Filtration
A mechanism was added to permit plasma to filter into a
new interstitial leg compartment. This mechanism is illus-
trated in Fig. C-2 in schematic form. Blood flow in the leg
tissues is driven under an arterial-venous pressure gradi-
ent (PAL – PVL) across an arterial resistance RAL and a
venous resistance RVL. The capillary pressure (PCLG) is
computed as a function of upstream and downstream pres-
sures and the precapillary/ postcapillary resistance ratio,
in accordance with the Landis–Pappenheimer formulation:
PCLG = RCLG * PAL + (1 – RCLG)*PVL
where RCLG = RVL/(RVL + RAL). Filtration rate into the
leg interstitium (QLEG) is based on the transcapillary hy-
drostatic pressure and oncotic pressure gradients multi-
plied by a leg capillary filtration coefficient (CFLG).
QLEG = (PCLG – PILG – PPC) * CFLG
where PILG is the leg interstitial pressure and PPC is the
plasma colloid osmotic pressure. It is assumed that inter-
stitial colloid osmotic pressure is negligible. The value of
PILG is determined from the leg interstitial volume (VILG)
and the tissue compliance (CTLG).
Because of the lack of detailed information regarding
the leg tissues and tissue pressure changes during stand-
ing, this represents a highly simplified model of leg filtra-
tion having the following major assumptions.
1. Leg tissue fluid volume is equal to 1.5 liters in supine
steady state.
2. Linear compliance permits tissue pressures to rise by
about 40 mmHg during standing when the fluid vol-
ume is increased by approximately 500 ml because of
plasma filtration. This large pressure increase is neces-
sary to oppose excessive filtration because of the equally
high change in capillary pressure.
Figure C-2. Schematic diagram of leg filtration mechanisms.
NASA/CR—2020-220487 467
Figure C-3. Block diagram of baroreceptor system.
3. The effects of lymph flow, tissue colloidal concentra-
tion, and tissue gel have not been included.
The total resistance to blood flow through the leg
muscle is given by the sum of the two variable resistances
RL = RAL + RVL
and the blood flow rate of the leg is taken to be the differ-
ence of pressure between the leg arteries (PAL) and veins
(PVL) divided by the resistance
QL = (PAL – PVL)/RL.
C.5 External Leg Vascular Pressure
An external pressure term (PXV), shown in Fig. C-2, was
included in the formulation for leg arterial and venous
pressure, as was an external tissue pressure term (PXT).
These terms are normally zero. By setting PXV and/or PXT
to values less than zero, the effects of lower body negative
pressure can be simulated. Values higher than zero will
simulate various events such as positive pressure leg gar-
ments, water immersion, dehydration of the legs, and a
muscle pump mechanism, all of which have the effect of
reducing venous leg blood volume and aiding in venous
return during standing.
C.6 Vascular Stress Relaxation Effect
A term representing instantaneous stress relaxation was
added to the stress relaxation block of the original model.
This term appears as a constant factor (normally zero),
which was found to be necessary to aid venous return dur-
ing tilt simulation. In that case, reverse stress relaxation
was used. Its physiological counterpart may be a combi-
nation of stress relaxation and the abdominal compres-
sion postural reflex, as well as a central venoconstrictor
effect [9].
Stress relaxation of the vascular system was extended
by the inclusion of new components with different time
constants for action. These new components are associ-
ated with 6-hour and 14-day relaxation phenonmena.
C.7 Baroreceptor System
The baroreceptor system in the original Guyton model
was changed by direct inclusion of separate aortic and
carotid effects and by separate inclusion of the autonomic
influence on both contractility of the heart and whole-
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body unstressed volume. Appropriate delays and reset-
ting mechanisms were used. A flow chart for the modified
system is given in Fig. C-3.
C.8 Modified Red Blood Cell Production
Algorithm
A new algorithm for red cell regulation was also imple-
mented in the recompartmentalized Guyton model. This
new block was based on the erythropoiesis regulatory simu-
lation model previously described in Chapter 3 and 6.
This model has greater capability than the blood cell sub-
routine in the original Guyton model, especially with re-
spect to the simulation of hemopoietic responses to
hypoxia, red cell infusion, and bedrest. A detailed descrip-
tion of this algorithm, as it appears in the modified Guyton
model, is presented in Ref. [3].
The new red blood cell algorithm was based on a kid-
ney sensor of oxygen partial pressure located in tissue of
constant metabolic rate and perfused with venous capil-
lary blood, flowing at a constant rate. These restrictions
permit erythropoiesis to be responsive primarily to changes
in hematocrit and arterial oxygen partial pressure, shifts
of oxyhemoglobin dissociation, and disturbances in oxy-
gen-carrying capacity of hemoglobin.
C.9 Renin-Angiotensin System
The original version of the Guyton model did not possess
a detailed representation of the renin-angiotensin system.
In particular, renin secretion as such was not present, and
the model did not respond correctly to low-level angio-
tensin II infusion. This original model contained what was
essentially a black box, with angiotensin level dependent
on tubular sodium flow. To extend the range of applicabil-
ity of the model, the black box was replaced with a more
physiologically oriented section. A flow chart of the added
system is contained in Appendix A (Fig. A-3). The new
system improved the mechanism for releasing angiotensin
into the circulation and permitted thirst and salt intake as
well as renal afferent and efferent arteriolar resistances to
depend on angiotensin levels.
C.10 Recommendations for an Improved
Orthostatic Model
The addition of gravity dependent elements to the Guyton
model, discussed in Chapters 3.2.5 and 9.6, provided new
capability to simulate changes in postural positions. The
cardiovascular model of Croston is capable of even greater
realism for short-term orthostatic tests. However, the
Guyton model, with a circulatory system open to fluid
transfer with adjoining compartments as well as with the
external environment, and long-term controllers is theo-
retically capable of longer-term simulations. In the cur-
rent project, the Guyton model failed to achieve the robust
blood pressure control during standing that is seen in the
human subject. It also did not achieve a longer term steady
state during standing. Additional modifications are there-
fore required in the Guyton model for longer-term orthos-
tatic capability. The object of these modifications would
be to produce a model capable of maintaining normal,
healthy ambulatory function. It is our hypothesis that un-
derstanding the hypogravic state is predicated on a better
understanding of the orthostatic state. The recommenda-
tions below may serve as a start in this direction.
Table C-2 and the associated Fig. C-4 illustrate a num-
ber of mechanisms that are believed to aid in orthostatic
protection. Orthostatic protection insures that blood pres-
sure levels are preserved at close to a normal level during
standing. Some of these mechanisms have already been included
in the Guyton model and are discussed in Chapter 9 and the first
part of this Appendix. These include:
a) a leg tissue compartment that can normally receive
about a half liter of plasma during standing;
b) a muscle contracting effect that decreases transmural
pressure and decreases leg fluid pooling;
c) valves in the leg veins that allows blood flow to move
only toward the central regions;
d) a passive distention effect at the leg veins affecting
postcapillary resistance and decreasing leg filtration;
e) autonomic and angiotensin effects on leg arteriolar
resistance which limits flow to the legs, raises arterial
pressure, and decreases capillary filtration.
In addition, there are other suggested areas for model
improvements as follows:
C.10.1 Factors Affecting Venous Capacitance
It is clear that a more faithful simulation of tilt re-
quires a greater degree of compensatory venous return than
was seen in the studies reported in Chapter 9. Venous re-
turn can be effectively enhanced in the model or in man
by reducing capacitance of the central veins and perhaps
leg veins. The mechanisms that are involved in these
changes arise from centrally mediated high pressure and
low-pressure baroreceptors in the upper body, from vaso-
constriction hormones, and from local effects such as re-
verse stress relaxation and passive elastic recoil.
Contraction of the leg and abdominal musculature, con-
sidered also to be important compensatory reflexes to
orthostatic pooling, are probably mediated via central and
local mechanoreceptors [10,11].
Observations on the behavior of the capacitance ves-
sels in the human have been restricted to the limbs, but
even here inconsistent results have been found during tilt
studies [12]. It is not possible at present to determine
whether changes in splanchnic blood volume are induced
actively or passively, although this generally is consid-
ered to be an important fluid source during acute hypov-
olemia [13,14]. Boyers, et al. [15], using a model for tilt
simulation, found it necessary to employ a low pressure
autonomic input sensitive to central blood volume or pres-
sure which acts, in part, on the veins to enhance venous
return. Evidence for this effect is not yet strong [16]. The
current version of the Guyton model does not include low
pressure autonomic effects other than those used to influ-
ence ADH release. Perhaps a new autonomic reflex path-
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way, mediated by low-pressure receptors which influence
venous resistance and capacitance, can be postulated and
incorporated for future evaluation.
C.10.2 Stress Relaxation of Veins
In the erect position, reverse stress relaxation takes
place in the large veins of the model following decre-
ments of central blood volume. This may occur more rap-
idly and intensively than heretofore suspected according
to recent evidence from Guyton’s laboratory and others
[17,18]. Such an effect greatly enhanced the present tilt
responses reported in Chapter 9.6. Quantitative studies on
the compensatory effects of stress relaxation and stress relax-
ation recovery following blood volume changes are mea-
ger [19]. It is important to ascertain where in the circulation
it occurs. If stress relaxation has an influence on the smaller
leg veins it would act in a direction to gradually increase
blood pooling, as is known to occur during standing.
C.10.3 Pre- and Post-Capillary Resistance
Previous simulations with the Guyton model have led
us to suggest that autoregulation effects (a mechanism
which adjusts precapillary resistance to meet local oxy-
gen demands) may be too strong and rapid in dampening
peripheral resistance changes following intravascular fluid
shifts either headward or feetward as occurs during pos-
tural changes. More recent studies on our part indicate
that a more powerful influence on postcapillary resistance
may be required rather than an attenuation of autoregula-
Figure C-4.  Modifications for an improved tilt simulation.  The
numbers correspond to the elements in Table C-2. (PVL = Venous
pressure in legs and PAL = arterial pressure in legs).
tion. Evidence for this hypothesis is only suggestive. Nev-
ertheless, it is important to note that venous capacitance
and venous resistance changes are theoretically indepen-
dent in the model, but not necessarily in the human vascu-
lature. Thus, any changes in the model that effect
autonomic influence on capacitance, such as discussed
above, should also be considered for their influence on
postcapillary resistance. In addition, it is important to con-
sider that under various conditions there may be a disso-
ciation in the reflex changes of the (arterial) resistance
and (venous) capacitance vessels due to competing con-
trol elements or perhaps redistribution of efferent auto-
nomic signals [20,21]. The role of pre-/post capillary
resistance takes on new importance in the Guyton model
now that there are two distinct capillary beds. These ele-
ments have been implicated in the regulation of regional
blood flow, number of patent capillaries, nutritional ex-
changes, plasma volume, and venous return.
C.10.4 Improved Leg Circulatory Elements
While the degree of fluid pooling in the legs appears
to have been adequately simulated by the current model it
should be realized that this is a preliminary study and that
many factors which control fluid pooling, filtration and
blood flow in the legs have not been included [22]. Fluid
pooling in legs during standing is known to be reduced by
the leg muscle pump, venous valves, autonomic vasocon-
striction and humoral (angiotensin) mechanisms as well
as by a buildup of fluid pressure in the interstitium [19].
All these effects have been included to some extent in the
model. However, their mathematical representation was
only estimated; quantitative data were mostly lacking. In
addition, there is evidence for the presence of other major
effects not presently included such as: a) catecholamine
influence [23], b) postural sway [11], and c) myogenic
vasoconstriction [21]. This latter effect acts in the face of
high transmural pressures to increase precapillary resis-
tance, induce sphincter closure and reduce filtration area.
Several other effects are detrimental to orthostatic toler-
ance such as stress relaxation and passive distention of arter-
ies and veins. These effects may be required for longer-term
simulations. For example, it has been suggested that pos-
tural sway and the venous (muscle) pump are responsible
for maintaining orthostatic tolerance during prolonged
standing or minimal upright activity. An improvement in
the leg muscle elements would do more than enhance the
tilt response. Because of the large mass of the skeletal
muscles, passive and active fluid mobilization, especially
when reinforced by the mechanical effect of muscle con-
traction, provides the potential for large changes in ca-
pacity within the entire circulation during a wide variety
of stress conditions.
C.10.5 Leg Interstitial Compartment
The leg interstitial compartment was modeled quite
simply as a water reservoir with a linear compliance. For
the present effort this appears to be adequate. However,
absent from this formulation is a lymphatic system, a tis-
sue gel, colloids and a nonlinear compliance, all of which
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Table C-2. Mechanisms for Improving Fidelity of Tilt Simulations
                     Element Modification Justification
1) Filtration of plasma between leg vasculature and Transfers about 300 – 500 ml plasma. The interstitial fluid volume
    interstitial fluid increases during standing and decreases during supine.
2) Autoregulatory effect on leg capillary surface area A local myogenic reflex that has been postulated to occur in
response to increased leg hydrostatic pressures by decreasing
effective capillary surface area.  The effect is to limit the filtration of
plasma.
3) Autoregulatory effect on leg venous resistance Decreases venous resistance when standing and lowers  capillary
pressure. Although evidence is not strong for this effect, it appears to
be necessary to prevent severe edema. The autoregulatory effect in
the model with legs currently only affects arteriolar resistances.
4) Passive distention effect on leg veins Decreases venous resistance proportional to the increase in
hydrostatic pressure.
5) Stress relaxation of leg veins Postulated mechanism similar to upper vein stress relaxation. It will
not improve the short-term maintenance of blood pressure and
venous return, but it will permit a more realistic gradual slow pooling
of blood in legs and thereby improve bedrest and long-term
standing simulations.
6) Muscle pump effect Increases  venous return from the legs and decreases leg pooling.
7) Effect of increasing leg tissue fluid pressure on Similar effect as the muscle pump, but is an automatic regulatory
    transmural pressure of leg veins effect rather than a fixed parameter.
8) Venous valves Slightly delays the rapid pooling of blood in legs by permitting leg
blood flow in only headward direction.
9) Abdominal compression effect Standing reflex that compresses splanchnic veins and releases a
small quantity of stored blood.  Effect is to restore venous pressure
and enhance venous return.
10) Instantaneous stress relaxation (and reverse Allows rapid reverse stress relaxation in large veins during standing
      stress relaxation) in large veins to enhance venous return. This effect was found to be necessary to
simulate appropriate response to tilt, infusion and hemorrhage.
11) Short-term autoregulatory flow effect Preliminary observations have shown that short-term autoregulation
is too strong and too rapid. It does not allow flow resistances to
decrease appropriately since it counteracts the central reflex
vasoconstriction, so the effect was decreased.
12) O2 consumption During standing O2 consumption increases by 10 to 20%. This
increases autoregulatory flow and  autonomic stimulation.
13) Renin-angiotensin response Preliminary results showed that the renin response to the off
transient to tilt was too slow. Angiotensin affects vessel constriction,
urine flow, and aldosterone production. See text for
recommendations.
14) ADH response Preliminary results showed that the ADH response was not
sustained as it is in the real system during tilt or zero-g
15) Cardiopulmonary autonomic response Decreasing cardiopulmonary volumes are known to elicit autonomic
responses during tilt, suggesting a low pressure receptor.  The model
currently has only high pressure receptors for volume and pressure
control.
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are important elements of the upper body tissue fluid com-
partment [24]. Data are not available to model a completely
realistic distributed parameter interstitial compartment
system.
C.10.6 Improvements in Endocrine Systems
This recommendation concerns improving the endo-
crine system of the Guyton model. The response to tilt of
ADH, angiotensin, and aldosterone were in good agree-
ment with available data. However, there are areas which
can be immediately addressed that might improve re-
sponses to tilt and other stresses. First, it was noted that
during the off transient to tilt, angiotensin did not fall as
rapidly as it does in the tilt recovery of man [25]. This was
believed to be due, in part, to the arterial pressure response
which was unrealistically low for a short period and, in
part perhaps, to an inadequate description of the renal
pressoreceptor releasing site of renin. Several model de-
scriptions have recently become available that would as-
sist in improving this response [26,27]. Secondly, the
aldosterone algorithm of the Guyton model has been re-
cently revised [28], and it is suggested that if feasible, it
be incorporated into the NASA/GE gravity dependent
model. Finally, data has recently appeared which may al-
low a revision of the ADH algorithm. This concerns the
ADH response to immersion and a quantitative descrip-
tion of the relative influence of blood volume and osmo-
larity on ADH concentration [29,30]. Unfortunately, there
is still much conflict in the literature regarding the regula-
tion and physiological role of ADH during postural changes
both during short-term and prolonged studies [31].
C.11 Conclusion
A few other factors should be considered in an orthostatic
model. Increasing the effects on cardiac contractility or
heart rate on improving venous return have not been con-
sidered thus far in our studies. Also, in most individuals,
orthostasis leads to syncope sooner or later during quiet
standing. Some individuals are more prone to this, per-
haps because of an inadequate sympathetic response. In
the current project no attempt was made to model syn-
cope, but it should be a future goal, especially in attempt-
ing to differentiate between individuals who are or who
are not prone to syncope. Finally, it should be noted that
many of the recommendations discussed above await more
physiological studies (rather than mathematical defini-
tion) prior to developing algorithms for incorporating them
into a model.
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Appendix D
Design, Development, and Validation of the Whole-Body Algorithm
This Appendix contains a detailed description of the de-
sign, development, and validation of a model that, for rea-
sons revealed in the discussion, has been termed a
Whole-Body Algorithm (WBA). This discussion is meant
to supplement that of Chapter 3.
D.1 Summary of Subsystems
The individual subsystem models used in this project were
carefully selected and modified to simulate the response
of a human subject to the stresses under investigation in
the Skylab medical experiments. These models are sum-
marized in the following paragraphs.
D.1.1 Long-Term Fluid and Electrolyte Subsystem
Model
The long-term model of circulatory, fluid, and elec-
trolyte control, originally developed by Dr. A. C. Guyton,
has been substantially modified to include the most cur-
rent formulations for many of the regulatory functions and
implemented in an interactive time-sharing mode. The sys-
tems analysis of overall circulatory regulation, as devel-
oped by Guyton, includes a large number of the
physiological subsystems that affect the circulatory sys-
tem. This model consists of 354 blocks. Each block repre-
sents at least one mathematical function that describes an
important physiological facet of circulatory regulation,
including autonomic, metabolic, renal, hormonal, and fluid
transport function.
The circuit of blood flow in the Guyton model is di-
vided into five volume segments: system arteries, system
veins, right atrium, pulmonary arteries, and pulmonary
veins-left atrium. Exchange of water, proteins, and elec-
trolytes (sodium and potassium) is permitted between the
plasma, interstitial, and intracellular fluid compartments
by way of diffusion, active transport, transcapillary ex-
change, and lymph flow. Heart function is represented in a
high degree of detail, which includes ventricular muscle
strength, heart hypertrophy and deterioration, and auto-
nomic and sympathetic stimulation. These characteristics
of the model can be viewed as the controlled system,
whereas the controlling system consists of three major
components: local control, hormonal control, and auto-
nomic control. The inclusion of such elements as hormonal
control, autoregulation, baroreceptor adaptation, erythro-
poiesis control, protein formation and destruction, venous
stress relaxation, and cardiac-conditioning factors clearly
indicates that the Guyton model was originally developed
to serve as a long-term model, i.e., simulate long-term adap-
tive events.
Many and varied experiments have been simulated
with the Guyton model, including some involving infu-
sions of water, electrolyte, plasma, and angiotensin. Vari-
ous pathologic conditions have also been simulated, in-
cluding congestive heart failure, loss of kidney function,
and nephritic proteinuria. The long-term simulation cho-
sen as a test for the Whole-Body Algorithm was bedrest,
because it appears to be a reasonable analog to zero-g.
The addition of gravity-dependent stress factors and the
inclusion of leg compartments in this subsystem greatly im-
proved the subsystem’s response to bedrest and weight-
lessness. Additional improvements were made by
modifying the original algorithm for red blood cell con-
trol [1] (see Appendix C).
D.1.2 Cardiovascular Subsystem Model
A model of the human cardiovascular system capable
of simulating bicycle-ergometry exercise was developed
under this project by Dr. R. Croston. Subsequent modifi-
cations to this model were made to enable simulation of
lower body negative pressure (LBNP) and tilt. The origi-
nal model of the cardiovascular circulatory system was
divided into 28 compartments, which described pulsatile
blood flow, pressure, and volume. The model was modi-
fied to include gravity effects, muscle pumping, venous
tone, venous valves, respiratory rate, and intrathoracic pres-
sure. Heart-period control, peripheral resistance, venous tone,
and other variables included in the new model were based on
classical cardiovascular mechanisms. In addition, metabolic
control mechanisms for oxygen uptake, for oxygen deficit,
and for metabolite accumulation were included to enable
simulation of metabolic changes. The feedback signals
for the control algorithms in the model came from the
chemoreceptors and from neurogenic response to muscu-
lar activity and to anticipatory stimuli. Exercise workload,
work rate, gravity, resting oxygen consumption, and blood
volume were required inputs. Typical outputs were oxygen
uptake, oxygen deficit, total metabolites, heart rate, vari-
ous blood flows, systolic pressure, mean arterial pressure,
diastolic pressure, stroke volume, and venous pressure.
D.1.3 Respiratory Subsystem Model
The third major subsystem selected for inclusion in
the Whole-Body Algorithm was the respiratory system.
The model previously developed by Dr. F. Grodins was
chosen as the best available (in 1975) representation. In
this model, the controlled system is divided into three
compartments (lung, brain, and tissue). The blood passes
through the lungs, and, after a transport delay dependent
on vascular volume and blood flow rate, the arterial blood
arrives at the brain or the tissue compartment. In this model,
carbon dioxide (CO2) and oxygen (O2) exchange rates are
governed by metabolism. Venous blood leaving the brain
combines, after a time delay, with venous blood from the
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tissue to form mixed venous blood. After another delay, this
mixed venous blood enters the lungs to complete the cycle
of gas transport and exchange. The real system is composed
of receptor elements that monitor chemical concentrations
and of afferent nerves that transmit this information to the
central nervous system, the neural centers, to motor nerves,
and to the respiratory muscles that drive the thorax lung
pump. In the model, conversely, this process is represented
by chemical concentrations at receptor sites (which are
inputs to the system) and by ventilation rate (which is the
major controlled variable). Typical short-term stresses for
which this model is suited include hypoxia, hypercapnia,
and acid base disturbances. Modification of the original
model provided the capability to simulate exercise.
D.1.4 Thermoregulatory Subsystem Model
A dynamic model of physiological regulation of body
temperature, originally developed by Dr. J. Stolwijk and
later modified slightly, basically accounts for the body’s
reaction to external temperature (environment) and for the
effects of metabolic heat production (exercise). The controlled
system consists of a representation of the thermal character-
istics of the various body compartments. These compartments
(or nodes) were designed to represent head, trunk, arms, hands,
legs, and feet. These compartments were further divided into
concentric layers designated as blood core, muscle, fat,
and skin. Each node appropriately produces metabolic heat
and also exchanges convective heat with adjacent com-
partments. The skin exchanges heat with the environment
by way of radiation, convection, and evaporation. The ther-
moregulatory model receives temperature signals from all
tissue compartments, and, after integration and process-
ing, the control system sends commands to all appropriate
compartments to change metabolic heat production, blood
flow, or the rate of sweat secretion.
D.2 Design and Development
The Whole-Body Algorithm was designed to provide the
capability of simulating long-term and short-term stresses
with a single “master” model. The long-term simulation is
accomplished by a circulatory, fluid, and electrolyte sub-
system model, which may be used to provide initial oper-
ating conditions for a set of three short-term models
representing the cardiovascular, respiratory, and ther-
moregulatory systems. These three short-term models,
which are designed to simulate the response to acute
changes both in the environment and in short-term experi-
ment stresses, operate in parallel and interchange infor-
mation as often as every 0.05 second of simulation time.
Using this approach, a Whole-Body Algorithm evolved
that could simulate with equal facility those adaptive
changes occurring over a period of days, weeks, or even
months and those experimental stresses in which signifi-
cant changes might occur in a matter of seconds.
D.2.1 Approach to Whole-Body Algorithm
Since all subsystem models were designed as feed-
back control systems with identifiable controller elements,
they have a certain formal compatibility. The technical
plan for integrating these subsystem models included veri-
fying the subsystem modeling approach, verifying the
compatibility of each subsystem model, providing for sys-
tem expansion, and unifying the system software programs
and languages and the subsystem computational approach.
The plan also included identifying interfaces between sub-
system models, providing uniform experimental checkout
of each subsystem and of the assembled algorithm, exam-
ining all interfacing closed loops for stability, developing
the executive program to control execution of the sub-
systems, and validating the Whole-Body Algorithm.
This plan led to development of a Whole-Body Algo-
rithm that is limited only by the detail of the individual
subsystem models, the lack of physiological experiment
data to further refine the models, and the lack of knowl-
edge regarding certain physiological phenomena. This
model provides a basis for studying physiological phe-
nomena and a basic model that can be refined as new pa-
rameters are recognized.
D.2.2 Subsystem Interfaces
The individual models have been described above in
the form in which they were used in the Whole-Body Al-
gorithm. In this section, the interfaces developed to repre-
sent the appropriate interaction between these subsystems
are described. A diagram illustrating these interfaces is
presented in Fig. D-1, where the interface variables are
defined as shown.
The general philosophy of interfacing the subsystems
was to combine the various models in a manner causing
the least number of modifications to the basic model for-
mulations, even at the cost of an occasional loss of com-
puting efficiency. Since the units used in each model were
substantially different, it was frequently necessary to con-
vert the units of variables passed between models. The
rule for the Whole-Body Algorithm was that conversion
factors, where necessary, would be applied on the receiv-
ing end of the transfer. It is recommended that all future
models be converted to a single set of consistent units.
D.2.2.1 Long-Term/Short-Term Interface. Although
technically the least difficult to accomplish, the long-term/
short-term interface (Fig. D-1) was one of the most impor-
tant in the Whole-Body Algorithm. This interface provided
the capability to simulate the spaceflight event sequence
(see Fig. 2-2). From the modeling viewpoint, the basic
plan was to use the long-term model to initialize the short-
term models for simulating any short-term experiments or
transient environmental conditions. After steayd-state con-
ditions were reached, the long-term model could be ini-
tialized for simulation of the subsequent long-term phase.
Since the long-term/short-term interchange under this plan
is sequential rather than simultaneous, the modeling prob-
lem consisted primarily of providing for the transfer of the
interface variables through a common block and of mod-
eling the mechanisms necessary to use these variables on
either side of the interface in a physiologically represen-
tative manner.
NASA/CR—2020-220487 476
A major problem encountered was the transfer of state
variables between models lacking identical initial condi-
tions. This particular problem manifested itself as a drift
from control steady-state conditions in the models at the
time of transfer. A procedure to solve this interface prob-
lem involved choosing a supine resting (but not basal)
state as the initial condition. This state was assumed to
exist before any short-term stress was initiated and is
closely related to the passive zero-g state. To properly
represent this state, all subsystem models had to be initial-
ized to this state at the time of transfer by matching meta-
bolic rates (equivalent to the resting supine oxygen
uptake), initial blood volumes, and major blood flows.
An additional problem was caused by the creation of
new environmental conditions by the short-term models.
The long-term/short-term interface had to include the ca-
pability to reinitialize the long-term model with the steady-
state values of variables computed by the short-term loop
(insensible water loss, oxyhemoglobin concentration, and
skin blood flow) after simulation of the environmental
stress. Including this capability provides the structure for
simulating the entire spaceflight sequence with environ-
mental stresses performed throughout the interval. The next
problem was to select, when simulating non-environmen-
tal stresses, the variables to exchange other than those
required to represent transient environmental changes in
the supine resting state. These variables should be direct
functions of the long-term stresses being simulated and of
the resultant hypotheses related to the level of physiologi-
cal detail present in the models. By assumption, the short-
term experimental stresses (other than environmental)
would always include complete recovery to the state that
existed before the stress. Hence, these stresses would not
be allowed to perturb the long-term model.
The requirements for simulating bedrest made it nec-
essary to identify important interfacing variables to more
accurately simulate that condition. Bedrest is associated
with the headward redistribution of blood and the result-
ant changes in blood volume, vasomotor conditions, he-
matocrit (due to plasma filtration), and blood flow through
the major flow paths. Changes in total blood volume and
total unstressed blood volume provide the necessary in-
Figure D-1. Subsystem interfaces of Whole-Body Algorithm.
CBF = trunk core blood flow
HBF = head blood flow
MBF = muscle blood flow
SBF = skin blood flow
RBF = renal blood flow
C0 = cardiac output
VO2 = oxygen uptake
RF = respiratory frequency
TC = trunk core temperature
PaO2 = arterial oxygen partial pressure
PaCO2 = arterial CO2 partial pressure
RO2R = resting oxygen requirement
BV = total blood volume
UBV = total unstressed blood volume
IWL = insensible water loss
OHC = oxyhemoglobin concentration
HM = hematocrit
NBF = nonmuscle blood flow
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formation to the short-term models for initializing blood
volume and vasomotor changes (except tone changes,
which were not considered in the initial bedrest hypoth-
esis). Hematocrit was passed through the interface to pro-
vide the respiratory subsystem effect due to changes in
red blood cell concentration. The blood flow changes in
the renal, muscle, and non-muscle paths of the long-term
model were passed through the interface to provide flow
changes in the major flow paths of the short-term cardio-
vascular models. These flow changes are converted to a
corresponding resistance changes and applied to the re-
spective flow paths represented in the cardiovascular
model. The renal blood flow changes was represented by a
resistance change in the renal arterioles; the muscle blood
flow changes was represented by a resistance change in
the leg arterioles; and the non-muscle blood flow change
was represented by a change in the resistance of the supe-
rior mesenteric artery. These hemodynamic changes were
then reflected in the respiratory and thermoregulatory sub-
systems by way of the flow parameters in their respective
interfaces with the cardiovascular subsystem during the
simultaneous operation of these short-term models.
Model changes, other than those required to accom-
modate the variables passed through the interface as dis-
cussed previously, are associated with the specific hypotheses
concerning the physiological changes that occur during
bedrest. These modifications, as well as the requirements
for additional variables to be passed through the interface
to represent these specific hypotheses, will change as dif-
ferent hypotheses are considered. One value of the design
approach selected for the Whole-Body Algorithm is the
relative ease with which new interface pathways and hy-
potheses can be added and tested without total disruption
of the system. These hypotheses and the required model
changes are discussed in detail in Chapter 9. The hypoth-
eses dealing with the occurrence of long-term rate changes
and reverse stress relaxation during bedrest has been left
in the Whole-Body Algorithm formulation. These points
should be considered when repeating the simulation of
bedrest with additional or different hypotheses.
It should be noted that all interfaces between the sub-
systems were designed for the simulation of the one-g re-
sponse to the stresses of interest with the hypothesized
physiological changes and responses as documented here.
The assumption of different conditions, other stresses, other
hypotheses, or other combinations of stresses and hypoth-
eses would require the passing of additional or different
variables through the interfaces. In most cases, additions
to or improvements in the subsystem models would be
required to accommodate the changes desired. The Whole-
Body Algorithm was designed as a research tool to facili-
tate these structural changes.
D.2.2.2 Cardiovascular/Respiratory Interface. The in-
terface between the cardiovascular and respiratory sub-
systems presented the most difficulty and, therefore,
received the most attention. The difficulty was related to
the physiological interaction and interdependence of these
two short-term subsystems and to the fact that a larger
number of short-term stresses of interest to this project
have responses manifested in these subsystems.
The initialized (resting) metabolic rate was different
in each model, and this difference was the first problem
encountered in the interacting of these two models. This
problem was, in fact, encountered in all the model inter-
faces. The initial metabolic rate in the cardiovascular
model was represented as a resting (non-exercising) oxy-
gen uptake for an alert and ready subject. In the other
models, the metabolic rate was initialized much closer to
a basal rate. This problem was solved by using the resting
oxygen requirement from the cardiovascular model to drive
all subsystem models to a state of mutual equilibrium.
Then the new state achieved was used as the initial condi-
tions for subsystem models for all subsequent simulations.
The other interface elements of these two models were
chosen to represent elements that changed significantly
during the stresses of interest and that would significantly
affect the subsystem model on the other side of the inter-
face. The model having the better physiological represen-
tation of the variable of interest determined the direction
in which these variables were passed. In most cases, this
selection was made easily, since the counterpart variable
of the interfaced subsystem model was generally repre-
sented non-physiologically or empirically in the other sub-
system model.  For example, respiration in the
cardiovascular model was poorly represented by external
pressure on the thoracic blood compartments. In some case,
however, modifications in the receiving model were nec-
essary to ensure proper model response to the passed vari-
able, specifically when the receiving model had not been
designed to respond to stresses generated in the sending
model (e.g., the cardiovascular response to environmental
stresses). For example, it was necessary to model changes
in inspired gas concentrations where the model simulated
the action of chemoreceptors, which are sensitive to
changes in arterial partial pressures of oxygen and carbon
dioxide. The chemoreceptor reflex was added to the car-
diovascular subsystem model to ensure sensitivity to in-
creases in carbon dioxide and decreases in oxygen in a
manner similar to the baroreceptor response to changes in
blood pressure. The premise for chemoreceptor control was
derived from Scher [2] and is shown in Fig. D-2. The basic
expression derived to produce the chemoreceptor auto-
nomic reflex is
AUNC = 1.0 + (0.03448 ∆pCO2 – 0.016 ∆pO2)
where AUNC is the chemoreceptor autonomic effect and
∆pCO2 and ∆pO2 are changes in arterial carbon dioxide
and oxygen partial pressures, respectively. Based on in-
formation from Duffin [3], it was necessary to limit the
effect of the changes in arterial pCO2 and arterial pO2. Re-
sults of this study showed that the response of the carotid
chemoreceptor was very low or zero for arterial pO2 greater
than 80 mmHg and for arterial pCO2 less than 30 mmHg.
The resulting autonomic factor was then applied to the
calculations of peripheral resistance, heart rate, and
strength of heart contractions in the manner depicted in
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Fig. D-2. These values in turn change blood pressure (which
acts on the baroreceptors and closes a second feedback
loop), as well as stroke volume and cardiac output. Car-
diac output is passed to the respiratory subsystem model
and thus completes the feedback loop across the interface.
The cardiovascular and respiratory subsystems, when
initially exposed to exercise, responded in an unrealistic
manner. It was noted, after all interface links were estab-
lished, that a very good response from both subsystems
was elicited for high exercise levels (150 to 200 watts) but
that a poor response (worse than that for the stand-alone
models) was elicited for the lower levels (100 watts and
below). This problem was traced to a poor representation of
the time-varying rate of oxygen uptake in the respiratory
subsystem model. Since oxygen uptake is numerically inte-
grated in the cardiovascular subsystem model (that is, the
area to the left of the curve of oxygen uptake compared to
time) to calculate oxygen deficit, a significantly different
circulatory response resulted. An altered response would
be expected, in this case, because oxygen deficit affects
many control functions in the cardiovascular model.
The studies of Whipp and Wasserman [4] indicate that
variation of oxygen uptake with time for exercise levels
greater than 100 watts cannot be represented accurately
by the single exponential function used in the respiratory
model (see Fig. D-3). Using this information, a new mul-
tiple exponential function for the higher exercise levels
and an improved single exponential function for lower
exercise levels were derived as shown in Fig. D-4 for 100
and 200 watts. Note that the curve for 200 watts, which is
represented by multiple exponential function, breaks af-
ter approximately 2 minutes of exercise, as was indicated
by the experimental data. This break corresponds to the
anaerobic threshold, which is also indicated by the ex-
perimental data (Fig. D-3). When the exponential func-
tion (rate of change of oxygen uptake, or VO2) is plotted
on a semi-logarithmic scale, it becomes a straight line the
slope of which is related to the time constant. Each exer-
Figure D-2. Block diagram of autonomic control system. The major components of the cardiovascular and respiratory control systems
are shown. A plus sign indicates that an increase in the input to a component increases its output; a minus sign indicates a decrease in
output. When pressure rises at the baroreceptors, the sensory nerves will increase firing and there will be decreased firing in sympathetic
fibers and increased firing in vagal fibers to produce vasodilation, decreased heart rate, decreased stroke volume, and decreased
peripheral resistance. Decreases in heart rate and stroke volume will decrease cardiac output, which, combined with decreased peripheral
resistance, will decrease blood pressure and, in turn, decrease pressure at the baroreceptors. An increase in arterial carbon dioxide partial
pressure (pCO2) or a decrease in arterial oxygen partial pressure (pO2) at the chemoreceptors will increase the sensory discharge to cause
decreased vagal and increased sympathetic activity, which will result in increased heart rate, increased stoke volume, and increased
peripheral resistance. The heart rate and stroke volume increases produce an increase in cardiac output, which, combined with the
increased peripheral resistance, increases the blood pressure. The combination of increased blood pressure and increased respiratory
minute volume resulting from respiratory effects should produce increased transport of oxygen to the tissues.
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cise level requires not only a different time constant but a
minimum of two exponential functions to represent oxy-
gen-uptake rates for exercise levels greater than 100 watts.
The curves for this subject also show the anaerobic threshold
to be very near the 2-minute mark of the exercise period for
all levels above 100 watts. After these new oxygen-uptake
functions were included in the respiratory subsystem
model, the oxygen-deficit function in the cardiovascular
model was tuned for these data and a good response from
both subsystems was elicited for all levels of exercise (see
Chapter 3).
D.2.2.3 Cardiovascular/Thermoregulatory Interface.
The principal functions of the thermoregulatory subsystem
model are to simulate changes caused by variations in
environmental parameters (for example, temperature, rela-
tive humidity, barometric pressure, cabin ventilation,
clothing) and to simulate increases in metabolic produc-
tion of heat (exercise). The function of the cardiovascular
system, in the context of thermoregulation, is to provide a
fluid medium for convective heat transfer away from tis-
sues warmer than the blood and into tissues cooler than
the blood.
The blood supply to the skin is of great significance
to both cardiovascular and thermoregulatory subsystems.
The skin exchanges heat with the environment through
the pathways of radiation and convection. The amount of
heat exchanged through these pathways is a function of
the skin temperature and the various environmental fac-
tors mentioned previously. The temperature of the skin is
determined through a heat balance of these environmental
heat exchanges, through conduction to the adjacent fat
compartment, and through convective heat exchange with
the blood supply. The skin temperature acts in a feedback
loop within the thermoregulatory subsystem, using the
mechanisms of vasoconstriction and vasodilation to con-
trol the production of sweat and the skin blood flow. There-
fore, since the skin blood flow is largely a function of the
state of thermoregulation, the value for this parameter is
computed and passed from the thermoregulatory subsystem
to the cardiovascular subsystem. The other parameter
passed from the thermoregulatory to the cardiovascular
subsystem is the direct influence of temperature on heart
rate. The temperature of pacemaker cells is known to in-
fluence heart rate. Since the thermoregulatory subsystem
computes temperatures in the trunk core, this parameter is
passed to the cardiovascular subsystem and is used to com-
pute an additive term for the heart rate which is directly
proportional to the change in temperature. Selkurt [5] in-
dicates that the magnitude of this effect is approximately
13 to 20 beats/min °C.
The remaining parameters of the cardiovascular/ther-
moregulatory interface are passed from the cardiovascular
subsystem to the thermoregulatory subsystem (see Fig. D-
1). The representation of the circulatory blood flow in the
original thermoregulatory model was very crude and, there-
fore, caused significant inaccuracies in its response. These
inaccuracies were expected to be relieved by interfacing
the model with a fully developed cardiovascular model.
This task was difficult, since the 28 blood-volume com-
partments of the cardiovascular subsystem had relatively
little resemblance to the 40 geometrical body tissue com-
partments of the thermoregulatory subsystem. Correspon-
Figure D-3. Rate of change in oxygen uptake VO2 as a function of
exercise duration for selected workloads. The subscript ss indi-
cates steady state; t indicates transient (from Ref. 4).
Figure D-4. New oxygen-uptake functions modeled in the respi-
ratory subsystem.
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dence was found, however, between the two systems on a
broader level. The blood flows that could be used directly
from the cardiovascular model were the venous return from
the brain and the sum of venous return flows from the
heart, the kidney, and the liver. These two flow paths were
used to replace the head core and trunk core blood flows,
respectively, in the thermoregulatory model. The total
muscle blood flow was passed from the cardiovascular to
the thermoregulatory model as well. The muscle blood
flow was distributed to various muscle tissues throughout
the body, using the original distribution fractions in the
thermoregulatory model as reported by Stolwijk [6] for rest
and for bicycle-ergometry exercise. The remainder of the car-
diac output was distributed to the remaining core and fat
blood flows. This procedure provided a workable inter-
face between the two models. However, in future studies,
refinement of these blood flows using experimental data
to acquire better representation of temperature distribu-
tion for the transient response to exercise is recommended.
A final variable passed from the cardiovascular to the
thermoregulatory subsystem was the metabolic rate. This
variable replaced an input parameter to the original ther-
moregulatory subsystem that had remained constant
through an experiment. This refinement was required in
the thermoregulatory model to improve the transient re-
sponse to exercise. The arteriovenous oxygen difference
computed in the cardiovascular subsystem included consid-
eration of factors such as oxygen debt, oxygen deficit, and
oxygen uptake in working muscle. These interface variables
much more accurately represented the metabolic expendi-
tures which resulted in the production of heat. The increase
in metabolic rate from a basal to a resting state, as required by
the design approach, was seen in the thermoregulatory model
as mild exercise. Since metabolic heat generated during
bicycle ergometry was distributed heavily to the leg
muscles, adjustments had to be made to distribute the rest-
ing metabolic heat more equitably to other muscle com-
partments by using a distribution ratio proportional to the
muscle mass fraction for each compartment.
An additional modification to the thermoregulatory
subsystem was the addition of a countercurrent heat ex-
change formulation in the model’s blood supply to im-
prove performance in a cool environment. The new
algorithm, as illustrated in Fig. D-5, represented the blood
compartment as being in intimate thermal contact with
the core compartments of the trunk, the arms, the legs, and
the returning venous blood. These mechanisms are increas-
ingly important in a cooler environment, where the venous
return flows from muscle and skin are significantly cooler
than the arterial blood supply.
In summary, the cardiovascular/thermoregulatory in-
terface addressed the shortcomings of the cardiovascular
model in the area of skin blood flow during exercise, the
shortcomings of the thermoregulatory model in the area of
blood flow rates, and the factors affecting metabolic use
of oxygen. The principal result of an increase of skin blood
flow in the cardiovascular subsystem was an increase in
cardiac output, which, in turn, affected all other flows in
the cardiovascular system. A primary benefit of this sub-
system interaction was that conditions of various levels of
skin blood flow during exercise could be studied. With
this combined model, the competitive effect of skin and
muscle blood flow could be studied at various ambient
temperatures for several levels of prolonged exercise and
other conditions.
The chemoreceptor effect on the cardiovascular sys-
tem and the respiratory system as well as the thermal-re-
ceptor effect on heart rate were bypassed during the
exercise simulation. These effects, known to exist under
abnormal conditions at rest, did not appear to be signifi-
cant during exercise in normal environments. The reason
for this apparent inconsistency during exercise and rest is
not known. The importance of these receptors should be
reevaluated if multiple stresses, such as exercise in hy-
poxic or hot environments, are to be considered.
D.2.3 Computer Program Architecture
Extensive planning for a software structure for the
Whole-Body Algorithm was required before it could be
implemented. Design considerations required a model ca-
pable of simulating long-term adaptive changes as well as
short-term acute experimental stresses. The approach taken
was to run the long-term model for the desired amount of
adaptation time and to initialize the short-term models
with its results. Then, the short-term models were executed
simultaneously and, on completion of the short-term ex-
periment, significant effects of the short-term stresses were
passed back to the long-term model to provide for further
simulation of the adaptive process.
This procedure furnished the structure whereby entire
spaceflights could be simulated using the Whole-Body
Algorithm. The total amount of computer core required
for the Whole-Body Algorithm was 29,200 decimal words.
To operate within the limits of a 20,000-word core size (in
the time-sharing mode), it was necessary to overlay the
program. In the overlay process, which is commonly used
in the programming of operating systems, parts of the pro-
gram are stored on mass storage devices (disks) until a
specified portion of the program (a segment) is required
during the execution. At that time, the segment is brought
into core and used until another segment of the program is
required. Using this technique, programs such as the WBA
may have a total size that is much larger than the available
core size. Communication between programs through com-
mon blocks enables the updating of variables that are
changed during execution.
The second advantage of this approach was that when-
ever the Whole-Body Algorithm completed a short-term ex-
periment, control was retuned to another segment brought
into core. If the short-term models were called again, the
programs were returned to core in their initialized state as
updated by the long-term simulation. Therefore, a new
short-term simulation could begin without memory of the
past simulation. Such an approach assured that all com-
puted variables were reset to their initial values without
the need for additional computer programming.
To obtain synchronous operation of the short-term
subsystems modes, an executive program was developed.
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Figure D-5. Schematic diagram of countercurrent heat exchange.
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The function of the executive program was to compare 
the value of time in the various subsystems and advance 
the time in the appropriate subsystem accordingly. The 
maximum difference in integration step sizes between the 
short-term subsystems occurred between the 
cardiovascular (0.002 second) and the thermoregulatory 
(3 second) models.   It was possible for one subsystem to 
advance by several integration steps before another 
subsystem was advanced by even one step. Additional 
software details are contained in Ref. 7. 
 
D.3 Validation Studies 
From the outset, it was apparent that to obtain the 
idealized data set required to completely evaluate and 
validate the Whole-Body Algorithm would not be 
possible. A literature search revealed that very few 
transient data were available for any of the stresses, and 
responses to graded levels of stresses were not available 
for many of the cases considered; exceptions were a few 
easily measured variables such as heart rate and 
ventilation rates. Experimental studies documented in the 
literature were almost always concerned with only one 
major physiological system and entirely neglected other 
important systems. For example, investigators who 
reported cardiovascular responses to graded levels of 
environmental temperatures failed to measure body 
temperatures or ventilation rates. In many cases, it was 
impossible to obtain confirming data, and validation was 
based on a single source. The task of validating the 
Whole-Body Algorithm was more difficult than the 
validation of many other physiological models because it 
contains more subsystems, more parameters, and more 
dependent variables than other physiological models.  
      All the short-term stresses chosen for simulation were 
similar to those already used to validate at least one of the 
short-term subsystem models operated alone. A summary 
of the short-term models and the corresponding stresses 
for which they were tested on a stand-alone basis is 
shown in Table 3-8. If validation had been restricted to 
testing subsystems of the Whole-Body Algorithm that 
had been tested previously on a stand-alone basis, data 
collection and validation would have been simpler, since 
portions of the necessary data were available and 
documented. However, all the models were not 
previously capable of responding to all the stresses. The 
formulation of the Whole-Body Algorithm has increased 
the capability of each of these models and provided a 
basis, through the interfacing links and simultaneous 
operation of all the models, for simulating additional 
stresses in an integrative manner. For example, the 
thermoregulatory model has been previously validated 
for a thermal stress at rest; however, the respiratory and 
cardiovascular subsystem models had no capability until 
now, to simulate thermal stresses.  Thus, it was necessary 
to attempt to locate a validation data set that included 
responses of these additional subsystems. Unfortunately, 
as previously discussed, physiological study of whole-
body integrated responses to stresses is not usually 
undertaken and many of the desired data were 
unavailable. Nevertheless, a wide variety of responses 
have been tested and the overall capability and potential 
of the Whole-Body Algorithm is evident from the results 
presented in Chapter 3. 
       In a model as versatile and complex as the Whole- 
Body Algorithm, it is possible to test an endless variety 
and combination of situations, stresses, and parameter 
changes. To limit these tests to a reasonable number and 
still demonstrate the validity of the model, several 
guidelines were imposed as follows.  
 
1. Only one stress at a time would be imposed on the 
model; multiple-stress validation simulations, such 
as exercise in a hot environment, would not be 
performed. 
2. A number of relevant short-term stresses would be 
used to validate all three subsystem models in the 
short-term section of the model. 
3. The long-term portion of the model would be 
validated with only a single stress. 
4. The emphasis on validation would be in the steady-
state domain, although the capability to simulate 
dynamic changes would be demonstrated. 
5. The model would be capable of performing 
experiments of short duration with the short-term 
subsystems and of passing changes representing new 
physiological steady state to the long-term 
subsystem, yet this capability would not be 
validated. Rather, an attempt was made to determine 
long-term fluid-electrolyte changes or other 
adaptation effects which resulted from thermal 
stress, hypoxia, etc. 
6. The reverse situation—automatically reinitializing 
the short-term subsystem models with changes 
resulting from a long-term stress—would be 
validated with a pre-and post-bedrest, exercise, and 
tilt stress following several simulated weeks of 
bedrest. This simulation would demonstrate the 
capability of the long-term subsystem to dynamically 
adapt through certain elements such as pressure-
receptor resetting, autoregulation of blood flows, and 
stress relaxation. 
7. During validation of the Whole-Body Algorithm no 
changes to the parameters of the model were 
permitted in order to create a better fit to the data 
beyond that already included in the stand-alone 
models prior to inclusion in the WBA.   
8. The data sets used for validating the individual 
models could be used to verify that the integrated 
model responds in a reasonable manner similar to the 
stand-alone model response.    
 
Table 3-9 is a summary of information related to the 
validation tests performed under these guidelines. The 
bedrest validation of the Whole-Body Algorithm is 
presented in Chapter 9.2 and will not be discussed further 
here. The following discussion is meant to supplement 
the simulations described in Chapter 3. 
 
D.3.1 Simulation of LBNP and Tilt 
D.3.1.1 Physiological Response to Tilt and LBNP. 
The physiological changes that occur when an individual 
assumes the erect position provide a hemodynamic stress 
on the entire circulatory system. The capability of the 
vasculature,the heart, and the nervous system to 
appropriately react to this stress formed the basis of the 
tilt-table test and the Lower Body Negative Pressure 
(LBNP) test. 
       Upon shifting from supine to erect position, 
changes occur in circulatory pressures and flows 
as well as in blood volume distribution. The 
arterial,  capillary, a nd  venous  pressures  
become markedly elevated in the dependent ex - 
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tremities to cause a net capillary filtration into the tissues.
This filtration can result in a loss of 5 to 10% of the supine
blood volume [8]. An additional 10% of blood volume is
shifted from the upper part of the body (mainly from the
thoracic cavity) to the legs, where it is pooled primarily in
the distensible venous segments [9]. Venous segments
below the heart tend to distend, whereas those above the
heart tend to collapse. In the absence of compensatory
mechanisms, the effective central venous pressure would
probably fall below that of the heart and result in insuffi-
cient cardiac pumping and orthostatic hypotension.
The defenses of the body against orthostatic hypoten-
sion consist of both passive and active elements [8,10,11].
Ultrafiltration into the tissues is minimized by increase of
tissue fluid pressure and lymphatic flow, reduction of the
pressure level in the veins by enhanced muscle pumping,
and transient venocontriction of the extremity venules.
Systemic arterial pressure is maintained, and even elevated,
by activation of intrathoracic and carotid blood pressure
receptors. The reduction in effective central blood vol-
ume caused by a shift of blood from the upper to the lower
part of the body is associated with a sustained increase in
sympathetic activity to the resistance vessels in muscles
and visceral organs and to the heart. This response main-
tains cardiac output and arterial blood pressure despite
reduced cardiac filling pressure. The increase in leg vas-
cular resistance also helps minimize venous pooling. Cen-
tral venous pressure must be maintained to promote
adequate right-ventricular filling.
The exact mechanisms controlling this adjustment
have not yet been explained, but it is believed that three
factors are important in preventing a debilitating fall in
central venous blood volume and pressure: (1) contrac-
tion of large venous channels and venous reservoirs such
as those in the visceral organs, (2) external compression of
veins by skeletal muscles in the legs, and (3) an external
pressure on the large abdominal veins exerted both by an
increased hydrostatic pressure on abdominal organs and
as an increase in abdominal muscular contraction. The net
effects induced by standing or tilting and by the influence
of the orthostatic defense mechanisms are a reduction in
central blood volume, a decreased cardiac output due to
reduced stroke volume (despite an increased heart rate),
and an increase in peripheral resistance, which acts to el-
evate the mean systemic blood pressure [12]. Orthostatic
hypotension develops when one or more of the compensa-
tory mechanisms are not adequate.
Lower body negative pressure tests, in which an in-
creased transmural pressure is created in the blood vessels
below the waist, can also cause a considerable degree of
venous pooling in the lower extremities, similar to that
found in tilt-table experiments [13]. Other hemodynamic
changes are also similar to the tilt response, such as de-
creases in cardiac output and stroke volume and increases
in heart rate. However, investigators believe that there are
certain fundamental differences between these two stresses
[14,15]. The most important difference is that a hydro-
static gradient exists in tilt but not in LBNP. The tilt ex-
periment causes a gravity gradient from the heart to the
extremities in every vascular segment, with varying
amounts of blood pooling. The quantity of pooled blood
depends on the length of the segment and its distance
from the heart. The effect of these two different kinds of
stresses on the cardiovascular system will be evident in
the following results. Lower body negative pressure has
been used in experimental studies as a means of creating
an effective “hemorrhage” in the central portions of the
vasculature [16] as well as of providing a hemodynamic
stress for crewmen in weightless spaceflight.
D.3.1.2 Simulation of LBNP/Tilt with the Whole-Body
Algorithm. The tilt experiment is simulated in the short-
term subsystem model by applying the gravity pressure
gradient terms to the vascular compartments. The overall
effect is a decrease in blood volume above the heart and
an increase in all segments below this region. In simulat-
ing LBNP, a negative pressure term applied externally to
the leg vessels increases the transmural pressure and re-
sults in a calculated increase in blood volume of the leg
compartments.
The cardiovascular subsystem model contains repre-
sentation of many of the elements previously discussed
that are involved in the physiological response to tilt and
LBNP. The model has elements that simulate the shift in
blood from upper to lower segments of the body, the barore-
ceptor reflex and the resulting sympathetic effects on heart
and vasculature, the muscle leg pump, venous valves, col-
lapsible and distensible veins, and stress relaxation. Ex-
travascular compartments are not represented in the
short-term model, and hence, transcapillary filtration and
lymph flow are not simulated. Such a limitation is not as
restrictive as it would first appear for the following rea-
sons. First, filtration into the tissues on standing is not
rapid; the process requires as long as 30 minutes to reach
a steady state [12]. Second, the baroreceptor reflexes are
fully developed within the first minute following postural
changes [10]. Third, most measurements of hemodynamic
variables during LBNP and tilt ae usually completed
within the first 5 minutes following the stress, well before
the major effect of ultrafiltration is felt.
Furthermore, although tilting may result in extravasa-
tion of plasma, there is not conclusive evidence that the
same is true during LBNP. Thus, the only real limitation
that exists in simulating tilt is that the model’s response
should be compared to experimental measurements taken
within several minutes after the stress is imposed.
Additional discussion of the physiology and simulation
of postural change is presented in Chapter 9.6. Simulations
of LBNP during spaceflight is discussed in Chapter 7.4.
D.3.2 Simulation of Respiratory Gas Disturbances:
Hypoxia and Hypercapnia
D.3.2.1 Physiological Response to Hypoxia. An ad-
equate supply of oxygen is essential to meet the varied
metabolic requirements of every body cell. Oxygen trans-
port from the inspired air to the individual cells involves
many processes and organs, each with its own regulatory
system. The essential components of the oxygen supply
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system are ventilatory gas exchange, cardiovascular sys-
tem function including cardiac pumping capability and
blood flow distribution, hemoglobin affinity for oxygen,
and hemoglobin concentration. All of these elements are
present in the Whole-Body Algorithm in varying degrees
of detail. In the normal subject, this complex system is
adjusted to maintain an adequate tissue oxygen tension
that meets the tissue requirements for the body as a whole.
In the stressed individual in whom either metabolic re-
quirements or oxygen supply are abnormal (as in exercise,
hypoxia, or anemia), the system readjusts its oxygen sup-
ply capability to maintain adequate oxygen supply to the
more critical organs such as the heart, the brain, and, in
the case of exercise, the muscles tissue [17].
The most common experimental method to induce
hypoxia consists of decreasing the oxygen content of the
inspired gas. Since oxygen transport to the body cells is
ultimately governed by diffusion, which is dependent on
the partial pressure gradient, the critical indicator of oxy-
gen level is its partial pressure (both in the inspired air
and in the blood) rather than the absolute concentration
(ml) O2 per ml blood). Breathing air with less than normal
oxygen will not cause noticeable effects either in pulmo-
nary ventilation or in overall cardiovascular function un-
til the inspired pO2 level falls significantly from its normal
value of 158 mmHg (corresponding to an inspired oxygen
concentration of 21%). Thus, mild acute hypoxia is not
considered a strong stimulus for physiological response
[18]. Acute inhalation of 8 to 10% oxygen results in mod-
erately severe hypoxia. Some of the more noticeable acute
physiological effects are a sharp increase in pulmonary
ventilation and a large rise in heart rate as well as in car-
diac output [19]. The small changes in blood pressure that
accompany this stress suggest that considerable vasodila-
tion has occurred [20]. Little quantitative information is
available for man regarding the redistribution of blood
that results in overall peripheral vasodilation. In general,
blood is believed to be shunted to tissues with high oxy-
gen extraction (heart, muscle, and brain) at the expense of
flow to tissue with low oxygen extraction (skin, viscera,
and kidney). Severe hypoxia results in a reflex bradycar-
dia and a significant and large vasoconstrictor effect. Be-
cause the WBA is not capable of simulating severe
hypoxia, these extreme effects are not discussed herein.
The body has developed a complex of regulating sys-
tems that are integrated both at the central nervous system
(CNS) level and at the local organ level. It is generally
accepted that the hypoxia-induced increase in ventilation
is a direct result of a decreased arterial pO2, causing in-
creased peripheral and central chemoreceptor activity [3].
Much less is known about the determinants of the accom-
panying cardiovascular changes. For many years, it was
believed that the chemoreceptors were mainly responsible
for stimulating most of the cardiovascular effects of hy-
poxia (or hypercapnia), but such a view is no longer ten-
able. The effects of chemoreceptors and other factors on
the heart, the resistance vessels, and the capacitance ves-
sels are shown in Fig. D-6 [2,19,21,24]. Figure D-7 is a
schematic view of the integration of these factors during
the hypoxic or hypercapnic stress. It is obvious that the
chemoreceptors provide only a part of the control neces-
sary to withstand a decrease in oxygen supply. The actual
degree and direction of cardiac and vasomotor behavior
depend on the degree of hypoxia, the particular vascular
bed, the animal species under investigation, and the rela-
tive influence of these competing local, autonomic, and
hormonal factors. It is experimentally difficult to separate
the various autonomic effects, and little quantitative in-
formation is available regarding the relative influence of
these determinants in man.
A complicating factor that must be considered is that
under the influence of low blood pO2, the respiratory
minute-volume output increases and, consequently, car-
bon dioxide is expired in greater than normal amounts.
Thus, hypoxia is usually associated with hypocapnia,
which is know to cause variation in central nervous activ-
ity, often in a direction that minimizes some of the cardio-
respiratory effects of hypoxia [22,25].
D.3.2.2 Physiological Response to Hypercapnia. Car-
bon dioxide is a substance that is normally inspired in
extremely small quantities (approximately 0.3 mmHg par-
tial pressure). However, because large quantities of CO2
are produced in the body by cell metabolism, the partial
pressures in the blood are relatively high (approximately
40 and 46 mmHg) in arterial and venous blood, respec-
tively). Blood carbon dioxide is one of several important
chemicals used by the body to indicate local and overall
rates of metabolism. These agents appear in various feed-
back pathways that adjust vascular resistance and blood
flow to supply sufficient oxygen to meet the demand and
to carry away toxic products of metabolism. During acute
hypercapnic stress, the resting individual is confronted
with an unfavorable environment for elimination of meta-
bolic carbon dioxide and must therefore increase minute
ventilation. The body responds to acute carbon dioxide
inhalation in many ways. For example, it responds as if
metabolism has suddenly increased, such as it would in
exercise or as if an accumulation of metabolites has oc-
curred by local occlusion of blood vessels. Besides the
ventilatory response, other changes observed are an in-
crease in blood pressure, heart rate, stroke volume, and
cardiac output with a decrease in overall vascular resis-
tance [26]. Except for the marked increase in blood pres-
sure, the overall response to hypercapnia is similar to those
previously described for hypoxia. Unlike oxygen, which
does not appear to cause significant whole-body responses
until its blood partial pressure has been reduced to about
40% of normal levels, the response to carbon dioxide is
more linear and dramatic changes can be observed when
blood pCO2 changes only slightly from normal physiologi-
cal values [3].
Although the ventilatory response to hypoxia and hy-
percapnia have been well studied and essentially under-
stood (primarily a chemoreceptor-activated response), few
studies of the cardiovascular effects of these disturbances,
particularly for carbon dioxide inhalation, have been re-
ported. Except for the brain (which is under local rather
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Figure D-6. Determinants of cardiovascular regulation during hypoxia and hypercapnia.
Figure D-7. Integrated cardiorespiratory regulation during hypoxia or hypercapnia.
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than autonomic control), little attention has been paid to
blood flow redistribution during hypercapnia.
It appears that the same mechanisms activated by
breathing oxygen-poor mixtures are also activated by in-
crease in carbon dioxide levels and act in very much the
same way, but here, also, little quantitative information is
available in man [22]. The scant attention paid to changes
in the cardiovascular system during hypercapnia repre-
sents a severe challenge to modeling. For example, al-
though peripheral blood flow resistance is known to
decrease during hypercapnia, the mechanism is not clear.
The few available studies in man have suggested that only
the brain and heart are known to vasodilate [26].
D.3.2.3 Simulation of Hypoxia and Hpercapnia with
the Whole-Body Algorithm. The respiratory model was
capable of simulating reasonable ventilatory responses to
hypoxia and hypercapnia before its incorporation into the
Whole-Body Algorithm. The controlling mechanism was
a chemoreceptor sensor responding to low levels of oxy-
gen and high levels of carbon dioxide. However, the car-
diovascular subsystem model was not capable of
responding to change in blood gas tensions, and addi-
tional modeling was required to account for this effect. In
attempting to cope with the lack of qualitative data re-
garding mechanisms controlling the cardiovascular sys-
tem and with few previous modeling guidelines to follow,
it was decided that only a gross approximation of the real
system was justified.
The first major assumption was that the feedback sys-
tems (Figs. D-6 and D-7) responding to low levels of oxy-
gen responded to increasing levels of carbon dioxide in
the same qualitative manner. For example, it was assumed
that both hypoxia and hypercapnia produce a local
vasodilating effect and a depressant effect on the heart.
Although all the evidence is not yet available to support
this assumption in its entirety, there is little evidence to
contradict it. The second major assumption was that, for
the purposes of this preliminary study, it would be pos-
sible to lump many of these effects into an effective
“chemoreceptor” feedback pathway. The sensor of this
pathway would have a graded response to increasing arte-
rial levels of carbon dioxide and decreasing levels of oxy-
gen. This response is similar to the response of the
ventilatory system chemoreceptors. The appropriate sen-
sitivities of these new chemoreceptors to each of the gases
would depend on available data regarding integrated ef-
fects in the intact animal. The actual level of oxygen and
carbon dioxide tension in the blood at any moment would
be obtained from the respiratory model that had previ-
ously been shown to provide good agreement with pub-
lished studies. In terms of the elements shown in Fig. D-6,
the cardiovascular “chemoreceptror” was used to repre-
sent a combination of local effects, chemoreceptor effects,
lung inflation reflex, and adrenal catecholamine effects.
The baroreceptor representation in the model was not
changed and could function independently of the
“chemoreceptor.” This configuration in the Whole-Body
Algorithm is summarized in Fig. D-2.
To appropriately simulate the data available for hy-
poxia and hypercapnia in normal resting man, it was nec-
essary to allow the chemoreceptors to affect heart rate,
cardiac contractility, muscle flow resistance, renal flow
resistance, and the resistance of flow through bone and fat
in a manner generally seen in experimental animals. Since
the sensitivities of the chemoreceptors to oxygen and to
carbon dioxide were not the same, these feedback path-
ways were not expected to respond identically for both
hypoxia and hypercapnia.
Brain blood flow was a variable already controlled by
the respiratory subsystem model, and no changes were neces-
sary in that section of the model. A chemoreceptor effect on
coronary and skin blood flow was not included, despite data
that demonstrated changes in these organs. Since their basal
flow was small compared to cardiac output, it was felt that
their effect on the overall system would be minimal.
Hypocapnia and hypoxia were simulated simply by
changing the values of the parameters representing inspired
air concentrations of oxygen, carbon dioxide and nitrogen.
D.3.3 Simulation of Thermal Stress
D.3.3.1 Physiological Responses to Thermal Stress
in Resting Man. If a resting man is exposed to a hot
environment for short periods, changes are observed not
only in the thermal regulating system but in other major
physiological systems as well, notably the circulatory and
ventilatory systems. Indeed, in a strict sense, all of these
subsystems act as a functional unit to reduce the thermal
stress on the body. Sweating, insensible heat loss from the
lungs, redistribution of blood flows (notably to the skin
tissues), and cardioacceleration all are manifestations of
thermoregulation and require a multiple system of regula-
tory loops [27,28].
The effects of heat exposure are first manifested by an
increase in skin temperature. As further heating takes
place, the temperatures in all deep tissue masses tend to
increase. In response, the body makes several adjustments
(Fig. D-8) that act to remove this excess heat load and
reduce its effects. These changes are discussed in the fol-
lowing paragraphs.
Blood flow through skin tissue increases as a result of
both local and centrally mediated effects. Increased skin
blood flow brings greater quantities of warm blood to the
body surface, where its thermal energy can be transferred
through the skin and, ultimately, by radiation and con-
duction to the environment. The normal skin blood flow
of 150 to 200 ml/min can increase to 3500 ml/min and
perhaps higher under maximum vasodilation [29]. The in-
crease in skin blood flow tends to increase skin tempera-
tures. If the environment is warmer than the body surface
(that is, if ambient temperature is greater than 32° to 34°C,
the body will gain heat by conduction and radiation; if
cooler, it loses heat. Radiation is usually the more impor-
tant route of heat exchange.
Because of the reduced or negative temperature gra-
dient between skin and surroundings, circulatory adjust-
ments alone are not adequate for dissipating heat by
radiation at ambient temperatures above 32° to 34°C. At
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these temperatures, sweating is initiated; evaporation of the
sweat removes heat from the body surface. Evaporative heat
loss by sweating is a particularly effective cooling mecha-
nism. Maximum sweating levels of nude resting man ap-
proach 400 ml/hr at ambient temperatures of 48°C. This
maximum sweating level represents 270 watts of cooling
power [30]. At these high temperatures, sweating and pul-
monary water loss becomes the only avenues of heat loss.
A humid environment and clothing decrease evaporation
of sweat and increase the heat load, whereas an increase in
free-air velocity on the skin decreases the heat load. The
major circulatory change appears to be a shift of blood
flow from central circulation to peripheral vasculature.
In resting man, renal, hepatic, and splanchnic flows
have been observed to decrease (by some as yet unknown
mechanism) when he is exposed to severe heat stresses,
whereas skin blood flow increases [31]. This readjustment
of arteriolar resistance elements results in a decreased pe-
ripheral resistance.
Heart rate has been observed to increase gradually
with increasing body temperatures; this increase probably
results from autonomic stimulation from the thermoregulat-
ing centers. This effect on the heart, together with the de-
crease in peripheral resistance, results in an increase in cardiac
output by as much as 80% [28,32]. No striking changes in
stroke volume (or blood pressure) have been seen, despite a
tendency for increased myocardial contractility [33].
The major response of the respiratory system to ther-
mal stress is an increase in minute volume. Whether this
effect is directly related to temperature is not know, but
the effect is gradual and mild until deep body tempera-
tures are increased from the normal value by more than 1°
to 1.5°C, where marked increases in minute volume have
been demonstrated [34]. The great effectiveness of the
overall thermoregulatory system is such that, during rest,
the core temperature is unlikely to rise more than 1°C even
when ambient temperatures are increased by 30°C [35].
D.3.3.2 Simulation of Thermal Stress with the Whole-
Body Algorithm. The thermoregulatory subsystem model
contained the major thermoregulatory elements, and it was
capable of accurate and detailed simulation of thermal
Figure D-8. Integrative physiological regulation of thermal stress at rest.
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stress in resting man even before it was integrated into the
Whole-Body Algorithm. For example, it contained ele-
ments for conduction, radiation, sweating, skin blood flow
regulation, shivering, and insensible pulmonary water loss.
However, except for skin blood flow, the cardiovascular
segments of the stand-alone model were only crudely de-
veloped and had no capability of simulating important
cardiovascular parameters such as blood pressure, periph-
eral resistance, heart rate, and stroke volume. It was felt
that the pulsatile cardiovascular model, when joined with
the thermoregulatory model, would contribute this infor-
mation as well as improve the cardiovascular portion of
the thermoregulatory subsystem. Conversely, the ther-
moregulatory model’s description of skin blood flow regu-
lation during heat stress was markedly superior to the same
formulation in the pulsatile cardiovascular model. As dis-
cussed previously, there are thermal effects on the cardio-
vascular system besides skin blood flow regulation. These
effects concern resistance changes in visceral organs and
thermal effects on heart rate. Compared to the available
data relating heart rate to deep body temperature
[30,32,34,36], little information was available concern-
ing blood flow redistribution in response to changes in
ambient temperatures. Consequently, only the former ef-
fect has been introduced in this version of the Whole-
Body Algorithm. These and other changes have been
described in detail earlier in this appendix. The effect of
temperature on ventilation has been omitted from the
model because this factor is not important for the ambient
temperatures of interest in the preset studies [34].
The simulation of an environmental thermal stress was
accomplished by changing values of the ambient dry-bulb
input parameter. Wall temperatures, affecting the radiant
elements of heat transfer, were also adjusted to be equal to
the dry-bulb temperature, and wet-bulb temperature was
set to correspond to a relative humidity of 35%.
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Appendix E
Sensitivity Analysis: A Simulation Technique with
Application to the Human Thermoregulatory System Model
Analysis of the effects of parameter variation on the out-
put (dependent) functions of a mathematical model can be
important in predicting errors that may occur when design-
ing technological control systems and in understanding the
importance of specific parameters in biological systems.
One of the simplest ways of understanding the response of
a model system to parameter variation is called sensitivity
analysis.
The conceptual basis of sensitivity analysis is straight-
forward. Small variations are made in the values of the
system parameters of a model, and the effects of these
changes are observed in the dependent variables during a
simulation procedure. Following this step, sensitivity func-
tions (described later) that describe the observed effects
are computed. Such functions contain a considerable
amount of information about the dynamic system under
investigation. The most important use of sensitivity analy-
sis is to determine the relative influence of different pa-
rameters on the system’s response. This information is
useful in assessing the validity of a model without the
need for extensive model-to-data comparison studies and
in guiding experimenters toward the investigation of the
most important parameters in a real system.
The literature of physiological systems contains few
examples that illustrate the formal application of sensitiv-
ity analysis, especially with regard to large-scale models [1,2].
The studies of ecological systems by Miller [3,4] provided
the framework for the present study. Several texts are de-
voted exclusively to sensitivity analysis [5,6], but their
sensitivity analysis is applied to nonbiological systems.
This appendix consists of a discussion of methods to
compute sensitivity functions and contains examples of the
manner in which these functions can be used to obtain
meaningful information about a complex mathematical
model of human thermoregulation. A more detailed study
is available [7].
E.1 Theoretical Background
E.1.1 Definition of Sensitivity
Consider a model with an output (dependent) func-
tion y, which depends also on a (normally fixed) param-
eter q. Let yo  be the reference (or normal) value of y obtained
when q = qo, and let ∆y represent the change in y that
results from a change in q to qo + ∆q. The incremental
sensitivity coefficient is defined as
        
∆S = ∆y
∆q (E1)
and the differential sensitivity coefficient is defined as
(E2)
when this limit exists.
The term sensitivity function is often used instead of
sensitivity coefficient to emphasize that S is not always
constant but is dependent both on time t and on the value
of q. In this appendix, S will be considered the mathemati-
cally rigorous definition of sensitivity, whereas ∆S will be
an approximation. Values for S (or ∆S) may be obtained
by several methods, both analytically and numerically, but
the primary interest here will be on a numerical approach.
E.1.2 Supplementary Behavior
The simulation of any model usually involves deter-
mining the supplementary motion that results from a para-
metric disturbance. Sensitivity analysis can provide a
convenient method for determining supplementary behav-
ior. Supplementary behavior is defined as the difference
between the varied behavior of the system y = y(t, q + ∆q)
and the fundamental behavior (or reference solution) of
the system yo = y(t, q). Thus,
∆y = y(t,q + ∆q) − yo (E3)
Eq. (E3) can be expanded by a Taylor series. By neglect-
ing higher order terms, it can be reduced to
     ∆y = S(t,q)∆q (E4)
In the general case for a system with m parameters, the
analogous form is
(E5)
This important relationship allows one to predict the
behavior of a system following a parametric variation us-
ing simple algebra and without the necessity of perform-
ing a simulation. However, knowledge of the sensitivity
function, or sensitivity functions, is required. In many
cases, this method of analyzing supplementary behavior
is often more convenient than a direct simulation of the
varied system.
∆y(∆qi
 
,...,
 
∆q
 
m
 
)
 
=  Σ Si
i=1
m
 
∆qi
S(t, q) =
∂y(t, q)
∂q
= lim
∆q→0
∆S
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E.1.3 Methods of Determining Sensitivity Functions
Assuming that the equations describing the dynamic
system are known and are easily differentiable, sensitivity
equations can be derived on the basis of the definition given
by Eq. (E2). In practice, the system equations and the sen-
sitivity equation are solved simultaneously on an analog
or a digital computer. The solution to the sensitivity equa-
tions consists of the sensitivity coefficients. The sensitiv-
ity equations are generally linear even if the original
system is nonlinear. For a system with n variables and m
parameters, there are n ×  m sensitivity coefficients that
may be obtained from a solution of the sensitivity equa-
tions. For large-scale systems, the derivation and the solu-
tion of the sensitivity equations become somewhat
impractical; more straightforward numerical methods can
be used to obtain the sensitivity functions.
In those cases where neither the analytic solution nor
the explicit formulation of the sensitivity equations is
readily obtainable, an empirical method is available. This
technique involves varying a single parameter by a small
increment about its normal value and performing a single
computer simulation. The sensitivity coefficient is obtained
by comparing the value of the output variable from this
run with its value during a run in which none of the pa-
rameters are perturbed from their reference positions. For
the general case having m parameters qi (where i = 1, . . . ,
j, . . . , m) and qj as the particular parameter of interest, the
incremental sensitivity function that describes the change
in y due to the variation ∆qj is given by
(E6)
If a parameter is perturbed by a small amount (for ex-
ample, 1%) and the sensitivity function is sufficiently smooth,
the value of ∆Sj determined from Eq. (E6) will be approxi-
mately equal to the true sensitivity coefficient defined by
Eq. (E2). This method requires that each sensitivity func-
tion Si (i = 1, . . . , m) be determined by a separate simula-
tion during which only a single parameter is perturbed.
E.1.4 Logarithmic Sensitivity Coefficients
An alternative approach to sensitivity analysis is one
that uses the function
       (E7)
where jS  is called the logarithmic sensitivity coefficient
(function). Note that jS  may be approximated by the ratio
of ∆y/y° to jj qq °∆ /  in the same way that Sj is approximated
by the ratio of ∆y to ∆qj. If jS  is known, then the percent
change in the output variable y is given by jS  multiplied
by the percent change in parameter qj.
Once the sensitivity functions are determined for each
parameter, it is possible to estimate the variation in y for any
combination of parametric changes. Let Ui be defined as the
fractional change of a parameter from its normal value
      (E8)
Equation (E5) can be rewritten using the definitions
given in Eqs. (E7) and (E8) as follows.
 (E9)
Solving this expression for y yields fewer parameter
disturbances.
     (E10)
This result allows the value of y to be computed easily
for any number of single- and multiple-parameter changes,
so long as these changes are small, in some sense. The
agreement between the values of a response variable y as
predicted by Eq. (E10) and those predicted by a complete
model system has been found to be surprisingly good even
when parameter values are changed by 100%, when highly
complex models are used, or when highly nonlinear mod-
els are used [7]. The deviation becomes more pronounced
as the operating point moves farther from the normal value
because Eq. (E5) does not include the higher order terms
of the Taylor expansion. These terms can become increas-
ingly significant for larger perturbations.
The sensitivity coefficient defined by Eq. (E1) or (E6)
depends on the total deviation of the parameter (∆q) from
some normal value and the time or time period for which
the sensitivity coefficient is computed. If the system is in
a steady state, the sensitivity coefficient no longer depends
on time. When the system under study is highly nonlinear
or when the value of a parameter may vary within broad
limits, sensitivity analysis can be difficult. When the dy-
namic system has many parameters (q1, q2, . . . , qm) with
values not known to a high degree of accuracy, the diffi-
culty will be compounded, since sensitivity functions may
depend on the particular values of all parameters. In the
general case, the sensitivity coefficient S(t, q1, q2, . . . , qm)
is a quantity associated with every point of parametric
∆Sj t, ∆qj( )= y t, qj + ∆qj( )− y t, q j( )∆q j
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space (i.e., every operating point) and changes with the
position of the point. Thus, it is essential to carefully de-
fine and specify the times and parameter limits that are of
primary interest.
E.2 The Performance Criterion
In many cases, when dealing with a model having many
dependent variables, it is desirable to define a single mea-
sure of overall system performance. Such a measure, which
can be called a performance criterion, could be extremely
useful in performing sensitivity analysis and parameter
estimation. Then, the effects of multiple-parameter varia-
tions can be related to changes in this single variable rather
than in a large number of dependent variables. However,
the definition of a performance criterion is not straight-
forward, since it depends on the purpose for which the
simulation is performed and on subjective judgments.
If Y is the performance criterion selected, then the
measure of deviance, as defined by Miller [3], is of the
form
D = f(Y – Y°)
where Y° is the normal value of Y. Note that Y itself may
depend on one or all of the system parameters. The mea-
sure of deviance D can be subjected to sensitivity analysis
in the same way as other system variables. The sensitivity
coefficients are obtained by forming the partial derivatives
Si = ∂D/∂qi, where qi (i = 1, . . . , m) are the m parameters of
the system. Approximate values of Si can be found by the
method of parameter variation previously described fol-
lowing Eq. (E6). Thus,
(E11)
Note that the value of D(qi) is zero by definition. The
number of sensitivity coefficients of a large-scale system
of n dependent variables and m parameters is reduced from
m ×  n to m when a single performance criterion is used as a
measure of overall system behavior since Si is computed
only for the variable D.
Although the choice of an overall performance crite-
rion of a model is somewhat arbitrary, experience has pro-
vided certain guidelines in its formulation. These are
discussed in the following paragraphs.
1. An overall performance criterion is a function of one
or more of the systems dependent variables. This func-
tion is usually (but not necessarily) one of the follow-
ing forms or a combination of them.
(E12a)
(E12b)
(E12c)
(E12d)
where Yj° is the value of the performance criterion in
the unperturbed case at some time tj, Yj is the corre-
sponding value of the performance criterion in the
simulation of interest, and ej = Yj – Yj°. The functions
of Eqs. (E12a) through (E12d) are similar to the error
criteria, or goodness of fit criteria, used in parameter
estimation. In parameter estimation analysis, the pa-
rameter values of a simulation model are adjusted un-
til model response agrees with the experimental data
according to a specified criterion function. In these cases,
the term Y – Y° is the difference between the model re-
sponse and the experimental response. Because of these
similarities, the techniques of sensitivity analysis can be
used advantageously in parameter estimation [7].
2. The choice of variables used in forming the perfor-
mance criterion should be related to the most impor-
tant variables of the system or to a combination of
variables that are representative of some index of over-
all behavior. This choice could, of course, change as
the objectives of the simulation study change. For ex-
ample, the Guyton model of circulatory regulation has
been extremely valuable in elucidating the mechanisms
that control long-term fluid volumes and blood pres-
sure changes. Although the Guyton model contains
more than 300 dependent variables, it is conceivable
that a meaningful performance criterion can be for-
mulated from only two variables, arterial blood pres-
sure and extracellular fluid volume, since all the other
variables are known to exert some influence on these
two. It would be possible and is sometimes desirable
to construct a performance criterion that gives more
weight to one variable than another and also gives dif-
ferent weights to the transient and steady-state re-
sponses. Miller [3] has shown that a number of
reasonable, but different, choices for the performance
criterion all produce very similar results in a particu-
lar example. He states, “generally a balanced measure
of all the output variables is more successful, and it is
unwise to use one single output variable as a ‘general
indication of model behavior.’”
3. The value of D should be zero when there is no perturba-
tion of parameters and should be positive otherwise.
4. The performance criterion chosen should correlate well
with other possible performance measures and with
intuitive estimates of model change.
5. The variables chosen to formulate D should be ca-
pable of easy and accurate measurement in the labora-
∆Si =
D qi + ∆qi( )− D qi( )
∆qi
=
D qi + ∆qi( )
∆qi
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tory, even though these experimental measurements
are not used in sensitivity analysis. The first reason
for this requirement is that the results can be more
easily interpreted and their validity judged if the be-
havior of these variables in the real system is known
for certain situations. The second reason is that sensi-
tivity analysis can be a very powerful tool for select-
ing those parameters for parameter estimation and this
latter technique does depend very heavily on experi-
mental measurements. The measure of deviance can
be used in the same form in sensitivity analysis as the
error criterion in parameter estimation analysis.
Although the discussion of performance criteria has
been with regard to a mathematical model’s behavior, these
functions are useful from a clinical medicine viewpoint as
well. For example, maximum oxygen uptake has long been
used as a measure of a cardiopulmonary function under
stress. It would be possible to use simulation models of
various subsystems to examine other variables or combi-
nations of variables as overall indices of subsystem be-
havior. The methods described in this appendix would
provide preliminary criteria. The most promising of these
could then be subjected to clinical trials.
In the next section, the usefulness of the performance
criterion in sensitivity analysis will be developed by ap-
plying these techniques to a complex human thermoregu-
latory model.
E.3 An Example of Sensitivity Analysis
In this section, some of the techniques of sensitivity analy-
sis will be applied to a complex model of the thermoregu-
latory system that has been described in Chapter 3 of this
document. For simplicity, the steady-state version of the
model will be used exclusively. This means that static sen-
sitivity coefficients will be determined and parametric sen-
sitivity during transient states will not be considered. The
following presentation is not meant to be a complete sen-
sitivity analysis but, rather, is suggestive of the type of
analysis that might be performed.
E.3.1 Computing Sensitivity Coefficients
A traditional analysis of parametric variation is illus-
trated in Fig. E-1, in which the effects of metabolic rate
RM (exercise) on certain important variables have been
plotted. Table E-1 contains definitions of the symbols used
in this model. Similar figures using other parameters for
the abscissa such as TCAB, TW, PCAB, and VCAB could
be prepared.
The sensitivity coefficients Si = ∂yi/∂RM (where y rep-
resents any variable) could be generated by computing
the slope of the curves shown. Since the slopes are some-
what steeper at the lowest values of RM, the sensitivity
coefficients are different at either end of the abscissa. For
this reason, sensitivity coefficients are usually related to a
perturbation from a specific operating point. Two operat-
ing points will be considered in this example, character-
ized by the input parameters shown in Table E-2. The first
Figure E-1. Effect of changing metabolic rate on selected ther-
moregulatory variables. (a) MUSCLE BF and SKIN BF; (b) THEAD
and TSKIN; and (c) QEVAP, QSTOR, QSENS, and QSHIV.
case represents a moderately relaxed, supine subject and
the other an exercising, standing subject, both in comfort-
able environments.
The sensitivity coefficients have been computed for a
selected variety of parameters and variables for each of
the two operating points. As shown in Table E-3, each
value has been computed by varying a single parameter,
listed on the left, by +10% away from the operating point
and determining the change in the particular variable
shown across the top of the table using computer simula-
tion of the model. The logarithmic sensitivity coefficients
were determined from Eq. (E7).
There is a large variation of values among the coeffi-
cients shown in Table E-3; the higher the value, the greater
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the effect of a given parameter on the designated variable.
The skin and head temperatures are relatively insensitive
to any environmental parameter, which is expected, since
negative feedback temperature regulation is an important
feature of the model. Similarly, exercising muscle blood
flow (case 2) is insensitive to all the parameters studied
except for metabolic rate, whereas, perhaps surprisingly,
the model predicts a generally higher sensitivity of the rest-
ing muscle flow (case 1) to all the input parameters. Other
differences in sensitivity between the two cases shown can
be easily noted from this table (especially the effects on
QSHIV, QEVAP, and QSTOR). This analysis enables one
to easily determine the sections of the model that are most
and least sensitive to a particular parameter. For example,
both free-air velocity (VCAB) and clothing resistance
(CLOV) are seen to have their greatest influence on shiv-
ering in the relaxed state and on sensible heat loss in the
exercising state. Also, it appears that many of the vari-
ables studied are more sensitive to wall temperature than
to air temperature. In general, it appears that RM, TCAB,
and TW exert a more profound influence on the model than
do TDEWC, VCAB, and CLOV. A determination of
whether these sensitivities are physiologically appropri-
ate is beyond the scope of this study. However, the rank-
ing of parameter importance as shown here provides a rapid
method, for someone familiar with the thermoregulatory
system, to evaluate certain characteristics of the model.
E.3.2 Use of the Performance Criterion
As mentioned previously in this appendix, it is desir-
able to formulate a single performance criterion which rep-
resents overall model behavior. In the case of the
thermoregulatory model, the variable QSTOR, represent-
ing the amount of heat stored in the body relative to the
reference state, appears to satisfy the requirements previ-
ously mentioned for a performance criterion. In the 41-
node model, QSTOR is defined as
(E13)
where Ti is the temperature of the ith body node, TSETi is
the reference set-point (corresponding to the temperature
in a neutral thermal environment), and Ci is the heat ca-
pacity (BTU per degree Fahrenheit) of the ith node. When
the subject is in a neutral environment, Ti = TSETi and
QSTOR = 0. Inasmuch as the individual body segment
temperatures are the net result of all the thermal forces
Table E-1. Thermoregulatory Model Glossary Terms
Symbol Definition
Mathematical notation
C Heat capacity
D Measure of deviance
DCOMPUTE Computed deviance
DPREDICT Predicted deviance
e Measure of error: difference between unperturbed and
perturbed model output or between model output and
corresponding experimental results
f Function
i,j Subscripts denoting iteration
m Number of parameters
N Number of variables
q System parameter
S Differential sensitivity coefficient
S Logarithmic sensitivity coefficient
T Temperature
t Time
U Fractional perturbation of a parameter
Y Performance criterion
y Dependent variable
∆ Change
∆S Incremental sensitivity coefficient
° Superscript denoting the unperturbed state of the model
Program notation
CLOV Clothing resistance
PCAB Barometric pressure
MUSCLE BF Muscle blood flow
QBASAL Basal metabolic rate
QEVAP Heat loss due to sweat evaporation
QSENS Sensible heat loss
QSHIV Heat generated due to shivering
QSTOR Heat stored in body relative to a reference state
RM Metabolic rate due to exercise
SKIN BF Skin blood flow
TCAB Ambient temperature
TDEWC Ambient dewpoint temperature
THEAD Head core temperature
TSET Set-point temperature
TSKIN Mean skin temperature
TW Ambient wall temperature
UEFF Efficiency of exercise
VCAB Free-air velocity
Table E-2. Input Parameters for Two Operating Points
Input parameter                 Value
Case 1*     Case 2**
RM, W (BTU/hr)   330      1165
QBASAL, W (BTU/hr)   283       283
UEFF, percent       0         13.5
TCAB, (°F)     68         75
TW, (°F)     68         75
TDEWC, (°F)     50         55
PCAB, (lb/in2)     14.7         14.7
CLOV, (clo)       0.35           0.5
*   Moderately relaxed
** Medium exercise
QSTOR = Σ  Ci
i=1
41
 
Ti − TSETi( )
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Table E-3. Sensitivity Coefficients From 10% Change in Parameter Values
Parameter           Sensitivity coefficient for—
QSTOR QEVAP QSENS QSHIV SKIN MUSCLE   THEAD   TSKIN
  BF       BF
Case 1*
RM   5.18   0.56   0.08 –6.77  0.10      0.37     0.00     0.02
TCAB   2.57   0.26 –1.16 –9.03  0.26    –3.15     0.00     0.05
TW   2.94   0.25 –1.23 –9.64  0.10    –3.36     0.00     0.05
TDEWC –0.03 –0.81 –0.00 –0.70  0.09    –0.29     0.00     0.00
VCAB   0.49   0.04   0.15   0.66  0.06      0.18     0.00   –0.01
CLOV   0.69 –0.07 –0.18 –1.56  0.10    –0.59     0.00     0.01
Case 2**
RM   0.62   1.51   0.11   0.00   1.35     1.28     0.01    0.01
TCAB   0.42   1.04 –1.62   0.00   1.04     0.01     0.01    0.04
TW   0.53   1.13 –1.77   0.00   1.11     0.01     0.01    0.04
TDEWC –0.06   0.00 –0.01   0.00   0.18     0.01     0.01    0.00
VCAB –0.03 –0.09   0.14   0.00 –0.03     0.01     0.00    0.00
CLOV   0.11   0.14 –0.21   0.00   0.21     0.01     0.02    0.01
*   Rest
** Exercise
acting on the body, QSTOR is a good indicator of overall
model performance. (A similar and related criterion might
be mean body temperature.) The variable QSTOR has al-
ready been used successfully to define the limits of ther-
mal comfort for manned spaceflight. The outside tolerance
limits have been set at QSTOR = ±300 BTU. (These limits
would be exceeded by slightly more than a 1°F) change in
mean body temperature, an indication that QSTOR is very
sensitive to changes in heat balance.)
The sensitivity coefficients for QSTOR relative to sev-
eral input parameters have already been presented in Table
E-3. As can be noted, QSTOR is many times more sensi-
tive to the parameters studied near the resting operating
point than in the exercising state. As a consequence, it can
be argued that the absolute values of the input parameters
should be known to a higher degree of accuracy during the
resting state as opposed to the exercising state to enable
achievement of the same degree of model accuracy.
The degree of linearity of QSTOR about the exercise
operating point has been tested, and the results are sum-
marized in Table E-4. The values in this table have been
obtained in exactly the same manner as those already de-
scribed in Table E-3, except that QSTOR is the only vari-
able studied and each parameter has been varied over a
±60% range from the operating point. The results suggest
that the sensitivities are extremely constant over a wide
range.
The parameters studied thus far have been input (en-
vironmental) parameters to the model; the values of input
parameters are usually known to a fairly high degree of
accuracy. However, the model contains many other param-
eters, called system parameters, that are properties of the
controlled or controlling systems and do not vary from
run to run, as do the input parameters. These parameters
represent various controller gains in the hypothalamic ther-
moregulatory centers of the model that control sweating,
shivering, vasodilation, and vasoconstriction. The values
of system parameters are not known with great certainty.
Examples of these parameters are skin/air-interface heat-trans-
fer coefficients, tissue thermal conductivities, basal blood flow
rates, and thermoregulatory control mechanisms.
The sensitivity coefficients of the seven thermoregu-
latory control parameters have been investigated with re-
spect to overall model performance as measured by QSTOR
to illustrate several points. (See Table E-5.)
E.3.3 Prediction of QSTOR From a Sensitivity
Model
It can be shown that the value of a particular variable
in a complex model can be predicted from simple alge-
braic equations that are functions of the sensitivity coeffi-
cients without the need to perform simulations of the entire
model on high-speed computers. Here, the attempt is to
predict values of QSTOR for a wide range of simultaneous
parameter variations.
Let D be a measure of deviance from some operating
point,
(E14)
D =
QSTOR −QSTOR°
QSTOR°
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Table E-4. Values of the Overall Performance Sensitivity Coefficient* for Single-Parameter Changes About the Nominal Operating
Point for Exercise**
QSTOR° = 97.2 W (332 BTU/hr)
Parameter          Sensitivity coefficient for percent change, of —
0.5 1 10 20 40 60
Increase
RM   0.626   0.627   0.619   0.738   0.696   0.668]***
TCAB   0.345   0.346   0.416   0.420]   0.276   0.169
TW   0.530   0.532   0.527   0.464]   0.291   0.242
TDEWC –0.055 –0.054 –0.058   0.063]   0.059   0.019
VCAB –0.028 –0.028 –0.026 –0.025 –0.024 –0.023]
CLOV   0.109   0.109   0.106   0.102   0.095   0.093]
UEFF –0.065 –0.065 –0.064 –0.064 –0.064 –0.064]
Decrease
RM   0.630   0.630   0.640   0.663   0.721  1.61]
TCAB   0.348   0.348   0.368   0.388]   0.450   0.653
TW   0.534   0.535   0.559   0.579]   0.632   0.744
TDEWC –0.051 –0.051 –0.047 –0.043 –0.036] –0.030
VCAB –0.026 –0.027 –0.028 –0.029 –0.032 –0.028]
CLOV   0.113   0.111   0.115   0.120   0.131   0.045]
UEFF –0.061 –0.063 –0.063 –0.063 –0.063 –0.063]
*    Equation (E15)
**  See Table E-2 for absolute values of parameters at operating point.
***See text for explanation of brackets
Table E-5. Sensitivity Coefficients for Thermoregulatory Control Parameters with Respect to Overall Performance
Each Parameter Varied Separately by 10%
System Parameter Normal value           Sensitivity coefficient
 Rest Exercise
CSW, W/ (BTU/hr–°F)        705 0.040   0.407
SSW, W/ (BTU/hr–°F)          63.9 0.091   0.068
CDIL, * (lbm/hr–°F)        143 0.115   0.174
SDIL, * (lbm/hr–°F)            9.2 0.025   0.019
CCON, (°F–1)            2.78 0.001   0.000
SCON, (°F–1)            2.78 0.000   0.000
PCHIL, (BTU/hr–°F)          25.7 2.1   0.000
*  Mass of blood
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The relative sensitivity coefficients Si in Table E-4
have been determined by varying one parameter at a time
(E15)
where qi is the value of any parameter, qi refers to the cor-
responding value at the operating point, and the symbol •=
means “is approximately equal.” Rewriting Eq. (E9) for n
parameters and substituting QSTOR for y results in a for-
mula for predicting D
(E16)
where Uj is defined by Eq. (E8). In this example, the con-
cern is with varying only those parameters listed in Table
E-4 and having those values for iS  listed in the ±1% col-
umns. Furthermore, the parameter values about the operat-
ing point for case 2 (Table E-2) will be restricted to a range
that has been shown to have reasonably constant sensitiv-
ity coefficients (see brackets in Table E-4). These ranges
are shown in absolute values in Table E-6.
A series of 24 runs was simulated with the thermoregu-
latory model. Each run consisted of changing all seven
parameters simultaneously. The actual parameter values
for a given run were obtained by choosing values randomly
within the limits given previously and assuming that all
values have the same probability of being chosen. For each
run, a value of D was computed (DCOMPUTE) from Eq. (E14)
using the simulated values of QSTOR and compared to
the value of DPREDICT determined from Eq. (E16). The val-
ues of iS  used in Eq. (E16) are shown in Table E-6, whereas
values for Ui were determined from the random perturba-
tions for each parameter. It should be emphasized that the
sensitivity coefficients in Eq. (E16) were obtained from simu-
lations performed by varying one parameter at a time by 1%
to predict values for D, whereas computed values for D result
from simulations in which all parameters are varied over a
much wider range simultaneously.
The results of this study are shown in Fig. E-2. The
dashed line represents perfect agreement between DPREDICT
and DCOMPUTE. The origin represents the operating point.
Although the agreement becomes very poor for negative
deviations from the operating point, it is encouraging to
see a reasonable correlation of all runs that can be described
by two straight lines intersecting the origin despite the
very wide range of random parameter variations. Thus, DPREDICT
allows a good estimate of D (and therefore QSTOR) between
the range of –0.2 < DPREDICT < +0.7. For example, assume that
it is desired to estimate the value of QSTOR for the follow-
ing conditions: RM = 1300 BTU/hr; TCAB = TW = 80° F;
and all other input parameters are identical to those given
in Table E-2, case 2. Then, Eq. (E16) can be represented by
only three terms which describe the perturbations of RM,
TCAB, and TW from the operating point, so that
This value can be used to estimate, from Fig. E-2,
DCOMPUTE = 0.125, which corresponds to QSTOR = 374 BTU.
The value actually obtained during simulation of this par-
ticular condition is QSTOR = 379 BTU. Values of D out-
side the range mentioned previously can also be predicted
once the correlation between DPREDICT and DCOMPUTE has been
established although the errors will be larger (Fig. E-2).
The deviation from the theoretical line in Fig. E-2 prob-
ably results from two errors: first, the assumption that sen-
sitivity is constant (especially for RM) over a range for
which it is not really constant (Table E-4) and, second,
the fact that higher order sensitivity coefficients were
neglected.
Table E-6. Values of Parameters and Sensitivity Coefficients Used for Predicting Changes in QSTOR
Parameter Value
  iS
Nominal   Min. Max.
RM, W (BTU/hr) 1165   330 2000  0.627
UEFF, percent     13.5       5     22 –0.0647
TCAB, (°F)     75     55     75  0.346
TW, (°F)     75     55     75  0.532
TDEWC, (°F)     55     45     65 –0.0536
VCAB, (ft/min)     30     10     50 –0.028
CLOV, (clo)       0.5       0.1       0.9  0.109
(E17)
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It would be possible to prepare a family of curves simi-
lar to those shown in Fig. E-2 for a series of important
operating points. Once this has been done, QSTOR could
be reasonably well predicted over a wide range in the man-
ner just illustrated. Other variables besides QSTOR could
be handled in the same way. Then, the relative values of
each term in Eq. (E16) would also provide a quantitative
measure of the importance of each parameter.
The usefulness of predicting model behavior with
simple algebraic equations rather than by direct simula-
tion of the original analog system (which involves solu-
tions of differential equations or computer based numerical
analysis) is, of course, obvious. Fundamentally, this pro-
cedure is not new, since it is based on linearization of a
system using a Taylor series expansion. However, the co-
efficients of the Taylor series in this case are the sensitiv-
ity functions, which have intrinsic meaning by themselves.
In addition, the results are expressed in terms of linear al-
gebraic equations rather than linear differential equations.
The technique illustrated in this example appears to be
applicable to most nonlinear, multivariable, multi-param-
eter models. However, the following disadvantages have
also become apparent: (1) all the sensitivity coefficients
must be computed in the desired time period, (2) the de-
gree of accuracy of the method around the operating point
should be established by some independent check, (3) in
highly nonlinear systems, higher order sensitivity functions
may have to be computed, or, alternatively, (4) a series of
first-order sensitivity functions may have to be computed
at closely spaced operating points. In addition, the equa-
tions for this procedure no longer describe a deterministic
system, even though the coefficients were generated from
one. There is a danger that persons not familiar with the
use of this method may extend it beyond its limitations.
Notwithstanding these restrictions, the method appears to
be powerful enough to be suitable for certain types of ap-
plication even with complex models, especially where
high-speed, large-core computers are not available.
Another important application of sensitivity analysis
is to investigate the interdependence of parameters. In Fig.
E-3, the metabolic rate and ambient temperature have been
varied simultaneously over a wide range and QSTOR con-
tour lines were drawn. The convergence of contour lines
toward the lower left shows that QSTOR becomes more
sensitive to simultaneous changes of TCAB and RM as
these parameters decrease in value. Also, there appears to
be a region of very high sensitivity near 550 BTU/hr and
80°F, a commonly encountered environment. Further sen-
sitivity analysis using these and other parameters would
be suitable for obtaining human tolerance limits and may
reveal minimum or maximum points of sensitivity. An
analysis of second-order sensitivity coefficients of the type
∂2y/∂(q1 • q2) would also help to reveal mutual interaction
effects between parameters.
These results have been illustrated for the steady-state
case. For models that are capable of predicting time-de-
pendent behavior, the quantitative relationships of sensi-
tivity coefficients are more complex than for the simpler
steady-state relationships. For example, in the computa-
tion of sensitivity coefficients for studying transient be-
havior, it is important to define the time limits of interest,
since sensitivity coefficients may be time-dependent.
E.4 Conclusions
Sensitivity analysis can be extremely useful early in the
model development process. Identification of the relative
importance of parameters can be made even in models that
are somewhat inaccurate [4]. A person familiar with the
subject matter of the model (but not necessarily familiar
with simulation techniques) can make a judgment con-
cerning the validity of the model, based on the reason-
ableness of the sensitivity relations. The possibility of
identifying the most important parameters of a system and
determining the accuracy needed in their measurement
(using error analysis techniques) means that one could
predict the effort required to produce a valid model before
massive resources were committed. It can also suggest the
relative priority in data collection because certain mea-
surements will be more critical than others for understand-
ing system behavior. One of the most important advantages
of sensitivity analysis during these early stages of devel-
opment is that it does not require extensive data collec-
tion to determine qualitative model validation.
Figure E-2. Overall measure of deviance of thermoregulatory
model due to variation of all input parameters simultaneously:
comparison of computed and predicted results.
       DPREDICT
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Once the model has been validated and its credibility
ascertained, the techniques of sensitivity analysis can be
used to perform advanced simulation studies such as noise
analysis, parameter estimation, stability analysis, and in-
verse sensitivity, all of which are derived from sensitivity
considerations. The examples discussed in this appendix
demonstrate the capability of using sensitivity coefficients
to form simple linear models of complex systems. The use
of these algebraic models for making rapid, first-order cal-
culations of system behavior should be explored further.
In addition, certain aspects of the system may have to be
modified more carefully by introducing new elements or
by using improved parameter values. A sensitivity analy-
sis performed on a validated model could provide the mo-
tivation, direction, and support for this effort. Finally, when
a model is used for making inferences regarding untested
situations, sensitivity analysis is useful for predicting un-
certainty in model behavior, based on measurement errors
in input data.
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Figure E-3. QSTOR contour lines for simultaneous changes in ambient temperature and metabolic rate.
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This Appendix provides a more detailed discussion of the
methods of computation and assumptions used to derive
the results, tables, and figures in Chapter 4, the Integrated
Metabolic Balance Analysis. Also included are descrip-
tions of error analyses and supplementary data as they per-
tain to the specific studies. The Appendix is divided into
subsections that generally correspond to the sections of
Chapter 4.
F.1 Skylab Water Balance Analysis
The discussion of the Skylab Water Balance Analysis in
Chapter 4.2 only presents and interprets the results of that
analysis. This part of Appendix F contains details of the
approach used in the analysis. Further details are also avail-
able [1,2].
F.1.1 Assumptions and Methods of Calculation
The daily change in total body water (i.e., daily water
balance), ∆TBW, is given by the algebraic sum of all liq-
uid quantities entering or excreted from the body accord-
ing to the following relationship [3]:
∆TBW
= water intake (food + drink) + metabolic H2O
- water excreted (urine + feces)
- evaporative water loss (skin + respiratory)     (1)
Water intake and water excreted were measured on a
daily basis during the Skylab missions and it was possible to
estimate metabolic water from the known units of fat, pro-
tein, and carbohydrate consumed. However, it was not pos-
sible to compute a daily water balance using only this
information since daily evaporative water loss, a signifi-
cantly large quantity, was not measured. An alternative
water balance equation can be derived which is indepen-
dent of both evaporative water loss and any liquid quantity
consumed or excreted by developing a complete gravimetric
(mass) balance. The daily change in body mass, ∆BWGT,
can be found by summing up the total masses (liquids and
solids) of all input (+) and (-) output quantities,
∆BWGT
= dry weight of food + water intake (food + drink)
- dry weight of excreta (urine + feces)
- water excreted (urine + feces)
- evaporative water loss (skin + respiratory)
- weight of metabolic CO2 + weight of
   metabolic O2 - dry skin loss (2)
Thus, combining Eq. (1) and (2),
∆TBW = ∆BWGT - dry weight of food
+ dry weight of excreta (urine + feces)
+ metabolic H2O + metabolic CO2
– metabolic O2 + dry skin loss (3)
The “dry skin loss” in these equations refer to sweat
solids, sebaceous residues, desquamated epithelium, as well
as nail and hair clippings. The metabolic H2O, CO2, and O2
refers to those insensible quantities produced or consumed
by metabolism of food stuffs as well as the catabolism of
body tissue (primarily body fat and protein).
All of the quantities on the right side of Eq. (3) were
measured directly except for the metabolic H2O, CO2, and
O2 and the dry skin loss. The metabolic quantities can be
estimated from the foodstuffs, while the dry skin loss can
be estimated from the infrequent total body water mea-
surements. The procedure used to compute these indirectly
measured quantities is given below.
The term net insensible metabolic losses (IML) is de-
fined as
IML
= metabolic H2O + metabolic CO2 - metabolic O2
= IML (foodstuff) + IML (body tissue) (4)
The insensible metabolic losses associated with food-
stuffs were determined indirectly from the daily amounts
of carbohydrate (CHO), fat (FAT), and protein (PRO) in the
ingested diet according to accepted stoichiometric rela-
tionships [3,4,5] for reduction of food to carbon dioxide,
water, and urinary nitrogen:
H2O(met) = EFF(0.555 CHO + 1.071 FAT + 0.413 PRO)          (5)
CO2 (met) = EFF(0.829 CHO + 1.427 FAT + 0.775 PRO)ρ(CO2)  (6)
O2 (met) = EFF(0.829 CHO + 2.019 FAT+ 0.967 PRO)ρ(O2)    (7)

The densities carbon dioxide and oxygen, ρ(CO2) and
ρ(O2), were taken as 1.977 and 1.429 g/1, respectively. EFF
is an efficiency factor to allow for incomplete digestion
across the gastrointestinal tract. A value of EFF was ob-
tained for each Skylab crewman based on a solids  (mass)
balance of food and feces according to the relationship:
 fooddry mission  Total
fecesdry mission   total- fooddry mission  Total
  EFF =
  (8)
An average value of EFF (±SD) of 0.962 ± .005 was
obtained; the individual crew values used in this study are
given in Table F-1.
Appendix F
Integrated Metabolic Balances: Details
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Substituting Eqs. (5) to (7) into Eq. (4) leads to the
following relationship
IML(foodstuff) =
EFF (1.009 CHO + 1.007 FAT + 0.563 PRO). (9)
Body protein (∆Protein Loss) and body fat (∆Fat Loss)
catabolism occurred during the course of the Skylab mis-
sion. It would be expected that these quantities would con-
tribute to the net insensible metabolic losses in a similar
manner as equivalent amounts of foodstuffs; i.e.,
IML (body tissue) =
1.007 (∆Fat Loss) + 0.563 (∆Protein Loss) (10)
It was not possible to estimate the metabolic losses
associated with body tissue metabolism on a daily basis.
However, this term was included numerically in the esti-
mate for dry skin loss, which was averaged over the entire
mission.
One of the purposes of this study was to obtain not
only estimates of daily water balance, but also to sum these
daily balances to compute the total body water changes
over large time intervals (up to several months). Errors in
the estimates of daily water balance would, therefore, be
cumulative over time. It has been estimated previously
that dry skin loss amount to at least 12-20 gm/day [6,7].
Exclusion of the difficult to measure insensible metabolic
losses that are a result of body tissue catabolism poten-
tially adds another 20 - 40 gm/day error in the water bal-
ance [8]. Summing these up, it can be seen from Eq. (3)
that failure to take skin and body tissue losses into ac-
count could underestimate daily water balance by at least
30 - 60 gm/day and produce errors at the end of a one-month
period of 1 - 2 liters in total body water calculations. Thus,
it was important to accurately estimate these quantities.
This was achieved by rewriting Eq. (3) using Eq. (4).
∆TBW = ∆BWGT
– dry weight of food
+ dry weight of excreta
+ IML(foodstuff) + IML(body tissue)
+ dry skin loss (11)
Define ∆TBW(balance) as the right side of Eq. (11)
excluding the last two terms, i.e.,
∆TBW = ∆TBW(balance) +
IML(body tissue) + dry skin loss (12)
In other words ∆TBW(balance) is the water balance
typically obtained from directly measured quantities ex-
cluding corrections for skin and body tissue losses. The
left side of Eq. (12) represents the true change in total
body water as measured, in the case of the Skylab crew, by
tritium dilution techniques before and after a period of
several weeks or months. Let this direct measurement of
total body water change be designated by TBW (direct),
and let the non-measured quantities be termed a correc-
tion factor, CF. Then
CF = IML(body tissue) + dry skin loss (13)
Use of Eq. (12) yields
)balance(TBW)direct(TBWCF ∆−∆= (14)
where
 
).foodstuff(IMLexcretaofweightdry
foodofweightdryBWGT
)balance(TBW
++
−∆=
∆
   (15)
The bar above the terms in Eqs. (14) and (15) represent
average daily quantities during the particular period be-
tween TBW measurements. During the Skylab experiments,
total body water measurements were obtained at the be-
ginning and end of each flight phase: preflight, inflight,
and postflight. (In the case of the 59-day mission, the mea-
surement at the start of inflight was not obtained). The
value ∆TBW(direct) was taken as the difference between
any two consecutive tritium dilution measurements, and
the value ∆TBW(balance) was computed from the uncor-
rected balance, Eq. (15), using the total quantities con-
sumed, excreted, or changed during this same time interval.
Thus, in the majority of cases, it was possible to com-
pute a separate correction factor for each flight phase for
each crewman. (Values for the terms in Eqs. (14) and (15)
can be found in Tables 4-6 and F-4). These values, ex-
pressed in gm/day, are shown in Table F-2. It can be ob-
served that the average CF value for preflight and inflight
phases were similar, indicating that the sum of skin and
tissue losses were similar during these phases. The low
Mission Man Pre-   In Post      Weighted
flight flight flight  Avg.**
28-day 1 0.967 0.966 0.968 0.967
2 0.954 0.966 0.947 0.957
3 0.961 0.965 0.972 0.965
59-day 1 0.967 0.965 0.982 0.968
2 0.958 0.960 0.953 0.958
3 0.959 0.959 0.967 0.960
84-day 1 0.950 0.955 0.948 0.953
2 0.960 0.969 0.973 0.968
3 0.963 0.961 0.959 0.961
Mean 0.960 0.963 0.963 0.962
SD ±.006 ±.004 ±.012 ±.005
* EFF = 1 - Fecal Solids
        Food Solids
**     The average values shown were weighted by the number of
observations in each phase of the flight for each mission.
Table F-1. Digestive Efficiency Factor of Skylab Crews, EFF*
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(and even negative) values for the postflight phase was
possibly a result of a normal dry skin loss that was masked
by a greater body tissue gain during the recovery period.
The final form of the water balance equation used in this
study can be written by combining Eqs. (9), (11), and (13):
∆TBW =
∆BWGT - dry weight of food + dry weight of feces
 + urine volume x(s.g. - 1.0) + EFF(1.009 CHO
 + 1. 007 FAT + 0. 563 PRO) + CF (16)
where “s.g.” is the specific gravity of urine obtained for each
sample and is given in Table F-3, and “urine volume x (s.g. -
1.0)” represents the dry urine weight. (See also Fig. 4-5 and
4-6 for a pictorial representation of Eqs. (16) and (18).
With the exception of s.g. and CF, each term in Eq.
(16) was measured daily and continuously over the entire
preflight, inflight, and postflight periods. The average val-
ues of these terms for each crewman are shown in Table
F-4.
The change in total body water during a period of N
consecutive days, ∆TBW(N) can be determined by algebra-
ically summing (i.e., integrating) the daily water balance
of each successive day, ∆TBWi, over the interval. Thus,
∑
=
∆=∆
N
i
iTBWNTBW
1
)(
(17)
In the water balance study ∆TBW(N) was computed
for each day of the mission starting from either the day of
launch or the day of recovery and summing backward and
forward in time from these reference points. Thus, ∆TBW(N)
had a value identically zero at the morning of launch or
the morning of recovery. Mean values of ∆TBW(N) were
used in this report by averaging the values for the three
crewmembers on each flight (n = 3) or by pooling two (n =
6) or three (n = 9) flights. The method of obtaining vari-
ances of ∆TBW(N) is presented at the end of this Chapter.
The effect that the correction factor has on estimating
∆TBW(N) is illustrated in Fig. F-1.
Evaporative water loss is a critical quantity in the
whole-body water balance. Evaporative water losses (EWL)
were estimated on a daily basis by rearranging the water
balance Eq. (1),
EWL =
= water intake(food + drink)
+ metabolic H2O
- water excreted(urine + fecal) - ∆TBW (18)
where ∆TBW is the quantity obtained from Eq. (16). (An-
other formulation for EWL is provided in Appendix F.2).
Average evaporative water loss for the entire Skylab
crew is illustrated in Fig. F-2 for a 2 week period before
and after launch and recovery. The changes in EWL during
the mission are too small to easily discern in Fig. F-2 but
can be noted in Table F-5.
Water balance graphs were prepared (see Chapter 4,
Figs. 4-9 and 4-10) using the following definitions for in-
take and output:
Total water intake =
= water(drink) + water(food) + metabolic H2O,   (19)
Total water output =
= urine volume + fecal water +
+ evaporative water loss (20)
Equations (19) and (20) form the basis of a partitional
water balance that is provided in Table F-5.  This table
presents data for each of the 3 Skylab missions and serves
as backup for Table 4-26 which is accompanied by a brief
interpretation.  The changes in body water cannot only be
Table F-2. Water Balance Correction Factor, CF [gm/day]
Mission Man Preflight     Inflight    Postflight
28-day 1  41.7  56.3    69.6
2 100.0 126.5    32.1
3   89.2  65.9   -11.2
59-day 1  66.6  66.6 -116.1
2  97.7  97.7   -49.0
3  63.6  63.6    14.7
84-day 1  24.9  26.0    74.1
2  54.4  42.9     -7.8
3  95.6  12.9   -27.9
     Mean  70.2  61.8      3.6
∗ Value shown are the everages of daily urine samples obtained
during the designated period.
Mission Man Preflight Inflight Postflight
28-day 1   1.019   1.020   1.017
2   1.028   1.027   1.020
3   1.009   1.013   1.009
59-day 1   1.016   1.021   1.016
2   1.021   1.021   1.019
3   1.023   1.025   1.022
84-day 1   1.016   1.021   1.014
2   1.020   1.021   1.017
3   1.028   1.031   1.015
     Mean   1.020   1.022   1.017
SD ±0.006 ±0.005 ±0.004
Table F-3. Urinary Specific Gravity (s.g.)*
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Figure F-1. Comparison of total body water for the Skylab crew on 59-day mission (N = 3) computed with and without correction
factors (CF) in the daily water balance. (Values are shown as changes from morning of launch; (—— ) with correction factor and (- - -)
without correction factor.
partitioned into rates of input and output but into fluid
compartments of the body.  Table F-6 presents the changes
in the intracellular, extracellular and plasma compartments
over the duration of each Skylab mission.  The combina-
tion of data in Tables F-5 and F-6 provides the first com-
plete gross assessment of fluid status in weightlessness.
The metabolic balance analysis accounts for changes in
total dry body tissue (∆TIS), protein (∆PRO) and fat (∆FAT)
computed from the following assumed relationships:
∆BWGT = ∆TBW + ∆TIS
         = ∆TBW + ∆PRO + ∆FAT (21)
Thus, changes in total tissue weight can be found by
subtracting ∆TBW from ∆BWGT. Daily changes in total
body protein were determined from the nitrogen balance:
∆PRO = 6.25 (N (diet)- N (urine) - N (feces) ) (22)
Daily changes in body fat were computed from Eq.
(21) as:
∆FAT = ∆BWGT - ∆TBW - ∆PRO = ∆TIS - ∆PRO   (23)
Total body changes in these quantities over any inter-
val of N days can be found by summing up (integrating)
the daily balances analogously to Eq. (17) for total body
water changes:
Change in Total Body Tissue = ∆TIS(N) = ∑∆
N
i
iTIS (24)
Change in Total Body Protein = ∆PRO(N) = ∑∆
N
i
iPRO   (25)
Change in Total Body Fat = ∆FAT (N) = ∑∆
N
i
iFAT (26)
where N is the number of days of interest, usually a com-
plete mission phase.
F.1.2 Water Balance Error Analysis
The use of an average constant value for CF in the
daily water balance rests on the assumption that day-to-day
skin and body tissue losses are similar (see Eq. (13)), and
implies a linear rate of tissue change.  Information indicat-
ing the variability of skin losses either on Earth or in space
is unavailable. The assumption of a linear rate of fat loss
was confirmed in the water balance study and body fat loss
was believed to make the largest contribution to the cor-
rection factor in that study. Rates of protein losses or gains
were also found to be nearly linear during the preflight
and postflight periods. Protein loss inflight appeared to
occur linearly over the first month before approaching a
steady state. Thus, the assumption of linearity of the CF is
reasonably correct for the entire preflight, inflight, and post-
flight periods except for the later portions of the inflight
phase. Thus, this assumption should not introduce signifi-
cant error into daily water and cumulative balances.
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The use of the correction factor insures that changes in
total body water over each flight phase, as obtained from the
corrected water balance, will be in absolute agreement with
directly measured total body water. Estimates of the CF, there-
fore, were highly dependent on the accuracy of the direct
tritium dilution method. These estimates have been shown
to be realistic when compared to independent data of skin
losses and body tissue losses. The use of direct total body
measurements in conjunction with the balance method has
been previously recommended as a technique to correct
metabolic whole-body balances for otherwise unaccount-
able losses and to minimize accumulative error [9].
Random experimental error for this method includes
sampling and instrumental errors associated with measur-
ing the terms in Eq. (16); that is, body weight, dry food, urine
volume and s.g., dry fecal mass and carbohydrate, fat and
protein. Random errors associated with instrumentation were
previously estimated to be less than ±65 g/day [2].
Since the quantities defined in Eqs. (17), (24), (25),
and (26) are sums of other random variables and if these
random variables can be assumed to be independent, then
errors (variances) associated with the summed quantities
can be expressed as:
  i
N
i
MMN XX )()(
22 ∆σ=σ ∑ (27)
where
   
)(2 XMNσ
represents the variance of the change in X (i.e., X = total
body water, tissue, protein or fat) for the average of M
subjects at the end of N days;
iM X)(
2 ∆σ
is the variance on the ith day of the average balance of X
for M subjects. In this fashion, the errors are observed to be
accumulative, starting from the reference day (i = 1, launch
or recovery day). The cumulative error represented by Eq.
(27) is probably an over-estimation of true error, since most
of the variance in the balance on any particular day was
due to random error. If the correction factor, CF, were de-
leted, it might be appropriate to use the above accumula-
tive error in the calculation, since the daily water balance
would always be underestimated by this quantity. For these
reasons, both accumulative and non-accumulative errors
were computed in this study. Accumulative errors were
used in the 14-day analysis while non-accumulative errors
have been plotted for the extended period (30-day and
entire mission) analysis. The non-accumulative variances
for M subjects on the Nth day were computed in the fol-
lowing fashion:
[ ]∑
−
∆−∆
=σ
N
i
2
i2
MN 1M
XX
)X( (28)
where ∆Xi is the water, tissue, fat, or protein balance for the
ith crewmember on the Nth day and X∆  is the average
Figure F-2. Average evaporative water loss for the Skylab crew
(N=9) at launch (a) and recovery (b).
n
SD
X
balance of M crewmen on the Nth day. Further details of
the error analysis can be found in the literature [2].
Equation (28) is derived from the traditional formula-
tion for standard deviation and standard error that is used
throughout this book, specifically,
Standard deviation (SD) = 
[ ]∑
−
−
n
i
2
i
1n
XX
Standard error (SE) =
where n is the number of samples, i is the iteration, Xi is the
value of interest, and     is the mean value.
F.2 Skylab Evaporative Water Loss
Analysis
The next part of this Appendix presents details of the Skylab
Evaporative Water Loss Analysis not found in Chapter 4.
Further details are available in the literature [10,11].
F.2.1 Assumptions, and Methods of Calculation
Two standard balance equations were combined to esti-
mate evaporative water loss, EWL, from the input and output
of fluids and solids for each crewman [3,12,13]. The first was
the water balance equation, Eq. (1), and the second was the
mass balance equation, Eq. (2). Solving Eq. (2) for EWL:
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EWL = dry weight of food
+ total water ingested from food and liquids
– (urine volume x urine s.g.) – wet weight of feces
– weight of CO2 expired
+ weight of O2 used - gain in body weight (29)
Note that the term “dry skin loss”, used in the previ-
ous section, Appendix F.1, were neglected in this balance
equation (primarily losses of sweat solids) and that this
omission can be a source of systematic error. Because the
differences in evaporative loss between flight phases were
rather small, it was important to estimate the magnitude of
these errors and locate their origins if possible. EWL esti-
mated by these balance methods included insensible wa-
ter losses from the respiratory tract and dermis, as well as
sensible sweat losses. Metabolic water, CO2, and O2 were
determined indirectly from the daily measured amounts of
protein, fat, and carbohydrate in the ingested diet accord-
ing to the relationships shown in Eqs. (5) to (7). Individual
urinary specific gravity values were used in the computa-
tions (see Table F-3). Average measured and derived val-
ues for the terms in these balances are presented for each
mission in Table F-7.
The evaporative water loss results presented in this
study were obtained using the mass balance equation, Eq.
(29). All terms in that relationship were measured either
directly or indirectly on a continuous daily basis. Since
total body water (TBW) was measured only several times
for each subject, EWL as computed from the water balance
equation (Eq. (1) or (18)), represented an average value for
the period between the TBW measurements. A compari-
son between these two formulations (water balance and
mass balance) served as a check on the accuracy of the
experimental procedures (see Table 4-6). Other factors such
as blood draws and sweat solids were estimated to be only
12-20 gm/day, a relatively insignificant amount relative
to daily EWL [6,7]. Therefore, these factors were not con-
sidered in the analysis.
 For the first few days of each flight, the crews experi-
enced motion sickness, anorexia, temperature stresses, and
*All liquid quantities are expressed in ml/day, all other quantities are in gm/day
**Data from the first 5 mission days were not included in determining these values
Table F-7. Measured and Derived Metabolic Data for Preflight and Inflight Phases; Average Daily Values for Each
Mission
     28-Day Mission        59-Day Mission      84-Day Mission      Skylab Mean ± SE
No. of days observed Pre 30 20 26
Inf. 23 54 79
Total water IngestedPre 2941 2678 3293 2971 ± 208
Inf. 2911 2670 2953 2845 ± 212
Food (Dry) Pre 594.9 641.5 611.0 615.8 ± 27.2
Inf. 598.5 686.4 638.2 641.0 ± 28.1
Urine Pre 1610 1333 1660 1535 ± 172
Inf. 1824 1386 1681 1630 ± 158
Fecal Water Pre 78.4 90.0 77.2 81.8 ± 10.9
Inf. 69.5 78.7 60.9 69.7 ± 6.9
Fecal Solids Pre 23.5 25.2 26.0 24.9 ± 1.8
Inf. 21.0 26.6 24.3 24.0 ± 1.7
Change in Body Weight Pre -44.5 16.7 0.0 -9.3 ± 14.5
Inf. -55.1 -25.9 3.8 -25.7 ± 12.5
Diet Protein Pre 107.4 123.4 120.0 116.9 ± 6.5
Inf. 102.3 117.9 120.0 113.4 ± 6.6
Diet Fat Pre 105.0 113.3 110.5 109.6 ± 3.3
Inf. 79.1 75.3 101.1 85.2 ± 4.5
Diet Carbohydrate Pre 355.1 378.8 356.4 363.4 ± 17.5
Inf. 394.4 468.3 393.5 418.7 ± 22.1
Metabolic Water Pre 352 381 363 365 ± 15
346 391 375 371 ± 15
Insensible Gas Loss Pre 164.4 176.7 166.6 169.2 ± 8.3
(CO2 – O2) Inf. 182.2 217.0 183.3 194.1 ± 10.4
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activities not typical of the remainder of the mission. Ma-
jor readjustments in fluid and electrolytes also occurred
during this period, and atypical, but appropriate changes
in EWL were demonstrated. The atypical first five days of
the inflight phase were omitted in the analysis. The ex-
perimental design provided that each subject serves as his
own control; his inflight data were compared to data from
his preflight control phase. Statistical analysis of the data
included the paired t-test, correlation analysis, and analy-
sis of variance with consideration for the unbalanced num-
ber of daily observations in each flight phase [14,15].
F.2.2 Error Analysis
Evaporative water loss is an indirect measurement and
is subject to the random errors or variation in the directly
measured components of the material balance equation.
These random errors were mainly the result of two sources
of variation: a) variation between daily observations and
between subjects due primarily to biological variability
and environmental disturbances; and b) variation due to
limited instrument resolution.
Table F-8 lists the sampling errors (SXi = instrument
error + biological variability) and the instrument errors
(Ei) for each term in the mass balance equation. Sampling
errors were taken as the standard errors of the mean of each
quantity for nine men during the inflight phase. Instru-
ment errors were obtained by estimating the precision of
each instrument from preflight and inflight studies [9,16].
The percent contribution of the errors associated with each
term toward the total variance of sampling errors and in-
strument errors are also shown in Table F-8. (The data for
the quantity iX  in Table F-8 are the mean values for only
six of the crewmen corresponding to the subjects presented
in Chapter 4, Table 4-6).
Since evaporative loss is given by a linear sum of terms
(see Table F-8, Equation (a)) an estimate of the standard
error in evaporative loss can be found by summing the
square of the errors for each term as shown in Table F-8,
Table F-8. Propagation of Error Analysis of Mass Balance Equation in Determining Evaporative Water Loss*
   Total Error 
 
Instrument Error 
I Quantity Inflight 
 Mean  
iX  
Standard 
Error 
iX
S  
Total Error 
Contribution 
10022 ×
XX
S/S
i
 
Instrument 
Error 
iE  
Instrument Error 
Contribution 
22 E/Ei  
 
1 Food (wet) 1063 + 50  4.2% ± 3 0.2% 
 
2 Water (drink) 2389 ± 190 60.6% ± 10 2.3% 
 
3 Urine x s.g. 1612 ± 140  34.7% ± 10 2.3% 
 
4 Feces (wet) 92 ± 8  0.1% ± 3 0.2% 
 
5 (CO2 – 02) 192 ± 9  0.1% ± 10 2.3% 
 
6 ∆Daily Body Wgt -53 ± 13  0.3% ± 64 92.7% 
 
  
                                   EWL = 1609  xS = ± 244 
 
100.0% 
 
E = ±66 
 
100.0% 
 
 
654321)( XXXXXXX EWL −−−−+= (Mass Balance Equation) (a)
2
XS (EWL) = ∑
=
6
1
2
i
Xi
S (Propagation of Sampling Errors) (b)
E2(EWL) = ∑
=
6
1
2
i
iE (Propagation of Instrument Errors) (c)
*Means and standard errors shown are pooled values for all inflight observations on all nine subjects; unless otherwise noted units are in grams
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Equations (b) and (c). This is only true, if the errors in each
term are statistically independent of one another (i.e., if
the correlation coefficients are zero).
While the assumption of error independence is rea-
sonable in computing total instrument error, this is not the
case for total sampling error. For example, it is possible
that the variation of water intake is highly correlated with
the variation in urine output. For the case where high cor-
relations exist, a more accurate estimate of Sx(EWL) can be
determined by taking into account the covariances, Sij. The
difference between the value of SX(EWL) in Table F-8 and
the corresponding value in Chapter 4, Table 4-6 (244 vs.
89) may arise from the fact that in the former case the
covariances were neglected. A more complete estimate of
the propagation of errors in which the covariance terms
were computed can be found in Ref. [10]. Nevertheless,
the simplified analysis of errors presented in Table F-8 is
very informative by demonstrating that the errors in com-
puting evaporative water loss are almost entirely due to
the total variation associated with measuring water intake
and urine. One would expect a large correlation and cova-
riance between water intake and urine since water intake
physiologically drives urine excretion.
Random sampling errors can usually be reduced by
increasing the number of samples. The large effect of water
and urine variability and the high correlation between
these quantities allow the precision of the evaporative loss
estimates to be improved by measuring water intake with
greater accuracy or, even better, by controlling water in-
take within smaller limits.
Total instrument error is due primarily to the body
mass measuring device as shown in Table F-8. Also, it ap-
pears from this table that most of the error in the measure-
ment of body weight is due to instrument error. Therefore,
the instrument and overall sampling error of the body mass
measurement can be reduced by improving the precision
of this instrument rather than by increasing the sample
size. However, this would not reduce the total error of the
estimate of evaporative water loss, since the total instru-
ment error was only a small component of the total sam-
pling error and the average total error of the weight change
measurements constituted only a small fraction of the fi-
nal value of evaporative loss and its total error. The instru-
ment error analysis also illustrates that the limiting
resolution of the mass balance technique in measuring
evaporative water loss on Skylab (in the absence of sig-
nificant biological fluctuations) is about ±70 gms, which
represents approximately a 4% error.
Systematic errors in the present technique are associ-
ated with the neglect of less significant terms in the mate-
rial balance equation. In particular, failure to account for
sweat solids, sebaceous residues, and desquamated epi-
thelium would systematically cause the calculated evapo-
rative loss to be overestimated by about 12-22 gm./day
[6,7]. This was a negligible fraction of the total evapora-
tive loss, but could account for about 50% of the discrep-
ancy found between the mass balance and water balance
techniques (see Table 4-6). The water balance method does
not require accounting for these solid residues. However,
uncertainties in other measured quantities may also ac-
count for this disagreement. Thus, it is not likely that seri-
ous systematic errors were present in the estimation of
evaporative loss in the present study.
F.2.3 Supplementary Metabolic Balance Data
Tables F-9 and F-10 present the measured and derived
data respectfully for each Skylab crew member that were
used in the balance equations to obtain the presented cal-
culations for evaporative water loss shown in Table 4-5.
This is also the detailed backup data used to compute the
mean mission values listed in Table F-7.
F.3 Skylab Sodium and Potassium
Balance
The following section provides a more extensive discus-
sion of the Skylab sodium and potassium balance analysis
than that presented in Chapter 4. Further details of this
analysis are available [17].
F.3.1 Assumptions and Methods of Calculations
Metabolic balances were performed for sodium and
potassium using the following basic equations:
Daily electrolyte balance = Dietary intake
– Urine exretion – Fecal excretion - CF (30)
Cumulative electrolyte balance over N days
= Change in total body electrolyte
= ∑
=
N
ai
Daily electrolyte balance (31)
where CF is a correction factor for sweat losses, unac-
counted losses, and error terms; “a” is the day the balance
begins (the first day of the mission phase); and “N” the day
the balance ends (last day of the mission phase). These
equations were added to the computer program that was
used to compute the Skylab water balances. The output of
the program allowed the visual display of the daily bal-
ance, the integrated or total balance, and the contribution
of each term in the balance toward producing short-term
and long-term changes in the balance. In the balance equa-
tions shown, the sweat losses, unaccounted losses, and er-
ror terms were combined since sweat losses were not
measured during the Skylab program.
In order to obtain reasonable estimates of the time
course and magnitudes of the daily balance and the changes
in total body potassium and sodium, the balances were
computed using correction factors based on matching the
measured changes in the total body pools of sodium and
potassium with the cumulative balances as computed from
Eq. (31). For sodium, this correction factor was based on
the product (plasma sodium concentration) x (extracellu-
lar f1uid volumes). For potassium, whole-body values were
measured directly.
The balance programs were run for a number of cases
for both sodium and potassium. For each case, balances
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were obtained for the nine Skylab crewmen separately and
in several combinations. Individual balances were run for
a complete mission, while the average balances for groups
of crewmen were run for a maximum of 28 consecutive
days. The integrated balances were computed using the
launch day as the day of reference. This allows a complete
picture for preflight through the first 28 days for any indi-
vidual crewman, mission, or combination of missions to
be obtained. In addition, balances were performed for the
14-day recovery phase for each astronaut.
Average balances were computed for five mission com-
binations: each of the three missions separately, for all
three missions combined, and for the 59-day and 84-day
missions combined. Balances were computed for four in-
tervals for each of these five mission combinations. The
four intervals included:
a) from 13 days before launch to mission day 14
b) from the day of launch to mission day 28
c) from 13 days before recovery to recovery day 14
d) from 28 days before recovery to the day of recovery.
These balances, when presented graphically, provide
a complete picture of the sodium and potassium balances
from 13 days before launch through 28 mission days fol-
lowed by 14 days of recovery. This interval corresponds to
all Skylab days for which data exists for all nine crewmen.
The correction factor, CF, in Eq. (30) was calculated
as follows:
( )
i
i
ii N
TBX
BalCF
∆
−=  (32)
where iBal  is the uncorrected average balance (i.e., diet -
urine - fecal) for mission phase i (i = preflight, inflight, or
postflight); ∆TBXi represents the directly measured total
body loss of electrolyte X (sodium or potassium) in phase
i; and Ni represents the number of days in phase i. While
∆TBX was measured directly for potassium, ∆TBX was not
measured for sodium. Therefore, in order to calculate ∆TBX
for sodium, the following assumptions were made:
a) Subjects were in steady-state preflight,
b) All changes in total body sodium and potassium come
from the exchangeable pools,
c) The exchangeable sodium pools can be represented as
the extracellular fluid volume (ECF) multiplied by the
plasma concentration of sodium [Na+] plasma,
  Days Metabolic Water 
ml/d 
Insensible Gas Loss 
(C02 – 02), gm/d 
Change in Body 
Weight, gm/d 
 
Mission Crewman Pre In Pre In Pre In Pre In 
 
28-Day 1 30 23 330 339 148.1 174.8 -30.0 -17.4 
 
 2 30 23 364 359 176.5 188.9 -46.7 -30.4 
 
 3 
 
30 23 363 341 168.6 182.9 -56.7 -117.4 
       Mean ± SE  352 346 164.4 182.2 -44.5 -55.1 
  
 
  ± 11 ± 6 ± 8.5 ± 4.1 ± 7.8 ± 31.4 
59-Day 1 20 54 327 352 152.6 198.0 +5.0 -24.1 
 
 2 20 54 337 342 147.7 177.9 -35.0 -24.1 
 
 3 
 
20 54 478 479 229.8 275.0 +80.0 -29.6 
 
       Mean ± SE  381 391 176.7 217.0 16.7 -25.9 
  
 
  ± 49 ± 44 ± 26.6 ± 29.6 ± 3.4 ± 1.8 
84-Day 1 26 79 365 377 169.8 185.3 +30.8 +10.1 
 
 2 26 79 358 364 166.1 183.4 -30.8 -7.6 
 
 3 
 
26 79 367 385 163.9 181.1 0.000 +8.9 
 
       Mean ± SE  363 375 166.6 183.0 0.0 3.8 
  
 
  ± 3 ± 6 ± 1.7 ± 1.2 ± 17.8 ± 5.7 
     Skylab Mean ± SE  365 371 169.2 194.1 -9.3 -25.7 
  
 
 ± 15 ± 15 ± 8.3 ± 10.4 ± 14.5 ± 12.5 
Table F-10. Components of Metabolic Balance for Each Skylab Crewmember: Derived Data Used in Balance Equa-
tions
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d) Errors in ECF volume measurement, plasma, and so-
dium concentration are small.
Using these assumptions, the correction factor for so-
dium was calculated as follows:
(33)
where
CFi  = correction factor for phase i,
i  = pre-, in-, or post-flight,
iBalNa
+
 = average uncorrected sodium balance for phase i
Ni  = number of days in phase i
∆ECNaj+ = change in extracellular sodium for period j
 = ∆(ECF x [Na+] plasma)j
 j  = interval of time where change was measured as
    indicated below,
 j assumes the following values:
for i = preflight; assume no change in TBNa, i.e.,
∆ECNa+ = 0,
for i = inflight, j = (R+0) – (Preflight Mean)
for i = postflight, j = (R+14) – (R+0)
where  R= day of recovery from orbit
The available data supports the hypothesis that the
crewmen were in a preflight steady-state with respect to
total body sodium and potassium. The measured preflight
changes in total body water, body weight, and ECF vol-
ume were relatively small as shown in Table F-11. If one
considers a nine man average, the changes in TBW, ECF,
and BWGT were 0.1667 ± 0.21 liters (mean ± SE), -0.27 ±
0.15 liters, and -0.056 ± 0.31 kg respectively and statisti-
cally are not significantly different from zero (t-test).
In addition to the assumptions described above, it was
assumed that all changes in total body sodium occurred in
the exchangeable pool, which is approximately 70% of the
total body sodium [19]. Bone calcium is known to change
during spaceflight [20], and some sodium loss might be ex-
pected to accompany the loss of bone calcium. If sodium
leaves the body in proportion to the sodium and calcium
ratio in bone, based on the calcium losses from the body,
approximately 1 meq of bone sodium would be lost during
the first month inflight. Estimates of exchangeable potas-
sium on the other hand show that it represents from 85 to
96% of total body potassium [19]. Therefore the measure-
ments are generally taken to accurately represent changes
in total body potassium.
A further assumption made for sodium was that ex-
changeable sodium can be approximated by the ECF vol-
ume times the plasma sodium concentration, [Na+]plasma.
The plasma compartment is in free communication with the
interstitium and lymph and these compartments combined
account for 57% of the total exchangeable sodium.  Nichols
[21] demonstrated that these compartments contribute 70%
of the sodium loss during acute sodium loss in dogs.
A potential problem with this analysis concerns the
errors associated with the measurements themselves. The
inflight change in total body sodium was calculated using
the following equation:
      ∆TBNa(inflight) = ECF2 x [Na+]2 - ECF1 x [Na+]1 (34)
Table F-11. Skylab Change in TBW, ECF, and Body Weight During Preflight*
      
Mission Days of 
Measurement 
 
Subject ∆TBW(liters) ∆ECF(liters) ∆BWGT(kg) 
28-Day Mission F-21**, F-1 
 
CDR -0.5  -0.1 
  SPT 
 
0.8  0.6 
  PLT 
 
-0.3  1.2 
59-Day Mission F-20, F-1 CDR 
 
  0.2 
  SPT 
 
  -1.3 
  PLT 
 
  1.5 
84-Day Mission F-15, F-1 CDR 
 
0.1 -0.2 0.8 
  SPT 
 
0.2 -0.1 -0.4 
 
 
 PLT 0.7 -0.5 -0.6 
 *  Data from Leach and Rambaut [18]
**F-21 refers to 21-days prior to launch
]/[ ijii NECNaBalNaCF
++ ∆−=
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where 1 = measured just prior to launch
2 = measured at recovery
The error in computing ∆TBNa is about two times that
of the error in the calculation of either preflight or postflight
extracellular sodium alone, since each term above contrib-
utes to the change. If the error associated with the sodium
concentration is nominally +1 meq and the error of the ECF
volume measurement is 0.5 liter (3-4%), the error in
∆TBNa(inflight) has a possible value of about 172 meq.
Inasmuch as the calculated value of ∆TBNa inflight
was approximately 100 meq, the error is greater than the
quantity being calculated. The daily balance is still within
acceptable accuracy since the error divided by the average
mission length (e.g.,172/57) equals only 3.0 meq/day. Nei-
ther does it much affect the difference between flight phases.
The error in the plasma Na+ concentration may be less than
1 meq decreasing the potential error in ∆TBNa in propor-
tion to the error of [Na+]plasma.
Total body potassium (TBK) was measured directly in
Skylab using whole-body isotope counts and was not de-
pendent on ECF volume measurements, which were a large
potential source of error for computing body sodium.
Therefore, the correction factor for potassium was calcu-
lated directly according to Eq. (32).
Table F-12 lists the individual preflight TBK mea-
surements from which the mean values of ∆TBK (preflight)
were computed and shown in Table F-13. Table F-14 shows
the average values of potassium balance (KBal (uncor-
rected)). Table F-15 summarizes the calculations for pre-
flight and inflight potassium skin losses.
Using the inflight values of KCF  in Table F-15, it is
possible to obtain a corrected daily average for potassium
balance:
  KBal (corrected) = KBal (uncorrected) - KCF . (35)
These results are presented in Table F-16. From these
values, the monthly total cumulative losses of potassium
at the end of each month of the mission can be obtained as
follows:
Total cumulative loss at the end of the inflight period i
(i = I, II, or III)
         = KBal (corrected)i x Ni (36)
where N the number of days in the inflight period i.
These values are presented in Table F-17.
Absolute values of TBK were determined by subtract-
ing the monthly losses from the directly measured TBK
(preflight mean). The methods of calculating these abso-
lute TBK values are presented below, along with a set of
sample calculations.
F.3.2 Sample Calculation (Subject #5):
F.3.2.1 Preflight Skin Loss. From Table F-12, the changes in
TBK during the preflight period are calculated as follows,
Subject F-20 & F-21 
 
F-14 & F-16 F-7 & F-8 F-1 & F-2 
1 3252 3309 3280 3301 
3202 
 
2 3876 3969 3937 3849 
3952 
 
3 3822 3839 3949 3920 
3803 
 
4 3333 3367 3314 3340 
 
5 3094 3080 3034 3039 
 
6 4536 4602 4687 4760 
 
7 3228 3258  3197 
 
8 3758 3698  3562 
 
9 
 
3612 3678  3551 
 
Mean 3612 3644  3607 
±SE ±448 ± 463  ± 521 
 
Table F-12. Preflight Total Body Potassium, TBK (meq)
* F-20 represents the 20th day prior to launch
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Subject N Preflight 
Mean±SD 
 
Postflight ∆TBK 
1 5 3269 ± 43 
 
2998 -271 
2 5 3917 ± 52 
 
3678 -239 
3 5 3867 ± 64 
 
3528 -339 
4 4 3339 ± 22 
 
3151 -188 
5 4 3062 ± 30 
 
3029 -33 
6 4 4647 ± 98 
 
4485 -162 
7 3 3228 ± 31 
 
3108 -120 
8 3 3673 ± 100 
 
3348 -325 
9 3 3614 ± 64 3169 -445 
 
 Mean 3624 3388 -236 
 SE± ± 484 ± 471 ± 125 
 
  Periods 
 
Mission Subject Preflight Inflight I* Inflight II Inflight III 
 
28-day 1 19.27 6.24 
 
  
 2 20.80 3.18 
 
  
 3 16.75 4.20 
 
  
59-day 4 14.66 0.79 9.35 
 
 
 5 16.17 0.92 13.17 
 
 
 6 20.20 5.16 21.77 
 
 
84-day 7 12.29 1.84 0.83 2.45 
 
 8 14.94 4.95 8.08 9.42 
 
 9 17.48 8.95 2.33 14.10 
 
(Mean ± SE) (1-9) 16.95 4.03 9.26 8.66 
  ± 2.80 ± 2.67 ± 7.65 ± 5.86 
 
 (4-9) 15.96    
  ± 2.70 
 
   
 (7-9) 14.90    
  ± 2.60    
 
Table F-13. Changes in TBK from Preflight Average*
Table F-14. Crew Average for Uncorrected Potassium Balance (meq/day)
* inflight periods I, II, and III refer to the first, second, and third inflight months
* Preflight value is mean of N measurements; only one postflight measurement was made.
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∆TBK (direct, preflight)
= TBK(F-1) –TBK(F-20)
=3039 - 3094 = -55 meq
From Table F-14, the uncorrected preflight potassium
balance is,
KBal (uncorrected, preflight) = 16.17 meq/day
From Table F-15, the preflight potassium correction
factor for skin losses is,
KCF = KBal (uncorrected, preflight)
     - ∆TBK (direct, preflight)/N days
 = 16.17 - (-55/20 days) = 18.92 meq/day
F.3.2.2 Inflight Skin Losses. From Table F-15, the inflight
change in TBK measured directly is,
∆TBK (direct, inflight) = -33 meq
From Table F-14 the uncorrected inflight potassium
balance is
KBal (uncorrected, inflight) for period I = 0.92 meq/day
for period II = 13.17 meq/day
 Preflight** Inflight 
 
Subject Direct 
∆TBK 
(meq) 
 
Uncorrected 
KBal 
(meq/day) 
KCF  
(meq/day) 
Direct 
∆TBK 
(meq) 
Uncorrected 
KBal 
(meq/day) 
N days 
KCF  
(meq/day) 
1 0 19.27 19.27 -271 6.24 28 15.92 
 
2 +25 20.80 19.55 -239 3.18 28 11.72 
 
3 +40 16.75 14.75 -339 4.20 28 16.31 
 
4 +7 14.66 14.31 -188 5.07 56 8.43 
 
5 -55 16.17 18.92 -33 7.05 56 7.63 
 
6 +224 20.20 9.00 -162 13.47 56 16.36 
 
7 -31 12.29 13.84 -120 1.37 84 3.14 
 
8 -196 14.94 24.74 -325 7.48 84 11.35 
 
9 -61 17.48 20.53 -445 8.46 84 13.76 
 
Mean 5 16.95 17.21 -236 6.28  11.62 
±SE ± 111 ± 2.80 ± 4.67 ± 125 ± 3.50  ± 4.55 
 
Table F-15. Estimation of Preflight and Inflight Potassium Skin Losses*
From Table F-15, the inflight potassium correction
factor for skin losses is,
KCF = [(KBal(uncorr)xN)I + (KBal(uncorr) x N)II
- ∆TBK(direct)]/(NI + NII)
= [0.92 x 28 days + 13.17 x 28 days - (-33)] / 56 days
= 7.63 meq/day
F.3.2.3 Corrected K+ Balances. The potassium balances
can be corrected simply by subtracting the correction fac-
tor, CFk from the uncorrected potassium balance:
KBal (corrected) = KBal (uncorrected) – KCF
So that from Tables F-14 and F-15:
KBal(corrected, preflight) = 16.17-18.92 = -2.75 meq/day
and
KBal  (corrected, inflight)  for period I = 0.92 - 7.63 = -6.71
for period II = 13.17 - 7.63 = 5.54
F.3.2.4 Monthly Inflight Losses (Gains), ∆TBK. The
changes in TBK for each monthly inflight period is com-
puted by summing the daily corrected balances over the
28 days in each period (see Table F-16 and F-17).
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  Periods 
 
Mission Subject Preflight Inflight I* Inflight II Inflight III 
 
28-day 1 0.00 -9.68 
 
  
 2 1.25 -8.54 
 
  
 3 2.0 -12.11 
 
  
59-day 4 0.35 -7.64 0.92 
 
 
 5 -2.75 -6.71 5.54 
 
 
 6 11.2 -11.20 5.41 
 
 
84-day 7 -1.55 -1.30 -2.31 -0.69 
 
 8 -9.80 -6.40 -3.27 -1.93 
 
 9 -3.05 -4.81 -11.43 0.34 
 
Mean ± SE 1-9 0.35 ± 5.54 -7.60 ± 3.32 -0.86 ± 6.37 -0.76 ± 1.14 
 
 4-9 -0.02 ± 6.9 
 
   
 7-9 -4.8 ± 4.39    
 
  Periods 
 
Mission Man Preflight Inflight I** Inflight II Inflight III 
 
28-day 1 0 -271 
 
  
 2 +25 -239 
 
  
 3 +40 -339 
 
  
59-day 4 +7 -214 +26 
 
 
 5 -55 -188 +155 
 
 
 6 +224 -314 +152 
 
 
84-day 7 -31 -36 -65 -19 
 
 8 -196 -179 -92 -54 
 
 9 -61 -135 -320 +10 
 
Mean  -5 -213 -24 -21 
±SE   ± 111 ± 93 ± 179 ± 32 
 
Cumulative Shift from Preflight  -208 -227 -243 
 
Table F-16. Crew Average for Potassium Balance (Corrected for Skin Losses), meq/day
* Inflight periods I, II, and III refer to the first, second, and third inflight months
Table F-17. Crew Averages for Monthly TBK Changes* (meq)
* TBK changes = KBal (corrected) x N (days)
** Inflight periods I, II, and III refer to the first, second, and third inflight months
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Inflight I Loss = -6.71 x 28 = -188 meq
Inflight II Gain = +5.54 x 28 = +155 meq
F3.2.5 Total Body K+ During Mission. The value for TBK
at the end of the several inflight periods is obtained as follows:
TBK(preflight mean, direct) = 3062
Inflight I ∆TBK = - 188
TBK at end of Period I =  2874 meq
Inflight II ∆TBK =  +155
TBK at end of Period II =  3029 meq
F.3.3 Alternative Method for Computing Electro-
lyte Sweat Losses
During the evaluation of Hypothesis #5 (Chapter 5),
another technique was discovered that could be useful for
indirectly estimating sweat losses of sodium and potas-
sium for the Skylab crew. Figure F-3 depicts a simplified
fluid-electrolyte model of the body for the purpose of il-
lustrating the exchange of fluid and electrolytes between
intracellular and extracellular compartments including in-
take, sweat, and renal losses. The quantities that have been
measured directly or derived are indicated with an aster-
isk. If only the water and sodium exchange across the ex-
tracellular compartment are considered (i.e., exclude
potassium and water exchange with the intracellular com-
partment), the extracellular sodium concentration can be
uniquely determined by knowing the initial concentra-
tion and any net changes which occur in the balance be-
tween intake and output from this compartment. This is
similar to the problem of determining the concentration of
a substance, X, in a holding tank after a certain quantity of
water and X has been added. Conversely, if the change in
concentration of X is known, the amount of substance
added can be derived. In this manner, it is possible to de-
termine the sodium sweat component by using the experi-
mental extracellular sodium concentration data and the
other components of the metabolic balances. Similarly,
potassium losses (from sweating and cell loss) can be esti-
mated from the plasma potassium concentration.
All the elements shown were included in the Guyton
model and the current version of the model can be used to
evaluate this technique; alternatively, it may be desirable
to formulate a much simpler model based on Fig. F-4. A
suggested mode of operation is shown in that graphic.
Known values of intake and renal losses are input into the
model, and values for electrolyte losses are assumed. The
normal mode of using the Guyton model does not include
forcing renal excretion as required by this method; thus,
the name “push-pull” has been adopted (i.e., fluids are
both pushed and pulled from the model). Predicted so-
dium and potassium responses are then compared to the
experimental response. Extracellular electrolyte concen-
trations and total body losses of electrolytes in a given
time period can both be compared. Iteration to obtain the
“best fit” between experimental and predicted results leads
to an estimated value of the electrolyte losses.
Preliminary results using this method have been en-
couraging. They have suggested that potassium and par-
ticularly sodium sweat losses were actually higher than
control during the first few days of flight, before being
reduced below control as originally estimated in Fig. 9-
18. This is in keeping with the results of evaporative water
losses which show the same trend. This information was
utilized in a simulation of combined hypotheses which
are shown in Chapter 5 (Figs. 5-32 and 5-33).
Figure F-3. Simplified fluid-electrolyte model.
Intake:
*W
*Na
*K
Renal Excretion:         *W  *Na  *K
Evaporation and Sweat:
       W*
       NA
       K
TBW* = VE + VI
Intracellular
Compartment
VI, [K]I
Extracellular
Compartment
VE, [Na]E*, [K]E*
W
K+ Loss
V = Volume
W = Water
Na = Sodium
K = Potassium
[ ] = Concentration
* = Known Quantities
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Figure F-4. Push-Pull simulation procedure for estimating unknown electrolyte loss rates.
F.4 Quantification of Tissue Loss
Resulting From Prolonged Spaceflight
This section describes details of the Skylab lean body mass
analysis that, for convenience, were not presented in Chap-
ter 4.5. The reader is also referred to the original reports for
a full discussion [22,23].
F.4.1 Methods of Calculation and Assumptions
Table F-18 summarizes alternative methods that were
used in this study to quantify lean body mass (LBM)*.
According to the references cited in Table F-18, the LBM
[24]  has a water content of about 73%, a potassium con-
tent of 60-70 meq/kg (in men), and a density of about 1.1
gm/cm3. In contrast, body fat contains less water (14%)
and negligible potassium content, and has a lower density
of about 0.9 gm/cm3. It is possible to estimate the relative
proportions of fat and lean tissue in the body by measur-
ing total body water (TBW), total body potassium (TBK),
or body density (D), and assuming a simple two-compart-
ment model (fat and fat-free). Body density is commonly
derived from body mass or weight (BWGT) divided by
body volume (BVOL). All of these measurements were avail-
able from the various Skylab experiments (see Table F-19).
Empirical relationships have been suggested for predict-
ing lean body mass from combinations of either TBW and
TBK or TBW, TBK, BVOL and BWGT. Losses in lean body
mass were obtained by using the relationships shown in
Table F-18 and by comparing the preflight period with the
first postflight day of recovery. An inflight metabolic nitro-
gen balance provided an additional measure of lean tissue
loss. The cumulative algebraic sum of nitrogen balances,
obtained each day of the mission, indicates the net loss (or
gain) of body nitrogen. Since protein contains an average of
16% nitrogen by weight, and lean body mass is composed of
19.4% protein, it is possible to quantify protein and lean
body mass from the cumulative nitrogen balance [24,25].
Table F-20 presents individual subject results for
inflight LBM changes derived from each method. This table
is presented in summarized form in Chapter 4.5, Tables 4-16
and 4-20. The values in this table were used to perform corre-
lation analyses between the various methods and these are
discussed in Chapter 4.5. Further detailed calculation of each
method can be found in the original report [22].
F.4.2 Experimental Approach
F.4.2.1 Measurements. Total body water (TBW) and to-
tal body potassium (TBK) were obtained by the isotopic
dilution of isotopic hydrogen and potassium, respectively
[18]. Body volume (BVOL) was computed from a
stereophotogrammetric method involving four cameras to
make two stereoscopic pairs of photographs from the front
and back and using computer analysis to determine the
volume of different body regions and of the body as whole
[34].  Body mass (BWGT) was measured by conventional
scales in terrestrial environment and by the principles of
oscillating masses during spaceflight [16].
The nitrogen balance consisted of daily monitoring
of dietary intake and daily collections and analysis of urine
and fecal excreta [35].  Only preflight and postflight mea-
surements were possible for TBW, TBK, and BVOL. Body
mass and metabolic balances of nitrogen and potassium
* In this study, it was assumed that the difference between the lean body
mass (body mass less storage fat) and fat-free mass (body mass less all
other extractable fat); i.e., the essential body fat (about 2% of body
weight), is negligible.
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were determined daily throughout the preflight, inflight,
and postflight period.
F.4.2.2 Pooling of Subjects. The periods of weight-
lessness associated with each of the three Skylab missions
were 28 days, 59 days, and 84 days. Data presented in this
and other reports [8] show that the largest losses in weight
occurred during the first month and suggest that minimal
changes were associated with the last two months, espe-
cially for body weight, body water, and lean body mass.
For this reason, as well as the limited number of subjects
available (three crewmembers on each flight), it was de-
cided to pool the results of all nine subjects in summariz-
ing changes in body composition. However, the data were
also examined and discussed with respect to duration of
flight. Paired t-tests were used to assess statistical signifi-
cance of inflight changes.
F.4.3 Errors in the TBK Method
In Chapter 4.5, it was discussed that the method based
on TBK did not at first provide reasonable results (labeled
“uncorrected” in Table 4-16). A correction factor was suc-
cessfully applied based on the assumption that a signifi-
cant amount of potassium leaves the cellular compartment
independently of other cell constituents due to osmotic
considerations. The inflight changes of lean body mass
calculated from the simple, uncorrected formula (LBM =
TBK/65) was –3.63 ± 1.93 Kg while that calculated by
applying a correction for an inflight osmotic effect was –
1.55 ±1.96 Kg. This latter value is in better agreement
with the other methods studied. The following section dis-
cusses the possible errors in the TBK method and demon-
strates precisely how the correction was applied.
F.4.3.1 Sources of Error. The unreasonably high values
for LBM losses derived from the uncorrected TBK method
were examined by considering the following factors:
a) The factor of 65 meq K+/kg LBM used in the calcula-
tions (see Table F-18) may be inappropriate for the as-
tronaut population. Values from the literature reveal
that the potassium content of lean body mass is nor-
mally within the range of 60 - 70 meq K+/kg [28,36,37].
If the mean inflight LBM loss of 1.5 kg obtained by the
average of the other methods is accepted, then the mea-
sured inflight loss of 235 meq K+ would require a con-
centration of 235/1.5 = 157 meq K+/kg LBM, and this
value is so far out of the normal range that other expla-
nations must be sought, such as those described in (b)
and (c) below,
b) The possibility must be considered that the measured
values of TBK were erroneous and that the potassium losses
were overestimated due to systematic errors in the tech-
nique. The total accuracy of the isotope dilution method
for 40K may be several percent [38].  A systematic error
of this magnitude could explain most of the discrep-
ancy in the calculation of LBM loss. It had been noted
that in certain pathological situations, this technique was
subject to large errors in predicting LBM [39].  However,
preflight values were reasonable, and it was not clear how
the inflight conditions or postflight measurements could
challenge the suitability of this method.
c) A significant fraction of the measured TBK loss may
have been unaccompanied by other cellular components
such as nitrogen and water (which together constitute
about 90% of LBM). As discussed in Chapter 4.5 the
ratios water:potassium:nitrogen in lost body mass are
often greater than the normal cellular ratios of these
components. Although it is not clear why this should
happen, and the metabolic balance data for nitrogen
and potassium do not support this conclusion, this phe-
nomenon is still a possibility on Skylab.
In addition to the high values of lean body mass loss
predicted by the uncorrected TBK method, the expected
intracellular water loss also appears rather high. Using a
value of 160 meq/liter for the intracellular potassium con-
centration [40],  it would be expected that 1.5 liters of cell
water would be lost with the observed decrement of 236
meq potassium assuming iso-osmotic loss and that potas-
sium was the most significant osmotically active substance
undergoing change. This was large compared to the total
weight loss of 2.39 kg, the measured total body water
change of 0.8 liters, or the derived intracellular water loss
of 0.5 liters [18].
One explanation for these discrepancies could have
been a mild, but persistent dilution of sodium concentra-
tion and osmolarity in extracellular fluid as measured from
plasma samples obtained at regular intervals throughout
the flight [18]. This was also noted in several bedrest stud-
ies [41,42],  and while it has not yet been explained, os-
motic balance requires that intracellular fluid be similarly
dilute [19]. Also, it can be calculated that a lesser amount
of water will be expected to accompany potassium osmoti-
cally from the cell if body fluids become hypotonic (see
Fig. 5-28; [22]). Therefore, two components of potassium
loss have been postulated: an osmotic loss which satisfies
osmotic balance in the face of extracellular dilution and a
muscle atrophy loss which was accompanied by nitrogen
and other cellular constituents. This assumption has been
translated into quantitative terms using the changes in
plasma sodium concentration as correction factors. A
sample calculation appears below.
F.4.3.2 Correction of the TBK Method. A mean change
in plasma sodium concentration of –4.53 mEq/l was mea-
sured during the inflight phase over a three-month period
(see Table F-21). Assume that a portion of the potassium
leaving the cellular compartment unaccompanied by pro-
tein and water is equivalent to the amount necessary to
dilute intracellular potassium to the same extent as so-
dium is diluted in the extracellular compartment (i.e., a
mean decrease in sodium concentration of 4.53 meq/1 mea-
sured throughout the inflight phase). Also assume that this
is a generalized potassium loss throughout the intracellu-
lar compartment; i.e., 29.6 liters (measured preflight).
Therefore, this component of the potassium loss, to
satisfy osmotic equilibrium, can be estimated to be
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Table F-18. Mathematical Description of Methods Used in Determining Body Composition Changes*
Note 1. All quantities expressed as kg (LBM, FAT, BWGT, Protein) or milliequivalents (TBK).
Note 2. Assume essential body fat is negligible; i.e., fat free mass = lean body mass.
Note 3. Symbols: TBW=total body water; TBK=total body potassium; LBM=lean body mass; BWGT=body weight; D=body density; N=nitrogen
osmotic loss = 4.53 meq/1 x 29.6 liters = 134 meq K+
The actual loss of potassium that can be claimed to be
a result of muscle atrophy (i.e., accompanied by nitrogen
and water) is the difference between the measured inflight
loss (Table F-19) and the osmotic loss:
muscle atrophy loss = 235 - 134 = 101 meq K+
The lean body mass (LBM) loss attributed to muscle atro-
phy is obtained from the relationship (Table F-18):
∆LBM = (∆TBK/65) = (101/65) = 1.57 kg
The protein loss (PRO) is assumed to be 19.4% of the LBM
loss:
∆PRO = 0.194 × 1.57 = 0.30 kg
Altenatively, the protein:potassium ratio of the LBM is
known to be 3.06 gm/meq [36], so that
∆PRO = 3.06 × 101 = 0.31 kg.
The fat loss is:
∆FAT = ∆BWGT - ∆LBM = 2.69 - 1.57 = 1.12 kg.
The intracellular water loss accompanying 101 meq K+
can be estimated from the concentration of cell K+ [40]:
    ∆intracellular water  = liters.liter/meq
meq
640
160
101
=



These calculations are summarized below for both the
uncorrected and corrected cases:
Method Concept 
Total Body Water Lean body mass is 73.2% water [26] 
 
Total Body Potassium Lean body mass contains 65 meq K+/kg [27,28]. This value 
is age dependent and has been adjusted to mean age of 
astronauts (40.7 years) 
 
Total Body Water + 
Total Body Potassium 
Lean body mass is estimated from sum of body water + cell 
solids + bone mineral. Cell solids estimated from TBK and 
bone mineral assumed to be a constant proportion of cell 
solids [28]. Assume inflight bone mineral loss does not 
contribute significantly to body weight change [29]. 
 
Cumulative Nitrogen 
Balance 
Cumulative inflight nitrogen balance assumes negligible loss 
of sweat component. Protein contains 16% nitrogen [30]; 
LBM contains 19.4% protein [24]. 
 
 
 
Body Density 
(Stereophotometric) 
Body segmented into fat and essential body mass 
compartments, each having characteristic density. Densities 
determined from average of four different studies [26,31-33]: 
Fat (0.9168 gm/cm3), LBM (1.0997 gm/cm3). 
 
“Combined” Method 
(Stereophotometric) 
Lean body mass is the difference between body weight and 
fat mass. Body fat is estimated as the difference between 
measured volume of body and sum of the calculated volumes 
of body water and cell solids [28]. Method uses combination 
of all data shown in Table F-19. Results of this method 
reported here were taken directly from Whittle [29] and 
cannot be derived precisely from values given in Table F-19 
because of the use of certain correction factors in the original 
calculations. 
 
Equation
LBM = TBW/0.732
LBM = TBK/65
where TBK* = preflight value
N Bal = N(diet) - N(urine) - N(feces)
∆Protein =
    N Bal x Mission Length x 6.25
∆LBM = ∆Protein/0.194
LBM = BWGT
where TBK* = preflight value
6.320
*TBK334.0
6.320
TBK
TBWLBM ++=



−=
D
51.5
01.6BWgtLBM



−−−−
8847
3340
64489940
9010
.
*TBK.
.
TBK
.
TBW
VolBody.
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 Body Wgt 
(Kg)1 
Body Volume 
(liters) 
Total Body Water 
(liters) 
Total Body Potassium 
(meq) 
 
Subject Pre Post ∆ Pre Post ∆ Pre Post ∆ Pre Post ∆ 
 
1 62.2 60.2 -2.0 59.00 56.62 -2.38 41.55 40.8 -0.75 3270 3000 -270 
 
2 77.9 74.3 -3.6 75.22 70.65 -4.57 48.80 48.0 -0.80 3915 3680 -240 
 
3 80.2 76.0 -4.2 76.42 71.26 -5.16 52.15 50.0 -2.15 3865 3530 -340 
 
4 68.6 64.6 -4.0 63.55 59.98 -3.57 42.50 41.9 -0.60 3340 3150 -190 
 
5 61.8 58.7 -3.1 56.74 53.58 -3.16 39.10 39.6 +0.50 3060 3030 -35 
 
6 88.0 84.1 -3.9 81.23 77.36 -3.87 53.60 51.9 -1.70 4645 4485 -160 
 
7 67.8 67.8 +0.1 63.87 64.52 +0.65 41.85 41.0 -0.85 3230 3110 -120 
 
8 71.5 68.6 -2.9 68.38 65.04 -3.34 45.40 44.9 -0.50 3675 3350 -325 
 
9 67.6 66.1 -1.5 63.71 61.98 -1.73 45.65 45.1 -0.55 3615 3170 -445 
 
 
Mean 71.7 68.9 -2.8* 67.57 64.55 -3.02* 45.62 44.8 -0.82* 3625 3390 -235* 
 
SD ± 6.7 ± 8.1 ± 1.4 ± 8.36 ± 7.56 ± 1.72 ± 5.00 ± 4.4 ± 0.75 ± 484 ± 471 ± 125 
 
 
Table F-19. Body Composition Parameters Before and After Skylab Mission
*p > 0.995 that postflight is different from preflight
Note 1. Preflight body weight is mean of daily measurements during 2-3 week period to launch. Postflight body weight value is the first
shipboard measurement after reentry.Measurements of other parameters were made less frequently preflight and were made on either the 1st or
2nd day postflight.
    Method 
Subject TBW TBK TBW + TBK Cumulative 
Nitrogen 
Balance 
 
Body Density Combined Method 
1 -1.02 -2.09 -1.17 -0.87 -2.43 -1.96 
 
2 -1.10 -1.80 -1.16 -2.00 +2.21 -0.86 
 
3 -2.93 -2.91 -2.74 -1.54 -4.20 -3.65 
 
4 -0.82 -0.32 -0.67 -1.88 -7.47 -2.85 
 
5 +0.69 -0.09 +0.48 -1.48 -4.61 -1.12 
 
6 -2.32 +1.34 -1.43 -1.54 -2.07 -3.38 
 
7 -1.16 -0.45 -0.94 -3.35 -4.49 -1.89 
 
8 -0.68 -2.15 -0.94 -1.84 +3.31 -0.39 
 
9 -0.75 -5.45 -1.65 -0.13 +4.06 -0.36 
 
Mean +1.12 -1.57 -1.14 -1.63 -1.74 -1.83 
SD ±1.03 ±1.96 ±0.85 ±0.87 ±4.03 ±1.25 
 
Normalized to 
∆BWGT = -2.72 
-1.22 -1.58 -1.15 -1.85 -1.56 -1.64 
 
Table F-20. Inflight Changes in Lean Body Mass for Each Skylab Subject using Various Methods*
  *in kilogram
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Body Composition Changes from TBK Loss
     Corrected for    Other
Uncorrected  Dilution Estimates
∆Lean body mass (kg)      -3.63    -1.57 -(1.2 to 1.6)
∆Fat (kg)     +0.94    -1.12 -(1.0 to 1.5)
∆Protein (kg)     -0.70    -0.31 -(0.2 to 0.4)
∆Intracellular water (liter)  -1.50    -0.64 -0.5
While this is a speculative exercise, the predicted body
composition variables (middle column) were in better
agreement with other independent measurements discussed
in Chapter 4.5 (last column) after the correction was ap-
plied. The computations for each crewman, based on the
above method, are shown in Table F-21.
F.4.4 Errors in the Nitrogen Balance
Errors in the nitrogen balance technique have been
reviewed by Hegsted [9], and discussed by Grande [24],
Calloway [30], Forbes [43],  Wallace [44],  and Steffee [45].
The two major errors most often mentioned were: (a) the
fact that certain losses are not measured in the usual bal-
ance study, especially fluid or nutrients lost through the
skin, thereby making the balances falsely high, and (b)
there is a consistent bias in most balance studies arising
from an overestimation of intake (the subject may not eat
all of the food offered, but cannot consume more than is
offered) and an underestimation of output (it is difficult to
collect all excreta and impossible to collect more excreta
than was actually produced) thus making the balances
falsely high. In the Skylab metabolic experiments, collec-
tion of excreta and measurement of food and water intake
were carefully performed and corrections were included
for food not eaten at each meal. However, it must be recog-
nized that it was more the responsibility of the crewmen
than the principal investigators to perform the actual col-
lection and reporting tasks during the inflight phase. Nev-
ertheless, the crewmembers were highly trained and well
motivated subjects and it is unlikely that consistent errors
were introduced.
With regard to other errors in the nitrogen balance, it
has been estimated that dermal losses of nitrogen were
found to be less than 0.5 g/day for sedentary men in a
comfortable environment. Sweating due to heavy exercise
may result in not more than another 0.5 g/liter of evapora-
tive loss [9,30] (it has been estimated that sweat losses of
the Skylab crew were less than one liter/day). The Skylab
subjects exhibited such high net nitrogen retentions dur-
ing the preflight phase of the study (3 gm/day ) that it
cannot be reversed by subtracting even 1 gm/day of un-
measured dermal losses. Further, it is important to note
that the preflight Skylab nitrogen balances are in good
agreement with the net retention found by other investiga-
tors for the particular dietary levels observed.
In attempting to explain the positive nitrogen bal-
ances that are normally seen in most normal subjects,
Steffee [45] suggests that another route of unmeasured
losses may be molecular nitrogen (gas). He says “there is
now increasing evidence to indicate that this route, hith-
erto regarded as unlikely in mammalian organism, may be
an important factor in nitrogen loss during generous in-
takes of protein in healthy subjects or during some patho-
logical condition. The evidence, based on various
approaches, has been reviewed and appears to provide a
likely explanation for the positive balance values”. It
should be noted that a positive nitrogen retention, if real,
argues as well for a positive total body potassium reten-
tion during the preflight phase. But TBK measurements do
not suggest any change in this quantity, a discrepancy we
cannot resolve.
The presence of these errors in the nitrogen balance
should serve as a warning to interpret the balance results
with some degree of caution. They do not, however, ne-
gate the fact that the Skylab crewmen’s nitrogen balance
changed direction upon launch and again upon recovery
(see Fig. F-9). The positive nitrogen balances observed
during the preflight phase could have been expected be-
cause of the following: a) the dietary nitrogen consumed
in the calibrated preflight phase was probably higher than
in the crew’s daily life prior to flight and b) the increased
activity of the crew as they exercised according to a rigid
schedule may have had an anabolic effect on lean body
mass. The dramatic shift in direction during the inflight
phase to a negative balance is in keeping with the concept
of atrophy of unused postural muscles in a microgravity
environment. This concept would also argue for the ob-
served postflight recovery of nitrogen when the subjects
return to a world of gravity and must reactivate and re-
build the postural muscles. The leveling off of nitrogen
loss after the first month during the last two flights sug-
gests that there was a lower limit of protein loss reached
irrespective of the level of exercise or time inflight.
F.5 Energy Balance and Body
Composition of Weight Loss During
Prolonged Spaceflight
This section of the Appendix presents the details of the
approach, assumptions and methods of computation asso-
ciated with Chapter 4.6.  Further details can be found in
Leonard [46,47].
F.5.1 Computational Procedures and Assumptions
The analysis for deriving body compositional changes
were based on two formulations: a) an equation of body com-
position and b) an equation for energy balance. In the first of
these equations, the change in body weight (∆BWGT) was
assumed to result from changes in total body water (∆TBW),
body protein (∆PRO), and body fat (∆FAT). Thus,
∆BWGT = ∆TBW + ∆PRO + ∆FAT (37)
For the second equation which describes energy bal-
ance, net energy utilization (Eutil), was computed as the
sum of energy intake from diet (Ediet ) minus energy ex-
creted in urine (Eurine) and feces (Efeces) plus energy avail-
able from body tissue catabolism (energy from body fat,
Efat and body protein, Epro). Thus,
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 Eutil* = Work (internal + external) + Heat lost
= Ediet - Eurine - Efeces + Efat + Epro (38)
As suggested by Eq. (38), the net energy available
from food and tissue metabolism is assumed to be utilized
entirely to perform work and produce heat. Eutil* is starred
(*) to designate that it could not be measured directly or
indirectly on a daily basis (i.e., by measuring work and
heat lost or oxygen consumption) as were the other terms
in Eq. (38). It was assumed that Eutil*, expressed as a daily
average quantity for the preflight, inflight, or postflight
phases, was constant throughout that phase for each crew
member.
For convenience, the remainder of the computational
procedures related to these equations are described in three
parts: (F.5.1.1) determination of Eutil*, (F.5.1.2) determina-
tion of daily estimates of ∆TBW and ∆FAT and the latter’s
caloric equivalent, Efat and (F.5.1.3) determining cumula-
tive estimates of weight and tissue changes. In addition,
(F.5.1.4) the computational procedures are provided for
estimates of energy requirements that would prevent loss
of body weight during spaceflight.
F.5.1.1 Determination of Mean Energy Utilization,
E
util
*
. Eutil* was determined from Eqs. (37) and (38) by as-
suming each term in these formulations represented over-
all mission quantities. For example, ∆BWGT, which
normally refers to daily changes in body mass would, in
this part of the analysis, refer to change in net mass be-
tween the day of launch and day of recovery. When used
in this way, the term is designated with a bar, thus ∆ BWGT .
Each term in Eq. (37), so designated, can be estimated
except for ∆ FAT . Body weight changes, ∆ , were
measured daily and directly, body water changes (∆ TBW )
by isotope dilution techniques at launch and recovery,
and protein losses (∆ PRO ) estimated from cumulative
daily nitrogen balance using a factor 6.25 to determine
the protein equivalent of nitrogen [30]. Refer to Table
F-22 for a summary of the methods used to compute each
term in this analysis.
Overall mission fat losses for each subject were thereby
calculated by solving Eq. (37) for ∆ FAT . Using the ca-
loric equivalent of this loss, , it was possible to derive
the cumulative energy utilized, *utilE , from Eq. (38) in
which dietE
 
was determined from the caloric equivalent of
dietary content of protein, fat and carbohydrate [3,4], urineE
from urinary nitrogen (Nurine) and taken to be 8.32 x Nurine.
fecesE  was measured directly by bomb calorimetry, and proE
was estimated from the caloric equivalent of the nitrogen
balance losses (i.e., proE  = 5.65 x 6.25 x BALN ). Each of
these terms representing daily quantities was summed over
the entire mission phase and used in Eqs. (37) and (38).
The value of *utilE  obtained from this calculation was di-
vided by the number of mission days to estimate Eutil*.
Values of Eutil* so computed, are shown in Table F-23.
F.5.1.2 Daily Estimates of Body Water and Body Fat
Changes. Daily changes in body fat were determined by
solving Eq. (38) for Efat, using the derived constant value
of Eutil* and daily measured values of the other compo-
nents Ediet, Eurine, Efeces, Efat, and Epro. Daily body fat changes
were converted from energy (Efat) to mass equivalents
(∆FAT) and used to compute ∆TBW from Eq. (37). Daily
body mass changes (∆BWGT) and body protein changes
(∆PRO) used in this computation were estimated as previ-
ously described.
F.5.1.3 Cumulative Estimates of Weight, Water, and
Tissue Changes. Cumulative changes in each of the
quantities in Eq. (37) were calculated by summing the
consecutive daily balances over any desired time inter-
val. The interval of each day’s balance period was taken to
be from morning to morning. The experimental protocol
specified that each day would begin after the last urine
and fecal void prior to breakfast. Body mass measurements
were made each day after overnight fasting. It was conve-
nient to use the morning of the day of launch as the refer-
ence point from which cumulative balances were computed.
Thus, the prelaunch period required a backward calcula-
tion from the point of reference (i.e., launch).
The calculation schema outlined above is shown in
the idealized graph Fig. F-5. The average net dietary in-
take (i.e., Ediet - Eurine - Efeces) is indicated by the lowest solid
curve. The dashed horizontal line represents the average
daily energy utilization, Eutil* , for the inflight period. The
difference between mean energy utilization and net di-
etary intake is the deficit between net calories derived from
the diet and the energy actually required. This energy dif-
ference is assumed to be supplied by fat and protein tissue
catabolism (carbohydrate stores in the body being assumed
insignificant) as suggested by Eq. (38). The area bounded
between the horizontal dashed and lower solid lines and any
two time intervals is the energy equivalent of the cumula-
tive tissue loss (protein + fat) during that interval. If daily
protein changes can be assumed from the nitrogen bal-
ance (hatched area in Fig. F-5), it is possible to derive
daily fat losses from this area of the graph as shown. The
difference between total weight loss and the sum of fat and
protein losses is then taken to be the daily change in body
water, as indicated by Eq. (37).
The data corresponding to the idealized representation
of Fig. F-5 is presented in Fig. 4-23. Figure F-6 show a similar
analysis except that each mission is shown separately. Con-
sidering only the inflight period, the difference between the
net caloric intake and the energy utilization curves is dimin-
ished for each longer mission. This was a result of increased
caloric intake (per kg of BWGT). These differences, aver-
aged over the inflight period are -448 kcal/day, -360 kcal/
day, and +23 kcal/day for the 28-day, 59-day and 84-day
missions respectively; (a negative sign indicates a dietary
deficiency whereby tissue is catabolized, and a positive sign
indicates a dietary excess whereby tissue is stored).
F.5.1.4 Estimates of Inflight Caloric and Exercise
Requirements to Prevent Loss of Body Weight. Af-
ter completing the above calculations it was possible to
undertake regression analyses of the type described by
Whittle [48] in attempts to estimate the caloric and exer-
BWGT
fat E
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Figure F-5. Estimation of tissue loss from energy balance compo­
nents. This figure is an idealized version of Fig. 4-23. 
cise requirements that would maintain preflight body 
weight during the inflight phase. For these analyses a re­
gression equation was derived and employed: 
*(39) 
where 11M = change in body mass, body fat, or body pro­
tein (gm/kg BWGT) over an inflight time interval, 11T 
* C is a constant, the slope of the line in Fig. 4-29, and is
not needed in the analysis.
(days), E0 = observed energy intake from food (kcal/d/kg 
BWGT) or observed energy expenditures for exercise (kcal/ 
d/kg BWGT), and ER = energy required from food at which 
no change in body mass or body fat occurs (kcal/d/kg 
BWGT) or energy required for exercise at which no change 
in body mass or body protein occurs (kcal/d/kg BWGT). 
Using Eq. (39) both caloric intake and exercise en­
ergy expenditures could be separately correlated with the 
average rate of body mass loss (/1M/ 11n. In addition, ca­
loric intake could be correlated with body fat assuming 
that an adequate diet would prevent loss of body fat. Simi­
larly, exercise could be correlated with body protein on 
the assumption that an adequate exercise level would pre­
vent the loss of body protein. The introduction of the term 
!).M/ J't,.T allows us to account for the effect of different mis­
sion lengths. Two sets of regression analysis were performed: 
a) using data for the entire mission, and b) using data for
only the first month of each flight (see Table F-30].
F.5.2 Supplementary Data for Energy Balance 
Analysis 
In Chapter 4.6 the results from the body composition 
and energy balance analysis are presented as mean values 
for each of the three Skylab missions. Tables F-24 to F-30 
are referred to in Chapter 4.6, and show the corresponding 
results for each crewman. Figures F-7 to F-10 are an alter­
nate method of viewing the daily estimated changes of 
body weight, body water, body protein, and body fat that 
are also illustrated in Fig. 4-28. 
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Table F-22. Methods for Computing Terms in Body Composition Equations
Note:
(1) Bar over symbol denotes overall mission phase mass losses or cumulative energy quantities summed over mission phase. Symbols without
bars referred to daily values of that quantity. ∆ = change in quantity, * denotes computed value.
(2)     are computed by summing the daily amounts of each quantity (as defined above) over each mission
phase; ( i.e. = dietE = Σ  ∑  dietE )
(3) Units are in gm or gm/day and kcal or kcal/day depending on the period for which they are computed.
Quantity Symbol Method of Computation 
 
Change in Body Mass, gm ∆ BWGT and ∆BWGT Direct body mass/weight measurements 
 
Change in Body Water, gm 
  ∆ TBW  
∆ TBW  
Isotope dilution (tritium) method performed before 
and after flight 
 
Solve Equation (37) for ∆TBW 
 
Change in Body Protein, gm ∆PRO and PRO∆  Nitrogen balance: 
∆PRO = 6.25 x NBAL = 6.25 x (Ndiet – Nurine – Nfeces) 
 
Change in Body Fat, gm FAT∆  
 
∆FAT 
Solve Equation (37) for FAT∆  
 
∆FAT = - Efat /9.461 
 
Energy in Diet, kcal  
Ediet 
From stoichiometric relationships and known amounts 
of carbohydrate, fat, and protein in diet: 
Ediet = 4.182 x diet carbohydrate (gm) 
 + 9.461 x diet fat (gm) 
 + 5.65 x diet protein (gm) 
 
Energy in Urine, kcal Eurine From urine nitrogen: 
EURINE = 8.32 x Nurine (gm) 
 
Energy in Feces, kcal Efeces From bomb calorimetry 
 
Energy in Catabolized Protein, 
kcal 
Epro Epro = -5.65 x PRO 
 
Energy in Catabolized Fat, kcal 
fatE   
Efat 
Efat = -9.461 x FAT∆  
 
Solve Equation (38) for Efat using Eutil* 
 
Net Energy Utilized, kcal *
utilE  
Eutil
* 
From Equation (38) 
Eutil
*= 
*
utilE /days of mission phase 
 
 
dietE , urineE , fecesE , proE , and ∆PRO  
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Table F-23. Net Utilization (Eutil*) [kcal/day]
Subject Preflight Inflight Postflight 
 
28-day mission 
 
   
1 2737 2861 3493 
 
2 3522 3572 2729 
 
3 3448 2969 2706 
 
59-day mission 
 
   
4 3037 3049 1485 
 
5 3354 3170 2248 
 
6 3994 3678 3633 
 
84-day mission    
7 2879 2842 3306 
 
8 3130 2973 2833 
 
9 3773 3031 3322 
 
Mean 3319 3127 2862 
±SD       +414       +300       +682 
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Table F-24. Tissue Components of Body Mass That Were Lost During the Inflight Phase [gm]
*Time period considered is from morning of launch (one-g) to morning of recovery (zero-g)
Mission Crewmember ∆Body 
Weight 
∆Total 
Body 
Water 
 
∆Tissue 
Solids 
∆Protein ∆Fat
28-day 1 -1100 -405 -695 -170 -525
 2 -2700 -180 -2520 -390 -2310
 3 -3200 -2090 -1110 -300 -810
 Mean -2330 -890 -1440 -290 -1155
 +SD +1100 +1080 +960 +110 +855
59-day 4 -3900 -1395 -2535 -365 -2170
 5 -4200 +125 -3725 -285 -3435
 6 -4200 -3345 -855 -295 -560
 Mean -3900 -1530 -2370 -320 -2055
 +SD +300 +1740 +1440 +40 +1440
84-day 7 0 -770 +770 -650 +1420
 8 -1400 -615 -785 -355 -425
 9 -1400 -1600 +200 -30 +230
 Mean -930 -995 +62 -350 +410
 +SD +810 +530 +790 +310 +935
 Skylab Mean -2390 -1140 -1250 -315 -935
 +SD +1460 +1090 +1425 +170 +1440
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Table F-25. Changes of Body Weight/Mass and Body Water Before and After Skylab Missions [Kg]
 Body Weight Total Body Water 
 
Crewman Preflight 
Mean 
∆1(a) ∆2(b) Preflight 
Mean 
 
∆1 ∆2 
1 62.21 -2.0 -1.1 41.55 -0.75 -0.41 
 
2 77.89 -3.6 -2.7 48.80 -0.80 -0.18 
 
3 80.18 -4.2 -3.2 52.15 -2.15 -2.09 
 
4 68.56 -4.0 -3.9 42.50 -0.60 -1.37 
 
5 61.82 -3.1 -3.6 39.10 +0.50 +0.12 
 
6 88.01 -3.9 -4.2 53.60 -1.70 -3.34 
 
7 67.75 +0.1 0 41.85 -0.85 -0.77 
 
8 71.51 -2.9 -1.4 45.40 -0.50 -0.62 
 
9 67.60 -1.5 -1.4 45.65 -0.55 -1.60 
 
Mean 71.73 -2.8 -2.4 45.62 -0.82 -1.14 
+SD +8.72 +1.4 +1.5 +5.00 +0.75 +1.09 
 
(a) ∆1 = Change from preflight mean to first shipboard measurement at recovery. Body mass waas measured
within several hours of recovery. Body water was measured on first or second day of recovery.
(b) ∆2 = Change from preflight mean to morning of day of recovery (a zero-g state). Total body water changes
estimted by correcting for wtaer intake and excretion between recovery a.m. and first shipboard measurement.
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Table F-27. Components of Energy Balance During Skylab Inflight Phase [kcal/d]
(See footnotes for Table F-26)
Energy Balance 
Component 
 
Crewman 
 
 1 2 3 4 5 6 7 8 9 
 
Total Dieta 2888 3031 2873 2888 2860 3927 3271 3149 3361 
 
Excreta:          
Urineb 132 150 135 111 138 186 152 146 160 
 
Feces 106 107 104 111 131 181 161 102 146 
 
Total Excreta 238 257 239 222 269 367 313 247 306 
 
Body Tissue Loss:          
Proteinc 34 79 60 35 28 28 44 24 2 
 
Fatd,e 178 720 274 348 551 90 -160 48 -26 
 
Total Tissuee 212 798 334 383 579 118 -116 72 -24 
 
Net Energy 
Utilizationf 
2861 3572 2968 3049 3170 3678 2842 2974 3031 
 
Table F-26. Components of Energy Balance During Skylab Preflight Phase [kcal/d]
a) Diet (kcal/day) = 4.182 diet carbohydrates (gm/d) + 9.461 x diet fat (gm/d) + 5.65 x protein (gm/d)
b) Urine energy = 8.32 x urine nitrogen (gm/d)
c) Energy from protein tissue loss = 5.65 kcal/gm
d) Energy from fat tissue lost = 9.461 kcal/gm
e) Minus sign denotes a gain of body tissue
f) Net energy utilization = Diet Excreta + Energy from body tissue lost
Energy Balance 
Component 
 
Crewman 
 
 1 2 3 4 5 6 7 8 9 
 
Total Dieta 2916 3166 3175 2851 2996 4214 3224 3149 3269 
 
Excreta:          
Urineb 106 105 110 93 108 166 116 121 135 
 
Feces 142 158 143 110 125 171 160 146 129 
 
Total Excreta 248 263 253 203 233 337 276 267 264 
 
Body Tissue Loss:          
Proteinc,e -104 -110 -106 -108 -121 -143 -117 -78 -98 
 
Fatd 173 730 632 497 712 260 47 326 866 
 
Total Tissuee 69 620 526 389 591 117 -70 248 768 
 
Net Energy 
Utilizationf 
2737 3523 3448 3037 3354 3994 2878 3130 3773 
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 Days Observed CHO (gm) FAT (gm) PRO (gm) Ediet(kcal)b 
(calculated) 
Ediet (kcal)c 
(bomb) 
 
Crewman Pre Inf Pre Inf Pre Inf Pre Inf Pre Inf Pre Inf 
 
1 30 28 319 376 105 79 105 101 2916 2888 2632 2498 
 
2 30 28 382 402 101 80 108 105 3166 3031 2901 2580 
 
3 30 28 364 394 109 72 110 97 3175 2873 2881 2497 
 
4 20 59 331 426 98 66 95 95 2851 2888 2561 2586 
 
5 20 59 315 368 110 76 112 107 2996 2860 2688 2511 
 
6 20 59 490 565 132 77 163 148 4214 3927 3716 3488 
 
7 26 84 363 398 108 100 121 118 3224 3271 3152 3202 
 
8 26 84 358 395 108 92 113 111 3149 3149 3088 3085 
 
9 26 84 348 385 116 109 127 128 3269 3361 3194 3285 
 
 Skylab Mean 363 412 110 83 117 111 3218 3139 2979 2859 
 +SD 52 60 10 14 19 18 400 349 358 400 
 
Table F-28. Energy Balance Terms Related to Dieta,d
a) CHO = dietary carbohydrates; FAT = dietary fat; PRO = dietary protein
b) EDIET (Calculated) = total energy derived from diet = (4.182)CHO + (9.461) FAT + (5.65) PRO
c) EDIET (Bomb) = total of diet measured by bomb calorimetry. (The number of samples used to obtain EDIET (Bomb) was somewhat less
than that used to compute EDIET (Calculated).
d) Regression coefficients for EDIET (Calc) vs. EDIET (Bomb): r = 0.93 (Preflight), r = 0.91 (Inflight); ratio Inflight/Preflight for EDIET
(Calc) = 0.975, for EDIET (Bomb) = 0.96.
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Table F-29. Energy Available versus Energy Utilized [kcal/day-kg BWGT]
a) Ediet = total energy available from dietary carbohydrates, fats, proteins (calculated)
b) Ediet net = Ediet  – energy in urine and feces
c) Eutil  = energy utilized = Ediet net + energy obtained from protein and fat catabolism.
  Ediet Ediet net Eutil 
 
Mission Subject Pre Inf Pre Inf Pre Inf 
 
28-day 1 46.9 46.4 42.9 42.6 44.0 46.0 
 
 2 40.7 38.9 37.3 35.6 45.2 45.9 
 
 3 39.6 35.8 36.4 32.9 43.0 37.0 
 
 Mean 44.7 40.4 38.9 37.0 44.1 43.0 
 +SD +4.5 +5.5 +3.5 +5.0 +1.1 +5.2 
 
59-day 4 41.6 42.1 38.6 38.9 44.3 44.5 
 
 5 48.5 46.3 44.7 41.9 54.3 51.3 
 
 6 47.9 44.6 44.1 40.5 45.4 41.8 
 
 Mean 46.0 44.3 42.5 40.4 47.6 45.9 
 +SD 3.8 +2.1 +3.4 +1.5 +5.4 +4.9 
 
84-day 7 47.6 48.3 43.5 43.7 42.5 42.0 
 
 8 44.0 44.0 40.3 40.6 43.8 41.6 
 
 9 48.4 49.7 44.5 45.2 55.8 44.8 
 
 Mean 46.7 47.3 44.7 43.2 47.3 42.8 
 +SD +2.3 +3.0 +2.9 +2.3 +7.3 +1.7 
 
Skylab Mean 45.0 44.0 41.4 40.2 46.4 43.9 
 +SD +3.6 +4.5 +3.3 +3.9 +4.9 +4.0 
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Table F-30. Diet, Exercise and Tissue Weight Change Data Used for Regression Analysis*
* These data used in regression analysis of Table 4-25
** Derived from Michel and co-workers [49] by dividing useful bicycle work by 22% efficiency. To compute total exercise performed
over the mission in watt-minute (W-min), multiply value in table for average daily exercise work (kcal/d-dg) by BWGT x 70 W-min/
kcal x 0.22 x N, where N is the number of inflight days in the Skylab Mission.
∆BWGT ∆FAT ∆PRO Subject Caloric Intake 
(kcal/d-kg) 
Average Daily 
Exercise Work    
    (kcal/d-kg)** 
 
(gm/d-kg) 
1 46.4 2.35 -0.632 -0.302 -0.0966 
 
2 38.9 1.35 -1.238 -0.977 -0.179 
 
3 35.8 1.62 -1.426 -0.361 -0.133 
 
4 42.1 3.68 -0.964 -0.537 -0.090 
 
5 46.3 3.83 -0.987 -0.941 -0.0788 
 
6 44.6 4.84 -0.809 -0.108 -0.0572 
 
7 48.2 4.00  0 +0.249 -0.114 
 
8 44.0 5.09 -0.233 -0.071 -0.0594 
 
9 49.7 4.76 -0.247 +0.041 -0.0855 
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Appendix G
Accomplishments and Recommendations
G.1 Accomplishments of the Systems
Analysis Project
The investigative areas will be grouped, for purposes of
summation, into four categories: (a) fluid, electrolyte, and
renal function; (b) cardiovascular function; (c) hematol-
ogy; and, (d) musculoskeletal function and body compo-
sition. The major systems analysis accomplishments for
each area are summarized in Table G-1. The results from these
studies have led to an interpretation of the spaceflight find-
ings that are summarized in Chapter 10. In addition to the
emphasis on interpreting physiological changes during space-
flight, this project has produced a number of accomplish-
ments regarding the technological tools and information
systems which have been indispensable to achieving its
overall goals. These technology accomplishments are de-
scribed in Chapter 3 and summarized in Table 10-1.
G.2 Recommendations for Model and
Simulation Improvements
Throughout this book recommendations have been im-
plicitly or explicitly made for improving the mathemati-
cal models or examining new model applications. For
convenience, these recommendations have been assembled
below. Although the recommendations, for the most part,
are highly summarized, details can be found in the appro-
priate parts of the book.
G.2.1 Recommendations for Guyton Model
G.2.1.1 Areas Identified for Future Model
Improvements
a) Develop a capability for simulating acid-base balance.
This would involve modification of the renal sytem,
the buffering system, and the respiratory system.
b) Formulation of upper body circulatory elements rep-
resenting collapsed veins in modified Guyton model.
c) Validate Guyton model for LBNP simulation.
d) Develop an advanced renal subsystem model includ-
ing peritubular capillary effects, third factor effects,
factors influencing intrarenal blood flow, and the ef-
fect of calcium on electrolyte excretion.
e) Hormonal regulation should be updated to reflect cur-
rent knowledge, especially with regard to multiple
and competitive influences, and identification of the
different mechanisms which dominate short-term vs.
long-term control.
f) Experimental measurements of hormone levels are  of-
ten obtained from urine samples. Existing models have
the capability only of predicting plasma concentrations
to hormones. It is recommended that a study be con-
ducted to determine feasibility of adding hormone
renal excretion capability to existing models.
g) Develop a new upright reference position for the model
in addition to its present supine reference.
h) Test a more natural means of simulating weightless-
ness by starting with an upright reference control po-
sition and then removing the gravity effects from the
reference model.
G.2.1.2 Recommendations for Additional
Simulation Studies
a) Now that a reasonable simulation of spaceflight has
been accomplished, it is important to make a detailed
analysis of the mechanisms that control specific re-
sponses. In most cases, redundant feedback pathways
exist. Determine which pathways predominate.
b) Determine the basic differences between simulations
of bedrest, immersion, head-down tilt and spaceflight.
What is the appropriate model stimulus for each of
these conditions?
c) Use models to create and evaluate circulatory indices
of performance, both inflight and postflight. These
algorithms should provide a simple measure of circu-
latory status.
d) The new leg compartments of the modified Guyton
model require additional validation studies, especially
for characterization of resistance elements, capaci-
tance elements and capillary exchange.
G.2.1.3 Recommendations for an Improved Simu-
lation of Postural Studies. The ability to simulate pos-
tural maneuvers, both head-up and head-down, has proved
to be a complex endeavor. Chapters 9.3.2, 9.6.3 and Ap-
pendix C.1 have described the model modifications that
provided basic structural and mechanistic capabilities to
respond to the gravitational vector. Appendix C.2 delin-
eated a set of recommendations for an improved orthos-
tatic model. Here we would like to mention several other
recommendations for improving the head-down tilt simu-
lation and, by extension, spaceflight simulation.
a) Addition of a Head Compartment. The model at
present does not contain a separate vascular compart-
ment above the heart level and does not exhibit col-
lapsed veins in the erect posture, nor refilling and
fluid storage during hypogravity and anti-orthostasis.
Reports from astronauts typically include symptoms
of head fullness, head tissue puffiness and neck vein
distention during prolonged hypogravity. Thus, the
model may have to be altered in some manner to re-
produce these effects. The most feasible approach is
the addition of collapsible veins in a separate
cephaled compartment.
b) Improved Resistance to Flow in Legs. The leg
resistance elements (both pre- and post-capillary) are
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Table G-1. Accomplishments of Systems Analysis Study
Fluid-Electrolyte Regulation
· Modification of the Guyton model (circulatory, fluid and electrolyte regulation) to include gravity-dependent elements, leg compart-
ments, and improvements in the erythropoietic, renal, autonomic and renin-angiotensin subsystems
· Validation of the modified Guyton model for fluid-loading, hemorrhage, and postural-change studies
· Simulation analysis of the fluid-electrolyte response to hypogravic studies including water immersion, head-down tilt, bedrest, and
spaceflight
· Analysis of evaporative water loss in the hypobaric, reduced-convective-flow environment of Skylab using metabolic balance
analysis and the modified Stolwijk thermoregulatory model
· Metabolic balance analysis of water, sodium, potassium, calcium, nitrogen, and magnesium including Skylab nine-man composite
summaries of dietary intake, renal excretion, and sweat losses
· Composite time profiles of the nine-man Skylab mean responses for plasma and urinary electrolytes, hormones, and total body
changes in water, sodium, and potassium
· Analysis of fluid-electrolyte regulatory feedback mechanisms involved in acute and long-term responses to weightlessness
· Interpretation of all Skylab data related to disturbances in body fluid volumes and their composition including a description of the
fluid-electrolyte status of the Skylab crewman and an integrated hypothesis to explain the behavior of renal-regulating hormones
· Major support of bedrest and Spacelab flight experiment proposals
Cardiovascular Regulation
· Development of a new pulsatile cardiovascular system model
· Validation of cardiovascular model for exercise, tilt, lower body negative pressure (LBNP) in one-g, and centrifugation.
· Modification of the pulsatile model to include elements responsive to hypoxia and hypercapnia
· Modification of the respiratory model of Grodins to include the capability to respond to exercise
· Simulations of the exercise response using the combined thermoregulatory, respiratory, and cardiovascular subsystem models of the
whole-body algorithm
· Simulation analysis of spaceflight LBNP and postflight exercise (supine and sitting) using the pulsatile model
· Simulation of disturbances in the circulatory system during short-term water immersion and head-down tilt and long-term bedrest
and spaceflight using the modified Guyton model and the whole-body algorithm
· Composite time profiles of the nine-man Skylab mean responses to LBNP
· Sensitivity analyses for effects of blood loss and venous compliance changes on tilt and LBNP responses
· Analysis to examine possible changes in inflight baroreceptor sensitivity
· Analysis of mechanical and metabolic efficiencies and other performance indices during bicycle ergometry flight experiments
· Modification of the pulsatile cardiovascular model to include physical training (conditioning) effects and evaluation of these
hypotheses against Skylab exercise data
· Formulation and evaluation of hypotheses to account for decreased orthostatic tolerance and decreased aerobic capacity during
inflight and postflight phases
· Analysis of cardiovascular response during the high-g of Shuttle reentry with reduced blood volume including identifying thresh-
olds for visual grayout
· Utilization of models to develop countermeasures for orthostatic intolerance during and after Shuttle reentry including fluid loading
and leg pressure garments
· Support of flight experiment proposal for advanced cardiopulmonary studies
Hematology
· Development of new models for control of erythropoiesis in the human and the mouse
· Simulation analysis of hematological responses to altitude hypoxia and descent, red cell infusions, bedrest, water-restricted dehy-
dration, and spaceflight
· Collaboration in a research program that examined suppressed erythropoiesis in dehydrated mice
· Analysis of all spaceflight and ground-based studies related to loss of red cell mass during hypogravity
· Formulation and tentative evaluation of candidate hypotheses to explain the “anemia” of spaceflight with particular emphasis on
explaining the differences in red cell loss among crewmen
· Simulations of clinical syndromes (anemias, polycythemias, and Hb abnormalities) and partial development of a teaching model of
erythropoiesis regulation
· Support of a Shuttle Spacelab experiment by predicting expected results, critical measurements, frequency of measurements, and
effect of blood sampling on the hematological response to microgravity.
Musculoskeletal System and Body Composition
· Metabolic mass, water and energy balance analyses including a new method for estimating cumulative total body changes (water,
fat, protein, electrolytes) as a function of flight duration
· Analysis of body composition changes (lean body mass and fat) based on body water, body potassium, nitrogen-potassium balance,
and body density data
· Analysis of inflight requirements for exercise and diet
· Interpretation of components of body weight loss based on fluid and energy regulation and gravity unloading
· Design and development of a new model for calcium regulation, including validation studies of bedrest and spaceflight
· Support of a flight experiment proposal for advanced calcium regulation studies
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presently modeled in a similar fashion as the upper
body. They both account for passive distention and
collapse, autonomic influence, angiotensin, vasocon-
striction, and viscosity effects. However, there are
undoubtedly some fundamental differences between
the lower and upper body resistance capacitance and
capillary elements. Mechanisms which are currently
under consideration for inclusion in the lower extrem-
ity elements include those due to: a) locally produced
vasoconstriction (myogenic), b) enhanced autonomic
effects, and c) chemical effects (i.e., catecholemines).
c) Improved Model of Collapsible Veins. Rather than
model the veins according to the linearization of the
compliance curve shown in Fig. 9-32, an alternative
approach is to allow the veins to completely collapse
at any point where transmural pressure approaches
zero. This produces a “waterfall” effect where flow is
independent of pressure drop. When pressure falls to
zero, the resulting cessation of flow causes pressure to
rise and the vessel reopens. This approach would likely
resolve some current problems encountered with the
model at the more extreme tilt angles and improve its
stability.
d) Differentiation of Transcapillary Filtration. Simu-
lations that are more realistic can be achieved by im-
proving the description of the differential behavior of
upper and lower body capillary filtration and the fac-
tors which influence this process. We believe that cap-
illary beds in the legs are especially suited to with-
stand elevated hydrostatic loads and the model should
reflect this notion.
G.2.2 Erythropoiesis Regulatory Model
G.2.2.1 Improvements in Model Design. Many fac-
tors have been discussed that are known to affect erythro-
poiesis, but have not been included in the proposed model.
This study has resulted in several specific recommenda-
tions for improvements in the model and suggestions for
related models.
a) The current model does not include a description of
the kinetics of stem cell differentiation in the bone
marrow. Such a description would represent the red
cell proliferation and maturation cycle from multipo-
tential cells to denucleated red cells. The model, thus
modified, would be able to predict the reticulocyte
index and have an improved characteristics of the bone
marrow transit delay, among other benefits.
b) The current model does not include extrarenal erythro-
poietin production or extramedullary erythropoiesis.
c) The model should have an updated description of the
renal sensor site(s), including the determination of
oxygen tension and factors effecting erythropoietin
productIon.
d) The kinetics of erythropoietin formation should in-
clude descriptions of “pro-Ep-plasma factors” and “Ep
inhibitors”.
e) Account for the effect of certain factors on erythro-
poietin that are not included in the current model,
such as iron levels, hormones other than erythropoi-
etin (i.e., growth hormone), and neural stimulation, as
well as inhibitors and activators of erythropoietin.
f) The effects of blood viscosity and blood volume
changes on blood flow and tissue oxygenation should
be added to the model.
g) Other factors that control oxygen transport are only
currently included as fixed parameters. They could be
added as variable elements. These factors include blood
flow, capillary diffusivity, arterial oxygen tension,
plasma volume, and oxygen-hemoglobin affinity.
h) Include an explicit representation of the DPG effect
on oxyhemoglobin affinity; consider implementing a
self-regulating mechanism perhaps based on levels of
tissue oxygenation
G.2.2.2 Simulation Studies with Improved Model
a) Sensitivity analysis with parametric variation study
of improved model
b) Characterization of bedrest response as a function of
different plasma volume time profiles and red cell de-
struction rates
c) Reexamination of spaceflight data in light of model
improvements and bedrest validation study.
G.2.2.3 Design and Develop Related Models
a) Teaching model for hematological abnormalities
b) Species-specific animal models for predicting results
and integrating data for ground-based and Shuttle ani-
mal experiments
c) Ferrokinetic models for iron uptake studies
G.2.3 Cardiovascular Model (LBNP and Exercise)
A number of recommendations for improvements in the
short-term cardiovascular model were suggested by the simu-
lations of LBNP and exercise discussed in Chapter 7.
a) If the model is to be used for real-time simulations
longer than a half hour it needs a more adequate rep-
resentation of longer-term mechanisms including tis-
sue filtration, hormonal regulation, baroreceptors ad-
aptation and delayed vessel compliance (stress relax-
ation and reverse stress relaxation).
b) The current model has a neural component that uses a
single autonomic signal for controlling flow resis-
tances, compartmental compliances, and cardiac con-
tractions. This signal combines the effects of sympa-
thetic and parasympathetic neural control. A superior
model can be achieved by developing a dual auto-
nomic controller containing separate elements for
these functions.
c) The current model is limited to the submaximal range
of exercise. To enable the capability for maximal oxy-
gen uptake tests, suggestions have been raised to im-
prove cardiac reserve or cardiac filling representations
in the model. Other areas should be examined that
control arterial pressure and heart rate at intense lev-
els of exercise.
d) The model should be adapted to differentiate between
levels of physical conditioning; i.e., to individualize
the model.
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e) A more specific type of individualization is the no-
tion that male and females responses to orthostatic
intolerance are thought to be quite different after
spaceflight. The model should be individualized for
these simulations based on gender.
f) An explicit representation of chemoreceptor stimula-
tion should be included to enable the model to re-
spond to changes in the content of inspired gases dur-
ing exercise.
g) Representation of whole leg compliance (as opposed
to leg venous compliance) should be included in the
model for comparison with gross leg compliance mea-
surements during LBNP. Also, there is a need for in-
troducing non-linear compliances for the leg veins
modeled after the upper body veins.
G.2.4 Calcium Regulatory Model
The model of calcium regulation did not reach the
same level of maturity in development and application as
the other math models in our repertoire. On the other hand
in the years since Skylab, the problem of calcium dem-
ineralization in space has assumed a much higher research
priority. The initial effort should be to reproduce the best
model currently published (see Chapter 8) and then to
validate the various sections.
a) Update the current NASA model to include all the
features of the most recent model by Jaros and co-
workers [Jaros GG, Guyton AC, Coleman TG, Ann.
Biomed. Eng., 8:103-141, 1980].
b) Modify the renal and intestinal subsystems so that
they are able to reproduce the excreta findings from
prolonged bedrest and spaceflight.
c) Modify the hormonal regulation subsystems so that
the behavior of the calcitropic hormones are in agree-
ment with published data for a variety of stresses in-
cluding bedrest.
d) Include in the model a description of bone regulatory
forces that control mineralization such as piezoelec-
tric and mechanical stresses.
e) The model will eventually need to include a much
improved skeletal subsystem that is representative of
the osteoblastic and osteoclastic processes.
f) Application of the model should be directed toward
the identification, development and design of coun-
termeasures for ameliorating bone demineralization
in spaceflight.
G.2.5 Whole-Body Algorithm (WBA)
G.2.5.1 General Recommendations. Some important
general recommendations include the following:
a) Top-Down Design Approach. As discussed in Chap-
ter 10, there was general agreement that an advanced
version of the Whole-Body Algorithm should be de-
signed as a single integrated system, using a  top-
down. approach. Such an approach would have the
following characteristics: a) a unified programming
language, b) a standard set of input-output specifica-
tions, c) a standard set of acceptable numerical inte-
gration methods, d) a unified documentation method,
e) a minimum of redundancy, g) the ability to develop
the subsystems independently, knowing that the final
products will be compatible, and h) a strongly coupled
set of unique subsystems. This is a more logical, real-
istic and natural approach.
A top down approach would eliminate the defi-
ciencies in the current model of having multiple auto-
nomic nervous systems or circulatory systems. An-
other problem with the current version is the weakly
linked artificial boundary between “short-term sub-
systems” and “long-term subsystems”. Thus, it is not
realistic at present to simulate exercise for more than
30 minutes because the hormonal changes, stress re-
laxation changes, and autoregulation functions a      re
not present in the short-term models.
Figure 2-2 illustrates one approach that incorpo-
rates both horizontal integration (different subsystems
linked in parallel fashion) and vertical integration (a
hierarchy of biochemical, cellular, tissue, and organ
function). The organism level is the top link in the
hierarchy; organs are connected to each other wherein
each organ is assigned 5 layers – organ system, organ,
tissue, cellular, biochemical. New versions of mod-
ules can be designed and substituted with a minimum
of interfacing difficulties.
b) Need for a Common Control Center. The real
physiological system is composed of many regulat-
ing systems with a common control center (the central
autonomic nervous system) and with many common-
alities in the basic controlled system (similar fluid
compartments, blood pathways, etc.). In contrast, the
integration of several self-contained models results
in different control centers and different descriptions
of the controlled system. An advanced top-down ap-
proach should lead to a model that is much more like
the real system. Unfortunately, the experimental ob-
servations upon which an advanced neural and bio-
chemical control system must be designed, are scarce
and in many cases, non-existent. Thus, new experi-
ments must be designed and additional information
must be collected before there is a solid basis with
which to pursue such a unified control center. Ex-
amples of the deficiencies in the current WBA include
lack of discrimination between sympathetic and para-
sympathetic control, lack of a lung stretch receptor
reflex; lack of connection between autonomics and
catecholamine release.
c) Validation Database Required. Validating a large-
scale system model such as the Whole-Body Algo-
rithm (or its advanced successor) requires a physiologi-
cal database that is as equally detailed and integrated.
However, it was found that much of the needed data
was lacking. One of the limitations of developing this
type of model was in finding data sets that stretched
across disciplinary boundaries so that a number of
model subsystems could be validated at the same time,
for the same stress, using data obtained from the same
laboratory. It is interesting to note that some of the
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most valuable data for validating the Whole-Body
Algorithm came from laboratories engaged in both
physiological research and modeling. Thus, this
project has provided additional support for advocat-
ing a continuing interdisciplinary research program
concerned with measuring whole-body responses to
combinations of environmental and metabolic distur-
bances. Once a large-scale model is validated it should
be capable of integrating large quantities of data such
as that available for Skylab. There are admittedly few
scientific projects in which such grandiose multi-dis-
ciplinary data collection occurs, but for those occa-
sions, large-scale models become a significant tool
for data analysis and interpretation.
d) Central Repository Concept. An advanced “digital
human” would require the collaboration of researchers
in many laboratories over a wide geographic area. A
nationwide time-sharing system would allow
contributors to afix their subsystem models into the
larger model. A central committee of experts would
administer the system, select the best models of each
type for inclusion in the system, establish standards for
programming language and interfaces, prepare
documentation, and approve modifications. This
approach would function as a central repository and
communication system and could evolve into an
important national resource contributing to the
development and application of physiological modeling.
e) Test the Full Capability of the Existing Model.
The WBA, as developed in this project, is very versa-
tile, capable of simulating many different conditions.
Limited resources permitted the examination of only
a few specific conditions, all related to spaceflight.
Thus, we did not address the many possibilities for
other important applications. Thus, even before de-
veloping a more advanced model, it may be useful to
put the current model to more complete use. For ex-
ample, the three short-term models of the WBA could
operate independently of the long-term model. This
short-term group was a significant accomplishment in
itself especially for its ability to simulate such com-
mon conditions as the exercise response, or exercise
combined with an environmental stress as hypoxia.
Each of these three short-term subsystem models (ther-
moregulatory, circulatory, and respiratory) were origi-
nally designed to simulate exercise, but the capabili-
ties for responding to combined stresses have never
been thoroughly investigated.
f) Individualized Models. The eventual goal of these
systems analysis efforts is to provide a capability to
predict normal responses for individual subjects in
the spaceflight environment. Thus, the models,
including the WBA, could be “tuned” for each
individual crewmember.
G.2.5.2 Specific Recommendations for More
Advanced Studies with the WBA
a) Improve and integrate the autonomic control system
for both the cardiovascular and repiratory subsystems.
This is particularly needed for central and local inte-
grated autonomic control for all stresses with the same
formulation or representation. Better discrimination
between sympathetic and parasympathetic control,
lung stretch receptor reflex, autonomic control affect-
ing catecholamine release from the adrenal medulla,
different representation of similar controllers in each
subsystem, and resetting or sensitivity changes in re-
ceptors and control centers are other areas which need
investigation.
b) Improve definition of the long-term/short-term inter-
face and improvements in the cardiovascular sub-
system are needed to better simulate the gray area be-
tween short-term and long-term changes (particularly
around one hour of simulated time). This is particu-
larly needed to simulate the plasma filtration, stress
relaxation changes, autoregulation, and many hor-
monal changes which do occur following many short
term stresses (such as head-up tilt in 1-g).
c) Improve representation and/or validation of long-term
adaptation/acclimatization (particularly since this is
an area of interest in spaceflight) to long-term stress.
Examples of long-term stresses that could be exam-
ined with complex integrated models include the long-
term effects of thermal stess, hypoxia, and exercise.
Data from people living in hot and cold climates and
at high altitudes may provide a starting place for such
study. Very little modeling activity has been con-
ducted for these purposes.
d) Improve respiratory-thermoregulatory subsystem in-
terface (other than through the cardiovascular sub-
system) to improve simulation of respiratory heat
losses and thermal influences on respiratory control.
e) Improve the flexibility for simulating different popu-
lation responses to stress such as the effect of train-
ing/conditioning, age, and gender.
f) Continue validation, particularly in the areas of tran-
sient responses (both on and off) to exercise and ther-
mal stress and multiple stresses for which data are
available. Examples of some of the combined short-
term stresses to which the WBA could be fruitfully
applied includes: a) exercise + hypoxia, b) exercise +
hypercapnia, c) exercise + thermal, d) exercise + de-
hydration, e) tilt + hypoxia, f) tilt + thermal stress, g)
hypoxia + hypercapnia, h) exercise + hypoxia + ther-
mal stress. Further testing of bedrest hypotheses is
also needed.
g) Changes in evaporative water loss have long-term ef-
fects on renal excretion. Validate the thermoregula-
tory model for spaceflight evaporative water loss and
utilize Whole-Body Algorithm to pass this informa-
tion to long-term model subsystem.
h) The addition of vestibular and musculoskeletal sub-
systems to an advanced whole-body model should be
considered. After a long-term spaceflight, stresses such
as orthostatic intolerance is not only a result of circu-
latory problems, but muscular and vestibular activity
as well. This would provide the capability, not present
in the current version, of altering otiolith/propriocep-
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tor function or tissue loading functions.
i) The degradation of hard tissues is not currently being
considered in the WBA. The accompanying loss of
calcium is a disturbing problem for long-term space-
flight. Excess calcium in the body fluids also pro-
duces alterations in hormone levels and renal func-
tion. These effects should be accounted for in more
advanced models.
It appears from the foregoing that this development of
a whole-body algorithm is not complete and probably
never will be complete. It is, however, a very good begin-
ning and this study has not only produced a very useful
tool, but has pointed the way for future work in this area.
G.3 Recommendations for Experimental
Studies
The ultimate value of a model lies in the degree to which
understanding of the system under study is enhanced.
However, any worthwhile scientific endeavor should not
only answer questions, but to suggest new ones. Thus, a
number of testable hypotheses were formulated during the
modeling process. All these items are legitimate research
issues suitable for experimental study. Some have been
addressed by others in varying levels of detail. In many
cases, the model has provided a scientific rationale for an
alternative hypothesis.
G.3.1 Fluid-Electrolyte and Circulatory Regulation
a) Regarding fluids shifted headward during hypogravic
stress:
i. does excess fluid remain in the upper body through-
out prolonged zero-g stress?;
ii. is this fluid stored primarily in circulatory com-
partments or do extravascular spaces accept a sig-
nificant portion?;
iii. does cephaled fluid shifts merely fill previously
collapsed veins in head and neck or does the volume
increase beyond the zone of free distensibility?;
iv. how much storage volume does this represent?;
v. does central hypervolemia return to normal dur-
ing prolonged periods of spaceflight as predicted
by the model or does it persist as suggested by
water immersion experiments.
b) During one-g postural change, what is the extent of
fluid movement between plasma and interstitium? Is
there a significant amount of plasma refilling during
standing due to reabsorption from the upper body’s
interstitial reservoir?
c) What is the origin of fluids which disappear from legs
during first several days after launch (i. e., blood, in-
terstitial, intracellular). Also, why is the amount of
fluid shifted from legs during weightlessness so much
greater than that associated with postural changes in
one-g?
d) Recent experiments onboard Spacelab failed to re-
veal a diuresis. There may still be an issue regarding
the voluntary withholding of fluids by astronauts the
first day of flight as well as confounding influences of
reclining for long-wait periods on the launch pad. The
model suggests that a zero-g diuresis and natriuresis
cannot be entirely suppressed.A definitive test for a
diuresis may have to await the availability of a human
centrifuge aboard Space Station. This would allow a
subject to adjust to 1-g and then suddenly be exposed
to microgravity.
e) Test the hypothesis, predicted by the model, that nor-
mally hydrated subjects in spaceflight will exhibit a
normal diuresis when challenged by a fluid load. This
study should be conducted well after the initial onset
of weightlessness and with a statistically significant
population.
f) One explanation for the fall in plasma volume during
the onset of hypogravity, in the absence of a diuresis,
is that transcapillary filtration increases and causes
an equivalent loss of plasma volume. The model sup-
ports this possibility but suggests that the effects are
transitory, and that interstitial fluid will eventually
return to normal. Lymph flow and plasma colloidal
oncotic pressure are factors to consider in this nor-
malization. Verify the details of transcapillary filtra-
tion during spaceflight, including the possibility of
increased protein permeability, as suggested by the
model.  Also, one should attempt todifferentiate be-
tween the tr anscapilla ry Starling forces in the legs
and above the heart during hypogravity maneuvers.
g) What is the etiology of hyponatremia and its effect on
fluid-electrolyte regulating hormones. What is the
contribution of natriuretic hormone in producing hy-
ponatremia and in opposing aldosterone’s effect on
sodium excretion.
h) Confirm the analysis which predicts reduced evapo-
rative water and sweat electrolyte losses
(hidromieosis) during prolonged spaceflight.
i) Confirm the model predictions of the effect of potas-
sium release from cells as a factor controlling aldos-
terone.
j) What are the long-term adaptive mechanisms that are
involved in circulatory and renal adaptation to pro-
longed spaceflight? That is, measurements are needed
of central venous pressure, cardiac output, leg blood
flow, renal flow, glomerular filtration rate, etc.
k) Additional inflight data is necessary during the first
several hours following launch. Particular data that is
required includes: urine flow; hematocrit; plasma elec-
trolytes; levels of aldosterone, ADH, and angiotensin;
fluid and electrolyte intake; sweat components; and
circulatory indices.
l) Test the hypothesis, predicted by the model, that the
renal-regulation hormones, angiotensin, aldosterone
and ADH, are governed early in flight by pressure-
volume regulating factors and later in flight by plasma
electrolyte regulation.
m) Conduct a meaningful assessment of renal function
in microgravity using renal stress tests in humans (fluid
loading, salt loading, dehydration) and animals
(glomerular and tubular dynamics using micropunc-
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ture techniques).
n) Carefully controlled experiments are required to study
metabolic rates, energy utilization, and thermoregu-
lation (i.e., evaporative water loss), during prolonged
spaceflight.
G.3.2 Cardiovascular
a) There is currently an inadequate description of the
circulatory mechanisms that accommodate redistrib-
uted blood volume over prolonged periods of weight-
lessness. These processes include venous stress relax-
ation and reverse stress relaxation, vascularization and
devascularization, baroreceptors and volume recep-
tor adaptation, and autoregulation of blood flow.
b) The contribution of venous sympathetic activity to cir-
culatory disturbances during spaceflight and recovery,
at rest and during orthostasis, needs to be elucidated.
c) No hypothesis for the resting tachycardia of space-
flight has been proposed and our studies have failed
to provide additional insight into its etiology.
d) The model has predicted a fall in venous pressure upon
entering weightessness is related to an increase in pe-
ripheral resistance. Determine the consequences of the
known increases of angiotensin during bedrest and
spaceflight on peripheral resistance. Is this a factor in
the decline of venous pressure, or are there other
causes?
e) The effects of physical conditioning on orthostatic in-
tolerance and exercise performance during and follow-
ing spaceflight needs to be confirmed and documented.
f) There does not appear to be adequate data describing
how simple blood volume loss uncomplicated by
weightlessness or similar conditions can modify the
normal circulatory response to centrifugation. Such
data would be highly useful to separate the effects of
blood volume loss from other aspects of cardiovascu-
lar deconditioning.
g) Several additional hypotheses remain to be tested in
an effort to obtain a more complete picture of the
LBNP response during spaceflight and recovery.
i. The influence of the slow adjustment of the circu-
latory capacity to a reduced blood volume (re-
verse stress relaxation). This hypothesis could
help explain the increased stability of cardiovas-
cular response to orthostatic testing.
ii. The influence of sympathetic tone which may be
decreased early inflight and increased upon re-
covery.
iii. Postulated changes in baroreceptor activity which
may occur in the immediate postflight period.
iv. The influence of fluid stored in the upper body
(originally derived from leg fluid) during zero-g
which may be available during LBNP stress.
G.3.3 Erythropoiesis Regulation
a) Earth-based human studies showing the effects of ex-
ercise training on indices of erythropoiesis (i.e., red
cell production, erythropoietin, iron uptake, stem cell
distribution, reticulocytosis) are needed to help inter-
pret the red cell response on Skylab. Red cell mass
appears to exhibit less of a decrement for crew who
exercised the most.
b) Earth based human studies showing the effects of nega-
tive caloric balance on the mechanisms of erythro-
poiesis are needed to help explain the effect of space
motion sickness-induced anorexia on erythropoietin.
c) Determine the acute decrease in red cell mass during
the first few days of spaceflight. Is this decrement ex-
plicable from the reduction in red cell production or
is their a destructive element involved (i.e., shortened
life span)?
d) Determine whether changes in P50 during bedrest and
spaceflight has an effect on red cell production.
e) Demonstrate whether or not changes in renal blood
flow occur during bedrest or spaceflight and if it has
an effect on red cell production.
G.3.4  Musculoskeletal Adaptation
a) Demonstrate that the prevention of muscle atrophy
will also lead to the prevention or retardation of bone
losses.
b) Characterize bone strains and loading patterns at clini-
cally relevant sites in humans during specific types of
movement and exercise in one-g.   This information
can be used to engineer the types of devices needed to
provide representative one-g loads during spaceflight.
G.4 Data Utilization:
Privacy Considerations
This project would have been nearly impossible to con-
duct if the data privacy policy that is currently in force
was effective in the Skylab era. Federal guidelines, used
by NASA’s astronauts, prohibit the release of individual
data to the general scientific community (even if coded
without identifiers) if the data can be associated with a
specific research subject. On a mission with only 3 astro-
nauts (as was the case in Skylab) it would be impossible to
shield the identity of the subject by merely using subject
codes. Most of NASA’s missions have few subjects, and
thus, unless the individual data can be averaged with those
from many missions (risking data degradation because each
mission is different from another) the data cannot legally
be used except by the principal investigator. NASA will
not permit this data to be released. Average data is cer-
tainly not as powerful as the use of individual responses,
as was demonstrated in the current project. There should
be no need to remind the reader how expensive it is in
time, resources and in human life, to collect space-based
data. Thus, an extremely important recommendation is to
modify the data sharing guidelines pertaining to human
scientific astronaut-subjects to allow appropriate data
analysis by third parties to occur and to permit the use of
individual-subject data.
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